GO,Function,Proteins,Gene Name,Ontology group,Count of protein,Number of proteins detected within the genome,GO frequency within the dataset (%),GO frequency within the genome (%),P-Value,P-Values_BH
GO:0005737,cytoplasm,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)E1BBN5(Evidence code:IBA/Database source:PANTHER:PTN001197468)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)E1BN72(Evidence code:IBA/Database source:PANTHER:PTN000678822)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622075)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MKY9(Evidence code:IBA/Database source:PANTHER:PTN000366978)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)Q3ZBJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433338)A2VDU1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E9L2(Evidence code:ISS/Database source:UniProtKB:O60477)E1B937(Evidence code:IEA/Database source:InterPro:IPR003732)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BER6(Evidence code:IEA/Database source:InterPro:IPR011778)Q3T178(Evidence code:ISS/Database source:UniProtKB:Q9UK41)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q2KJC8(Evidence code:IBA/Database source:PANTHER:PTN000054102)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR005937)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR005937)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T148(Evidence code:IEA/Database source:InterPro:IPR027528)P00435(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)A5PJL3(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MQ57(Evidence code:IBA/Database source:PANTHER:PTN000022759)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0IIA3(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)Q3MHF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KJA1(Evidence code:IEA/Database source:InterPro:IPR004148)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001482048)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)P84798(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BQ04(Evidence code:IBA/Database source:PANTHER:PTN000344873)E1BIX3(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9XTA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:Q15735|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q6VNB8|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR030703)F2Z4K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q09139(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9TTK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)A6H767(Evidence code:ISS/Database source:UniProtKB:P28656)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)E1BMI4(Evidence code:IBA/Database source:PANTHER:PTN000041126)G5E526(Evidence code:IEA/Database source:UniProtKB:Q93096|ens)E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)G3X793(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q8NDG6|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VCN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZC42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MBM5(Evidence code:IEA/Database source:UniProtKB:Q9ER41|ens)A3KMV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5D7P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q3SWY3(Evidence code:ISS/Database source:UniProtKB:P12268)A7Z045(Evidence code:IEA/Database source:UniProtKB:Q96KN1|ens)Q28007(Evidence code:IEA/Database source:InterPro:IPR005720)Q5E9Y6(Evidence code:IEA/Database source:InterPro:IPR004097)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)F1ME41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7YY57(Evidence code:IEA/Database source:UniProtKB:Q52LW3|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q5SXA9|ens)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E9K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2HJJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VD53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A0JN39(Evidence code:IEA/Database source:InterPro:IPR016460)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)E1B9H1(Evidence code:IEA/Database source:UniProtKB:Q99JR5|ens)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N6V1(Evidence code:IEA/Database source:UniProtKB:O43182|ens)A5PK65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MWD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)F1MXQ5(Evidence code:IBA/Database source:PANTHER:PTN000021568)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)E1BPZ4(Evidence code:IBA/Database source:PANTHER:PTN000395915)A7Z052(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QLG1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)P61283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5E9D5(Evidence code:ISS/Database source:UniProtKB:Q9R0P5)A4IFC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FV74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2T9S0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)P61356(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)A6QP29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q17QL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN001016925)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0Z7(Evidence code:IEA/Database source:UniProtKB:P09417|ens)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)F1MT13(Evidence code:IEA/Database source:UniProtKB:O15018|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)Q2NKY7(Evidence code:ISS/Database source:UniProtKB:Q9DE33)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)A7YY70(Evidence code:IBA/Database source:PANTHER:PTN000000493)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A6QLY4(Evidence code:IBA/Database source:PANTHER:PTN001797383)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P11064(Evidence code:IEA/Database source:InterPro:IPR002115)Q59A32(Evidence code:IEA/Database source:InterPro:IPR004733)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)Q17QQ3(Evidence code:ISS/Database source:UniProtKB:P60879)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)O46415(Evidence code:IBA/Database source:PANTHER:PTN000153092)A4IFC4(Evidence code:IBA/Database source:PANTHER:PTN001744534)E1BFE6(Evidence code:ISS/Database source:UniProtKB:Q9Z2C4)P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SZJ9(Evidence code:IEA/Database source:InterPro:IPR005002)Q1JPG7(Evidence code:IBA/Database source:PANTHER:PTN000212670)O02811(Evidence code:ISS/Database source:UniProtKB:P42356)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR005937)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9Z2J0)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens)E1BP38(Evidence code:IEA/Database source:UniProtKB:Q6GYP7|ens)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)P68107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A2VDS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8CJF7|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)P81948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000225966)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BB00(Evidence code:IEA/Database source:UniProtKB:Q8WXI3|ens)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N1X8(Evidence code:IBA/Database source:PANTHER:PTN000629506)A2VDK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08DI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:Q8BGX0|ens)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2HJB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2HJ86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)E1BPM0(Evidence code:IBA/Database source:PANTHER:PTN000022879)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925)F6PW02(Evidence code:IEA/Database source:GO:0006888)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)Q0VCK2(Evidence code:IBA/Database source:PANTHER:PTN000395870)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q1JP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)E1BJP2(Evidence code:IBA/Database source:PANTHER:PTN000571279)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MX23(Evidence code:IEA/Database source:InterPro:IPR004148)Q3SZI0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)O62768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32L99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR036695)F1N6C1(Evidence code:IBA/Database source:PANTHER:PTN001147562)F1MMT3(Evidence code:IEA/Database source:UniProtKB:O75970|ens)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MM21(Evidence code:IBA/Database source:PANTHER:PTN000090250)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QQ21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BCH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)Q0VC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N2E4(Evidence code:IEA/Database source:UniProtKB:P59900|ens)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q27971(Evidence code:ISS/Database source:UniProtKB:Q07009)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BNB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR014758)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)E1BIA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR002301)Q3T0R1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A1A4J1(Evidence code:IEA/Database source:InterPro:IPR009161)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1B719(Evidence code:IBA/Database source:PANTHER:PTN001506277)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000451|I)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q5EA61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6H7B5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BMC0(Evidence code:IBA/Database source:PANTHER:PTN000015249)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MX60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MJP2(Evidence code:IBA/Database source:PANTHER:PTN000341955)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32KW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MQD1(Evidence code:IBA/Database source:PANTHER:PTN000021568)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR002315)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR002318|I)P02638(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q32LM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)E1BCW1(Evidence code:IBA/Database source:PANTHER:PTN000486924)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)A5D980(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR005937)A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZBL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR002318|I)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A6QLE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A8E4N3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QLG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A8E641(Evidence code:IEA/Database source:InterPro:IPR011778|I)P02694(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A8E657(Evidence code:IBA/Database source:PANTHER:PTN000875283)Q2NKZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BFJ4(Evidence code:IEA/Database source:UniProtKB:Q99MV7|ens)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q9Y6Z7|ens)E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens)G3X6L5(Evidence code:IEA/Database source:UniProtKB:Q96BM9|ens)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000924|I)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q2YDJ9(Evidence code:ISS/Database source:UniProtKB:Q9Y5P6)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0N5(Evidence code:IBA/Database source:PANTHER:PTN000622075)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)E1B953(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BMN0(Evidence code:IBA/Database source:PANTHER:PTN000066595)E1BMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314)Q58DC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q28046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR009161)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0E0(Evidence code:IBA/Database source:PANTHER:PTN000517250)Q5E9B7(Evidence code:ISS/Database source:UniProtKB:O00299)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)Q2YDE9(Evidence code:ISS/Database source:UniProtKB:P47226)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1)Q0IIM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BE13(Evidence code:IBA/Database source:PANTHER:PTN000005165)P62964(Evidence code:IEA/Database source:InterPro:IPR031279)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)F1MTH3(Evidence code:IEA/Database source:UniProtKB:Q6ZPF3|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)Q5E953(Evidence code:IBA/Database source:PANTHER:PTN000308898)F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FUD0(Evidence code:IBA/Database source:PANTHER:PTN001598237)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q0VCX5(Evidence code:IEA/Database source:InterPro:IPR004403)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P61211)F1N2I0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)F1MLE1(Evidence code:IEA/Database source:UniProtKB:Q9P265|ens)A2VDQ6(Evidence code:IEA/Database source:UniProtKB:P55288|ens)G3N201(Evidence code:IEA/Database source:UniProtKB:Q9Y2M2|ens)Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR009976)P16116(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q9N287(Evidence code:ISS/Database source:UniProtKB:Q9UKB3)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1B8X4(Evidence code:IBA/Database source:PANTHER:PTN000102039)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P31408(Evidence code:IEA/Database source:UniProtKB:P62814|ens)E1BG38(Evidence code:IEA/Database source:InterPro:IPR015212)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MBI8(Evidence code:IBA/Database source:PANTHER:PTN000022879)O02675(Evidence code:IEA/Database source:InterPro:IPR011778)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)G3X7J6(Evidence code:IBA/Database source:PANTHER:PTN000341338)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FV68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q29460(Evidence code:ISS/Database source:UniProtKB:Q61205)E1BKQ2(Evidence code:IBA/Database source:PANTHER:PTN000405433)Q17R11(Evidence code:IEA/Database source:UniProtKB:Q86Y13|ens)Q0P5L0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)O46414(Evidence code:IBA/Database source:PANTHER:PTN000153092)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)Q32L40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR004493)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P02639(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0VCP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551)O97764(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q0P568(Evidence code:IEA/Database source:UniProtKB:P70362|ens)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6QLD1(Evidence code:IEA/Database source:UniProtKB:Q96A65|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR015212)A3KN22(Evidence code:IBA/Database source:PANTHER:PTN000629506)P37359(Evidence code:IEA/Database source:UniProtKB:P25713|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)P48644(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)Q58DA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224)Q0III2(Evidence code:ISS/Database source:UniProtKB:O43462)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)Q8SPX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)F1MX04(Evidence code:ISS/Database source:UniProtKB:B2RU06)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q9NQI0)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q32LB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)F1MNF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433338)A0JNJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A6H769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3T0X5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)Q17R10(Evidence code:IEA/Database source:InterPro:IPR030115)G5E567(Evidence code:IEA/Database source:UniProtKB:Q96P70|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0963)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q14145|ens)E1BL29(Evidence code:IBA/Database source:PANTHER:PTN001621808)A7MBG0(Evidence code:IEA/Database source:InterPro:IPR027529)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:, PACSIN2 MIB2 SOX4 ALOX15 STK26 TJP1 CDK1 UFM1 NIM1K MAPK10 TAF8 ALPK2 IPO4 PTGES3 NF2 BEX5 DHX8 SPRY4 ATP2B2 MAP3K8 GNAI1 MVB12A TDRD5 BRINP1 DTD2 WWTR1 CRMP1 VPS28 AXIN1 FKBP9 PSMC1 PSMC2 ASB14 SWAP70 CORO7 EIF3M GPX1 BCL3 MAPK12 NLRP5 STRAP RNF112 SEPT7 GPHN PPP2CB VPS36 SRI DCTN3 MRI1 TRIM68 MTAP SH3GL1 PREX1 VPS4B CNP CTTN POLD3 VTA1 BLM CAPN7 COPE PREP SRF PURA INPP5J RFFL ARFGEF1 NUAK1 MPP5 ARF6 RPS19 PSMA4 TRAPPC2L ABL1 MAPKAPK3 WDFY3 BICD2 HDAC5 TUBA3E AP5Z1 ARHGAP35 FABP7 LYST FIGNL1 NAP1L1 PRKACA PKP4 MKL1 CLIC6 CCT3 ALDH1A3 SNRPN NUDT16 UXS1 PTP4A1 SSH2 MYO9B MAPK11 LIN7C TDRD9 SNX3 CDC42SE2 NMRAL1 IKBKG ADH5 PINK1 GRB2 PLK4 TOR1B RANBP10 TUBGCP2 STAT5B SETX IMPDH2 FAM84B DPYD PRUNE1 SMG1 LOC101902172 ARHGAP29 SMTNL1 WWC1 PAN2 PSMB2 KLC4 VPS26A AGO3 COPB1 ARCN1 MX2 PPP3CC XPNPEP1 MARK3 TINAGL1 TMEM184A DLG1 SEC24A FKBP4 ARHGAP6 DDT NDRG1 RDX ACTR1A MAP3K10 DYNC1I2 FHIT CCT5 STAT5A CAPN11 ERCC2 EPM2AIP1 PPP1R1C WDR6 LOC515358 PSMB4 PDCD4 BANF1 METAP2 DSTN PABPC4 COPS8 TUBB3 DHX34 RPL27 LAMP1 TBC1D2 BRAF ARPC5L GNPDA2 SPOPL TACC1 ZFYVE26 QDPR ACAT2 MAPK9 DNM2 CDC27 PDZD2 ECT2 TOM1 BRCA2 CCT8 RTN4R SEPT2 MYO6 SLC34A1 MAP3K1 TET3 HINT3 CDK5RAP2 ISOC1 ACTN2 CLTA ACP1 GART PTTG1IP SNAP25 WEE1 FTL SH3BGRL2 MTMR1 PARP1 PCBD1 PMM2 PKLR PI4KA TUBB4A IQGAP2 PSMC6 PCMT1 SLC23A1 PPP1CC TTI1 RALGAPA1 SNX27 DAB2IP CSNK1A1 CAMK2D EIF2B5 FKBP1B SCLY STK25 PTPN23 AHCTF1 DGCR8 RANBP2 TUBA4A RNF128 CSNK1G2 HCFC1 AIMP2 MCTS1 ASB10 CASP3 UBE2Z WASF2 RAP2C TRIM23 PIP4K2C TUBA8 TUBA1D SULT1A1 COPS5 PRKCI RASAL1 AHCYL2 DNAJC7 PTPN14 TNPO3 TFG GOLGA4 PPID PKIB SP7 DHX9 ARPC1A HIPK4 AIFM1 RACGAP1 SEC23B SH3GL3 MPI EIF4A3 CSNK1G3 TXNRD1 PTGR2 RARS2 LRRK1 MPDZ TSN RGS6 CHMP1B STK3 S100A14 GPN1 KIF2A COPS6 CASP6 PCBP2 SPTBN4 ISPD XPOT CTU1 IDE DNM1 SEPT6 EMILIN3 UBE2V1 EEF1E1 CAMK2B CAPN2 PAFAH1B1 PABPC1L MARS SDCCAG8 CLUH IARS RPS18 EIF6 PFKL BTBD11 ANKHD1 XPO1 NFKB1 SGSM2 SSB GIPC1 CKB COPS3 POLQ PAK3 LEF1 UBE2L3 PPP2R5A ROCK2 APC2 GALK1 BCL9 ANXA11 TDRD1 MAP3K14 NDRG2 NEDD4 CYFIP2 PRKCB RNF165 BRCC3 UBXN1 CAPN5 PHACTR4 RPL11 SHMT2 CDC5L RAD23B QARS PTPA CHMP4A GARS PASK MRVI1 AARS S100B SGTA DYRK2 CDK6 PKHD1 UBR2 USP9X PTPN6 PSMC3 KLK6 USP20 PSMA2 LZTFL1 POU4F2 GLI1 AARS2 COL2A1 RPAP2 FAM213B PDCD6 TDRD7 RSPH3 RPS9 TNFAIP8L3 AGO4 DPYSL5 RBP1 SAP18 AASS CCT7 RNF17 SYNJ1 CIB1 SPAST DOCK10 PPP2CA ZFHX3 CHMP2B PRKAR2A LRPPRC COLEC10 MROH2B ARL8A CPNE1 PAK1 VPS29 SLIT2 EPRS SMG6 GMPPB PANK4 PSMB10 MAPK13 IKBKAP CTNND1 LOC533307 NEU4 AP2A1 IRF1 GTPBP1 SCIN PFKP COPS4 ATOX1 CLIC1 PDCD10 RAB3B TES TMC6 DNMT3A HSPH1 PKN1 SNF8 BIRC6 CRABP1 ANKIB1 MYO1A TIAM2 RYR1 SH2B2 TNKS1BP1 UFC1 PIGT INTS3 MAGI1 CYFIP1 MTHFD1 MAPK4 COPA MAP2K4 ETF1 DNPH1 ARL1 CHML PEF1 DIP2B CDH11 SSUH2 EXOC5 AKR1B1 DNAJC12 TRAF6 NAE1 MAP3K4 BFSP1 ATP6V1B2 ARHGEF1 ARAP3 PSEN1 SYNGAP1 DPYSL2 HUWE1 RAB23 OTUD7B EXD3 FRS2 LOC101905447 SNRPE PPP2R5E RAB4A PAFAH1B3 RAB11FIP1 DZIP3 RBM42 TAX1BP3 TWF1 FTH1 RPS6KA5 TCP1 LARS G6PD KPNB1 TPR BAIAP2 EIF4E1B HYAL1 RPS6KA2 KCNMA1 MB21D1 S100A1 SEPT8 AGTPBP1 KLHL26 CRYZ UFD1L COMT CRABP2 TSC2 GLI2 COPZ1 PRKACB EXOC4 PIWIL2 ARHGEF12 UBE2M MT3 CLIC4 ALDH1A1 EIF4H SIRT2 CPSF3L GLRX3 STAT1 MBTPS2 MICAL3 CLINT1 LTA4H IER5 TSG101 CRYL1 PRMT5 DDX20 RPS15A EIF4G1 DDX4 NCOA3 CXXC5 LOC100141266 DHX37 SPG20 RPS7 PSMA1 DCTN2 HEPACAM NAPRT AFAP1L2 IPO9 MYO1C KEAP1 BLMH ADSS PKNOX1 DYNLL2 OSBP TUBB1 CMTR2 UBE2V2 TGM3 PSMC5 PAK4 PAK6 ITPR1 DGKQ CAND1 PTPRM SVIL PABPN1 CDK3 MTRR CPPED1 NAP1L4 PALM TYK2 ACLY MIDN COPB2 SEPT11 RAB30 BRCA1 ANKRD17 CRYM PFKM SPAG1 ABHD12 TSC22D1 CTNNA1 PITPNA PIK3CD ALDH9A1 CUBN UBQLN1 ZMYM5 SPTB ZMYM4 DYNLT1 SPOCK1 STRIP2 DHFR CRYAB STXBP1 NPAT EGLN3 PDXP APEH IMPA1 PAK2 NPEPPS DDX58 UBE4B NIF3L1 FKBP2 DNAJB11 EIF3K PCM1 NDC1 PSMA7 RAPGEF2 SH3PXD2A CSNK1G1 MAPK8IP3 COPS2 CUL3 EIF3I GK ARL6 JAK2 DNPEP NRBF2 FMNL3 SH3GLB1 FOXO4 STAT3 CPS1 MAPK1 GRHPR GNAT3 PSMA3 PSMD12 NADSYN1 RPGRIP1L ARL2 VBP1 KIF13B TAF10 XPO7 FERMT2 VPS35 GPSM2 RASAL2 PSMB8 SHC1 IPO5 DNAJB4 ACTR5 AIFM2 ALDH1L1 MYH14 PSMB3 SDCBP2 DNAJB1 PABPC1 PSMB9 PFDN2 DYNLL1 FAM129B EIF4A1 SIKE1 UTRN MASTL MCM3AP E2F1 CCT6B TUBA1A TNPO1 RAN PEX1 HTRA1 CDK17 UBTD2 ZFYVE27 UBXN6 SRC SPR LIPE PLK3 MAP3K9 FLNC PPP1CB EIF3F PACSIN3 MOB1B PIN1 LOC100295712 COPG2 ARL4A MALT1 SNX19 UBE2K ACSS2 DSTYK RGS14 FBXO40 BZW2 ACTR1B TSTD1 RPS28 WNK1 ATP1A2 SRSF1 HPS6 KHDRBS1 ELMO2 TLDC1 PBDC1 BDNF AMDHD1 SYDE2 TAOK3 TRIP12 RHPN2 USP36 SEC23A RPS6KA4 ALDH1L2 CPNE6 CELF3 MMS19 WRN RNF220 NCF2 ARVCF RARS MYLK2 PUS3 CAMK2A UBE2G2 AXIN2 ABCE1 OXT PCBP1 TAOK2 TEKT4 DDX1 CHMP4B GAPDHS BRD2 VAV2 EIF3G PNPT1 NARS SH3BP4 SPATA5L1 PGLS KATNAL2 DICER1 ZAP70 NXF3 VPS25 SH3GLB2 COG5 HCFC2 NFE2L2 EIF1 LRRK2 ACTA1 ATP6V1B1 CCAR2 AOX1 PUM1 WARS2 RPL8 BRSK2 NSFL1C BDH2 GCHFR ARL8B FGF1 STRN3 PNPLA2 TOR1A PHPT1 MYLK3 EIF4A2 SBF1 CAD ALDOB EIF2S1 STK36 PPP3CA EIF3B EXOC8 SRGAP3 LYPLA1 DYNLRB1 CHMP3 AP3B2 SLK,CC,778,778 of 1304,33.05,59.66,0,0
GO:0005634,nucleus,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)E1BB00(Evidence code:IEA/Database source:UniProtKB:Q8WXI3|ens)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR027107)G3X793(Evidence code:IBA/Database source:PANTHER:PTN000622075)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:Q9R1C7|ens)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR028363)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR030449)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)A0A0A0MP90(Evidence code:IEA/Database source:InterPro:IPR002119)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:A0A024R1Y6)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818)F1MUD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR003888|I)F1N1T6(Evidence code:IEA/Database source:UniProtKB:A0A024R419)F1MIL2(Evidence code:IEA/Database source:InterPro:IPR009146)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628|I)E1BCY1(Evidence code:IEA/Database source:UniProtKB:A6ND36|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4J6)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MYE0(Evidence code:IEA/Database source:UniProtKB:A0A024R499)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)M5FK72(Evidence code:IEA/Database source:InterPro:IPR026936)G3MY25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462267)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q8VBV7|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P17612)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)F1MI25(Evidence code:IEA/Database source:UniProtKB:P15822|ens)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0II93(Evidence code:IEA/Database source:InterPro:IPR015245)Q3T087(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BNH7(Evidence code:IEA/Database source:InterPro:IPR006560)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KIW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SYU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6H7B5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q08DY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BAI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR014978)Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0VCN1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:F8VVT9|ens)A5PJT2(Evidence code:IEA/Database source:UniProtKB:Q9NVR2|ens)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR002119)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens)G8JL00(Evidence code:IEA/Database source:InterPro:IPR002119)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O43439|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628|I)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)A6QQ21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P37359(Evidence code:ISS/Database source:UniProtKB:Q61221)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)F1MU40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1)E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)Q3SWY3(Evidence code:ISS/Database source:UniProtKB:P12268)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)A6QLP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MQ38(Evidence code:IEA/Database source:UniProtKB:P58545|ens)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9HB09|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N053(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N2P2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)F2Z4E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P02510(Evidence code:ISS/Database source:UniProtKB:P02511)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)E1BNQ9(Evidence code:IEA/Database source:UniProtKB:Q00PI9|ens)Q32L48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)P48818(Evidence code:IEA/Database source:UniProtKB:P49748|ens)F1N226(Evidence code:IEA/Database source:UniProtKB:Q06481|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)F1MVZ2(Evidence code:IBA/Database source:PANTHER:PTN000678822)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR004582|I)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040|I)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4IFC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)Q3MHY4(Evidence code:IEA/Database source:InterPro:IPR004367)Q32L41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622075)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)E1BL49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR006536)E1BKL9(Evidence code:IEA/Database source:UniProtKB:Q14517|ens)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945)E1BDZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G5E526(Evidence code:IBA/Database source:PANTHER:PTN000596947)F1MLE1(Evidence code:IEA/Database source:UniProtKB:Q9P265|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR008013)P61085(Evidence code:IEA/Database source:UniProtKB:P61087|ens)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR002119)F1MT17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)F1N281(Evidence code:ISS/Database source:UniProtKB:Q7Z4V0)F1N0D7(Evidence code:IEA/Database source:UniProtKB:A0A024RDY6)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004826|I)E1BCF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR026607)A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)Q17QL4(Evidence code:IEA/Database source:UniProtKB:A0A024R9Y7)P46196(Evidence code:ISS/Database source:UniProtKB:P28482)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)A7MAZ5(Evidence code:IEA/Database source:InterPro:IPR005818)E1B8Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q95115(Evidence code:IEA/Database source:InterPro:IPR001217)A6QNT4(Evidence code:IEA/Database source:InterPro:IPR026784)E1BPV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)A6QNN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3MYD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q05B89(Evidence code:ISS/Database source:UniProtKB:Q9EQ80)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P34158)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:A0A024RC95)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR003893)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P10881(Evidence code:IEA/Database source:InterPro:IPR002344)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BM22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:O54983|ens)E1BEB7(Evidence code:IEA/Database source:UniProtKB:Q8WWH5|ens)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1B8Q8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)P06526(Evidence code:IEA/Database source:InterPro:IPR018944)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:A0A140VK27)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)E1BG94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0P5L0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MXR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MN42(Evidence code:IBA/Database source:PANTHER:PTN000623091)F1MYZ3(Evidence code:IEA/Database source:InterPro:IPR003888|I)Q2TA40(Evidence code:IEA/Database source:InterPro:IPR002164)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5D7C4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BC24(Evidence code:IEA/Database source:InterPro:IPR012099)G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)G3MZY8(Evidence code:IEA/Database source:UniProtKB:P08775|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623091)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)Q32KX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004826|I)A7YW98(Evidence code:IEA/Database source:UniProtKB:P54136|ens)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P35509(Evidence code:IBA/Database source:PANTHER:PTN000225966)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3X7J6(Evidence code:IBA/Database source:PANTHER:PTN000341338)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR002119)Q1LZE9(Evidence code:IEA/Database source:UniProtKB:O95084|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443)E1BF32(Evidence code:IBA/Database source:PANTHER:PTN000035347)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)Q17QN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MLP0(Evidence code:IEA/Database source:InterPro:IPR029833)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)E1BGA4(Evidence code:IEA/Database source:InterPro:IPR006560)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)E1BH22(Evidence code:IEA/Database source:InterPro:IPR002119)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)E1BL97(Evidence code:IEA/Database source:InterPro:IPR029547)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR017164)E1B7Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O88286|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)Q2KHT7(Evidence code:IEA/Database source:UniProtKB:P42677|ens)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR001951|I)E1BJ67(Evidence code:IEA/Database source:InterPro:IPR004367)Q2KII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BPI3(Evidence code:IEA/Database source:UniProtKB:P42685|ens)Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN000383724)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N3L9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR000747)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PJW1(Evidence code:IEA/Database source:InterPro:IPR003923)Q05B83(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3X8E7(Evidence code:IEA/Database source:UniProtKB:Q8CFE5|ens)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)A5PK67(Evidence code:IEA/Database source:UniProtKB:Q9C002|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)Q3T0V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PKI6(Evidence code:IBA/Database source:PANTHER:PTN000317389)Q5E938(Evidence code:IEA/Database source:UniProtKB:P41567|ens)Q3MI00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7Z061(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q8CFT2|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)Q3SYX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q1RMU0(Evidence code:IEA/Database source:InterPro:IPR006988|I)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR004806)A7E3X2(Evidence code:IBA/Database source:PANTHER:PTN000225966)E1BP38(Evidence code:IEA/Database source:InterPro:IPR027107)Q5E9F8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BET5(Evidence code:IEA/Database source:UniProtKB:P28290|ens)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR033486)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)A1A4P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q15819|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)E1BJV5(Evidence code:IEA/Database source:InterPro:IPR000690)Q0VCK2(Evidence code:IBA/Database source:PANTHER:PTN000395870)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:B0LPF3|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:Q8BGX0|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR017357|I)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000451|I)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR017995)Q3MHL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)F1N2I0(Evidence code:IEA/Database source:UniProtKB:P26374|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)Q2QDE9(Evidence code:IBA/Database source:PANTHER:PTN000889801)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR003888|I)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000225966)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR009110|I)Q3T0N5(Evidence code:IBA/Database source:PANTHER:PTN000622075)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T0X5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)P61635(Evidence code:IEA/Database source:InterPro:IPR001217)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F1MV26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MCX4(Evidence code:IEA/Database source:UniProtKB:P29597|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)P00423(Evidence code:IEA/Database source:UniProtKB:P13073|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P84798(Evidence code:IEA/Database source:InterPro:IPR019038)E1BC18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens)Q1RMW4(Evidence code:IEA/Database source:UniProtKB:Q8NEU8|ens)Q9BE45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q6NS86|ens)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)E1BF96(Evidence code:IEA/Database source:InterPro:IPR003617|I)F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62269|ens)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)E1BJP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q28165(Evidence code:ISS/Database source:UniProtKB:Q86U42)Q1LZ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MBK6(Evidence code:IEA/Database source:UniProtKB:A2A884|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)E1BJE7(Evidence code:IEA/Database source:UniProtKB:O60318|ens)P02638(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q8CHW4|ens)Q1JPD9(Evidence code:IEA/Database source:UniProtKB:A0A024QYX2)Q2TBX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)B0JYL6(Evidence code:IEA/Database source:InterPro:IPR001217)E1BK57(Evidence code:IEA/Database source:InterPro:IPR001699|I)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q96GX5)Q3T0M9(Evidence code:ISS/Database source:UniProtKB:P40617)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)F1MBP8(Evidence code:IEA/Database source:UniProtKB:A0A024R7W9)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281)O19137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:A0A140VJD0)A6QP24(Evidence code:ISS/Database source:UniProtKB:Q9NTI7)Q2KI57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PK20(Evidence code:IEA/Database source:InterPro:IPR005818)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4IFC8(Evidence code:IBA/Database source:PANTHER:PTN000048763)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QR44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)F1MF37(Evidence code:IEA/Database source:UniProtKB:Q70CQ4|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR002119)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)F1MRP8(Evidence code:IEA/Database source:UniProtKB:Q5JYA6|ens)E1B9B6(Evidence code:IEA/Database source:UniProtKB:A0A024RBL3)E1BN72(Evidence code:IBA/Database source:PANTHER:PTN000678822)Q1MW18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698511)Q32PF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A3KMV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1N5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BAN2(Evidence code:IBA/Database source:PANTHER:PTN000553509)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)F1MNR5(Evidence code:IBA/Database source:PANTHER:PTN000682064)Q5E9F9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)G3N068(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q0II50(Evidence code:ISS/Database source:UniProtKB:Q9BQ65)E1B8G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BD77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622075)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR002119)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P58108(Evidence code:ISS/Database source:UniProtKB:O54950)P17667(Evidence code:IEA/Database source:InterPro:IPR002546)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A6QNS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR021169)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A1A4R2(Evidence code:IEA/Database source:InterPro:IPR026306)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:A0A024R6A3)F1MUU2(Evidence code:IEA/Database source:UniProtKB:Q8TDR2|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PJL3(Evidence code:IBA/Database source:PANTHER:PTN000622075)E1BHN9(Evidence code:IEA/Database source:UniProtKB:Q3TPJ7|ens)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A6H767(Evidence code:IEA/Database source:InterPro:IPR002164)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)F1MHP1(Evidence code:IEA/Database source:UniProtKB:O15042|ens)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3N346(Evidence code:IEA/Database source:InterPro:IPR029518)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR030703)Q3SX07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)Q08DI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)O02754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)F1MPR9(Evidence code:IEA/Database source:UniProtKB:Q6P4R8|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1B8E2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)A5D7F6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A5PJT8(Evidence code:IBA/Database source:PANTHER:PTN000889801)G3N201(Evidence code:IEA/Database source:UniProtKB:Q9Y2M2|ens)F1MU53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)Q08E07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9R078|ens)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A1A4I8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)A7E3A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0539)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR008013)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)A4FUE0(Evide, NUDT16 ASB10 TSC2 MAPK11 CDK6 PRPF40A EFTUD2 POLR2F PRKCB SP1 DDX1 DHX9 HIST1H2AC GOLGA3 PALM IKBKG HIST1H1A HIST2H2BF KMT2A FASTKD2 TLE6 PTPN6 MVB12A NR1I2 FAM83G TET3 NDRG1 HIST1H2BJ PMM2 IER5 PPP3CA PTPA IRS1 EGR4 PFKM FAM129B UBN1 TIGD5 TOR1A DXO RNF165 TEKT4 CCNY XPO1 COPS8 PRKACA EIF4A3 DNAJB11 HIVEP1 PRKDC NLRP5 PSMA3 CAPN2 DLG1 BCL3 FIGNL1 STRAP NXF3 RPL11 WHSC1L1 PIN1 PSMC6 HIST2H3D PRKACB TNPO1 ATF6B GPN1 COPS3 MIER1 ANHX SMARCA2 HEYL NMRAL1 PIAS1 AGAP2 INTS10 H2AFZ ANKRD17 SIRT2 GPKOW BCL9 VPS25 CHMP4B LOC104975684 CBFA2T2 TDRD9 NR2F6 CDK1 PSMB4 CLCC1 SNRNP200 COPS6 MT3 LRPPRC ETV2 PRUNE1 TPR ZNF516 MNX1 DNMT3A AIFM1 IMPDH2 MICAL3 FOXO4 SOX1 BTBD3 BCL2L12 KHDRBS1 NUP214 LSM4 HIST1H2BA GLI2 INTS3 AEBP2 LOC613345 OSBP GLO1 HIST1H2BB CRYAB TACSTD2 HNRNPUL2 HIST1H2BN IPO5 MAP3K14 ACADVL APLP2 TAOK2 MAGI1 PDCD4 BRSK2 ATRX RAD17 RUNX1 AXIN2 SF3A1 SH3BGRL2 POU4F2 CCNL2 GCHFR NUMA1 MAPK10 SNRNP70 DHX8 LOC614206 MMS19 HNRNPL FAT1 INO80 IDE MX2 ERCC2 CHD9 PTP4A1 DIP2B SGTA MKL1 GATA6 UBE2K LOC614881 CUX2 SHMT2 ZNF438 ZIC2 CDK13 LOC526488 NFE2L2 DLX2 DMRTC2 CAND1 BCL9L PTPN14 NPAT NIPBL UBE2L3 MAGED2 MAPK1 SMG1 HIST1H1D IPO8 STAT5A FAM120B ZFHX3 CPNE1 TNKS1BP1 LOC515042 LOC100297725 NIF3L1 EPM2AIP1 BLM RAN IGFBP3 UBE4B CFTR ZBTB4 ALDH1A3 CHD8 IRF1 PAN2 ZBTB8A UFM1 ASXL1 ALKBH2 TSHZ1 IRX1 PPP2CA SSB RGS14 LOC100300167 PPP1CB CRYM TRUB1 AP5Z1 XPOT SALL4 DNTT LTA4H TCF7L2 PSMD2 E2F1 RBM42 ONECUT2 CDK17 KMT2C NAP1L4 SP7 BRD1 RACGAP1 HINT3 SWAP70 TNPO3 MDN1 ACTR5 RAX OTUB1 ROCK2 PKN1 POLR2A ECT2 TNRC18 CDK3 TCF20 TFDP2 MAF RARS RUVBL2 CSNK1G3 FKBP4 EXD3 PPWD1 HIST1H2AJ PRSS23 SMG6 DGKQ SOX17 CLIC4 KIAA2022 PSMD13 SNRPN ZBTB22 GNAI1 UBXN6 CNP ZNF750 MYCBP2 ASH1L PASK HIST2H2AB BRCC3 SOX13 DOCK10 SMTNL1 WEE1 TRIP12 PTTG1IP WIZ WWC1 RPS27 LOC619094 CCNL1 HIST1H2BI FRK DICER1 PCBP2 PPP2CB LOC613363 EEF1E1 EN1 AIMP2 VPS36 TAF10 RFC2 BTBD7 PSMA7 RPS6KA4 SAMHD1 MGC165862 LANCL2 PSMC5 EIF3K CC2D1A EIF1 DNAJB1 PRMT6 SHISA5 CDC27 SETD1B CTBP1 ZNF394 NAB2 RAD23B CSNK1G1 RALGAPA1 H3F3B SSFA2 SAPCD2 PLK3 RPAP2 RFX5 FERMT2 PRMT5 AGTPBP1 PFDN2 ARVCF SYF2 UBE2V2 ARID3A ACAT2 PINK1 RPS6KA5 ZNF638 PKIB PCBD1 GRB2 AXIN1 TRIM23 RAD21L1 ZMYND8 DUSP3 TERF2 HSPA9 NFKB1 SRC MALT1 HOXA7 TSC22D1 CDK12 TAF8 LRRK2 DNAJB2 CHML ZBTB17 TJP1 CD3EAP DNASE1L1 KMT2B CSNK1G2 MAPK4 NCOA3 MAPK13 ANXA11 PSMA1 PTPN23 BAG5 STAT3 HSPH1 HBP1 EIF4G1 LOC525433 TYK2 TAX1BP3 COX4I1 UHMK1 SRSF1 POLD3 LOC617043 S100A4 APPL2 NFKBIZ ZNF366 PAXIP1 ZMYM5 BRCA2 MEGF8 PPP1R10 ZNF462 KDM3B RPS18 ARL2 SRF SFPQ COPS4 MICAL2 BCL11A PABPN1 LMO2 ZBTB18 HIVEP3 PKNOX1 MYO1C PYGO2 NSFL1C ESRP1 MCM3AP S100B ATM CAD PHF14 EIF2B5 GPRC5B VBP1 STAT1 TBX3 MASTL ARL4A SPAST COPS5 TRIM68 CRABP2 CPSF4 WWTR1 LRWD1 FAM212B TNPO2 HIST1H1E SIRT6 RIF1 BRCA1 PSMB8 LIG1 PIWIL2 FOXF1 DGCR8 COPS2 SNF8 EIF6 PRDM13 USP31 SUZ12 PRKCI RREB1 CPSF3L H2AFJ IKBKAP CDC5L RAI1 PLEKHG1 NUAK1 NIM1K LHX4 PURB SPOPL PCNP RANBP10 LOC615183 PUM1 KATNAL2 CHMP4A RUVBL1 PABPC4 RPS6KA2 PSMC2 MYLK2 LOC614378 USB1 HIST3H2BB ZFHX2 IPO7 HCFC1 INSM1 MAPK9 HIST3H2A PSMB10 SAP18 PRKAG1 MYF5 PLK4 GON4L DOT1L VPS4B SNRPE KANSL3 CLIC1 RSBN1L CUL3 PSEN1 STK35 E2F7 MAPK12 MIDN SMARCAL1 DNPH1 PPP1CC H1FX TRAF6 PSMB9 PDCD6 NAP1L1 ASH2L HCFC2 U2SURP PTPRN KDM6B PAFAH1B1 KIF23 HDAC5 PUS3 POLA1 BCOR ETAA1 CEBPA NFRKB MYO6 RAD18 CIC CCAR2 MAML2 DNASE1L2 SSUH2 ZNF446 CTDSP1 DYNLL1 HIPK4 CLIC6 TSN NF2 CELF3 NACC1 PRKAB1 PSMA4 XPO7 NCOR1 gata4 AHCTF1 MEIS1 CIB1 PPP1R7 BRD2 EIF2S1 CHD7 CMTR2 PSMB2 CSRP1 PARP1 DEPDC1 PURA ZNF367 ASB14 TERF1 PSMB3 TBC1D2 MGA STK36 LOC523702 H3F3C SPEN POLQ ESRRG ARID1B OTUD7B ABL1 FGF1 LIPE LEF1 UBE2Z PPID FOXI3 SETX BCL11B GCK UBE2V1 POU3F1 RPL23A ARID1A EGLN3 ZHX3 GLI1 TDG RAX2 AHR ADARB1 PABPC1 SHOX2 BANF1 CHD6 PELP1 ZNF148 ARFGEF1 HIST2H2BE SIM2 PPP1R13B GCFC2 PSMD1 PPIE AGO4 ALDH1L2 EIF3G SEC13 WRN KNOP1 SOX8 PCBP1 SOX4 CXXC5 MAPKAPK3 MECP2 MTAP MARCH7 STAT5B MRI1 DNM1 LPIN2 DEK TRA2A LOC785479 PSMA2 DYRK2 HUWE1 RPL30 MOB1B WDFY3 APPL1 CIDEC PRPF8 MBD6 RNF112 UHRF1 POLE4 TOP2B CTNND1 EHMT2 CSNK1A1 RANBP2 PPM1D JAK2,CC,634,634 of 1172,26.93,54.1,3.542E-247,9.476E-244
GO:0005829,cytosol,A7YY62(Evidence code:IEA/Database source:GO:0045022)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN001229949)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)Q2TBX2(Evidence code:TAS/Database source:)E1BBT9(Evidence code:IEA/Database source:UniProtKB:O95757|ens)A5PK51(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens)P46195(Evidence code:IBA/Database source:PANTHER:PTN000563396)F1MHL2(Evidence code:IEA/Database source:UniProtKB:Q92625|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)G5E567(Evidence code:IBA/Database source:PANTHER:PTN000108134)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)Q3ZBU7(Evidence code:TAS/Database source:)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q32LB3(Evidence code:IEA/Database source:UniProtKB:Q7LFL8|ens)F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107947)E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)Q3ZBF0(Evidence code:IEA/Database source:UniProtKB:Q6IA69|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BGT8(Evidence code:IEA/Database source:UniProtKB:Q08AE8|ens)Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:Q9WTX5)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q12792|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)E1BCH6(Evidence code:ISS/Database source:UniProtKB:A4D126)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q2KHV6(Evidence code:IEA/Database source:GO:0034498)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)P61356(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4FUD6(Evidence code:ISS/Database source:UniProtKB:Q96JJ3)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)E1BFI2(Evidence code:IBA/Database source:PANTHER:PTN000568260)P61763(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9F9(Evidence code:IEA/Database source:UniProtKB:A0A140VK70)A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)Q0VC66(Evidence code:ISS/Database source:UniProtKB:P53088)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)Q08DK5(Evidence code:IEA/Database source:UniProtKB:Q9NR46|ens)Q32PA4(Evidence code:IEA/Database source:InterPro:IPR028441)O02675(Evidence code:ISS/Database source:UniProtKB:Q16555)Q5I598(Evidence code:IBA/Database source:PANTHER:PTN000472667)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:A0A024RC95)F1MNS8(Evidence code:IEA/Database source:UniProtKB:Q13442|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)Q3T0V3(Evidence code:IEA/Database source:UniProtKB:Q9UBQ5|ens)E1B793(Evidence code:IEA/Database source:UniProtKB:A0A140VJW1)P02694(Evidence code:IEA/Database source:InterPro:IPR031264)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q0VD53(Evidence code:IEA/Database source:GO:0042147)E1BB16(Evidence code:IEA/Database source:GO:0042147)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256598)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q9H832|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:A0A024R1J8)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)E1BMN4(Evidence code:IEA/Database source:UniProtKB:P28336|ens)E1BET5(Evidence code:IEA/Database source:UniProtKB:P28290|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q9UKS6|ens)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)F1MRI6(Evidence code:IEA/Database source:GO:0045022)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)E1BPI3(Evidence code:IEA/Database source:UniProtKB:P42685|ens)A7MBC5(Evidence code:IEA/Database source:UniProtKB:P41252|ens)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q5NUA6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJE7(Evidence code:IEA/Database source:UniProtKB:O60318|ens)F1MW03(Evidence code:IEA/Database source:UniProtKB:Q8NFU3|ens)P31404(Evidence code:ISS/Database source:UniProtKB:P50516)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB:Q9NQW7|ens)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens)P31408(Evidence code:ISS/Database source:UniProtKB:P62814)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:A0A024RDI0)E1BB52(Evidence code:IEA/Database source:UniProtKB:A0A024RA85)E1BAF6(Evidence code:IEA/Database source:UniProtKB:P48634|ens)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)Q75WB5(Evidence code:IBA/Database source:PANTHER:PTN000146326)F1MQ38(Evidence code:IEA/Database source:UniProtKB:P58545|ens)P61283(Evidence code:IEA/Database source:UniProtKB:A0A024R5H0)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4J6)F1MQA8(Evidence code:IEA/Database source:UniProtKB:Q8NDI1|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)Q5E994(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BP91(Evidence code:IEA/Database source:UniProtKB:P55786|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)E1BNY9(Evidence code:IEA/Database source:UniProtKB:A0A024R9W5)E1BJF4(Evidence code:IEA/Database source:UniProtKB:A6NMQ1|ens)Q5BIM5(Evidence code:IEA/Database source:UniProtKB:Q5T4F4|ens)E1BQ15(Evidence code:IEA/Database source:UniProtKB:J3KR49|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)A6H7B5(Evidence code:IEA/Database source:UniProtKB:Q9UNS2|ens)E1BIU0(Evidence code:IEA/Database source:UniProtKB:P53992|ens)P16386(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)F1MM21(Evidence code:IEA/Database source:UniProtKB:P49758|ens)A6QL80(Evidence code:IEA/Database source:UniProtKB:Q922H1|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)P35071(Evidence code:IBA/Database source:PANTHER:PTN000658664)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:P31644|ens)E1BIU7(Evidence code:IEA/Database source:GO:0045022)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)Q5E9L5(Evidence code:IBA/Database source:PANTHER:PTN000109455)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:A0A140VK27)Q0VCK0(Evidence code:IEA/Database source:UniProtKB:P31939|ens)A2VDS1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)Q32PF2(Evidence code:IEA/Database source:UniProtKB:A0A024R1T9)E1BI31(Evidence code:IEA/Database source:UniProtKB:Q86TI2|ens)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:A0A024R7C0)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1N152(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KII5(Evidence code:IEA/Database source:UniProtKB:A0A024QZZ7)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q5GJ75|ens)E1BHZ4(Evidence code:IEA/Database source:UniProtKB:Q9UPT8|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)A3KMV8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SX42(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)A7E3X2(Evidence code:IEA/Database source:UniProtKB:A0A024R5W3)E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)E1BFI8(Evidence code:IEA/Database source:UniProtKB:Q07617|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:Q9DB34|ens)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q92598|ens)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)E1BK77(Evidence code:IEA/Database source:UniProtKB:Q96HP0|ens)P48452(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4C6)F1N746(Evidence code:IEA/Database source:UniProtKB:Q9Y3P9|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)E1BPM0(Evidence code:IEA/Database source:UniProtKB:O95294|ens)A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)E1BHN9(Evidence code:IEA/Database source:UniProtKB:Q3TPJ7|ens)O97764(Evidence code:ISS/Database source:UniProtKB:Q08257)F1MN90(Evidence code:ISS/Database source:UniProtKB:Q96AQ7)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q9H3U1|ens)A7YW98(Evidence code:ISS/Database source:UniProtKB:P54136)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q8R1F1|ens)F1MNG6(Evidence code:IBA/Database source:PANTHER:PTN000297583)Q3T0M0(Evidence code:IEA/Database source:GO:0042147)Q0II26(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P43033(Evidence code:IDA/Database source:)E1BGE5(Evidence code:IEA/Database source:UniProtKB:O95373|ens)A2VE21(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)E1BCY1(Evidence code:IEA/Database source:UniProtKB:A6ND36|ens)E1BKQ2(Evidence code:IEA/Database source:UniProtKB:Q6WKZ4|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)Q3T054(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)Q647I9(Evidence code:IDA/Database source:)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)Q2YDE9(Evidence code:IEA/Database source:UniProtKB:A4D0U5|ens)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens)P80227(Evidence code:IEA/Database source:UniProtKB:A0A024R2U9)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:A0A087WYT3)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)Q2KJD2(Evidence code:IEA/Database source:GO:0042147)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)G3N3N1(Evidence code:IDA/Database source:)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens)Q17QL4(Evidence code:IEA/Database source:UniProtKB:A0A024R9Y7)F1MYE0(Evidence code:IEA/Database source:UniProtKB:A0A024R499)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:A0A024RDV9)Q08DW1(Evidence code:IEA/Database source:GO:0042147)P48818(Evidence code:IEA/Database source:UniProtKB:P49748|ens)Q8SPX7(Evidence code:ISS/Database source:UniProtKB:P14755)F6RRD7(Evidence code:IEA/Database source:UniProtKB:Q8IXW5|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:A3RJH1|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB:P25789|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)Q32P83(Evidence code:IBA/Database source:PANTHER:PTN000328285)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:P49588|ens)G3N337(Evidence code:IBA/Database source:PANTHER:PTN000237128)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)A7Z052(Evidence code:IEA/Database source:UniProtKB:A0A087X295)Q2HJ94(Evidence code:IEA/Database source:UniProtKB:O60884|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:A0A024R0F8)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)Q28021(Evidence code:TAS/Database source:)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:A0A140VJR0)E1BC24(Evidence code:IEA/Database source:UniProtKB:Q9NU22|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)A6QP29(Evidence code:IEA/Database source:UniProtKB:Q9BYX2|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q8BU31|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)G3N0Y7(Evidence code:IEA/Database source:UniProtKB:Q9NTX9|ens)F1MS56(Evidence code:IBA/Database source:PANTHER:PTN000501326)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:Q6PFX9|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)Q32L41(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)P26882(Evidence code:IEA/Database source:UniProtKB:E5KN55|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)O62768(Evidence code:TAS/Database source:)Q3SZA0(Evidence code:IBA/Database source:PANTHER:PTN000091645)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MB84(Evidence code:IBA/Database source:PANTHER:PTN000107947)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61457|ens)A5PK86(Evidence code:IEA/Database source:UniProtKB:P41279|ens)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens)F1MD79(Evidence code:IEA/Database source:GO:0042147)A2VDN5(Evidence code:IEA/Database source:UniProtKB:E5KRP5|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:Q80ZJ1|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens)A6QLP2(Evidence code:IEA/Database source:UniProtKB:Q68FL4|ens)Q3SZC2(Evidence code:IEA/Database source:UniProtKB:P28065|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)E1BM45(Evidence code:IEA/Database source:UniProtKB:A0A024R2C3)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q1JQ98(Evidence code:IEA/Database source:GO:0042147)A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens)Q58CY6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)E1B8G9(Evidence code:IEA/Database source:UniProtKB:Q8N257|ens)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62269|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)Q3MHH4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BDD9(Evidence code:IEA/Database source:UniProtKB:W0Z7M9|ens)Q2KIT4(Evidence code:IEA/Database source:UniProtKB:Q9UDY4|ens)E1BG38(Evidence code:IEA/Database source:UniProtKB:Q92888|ens)Q05204(Evidence code:IEA/Database source:GO:0090160)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)F1MNM7(Evidence code:IEA/Database source:UniProtKB:Q96Q06|ens)F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)Q3T0M9(Evidence code:IEA/Database source:UniProtKB:A0A024R9Z2)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)P35605(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1B8E3(Evidence code:IEA/Database source:UniProtKB:Q86SG2|ens)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BM86(Evidence code:IEA/Database source:UniProtKB:Q6ZN04|ens)A5PKA5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BB73(Evidence code:IEA/Database source:UniProtKB:P32019|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)G3MWR8(Evidence code:IEA/Database source:UniProtKB:Q7RTP6|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F2Z4E8(Evidence code:IEA/Database source:UniProtKB:A0A024RCJ9)A4FV68(Evidence code:IEA/Database source:UniProtKB:Q16537|ens)P83437(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)Q4TVR5(Evidence code:IBA/Database source:PANTHER:PTN000357044)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)E1BCW3(Evidence code:IEA/Database source:UniProtKB:Q9WUA3|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)A1A4J1(Evidence code:IEA/Database source:UniProtKB:P12382|ens)F1N1V1(Evidence code:IEA/Database source:UniProtKB:A0A024R0G2)Q2HJH1(Evidence code:IEA/Database source:UniProtKB:E7ETB3|ens)E1BG23(Evidence code:IEA/Database source:UniProtKB:Q96LD4|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)P48644(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BEB7(Evidence code:IEA/Database source:UniProtKB:Q8WWH5|ens)Q17R14(Evidence code:IEA/Database source:GO:0061502)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q8TCU6|ens)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)F1MGX4(Evidence code:IEA/Database source:UniProtKB:O95466|ens)E1BDC9(Evidence code:IEA/Database source:GO:0042147)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)A4IFE6(Evidence code:IEA/Database source:UniProtKB:P61221|ens)Q1JPD9(Evidence code:IEA/Database source:UniProtKB:A0A024QYX2)Q5EAC2(Evidence code:IBA/Database source:PANTHER:PTN000122964)A6QLR2(Evidence code:IBA/Database source:PANTHER:PTN000236067)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)Q58CS7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A1A4P5(Evidence code:TAS/Database source:)Q3SWY3(Evidence code:IEA/Database source:UniProtKB:P12268|ens)E1BQ01(Evidence code:IEA/Database source:UniProtKB:Q8N1G0|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q6P1N0|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q2YDM1(Evidence code:IEA/Database source:GO:0042147)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens)A6QNT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q56JX6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)P11019(Evidence code:ISS/Database source:UniProtKB:P50518)Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061)A7MBG0(Evidence code:IEA/Database source:UniProtKB:A0A024R5Q7)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F1N2I0(Evidence code:IEA/Database source:UniProtKB:P26374|ens)P48034(Evidence code:ISS/Database source:UniProtKB:Q06278)F1N281(Evidence code:IEA/Database source:UniProtKB:Q7Z4V0|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)A6QQ47(Evidence code:IEA/Database source:GO:0042147)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36551|ens)Q9TRY0(Evidence code:ISS/Database source:UniProtKB:Q9QVC8)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)A4FUD1(Evidence code:IEA/Database source:UniProtKB:Q9HCN4|ens)A2VDZ4(Evidence code:IEA/Database source:UniProtKB:O00444|ens)A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:A0A024R8M0)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB:Q9Y4Z0|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)Q58DA7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q1RMX7(Evidence code:IEA/Database source:UniProtKB:Q99J77|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:G3V1L9|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:A0A140VK54)E1B8H4(Evidence code:IEA/Database source:GO:0042147)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q6FGM0|ens)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62191|ens)Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789)Q5EA61(Evidence code:IEA/Database source:UniProtKB:P12277|ens)A4FV74(Evidence code:IEA/Database source:UniProtKB:A0A024R4D1), FAM160A2 CRYAB KMT2A TRIM68 HCFC2 BTBD6 GLO1 UBXN1 GARS VBP1 HSPA4L NAPRT DNAH7 GUK1 ANKS1A COPS5 PFKM PINK1 YES1 IPO9 DCTN2 TUBB4A ZBTB4 SIRT2 CXXC5 CTBP1 ZC3HAV1 EPRS NADSYN1 TRAF6 GIPC1 SPIRE1 SKP1 SAPCD2 SPHK2 CRMP1 SEC23B TAOK2 PDGFC LRRK1 TWF1 BICD2 ISPD CAPN2 VPS4B KNTC1 S100A14 SNX8 SNX3 RPL27 ELMO2 BAG5 DHTKD1 STXBP1 PSMC2 COPB1 DUSP3 MAPK9 CTU1 DNAJC13 SH3GLB2 PHPT1 DPYSL2 MTHFR DNAJB2 ALDH1A3 PDAP1 ALOX15B EPS8L1 EIF3K STK36 RBP1 RAPGEF2 VPS26A GCC2 LPIN2 UBE2Z NF2 ARFGEF1 NMBR SSFA2 WNK1 PACSIN3 MCTS1 LMTK2 FGF1 FRK IARS PCBP2 NFE2L2 MCM3AP TSTD1 ATP6V1A XPNPEP1 CTNNA1 CHMP4B ATP6V1B2 ABL1 WDFY3 CDK13 PRRC2A RBX1 PRUNE1 OPLAH BTBD3 BANF1 PMM2 EHBP1 AIFM1 CHMP1B NPEPPS APPL1 UBXN6 HUWE1 POLA1 ZFYVE27 CLASP2 SGTA PLEKHA5 COPS3 SEC24C LIPE GCFC2 RGS6 PRMT3 CAD CFTR FOXO4 GLI1 GABRA5 PTPN23 LITAF PRMT6 LTA4H ATIC SCLY FNDC3A ACLY DPP9 ZCCHC6 KEAP1 MVB12A BCR HTRA1 HIST1H2BI TNFAIP8L3 ZC3H4 GCK BCL3 RANBP10 CHMP2B NSFL1C CSNK1G1 RAB23 SPAG1 CHMP2A CD3EAP DCTN3 HSPH1 FLNC SRC IKBKAP MAP3K14 DOCK6 PPP3CA RABGAP1 MALT1 RASAL1 SNRPE EXOC8 PCM1 PEX1 SMG6 ACSS2 APC2 PACSIN2 MIDN CRYZ CIDEC UNC45A RARS ANO6 MAPK1 FAM129B PPIP5K2 VPS29 AIMP2 PAFAH1B1 IPO7 COPG2 ALOX15 FAM83G RAB11FIP1 WWC1 RAN TXLNG NLRP5 SNX33 GTPBP1 ADARB1 TES ACAT2 RAPGEF4 AKR1A1 APEH EGLN3 DENND1A PTGES3 AGO4 DOCK10 VAMP3 AFAP1L2 ARF6 PPP2R5A TXNDC17 MAGED2 IRS1 CORO7 SPG20 RAB9A ACADVL CRYL1 RPAP2 DDX1 OSBP TOM1 PSMA4 RAD23B PRNP AIFM2 RABIF RUNX1 AARS UAP1L1 PCBP1 ARL2 MARCH7 WDR6 DNAJA2 EIF2B5 GPSM2 PAK1 IRS4 ROCK2 WWTR1 PDE4D MDN1 ZAP70 TBC1D2 RAP2C DGKQ FAM217B PGM3 NBEA TSC2 TNKS DDX58 PPP2CA BAIAP2L1 VPS35 ARID3A PAK2 GCHFR IDE PCNT PPID EIF4G1 GOLGA3 XPO1 G6PD PRMT5 TXNRD1 COPS4 STK26 PDXP GRHPR CCT5 EPS15 MYO9B VPS25 PCBD1 MAP3K8 SETD1B ANKFY1 SPAST RAP2A RASEF AKAP12 AHCYL2 PSMB9 CCT3 PSMD13 PIGN RUVBL1 CRYM HK2 BAIAP3 AP1S1 MTHFD1 FAM213B CAND1 DYRK2 AGTPBP1 DNAJC7 HIST3H2BB RPS18 SNF8 QARS MARS MKL1 DNAJB4 ARHGEF1 LAMP1 UBQLN1 GOLGA4 PLIN4 PPP2R2A STRIP2 ARL4A TNRC18 PRKCI COPB2 CTTN ANKRD23 BAIAP2 BLM MEX3B SNX27 IPO8 PUM1 INPP5B PRKACB HIC1 PPP1R13B MICAL3 LRRK2 HIST1H2BB PPP2R5E COG5 UNC13B DSTYK MRI1 PPM1D CPSF3L PFKP PRPF40A PFKL DENND2D DNPEP TRIM47 NCOA3 TSG101 ALDH1A1 TRUB1 MYO1D PREX1 FMNL3 MB21D1 FMNL1 VPS52 PABPC4 LANCL2 STARD10 CTNND1 TOP2B ABCE1 GPRC5B GSS LARS PNPT1 ARL6 CHMP3 PFDN2 IMPDH2 ZNF687 USP9X CC2D1A CRKL PDCD4 GOLPH3 ARL1 KPNB1 DDX20 SEC24A CDK6 RPS28 XPOT ATP6V1E1 EIF6 ADSS PASK STRAP NUMA1 CHML AOX1 ZNF438 CLIC4 BRCA2 VPS51 CPOX FKBP4 CDK1 KIF14 GPN1 PLK4 SEC23A RPS19 IKBKG GNA13 LSM4 CNP GLRX3 NFKB1 PDCD10 NANS TJP1 STAMBP DENND2A DAAM1 SH3GL1 NDRG1 PDCD6IP MOB1B RPS6KA4 SRI ASNS PSMC1 FHIT CKB COPS8,CC,430,430 of 769,18.27,55.92,4.965E-177,8.855E-174
GO:0016020,membrane,F1MG76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QP06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BB93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G5E618(Evidence code:IEA/Database source:UniProtKB:Q9Y566|ens)F1N4S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q673L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MD25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MTK2(Evidence code:IEA/Database source:UniProtKB:Q6P9B6|ens)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)Q3ZCB8(Evidence code:IEA/Database source:InterPro:IPR002809|I)Q3T0W2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006042|I)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens)A4IFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR005821)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1B813(Evidence code:IEA/Database source:InterPro:IPR001190|I)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q6Y1E2(Evidence code:IEA/Database source:InterPro:IPR008253)G3X6G8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR020849)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR003378)E1BIL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BJU6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJ59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B7G0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MW12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N7K7(Evidence code:IEA/Database source:InterPro:IPR001190|I)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P63217(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SZ20(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)F1MNP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q148L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001320|I)P05630(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7Z035(Evidence code:IEA/Database source:InterPro:IPR030544)Q0VCP0(Evidence code:IEA/Database source:InterPro:IPR004752)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)Q28053(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MBJ3(Evidence code:IEA/Database source:InterPro:IPR001382|I)P83437(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MKI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)Q5EA65(Evidence code:ISS/Database source:UniProtKB:Q9H3H5)E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001320|I)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR005821)Q1JQ95(Evidence code:IEA/Database source:InterPro:IPR008253)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BF06(Evidence code:IEA/Database source:InterPro:IPR006052|I)F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I)Q0VCR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q17QE7(Evidence code:IEA/Database source:InterPro:IPR005076)E1BMG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDU1(Evidence code:IEA/Database source:InterPro:IPR007875)E1BHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32L41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QR35(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MB15(Evidence code:IEA/Database source:InterPro:IPR000539)F1N416(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MFH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMN0(Evidence code:IBA/Database source:PANTHER:PTN000066595)F1MEX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BAI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N4T0(Evidence code:IEA/Database source:InterPro:IPR003929)E1BMN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MK52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P23956(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR006011|I)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR020849)B0JYK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7F2(Evidence code:IEA/Database source:InterPro:IPR001565)F1MD64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G5E6J0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N758(Evidence code:IEA/Database source:InterPro:IPR006211)Q95JC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SZJ7(Evidence code:IEA/Database source:InterPro:IPR002000)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4FUZ5(Evidence code:IEA/Database source:InterPro:IPR005016)E1BM97(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QL5(Evidence code:IEA/Database source:InterPro:IPR005045)A4FUD6(Evidence code:ISS/Database source:UniProtKB:Q96JJ3)A2VE13(Evidence code:IEA/Database source:InterPro:IPR008253)F1MCB5(Evidence code:IEA/Database source:InterPro:IPR003020|I)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MSU3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P23389(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P32592(Evidence code:ISS/Database source:UniProtKB:P11835)F1MZZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8HYW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)Q09YM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BP63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHG3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TBI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000699|I)F1MG24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4M2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821)E1BAK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)D7GLD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6H7B0(Evidence code:IEA/Database source:InterPro:IPR008253)P48818(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08E55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29455(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2YDG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58CZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N4L1(Evidence code:IEA/Database source:InterPro:IPR001717|I)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BCG1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3X7E9(Evidence code:IEA/Database source:InterPro:IPR003532)A7YWN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MY32(Evidence code:IEA/Database source:InterPro:IPR003342)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q05204(Evidence code:IEA/Database source:InterPro:IPR002000)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR000699|I)F1MS75(Evidence code:IEA/Database source:InterPro:IPR002443|I)F1N3Q4(Evidence code:IEA/Database source:InterPro:IPR004965)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B9D3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N3I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)A6QQM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1ME12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N5Z0(Evidence code:IEA/Database source:InterPro:IPR000425)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MT41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BLU2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2TA30(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E0AE16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIP5(Evidence code:IEA/Database source:InterPro:IPR026628)A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P31407(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BK86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)C3V9V7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BM92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MXQ8(Evidence code:IEA/Database source:InterPro:IPR001382|I)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1JQB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QLR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7YY65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)E1BM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B9W1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B8X1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC83(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VC12(Evidence code:IEA/Database source:InterPro:IPR006977)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR001879|I)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q00KA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR017104)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BFN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q3ULJ0|ens)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P10897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MB64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MC27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9BDR7(Evidence code:IEA/Database source:InterPro:IPR003110)E1BMA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P06623(Evidence code:IEA/Database source:InterPro:IPR008431)Q1RMK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P31408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P30671(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29RM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4IFN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q765N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408)Q0III2(Evidence code:IEA/Database source:InterPro:IPR001193)P81127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR002438)Q08D78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MW11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR005821)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)F1MF38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KI18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BL94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VD06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)A6QQK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR000699|I)F1MGE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000699|I)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR002126|I)P10279(Evidence code:IEA/Database source:InterPro:IPR000817|I)P02722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MRN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MSN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P35071(Evidence code:IEA/Database source:InterPro:IPR009147)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)Q1RMV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BB36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O18875(Evidence code:IEA/Database source:InterPro:IPR002984)P53712(Evidence code:ISS/Database source:UniProtKB:P09055)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)A5D7H9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MMF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q01107(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MRI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BF53(Evidence code:IEA/Database source:InterPro:IPR002126|I)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR020849)Q1JPD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36552|ens)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SZ26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC71(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BGU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A3KN28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR016251)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BI45(Evidence code:IEA/Database source:InterPro:IPR006043|I)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VE11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BGZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR020849)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q0VCP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BN79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P31836(Evidence code:IEA/Database source:InterPro:IPR009138)E1BB73(Evidence code:IEA/Database source:UniProtKB:P32019|ens)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001320|I)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP76(Evidence code:IEA/Database source:InterPro:IPR001050)O46405(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q8MII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3ZC26(Evidence code:IEA/Database source:InterPro:IPR001734)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)F1MPT8(Evidence code:IEA/Database source:InterPro:IPR005045)Q2TA46(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR000699|I)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)O46631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001320|I)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR002153|I)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)F1N226(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P56560(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIS6(Evidence code:IEA/Database source:UniProtKB:Q70IV5|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MGS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32KW9(Evidence code:IEA/Database source:InterPro:IPR007743)Q2HJA3(Evidence code:IEA/Database source:InterPro:IPR002659)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QNP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q95J79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A8E4P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0VC64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJ41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MX24(Evidence code:IEA/Database source:InterPro:IPR003492|I)P11456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000998)F1MS08(Evidence code:IEA/Database source:InterPro:IPR002443|I)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q95JH2(Evidence code:IEA/Database source:InterPro:IPR004552)Q3SZ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9XS26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001320|I)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR017104)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BPQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BIJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7MBI9(Evidence code:IEA/Database source:InterPro:IPR001046)E1BAI4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MW09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A0JNB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MTF9(Evidence code:IEA/Database source:InterPro:IPR003531)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR020849)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR003938|I)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q08E50(Evidence code:IEA/Database source:InterPro:IPR001390)A2VE81(Evidence code:IEA/Database source:InterPro:IPR008253)A5PJQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A4IFM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q32P83(Evidence code:IBA/Database source:PANTHER:PTN000328285)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)V6F7Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KI29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR016251|I)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR002126|I)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BQ05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MRA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQ97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR020849)Q08DS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A6QQ36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A8KC68(Evidence code:IEA/Database source:InterPro:IPR000460)E1B968(Evidence code:IEA/Database source:InterPro:IPR002293)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001190|I)Q32PI9(Evidence code:IEA/Database source:InterPro:IPR000920)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0P5B1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)F1MMU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KHY1(Evidence code:ISS/Database source:UniProtKB:Q9Z140)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BI49(Evidence code:IEA/Database source:InterPro:IPR001382|I)F1MWK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N0J3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3SX42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N3Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q05B70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N2I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N5P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MKY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BGL9(Evidence code:IEA/Database source:InterPro:IPR001565)A5D7H3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)F1MLR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR005821)E1BM45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N740(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P35605(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MY84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q4ZJV8(Evidence code:IEA/Database source:InterPro:IPR013525)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A5D7N8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P02715(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KJI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MPN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BAW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q1JQC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q0V7N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KI48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58CS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q58CW5(Evidence code:IEA/Database source:InterPro:IPR005016)P61420(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q3T110(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MNY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A8DC37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A7YY70(Evidence code:IEA/Database source:InterPro:IPR003841)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N2S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G3N271(Evidence code:IEA/Database source:InterPro:IPR006042|I)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR001879|I)A7YWN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)G5E5T3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)F1MS16(Evidence code:IEA/Database source:InterPro:IPR006408)P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)A2VE53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)Q2KIT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0472)E1BBS6(Evidence code:IEA/, GPR75 RC3H2 ADAM15 SYTL2 SPCS3 UBXN6 BOC RAB39B SHANK1 ULBP11 C5AR1 MVB12A COPZ1 KIAA1549L TLDC1 CACNA1B EMC3 MGC126945 TFRC LOC100298868 CHMP4B LRRC24 SPTBN4 DSTYK SPTA1 PTPRZ1 CACNA1S PCDHA13 LOC786796 PCDHGC3 PLP2 LGR6 DIRAS2 PRKAR2A VAMP1 LFNG CNNM2 LIN7A SYNE3 CD44 DCTN2 TMEM125 IFNLR1 LOC100337053 MARCO GK2 GNG5 SHMT2 VPS35 STARD10 GRIA4 ATP13A1 GRIA1 ATP5D CDC42SE2 PRKACB CLINT1 SLC33A1 KCNG4 APP EDEM2 COG5 ATP7B SEC23A fgfr3 METTL7A RAB3A HPS6 TMEM59 SEZ6L2 SCARA3 SNX27 DAD1 C1QTNF5 DPAGT1 GRIA3 NOA1 TPCN2 CMTM7 ITGAV ADCY7 TNFSF15 LOC100848815 TMEM68 TJP1 FAT1 GBGT1 TENM3 SNX19 NRXN1 SPRY4 PPP1R3F GCHFR SCAMP2 GNAT1 FZD1 CDH22 FREM2 CYP2R1 NEU4 TENM2 KL KCNT2 NMBR ATP1A1 DHRS3 PROM1 ATP6V0C PDXP LOC788626 EPHB4 STX7 OR51Q1 MAPK1 OSBP RRAS NPC1 SPAST SYT4 PIEZO1 SVIL TMEM200B AP2B1 ERBB4 SLC1A5 EXT1 LOC531090 LAMP2 COX4I1 CDHR1 ITGB6 ABHD17C VAMP3 SERINC3 HCN1 CLIC1 TMEM30A ELMO2 MAL2 SLC4A7 CYP7A1 RXFP3 SCO1 CHGB ITGB2 SPAG4 ATP8B1 atp1A3 RHOT1 BACE1 VTA1 CACNA1A ULBP15 RNF139 COPA FKBP1B OR5M11 CDON VPS4B LOC614090 TRAP1 ITPR2 ABCA1 MARCH5 EMC10 SCN3A SYVN1 MFN2 CTNNA1 PLLP ACADVL MBTPS1 DNAJC5 LOC100125916 GPRC5C TSPAN2 VPS25 SLC4A2 CLTA DYSF ABCA7 IL13RA1 ENTPD2 TMTC2 CDH11 LAMP1 RYR1 SLC12A1 PALM AIFM2 GPR179 PKN1 MYOF TIMM17B PINK1 MFSD6L LIN7B SAR1B DSEL TMEM106B AQP5 TMPRSS9 PTGFRN GIPC1 PTPRN SLC19A2 NINJ1 SNX9 RAB3B PDZK1IP1 IMMT ATP6V1B1 ALOX15 CLDN7 AP2M1 ST8SIA3 RAPGEF2 PKHD1 HERC4 GLI2 TMED2 PROM2 MAN1B1 SLC25A29 GPR4 G0S2 FLOT2 CD63 SIRPB1 MTCH1 BIRC6 NDC1 SEPT2 TMEM114 SHISA5 LOC100295883 FNDC3A SLC29A1 YIPF3 STK26 MYO1C LAPTM5 PHKB PTH2R PTPRA ARL8B LRP4 AP2A1 LETM1 ALOX15B OR13C3 NRXN2 TPST2 GPD1L AP2S1 GALNT2 LOC788634 CYB561 ITPRIP LMTK3 F11R FCER1G PRTG CNP FAM174B ATP6V1B2 SNX33 SMIM1 GNG7 DPP4 REEP5 SNX18 UTRN ARL1 TRPM7 SORD CACNA1H SOX1 SRI TLR4 UGT2B10 CLDN3 ATP2B4 MBTPS2 NAPG SLC6A20 LOC512672 LOC523126 VPS29 SCN11A RAB26 ZAP70 EMB PNPLA2 VSIG2 FLOT1 NPTN VPS52 KCNC4 TEX2 RYR2 FRMD5 ITPR1 KHDRBS1 LOC786512 PRNP SLC25A4 ATP13A5 RDX HAS2 TACSTD2 CORO7 CFTR SPHK2 ENG MGAT2 RGR SLC6A8 ITGB1 CACNA1C SLC6A14 RANBP2 ATP2C2 POMGNT1 DSC1 LMTK2 CDH7 SCAP RAP2C GPRC5B SNX8 CPOX GNAS WRB DPM3 SEC24A SOGA3 ST7L TYK2 NDRG1 SLC23A1 COPB1 IGSF8 SLC45A4 RAP2A ECE1 ARCN1 CACNA1F PPP2R5A CCDC149 CES5A NCAM1 INPP5B GRIA2 PCDH20 GALNT7 CACNA1D SDC3 CD80 SLC35B1 SLC5A11 KIT SNF8 UNC13B TMEM30B UBL3 RYR3 CHMP4A SIRPA GRIK4 TRPC3 RIMS1 RNF112 ZFYVE27 ANKFY1 APLP2 MAOB SYNM TOR1A DNM2 RAB25 NAALAD2 IRGC B3GALT4 GK KCNF1 ATP1A2 BTNL2 TYROBP GPM6B MRVI1 MANSC1 TSPAN14 GRB2 IDE BCAP31 BFSP1 SEC23B CLN3 M6PR PTPRM SLC12A2 ABHD2 AGPAT1 GNG10 COPE HAS3 GRIN3B AP2A2 PRKACA CAMK2B IGSF5 LIN7C LEMD3 SLC11A2 CLIC6 LOC509854 LY6H IL9R FLT3 RIT1 KCNH6 TSC2 SWAP70 TMEM184A GABRA5 OCLN PGRMC2 PLA2G16 CLDN8 RABIF CD97 SDK2 DSCAML1 FIS1 CIB1 TMEM256 PCDH8 CLIC4 JAK2 PI4KA GNAI1 PIGK ROCK2 SDK1 FAT2 PCDH12 XKR7 KCNA4 PCDH1 ADAM7 ITGAD HRAS AP2B1 LOC100850276 NLGN2 SLC7A2 TMPRSS2 MPZL1 VPS28 ITGA2 PEX13 MAGI1 TMC3 CPNE6 TMPRSS6 MAN1A2 PTK7 ATP11A RHOT2 VAMP5 CHMP2B ABCC3 GRAMD3 KLRF2 DNER SUSD5 ITGAL SYT6 SLC44A2 KCNG2 ASTN1 AAK1 SCN10A PIGN VPS36 FRAS1 COPB2 ARL6 LIPE CSPG4 ABCG8 EFHD1 RNF128 TMPO TOM1 PEX2 JSRP1 CHRNE ENTPD6 FNDC3B LRRC32 SLC22A23 SUSD2 PTTG1IP PPP3CA CHMP3 MGAT1 HTRA1 SERINC2 ATP6V0D1 TM4SF18 SYNGAP1 VAMP2 TMEM2 FCGR2A SLC34A1 PAK1 LRRC26 LRP6 LOC100337457 KCNC3 PTH1R ITGB7 PSEN1 CAPN2 LOC100299180 ATP2B3 RAB3C IKBIP DNAJB4 QSOX2 LMAN1L MARCH8 ULBP3 LOC515333 ADORA2A TTYH3 RRH CLDN4 DBH HEPACAM CYP2J2 ABHD12 JAK1 ACE TMEM263 FKBP2 GRM7 ARFGEF1 CNGB3 CCNYL1 KCNMA1 NRCAM SORL1 CACNA1E TMC6 TRPM4 LGR4 RNF130 CLCC1 AP1S1 PAFAH1B1 KCNH5 SERINC5 ATP2B2 COMT SLC39A6 DNAJA2 DPEP3 TIAM2 SLC6A5 HHIPL1 MTG1 CHMP1B DPYSL2 CPT1B CPNE1 SCN2B MPV17 FAM205A CAMK2D PANX3 ARID1B COPG2 TRPC1 ARL4A PIP4K2C PRKCB BCR LSM4 VPS26A TRPC2 ATP6AP2 SLC25A26 EPHA6 SGTA ITGA9 F2R TXNDC11 BEST3 BAIAP2 WC1 SCN8A SLC17A8 SCN5A NOTCH4 SH3GL1 PIGO TMC5 AP3B2 ANO6 STEAP4 RAB4A ANKLE2 MEGF8 TMEM171 SLC5A9 SH3GLB1 RAB30 IFITM1 CHGA GLT8D1 ALCAM OTOF STXBP1 SEC13 DCHS2 NDUFS3 SLC44A1 ITM2B STRN3 SLC31A1 SNAP25 NHSL1 CYSTM1 DCST2 BoLA SEC11A PDGFC TSPAN9 PKDREJ PCDHB8,CC,643,643 of 1837,27.32,35,2.111E-173,2.824E-170
GO:0005524,ATP binding,F1MKY9(Evidence code:IEA/Database source:InterPro:IPR004166)A4IFE6(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q2HJ82(Evidence code:IEA/Database source:InterPro:IPR015726)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR000330|I)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR010339)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q12792|ens)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q27966(Evidence code:IEA/Database source:InterPro:IPR001609)F1MN42(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR003959|I)A8QID1(Evidence code:IEA/Database source:InterPro:IPR000719)Q2NL22(Evidence code:IEA/Database source:InterPro:IPR011545)Q28141(Evidence code:IEA/Database source:InterPro:IPR011545)E1BG90(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHE5(Evidence code:IEA/Database source:InterPro:IPR004536|I)Q08E58(Evidence code:IEA/Database source:InterPro:IPR013815)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)G3MW11(Evidence code:IEA/Database source:InterPro:IPR003439|I)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR000738|I)F1MI74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040)F1MU48(Evidence code:IEA/Database source:InterPro:IPR001154|I)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MIM5(Evidence code:IEA/Database source:InterPro:IPR011704)A7MB57(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3N1E4(Evidence code:IEA/Database source:InterPro:IPR001752)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000719)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N734(Evidence code:IEA/Database source:InterPro:IPR000330)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens)P43481(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BNQ2(Evidence code:IEA/Database source:InterPro:IPR011545)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q08E52(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BC24(Evidence code:IEA/Database source:InterPro:IPR011704)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR003439|I)E1BA03(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MN60(Evidence code:IEA/Database source:InterPro:IPR006408)E1BMP3(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3T0K2(Evidence code:IEA/Database source:InterPro:IPR002194|I)E1BH78(Evidence code:IEA/Database source:InterPro:IPR011545)F1N6C1(Evidence code:IEA/Database source:InterPro:IPR000719)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR000330)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR000738|I)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q2HJB1(Evidence code:IEA/Database source:InterPro:IPR003959)Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404)Q58D16(Evidence code:IEA/Database source:InterPro:IPR000719|I)P31408(Evidence code:IEA/Database source:InterPro:IPR000194|I)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001278|I)A0JN96(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHZ1(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q5W5U4(Evidence code:IEA/Database source:InterPro:IPR011545)P10568(Evidence code:IEA/Database source:InterPro:IPR001609)E1BN72(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q3ZCI9(Evidence code:IEA/Database source:InterPro:IPR002194|I)G3N326(Evidence code:IEA/Database source:InterPro:IPR000330)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MNA1(Evidence code:IEA/Database source:InterPro:IPR011545)A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000559|I)A4IFE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I)Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR011545)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752|I)A4IFM7(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4FUH1(Evidence code:IEA/Database source:InterPro:IPR001270|I)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)P05131(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MW09(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752|I)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR014930)Q28021(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR030334)E1BBT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)A5PJP8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MG18(Evidence code:IEA/Database source:InterPro:IPR000719|I)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MY45(Evidence code:IEA/Database source:InterPro:IPR011761)F1MWD3(Evidence code:IEA/Database source:InterPro:IPR002194|I)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR003439|I)A6H768(Evidence code:IEA/Database source:InterPro:IPR000705|I)E1BKM6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MM57(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MLB2(Evidence code:IEA/Database source:InterPro:IPR000330)Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR004887|I)F1MLB1(Evidence code:IEA/Database source:InterPro:IPR000330)E1B9B6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRI6(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR011704|I)G3MW12(Evidence code:IEA/Database source:InterPro:IPR003439|I)A5PK75(Evidence code:IEA/Database source:InterPro:IPR001270|I)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N159(Evidence code:IEA/Database source:InterPro:IPR013815)P00517(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VDN5(Evidence code:IEA/Database source:InterPro:IPR003959|I)Q95M13(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MKU1(Evidence code:IEA/Database source:InterPro:IPR011545)Q05B83(Evidence code:IEA/Database source:InterPro:IPR003959)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539|I)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q2KI72(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N5W5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR011545|I)E1BAN2(Evidence code:IEA/Database source:InterPro:IPR003959)G3N2C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1N1K6(Evidence code:IEA/Database source:InterPro:IPR035699)E1BN63(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X7J5(Evidence code:IEA/Database source:InterPro:IPR010448|I)P46196(Evidence code:IEA/Database source:InterPro:IPR000719|I)A1A4M8(Evidence code:IEA/Database source:InterPro:IPR001270|I)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q17R14(Evidence code:IEA/Database source:InterPro:IPR001609)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BL08(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MMC7(Evidence code:IEA/Database source:InterPro:IPR001609)A6QNN6(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003694|I)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000719)A4IFF6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MNE5(Evidence code:IEA/Database source:InterPro:IPR003959|I)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR009161)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B8H0(Evidence code:IEA/Database source:InterPro:IPR000719)G3X696(Evidence code:IEA/Database source:InterPro:IPR000719|I)P05126(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MBM5(Evidence code:IEA/Database source:InterPro:IPR010448|I)Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR011545)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MG24(Evidence code:IEA/Database source:InterPro:IPR003439|I)E1BC36(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR004166)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR000719)Q0VC88(Evidence code:IEA/Database source:InterPro:IPR002891)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MG13(Evidence code:IEA/Database source:InterPro:IPR001609)Q32L40(Evidence code:IEA/Database source:InterPro:IPR002194|I)E1BDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q08DA1(Evidence code:IEA/Database source:InterPro:IPR005775)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR001609)Q3T084(Evidence code:IEA/Database source:InterPro:IPR002194|I)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR000719)E1BA80(Evidence code:IEA/Database source:InterPro:IPR001609)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)P61085(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR011704|I)E1BB49(Evidence code:IEA/Database source:InterPro:IPR000719|I)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR000719|I)A1A4J1(Evidence code:IEA/Database source:InterPro:IPR009161)F2Z4F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q3SZ54(Evidence code:IEA/Database source:InterPro:IPR011545)E1BDZ3(Evidence code:IEA/Database source:InterPro:IPR000330)E1BB50(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QP44(Evidence code:IEA/Database source:InterPro:IPR006204)Q59A32(Evidence code:IEA/Database source:InterPro:IPR011761|I)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MUU2(Evidence code:IEA/Database source:InterPro:IPR000719|I)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408|I)Q0IIM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q2NKZ1(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3SYZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000719|I)P31407(Evidence code:IEA/Database source:InterPro:IPR000194|I)E1BP55(Evidence code:IEA/Database source:InterPro:IPR003959)P35509(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLB8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000719|I)P62194(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR005479|I)E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752)Q4ZJV8(Evidence code:IEA/Database source:InterPro:IPR003439|I)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q17QG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q4TVR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR001208|I)A7YSY2(Evidence code:IEA/Database source:InterPro:IPR003959|I)F1MM88(Evidence code:IEA/Database source:InterPro:IPR000719)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR000719|I)P31404(Evidence code:IEA/Database source:InterPro:IPR000194|I)E1BJM5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR011545)V6F977(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR011704|I)Q0V8H0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VE07(Evidence code:IEA/Database source:InterPro:IPR000719|I)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q0VD48(Evidence code:IEA/Database source:InterPro:IPR003959|I)A6QLW1(Evidence code:IEA/Database source:InterPro:IPR000719)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MEM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QPF2(Evidence code:IEA/Database source:InterPro:IPR006935)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q3SWY6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N3T0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPM4(Evidence code:IEA/Database source:InterPro:IPR000330)A4FV09(Evidence code:IEA/Database source:InterPro:IPR004567)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR010339)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR011545)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR001609)E1BIM8(Evidence code:IEA/Database source:InterPro:IPR000719|I)P58108(Evidence code:ISS/Database source:UniProtKB:P80385)A3KN22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000738|I)P68138(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q1RMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1N3K4(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens)F1MRW7(Evidence code:IEA/Database source:InterPro:IPR011545)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR012947|I)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1N758(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR012947|I)F1MVZ2(Evidence code:IEA/Database source:InterPro:IPR000719)F1MUF5(Evidence code:IEA/Database source:InterPro:IPR000850)F1N724(Evidence code:IEA/Database source:InterPro:IPR011704|I)G3X793(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001278|I)F1MH24(Evidence code:IEA/Database source:InterPro:IPR000719)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR035699)Q75WB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MX93(Evidence code:IEA/Database source:InterPro:IPR001609|I)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR000330)G5E631(Evidence code:IEA/Database source:InterPro:IPR011545)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0IIK5(Evidence code:IEA/Database source:InterPro:IPR011545)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752|I)A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I)P35071(Evidence code:IEA/Database source:InterPro:IPR003439|I)P17599(Evidence code:IEA/Database source:InterPro:IPR013815)A5PK86(Evidence code:IEA/Database source:InterPro:IPR000719)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312|I)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q5EA61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MC27(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B847(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)F1MS16(Evidence code:IEA/Database source:InterPro:IPR006408)Q3ZCH0(Evidence code:IEA/Database source:InterPro:IPR012725)F1ML89(Evidence code:IEA/Database source:InterPro:IPR005479|I)A4FV00(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR013815)Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR009161)E1BJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)F1MQ85(Evidence code:IEA/Database source:InterPro:IPR000330)P67827(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B793(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR000719|I)D3IVZ2(Evidence code:IEA/Database source:InterPro:IPR011545)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR012724)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR003959|I)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752|I)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)Q08E45(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB90(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2HJ58(Evidence code:ISS/Database source:UniProtKB:P60891)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0067)E1BB52(Evidence code:IEA/Database source:InterPro:IPR000719|I)P48734(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I), ALPK2 ABCE1 PGK2 SPEG SMARCA2 RUVBL2 TWF1 NLRP5 MYO1C CDK17 HCK PSMC2 ACTR3B PEX1 ULK3 EIF4A3 DHX9 DYRK2 SEPHS2 TTLL12 TRPM4 LOC523126 KIFC1 IARS GARS NLRP12 RUNX1 TOP2B KIF13A VWA8 YES1 KIF26A UBE2L3 UHMK1 LRRK2 CHD6 ABCC5 CHORDC1 KIT DHX37 LARS PAK1 MDN1 ABCA7 PAK6 CDC42BPB ATP2B2 MYLK3 CCT3 SNRNP200 LRRK1 INO80 DGKQ MARS PIP4K2C VPS4A TRAP1 MATK ATP6V1B2 PTPA RARS2 STK3 NEK10 DDX4 MYO1A NIM1K SMG1 CCT8 SRCAP KIF5A TDRD9 MTHFD1 ACTR1B NARS DICER1 KIF2A MYLK2 TOR2A ATM PRKACB LOC509854 KIF5B CDC42BPA ROCK2 EIF4G1 CAMK2B ATP2C2 HSPA4L MAP2K4 TEC MYLK4 KIF14 RPS6KA4 CARNS1 CCT5 KIF26B ABCC3 GALK1 TAOK2 RPS6KA2 OXSR1 MYH14 CHD8 GSS EP400 NUAK1 LMTK2 PSMC1 DNAH10 LOC100337053 TOR1A BRAF SYN2 PRKACA SPAST fgfr3 DDX58 RFC2 ATP8B1 PIK3CD ATP11A LOC100299180 MAPK9 ZAP70 STK26 CAMK2D BLM KATNAL2 NLRP7 GK KIF5C PSMC3 MARK3 EPHB4 MYO5A DNHD1 WNK1 TOR4A MAPK1 TOR3A MYH11 MYO1D LCK MAP3K14 MYO1F NVL ATP7B NADSYN1 RPS6KA5 ERCC2 TRIO NEK3 FIGNL1 PFKP FLT3 ABL1 PEAK1 SLK PRKCB TOR1B EIF4A2 MYO18A ABCA1 CDK6 TRPM7 CAMK2G PAPSS2 CSNK1G1 MYO15A TCP1 NLRP14 ATP1A1 MYO9A CCT6B PTK7 MYO18B UBE4B UBE2K PRKCI ATP13A5 DNAH5 HIPK4 PAK4 PFKL ACTR1A LOC515333 EIF4A1 CHD9 CDK12 FUK GART TYK2 STK35 ATP2B4 HSPH1 CCT7 MAPKAPK3 PKN1 ATP6V1B1 NAV3 CSNK1G3 GSK3A MAST4 PSMC5 CAD KIF15 ABCG8 FRK UBE2G2 DSTYK MCM4 SPATA5L1 NEK9 MAPK12 ATP6V1A PASK MAP3K10 MASTL WRN SIK3 DCLK2 DYNC1H1 DHX57 MYO5B OBSCN STK24 PI4KA VPS4B PIK3R4 NME3 DHX8 MYO7B PAK3 FANCM KIF1B STK25 MAP3K4 JAK2 CHD7 PANK4 RUVBL1 PLK3 TAOK3 KIFC3 WEE1 PAK2 PINK1 POLQ MYO9B SRC PRKAG1 UBE2M EPRS ACTA1 UBE2D2 MAP3K9 CDK3 CNNM2 DDX20 AARS2 ASNS ERBB4 WARS2 JAK1 AARS BRSK2 AK9 DNAH11 MAPK11 EPHA6 RARS AAK1 DNAH7 OPLAH MYO5C GUK1 SMARCAL1 DDX3X MAPK4 DDX1 QARS KIF13B GCK CFTR SYN1 MAP3K8 HK2 MYO6 CKB LMTK3 MAPK13 MAP3K1 IDE PRKDC TDG ATP2B3 HSPA9 CPS1 MAPK10 ACLY PFKM DHX34 MB21D1 ATRX CSNK1A1 STK36 PLK4 DDX3Y DNAJA2 PSMC6 KIF23 NME1 CAMK2A CSNK1G2 PRPS1 ATP1A2 ADCY7 CDK13 CDK1 LIG1,MF,320,320 of 403,13.59,79.4,7.982E-166,8.542E-163
GO:0005886,plasma membrane,Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)P30671(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BM45(Evidence code:IEA/Database source:UniProtKB:A0A024R2C3)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)F1MJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N4S4(Evidence code:IBA/Database source:PANTHER:PTN000422281)E1B968(Evidence code:IEA/Database source:UniProtKB:P52569|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635134)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR020894)F1N5R0(Evidence code:IEA/Database source:UniProtKB:Q9Y345|ens)F1MT41(Evidence code:IBA/Database source:PANTHER:PTN000258543)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7Z052(Evidence code:IEA/Database source:UniProtKB:A0A087X295)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q3UUY6|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63086)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR020894)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001107229)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)F1N1D4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q9UKS6|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QLR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)F1MNS8(Evidence code:IEA/Database source:UniProtKB:Q13442|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q1KZG4(Evidence code:IEA/Database source:UniProtKB:A0A024R366)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)E1BDI1(Evidence code:IEA/Database source:UniProtKB:Q9DA79|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)Q01107(Evidence code:IEA/Database source:InterPro:IPR020894)E1BC13(Evidence code:IEA/Database source:UniProtKB:Q14003|ens)E1BET5(Evidence code:IEA/Database source:InterPro:IPR026648)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)F1N3I2(Evidence code:IBA/Database source:PANTHER:PTN000422281)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305)F1N611(Evidence code:IEA/Database source:UniProtKB:Q9H4G0|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:A0A024R1J8)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)G3MWR8(Evidence code:IEA/Database source:UniProtKB:Q7RTP6|ens)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N416(Evidence code:IEA/Database source:InterPro:IPR020894)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BG38(Evidence code:IEA/Database source:UniProtKB:Q92888|ens)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR020894)P02715(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1MQA8(Evidence code:IEA/Database source:UniProtKB:Q8NDI1|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005674)E1BMN4(Evidence code:IEA/Database source:UniProtKB:P28336|ens)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q6P1N0|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN000634601)A7MBG0(Evidence code:IEA/Database source:UniProtKB:A0A024R5Q7)E1B9S9(Evidence code:IBA/Database source:PANTHER:PTN000004140)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR020894)E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BGE2(Evidence code:IEA/Database source:UniProtKB:O75691|ens)P31407(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:A0A024R1Y6)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)F1MWI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MYE0(Evidence code:IEA/Database source:UniProtKB:A0A024R499)O02811(Evidence code:ISS/Database source:UniProtKB:P42356)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)F1N2Q9(Evidence code:IEA/Database source:UniProtKB:Q96HU8|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:A0A140VJR0)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)Q8WN96(Evidence code:IBA/Database source:PANTHER:PTN001416417)E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28827|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q08DN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323194)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)F1N2D3(Evidence code:IEA/Database source:UniProtKB:G3V1L9|ens)F1MJZ6(Evidence code:IEA/Database source:UniProtKB:O75954|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8NFT8|ens)P31408(Evidence code:ISS/Database source:UniProtKB:P62814)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)F1MDE1(Evidence code:IEA/Database source:UniRule:UR000484796)G3MYM1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR020894)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR020894)F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q1JQB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)Q29455(Evidence code:ISS/Database source:UniProtKB:Q9H3Z4)Q32PF2(Evidence code:IEA/Database source:UniProtKB:A0A024R1T9)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000818658)E1BKU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)A7MB64(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR020894)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444)P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3T099(Evidence code:IEA/Database source:UniProtKB:Q9UGM6|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR020894)Q3SZ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q95JC7(Evidence code:ISS/Database source:UniProtKB:Q15758)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q1LZF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090250)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)Q6Y1E2(Evidence code:IEA/Database source:UniProtKB:Q04941|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)E1BF53(Evidence code:IEA/Database source:InterPro:IPR020894)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BBK9(Evidence code:IEA/Database source:UniProtKB:Q8IYJ3|ens)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN001124099)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR020894)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR020894)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A4IFM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)E1BHM6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q9TU34(Evidence code:IBA/Database source:PANTHER:PTN001416417)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)P38408(Evidence code:TAS/Database source:)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)F1N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MMU9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MF97(Evidence code:IEA/Database source:UniProtKB:Q14112|ens)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P21282(Evidence code:ISS/Database source:UniProtKB:Q9Z1G3)F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BFE6(Evidence code:ISS/Database source:UniProtKB:Q9Z2C4)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)A0JNB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B7G0(Evidence code:IBA/Database source:PANTHER:PTN000466212)P31836(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:A0A024RDI0)Q08DA1(Evidence code:ISS/Database source:UniProtKB:P05023)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)E1B7T1(Evidence code:IEA/Database source:UniProtKB:Q7Z7B0|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)A6QQP7(Evidence code:ISS/Database source:UniProtKB:O75923)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)F1MML3(Evidence code:IEA/Database source:UniProtKB:Q5H9F3|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q3T0M9(Evidence code:ISS/Database source:UniProtKB:P40617)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2YDG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P63217(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BN05(Evidence code:IEA/Database source:UniProtKB:Q8BMF8|ens)A2VDU1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MM21(Evidence code:IBA/Database source:PANTHER:PTN000090250)A7YWH4(Evidence code:IBA/Database source:PANTHER:PTN000422281)A6QP06(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)Q2TA46(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q9NZM1|ens)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)O02675(Evidence code:IEA/Database source:UniProtKB:A0A1C7CYX9)A2VE81(Evidence code:IEA/Database source:UniRule:UR000001395)Q0VCK0(Evidence code:IEA/Database source:UniProtKB:P31939|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:A0A024RDV9)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)Q2KJD2(Evidence code:ISS/Database source:UniProtKB:P63024)F1N0J3(Evidence code:IBA/Database source:PANTHER:PTN000642368)A2VE13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:A0A024RC95)Q2KIT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR020894)G3X6L9(Evidence code:IEA/Database source:UniProtKB:Q8CGC7|ens)E1BLK3(Evidence code:IEA/Database source:UniProtKB:Q9JJA9|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)F1MNM7(Evidence code:IEA/Database source:UniProtKB:O88492|ens)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)E1BAF6(Evidence code:IEA/Database source:UniProtKB:P48634|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)P31404(Evidence code:ISS/Database source:UniProtKB:P50516)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)E1BPM0(Evidence code:IEA/Database source:UniProtKB:O95294|ens)F1ML52(Evidence code:IEA/Database source:UniProtKB:Q8TDN1|ens)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR020894)Q2KI18(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q08DD1(Evidence code:IEA/Database source:UniProtKB:P50428|ens)F1MP22(Evidence code:IBA/Database source:PANTHER:PTN000004140)Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287)E1BF03(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1BIB9(Evidence code:IBA/Database source:PANTHER:PTN000004140)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7YY70(Evidence code:IEA/Database source:InterPro:IPR029848)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)Q29450(Evidence code:IEA/Database source:InterPro:IPR009398|I)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3X7P3(Evidence code:IBA/Database source:PANTHER:PTN000090250)A2VDV7(Evidence code:IEA/Database source:UniProtKB:O15393|ens)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)A7Z045(Evidence code:IEA/Database source:UniProtKB:Q96KN1|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)F1MHP0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)E1B9D3(Evidence code:IBA/Database source:PANTHER:PTN002091395)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001283)A6QQ36(Evidence code:IBA/Database source:PANTHER:PTN000422281)E1BHR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BLU2(Evidence code:IEA/Database source:UniProtKB:O60779|ens)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q2YDE9(Evidence code:IEA/Database source:UniProtKB:A4D0U5|ens)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)G3N152(Evidence code:IEA/Database source:InterPro:IPR020894)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003)Q17QR2(Evidence code:IEA/Database source:UniProtKB:A0A140VK54)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-1003), SNF8 GNG7 BEST3 PIGN CIB1 PHKB ULBP11 SLC7A2 PROM1 DAB2IP RAB37 LIN7B TEC CRYAB ARHGAP21 LOC786512 SLC6A5 PTGFRN ECE1 CCNY CPNE1 RAB3B LIPE WDR6 GRB2 PROM2 MARK3 MAPK1 KNTC1 CD97 CDH11 PREX1 RAP2C DAAM1 F2R TTYH3 ALOX15 PACSIN3 PSEN1 VAMP5 GRIA3 CACNA1D LOC531090 CTNNA1 TMEM184A FLOT2 BCL3 PDAP1 SRI NDRG1 FHIT GNAI1 DPEP3 RIF1 HCFC2 DSC1 KCNC3 SSFA2 NEDD4 RAB3C DPP4 AFAP1L2 PRTG CD63 CHMP2B LOC788634 STRN3 STAT3 RNPEP EPB41L1 NF2 PKP4 MICAL3 NRXN1 CDH22 OR5M11 ARHGEF1 PCDH8 CHRNE PPP3CA SHANK1 EHBP1 PPP2CA PIK3CD NMBR RAB25 NDC1 SYT4 TNFAIP8L3 CC2D1A ATP1A2 PRNP RAB17 ADSS CACNA1F DNM2 CDHR1 TFRC ALOX15B AKAP12 S100A14 CLDN3 UTP20 ATP6V1B1 SEZ6L2 PALM ATP2B4 ITGB1 ABHD2 CHMP4A BAIAP2L1 GRIN3B IRS1 PI4KA SWAP70 ARL6 ABCA1 DIRAS2 SCRIB PDE4D AQP5 TMPRSS6 ITPR2 TNFSF15 PTPRM STX7 RAB3A LIN7A FLOT1 PIEZO1 ZFYVE27 CACNA1B F11R RGS14 BRCA1 TJP1 TSPAN9 FAM129B KIT DNER ATP6V1B2 NSFL1C CFTR INPP5J LRP6 SCN10A LOC614090 ATP8B1 PCDH20 PCDH12 SH2B2 LOC788626 CSPG4 CAPN2 GABRA5 GPR4 OR51Q1 ARRDC1 DNAJC5 ACLY MCTS1 CTTN AMER3 SHC1 ADORA2A CTNND1 LCK ITPRIP PCDHA13 GNAS ARVCF AP2B1 AP2M1 WARS2 ZAP70 UTRN BCR FAT2 GNG10 GRIA2 RAB39B SLC1A5 OR13C3 PTH1R GPD1L LGR4 AXIN1 ABHD17C MICALL2 PLP2 PDXP CDH7 AP2S1 RAB23 BRAF PRKACA SYTL1 CD44 PTK7 PAK1 BFSP1 BAIAP3 NBEA TSPAN14 CBLC C1QTNF5 HCN1 SMPDL3B PACSIN2 DCHS2 PCDHGC3 UBQLN1 CDC42SE2 LANCL2 FCER1G CLDN8 CLIC4 SCN11A SVIL SYN2 AAK1 TDG SERINC3 ITPR1 VPS28 KIF14 PPP1R13B GNA14 BACE1 HTRA1 COPB1 SCN8A NID2 GRIA1 ATP6V1C1 ATP2B3 RFFL SDCBP2 KCNMA1 MTMR1 HFE2 LY6H IFNLR1 NCAM1 SERINC5 TMEM30A TACSTD2 WDFY3 ATP1A1 MAPK8IP3 CKAP5 COMT IRS4 FILIP1 DGKQ DYSF RAB26 MARCH7 BICD2 BCORL1 TSG101 DLG1 ARL4A GLO1 ITGAL GPRC5C LITAF PRKACB GNG5 ROCK2 GLDN SPRY4 RGS6 BoLA SYTL2 AP2A2 STEAP4 FRS2 UBL3 VAV2 MPP5 MYOF ABCA7 DPYSL2 OCLN ATIC SPG20 CCT3 RDX CPNE6 ANO6 TLR4 CLDN7 FMNL1 RAPGEF2 VAMP3 ATP11A MAL2 TRAF6 INO80 LRRK2 ALDH1A3 DNAJB4 FAT1 EPRS GRASP TRPM7 PLIN4 CLIC1 VAMP2 DSTYK NPC1 CCNYL1 PRRC2A EPS15 PDGFC ATP6V1A JAK2 LIN7C TRPM4 RAP2A RASAL1 KCNG4 PKN1 PCDH1 PNPLA2 SIRT2 ARSA CACNA1E ITM2B PANX3 MYO1C TPCN2 LAMP1 SLC34A1 CNNM2 GRM7 MTSS1L FMNL3 ADCY7 RNF112 AXIN2 TMPRSS2 KCNA4 FAM84B YES1 SCN5A ARF6 SNAP25 RTN4R SRC SLC23A1 RYR1 SHANK2 SEPT2 GPR179 PTPRN FLNC SYT6 LOC100850276 SCN3A SLC19A2 PRKAR2A CLDN4 CAMK2D TES ALCAM PCDHB8 TSPAN2 IDE STAMBP TMEM59,CC,372,372 of 630,15.8,59.05,2.208E-160,1.969E-157
GO:0016021,integral component of membrane,F1MMH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMX7(Evidence code:IEA/Database source:InterPro:IPR000276|I)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMN4(Evidence code:IEA/Database source:InterPro:IPR000276|I)A4IFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMQ1(Evidence code:IEA/Database source:InterPro:IPR012561|I)A6QQ47(Evidence code:IBA/Database source:PANTHER:PTN000409559)G3X8A9(Evidence code:IEA/Database source:InterPro:IPR000276|I)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC83(Evidence code:IEA/Database source:InterPro:IPR002259|I)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4)E1BFN9(Evidence code:IEA/Database source:InterPro:IPR037440)A5D7F4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR001757|I)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR009460)P02722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B749(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MY84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3MU93(Evidence code:IEA/Database source:InterPro:IPR010660)Q08DD1(Evidence code:IEA/Database source:UniProtKB:P50428|ens)M5FK87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7H3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)G3MXA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BC61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1JQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QR68(Evidence code:IEA/Database source:InterPro:IPR007274)E1BKU0(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q3SYV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N758(Evidence code:IEA/Database source:InterPro:IPR016245)E1BB36(Evidence code:IEA/Database source:InterPro:IPR007754)E1BB56(Evidence code:IEA/Database source:InterPro:IPR012858)Q29423(Evidence code:IEA/Database source:InterPro:IPR001231)Q29RM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q58CZ7(Evidence code:IEA/Database source:InterPro:IPR000301|I)Q148L2(Evidence code:IEA/Database source:InterPro:IPR001757)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BA07(Evidence code:IEA/Database source:InterPro:IPR011701)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MIU3(Evidence code:IEA/Database source:InterPro:IPR012496)Q8WN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VCR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MS75(Evidence code:IEA/Database source:InterPro:IPR004842)A8DC37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005404)F1MMG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR005292|I)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1RMV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)B0JYK2(Evidence code:IEA/Database source:InterPro:IPR003392|I)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BF53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFH3(Evidence code:IEA/Database source:InterPro:IPR003644)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MK52(Evidence code:IEA/Database source:InterPro:IPR008795)F1MC27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7V2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O46405(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q00KA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BJW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BI45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5E9E7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BAW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MYG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR000832|I)F6R7C3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P63026(Evidence code:IEA/Database source:InterPro:IPR001388)G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MZZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A8E4P5(Evidence code:IEA/Database source:InterPro:IPR001614)Q0VCU9(Evidence code:IEA/Database source:InterPro:IPR012496)Q05037(Evidence code:IEA/Database source:InterPro:IPR012897|I)A4IFM4(Evidence code:IEA/Database source:InterPro:IPR004031)A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729)A2VE81(Evidence code:IEA/Database source:InterPro:IPR002958)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR001757|I)P02715(Evidence code:IEA/Database source:InterPro:IPR002394|I)F1MNY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1JPD9(Evidence code:IEA/Database source:InterPro:IPR017978)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O18875(Evidence code:IEA/Database source:InterPro:IPR000175)E1BBS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJD2(Evidence code:IEA/Database source:InterPro:IPR001388)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)F1MRG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MX24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VE11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P32592(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR001426)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08DA1(Evidence code:IEA/Database source:InterPro:IPR001757|I)F1MR98(Evidence code:IEA/Database source:InterPro:IPR000276|I)G3N271(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQ97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P31836(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MS16(Evidence code:IEA/Database source:InterPro:IPR001757)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08D78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BDL0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR015338|I)P11456(Evidence code:IEA/Database source:InterPro:IPR000296)Q765N9(Evidence code:IEA/Database source:InterPro:IPR004031)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7H9(Evidence code:IEA/Database source:InterPro:IPR000175)E1BN79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJA5(Evidence code:IEA/Database source:InterPro:IPR004687|I)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR009471)Q2TA30(Evidence code:IEA/Database source:InterPro:IPR007007)Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1)F1MPT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MSU3(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q3SZ26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BLU2(Evidence code:IEA/Database source:InterPro:IPR002666|I)Q17QL5(Evidence code:IEA/Database source:InterPro:IPR030351)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005405)Q58CW5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MF38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q05B70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BBU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KIP5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MGS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BFD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQ87(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P47803(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1B8X1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MNP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR030172)Q58DS4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N3I4(Evidence code:IEA/Database source:InterPro:IPR006614|I)G3X828(Evidence code:IEA/Database source:InterPro:IPR000276|I)G3MW09(Evidence code:IEA/Database source:InterPro:IPR011527|I)Q28053(Evidence code:IEA/Database source:InterPro:IPR008155|I)Q4ZJV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR001757|I)A7MB15(Evidence code:IEA/Database source:InterPro:IPR017981)A5PJQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJ41(Evidence code:IEA/Database source:InterPro:IPR000301|I)Q0VCP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MW11(Evidence code:IEA/Database source:InterPro:IPR011527|I)F1MP76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR000832|I)C3V9V7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N2S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR001757|I)Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653)A4FUW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q01107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3T110(Evidence code:IEA/Database source:InterPro:IPR008661)Q8WN91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q8HYW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XS26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P35071(Evidence code:IEA/Database source:InterPro:IPR011527|I)Q32LK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2YDG0(Evidence code:IEA/Database source:InterPro:IPR017978)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MS08(Evidence code:IEA/Database source:InterPro:IPR004842)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VDQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KI29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MWK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MN60(Evidence code:IEA/Database source:InterPro:IPR001757)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B813(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O46631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MJ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQ36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MKY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR001757|I)E1BPQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BL94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X812(Evidence code:IEA/Database source:InterPro:IPR008297|I)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N5Z0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MPF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N416(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0V7N0(Evidence code:IEA/Database source:InterPro:IPR001388)E1B9D3(Evidence code:IEA/Database source:InterPro:IPR017978)E1BQ05(Evidence code:IEA/Database source:InterPro:IPR018629)Q0V7N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X6Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BJU6(Evidence code:IEA/Database source:InterPro:IPR012315)E1BF06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08E50(Evidence code:IEA/Database source:InterPro:IPR005435|I)E1BPU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9TU34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5E9F1(Evidence code:IEA/Database source:InterPro:IPR008417)A3KMX1(Evidence code:IEA/Database source:InterPro:IPR005331|I)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q95J79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q6BBL6(Evidence code:IEA/Database source:InterPro:IPR004031)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7N8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QQK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7YY70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)A2VE13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08DB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QR35(Evidence code:IEA/Database source:InterPro:IPR007273)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR001426)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3SZJ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BGZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MMU8(Evidence code:IEA/Database source:InterPro:IPR012496)E1BHG3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N740(Evidence code:IEA/Database source:InterPro:IPR003644)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR011527|I)G3X7E9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VC64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BMA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MJZ6(Evidence code:IEA/Database source:InterPro:IPR000301|I)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KI18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7MBI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BGL9(Evidence code:IEA/Database source:InterPro:IPR028701)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BP63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G5E6J0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XSK2(Evidence code:IEA/Database source:InterPro:IPR000301|I)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N226(Evidence code:IEA/Database source:InterPro:IPR008155)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR029601)F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VC12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N4L1(Evidence code:IEA/Database source:InterPro:IPR011531|I)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BB93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q95JC7(Evidence code:IEA/Database source:InterPro:IPR001991|I)P81134(Evidence code:IEA/Database source:InterPro:IPR012493)A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BN52(Evidence code:IEA/Database source:InterPro:IPR003644)A6QR09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q673L2(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q6Y1E2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1RMK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N7K7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0P5B1(Evidence code:IEA/Database source:InterPro:IPR007223|I)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MD25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q6Q146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P10897(Evidence code:IEA/Database source:InterPro:IPR028837)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005459)F1N4T0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR001757|I)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A6QNP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BLE8(Evidence code:IEA/Database source:InterPro:IPR000162|I)A6QQP7(Evidence code:IEA/Database source:InterPro:IPR006614|I)A7YWN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B757(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N1D4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MGE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJ59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MLX5(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MG76(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1JQC7(Evidence code:IEA/Database source:InterPro:IPR005828)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BK86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VE53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9XT97(Evidence code:IEA/Database source:InterPro:IPR001108|I)E1BMY3(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR009460)E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR011527|I)O62826(Evidence code:IEA/Database source:InterPro:IPR005458)E1B968(Evidence code:IEA/Database source:InterPro:IPR004755)F1N5T9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MCW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A2VDN5(Evidence code:IEA/Database source:UniRule:UR000107246)E1BEB2(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM92(Evidence code:IEA/Database source:InterPro:IPR008795)Q2KIN6(Evidence code:IEA/Database source:InterPro:IPR007248)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)B6ULZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N2I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q08E55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZC71(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A3KN28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MQP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BJ99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR000175)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR009460)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BKQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q09YM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BKL9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0P559(Evidence code:IEA/Database source:InterPro:IPR007593)Q09YL9(Evidence code:IEA/Database source:InterPro:IPR001388)E1BAK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MPT8(Evidence code:IEA/Database source:InterPro:IPR030352)Q08DW9(Evidence code:ISS/Database source:UniProtKB:Q99LR1)G3MW12(Evidence code:IEA/Database source:InterPro:IPR011527|I)Q3T0W2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P56560(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MCB5(Evidence code:IEA/Database source:InterPro:IPR013769)A4IFK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A8KC68(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM45(Evidence code:IEA/Database source:InterPro:IPR037671)A7YY65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR000832|I)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MPN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P67810(Evidence code:IEA/Database source:InterPro:IPR019756|I)F1MEC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MTF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3X6G8(Evidence code:IEA/Database source:InterPro:IPR002131)A6H7B0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MRI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MWI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5EA65(Evidence code:IEA/Database source:InterPro:IPR000715)E1B7G0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q95M13(Evidence code:IEA/Database source:InterPro:IPR016248)E1BPZ1(Evidence code:IEA/Database source:InterPro:IPR006581)Q8MII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KJI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR026082)O18784(Evidence code:IEA/Database source:InterPro:IPR004729|I)Q3B7N4(Evidence code:IEA/Database source:InterPro:IPR004031)E1B9W1(Evidence code:IEA/Database source:InterPro:IPR004031)F1MSN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A5D7F2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MT41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MG24(Evidence code:IEA/Database source:InterPro:IPR026082)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N5R0(Evidence code:IEA/Database source:InterPro:IPR000175)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N5P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VD06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)V6F7Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A4FV32(Evidence code:IBA/Database source:PANTHER:PTN001023612)F1MLR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q5E9C2(Evidence code:IEA/Database source:InterPro:IPR003038)G3N127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR001757|I)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)Q1JQB3(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0VCP0(Evidence code:IEA/Database source:InterPro:IPR024371)Q32PI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q17QB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BIJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1ME12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q3ZCB8(Evidence code:ISS/Database source:UniProtKB:Q9P0I2)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MFY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BGU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)E1BHB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)A7YWN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F6Q9J4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1N4S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MD64(Evidence code:IEA/Database source:InterPro:IPR027272)A5PJQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)G3MY32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2KI48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884|I)F1MIU7(Evidence code:IEA/Database source:InterPro:IPR030307)Q28146(Evidence code:IEA/Database source:InterPro:IPR037440)G3N0Y0(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q2KHY2(Evidence code:IEA/Database source:InterPro:IPR001388)E1BKW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)P23956(Evidence code:IEA/Database source:UniProtKB-KW:KW-0812)Q2HJ40(Evidence code:IEA/Database source:InterPro:IPR009119|I), ITGA9 TIMM17B MAN1B1 OR51Q1 ITGAL NMBR LRRC24 OTOF VPS51 OR5M11 SERINC3 SLC29A1 SCO1 EMC10 NRXN2 PCDHGC3 SLC44A1 ATP7B RYR3 SLC25A4 PIGK TMEM106B SLC5A9 CSPG4 Notch1 ARSA CACNA1H SLC44A2 ABCC5 CNGB3 CYP7A1 LFNG RNF112 PKDREJ CMTM7 SLC31A1 ADORA2A TMEM263 ERBB4 MGAT2 DCST2 CD44 REEP5 TSPAN2 ATP13A1 ITGB6 SLC17A8 F11R TMC5 ITPR2 TMEM68 SLC12A1 FCGR2A HCN1 KCNC3 SCARA3 ABCC3 DHRS3 TMPRSS9 ENG NPC1 CACNA1D CDH7 FREM2 F2R PROM1 LMTK3 PCDH12 SCN8A CD80 CLIC4 LRP4 CACNA1E STEAP4 SLC23A1 MFSD6L GLT8D1 LRRC32 SLC39A6 CD97 PEX2 VAMP2 SCN10A SPAG4 LAMP1 GPM6B TMC6 KCNA4 CLDN8 LOC100125916 TPCN2 GAL3ST2 OCLN ATP8B1 CHRNE TMEM2 GPRC5B DPEP3 SLC6A8 QSOX2 VAMP3 TRPM4 SIRPB1 CLN3 UGT2B10 IGSF8 ITGB2 EPHB4 DBH ATP1A1 RRH LOC100337457 ITGAD NCAM1 ATP2B3 GRIA3 RNF128 LOC512672 LOC786512 COX4I1 COMT EXT1 M6PR CLDN3 MARCH8 SLC6A14 CES5A LAPTM5 TENM3 NINJ1 METTL7A POMGNT1 SDK2 ITM2B RXFP3 WRB SLC19A2 TMEM30A KCNC4 SERINC2 EMB GRAMD3 ADAM15 PDZK1IP1 CACNA1C NAALAD2 AIFM2 CACNA1S ANKLE2 ULBP3 RGR FNDC3A CYP2R1 GRIA4 KCNH6 TMEM171 SDK1 MYOF OR13C3 LOC509854 APP ABCG8 FLT3 ATP2B4 FZD1 PGRMC2 TSPAN14 CCDC149 LOC523126 SDC3 PTH2R TMED2 ITGAV LRRC26 ATP2C2 SPCS3 TXNDC11 MEGF8 ADAM7 DSC1 ADCY7 TM4SF18 CDHR1 atp1A3 HAS3 CFTR CYSTM1 GPRC5C LOC788634 CNNM2 SLC12A2 SOX1 CDH11 TMEM184A TMEM256 PTK7 SHISA5 ITGB1 ATP2B2 ABHD2 PTPRZ1 LOC786796 SIRPA PCDHA13 LOC100850276 SUSD5 MAN1A2 ATP13A5 IGSF5 VSIG2 NOTCH4 HEPACAM AQP5 DPP4 KCNG4 FAT2 CDH22 VAMP1 GPR179 XKR7 SUSD2 PCDH20 KCNMA1 SYNE3 TNFSF15 GABRA5 PTPRM ITPR1 BCAP31 CHST14 SLC25A29 TYROBP CLDN4 LETM1 TMPO TEX2 MARCH5 SLC34A1 INPP5B MAL2 HERC4 SCAMP2 PTPRN EPHA6 MGAT1 TLR4 ALCAM LAMP2 SLC45A4 TMC3 CDON FRAS1 ZFYVE27 LOC100299180 IL13RA1 CPT1B FCER1G MANSC1 PRTG TSPAN9 MRVI1 KCNF1 PNPLA2 SLC11A2 SYT6 GRIA2 RNF139 RHOT2 TFRC TMEM200B TMPRSS6 CD63 RHOT1 APLP2 TRPM7 SCN5A FIS1 YIPF3 SLC4A2 CLIC1 SMIM1 BOC SLC1A5 ATP6AP2 IMMT FREM1 SLC25A26 C5AR1 PLP2 FAM174B MARCO SCAP PEX13 CYP2J2 KIAA1549L NRCAM CYB561 LOC100295883 TRPC3 KCNT2 TPST2 ATP1A2 B3GALT4 BTNL2 GRM7 DYSF ENTPD2 SCN2B TTYH3 FRMD5 TMEM125 SCN11A LGR4 SLC5A11 GPR75 BEST3 AGPAT1 TMEM59 SLC22A23 KCNH5 PKHD1 PPP1R3F IKBIP ST8SIA3 PSEN1 LOC614090 RYR2 PANX3 LOC515333 TRPC2 SLC7A2 SERINC5 GRIK4 SPAST LOC531090 GALNT7 CACNA1F PROM2 MPV17 SEZ6L2 WC1 KLRF2 MBTPS1 DPM3 ST7L DCHS2 CACNA1B LMAN1L SLC6A20 RYR1 SCN3A ARID1B ULBP15 FAT1 IFITM1 STXBP5 SYVN1 TMEM30B ABHD12 LOC100337053 MGC126945 ITGA2 MAOB SLC4A7 PCDH1 NLGN2 PIGN MTCH1 LOC100298868 PTH1R GALNT2 FNDC3B PCDHB8 SEC11A PCDH8 BoLA IL9R LGR6 PLLP PIGO HAS2 KIT LMTK2 GRIN3B DPAGT1 IFNLR1 ECE1 fgfr3 SORL1 SLC35B1 ENTPD6 ABCA7 TRPC1 CLDN7 TMEM114 TACSTD2 SYT4 PTGFRN ABCA1 STX7 SLC6A5 TMPRSS2 DNER NPTN GRIA1 DSCAML1 PTPRA PLEKHB2 ASTN1 DAD1 G0S2 ATP11A KL GPR4 LRP6 SLC33A1 MPZL1 PLA2G16 LEMD3 DSEL EMC3 KCNG2 ANO6 SOGA3 NDC1 FAM205A ITGB7 LOC100848815 ULBP11 PIEZO1 RNF130 CLCC1 TMTC2 PTTG1IP MBTPS2 GK2 MFN2 SLC27A3 NRXN1 LOC788626 VAMP5 SNX19 ATP6V0C BACE1,CC,444,444 of 1299,18.86,34.18,2.278E-121,1.219E-118
GO:0005654,nucleoplasm,F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)A2VDN5(Evidence code:IEA/Database source:UniProtKB:E5KRP5|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)P02694(Evidence code:IEA/Database source:UniProtKB:A0A0A0MQT0)E1BIP2(Evidence code:IEA/Database source:UniProtKB:A0A024R151)E1BDE3(Evidence code:IEA/Database source:UniProtKB:A0A024R461)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)A4FUD1(Evidence code:IEA/Database source:UniProtKB:Q9HCN4|ens)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB:A0A024R2W7)E1BGE5(Evidence code:IEA/Database source:UniProtKB:O95373|ens)Q5E9K0(Evidence code:IEA/Database source:UniProtKB:A0A140VJS6)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1BE97(Evidence code:IEA/Database source:UniProtKB:Q7LBC6|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:F1D8P9|ens)Q32LB3(Evidence code:IEA/Database source:UniProtKB:Q7LFL8|ens)F1MQH2(Evidence code:IEA/Database source:UniProtKB:A0A0B4J1T8)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0M9(Evidence code:IEA/Database source:UniProtKB:A0A024R9Z2)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)E1BJV5(Evidence code:IEA/Database source:UniProtKB:Q14966|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)O19137(Evidence code:IEA/Database source:UniProtKB:O95639|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q14190|ens)E1BHZ4(Evidence code:IEA/Database source:UniProtKB:Q9UPT8|ens)F1MVT7(Evidence code:IBA/Database source:PANTHER:PTN000192346)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62191|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)E1BGT8(Evidence code:IEA/Database source:UniProtKB:Q08AE8|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:A0A024R7W9)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BAF6(Evidence code:IEA/Database source:UniProtKB:P48634|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BH30(Evidence code:IEA/Database source:UniProtKB:Q96BY7|ens)E1BB93(Evidence code:IEA/Database source:UniProtKB:Q9BWV1|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:A0A024R136)A4FV74(Evidence code:IEA/Database source:UniProtKB:A0A024R4D1)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:A0A024R7E0)E1BBH8(Evidence code:IEA/Database source:UniProtKB:A0A024RBA3)Q2KII5(Evidence code:IEA/Database source:UniProtKB:A0A024QZZ7)F1MWT0(Evidence code:IEA/Database source:UniProtKB:Q9NTJ4|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)F1MML3(Evidence code:IEA/Database source:UniProtKB:Q5H9F3|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)F1N281(Evidence code:IEA/Database source:UniProtKB:Q7Z4V0|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61457|ens)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1N1V1(Evidence code:IEA/Database source:UniProtKB:A0A024R0G2)E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MHP1(Evidence code:IEA/Database source:UniProtKB:O15042|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)F1MI25(Evidence code:IEA/Database source:UniProtKB:P15822|ens)P61283(Evidence code:IEA/Database source:UniProtKB:A0A024R5H0)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)Q08DK5(Evidence code:IEA/Database source:UniProtKB:Q9NR46|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1BQ01(Evidence code:IEA/Database source:UniProtKB:Q8N1G0|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)G3MZ78(Evidence code:IEA/Database source:UniProtKB:Q9H0L4|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)F1N2G1(Evidence code:IEA/Database source:UniProtKB:Q8NFC6|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)Q32L41(Evidence code:IEA/Database source:UniProtKB:P30047|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)F1MLT6(Evidence code:IEA/Database source:UniProtKB:A2RRH5|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:A0A024R7L6)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O95785|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:A0A087WYT3)A6H7B5(Evidence code:IEA/Database source:UniProtKB:Q9UNS2|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN000192346)Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)Q2KIT4(Evidence code:IEA/Database source:UniProtKB:Q9UDY4|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q2L6I0|ens)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q2TBI4(Evidence code:IEA/Database source:UniProtKB:A0A140VJY2)Q32PD5(Evidence code:IEA/Database source:UniProtKB:B0ZBD0|ens)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN000192346)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)E1BNY9(Evidence code:IEA/Database source:UniProtKB:A0A024R9W5)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)Q3T087(Evidence code:ISS/Database source:UniProtKB:P62913)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)Q28104(Evidence code:IEA/Database source:UniProtKB:M0QXB4|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:A3RJH1|ens)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:A0A140VK27)P26882(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q9UJQ4|ens)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)Q2NL22(Evidence code:IEA/Database source:UniProtKB:A0A024R8W0)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:P31644|ens)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:P18564|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)A5D7P5(Evidence code:IEA/Database source:UniProtKB:Q9BSJ2|ens)Q9TTA5(Evidence code:IEA/Database source:UniProtKB:Q9NZC9|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:Q9HAU0|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)E1BDU9(Evidence code:IEA/Database source:UniProtKB:Q8WXI9|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:W0Z7M9|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens)Q17QN3(Evidence code:IEA/Database source:UniProtKB:X5DP00|ens)A6QQX8(Evidence code:IEA/Database source:UniProtKB:Q53GS9|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:A4LAA3|ens)Q08DB4(Evidence code:IEA/Database source:UniProtKB:B0QZ18|ens)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:Q8IVL1|ens)E1BEJ7(Evidence code:IEA/Database source:UniProtKB:Q9Y5Z7|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P13349|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:A2ABF8|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)Q0VCY7(Evidence code:ISS/Database source:UniProtKB:Q07955)E1BL97(Evidence code:IEA/Database source:UniProtKB:Q9UN79|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)P27214(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7YW98(Evidence code:IEA/Database source:UniProtKB:P54136|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)E1BJF4(Evidence code:IEA/Database source:UniProtKB:A6NMQ1|ens)Q32S26(Evidence code:IEA/Database source:UniProtKB:P25440|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:A0A140VK54)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:Q03052|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)Q3SZ43(Evidence code:IEA/Database source:UniProtKB:A0M8W4|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q9NR48|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:A0A024R7C0)E1BBS6(Evidence code:IEA/Database source:UniProtKB:Q6ZRP7|ens)E1BAW2(Evidence code:IEA/Database source:UniProtKB:A0A024R5J7)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q9H832|ens)Q5BIM5(Evidence code:IEA/Database source:UniProtKB:Q5T4F4|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q5GJ75|ens)A5PKA5(Evidence code:IEA/Database source:UniProtKB:Q96L92|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)G3MWR8(Evidence code:IEA/Database source:UniProtKB:Q7RTP6|ens)E1B8T3(Evidence code:IEA/Database source:UniProtKB:Q9UGU0|ens)E1B8E3(Evidence code:IEA/Database source:UniProtKB:Q86SG2|ens)E1B8G9(Evidence code:IEA/Database source:UniProtKB:Q8N257|ens)F1N2I0(Evidence code:IEA/Database source:UniProtKB:P26374|ens)F1MRP8(Evidence code:IEA/Database source:UniProtKB:Q5JYA6|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)E1BM86(Evidence code:IEA/Database source:UniProtKB:Q6ZN04|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)P48452(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4C6)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q92598|ens)Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z5H3)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:B0LPF3|ens)Q9TU47(Evidence code:IEA/Database source:UniProtKB:P56537|ens)F1MHL2(Evidence code:IEA/Database source:UniProtKB:Q92625|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)A4IFC8(Evidence code:IEA/Database source:UniProtKB:P18858|ens)F2Z4E8(Evidence code:IEA/Database source:UniProtKB:A0A024RCJ9)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)E1BFV5(Evidence code:IEA/Database source:UniProtKB:Q7RTV3|ens)G3N0Y7(Evidence code:IEA/Database source:UniProtKB:Q9NTX9|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)Q32PF2(Evidence code:IEA/Database source:UniProtKB:A0A024R1T9)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q13617|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)E1BGK7(Evidence code:IEA/Database source:UniProtKB:J3KTH2|ens), ADARB1 CAND1 GLI1 GTF3C6 SPAST KMT2A RBP1 SLC44A1 CTDSP1 GOLGA3 GPN1 MAPKAPK3 IPO7 PSMB2 NFKB1 NUDT16 MYO6 RPS6KA4 KDM3B NR1I2 CXXC5 EPHA6 PPP1CC ARL4A PTPN23 ZNF638 PTPA NUMA1 DHX9 BAIAP2L1 PUM1 CPSF4 SIM2 ZC3H4 EPM2AIP1 PSMC1 SYVN1 SPIRE1 COPS5 PIN1 PPP1CB PRRC2A BRCA2 ATG2B BOC SPEN CRKL RACGAP1 COPS8 RUVBL1 NACC1 MBD6 HIST1H2BI MAN2C1 CCAR2 RPS6KA5 BCORL1 PTTG1IP ZCCHC6 ZNF438 PCBD1 ACSS2 TOP2B DENND2D RPP25 SNF8 U2SURP SCRIB SFPQ GCC2 SP1 TRPM4 HIVEP1 BANF1 UHMK1 INO80 SH3GLB2 SMG1 CHD6 LITAF ZNF687 DUSP3 CSTF2T INA BOD1L1 SETX CAD GCHFR MAGI1 WDR27 MVB12A KIF23 MYO1C ESRP1 CTBP1 HIC1 WIZ PTGES3 COPS3 OSBP RAD18 STRAP ZMYM5 DNM1 DNAJB4 PPP1R10 PCBP2 TRAP1 RPS19 ZMYM4 RNF112 HUWE1 GPKOW CDC27 RPL11 MRI1 COPE TNKS DDX1 LTA4H PPID PTPN14 SETD1B GCFC2 HOXA7 PLCB3 DOCK10 PCBP1 SALL4 TRIP12 EIF4A3 BCL3 GABRA5 AP5Z1 E2F1 ITGB6 ONECUT2 TUBGCP2 SMARCAL1 RUNX1 BCL9L DHX8 FAM129B SMARCA2 PLEKHA5 CDC5L NPAT DENND1A GATAD2B MKL1 JAK2 XPOT EAF2 SNRPN USP39 UBQLN1 ATRX CPNE1 PPP1R13B NAV2 HCFC2 SIRT6 DYRK2 MYF5 SRI EHMT2 KPNB1 PRKDC TAF10 SRSF1 SOX13 RAD23B ANXA11 RARS TDG POLA1 BRD2 STAMBP ZBTB4 KHDRBS1 POU3F1 CDK6 WWTR1 DNAJC7 UBE2V2 ASH1L KEAP1 QSOX2 LRRC32 CNP DOT1L UBE2Z ZFYVE27 TNFAIP8L3 SNX27 CIB1 TAF8 MICAL3 TCF20 ANKRD23 HIST3H2BB CHML PLEKHG1 RAI1 WRN CPSF3L MEX3B UTRN ABL1 ARID1A STRN3 NCOA3 AGO4 ZHX3 PPP3CA HSPH1 MIER1 ARID3A TNRC18 CLINT1 GRB2 EIF6 ANKS1A FERMT2 LIG1 HIST1H2BB SEC13 ZNF367 FAM217B KANSL3 CHD7 ACLY SNRNP200 SNRNP70 CUL2 NSFL1C TAF4B,CC,237,237 of 315,10.07,75.24,4.941E-121,2.404E-118
GO:0009987,cellular process,F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens),FMNL1,BP,1,1 of 3971,0.04,0.03,8.698E-113,3.879E-110
GO:0000166,nucleotide binding,F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0II58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5E9F9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P31404(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TBH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR010997)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08DA1(Evidence code:IEA/Database source:InterPro:IPR023299)F1N3Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MW12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BN72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58DV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR023299)G3MXV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MWD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BC41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MS16(Evidence code:IEA/Database source:InterPro:IPR023299)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1B953(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E6P3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1RMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A1A4J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BGB0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MXH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q75WB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3N1E4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5EAC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BNQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MW09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006134|I)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR002318|I)P10568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I)A5PJJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SWY3(Evidence code:ISS/Database source:UniProtKB:P12268)G5E5T3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MEM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2NKZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q58DC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MG18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BFA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BIL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BNQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MVC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)D3IVZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N2Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MMC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3N2C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P61085(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MXH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q05B83(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR023299)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q17R14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MW11(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)D3K0R6(Evidence code:IEA/Database source:InterPro:IPR023299)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MUU2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TBI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q28007(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZBF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2KIW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A3KN22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SZ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MB90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7YSY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BPK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BKQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BBT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001412|I)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0P5I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P62194(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P81948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR023299)Q17QG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08E45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q17QB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5D7A4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q32L40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR023299)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1ML89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MG13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MMQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBB1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2YDJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000924|I)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P0C7Q4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BC36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5D7N6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MX93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08DI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR023299)F1MUC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR001412|I)F1MG24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR010997)E1B870(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MY45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E5S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MLR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N1I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QPN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BA80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BBN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P68138(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5PJP8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3X6L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR002318|I)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0V8H0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1N758(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3MZH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJ86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q1JP95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR023299)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7E3C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MN60(Evidence code:IEA/Database source:InterPro:IPR023299)Q32KW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BNV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q9TTA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR002314|I)Q0VCP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BJK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MM57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q4PS77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4FUZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q5EA61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3ZC28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T0M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F2Z4H6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q4ZJV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BCG1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)P38408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I)G3N3N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MU48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2HJ58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q2T9S0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F6RP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)F1MI74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)Q3T084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0547), MARK3 PI4KA TUBA1A GALK1 KIF5C PSMC2 ROCK2 ATP6V1A DNM1 RRAS BLM TYK2 ATP1A1 ABCC3 LOC100337053 NIM1K TUBA8 RP2 MAPK10 ATP13A5 KIF13A CCT5 KIF15 ATP2B3 STK25 GNAT2 RAN LOC533307 GNA13 DDX3X UBE2D2 PFKL KIF13B SAMHD1 CSNK1A1 HRAS SMG1 TOR2A OPLAH EIF4A3 GART KIF26A RHOT2 HINT3 KIF26B NOA1 GSS MATK RAB26 DHX37 LOC509854 PAK2 QARS POLA1 KIF2A AARS MYO1A NARS CDK3 IMPDH2 LOC100299180 TDRD9 EPHA6 EPHB4 DHX8 PRKACA MAPKAPK3 CCT7 GTPBP1 MYLK4 ARL8B KIFC3 MAST4 PAK6 GNA12 PFKP ASNS RAP2A HSPH1 EFTUD2 CAD DDX3Y HSPA9 NLRP14 DIRAS2 CAMK2D MYO1C MYO1F NLRP7 DXO NLRP5 UBE2K PTPA IDE MYO9A RFC2 WEE1 ATP7B PKN1 ADCY7 MYO1D CCT3 RAB3A PRKCB CCT8 LOC523126 SRC ATP2B4 PLK4 PLK3 STK35 RAB39B ARL1 MAP3K9 CDC42BPB TRAP1 DSTYK DICER1 DPYD NADSYN1 MAPK9 PSMC6 UBE2M ATM EIF4A1 CSNK1G2 PRKAG1 JAK2 DDX4 SPATA5L1 MYO6 HCK YES1 PRKDC MYO18A HSPA4L RAB4A MB21D1 RARS2 GNAT1 NEK3 MCM4 SEPT6 CSNK1G1 PSMC5 PFKM NME1 ACTR1A PIP4K2C TUBA4A ATP8B1 UBE2G2 CAMK2A RAB30 FLT3 RIT1 MASTL FHIT BRAF ACLY RHOT1 PAK3 RARS TUBB4A CDK12 TCP1 SEPT7 ABL1 FRK ATP11A fgfr3 CPS1 GSK3A MYO15A MYO5B LOC783604 ARL2 CDK1 GMPPB RUVBL1 EPRS RAB25 GNAT3 HK2 ERCC2 AAK1 CDK6 KIF23 MYO5C FIGNL1 RAP2C MX2 VPS4B PANK4 KIT ATP2C2 LOC515333 MDN1 MARS ABCA1 RAB3C RAB3B JAK1 WRN ARL16 CARNS1 KIF14 MYO7B LOC100336669 DHX9 GNAL MYO18B KIF1B PRKACB PRKCI DNM2 CHD8 UBE2L3 LIG1 CSNK1G3 GCK ACTA1 GNAS PRKAR2A CFTR EIF4A2 MAP2K4 SAR1B WARS2 GUK1 DDX1 GNAI1 ARL8A RUVBL2 DGKQ SPAST KIF5B AARS2 MAP3K10 DHX57 NME3 ERBB4 MYO5A TUBA1D PSMC3 ATP1A2 PIK3CD DHX34 KATNAL2 RPS6KA5 KIFC1 MAPK11 CDK13 GUCY1A3 MAPK12 ABCE1 ACTR1B MAPK13 MYH11 LCK KIF5A ATP2B2 IRGC TEC PAK4 ADSS MYO9B SMARCAL1 MAPK1 CAMK2B RPS6KA4 NUDT16 LOC100141266 GARS SEPT8 TUBB1 MYH14 GPN1 MTG1 PSMC1 PAK1 ARL6 CKB MYLK2 ARL13B ARL4A TUBA3E TRIM23 GK ABCG8 ABCA7 GNA14 ZAP70 IARS ARF6 RNF112 TOP2B PRPS1 SEPT2 TUBB3 LOC100295712 LARS NLRP12 CCT6B SEPT11 RPS6KA2,MF,306,306 of 677,13,45.2,3.326E-110,1.369E-107
GO:0005622,intracellular,F1MU53(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1MMN0(Evidence code:IEA/Database source:InterPro:IPR000315)F1MHB9(Evidence code:IEA/Database source:GO:0048016)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q5E9S7(Evidence code:IEA/Database source:GO:0007264)Q27995(Evidence code:IEA/Database source:GO:0007263)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)Q27971(Evidence code:IEA/Database source:InterPro:IPR001300|I)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)G3N2N6(Evidence code:IEA/Database source:InterPro:IPR001909|I)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR002121)F1MQ96(Evidence code:IBA/Database source:PANTHER:PTN000683254)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)Q3ZC28(Evidence code:IEA/Database source:InterPro:IPR024156)Q56JV6(Evidence code:IEA/Database source:InterPro:IPR002108)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)C3VEX2(Evidence code:IEA/Database source:InterPro:IPR001666)E1BKU0(Evidence code:IEA/Database source:GO:0007189)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR018277)Q17QT7(Evidence code:IEA/Database source:UniProtKB:Q9H0Q0|ens)F1N6C0(Evidence code:IEA/Database source:GO:0019722)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)F1MY16(Evidence code:IEA/Database source:GO:0035556)E1BD05(Evidence code:IEA/Database source:GO:0006405)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR002359)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)F1MY84(Evidence code:IEA/Database source:GO:0035556)Q3SX45(Evidence code:IEA/Database source:GO:0035556)E1BKJ6(Evidence code:IEA/Database source:GO:0014065)A5PKC1(Evidence code:IEA/Database source:GO:0035556)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)F1MN90(Evidence code:IEA/Database source:InterPro:IPR003508)Q3B7N3(Evidence code:IEA/Database source:GO:0006886)A6QLN9(Evidence code:IEA/Database source:InterPro:IPR020592)F1MCY2(Evidence code:IEA/Database source:UniProtKB:Q501J7|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)Q2HJ54(Evidence code:IEA/Database source:InterPro:IPR001666)Q1LZF7(Evidence code:IEA/Database source:GO:0007189)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)G3N3N1(Evidence code:IEA/Database source:InterPro:IPR024156)F1MP51(Evidence code:IEA/Database source:UniProtKB:Q8NCM2|ens)Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)G3N065(Evidence code:IEA/Database source:GO:0072332)F1N657(Evidence code:IEA/Database source:GO:0035556)E1BG23(Evidence code:IEA/Database source:InterPro:IPR000315)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q0IIM2(Evidence code:IEA/Database source:InterPro:IPR024156)E1BQ22(Evidence code:IEA/Database source:InterPro:IPR000315)E1BIX3(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q2TA37(Evidence code:IEA/Database source:InterPro:IPR024156)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN000584058)Q1JQD5(Evidence code:IEA/Database source:GO:0035556)G3MXV5(Evidence code:IEA/Database source:GO:0072383)E1BM69(Evidence code:IEA/Database source:InterPro:IPR000315)G3MZ78(Evidence code:IEA/Database source:UniProtKB:Q9H0L4|ens)A5PK70(Evidence code:IBA/Database source:PANTHER:PTN000887110)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A8WFQ1(Evidence code:IEA/Database source:InterPro:IPR000315|I)F1MS53(Evidence code:IEA/Database source:GO:0007264)A5PK10(Evidence code:IEA/Database source:InterPro:IPR004152)F1MQ43(Evidence code:IEA/Database source:GO:0007264)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)F1MKU3(Evidence code:IEA/Database source:InterPro:IPR000315)Q5BIP4(Evidence code:IEA/Database source:InterPro:IPR004152)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR000315)A6H7F7(Evidence code:IEA/Database source:InterPro:IPR006722)Q3T087(Evidence code:IEA/Database source:InterPro:IPR020929)F1MK99(Evidence code:IEA/Database source:GO:0035556)A7YVE7(Evidence code:IEA/Database source:GO:0035556)Q2YDM1(Evidence code:IEA/Database source:InterPro:IPR024156)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)E1BGQ4(Evidence code:IEA/Database source:InterPro:IPR001909|I)P63097(Evidence code:IEA/Database source:UniProtKB:B2RSH2|ens)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672)Q3T0T7(Evidence code:IEA/Database source:InterPro:IPR006687)E1BN32(Evidence code:IEA/Database source:GO:0035556)G3X6L5(Evidence code:IEA/Database source:InterPro:IPR024156)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002121)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR001912|I)P43481(Evidence code:IEA/Database source:GO:0035556)F1MQD1(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q32LM6(Evidence code:IEA/Database source:GO:0048489)Q2KI07(Evidence code:IEA/Database source:InterPro:IPR024156)E1BF06(Evidence code:IEA/Database source:GO:0007250)F6QPI1(Evidence code:IEA/Database source:GO:0007263)Q58DL5(Evidence code:IEA/Database source:GO:0007264)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1B870(Evidence code:IEA/Database source:InterPro:IPR024156)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR001300|I)A1A4I4(Evidence code:IBA/Database source:PANTHER:PTN000683254)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530)E1B7G6(Evidence code:IEA/Database source:GO:1990126)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)F1MLZ5(Evidence code:IEA/Database source:GO:0008333)F1N7V2(Evidence code:IEA/Database source:UniProtKB:Q9H0T7|ens)P05126(Evidence code:IBA/Database source:PANTHER:PTN000683254)E1BNM4(Evidence code:IEA/Database source:InterPro:IPR001909|I)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR002108)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR000315|I)F1MCK0(Evidence code:IEA/Database source:UniProtKB:Q8N3A8|ens)E1BBX9(Evidence code:IEA/Database source:GO:0035556)Q3T0M9(Evidence code:IEA/Database source:InterPro:IPR024156), ZNF446 TRIM14 INPP5A ANO6 TBC1D2 RASGEF1A NOS2 RPS28 CAPN2 TBC1D22B ZFP37 RPS7 ABI1 BLM PRKCI RPL23A IKBKG ARL13B TWF1 MYLK4 PITPNM2 ADORA2A RPS19 FAM49A CALM1 MT3 RPS27 TUBB3 RPL27 RPS4X AKAP13 POM121L2 RPL9 RPL22 WASF2 CSPG4 ASB2 NYAP1 CDC42BPA MRPL3 CIDEC RANBP6 VWA1 PHACTR4 PSEN1 SGSM2 SRI PITPNA PTH1R ALOX15B ARF6 KCNH5 RPL35A ZNF385C SPATA13 TRIM47 MYLK3 ARL6 TRIM68 CAPN7 ARL2 ZNF394 BRAF OXSR1 KIF13A LOC516599 CSTF2T NME3 CLIC4 LRRK2 TRIM37 RAPGEF6 TOM1L2 DOCK9 ATF6B RPS4Y1 BSPRY TOM1 RNF31 TRAPPC2L RPL11 UNC13A CIT ARL1 RPL30 ZNF316 GNAI1 RPL28 SAR1B RP1L1 ARL8A WRN RPS9 KIT CAPN5 LIN7A ARL8B TNFSF15 NDNF BCAR3 RPL38 CHMP2B ARL16 CAPN11 PKN1 RPL8 RABGAP1 BCL11B LOC511302 ANKRD50 RPS27L RPS18 RPS17 DENND3 RAB17 PRKCB ZNF282 DSTN TRIM23 PARP8 UNC13C ARL4A,CC,122,122 of 95,5.18,128.42,1.186E-81,4.531E-79
GO:0006468,protein phosphorylation,P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR000719)Q2KI72(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN63(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VE07(Evidence code:IEA/Database source:InterPro:IPR000719)E1BG90(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B847(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SYZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRI6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000719|I)A0JN96(Evidence code:IEA/Database source:InterPro:IPR000719)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X793(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18052|ens)F1N3T0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP3(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1B793(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q58D16(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MM88(Evidence code:IEA/Database source:InterPro:IPR000719|I)P43481(Evidence code:IEA/Database source:InterPro:IPR000719|I)P48734(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N758(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4FV00(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MH24(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PK86(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLW1(Evidence code:IEA/Database source:InterPro:IPR000719|I)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR000719|I)P58108(Evidence code:IEA/Database source:GO:0004679)E1BKM6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MUU2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q08E45(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHZ1(Evidence code:IEA/Database source:InterPro:IPR000719|I)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIM8(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q95M13(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MKY9(Evidence code:IEA/Database source:InterPro:IPR004166)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLB8(Evidence code:IEA/Database source:InterPro:IPR000719|I)P05126(Evidence code:IEA/Database source:InterPro:IPR000719|I)P05131(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLJ0(Evidence code:IEA/Database source:GO:0004672)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB52(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB90(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BA03(Evidence code:IEA/Database source:InterPro:IPR000719)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFF6(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X696(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q08E52(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB57(Evidence code:IEA/Database source:InterPro:IPR000719|I)P00517(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q4TVR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SZK4(Evidence code:IEA/Database source:GO:0004672)Q2HJ82(Evidence code:IEA/Database source:InterPro:IPR015726)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR000719|I)A8QID1(Evidence code:IEA/Database source:InterPro:IPR000719)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR000719|I)P67827(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFM7(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X736(Evidence code:IEA/Database source:UniProtKB:P61201|ens)E1BC36(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MN42(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9Y478|ens)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR004166)E1B9B6(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SWY6(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP5(Evidence code:IEA/Database source:InterPro:IPR000719|I)P35509(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N6C1(Evidence code:IEA/Database source:InterPro:IPR000719)A5PJJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MG18(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR000719)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)F1N3K4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N5W5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MC27(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BJM5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MJ90(Evidence code:IEA/Database source:GO:0004689)F1MY16(Evidence code:IEA/Database source:GO:0004691)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000719)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR000719|I)V6F977(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N1T6(Evidence code:IEA/Database source:GO:0004672)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)E1BN72(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B8H0(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB50(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR014930)E1BL08(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB49(Evidence code:IEA/Database source:InterPro:IPR000719|I)P46196(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q58DV4(Evidence code:IEA/Database source:GO:0004672), IGFBP3 PAK4 MAPK9 WNK1 STK24 DYRK2 MAP3K1 BRSK2 MAPKAPK3 LMTK2 RPS6KA5 STK3 PAK2 MAPK11 PTPRA MAP3K4 RPS6KA4 MYLK3 ATM STK36 JAK2 MATK NEK9 KIT CDK1 ERBB4 MAPK10 AAK1 MAP3K8 PIK3R4 JAK1 CAMK2D PRKAG1 TAOK2 STK35 PAK3 PTK7 RPS6KA2 TYK2 MARK3 CAMK2A NEK10 PKN1 SRC fgfr3 ALPK2 CAMK2B GSK3A PRKCB PRKACB ERCC2 FRK CDC42BPB ROCK2 ABL1 CDK13 CSNK1G2 ZAP70 MAPK13 PAK6 PLK4 MAP2K4 NEK3 SLK PAK1 YES1 PRKACA DCLK2 MAST4 DSTYK TBRG4 SPEG LRRK2 MAP3K10 PRKCI EPHB4 ULK3 PIK3CD FLT3 CSNK1G1 PLK3 CSNK1A1 MYLK2 EPHA6 MASTL COPS2 CDK6 CDK17 TRIO WEE1 CAMK2G PRKAB1 COPS8 TRPM7 NUAK1 STK25 PINK1 CSNK1G3 LRRK1 CDK3 MYLK4 TAOK3 OXSR1 PRKDC MAP3K9 TEC MAPK12 STK26 LMTK3 MAPK4 PASK PHKB AKAP13 UHMK1 LCK SIK3 FASTKD2 BRAF FAM20C NIM1K PEAK1 OBSCN CDK12 HCK CDC42BPA MAP3K14 HIPK4 MAPK1 FASTK,BP,129,129 of 125,5.48,103.2,7.941E-79,2.833E-76
GO:0043227,membrane-bounded organelle,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,CC,1,1 of 2520,0.04,0.04,2.038E-72,6.817E-70
GO:0043229,intracellular organelle,E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7),SLC23A1,CC,1,1 of 2510,0.04,0.04,3.03E-72,9.539E-70
GO:0071704,organic substance metabolic process,F1MS56(Evidence code:IEA/Database source:InterPro:IPR005843|I),PGM3,BP,1,1 of 2421,0.04,0.04,1.403E-69,4.171E-67
GO:0004672,protein kinase activity,P05126(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)A8QID1(Evidence code:IEA/Database source:InterPro:IPR000719)Q95M13(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MM88(Evidence code:IEA/Database source:InterPro:IPR000719|I)P67827(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B847(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000719)E1B9B6(Evidence code:IEA/Database source:InterPro:IPR000719|I)A2VE07(Evidence code:IEA/Database source:InterPro:IPR000719)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000719)F1N758(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLB8(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SWY6(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB57(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q08E52(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q58D16(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X793(Evidence code:IEA/Database source:InterPro:IPR000719)A4IFM7(Evidence code:IEA/Database source:InterPro:IPR000719|I)P43481(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q58DV4(Evidence code:IEA/Database source:InterPro:IPR010622)E1BG90(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BA03(Evidence code:IEA/Database source:InterPro:IPR000719)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BC36(Evidence code:IEA/Database source:InterPro:IPR000719|I)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000719|I)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR000719)F1MC27(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLW1(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)P46196(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N3K4(Evidence code:IEA/Database source:InterPro:IPR000719|I)P05131(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q08E45(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9Y478|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MH24(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR000719|I)V6F977(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4IFF6(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BKM6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB52(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP5(Evidence code:IEA/Database source:InterPro:IPR000719|I)A4FV00(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N1T6(Evidence code:IEA/Database source:InterPro:IPR010622)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJP8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SYZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MUU2(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR000719)F1N3T0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN72(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MG18(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q4TVR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BJM5(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BHE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN63(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N5W5(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BL08(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR000719|I)P48734(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BIM8(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1N6C1(Evidence code:IEA/Database source:InterPro:IPR000719)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR000719)E1BMP3(Evidence code:IEA/Database source:InterPro:IPR000719|I)A0JN96(Evidence code:IEA/Database source:InterPro:IPR000719)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q3SZK4(Evidence code:IEA/Database source:InterPro:IPR010622)E1BHZ1(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MN42(Evidence code:IEA/Database source:InterPro:IPR000719|I)P00517(Evidence code:IEA/Database source:InterPro:IPR000719|I)Q2KI72(Evidence code:IEA/Database source:InterPro:IPR000719|I)P35509(Evidence code:IEA/Database source:InterPro:IPR000719|I)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRI6(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B8H0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR000719|I)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1B793(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR000719)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR000719|I)A7MB90(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB49(Evidence code:IEA/Database source:InterPro:IPR000719|I)G3X696(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BB50(Evidence code:IEA/Database source:InterPro:IPR000719|I)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000719|I)F1MVZ2(Evidence code:IEA/Database source:InterPro:IPR000719|I)A5PK86(Evidence code:IEA/Database source:InterPro:IPR000719|I), PRKCB CDK3 ULK3 fgfr3 RPS6KA2 NEK9 CSNK1A1 MAP3K10 LRRK2 MAST4 TRIO MAP3K1 CDC42BPB NUAK1 STK24 CAMK2B UHMK1 ERBB4 LCK GSK3A STK25 YES1 PAK1 MATK MAPK11 MYLK2 KIT FASTK DYRK2 PAK6 PLK4 PLK3 CDK6 PKN1 ROCK2 TYK2 PAK4 LMTK3 PIK3R4 ERCC2 MAPK1 MAP3K9 PRKACB CAMK2A PRKAB1 PRKDC CAMK2D AAK1 PTK7 SIK3 NEK3 TEC TAOK2 CDK13 PINK1 MAPK10 FASTKD2 MARK3 MAP2K4 JAK2 MAPKAPK3 EPHB4 STK35 OXSR1 MAP3K4 HCK NIM1K MYLK4 DSTYK PASK CSNK1G1 EPHA6 TAOK3 WNK1 CAMK2G DCLK2 RPS6KA4 STK26 MAP3K14 MAPK4 CDK1 SRC LRRK1 MAPK13 MYLK3 STK3 BRAF TBRG4 NEK10 MASTL CDK17 PRKACA MAPK9 CSNK1G3 OBSCN LMTK2 ZAP70 PAK2 PEAK1 PAK3 JAK1 PRKCI STK36 MAPK12 FRK WEE1 ABL1 CSNK1G2 HIPK4 SLK FLT3 CDK12 RPS6KA5 BRSK2 MAP3K8,MF,115,115 of 116,4.89,99.14,2.429E-69,6.84E-67
GO:0050794,regulation of cellular process,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens),WNK1,BP,1,1 of 2267,0.04,0.04,2.722E-65,7.282E-63
GO:0044237,cellular metabolic process,Q2NL31(Evidence code:IEA/Database source:InterPro:IPR000649)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR010997)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR010997), MRI1 WRN BLM,BP,3,3 of 2375,0.13,0.13,7.612E-65,1.94E-62
GO:0003677,DNA binding,Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR009057)F2Z4E8(Evidence code:IEA/Database source:InterPro:IPR000558|I)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR002119|I)A6QPF2(Evidence code:IEA/Database source:InterPro:IPR006935)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN000192346)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001723|I)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q05B83(Evidence code:IEA/Database source:InterPro:IPR008921)E1BK57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MKK8(Evidence code:IEA/Database source:InterPro:IPR010578)G3MZR4(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006134)F1MU48(Evidence code:IEA/Database source:InterPro:IPR001154|I)A6QLP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q0V8G1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0371)E1BKB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BDX0(Evidence code:IEA/Database source:InterPro:IPR012890)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR001208|I)F1MLP0(Evidence code:IEA/Database source:InterPro:IPR029833)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR000747|I)Q2NL18(Evidence code:IEA/Database source:InterPro:IPR003650)A5D7N8(Evidence code:IEA/Database source:InterPro:IPR013146)E1BGW2(Evidence code:IEA/Database source:InterPro:IPR000558|I)G5E655(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818|I)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q32L48(Evidence code:IEA/Database source:InterPro:IPR000558|I)A0A0A0MP90(Evidence code:IEA/Database source:InterPro:IPR002119|I)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1B9S7(Evidence code:IEA/Database source:InterPro:IPR002653)E1B8G9(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BM22(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MV26(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BCK9(Evidence code:IEA/Database source:InterPro:IPR009057)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)F1MXR2(Evidence code:IEA/Database source:InterPro:IPR001356|I)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)E1BL97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BDI3(Evidence code:IEA/Database source:InterPro:IPR001098|I)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR001356|I)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)A5PK61(Evidence code:IEA/Database source:InterPro:IPR000164|I)F1N4U8(Evidence code:IEA/Database source:InterPro:IPR026905)E1BCF7(Evidence code:IEA/Database source:InterPro:IPR000047|I)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)F1N5F3(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3MYD7(Evidence code:IEA/Database source:InterPro:IPR000164|I)E1BGZ3(Evidence code:IEA/Database source:InterPro:IPR001606|I)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR020587)O02754(Evidence code:ISS/Database source:UniProtKB:P05554-2)E1BG94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)P17667(Evidence code:IEA/Database source:InterPro:IPR002546)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A6QQ14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BGF9(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR002100|I)E1B925(Evidence code:IEA/Database source:InterPro:IPR001606|I)E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR012308|I)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR020838)E1BHB8(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BFM5(Evidence code:IEA/Database source:InterPro:IPR002857)E1BJ93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)P61635(Evidence code:IEA/Database source:InterPro:IPR013801)F1MIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR008013)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532)G3MY13(Evidence code:IEA/Database source:InterPro:IPR001356)E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR001606|I)O97764(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8C6L5)E1B7I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR002857)F1MT17(Evidence code:IEA/Database source:InterPro:IPR001356|I)G3N2D1(Evidence code:IEA/Database source:InterPro:IPR026905)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR001356|I)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001723|I)G8JL00(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q0VCF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MU40(Evidence code:IEA/Database source:InterPro:IPR001356|I)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR002119|I)P61283(Evidence code:IEA/Database source:InterPro:IPR004122|I)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1)E1BLB9(Evidence code:IEA/Database source:InterPro:IPR000047|I)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR001098)Q2KII5(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3MY25(Evidence code:IEA/Database source:InterPro:IPR007889|I)A7E3A6(Evidence code:IEA/Database source:InterPro:IPR009057)F1MC99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MVT7(Evidence code:IBA/Database source:PANTHER:PTN000192346)G3MY92(Evidence code:IEA/Database source:InterPro:IPR015660)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR006110|I)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BGA4(Evidence code:IEA/Database source:InterPro:IPR017956)E1BL49(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1MBK6(Evidence code:IEA/Database source:UniProtKB:A2A884|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens)P06526(Evidence code:IEA/Database source:InterPro:IPR002054|I)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q2KJC1(Evidence code:IEA/Database source:InterPro:IPR009057)G3MYE7(Evidence code:IEA/Database source:InterPro:IPR001739|I)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR003150|I)G3N068(Evidence code:IEA/Database source:InterPro:IPR000558|I)P18493(Evidence code:IEA/Database source:InterPro:IPR001510|I)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR002857)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR001356|I)E1BH22(Evidence code:IEA/Database source:InterPro:IPR002119|I)B0JYL6(Evidence code:IEA/Database source:InterPro:IPR013801)Q5E9F8(Evidence code:IEA/Database source:InterPro:IPR000164|I)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040|I)A7MAZ5(Evidence code:IEA/Database source:InterPro:IPR005818|I)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR013801)F1MUD2(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR011539|I)E1B8E2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR009057)E1BAI9(Evidence code:IEA/Database source:InterPro:IPR001356|I)A4FUE0(Evidence code:IEA/Database source:InterPro:IPR001356|I)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)M5FMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)E1BGN3(Evidence code:IEA/Database source:InterPro:IPR000164|I)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR002119|I)G3N053(Evidence code:IEA/Database source:InterPro:IPR000558|I)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN000192346)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000684|I)F1ML85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)G3N3L9(Evidence code:IEA/Database source:InterPro:IPR000558|I)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR002119|I)E1BC18(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1N1F9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR008013)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR001951|I)E1BBH8(Evidence code:IEA/Database source:InterPro:IPR001739|I)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q7YRX0(Evidence code:IEA/Database source:InterPro:IPR001356|I)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR009057)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q2HJ84(Evidence code:IEA/Database source:InterPro:IPR001356|I)F1MBH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)F1N453(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)Q32LH8(Evidence code:IEA/Database source:InterPro:IPR006642)Q1MW18(Evidence code:IEA/Database source:InterPro:IPR001356|I)A5D9H9(Evidence code:IEA/Database source:InterPro:IPR011722|I)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818|I)Q32KX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001723)Q95115(Evidence code:IEA/Database source:InterPro:IPR013801)E1BD77(Evidence code:IEA/Database source:InterPro:IPR001356|I)Q5E9A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004826|I)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0238)Q32LB3(Evidence code:IEA/Database source:InterPro:IPR002857)G3N2P2(Evidence code:IEA/Database source:InterPro:IPR000164|I)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR009057)A5PK20(Evidence code:IEA/Database source:InterPro:IPR005818|I)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004826|I), TERF1 HIST1H2BB HIST3H2A FANCM ZMYM4 ZNF148 ESRRG IRF1 RFC2 TBX3 SIM2 LOC523702 DHX9 POLA1 TOP2B FOXO4 ZFHX4 MGA GCFC2 MCM4 ZBTB22 TCF7L2 AEBP2 SFPQ EN1 HEYL TMPO HIST1H2BJ LOC526488 H1FX AIFM2 HIST1H2BN HIST1H2AC IRX1 OTUD7B HIST3H2BB LOC100300167 TSN LOC525433 DDX1 SNAPC4 BCL3 ONECUT2 SP7 SOX13 POLG ZFHX3 PURB H3F3C ASXL1 DLX2 PURA POU3F1 AIFM1 LOC615183 LOC100297725 ARID3A MYO18A CEBPA E2F1 MYF5 ZBTB8A HBP1 POLE4 ZHX3 SRF ARID1A TAF4B BRCA1 E2F7 RC3H2 LIG1 ZBTB18 INO80 RAX TET1 LEF1 STAT3 SOX1 GATA6 BLM TSHZ1 ARID1B CRYZ MB21D1 ETV2 KMT2A CUX2 ASXL3 ERCC2 HOXA7 NR2F6 LOC104975684 SOX4 MNX1 HIST1H2AJ BANF1 DNMT3A SHOX2 POLQ HIST1H2BI TIGD5 NCOR1 FOXI3 EPM2AIP1 ASCL4 POLR2F WRN ASH1L LOC614206 HIVEP3 ZBTB17 DNTT INSM1 CDC5L MECP2 RFX5 LOC614378 PARP1 KMT2B TDG POU4F2 HIST2H2AB STAT1 H3F3B RUNX1 HIST1H1D STAT5B HIST2H2BF NFKB1 CIC TERF2 ANHX MEIS1 DMRTC2 SOX8 GLI1 HIST2H3D H2AFJ HIST1H2BA ZMYM5 POLR2A AHR LOC613363 H2AFZ LOC617043 SOX17 SP1 gata4 SWAP70 GTF3C6 LOC619094 MBD6 UHRF1 RAX2 MIER1 CHD8 LOC614881 PKNOX1 FOXF1 HIST2H2BE IMPDH2 PRKDC RAD18 LHX4 POLDIP2 HIST1H1A TFDP2 NR1I2 STAT5A ZFHX2 PCBP1 NFE2L2 TAF10 GLI2 EGR4 CXXC5 LOC613345 GON4L HIST1H1E MAF,MF,181,181 of 481,7.69,37.63,9.132E-58,2.221E-55
GO:0005794,Golgi apparatus,Q17QB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q0VC12(Evidence code:IEA/Database source:UniProtKB:Q9GZM5|ens)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)E1BBS6(Evidence code:IEA/Database source:UniProtKB:Q6ZRP7|ens)P83437(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A3KMX1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q8BHJ6|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)Q08DS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)G3X7D3(Evidence code:IBA/Database source:PANTHER:PTN001179054)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A6QR35(Evidence code:IEA/Database source:UniProtKB:A0A140VK92)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)P11456(Evidence code:TAS/Database source:)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56817)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BB36(Evidence code:IEA/Database source:UniProtKB:Q10469|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9CRA5|ens)F1N0M7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q9H3U1|ens)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q8BHC1)F1MX39(Evidence code:IBA/Database source:PANTHER:PTN001179054)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A7Z035(Evidence code:IEA/Database source:InterPro:IPR030544)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)Q32LF7(Evidence code:IEA/Database source:UniProtKB:B2RAZ5|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1BB52(Evidence code:IEA/Database source:UniProtKB:A0A024RA85)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MKI1(Evidence code:IEA/Database source:UniProtKB:A0A024RDX3)E1BLW3(Evidence code:IEA/Database source:UniProtKB:Q8N653|ens)E1B9D0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens)Q0V8F1(Evidence code:IEA/Database source:InterPro:IPR027331)P02668(Evidence code:IDA/Database source:)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q2KHV3(Evidence code:ISS/Database source:UniProtKB:Q99732)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P35605(Evidence code:ISS/Database source:UniProtKB:O55029)F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q687X5|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q9NR48|ens)A7MBC2(Evidence code:IEA/Database source:UniProtKB:Q6P996|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:A0A024R7L6)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)E1BMM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q9Y2H6|ens)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BPZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1BI49(Evidence code:IEA/Database source:UniProtKB:O60476|ens)E1BQ15(Evidence code:IEA/Database source:UniProtKB:J3KR49|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0333)Q5E9E7(Evidence code:IBA/Database source:PANTHER:PTN001012071)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens), RAB30 YIPF3 ARHGAP21 QSOX2 COG5 CHST14 STK26 STK25 TRIM68 MAPK1 SERINC5 PRMT5 DLG1 CDK5RAP2 ABCA1 AP2B1 YES1 COPA RAB39A BICD2 SYN1 SCAMP2 NEDD4 GCC2 M6PR ARL1 VPS52 CUBN BACE1 DYNLT1 MGAT2 AP1S1 PDCD10 SH3GLB1 GOLGA3 GOLPH3 B4GALNT3 LRRK2 UNC45A RAB39B RAB42 NSFL1C CLINT1 FAM20A TMC6 TMEM59 OSBP B4GALT4 TSC2 CDK13 EXT1 PTPRN COPB1 STRN3 POMGNT1 ATP8B1 GOLGA4 ARFGEF1 ATP7B LZTR1 CHPF2 APC2 GAL3ST2 PSEN1 CTTN VAMP5 UHMK1 TMEM30A LMTK2 UNC13B KIFC3 CORO7 CSN3 ARCN1 TRPM4 SAR1B ABCA7 SERINC3 COPZ1 LITAF NPC1 VPS51 BCL9 SCAP COPB2 ATP2B3 COPE CLCC1 STEAP4 ASH1L PDXDC1 MVB12A FAM20C RAB33B B3GALT4 CAPN2 CHPF VPS41 MYO6 FNDC3A LFNG GALNT7 GALNT2 ST8SIA3 SORL1 TNKS TRAPPC2L ITM2B LRP6 CUL3 TPST2 COPG2 PRNP MAN1A2 CLASP2 ARL2 CAND1 RAB3B FMNL3 TRAPPC4 GLT8D1 SYT4,CC,122,122 of 202,5.18,60.4,1.656E-56,3.852E-54
GO:0046872,metal ion binding,E1BBX9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MKZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28007(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR010606|I)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32LB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QR44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SYX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJ58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MY45(Evidence code:IEA/Database source:InterPro:IPR011761)A5D7L9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5BIM5(Evidence code:IEA/Database source:InterPro:IPR000306)F1MY77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N5J5(Evidence code:IEA/Database source:InterPro:IPR018957)F1MXW0(Evidence code:IEA/Database source:InterPro:IPR000907|I)Q0III9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3X7G7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KHT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BHZ4(Evidence code:IEA/Database source:InterPro:IPR000571|I)F1MS56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MGL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3N346(Evidence code:IEA/Database source:InterPro:IPR029518)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5PJM0(Evidence code:IEA/Database source:InterPro:IPR000571)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32L93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6REL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1ML89(Evidence code:IEA/Database source:InterPro:IPR011761)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P04896(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BNM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MRN7(Evidence code:IEA/Database source:UniRule:UR000169786)A7MBA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MI25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BC37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N1M2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BD77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BJP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O46415(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BF96(Evidence code:IEA/Database source:InterPro:IPR000571|I)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02510(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BQ22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BGQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MS27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P23206(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P37359(Evidence code:IEA/Database source:InterPro:IPR000006|I)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MD79(Evidence code:IEA/Database source:InterPro:IPR000306)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MQ85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7E305(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MEU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BCF8(Evidence code:IEA/Database source:InterPro:IPR000571)G3X812(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N3S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02459(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6QHJ6(Evidence code:IEA/Database source:InterPro:IPR000571|I)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P13608(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KJC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MZE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QR47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32LH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QQX8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BMN9(Evidence code:IEA/Database source:InterPro:IPR008899)E1B7S1(Evidence code:IEA/Database source:InterPro:IPR000571)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BP22(Evidence code:IEA/Database source:InterPro:IPR000571|I)Q5EAC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q27995(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P32592(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BA23(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MP30(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q24K02(Evidence code:IEA/Database source:InterPro:IPR011249)F1MLY5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2HJ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q01107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SZI0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1B9X1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q32S24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q1LZ94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58CS5(Evidence code:IEA/Database source:InterPro:IPR000306)E1BEL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P51176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MK99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3N065(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0P571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3MX12(Evidence code:IEA/Database source:InterPro:IPR010606|I)P20456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VFX8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2YDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N1C5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BPS3(Evidence code:IEA/Database source:InterPro:IPR000306)C3VEX2(Evidence code:IEA/Database source:InterPro:IPR004177)F1MKU1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58DC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MU53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BJV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BM69(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P27479(Evidence code:IEA/Database source:InterPro:IPR000907|I)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MF74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P48034(Evidence code:IEA/Database source:InterPro:IPR002888|I)F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P0C7Q4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P35466(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BD03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BL62(Evidence code:IEA/Database source:InterPro:IPR002888|I)A1A4J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3N2N6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR000306)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q29RL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR011761)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P06526(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BDU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BP63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MY16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q864U1(Evidence code:IEA/Database source:InterPro:IPR018957)A5PKC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O46414(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02639(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR006121|I)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2T9P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SYY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1B8T3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QQN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A1L568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)O19137(Evidence code:IEA/Database source:InterPro:IPR000571|I)P02638(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7E348(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MII9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0V8A7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A6QNU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A8WFQ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3MHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3T0E0(Evidence code:IEA/Database source:InterPro:IPR006121|I)A5PJV3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BNV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MJ18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P02465(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G3N0D9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DF2(Evidence code:IEA/Database source:InterPro:IPR018957)F1MHX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BKP2(Evidence code:IEA/Database source:InterPro:IPR000571)Q59A32(Evidence code:IEA/Database source:InterPro:IPR011761)Q6TNF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q95KV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BG23(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)G5E5M1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BC39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BPV9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6R7C3(Evidence code:IEA/Database source:InterPro:IPR018957)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q58DA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7YY57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A4FUZ1(Evidence code:IEA/Database source:InterPro:IPR004361|I)F2Z4H6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BL04(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MDC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)E1BIQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N6T8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A7MBF5(Evidence code:IEA/Database source:InterPro:IPR037217)P38408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1N2S5(Evidence code:IEA/Database source:InterPro:IPR018957)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)P10897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MF35(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F1MJP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479)F6QK60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0479), UNC13C ASAP2 SCIN DPYD MIB2 PRUNE1 CXXC5 KIT DGCR8 ZNF394 PRPS1 CARNS1 NRAP ZFYVE27 ZMYND8 RNF187 ALOX15B ACTN3 ZBTB8A PLEKHM1 USP5 RPS27 ZC3H4 PGM3 WEE1 AGAP1 DMRTC2 NR1I2 KDM6B NUDT16 MBNL1 LETM1 SEC24A AARS XPNPEP1 ECE1 GMPR2 MICALL2 CPS1 SAR1B GNAS ZNF282 PRKCI ATP13A5 EGLN3 BRCC3 ITGAL HIVEP1 GPATCH8 GATA6 EXT1 SAMHD1 PPP2CB UTRN RAN ZFHX2 RACGAP1 RHOT1 FTL KMT2B PPP1R10 PDXP CRYAB RNF128 TRIM68 ZNF316 CYP7A1 PDE4D COL10A1 MT3 ERCC2 ANKFY1 MBTPS2 ATRX ZSWIM8 CIB1 LOC540627 KCNMA1 CYP2R1 ZC3HAV1 NOTCH4 NR2F6 DPEP3 LTA4H COL2A1 UNK NPEPPS ACAN FKBP9 TDRD1 MARCH7 WHSC1L1 CYB5R4 METAP2 USP39 BSN PARP12 COMT DXO RC3H2 GSS NOS2 ITGB2 UHRF1 AMPD3 CAT EGR4 PFKP ADCY7 DNPEP ACLY PAH VPS29 UNC13B ADH5 IDE MLLT6 DNAJA2 DSC1 MPI RAI1 RHOT2 SEC23A TGM3 COL11A2 ACTN2 LMO2 FGD3 HBE1 MARCH5 ADAMTS4 SEC23B AARS2 TGM2 CDC42BPB PARP1 PPP3CA UNC13A ZNF385C MYLPF HERC2 IMPA1 CRIP2 TES DYSF RNF220 MARCH8 FBXO40 WDFY3 PITPNM2 DDX58 LOC100295883 CPPED1 ZNF446 PPP1CC ZNF638 EFHD1 CAPN2 LOC516599 RPAP2 NRXN1 ALOX15 CYP2J2 MICAL2 TRAF6 SCO1 STK25 AOX1 KMT2C ADAMTS5 GNAT3 S100A4 TRMT1L INSM1 PPM1D AOX4 PFKL ZMYM5 ZFP37 PLCG1 KMT2A ZFYVE26 GNAT2 CHORDC1 CAD USP20 DNTT GATAD2B RNF139 POLA1 AKAP13 ALKBH2 BRCA1 CDC42BPA PPP1CB FTH1 S100A1 ATP1A1 ITGB1 PRNP PPP2CA ATP7B GNAI1 MICAL3 HDAC5 EFCAB3 P4HA2 SORD RPS27L TCF20 IKBKG SMPDL3B ATP2B4 PEPD ITGAV CPSF4 S100B PYGO2 PAN2 USP13 RFFL IMPDH2 ARFGAP1 RNF31 TRIM37 CSRP1 ATOX1 AMDHD1 DHX9 ATP1A2 MYO9B AEBP2 ARL1 CBFA2T2 ZBTB18 MMP19 COL1A2 BRD1 RNF112 PHF14 ADSS LENG9 GART TGM1 gata4 PFKM TRIM47 ZNF148 PRKCB PHF3 LFNG DBH ASH1L ESRRG ZFHX3 PEX2 DICER1 GLRX3 ITGA2 ARHGAP29 MB21D1 AGO3 GLO1 TRIM23 XIRP2 ROCK2 CYCS ANKIB1 AGAP2 BRAF VAV2 IDO1 GNA14 SH3RF3 POMGNT1 CYB561 TLL2 ZNF750 ARSA RNF165 SIRT2,MF,281,281 of 1125,11.94,24.98,4.396E-56,9.802E-54
GO:0045944,positive regulation of transcription by RNA polymerase II,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q91X20|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BHB8(Evidence code:IEA/Database source:UniProtKB:Q9Y2V3|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)F1MJY3(Evidence code:IEA/Database source:UniProtKB:O43151|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)F1ML85(Evidence code:IBA/Database source:PANTHER:PTN000837813)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9HB09|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)E1BGF3(Evidence code:IEA/Database source:GO:0001205)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR033897)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)E1BGG6(Evidence code:IEA/Database source:UniProtKB:P48382|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q7YRX0(Evidence code:IEA/Database source:UniProtKB:Q96IS3|ens)E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)E1B9X1(Evidence code:IBA/Database source:PANTHER:PTN000383895)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens), GSK3A TAF2 BCL11B ASH2L PKNOX1 GLI1 DHX9 RAX DLX2 ATRX TMPRSS6 ARID3A LEF1 NIPBL NFE2L2 ZBTB17 HFE2 FGF1 KMT2A GLI2 SIRT2 TFDP2 NCOA3 EAF2 PTPRN TCF7L2 MYDGF ZNF750 POU4F2 WWTR1 AGAP2 YES1 ETV2 FOXF1 PPP3CA MYO6 SMARCA2 LITAF FOXO4 TCF20 GATA6 CHD7 NFKB1 ERCC2 KDM6B ESRRG STRN3 BRCA1 TET3 SBNO2 SP1 DOT1L AHR SOX4 RPS6KA5 CDK13 IKBKG NR1I2 MYF5 MLLT6 CDC5L STAT5A TRAF6 MKL1 SALL4 E2F1 MAML2 TAF4B ATF6B EN1 ASXL1 BCL9 BCL2L12 BCL3 HSPH1 PLAC8 COPS5 HCFC1 BCL9L STAT5B PIN1 CDK12 LPIN2 ASH1L LRP6 PRKDC SRF SETX SP7 SOX17 SFPQ ZNF462 RFX5 PFKM DDX58 E2F7 TNKS ONECUT2 RUNX1 INO80 DAB2IP RAX2 CCNL1 IER5 AHI1 RPS6KA4 MEIS1 SOX1 SHOX2 CDON RREB1 HOXA7 RAI1 LMO2,BP,114,114 of 177,4.84,64.41,4.473E-55,9.575E-53
GO:0006807,nitrogen compound metabolic process,F1ML89(Evidence code:IEA/Database source:InterPro:IPR005483|I)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR005483|I)Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003010), CPS1 CAD NADSYN1,BP,3,3 of 2021,0.13,0.15,6.715E-55,1.382E-52
GO:0005856,cytoskeleton,Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q32LP2(Evidence code:IEA/Database source:InterPro:IPR000299)Q0VCP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60880|ens)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F2Z4C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2HJ86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2T9S0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A5D7P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1B953(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P68138(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A2VDK6(Evidence code:IEA/Database source:InterPro:IPR028288)A7YY37(Evidence code:IEA/Database source:InterPro:IPR000299)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MGE1(Evidence code:IEA/Database source:InterPro:IPR000299)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000299)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR000299|I)Q56JV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MG13(Evidence code:IEA/Database source:InterPro:IPR000299|I)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR000299)Q32L40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P81948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BIG2(Evidence code:IEA/Database source:InterPro:IPR000299)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MNF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BLT3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6H769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)F1ME41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q28046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BJK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q1JP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A4IFE3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)Q0VBX2(Evidence code:IEA/Database source:InterPro:IPR000299)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F2Z4K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)Q3T0S5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q2HJB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0VC86(Evidence code:IEA/Database source:InterPro:IPR000299)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR000299)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR000299)F6RP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2HJJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3MHR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)E1B7G7(Evidence code:IEA/Database source:InterPro:IPR000299|I)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)A8E4N3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1N611(Evidence code:IEA/Database source:InterPro:IPR000299|I)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206)F1MKE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0206), DCTN2 DHX9 RDX SEPT8 SNAP25 CLTA TUBA1A MVB12A TUBA1D CIB1 SEPT11 CDK1 UBXN6 ROCK2 TUBB3 ALOX15B ARL6 DNM2 TUBGCP2 DYNLT1 PAFAH1B1 LOC533307 SPAST ACTA1 CTNNA1 MMS19 WASF2 EPB41L4A BFSP1 ARPC5L DPYSL2 ANXA11 NSFL1C PDXP UTRN ZFYVE26 MAPK1 FRMD5 PTPN14 PPP2CA MYO7B TWF1 MYO15A DCTN3 ERCC2 JAK1 TCP1 LOC101905447 DYNC1I2 TUBA4A NF2 ARL8B RNF128 CSNK1A1 KATNAL2 SEPT7 SEPT2 LOC100141266 NDRG1 SPTBN4 MICAL3 RPS7 LRPPRC LOC101902172 SCIN TUBB1 ARPC1A ACTR1B DNM1 CCT8 DGKQ TLN2 TUBB4A GNAI1 BAIAP2 USP20 TUBA3E CDC42SE2 PKP4 ALDOB PINK1 TUBA8 ARL2 PTK2 SVIL PLK4 JAK2 CAMK2B TEC TYK2 LOC100295712 PPP2CB KLC4 BRCC3 DYNLL1 DYNLL2 MASTL PLEKHH3 FKBP4 TEKT4 DYNLRB1 RSPH3 SEPT6 EPB41L1 KIF2A SPTB,CC,106,106 of 165,4.5,64.24,2.592E-51,5.137E-49
GO:0004674,protein serine/threonine kinase activity,A5PJJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A6QLB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)P05131(Evidence code:IEA/Database source:InterPro:IPR000961|I)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471)E1BA03(Evidence code:IEA/Database source:InterPro:IPR033923)A7MB90(Evidence code:IEA/Database source:InterPro:IPR022247)G5E5G9(Evidence code:IEA/Database source:InterPro:IPR033923)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR031559|I)A6QQE0(Evidence code:IEA/Database source:InterPro:IPR015726)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q16644)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)P46196(Evidence code:ISS/Database source:UniProtKB:P28482)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR028570)Q0VCE7(Evidence code:IEA/Database source:InterPro:IPR020658)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR039071)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR014930)E1BP72(Evidence code:IEA/Database source:InterPro:IPR000961|I)F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)P00517(Evidence code:IEA/Database source:InterPro:IPR000961|I)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR024678|I)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR039071)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR033923|I)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BFR5(Evidence code:IEA/Database source:InterPro:IPR000961|I)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR034372)F1N6C1(Evidence code:IBA/Database source:PANTHER:PTN001147562)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR000961|I)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR000961|I)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1BN61(Evidence code:IEA/Database source:InterPro:IPR000961|I)E1BH93(Evidence code:IEA/Database source:InterPro:IPR000961|I)P05126(Evidence code:IEA/Database source:InterPro:IPR000961|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR000961|I)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BN72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR000961|I)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR033923|I)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519|I)Q2HJ82(Evidence code:IEA/Database source:InterPro:IPR015726)G3X696(Evidence code:IEA/Database source:InterPro:IPR022165)F1MG18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E45(Evidence code:IEA/Database source:InterPro:IPR039071)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A5PJP8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1MUU2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)A0JN96(Evidence code:IEA/Database source:InterPro:IPR024205)A7E3X2(Evidence code:IEA/Database source:InterPro:IPR022247)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR004166|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR000961|I)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR039071)E1BN63(Evidence code:IEA/Database source:InterPro:IPR024678)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)P67827(Evidence code:ISS/Database source:UniProtKB:P48729)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR033700)Q08E52(Evidence code:IEA/Database source:InterPro:IPR033923)V6F977(Evidence code:IEA/Database source:InterPro:IPR034672)A4IFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0723)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)F1MKY9(Evidence code:IEA/Database source:InterPro:IPR004166)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR033624|I), CDK3 CSNK1G3 GSK3A PRKACB MAPK10 PIK3R4 PAK6 CSNK1G2 PAK4 SMG1 OBSCN FAM20C TAOK3 MAPKAPK3 MAP3K14 MAPK1 MAPK12 TRIO PLK3 CAMK2G CDC42BPA CDC42BPB AAK1 NUAK1 CDK6 PRKACA OXSR1 MAPK9 CDK1 CAMK2B PAK2 DYRK2 MAP3K1 MASTL UHMK1 LRRK1 STK25 RPS6KA2 MAPK13 PRKCI TAOK2 RPS6KA5 MAST4 PRKCB ROCK2 MAP3K10 NIM1K PINK1 PKN1 PAK3 BRSK2 PASK CDK13 ATM SPEG SLK MYLK4 MAP3K8 CAMK2A MYLK2 LRRK2 MAP2K4 STK35 STK3 CSNK1G1 MAPK11 PRKDC DSTYK CDK12 TRPM7 RPS6KA4 CAMK2D WNK1 BRAF CSNK1A1 MAP3K9 MAP3K4 PLK4 PAK1 SIK3 NEK3 LMTK2 ALPK2 DCLK2 MARK3,MF,85,85 of 90,3.61,94.44,9.065E-51,1.732E-48
GO:0016310,phosphorylation,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SZD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VC88(Evidence code:IEA/Database source:GO:0004020)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A2VE07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P02638(Evidence code:NAS/Database source:)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VC86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A0JN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q58DV4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q17R18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q08E45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR031559)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BJM1(Evidence code:IEA/Database source:GO:0003951)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)B3IVN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2HJ58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1JPG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q5EA61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MUF5(Evidence code:IEA/Database source:GO:0019205)A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2YDP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2NKZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MNG6(Evidence code:IEA/Database source:GO:0033857)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BHE5(Evidence code:IEA/Database source:GO:0004756)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1RMR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BN82(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), LCK NADK FRK PAPSS2 MAPK13 NME3 RPS6KA2 GK2 CSNK1A1 PANK4 MASTL STK24 MYLK2 PI4KA DSTYK HCK EPHA6 S100B PFKM FLT3 PTK2 CDK13 PIP4K2C STK3 MAPK9 CDK1 PAK6 PLK4 FASTK PIK3CD GCK CSNK1G3 ADK LRRK2 ABL1 ATM BRAF CAMK2A MAPK11 MATK SMG1 KIT WEE1 GK PGK2 ITPKA STK25 PLK3 SPHK2 JAK1 MAP3K9 DGKQ PRKCI PKM RPS6KA4 PRPS1 JAK2 ZAP70 PKLR MAP3K10 CKB ROCK2 PRKACB AK9 YES1 MAPKAPK3 EPHB4 AAK1 PKN1 CDC42BPB CSNK1G1 TSKS MARK3 PAK4 MAST4 fgfr3 MAPK12 LOC538702 MAPK1 TYK2 SRC CAMK2D NME1 CDK12 PPIP5K2 PRKACA PFKL TEC MAPK10 HK2 SEPHS2 PAK2 PACSIN2 CAMK2B PRKDC PAK1 STAT3 GALK1 PAK3 MAPK8IP3 GUK1 RPS6KA5 PRKCB PFKP,BP,104,104 of 164,4.42,63.41,5.257E-50,9.7E-48
GO:0016740,transferase activity,F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q17QG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PK45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZBM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BCH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B9D0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q7YRV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B7Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5EA61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BM12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08DV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5EA65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2NKZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N0M7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BM45(Evidence code:IEA/Database source:InterPro:IPR017852)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BEN4(Evidence code:IEA/Database source:InterPro:IPR018357)Q17QE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BNY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q29RU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5E9E7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)O02811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QL80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q08DQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0P582(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q17QI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2HJ58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MJ10(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BE66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4FV33(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B8R5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G8JKZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5D7I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)B3IVN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A2VE03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P29702(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PJZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VCB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A3KN22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q1RMX2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A1A4J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3MZY8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P11181(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32PG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BMM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A2VDS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q2YDJ9(Evidence code:IEA/Database source:InterPro:IPR018357)G3MZP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3SZ20(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q58CZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A3KMX1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q32LF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P61085(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)Q08DM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P51176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P06526(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)Q1JPG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B729(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A6QQ14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1N638(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)G3MX12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BGA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A1A4K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MSM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)P10950(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MDC0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808)E1BLB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0808), ABL1 PAK4 UHRF1 UBE2G2 B3GALT4 TPST2 FRK PRMT6 CDK12 MAPK13 PARP1 PLK3 COLGALT1 RNF112 RPS6KA4 TRPT1 PCMT1 GK KMT2A GK2 MARCH5 pofut2 POMGNT1 ISPD CHPF2 TYK2 PANK4 JAK1 GCK GART CDK1 KMT2C DNMT3A CAMK2D TRIP12 CKB GALNT7 PAK1 PAK3 SRM RNF220 DPAGT1 COMT SRC LOC538702 WEE1 HCK B4GALNT3 ZAP70 KIT PIGN PRKACA GMPPA GBGT1 ATIC MAP3K9 HUWE1 RNF128 GLT8D1 AGPAT1 PAK2 PI4KA LFNG PARP8 PRMT3 MAPK9 PRMT5 HAS2 GFPT2 JAK2 SULT1A1 PARP14 ACAT2 METTL7A MYLK2 PRPS1 NEDD4 GALK1 PIK3CD ITPKA TNKS DOT1L PRIM1 UMPS YES1 DSTYK RPS6KA2 EXT1 PKM TRMT1L MAPK12 MAPKAPK3 TGM3 NME3 STK25 ITCH PRKCB FNTA TRAF6 HECTD3 FLT3 CPT1B fgfr3 ST8SIA3 AAK1 GALNT2 CTU1 HS3ST1 UBE2M UGT2B10 UBE2D2 PFKL MATK NAPRT POLR2A POLA1 CSNK1G1 DBT MAPK10 WHSC1L1 MB21D1 NEDD4L PFKM MARK3 RPS6KA5 PGK2 PFKP EPHB4 ROCK2 CHPF MTAP BRCA1 LCK MAPK11 GUK1 SCLY UBE2L3 SMG1 MARCH8 GMPPB CMTR2 CSNK1A1 SHMT2 PRKACB TAT EPHA6 CDC42BPB MAST4 PIP4K2C CAMK2B RANBP2 ACLY CHST14 CDK13 B4GALT4 KMT2B HK2 ASH1L MGAT1 PAK6 UBE2K TAOK3 DPH2 TGM2 TEC BRAF DNTT PKLR HS3ST6 PLK4 CSNK1G3 POLE4 MAP3K10 SULT1C4 HERC2 DGKQ ATM NSUN2 NME1 GYG2 MAPK1 ASMT ANKIB1 MASTL PRKCI PKN1 PRKDC,MF,187,187 of 633,7.94,29.54,5.501E-47,9.811E-45
GO:0016301,kinase activity,A7MB57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2HJ58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A3KMY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BMP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MNR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BH93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A0JN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q17R18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR001206)E1BN82(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G5E5G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2NKZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BE66(Evidence code:IEA/Database source:InterPro:IPR018936|I)A4FV09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1JPG7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VC86(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q32KN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A6QR34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4FV33(Evidence code:IEA/Database source:InterPro:IPR005522)Q58DV4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A2VE07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P43481(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MCX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46195(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BPI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q2KI72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BCP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)O02811(Evidence code:IEA/Database source:InterPro:IPR018936|I)F1N3K4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BN61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MSH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR018936|I)F1MAZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)B3IVN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MQ96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR018936|I)F1MQH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BA03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MXG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0P5F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SZD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BP72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q1RMR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q58D16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q5EA61(Evidence code:IEA/Database source:InterPro:IPR022413|I)A5PJL3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MDL4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MTD8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A2VDZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)F1MRU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G3MZE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A1A4J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)G3X793(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)A5PK70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BME6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q08E45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BJM1(Evidence code:IEA/Database source:InterPro:IPR001206)Q2YDP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q0VCE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B7J7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)Q3SWY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR018936|I)Q95M13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)E1B7H4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0418), YES1 PRPS1 NME1 GK AAK1 JAK1 ZAP70 RPS6KA2 LCK MAST4 STK3 ADK RPS6KA4 CSNK1G3 MASTL PKN1 DGKQ MAPK8IP3 PAK4 LOC538702 PIK3CD PANK4 MAPKAPK3 CDK6 PAK1 MAPK10 PKLR PTK2 EPHB4 GK2 WEE1 PGK2 GCK ITPKA FASTK STK24 KIT PFKP CSNK1G1 ROCK2 TYK2 GALK1 CAMK2D PINK1 PRKACA PFKM GUK1 CAMK2B FRK MAPK9 TRPM7 SRC JAK2 PI4KA MAP3K9 RPS6KA5 MAPK13 TEC ATM MARK3 PKM CDK13 CSNK1A1 PRKCI LRRK2 SMG1 EPHA6 DSTYK PAK6 CDK1 ABL1 PIP4K2C NADK CDC42BPB PACSIN2 MATK CKB MAPK12 BRAF HCK PLK4 PRKACB FLT3 MYLK2 PAK2 PFKL MAPK11 NME3 HK2 CAMK2A SPHK2 TSKS PLK3 PRKCB CDK12 PAK3 STK25 PRKDC fgfr3 MAP3K10 MAPK1,MF,101,101 of 174,4.29,58.05,4.541E-46,7.838E-44
GO:0005509,calcium ion binding,Q17QR9(Evidence code:IEA/Database source:InterPro:IPR019577)F1N416(Evidence code:IEA/Database source:InterPro:IPR000233|I)P02638(Evidence code:IEA/Database source:InterPro:IPR001751|I)F1MKV7(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q2KJC8(Evidence code:IEA/Database source:InterPro:IPR002048)Q28046(Evidence code:IEA/Database source:InterPro:IPR030012)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR001881|I)P85100(Evidence code:IEA/Database source:InterPro:IPR002048)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR002048)E1BI49(Evidence code:IEA/Database source:InterPro:IPR001382|I)Q3ZC55(Evidence code:IEA/Database source:InterPro:IPR002048)F1MP30(Evidence code:IEA/Database source:InterPro:IPR037302)E1B9K4(Evidence code:IEA/Database source:InterPro:IPR001881|I)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001283)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR002126|I)P13608(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q27971(Evidence code:IEA/Database source:InterPro:IPR002048|I)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR002126|I)F1MNH3(Evidence code:IEA/Database source:InterPro:IPR001881|I)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001972)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR002048)A5D7I1(Evidence code:IEA/Database source:InterPro:IPR002048)Q8WN96(Evidence code:IBA/Database source:PANTHER:PTN001416417)E1BE11(Evidence code:IEA/Database source:InterPro:IPR001881|I)G3N152(Evidence code:IEA/Database source:InterPro:IPR002126|I)P05059(Evidence code:IDA/Database source:)Q0III9(Evidence code:IEA/Database source:InterPro:IPR002048)E1BPS6(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BMQ1(Evidence code:IEA/Database source:InterPro:IPR029996)E1BF53(Evidence code:IEA/Database source:InterPro:IPR000233|I)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001283)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR002126|I)A7MBJ3(Evidence code:IEA/Database source:InterPro:IPR001382|I)E1BC61(Evidence code:IEA/Database source:InterPro:IPR003915)Q1LZ81(Evidence code:IEA/Database source:InterPro:IPR002048)A7MBG5(Evidence code:IEA/Database source:InterPro:IPR002048)Q0P571(Evidence code:IEA/Database source:InterPro:IPR002048)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR014741)G3X812(Evidence code:IEA/Database source:InterPro:IPR001881|I)A6QP57(Evidence code:ISS/Database source:UniProtKB:Q08188)F1MZD0(Evidence code:IEA/Database source:InterPro:IPR001881|I)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q0IIA3(Evidence code:IEA/Database source:InterPro:IPR002048)P02639(Evidence code:IEA/Database source:InterPro:IPR001751|I)F1MK99(Evidence code:IEA/Database source:InterPro:IPR037302)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q3MHP3(Evidence code:IEA/Database source:InterPro:IPR028493)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR002048)Q17QE5(Evidence code:IEA/Database source:InterPro:IPR002048)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR002126|I)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR002126|I)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002048)F1N5P0(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR001881|I)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR002048)G3MXQ8(Evidence code:IEA/Database source:InterPro:IPR001382|I)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR002048)Q01107(Evidence code:IEA/Database source:InterPro:IPR000233|I)Q00KA9(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:P04350|ens)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001283)Q9TU34(Evidence code:IBA/Database source:PANTHER:PTN001416417)A7Z031(Evidence code:IEA/Database source:InterPro:IPR002048)A0JNJ5(Evidence code:IEA/Database source:InterPro:IPR002048)Q17QM6(Evidence code:IEA/Database source:InterPro:IPR002048)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR002048|I)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR014815|I)F1MF97(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q08DD1(Evidence code:ISS/Database source:UniProtKB:P15289)E1BH09(Evidence code:IEA/Database source:InterPro:IPR001881)P27214(Evidence code:IEA/Database source:InterPro:IPR001464|I)P81282(Evidence code:IEA/Database source:InterPro:IPR001881|I)Q0II63(Evidence code:IEA/Database source:InterPro:IPR002048)P0CG25(Evidence code:IEA/Database source:InterPro:IPR002048)Q2T9P0(Evidence code:IEA/Database source:InterPro:IPR002048)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR002048|I)P07507(Evidence code:IEA/Database source:InterPro:IPR000294|I)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q5E9Z2(Evidence code:IEA/Database source:InterPro:IPR001881)F1MF35(Evidence code:IEA/Database source:InterPro:IPR001881|I)P35466(Evidence code:IEA/Database source:InterPro:IPR001751|I)Q0VCA3(Evidence code:IEA/Database source:InterPro:IPR002048)F1MMQ8(Evidence code:IEA/Database source:InterPro:IPR002048)F1N6C0(Evidence code:IEA/Database source:InterPro:IPR002048|I)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR002126|I)P60902(Evidence code:IEA/Database source:InterPro:IPR001751)F1MLJ7(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens)A6QQP7(Evidence code:ISS/Database source:UniProtKB:O75923)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR002048)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR000233|I)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR037302)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR001881|I)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002048)P08487(Evidence code:IEA/Database source:InterPro:IPR002048)F1MD94(Evidence code:IEA/Database source:InterPro:IPR001881)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)A5D7S6(Evidence code:IEA/Database source:InterPro:IPR002048), SPOCK1 CDH22 S100B CUBN FKBP9 SCIN FAT2 MYL3 RYR1 MAN1A2 ACTN2 UNC13B HMCN2 SYT6 PCDHGC3 ACAN CAPN2 CDHR1 SVEP1 SYT4 RYR3 EPS15 ITPR2 HMCN1 PCDHB8 CHGA ACTN3 MEGF8 PCDHA13 OTOF CDH7 SYTL2 FAM20C PCDH1 EDEM2 PKDREJ PDCD6 TBC1D9B MYLPF CBLC NOTCH4 TGM3 FBN3 PCDH20 SRI S100A1 UNC13A BAIAP3 S100A14 USP32 CIB1 PCDH8 PCDH12 CACNA1B DNER CD97 RYR2 MAN1B1 CAPN11 DSC1 LRP4 TUBB4A SYTL1 ITPR1 RASEF MYL1 EFHD1 RHOT2 PLCB3 NID2 ARSA VWA2 ANXA11 VCAN EFHB EFCC1 EFCAB3 RHOT1 MGP ALOX15B HABP2 TLL2 S100A4 LETM1 SPTA1 CALM1 DCHS2 S100A10 SLIT2 TMEM2 DYSF DNAH7 CDH11 LOC786512 UNC13C FAT1 CACNA1E PLCG1 MATN3 TRPM4 PEF1,MF,101,101 of 203,4.29,49.75,1.411E-41,2.36E-39
GO:0000122,negative regulation of transcription by RNA polymerase II,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q3UH06|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens)Q32LB3(Evidence code:ISS/Database source:UniProtKB:Q7LFL8)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:O14529|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:Q05925|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)F1N312(Evidence code:IEA/Database source:UniProtKB:Q56A10|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)E1BPI3(Evidence code:IEA/Database source:UniProtKB:P42685|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1MZQ1(Evidence code:IEA/Database source:UniProtKB:Q9H0E3|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1ML16(Evidence code:IEA/Database source:InterPro:IPR028424)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q8K1A6|ens)E1BGF9(Evidence code:IBA/Database source:PANTHER:PTN001435424)Q17QV0(Evidence code:IEA/Database source:UniProtKB:P57722|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)G3MY13(Evidence code:IEA/Database source:GO:0001078)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)A0JN76(Evidence code:ISS/Database source:UniProtKB:Q9WUK6)E1BGG6(Evidence code:IEA/Database source:UniProtKB:Q9JL61|ens)F1MI25(Evidence code:IEA/Database source:UniProtKB:F8VPM9|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579358)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens)E1BJK0(Evidence code:IEA/Database source:UniProtKB:P78414|ens)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Z1Z2|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)G3MYE7(Evidence code:IEA/Database source:InterPro:IPR017353)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens), TCF7L2 OTUD7B HOXA7 ARID1A DAB2IP DDX20 RREB1 GLI2 ZNF366 CXXC5 PLK3 CUX2 GCFC2 SFPQ PRDM13 EN1 TDG DLG1 POU4F2 CDK6 NFKB1 EHMT2 RIF1 SPEN ZNF608 SIRT2 CRYM CTBP1 SUZ12 CBFA2T2 WWTR1 PPID FRK FOXF1 SAP130 WWC1 HIC1 NIPBL CC2D1A ZHX3 PCBP3 STRN3 TSHZ1 PSEN1 GATA6 HFE2 ZBTB18 RFX5 HIVEP1 BCL11A TMPRSS6 PURB SHOX2 DLX2 SALL4 PEX2 SOX17 ARHGAP35 E2F7 CUL3 HIST1H1D IRX1 NR2F6 TBX3 AEBP2 ZFHX3 STRAP PIAS1 INSM1 BCOR SIM2 ZBTB4 PRMT6 TPR MECP2 PHF14 E2F1 UHRF1 LEF1 TRAF6,BP,80,80 of 115,3.4,69.57,4.203E-41,6.816E-39
GO:0042802,identical protein binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q99961|ens)Q0VCN1(Evidence code:IEA/Database source:UniProtKB:Q9HBL8|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)F1MZI1(Evidence code:IEA/Database source:UniProtKB:O43586|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)P35466(Evidence code:IEA/Database source:UniProtKB:P07091|ens)Q2HJ58(Evidence code:IEA/Database source:UniProtKB:P60891|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)F6PR93(Evidence code:IEA/Database source:InterPro:IPR011717)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens)E1BM12(Evidence code:IEA/Database source:UniProtKB:P19623|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)A6QR68(Evidence code:IEA/Database source:UniProtKB:O15431|ens)P62964(Evidence code:IDA/Database source:)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)F6PW02(Evidence code:IEA/Database source:InterPro:IPR033512)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)A5PKI0(Evidence code:IEA/Database source:InterPro:IPR037929)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28827|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q15742|ens)Q08DK5(Evidence code:IEA/Database source:UniProtKB:Q9NR46|ens)Q1KZG4(Evidence code:IEA/Database source:UniProtKB:P49789|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q2KHV6(Evidence code:IEA/Database source:UniProtKB:Q9Y5X2|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)Q08DW1(Evidence code:IEA/Database source:UniProtKB:Q9R0M6|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A6QLN9(Evidence code:IEA/Database source:UniProtKB:Q8R2Z5|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)F1N226(Evidence code:IEA/Database source:UniProtKB:Q06481|ens)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q13867|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)A1A4J1(Evidence code:IEA/Database source:UniProtKB:P17858|ens)Q05B89(Evidence code:IEA/Database source:UniProtKB:Q9GZT8|ens)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)Q08DM8(Evidence code:IEA/Database source:UniProtKB:Q15631|ens)F1MX23(Evidence code:IEA/Database source:UniProtKB:Q99963|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q7L775|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)P02668(Evidence code:IPI/Database source:UniProtKB:P02668)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q8IY63|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)Q3T105(Evidence code:IEA/Database source:UniProtKB:Q14376|ens)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB:O14818|ens)Q29460(Evidence code:IEA/Database source:UniProtKB:Q15102|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A2VDZ4(Evidence code:IEA/Database source:UniProtKB:O00444|ens)Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)A5D7C4(Evidence code:IEA/Database source:UniProtKB:Q9Y5L0|ens)G3MY14(Evidence code:IEA/Database source:UniProtKB:P11908|ens)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)E1BFN3(Evidence code:IEA/Database source:UniProtKB:Q8N157|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61457|ens)A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB:Q13554|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BH09(Evidence code:IEA/Database source:UniProtKB:Q5GFL6|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)E1BM28(Evidence code:IEA/Database source:UniProtKB:O43598|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)P80227(Evidence code:IEA/Database source:UniProtKB:P13798|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q05B70(Evidence code:IEA/Database source:UniProtKB:Q96HH9|ens)F1N152(Evidence code:IEA/Database source:UniProtKB:Q92743|ens)E1B7H2(Evidence code:IEA/Database source:UniProtKB:Q63870|ens)E1BI31(Evidence code:IEA/Database source:UniProtKB:Q86TI2|ens)Q08DW2(Evidence code:IEA/Database source:UniProtKB:Q14558|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)Q0VD00(Evidence code:IEA/Database source:UniProtKB:Q96SI1|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens)Q2KIT8(Evidence code:IEA/Database source:UniProtKB:Q13630|ens)F1MP76(Evidence code:IEA/Database source:UniProtKB:O75056|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q6BBL6(Evidence code:ISS/Database source:UniProtKB:Q9Z0G9), PRNP IMPA1 SH3GL1 NMRAL1 BRCA2 PSTPIP1 GRB2 SLIT2 S100A4 PRPS1 KHDRBS1 SGTA PACSIN2 DDX58 SETX PEAK1 TTC21B COL1A2 PFKM RASEF CLDN3 SRM CRYAB SLC31A1 CRABP1 PAK2 SNRNP200 C1QTNF5 TFG UBQLN1 APPL1 PTPRM LCK LRP6 NAB2 SH3GLB2 FHIT NFKB1 SNX8 CRKL SYT6 MALT1 IER5 RAB9A KMT2A DAB2IP VWA1 CHMP1A TPCN2 APLP2 BLMH TRAF6 IKBKG PFKL NIF3L1 TRIM23 TSN SH3GL3 S100B EPM2AIP1 E2F7 CAMK2A VPS4B CSN3 STK3 ST8SIA3 DAAM1 AMOTL1 CAT GALE PSMA7 PAFAH1B3 DCTN2 CHMP4A EMILIN1 VPS41 DNM1 SEC13 TFRC COL2A1 SLK JAK2 PDCD6 TCL1A CHMP4B PLK4 SORD MRI1 TNPO3 PRPS2 ARRDC1 GPSM2 AQP5 SNX33 EPRS AHI1 RAD18 DHX8 CAD ADORA2A SDCBP2 KEAP1 LRRK2 AXIN1 PCBD1 UHRF1 SH3BP4 CAMK2B FOXO4 VWA2 G6PD GARS DNPH1 DGCR8 APEH EIF4G1 GRAMD3 HTRA1 COL7A1 DPP9 PRPSAP1 LRRK1 EPS15 KCTD15 MYBPC3 HCFC1 HCN1 TSTA3 SDC3 GCC2 BANF1 STK26 CLDN4,MF,133,133 of 379,5.65,35.09,1.217E-40,1.915E-38
GO:0043547,positive regulation of GTPase activity,F1MHG5(Evidence code:IBA/Database source:PANTHER:PTN001141612)E1B801(Evidence code:IEA/Database source:GO:0005096)F1MJI3(Evidence code:IEA/Database source:GO:0005096)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)A5D793(Evidence code:IEA/Database source:GO:0005096)F1MD62(Evidence code:IEA/Database source:GO:0005096)F1MM72(Evidence code:IEA/Database source:GO:0005096)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR028557)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR028558)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028443)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR037769)P48820(Evidence code:IEA/Database source:GO:0005096)A6QNV8(Evidence code:IEA/Database source:GO:0005096)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)A0JN64(Evidence code:IEA/Database source:GO:0005096)E1BIQ2(Evidence code:IEA/Database source:GO:0005096)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR003913|I)E1BNB7(Evidence code:IEA/Database source:GO:0005096)F1MXV4(Evidence code:IEA/Database source:GO:0005096)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)E1B714(Evidence code:IEA/Database source:GO:0005096)G3MYM2(Evidence code:IEA/Database source:GO:0005096)A7YY57(Evidence code:IEA/Database source:GO:0005096)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)A7MB27(Evidence code:IEA/Database source:GO:0005096)E1BP38(Evidence code:IEA/Database source:InterPro:IPR027107)Q29RJ2(Evidence code:IEA/Database source:GO:0005096)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR037858)E1BJP2(Evidence code:IEA/Database source:GO:0005096)E1BPM0(Evidence code:IEA/Database source:GO:0005096)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)E1BB77(Evidence code:IEA/Database source:GO:0005096)F1MM21(Evidence code:IEA/Database source:UniProtKB:P49758|ens)F1MZA2(Evidence code:IEA/Database source:GO:0005096)F1N746(Evidence code:IEA/Database source:InterPro:IPR033185)P04896(Evidence code:ISS/Database source:UniProtKB:P63092)E1B800(Evidence code:IEA/Database source:GO:0005096)F1MGL2(Evidence code:IEA/Database source:GO:0005096)F1N2I0(Evidence code:IEA/Database source:GO:0005096)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q0V8A7(Evidence code:IEA/Database source:GO:0005096)Q58DV1(Evidence code:IEA/Database source:UniRule:UR000136804)G3X7P3(Evidence code:IEA/Database source:GO:0005096)E1BPU0(Evidence code:IEA/Database source:GO:0005096)F1MTH3(Evidence code:IEA/Database source:GO:0005096)F1MKZ2(Evidence code:IEA/Database source:GO:0005096)F1N6V1(Evidence code:IEA/Database source:UniProtKB:O54834|ens)F1MBI8(Evidence code:IEA/Database source:GO:0005096), ARHGAP21 ARHGAP35 SRGAP3 LARS ECT2 ARHGAP20 ARHGAP22 RGS14 MYO9B MYO9A PKP4 BCR RANBP2 RGS1 SNX18 F11R TBC1D2 GARNL3 AGAP2 TSC2 ARHGAP26 SIPA1L1 DENND1A SGSM2 AXIN1 TBC1D4 ARHGAP29 RTN4R ARHGAP36 RALGAPA1 TBC1D24 ARAP3 RACGAP1 RASAL1 S100A10 DAB2IP RGS6 ARHGEF12 RABGAP1 GNAS RASAL2 AGAP1 CHML RAPGEF2 PREX1 PIN1 ARFGAP1 RP2 AXIN2 LRRK2 TIAM2 ASAP2 ARHGAP6 SYNGAP1,BP,54,54 of 36,2.29,150,2.058E-39,3.146E-37
GO:0005525,GTP binding,P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001408)Q58DW6(Evidence code:IEA/Database source:InterPro:IPR001806|I)P38408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q17QB7(Evidence code:IEA/Database source:InterPro:IPR001806|I)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR001806|I)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR002453|I)P81948(Evidence code:IEA/Database source:InterPro:IPR002452|I)Q08DC2(Evidence code:IEA/Database source:InterPro:IPR001806|I)E1BLD5(Evidence code:IEA/Database source:InterPro:IPR001806|I)P11023(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q3T0T7(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q9BDI7(Evidence code:IEA/Database source:InterPro:IPR000375|I)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR002452|I)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR001806|I)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR030381)E1BPU0(Evidence code:IEA/Database source:InterPro:IPR005225)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR002452|I)G3X7D3(Evidence code:IEA/Database source:InterPro:IPR001806|I)A5PJP3(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q3ZC28(Evidence code:IEA/Database source:InterPro:IPR005225|I)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR002452|I)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)E1BIL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR002453|I)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)E1B870(Evidence code:IEA/Database source:InterPro:IPR006689|I)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR001806|I)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q0II28(Evidence code:IEA/Database source:InterPro:IPR001806|I)P10949(Evidence code:IEA/Database source:InterPro:IPR001806|I)A4FUD7(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q0VCP4(Evidence code:IEA/Database source:InterPro:IPR016491|I)Q2YDJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q08DF2(Evidence code:IEA/Database source:InterPro:IPR015894|I)Q58DC5(Evidence code:IEA/Database source:InterPro:IPR000795)A7MBG0(Evidence code:IEA/Database source:InterPro:IPR001114|I)Q29RR0(Evidence code:IEA/Database source:InterPro:IPR001806|I)G5E6P3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)A6QPX8(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2NKY7(Evidence code:IEA/Database source:InterPro:IPR008113|I)Q6Q137(Evidence code:IEA/Database source:InterPro:IPR008115|I)A7Z031(Evidence code:IEA/Database source:InterPro:IPR001806|I)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR002452|I)F6RP72(Evidence code:IEA/Database source:InterPro:IPR002452|I)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q2YDM1(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q3SZN0(Evidence code:IEA/Database source:InterPro:IPR016491|I)A7MBB1(Evidence code:IEA/Database source:InterPro:IPR015894|I)Q2KI07(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q17QU4(Evidence code:IEA/Database source:InterPro:IPR001806|I)P04696(Evidence code:IEA/Database source:InterPro:IPR001408)Q08DW1(Evidence code:IEA/Database source:InterPro:IPR001806|I)F1MX39(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q0IIM2(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q3T054(Evidence code:IEA/Database source:InterPro:IPR001806|I)P04896(Evidence code:IEA/Database source:InterPro:IPR000367)Q3T107(Evidence code:IEA/Database source:InterPro:IPR001806|I)G3X6L5(Evidence code:IEA/Database source:InterPro:IPR005225|I)E1B801(Evidence code:IEA/Database source:InterPro:IPR001806)P63097(Evidence code:IEA/Database source:InterPro:IPR001408)Q4PS77(Evidence code:IEA/Database source:InterPro:IPR006073|I)Q3T0M9(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q58DV1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR001806|I)P04695(Evidence code:IEA/Database source:InterPro:IPR001408)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR002453|I)Q32KW9(Evidence code:IEA/Database source:InterPro:IPR007743|I)Q2TBH7(Evidence code:IEA/Database source:InterPro:IPR001806|I)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR001806|I)G3N3N1(Evidence code:IEA/Database source:InterPro:IPR005225|I)Q08DF4(Evidence code:IEA/Database source:InterPro:IPR000375|I)A4FUD3(Evidence code:IEA/Database source:InterPro:IPR000795|I)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0342)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR000375|I)F1N1I1(Evidence code:IEA/Database source:InterPro:IPR003191|I)F1MGL2(Evidence code:IEA/Database source:InterPro:IPR001806)A2VE99(Evidence code:IEA/Database source:InterPro:IPR016491|I)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR002452|I)Q2TA37(Evidence code:IEA/Database source:InterPro:IPR005225|I)E1B953(Evidence code:IEA/Database source:InterPro:IPR002453)P10948(Evidence code:IEA/Database source:InterPro:IPR001806|I)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q32LB9(Evidence code:IEA/Database source:InterPro:IPR006073|I)F1N7V2(Evidence code:IEA/Database source:InterPro:IPR001806)E1BAI0(Evidence code:IEA/Database source:InterPro:IPR001806|I)E1BIQ2(Evidence code:IEA/Database source:InterPro:IPR001806), GNAT3 RAB25 GNA14 RAB30 RAP2A GNAL TUBB1 TUBA4A RAB31 RAB37 RAB3A SAR1B MX2 LOC100141266 NUDT16 HRAS MFN2 LRRK2 TUBA1D RAB39A RAB22A ARL13B TUBA3E MB21D1 GNA12 TUBB3 GPN1 ARL16 RHOT1 TRIM23 RAB4B RAB3C RAB33B SEPT8 GMPPB RNF112 GTPBP1 ADSS RAB26 GNA13 RAB12 SEPT2 SEPT7 RASEF TUBA1A LOC100295712 RHOT2 ARL1 SEPT6 LOC783604 ARL8B RAB39B GNAT2 RAB9A RAB42 ARL6 RAN GNAS RAB24 ARL8A ARHGAP35 GNAI1 MTG1 ARL4A RP2 RAP2C GNAT1 RRAS TUBB4A IRGC RAB4A RIT1 ARF6 DNM1 EFTUD2 SAMHD1 DNM2 LOC100336669 AGAP1 SEPT11 TUBA8 ARL2 LOC533307 RAB3B DIRAS2 NOA1 RAB17 RAB23 AGAP2,MF,89,89 of 165,3.78,53.94,5.49E-39,8.161E-37
GO:0019222,regulation of metabolic process,F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens),SH2B2,BP,1,1 of 1349,0.04,0.07,5.693E-39,8.234E-37
GO:0008270,zinc ion binding,Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735)G3X743(Evidence code:IEA/Database source:InterPro:IPR014782|I)Q24JZ9(Evidence code:IEA/Database source:InterPro:IPR004181)Q3T0M0(Evidence code:IBA/Database source:PANTHER:PTN000122545)E1BD77(Evidence code:IEA/Database source:InterPro:IPR003604)F1N1C5(Evidence code:IEA/Database source:InterPro:IPR001293)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR000433)F1N0J8(Evidence code:IEA/Database source:InterPro:IPR007527)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR001250)F1MI25(Evidence code:IEA/Database source:InterPro:IPR003604)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895)Q32P83(Evidence code:IEA/Database source:UniProtKB:P47224|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR000679|I)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR000679|I)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)F6QK60(Evidence code:IEA/Database source:InterPro:IPR017328)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR001607)F1MKS6(Evidence code:IEA/Database source:InterPro:IPR000834)P05126(Evidence code:IEA/Database source:InterPro:IPR014375)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR001607)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR002857|I)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628|I)E1B847(Evidence code:IEA/Database source:InterPro:IPR007527)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628|I)Q2YDE9(Evidence code:IEA/Database source:InterPro:IPR010442)Q3ZC24(Evidence code:IEA/Database source:InterPro:IPR011016)F1MXI4(Evidence code:IEA/Database source:InterPro:IPR003604)Q32LB3(Evidence code:IEA/Database source:InterPro:IPR002857)P02638(Evidence code:IEA/Database source:InterPro:IPR028481)A7Z056(Evidence code:IEA/Database source:InterPro:IPR001607)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR001293|I)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR000315)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR000315)Q2HJI9(Evidence code:IEA/Database source:InterPro:IPR024766)E1B9S7(Evidence code:IEA/Database source:InterPro:IPR002653)A6QP33(Evidence code:IEA/Database source:InterPro:IPR010507)O19137(Evidence code:IEA/Database source:InterPro:IPR001878|I)E1BFM5(Evidence code:IEA/Database source:InterPro:IPR002857)Q32L99(Evidence code:ISS/Database source:UniProtKB:Q8N8N7)F1N413(Evidence code:IEA/Database source:InterPro:IPR007728)F1MKA6(Evidence code:IEA/Database source:UniRule:UR000375824)A6QR47(Evidence code:IEA/Database source:InterPro:IPR011016)F1MKU1(Evidence code:IEA/Database source:UniRule:UR000401119)F1MRT9(Evidence code:IEA/Database source:InterPro:IPR000433)A7E305(Evidence code:IEA/Database source:InterPro:IPR007527)E1BAR2(Evidence code:IEA/Database source:InterPro:IPR001878|I)E1BM69(Evidence code:IEA/Database source:InterPro:IPR000315)Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628|I)G3N065(Evidence code:IEA/Database source:InterPro:IPR003604)F1MJP2(Evidence code:IEA/Database source:InterPro:IPR011016)Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR002328|I)O97764(Evidence code:IEA/Database source:InterPro:IPR002364)E1BCW1(Evidence code:IEA/Database source:InterPro:IPR003126)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)Q3SZH7(Evidence code:IEA/Database source:InterPro:IPR012777|I)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BL52(Evidence code:IEA/Database source:InterPro:IPR024766)F1MKU3(Evidence code:IEA/Database source:InterPro:IPR000315)E1BER3(Evidence code:IEA/Database source:InterPro:IPR000834)E1BQ22(Evidence code:IEA/Database source:InterPro:IPR000315)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)A8WFQ1(Evidence code:IEA/Database source:InterPro:IPR000315)A6QLT9(Evidence code:IEA/Database source:UniRule:UR000375824)F1MF35(Evidence code:IEA/Database source:InterPro:IPR006026)F1MLX9(Evidence code:IEA/Database source:InterPro:IPR014311)A1L548(Evidence code:IEA/Database source:InterPro:IPR001607)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)Q2HJH1(Evidence code:IEA/Database source:InterPro:IPR001948)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR002857|I)E1BG23(Evidence code:IEA/Database source:InterPro:IPR000315)P18493(Evidence code:IEA/Database source:InterPro:IPR001510|I)E1BDU9(Evidence code:IEA/Database source:InterPro:IPR000679|I)G3MX12(Evidence code:IEA/Database source:InterPro:IPR000433)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR003604)F1MHR5(Evidence code:IEA/Database source:InterPro:IPR010507)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)F1MMN0(Evidence code:IEA/Database source:InterPro:IPR000315)Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654)Q0VD59(Evidence code:IEA/Database source:InterPro:IPR011016)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BP91(Evidence code:IEA/Database source:InterPro:IPR014782)Q58D31(Evidence code:IEA/Database source:InterPro:IPR002328)E1BJV5(Evidence code:IEA/Database source:InterPro:IPR000690|I)A6QPH9(Evidence code:IEA/Database source:InterPro:IPR010507)E1BP63(Evidence code:IEA/Database source:InterPro:IPR011016)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895)G3N0A8(Evidence code:IEA/Database source:InterPro:IPR003126), IDE RNPEP PIAS1 VPS29 ZFHX2 FBXO40 SEC24C MIB2 ZSWIM6 CAD MPI HIVEP1 SEC23B SEC23A SEC24D RABIF GLI2 GATA6 gata4 EPRS SIRT2 MMP19 USP13 AGTPBP1 PRKCB USP39 KMT2A SAMHD1 ESRRG MAP3K1 NR1I2 TES MARCH5 MATR3 CXXC5 S100B USP20 MYCBP2 TRAF6 TRIM23 RNF31 RBX1 OTUD7B ZMYM6 CPSF4 TET1 PTGR2 EHMT2 AARS2 MARCH7 DDX58 UTRN ZSWIM8 ZCCHC6 LOC516599 CHORDC1 NR2F6 ZNF385C RNF165 ADH5 CRYZ UBR2 GLO1 LTA4H MT3 LOC780968 BSPRY CPXM2 TRIM68 TNKS TRIM37 AARS TLL2 GDA USP5 LITAF DNPEP KMT2B TRIM47 PARP1 GATAD2B HERC2 ZFHX3 ZMYM4 BRCA1 UHRF1 TRIM14 PEX10 MARCH8 BLM NPEPPS SORD ZNF638 ZMYM5 RNF139 SEC24A UBR4,MF,97,97 of 207,4.12,46.86,2.417E-38,3.403E-36
GO:0005783,endoplasmic reticulum,E1BFD1(Evidence code:IBA/Database source:PANTHER:PTN000469495)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MRU0(Evidence code:IEA/Database source:UniProtKB:P36888|ens)E1BJ75(Evidence code:IEA/Database source:InterPro:IPR033212)Q3SZ26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)F1N0J3(Evidence code:IEA/Database source:UniProtKB:P98196|ens)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)P55156(Evidence code:ISS/Database source:UniProtKB:P55157)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q32LH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MDD5(Evidence code:IEA/Database source:UniProtKB:Q16787|ens)A4FUH1(Evidence code:IEA/Database source:InterPro:IPR017378)Q29RN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q2KJC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)A4FUW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q8MII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)Q29RM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q9BZR6|ens)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR013547)Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)F1MD64(Evidence code:IEA/Database source:UniProtKB:Q92508|ens)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q5EA65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MNU6(Evidence code:IBA/Database source:PANTHER:PTN000080880)F1MIU7(Evidence code:IEA/Database source:UniProtKB:Q5K4L6|ens)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)E1BI49(Evidence code:IBA/Database source:PANTHER:PTN000201533)A7MBJ3(Evidence code:IEA/Database source:UniProtKB:Q9BV94|ens)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q2TBL9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)G3MXQ8(Evidence code:IEA/Database source:UniProtKB:Q9UKM7|ens)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3ZC71(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR027670)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)Q5PXY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1MMG6(Evidence code:IEA/Database source:UniProtKB:Q6AZY7|ens)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q0P568(Evidence code:IEA/Database source:UniProtKB:Q541A5|ens)A1A4M8(Evidence code:IEA/Database source:UniProtKB:Q9H497|ens)Q3SZN2(Evidence code:ISS/Database source:UniProtKB:Q15437)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)P02465(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z3H5)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR017378)A2VE53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q56JX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)Q3T0I5(Evidence code:IEA/Database source:GO:0032471)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)P61356(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)Q5E9F1(Evidence code:IEA/Database source:InterPro:IPR008417)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)Q32PA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)A5PK45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0256)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens), ANKLE2 ITPR1 DAD1 CIDEC BACE1 FLT3 CRTAP WRB BRINP1 AGPAT1 ARSA KEAP1 ATP11A SEC23A LARS MTTP TRAPPC2L CYB5R4 JSRP1 AHCYL2 LRRK2 LAMA3 TOR2A SEZ6L2 FKBP9 TOR1B TXNDC11 SLC35B1 BRSK2 REEP5 SEC24A RTN4R P4HA2 FAM213B CUBN PIEZO1 SHISA5 CIB1 UBQLN1 DPAGT1 BAIAP3 SLC27A3 CYP7A1 UBXN1 FAM20A MAN1A2 EDEM2 SPCS3 PRNP PSEN1 TRAPPC4 SYVN1 MARCH5 HPS6 DLG1 ARCN1 PIGK SEC13 MAN1B1 SCAP SPAST CLCC1 CFTR DNAJB11 DPM3 EXT1 RNF139 CRABP2 PDCD6 SCARA3 SEC11A UFD1L TOR3A SEC23B NPC1 TMC6 COL1A2 SAR1B ITPR2 DBH TMEM30A TOR1A IKBIP ATP8B1 DNASE1L1 RPS28 FIS1 CAPN2 RPL27 SORL1 BCAP31 KCNMA1 ZFYVE27 PROM1 FKBP2 UGGT2 COLGALT1 TRPM4 AQP5,CC,99,99 of 220,4.21,45,6.283E-38,8.621E-36
GO:0045202,synapse,E1BMQ1(Evidence code:IEA/Database source:GO:0016079)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A6QLG5(Evidence code:IEA/Database source:UniProtKB:Q6ZWN5|ens)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62270|ens)F1MCW8(Evidence code:IEA/Database source:UniProtKB:Q8BMF5|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A7MB16(Evidence code:IEA/Database source:UniProtKB:Q8JZQ9|ens)E1BB27(Evidence code:IEA/Database source:InterPro:IPR030524)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)E1BGL9(Evidence code:IEA/Database source:GO:0048791)A6QP06(Evidence code:IEA/Database source:GO:0048791)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)F1MG56(Evidence code:IEA/Database source:UniProtKB:Q6P1F6|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)A2VDQ6(Evidence code:IEA/Database source:UniProtKB:P55288|ens)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)F1MDV3(Evidence code:IEA/Database source:UniProtKB:Q99L88|ens)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)E1BMN9(Evidence code:IEA/Database source:InterPro:IPR008899)Q5E963(Evidence code:IEA/Database source:UniProtKB:Q9D898|ens)E1BBK9(Evidence code:IEA/Database source:GO:0048791)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)P02715(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365476)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0770)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)A6H769(Evidence code:IEA/Database source:UniProtKB:P62082|ens)P68102(Evidence code:IEA/Database source:UniProtKB:Q6ZWX6|ens)E1BFV9(Evidence code:IEA/Database source:UniProtKB:Q0QWG9|ens), OTOF LRRK2 RPS9 VAMP3 RPS18 GRIK4 SNAP25 ABHD17C GABRA5 SEPT11 LIN7C EIF3B DLGAP1 DLG1 CYFIP1 SYT6 SYTL2 RNF112 SDK2 LAMB2 LRP6 PPP2R2A RAPGEF2 CDH11 VAMP1 UNC13A UTRN LIN7A PCDHB8 VAMP2 SPG20 DNM2 PTPRN GRIA2 CAMK2B SNTB1 CYFIP2 SYN1 BSN ARPC5L SYTL1 NRXN1 GRIA1 CHRNE EXOC4 LIN7B TRAPPC4 FBXO45 PPP2CA SYN2 COPS4 PTPRZ1 DLGAP3 GRIA3 DENND1A AKR1A1 WASF2 RPS7 EIF2S1 GRID2IP,CC,60,60 of 60,2.55,100,2.338E-37,3.128E-35
GO:0005694,chromosome,G3N068(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BEE6(Evidence code:IBA/Database source:PANTHER:PTN000344873)F2Z4E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BL49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N2P2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P0C0S4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BGW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N3L9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1N413(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3MZR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1N453(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N053(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1MV26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q32L48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A5PK20(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3ZBX9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1MUD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)G3MYD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BM22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1B8G9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q5E9F8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1N5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G3N131(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A7MAZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q3T0W4(Evidence code:IEA/Database source:UniProtKB:Q15435|ens)A0A0A0MP93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q2KII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)G8JL00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A0A0A0MP90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A5PK61(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BQ04(Evidence code:IBA/Database source:PANTHER:PTN000344873)E1BC18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)F1MMU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A4IFU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BH22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)A0A0A0MPA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1B7N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)E1BGN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)P61283(Evidence code:IEA/Database source:UniProtKB-KW:KW-0158)Q864U1(Evidence code:ISS/Database source:UniProtKB:P48754), LOC614378 CDK13 WRN HIST1H2BB PPP2CA PAXIP1 CSNK1A1 LOC614206 LOC613345 SEPT7 SAMHD1 H2AFZ HIST1H2BJ LOC613363 EHMT2 LOC523702 HIST2H2BE HIST1H2BA SEPT2 SEPT6 DCTN3 LOC525433 HIST1H2BN PPP2CB HIST1H1E H2AFJ NSFL1C HIST2H2BF RAD21L1 LOC100297725 LOC100300167 HIST3H2BB H3F3B LOC615183 HIST1H1A HIST1H1D PPP1R7 LOC614881 SIRT2 HIST1H2BI LOC104975684 HIST1H2AC PPP1CC H3F3C BLM LOC617043 H1FX HIST3H2A CDK12 HIST2H2AB HIST1H2AJ LOC619094 HIST2H3D BANF1 BRCA1,CC,55,55 of 47,2.34,117.02,1.111E-36,1.45E-34
GO:0003924,GTPase activity,P63217(Evidence code:IEA/Database source:InterPro:IPR001770)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR001806)E1B801(Evidence code:IEA/Database source:InterPro:IPR001806)A6QPX8(Evidence code:IEA/Database source:InterPro:IPR001806)P04695(Evidence code:IEA/Database source:InterPro:IPR001019|I)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884|I)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR003008)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR003008)A7MBB1(Evidence code:IEA/Database source:InterPro:IPR015894)E1BAI0(Evidence code:IEA/Database source:InterPro:IPR001806|I)G3X7D3(Evidence code:IEA/Database source:InterPro:IPR001806)Q3SZ98(Evidence code:IEA/Database source:InterPro:IPR001770)Q08DF4(Evidence code:IEA/Database source:InterPro:IPR001401|I)P10948(Evidence code:IEA/Database source:InterPro:IPR001806|I)A7Z031(Evidence code:IEA/Database source:InterPro:IPR001806)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR001806)P04896(Evidence code:IEA/Database source:InterPro:IPR000367|I)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469|I)A5PJP3(Evidence code:IEA/Database source:InterPro:IPR001806)F1MX39(Evidence code:IEA/Database source:InterPro:IPR001806)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR003008)P04696(Evidence code:IEA/Database source:InterPro:IPR001019|I)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR003008)Q17QU4(Evidence code:IEA/Database source:InterPro:IPR001806)P30671(Evidence code:IEA/Database source:InterPro:IPR001770)Q32LB9(Evidence code:IBA/Database source:PANTHER:PTN000119716)A4FUD3(Evidence code:IEA/Database source:InterPro:IPR000795)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR003008)Q58DW6(Evidence code:IEA/Database source:InterPro:IPR001806)Q08DC2(Evidence code:IEA/Database source:InterPro:IPR001806)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q17QB7(Evidence code:IEA/Database source:InterPro:IPR001806)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367|I)E1BIQ2(Evidence code:IEA/Database source:InterPro:IPR001806)F1MGL2(Evidence code:IEA/Database source:InterPro:IPR001806)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)Q08DW1(Evidence code:IEA/Database source:InterPro:IPR001806)F1N7V2(Evidence code:IEA/Database source:InterPro:IPR001806)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR003008)Q3T107(Evidence code:IEA/Database source:InterPro:IPR001806)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019|I)Q2TBH7(Evidence code:IEA/Database source:InterPro:IPR001806)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR001806)P81948(Evidence code:IEA/Database source:InterPro:IPR003008)E1B953(Evidence code:IEA/Database source:InterPro:IPR003008)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR003008)A4FUD1(Evidence code:IEA/Database source:InterPro:IPR030230)P63097(Evidence code:IEA/Database source:InterPro:IPR001019|I)Q32KW9(Evidence code:IBA/Database source:PANTHER:PTN001595864)Q29RR0(Evidence code:IEA/Database source:InterPro:IPR001806)Q9BDI7(Evidence code:IEA/Database source:InterPro:IPR001401|I)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR001806)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR003008)Q58DC5(Evidence code:IEA/Database source:InterPro:IPR000795)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR001806)Q3T054(Evidence code:IEA/Database source:InterPro:IPR001806|I)A4FUD7(Evidence code:IEA/Database source:InterPro:IPR001806)E1BLD5(Evidence code:IEA/Database source:InterPro:IPR001806)Q0II28(Evidence code:IEA/Database source:InterPro:IPR001806)P10949(Evidence code:IEA/Database source:InterPro:IPR001806|I)P11023(Evidence code:IEA/Database source:InterPro:IPR001806|I)Q08DF2(Evidence code:IEA/Database source:InterPro:IPR015894)F1N1I1(Evidence code:IEA/Database source:InterPro:IPR003191|I)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469|I)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR001401|I)F6RP72(Evidence code:IEA/Database source:InterPro:IPR003008)P38408(Evidence code:IEA/Database source:InterPro:IPR000654|I)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR001806), GNG5 RAP2C ARHGAP35 RAB12 GNAT1 MFN2 LRRK2 TUBA1A RHOT1 MTG1 TUBB4A LOC783604 RAB23 RAB39A GNG10 DNM1 RAB3B RASEF RAP2A GNAS GNA13 RAB22A RAB42 TUBB3 GNAT2 TUBB1 RAB39B GNG7 NOA1 EFTUD2 ARL2 TUBA3E RAB25 RAB31 RHOT2 RAB30 GNAL AGAP2 AGAP1 ARL1 RAB9A RAB17 TUBA8 RAB24 GNAT3 RAB4A RRAS TUBA4A LOC533307 LOC100141266 GPN1 GNAI1 IRGC RAB26 MX2 RIT1 TUBA1D GTPBP1 TRIM23 DIRAS2 RAN RAB33B RAB37 RAB4B RAB3C RAB3A RNF112 LOC100336669 GNA12 DNM2 LOC100295712 GNA14 HRAS,MF,73,73 of 111,3.1,65.77,1.607E-36,2.047E-34
GO:0048471,perinuclear region of cytoplasm,Q1RMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)A6H7F7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)A4FUC9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)O46382(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P00517(Evidence code:ISS/Database source:UniProtKB:P17612)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q3ZC12(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)Q3SZ65(Evidence code:IEA/Database source:UniProtKB:Q14240|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)Q29RU0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q5E9B7(Evidence code:IEA/Database source:UniProtKB:O00299|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IF89(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)O18964(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)Q95106(Evidence code:ISS/Database source:UniProtKB:P21237)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q3SZN2(Evidence code:IEA/Database source:UniProtKB:Q9D662|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)A2VDN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)A7Z056(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q647I9(Evidence code:IDA/Database source:)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens)Q9TU34(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)E1BKL9(Evidence code:IEA/Database source:UniProtKB:Q14517|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F6Q0K7(Evidence code:IBA/Database source:PANTHER:PTN002204142)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)Q0VCN1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P11456(Evidence code:IEA/Database source:UniProtKB:P20645|ens)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828), TMEM184A DLG1 ATP7B TRAPPC2L TSC2 VAMP5 NDRG2 RAB3C RHPN2 PSEN1 NPC1 ABCA1 ARFGEF1 PRKACA APC2 SYT4 EIF3G GALNT2 EIF4A2 SNAP25 SNF8 SLK LAMP1 FIGNL1 RNF128 PTPRM SRC CLIC1 CLINT1 EXOC8 SYNJ1 MYO9B RAB3B BDNF DDX4 MYO6 SEC23B fgfr3 ATP2C2 CYFIP2 TFRC AXIN1 S100B RASEF CYFIP1 OSBP ABL1 RAB4A SPAST EIF4H TRAF6 BAG5 USP20 STX7 SIRT2 COPS8 NEDD4 STK26 DCTN3 RAPGEF2 PINK1 UBQLN1 NLRP5 VPS35 MRVI1 TAF10 LMTK2 CDK5RAP2 TAF8 S100A4 ITPR1 PKP4 FAT1 MT3 S100A14 WWC1 NF2 CLIC4 SPATA32 LRPPRC TWF1 NMRAL1 M6PR VPS52 PKHD1 CIB1,CC,86,86 of 170,3.65,50.59,3.752E-36,4.669E-34
GO:0042803,protein homodimerization activity,Q2NL34(Evidence code:ISS/Database source:UniProtKB:O75208)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR013867)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)P02638(Evidence code:ISS/Database source:UniProtKB:P04271)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)G3N2I5(Evidence code:IEA/Database source:UniProtKB:D3W0D1|ens)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB:Q9NQW7|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)A6QPK5(Evidence code:IBA/Database source:PANTHER:PTN000927455)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)Q8SPX7(Evidence code:IEA/Database source:UniProtKB:Q9Y2S2|ens)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB:Q13554|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)P02510(Evidence code:ISS/Database source:UniProtKB:P02511)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR017751)P48034(Evidence code:ISS/Database source:UniProtKB:Q06278)A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36551|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BCH6(Evidence code:ISS/Database source:UniProtKB:A4D126)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)E1BM28(Evidence code:IEA/Database source:UniRule:UR000107503)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR013867)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)P42891(Evidence code:IPI/Database source:UniProtKB:P42891)Q1LZA3(Evidence code:IBA/Database source:PANTHER:PTN000206333)Q3T105(Evidence code:IEA/Database source:UniProtKB:Q14376|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q5EAC2(Evidence code:ISS/Database source:UniProtKB:Q08220)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)E1BM12(Evidence code:IEA/Database source:UniProtKB:P19623|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BFJ4(Evidence code:IEA/Database source:UniProtKB:Q99MV7|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens)E1BMI4(Evidence code:IEA/Database source:UniProtKB:Q8NBZ7|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)Q28007(Evidence code:IDA/Database source:)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q2HJ58(Evidence code:ISS/Database source:UniProtKB:P60891)F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107684)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)Q0VCK0(Evidence code:ISS/Database source:UniProtKB:P31939)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens), COQ9 IKBKG TERF1 ZBTB4 SFPQ ADH5 ANO6 SLIT2 NUDT16 S100B LRRK2 FCER1G KLRF2 XPNPEP1 TDG CUBN TSC2 CHMP4A TCF7L2 NFKB1 G6PD CEBPA CRYL1 CAMK2B PFKM GRHPR CRYAB EPRS ZHX3 GPD1L AOX1 EXT1 MAPK4 BLM CPOX GIPC1 TENM3 ISPD CAMK2A DNPH1 TERF2 DPP4 ECE1 ASNS GALE SP1 GSS BANF1 SDCBP2 STAT3 TSG101 IDE ARID3A SRM PDCD6IP KMT2A SNF8 RNF17 CHMP4B VPS25 OLFML2A UXS1 PDCD6 LRP6 CAT IMPA1 CHMP1A RPS19 VPS4B SYT6 SLK PTPA DPYD STK26 PDGFC TENM2 DAB2IP ALDH1A3 SRF PTH1R DGCR8 TFRC PRPS1 CTBP1 PDCD10 TPR WRN S100A10 ATIC KEAP1 CRYM WWTR1 KIT CUL3,MF,94,94 of 210,3.99,44.76,5.523E-36,6.717E-34
GO:0016787,hydrolase activity,Q08D90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E998(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P62194(Evidence code:IEA/Database source:InterPro:IPR005937)Q8HYW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BA23(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MEM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P16386(Evidence code:IEA/Database source:InterPro:IPR002168|I)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2YDJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P11064(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2T9T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BEQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A4FUF1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MMF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P0C6R3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QL8(Evidence code:IEA/Database source:InterPro:IPR003140)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P61287(Evidence code:IEA/Database source:InterPro:IPR004843|I)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0V8H0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P31408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5EA59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BLB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q29460(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KJI4(Evidence code:IEA/Database source:InterPro:IPR000407)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033562)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PJT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QPF2(Evidence code:IEA/Database source:InterPro:IPR006935)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P48452(Evidence code:IEA/Database source:InterPro:IPR004843|I)Q3SZ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR005937)F1MQD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P06623(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BB73(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MLX9(Evidence code:IEA/Database source:InterPro:IPR006680)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5D7T5(Evidence code:IEA/Database source:InterPro:IPR004843|I)F1MCT1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)O02675(Evidence code:IEA/Database source:InterPro:IPR006680)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QQN6(Evidence code:IEA/Database source:InterPro:IPR004843)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MXQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MRN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MHB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0VCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BNQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3MHR0(Evidence code:IEA/Database source:InterPro:IPR003140)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F6QK60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MNA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MKI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0V897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P20456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MS27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0II50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2TBQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5D980(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)H7BWW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q75WB5(Evidence code:IEA/Database source:InterPro:IPR002821)G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006680)P11019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BPC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3T0Y1(Evidence code:IEA/Database source:InterPro:IPR016615)Q9TTA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR005937)G5E631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BN79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PJV3(Evidence code:IEA/Database source:InterPro:IPR006680)Q3T0X5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A7MBJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q58DC0(Evidence code:IEA/Database source:InterPro:IPR004843)E1BIU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR005937)E1BIX3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q32KW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A4FUD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BHX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR004843|I)Q08DI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)G5E5C6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q0P594(Evidence code:IEA/Database source:InterPro:IPR004843|I)F1MGC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P22571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q32PA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1N0J3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MF35(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QLS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BER6(Evidence code:IEA/Database source:InterPro:IPR006680)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR005937)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P31407(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)E1BEZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)D3IVZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A1A4Q9(Evidence code:IEA/Database source:InterPro:IPR000086|I)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MS16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q9XTA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q17QK4(Evidence code:IEA/Database source:InterPro:IPR006439)P67774(Evidence code:IEA/Database source:InterPro:IPR004843|I)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A8E641(Evidence code:IEA/Database source:InterPro:IPR006680)A7YWN0(Evidence code:IEA/Database source:InterPro:IPR000407)E1BD03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)Q1JPJ2(Evidence code:IEA/Database source:InterPro:IPR000587)Q08DW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P31404(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)F1MN60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)A6QQD4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378)P80227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0378), KLK7 CAPN2 CTSV RUVBL1 PSMC5 atp1A3 AMPD3 PDXP DNASE1L1 DXO DHX8 SSH2 LIPE ACE DPEP3 HINT3 USP20 PRSS23 ACP1 RPAP2 HDAC5 EIF4A3 DUSP3 DHX9 LOC505658 VPS4B LOC100125946 PSMB2 DNM1 PSMA7 NPEPPS ATP2C2 CES4A LYPLA2 RHOT2 PPP1CC USP13 FHIT DHX57 PAN2 ATP6V1B2 ABHD4 DHX34 ABHD2 ATP1A2 PSEN1 INPP5J SAMHD1 DNPEP PAFAH1B3 ENTPD6 PNPLA2 ADAMTS4 IDE DNASE1L2 ADAMTS5 PTPRA FANCM SPAST PPP3CA EIF4A1 PSMC1 CAPN5 CNP CFTR INPP5B GDA EIF4A2 PPP3CC PCSK6 SYNJ1 ATP1A1 DPYSL2 PIGK HYAL1 SMPDL3B LYZ LYZ1 CAPN11 ATP13A5 INPP5A ATIC DDX4 PRUNE1 LTA4H DHX37 LYPLA1 LIPF PSMB3 SIRT2 TSN RUVBL2 HTRA1 TDRD9 MBTPS2 HABP2 PTPRM ATP7B PTPRZ1 PSMB10 PSMB4 ATP2B4 DNPH1 CHD8 HDAC10 IMPA1 RHOT1 PDE4D USB1 PGLS PTPN6 HEXB DDX1 OPLAH MAN1B1 PSMA2 CAD ATP6V1E1 CASP6 ATP8B1 OTUB1 SMARCAL1 DNM2 PSMC2 DDX3X CES5A GNPDA2 DPP4 PLCG1 AGO3 METAP2 AMDHD1 PSMA1 PSMB9 DICER1 EDEM2 ABHD17C BACE1 CPPED1 PTPN23 ARSA PSMC6 CAPN7 IRGC GPN1 KATNAL2 PLCB3 PPP1CB MMP19 ACR TMPRSS9 PPP2CB RNASE2 SPCS3 FUCA1 SEC11A TMPRSS6 PDE6H KLK6 PHPT1 ATP11A CASP3 PSMA3 TLL2 DUSP7 PSMA4 MAN1A2 CRMP1 PSMB8 ERCC2 PSMC3 ECE1 BRCC3 ATP6V1B1 PTPN14 DDX3Y NUDT16 TMPRSS2 ATP2B3 PREP EPHX2 PPP2CA AHCYL2 USP5 DPYSL5 ENTPD2 PPM1D XPNPEP1 ABHD12 ATP6V1A ATP2B2 PTPN5 APEH,MF,193,193 of 836,8.2,23.09,6.993E-36,8.315E-34
GO:0055114,oxidation-reduction process,Q148K4(Evidence code:IEA/Database source:InterPro:IPR006094)Q58DM4(Evidence code:IEA/Database source:InterPro:IPR005123)A6QP05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZBD3(Evidence code:IEA/Database source:GO:0004505)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR001093|I)Q3MHW4(Evidence code:IEA/Database source:InterPro:IPR023753)F1MJY3(Evidence code:IEA/Database source:GO:0070579)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001236|I)Q2KIT8(Evidence code:IEA/Database source:GO:0016491)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR005123|I)F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139|I)Q58DA7(Evidence code:IEA/Database source:GO:0015035)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR005123|I)Q27995(Evidence code:IEA/Database source:InterPro:IPR001094|I)Q3T046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZBW6(Evidence code:IEA/Database source:GO:0008670)O46414(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)F1MF26(Evidence code:IBA/Database source:PANTHER:PTN001038805)P48034(Evidence code:IEA/Database source:InterPro:IPR002346|I)P00435(Evidence code:IEA/Database source:InterPro:IPR000889)Q17QK8(Evidence code:IEA/Database source:InterPro:IPR006393)Q28007(Evidence code:IEA/Database source:InterPro:IPR005720|I)P00376(Evidence code:IEA/Database source:InterPro:IPR001796|I)P16116(Evidence code:IEA/Database source:InterPro:IPR018170|I)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BBS6(Evidence code:IEA/Database source:InterPro:IPR017905|I)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR015590|I)A7YY67(Evidence code:IEA/Database source:InterPro:IPR011407|I)Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225)Q59A28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZCJ2(Evidence code:IEA/Database source:InterPro:IPR018170|I)Q32L93(Evidence code:IEA/Database source:InterPro:IPR001093|I)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q8TDZ2)F1MHR3(Evidence code:IEA/Database source:InterPro:IPR015590|I)F1MMK2(Evidence code:IEA/Database source:InterPro:IPR001282|I)A5PJM4(Evidence code:IEA/Database source:InterPro:IPR000103|I)F1MHF7(Evidence code:IEA/Database source:GO:0047134)F1MQ57(Evidence code:IEA/Database source:GO:0008940)E1BJA2(Evidence code:IEA/Database source:InterPro:IPR016156|I)E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)O97764(Evidence code:IEA/Database source:InterPro:IPR013149|I)P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)P48818(Evidence code:IEA/Database source:InterPro:IPR006089|I)Q58D31(Evidence code:IEA/Database source:InterPro:IPR002328|I)P10897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0249)P23709(Evidence code:IEA/Database source:InterPro:IPR001268|I)Q32L99(Evidence code:IEA/Database source:InterPro:IPR013149)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006109|I)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I)A8E657(Evidence code:IEA/Database source:InterPro:IPR005097)A5D9D7(Evidence code:IEA/Database source:GO:0051213)Q3T0Z7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR011407|I)Q5I598(Evidence code:IEA/Database source:InterPro:IPR003171|I)Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR002328|I)A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000672|I)F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139|I)P48644(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603)P00432(Evidence code:IEA/Database source:InterPro:IPR011614|I)P27479(Evidence code:IEA/Database source:InterPro:IPR000907|I)Q4JIJ2(Evidence code:IEA/Database source:InterPro:IPR001094|I)F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139|I)P56560(Evidence code:IEA/Database source:InterPro:IPR001613|I)Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR008259|I)F1MXW0(Evidence code:IEA/Database source:InterPro:IPR000907|I)E1BKY9(Evidence code:IEA/Database source:InterPro:IPR001260|I)Q2KHX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I)Q32LH7(Evidence code:IEA/Database source:InterPro:IPR001433|I)F1MF74(Evidence code:ISS/Database source:UniProtKB:O94851)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens)P37141(Evidence code:IEA/Database source:InterPro:IPR000889)O62768(Evidence code:IEA/Database source:InterPro:IPR004099|I)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424|I)E1BL62(Evidence code:IEA/Database source:InterPro:IPR002346|I), LDHD ALKBH2 DHRS12 PCBD1 IMPDH2 SQRDL TET3 UEVLD TSTA3 EGLN3 LOC540627 FAM213B PHGDH GLRX3 P4HA2 NOS2 BDH2 DECR2 FTH1 CYP7A1 SH3PXD2A AOX1 GPX1 SPR DPYD DHFR AKR1B1 DHRS3 QSOX2 ALDH9A1 ALDH1L1 HSD3B7 CRYZL1 AKR1A1 GMPR2 CYP2R1 MICAL3 ALDH1A3 G6PD AIFM2 TXNDC17 GPHN AIFM1 LOC100295883 CRYZ DBH CYCS ACADVL SORD CYB561 NDUFS3 PTGR2 GPD1L PAH AASS PLOD3 QDPR ALDH1L2 MTHFR ADH5 MTHFD1 CTBP1 ALDH1A1 CYP2J2 DHTKD1 CAT ALOX15 MTRR GRHPR MAOB HAO2 ALOX15B CPOX CRYM CRYL1 CYB5R4 MICAL2 STEAP4 GPX3 TXNRD1 GAPDHS AOX4,BP,82,82 of 162,3.48,50.62,1.388E-34,1.614E-32
GO:0051171,regulation of nitrogen compound metabolic process,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1191,0.04,0.08,2.479E-34,2.823E-32
GO:0005739,mitochondrion,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)F1N1T6(Evidence code:IEA/Database source:UniProtKB:A0A024R419)O62768(Evidence code:IBA/Database source:PANTHER:PTN002456829)A4FUD1(Evidence code:IEA/Database source:UniProtKB:Q9HCN4|ens)Q08E34(Evidence code:IEA/Database source:UniProtKB:O94826|ens)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P56560(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)G3N127(Evidence code:IEA/Database source:UniProtKB:P27469|ens)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q4PS77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)Q17QI3(Evidence code:IBA/Database source:PANTHER:PTN000432235)A8E657(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)F1ML89(Evidence code:IEA/Database source:UniProtKB:Q8C196|ens)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BFI2(Evidence code:IEA/Database source:UniProtKB:Q96HY7|ens)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q148D3(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z4C3)A5PKL1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A1A4J8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q5E9B7(Evidence code:IEA/Database source:UniProtKB:Q9Z1Q5|ens)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens)Q3ZC24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P05630(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A4IFE6(Evidence code:IEA/Database source:UniProtKB:P61221|ens)Q2NL34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A1A4P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR027089)Q2TBI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)Q05B89(Evidence code:IBA/Database source:PANTHER:PTN000351096)P11181(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BFB5(Evidence code:IEA/Database source:InterPro:IPR033495)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36551|ens)P00376(Evidence code:ISS/Database source:UniProtKB:Q920D2)A5D7A2(Evidence code:IBA/Database source:PANTHER:PTN000078675)F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433398)Q08DK7(Evidence code:ISS/Database source:UniProtKB:Q8N8R3)A7YY65(Evidence code:IBA/Database source:PANTHER:PTN001324730)Q5EA61(Evidence code:ISS/Database source:UniProtKB:Q04447)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)F1MKA6(Evidence code:IBA/Database source:PANTHER:PTN000206956)E1BDI3(Evidence code:IBA/Database source:PANTHER:PTN000030201)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:F8VVT9|ens)A6QR09(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q647I9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)P61763(Evidence code:ISS/Database source:UniProtKB:O08599)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)A4IFC8(Evidence code:IBA/Database source:PANTHER:PTN000048763)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q58CZ9(Evidence code:ISS/Database source:UniProtKB:Q8QZR1)P00432(Evidence code:IBA/Database source:PANTHER:PTN000157252)A6QLT9(Evidence code:IBA/Database source:PANTHER:PTN000206956)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)P61287(Evidence code:ISS/Database source:UniProtKB:P36873)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:O54983|ens)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)E1BIP2(Evidence code:IEA/Database source:UniProtKB:A0A024R151)Q3SZK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3T099(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)E1BPX9(Evidence code:IEA/Database source:UniProtKB:E5KNY5|ens)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q32KZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BEB7(Evidence code:IBA/Database source:PANTHER:PTN000349172)P81127(Evidence code:IEA/Database source:UniProtKB:Q99747|ens)F1MZL5(Evidence code:IBA/Database source:PANTHER:PTN000812494)Q5E9F1(Evidence code:IEA/Database source:GO:0051561)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A6QLB8(Evidence code:IEA/Database source:GO:1901030)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)P0C2B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens)Q3ZBX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q148K4(Evidence code:IEA/Database source:UniProtKB:Q7TNG8|ens)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)E1BDG9(Evidence code:IEA/Database source:UniProtKB:Q3SY69|ens)P48818(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)F1MI25(Evidence code:IEA/Database source:UniProtKB:P15822|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens)P02722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496)Q2KIN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0496), SIRT2 ADH5 FASTKD2 TXNRD1 GPN1 TOMM70A LETM1 MAOB BRAF MAPK1 G0S2 FKBP4 MTG1 MAPK9 ACAT2 AASS GK AIFM1 RARS2 PPP3CA CPS1 RHOT2 DHTKD1 NOA1 FH OXR1 SORD SCO1 CLIC1 DYNLL1 GCK BDNF MARCH5 ATP5D ABCE1 COQ9 PFDN2 GOLPH3 HSPA9 MFN2 TRAP1 NDUFS3 CD3EAP NIF3L1 DBT KIAA0391 CPT1B CPOX DHFR GARS GK2 TDRD9 SLC25A29 MTCH1 CKB CAMK2A LRRK1 AARS2 POLG AGAP2 SLC25A26 NLRP5 FIS1 SRC STXBP1 NFKB1 LIG1 IDE LOC538702 TAT CAT AARS SOX4 PPP1CC CRYM CDK1 PRKACA KIF1B SLC44A1 TBRG4 CRYAB LIPE RHOT1 WARS2 SHMT2 LRPPRC EFHD1 MTIF3 CLIC4 TIMM17B COX4I1 TRUB1 NAPG SPHKAP BCAP31 PNPT1 CYCS GSK3A AGTPBP1 MRPL52 PSEN1 BAG5 POLDIP2 AIFM2 GPAT2 MRPL3 LRRK2 LDHD TNRC18 ARL2 ALDH1L2 ACADVL IMMT HIVEP1 VPS35 SH3GLB1 PINK1 RAI1 SLC25A4 MPV17,CC,120,120 of 380,5.1,31.58,2.232E-33,2.488E-31
GO:0043169,cation binding,E1BD03(Evidence code:IEA/Database source:InterPro:IPR000222)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR006048), PPM1D GBE1,MF,2,2 of 1145,0.08,0.17,2.379E-31,2.598E-29
GO:0006355,"regulation of transcription, DNA-templated",A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1BG94(Evidence code:IEA/Database source:InterPro:IPR003316)E1B9T7(Evidence code:IBA/Database source:PANTHER:PTN000502888)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628|I)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q2NL18(Evidence code:IEA/Database source:InterPro:IPR003650)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR003894|I)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR017970)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR001699|I)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628|I)A6QLP0(Evidence code:IEA/Database source:InterPro:IPR001766|I)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)G3N2N6(Evidence code:IEA/Database source:InterPro:IPR001909|I)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004826|I)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR003894|I)G3MYE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BPS0(Evidence code:IEA/Database source:InterPro:IPR004827)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q7YRX0(Evidence code:IEA/Database source:InterPro:IPR017970)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR000327|I)Q2HJ84(Evidence code:IEA/Database source:InterPro:IPR008422)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A6QL80(Evidence code:IBA/Database source:PANTHER:PTN000109455)F1MIL2(Evidence code:IEA/Database source:InterPro:IPR009146)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR003893|I)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)E1B9H3(Evidence code:IEA/Database source:InterPro:IPR025224)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR000679|I)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8CJF7|ens)E1BP38(Evidence code:IEA/Database source:UniProtKB:Q6GYP7|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MU53(Evidence code:IEA/Database source:InterPro:IPR001909|I)A6QNN4(Evidence code:IEA/Database source:InterPro:IPR003309)F1MPR1(Evidence code:IEA/Database source:InterPro:IPR037644)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR017431|I)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A6QP40(Evidence code:IEA/Database source:InterPro:IPR019139)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1ML85(Evidence code:IEA/Database source:InterPro:IPR013767)Q1MW18(Evidence code:IEA/Database source:InterPro:IPR017970)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR000679|I)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000451|I)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR000327|I)E1BHB8(Evidence code:IEA/Database source:InterPro:IPR017970)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628|I)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)G3X812(Evidence code:IEA/Database source:InterPro:IPR022355)E1BGQ4(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BJP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)F1MKK8(Evidence code:IEA/Database source:InterPro:IPR010578)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR003822|I)F1MT17(Evidence code:IEA/Database source:InterPro:IPR017970)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)A5D7F6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR001909|I)A4FUE0(Evidence code:IEA/Database source:InterPro:IPR008422)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR009110|I)E1BD77(Evidence code:IEA/Database source:InterPro:IPR017970)Q95115(Evidence code:IEA/Database source:InterPro:IPR001217|I)Q2KIM2(Evidence code:IEA/Database source:InterPro:IPR027093)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR031169)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR014978)E1BNM4(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MIK5(Evidence code:IEA/Database source:InterPro:IPR022097)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR001827|I)E1BLB9(Evidence code:IEA/Database source:InterPro:IPR017970)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR004827)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR001217|I)A6QNT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1B7I2(Evidence code:IEA/Database source:InterPro:IPR000418)F1N4U8(Evidence code:IEA/Database source:InterPro:IPR007759)E1BQ37(Evidence code:IBA/Database source:PANTHER:PTN000573360)E1BL97(Evidence code:IEA/Database source:InterPro:IPR029547)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)O02754(Evidence code:IEA/Database source:InterPro:IPR004827)Q3MHL6(Evidence code:IEA/Database source:InterPro:IPR000580)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004826|I)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR017970)Q32S26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A0JND4(Evidence code:IEA/Database source:InterPro:IPR026741)F1MZQ1(Evidence code:IEA/Database source:InterPro:IPR024137)G3N2D1(Evidence code:IEA/Database source:InterPro:IPR007759)Q1RMU0(Evidence code:IEA/Database source:InterPro:IPR006988|I)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR003316)F1MC99(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000685235)Q08DJ3(Evidence code:IEA/Database source:InterPro:IPR015096)A5PJW1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MXR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BE02(Evidence code:IEA/Database source:InterPro:IPR003316)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR003150)P61635(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)A6QNK4(Evidence code:IEA/Database source:InterPro:IPR000580)E1BCF7(Evidence code:IEA/Database source:InterPro:IPR017970)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MY77(Evidence code:IEA/Database source:InterPro:IPR037967)E1BK57(Evidence code:IEA/Database source:InterPro:IPR001699|I)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569)P17667(Evidence code:IEA/Database source:InterPro:IPR002546)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)E1BAI9(Evidence code:IEA/Database source:InterPro:IPR017970)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR001275|I)F1MU40(Evidence code:IEA/Database source:InterPro:IPR017970)F1MBH4(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1BDX0(Evidence code:IEA/Database source:InterPro:IPR012890)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)M5FMX2(Evidence code:IEA/Database source:InterPro:IPR031265)E1BJ67(Evidence code:IEA/Database source:InterPro:IPR015431)B0JYL6(Evidence code:IEA/Database source:InterPro:IPR001217|I)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)E1B8X8(Evidence code:IBA/Database source:PANTHER:PTN000139030)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)Q9BE45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805)E1BDU9(Evidence code:IEA/Database source:InterPro:IPR000679|I)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR000040|I)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0805), INSM1 RPS6KA4 E2F1 SUZ12 ESRRG PRMT5 HEYL PAXIP1 ARID3A CPNE1 KEAP1 PKN1 HDAC5 WWTR1 CBFA2T2 EN1 MGA ERCC2 RPS6KA5 NR1I2 FOXO4 CDC5L ZFP37 MAF TAF4B MECP2 PARP1 IKBKG CREBRF MCTS1 USP13 TCF7L2 RAX2 HBP1 PTPRN POU3F1 PKNOX1 CHD8 PRMT3 TLE6 IRX1 HCFC1 CCAR2 PRKCB gata4 AHCTF1 RALGAPA1 RUVBL1 ZNF446 LOC515042 MN1 SOX4 IRF1 RPAP2 LRRFIP1 VPS36 AHR LHX4 GATA6 NFKB1 RREB1 PRMT6 POU4F2 RAX NR2F6 MAPK13 NOTCH4 ZNF316 SRF UBE2L3 SIM2 GON4L CUX2 ZBTB8A KDM3B MAML2 ZNF394 MEIS1 NCOA3 ZFHX2 STAT5A EAF2 MIER1 SMARCA2 ZNF282 CIDEC MMS19 SOX1 IKBKAP HOXA7 SHOX2 ATF6B STAT5B FAM120B ETV2 ASXL1 SFPQ SOX13 SP1 CEBPA TSC22D1 NFE2L2 ZFHX3 BRD2 SBNO2 SAP130 ASXL3 NAB2 FHIT SOX17 KMT2B UHRF1 AEBP2 TFDP2 FOXI3 PAK6 FUBP1 TAF10 ONECUT2 E2F7 ZNF148 RFX5 STAT3 SALL4 TSC22D3 DLX2 TAF8 DDX1 ZMYND8 TBX3 ZNF750 KMT2A MYF5 DYNLL1 EGR4 LOC526488 ANHX BRCA1 VPS25 ZMYM5 DMRTC2 MNX1 FOXF1 GCFC2 DHX9 SOX8 CCNL1 STAT1 Gli3 BRCA2 SAP18 RUVBL2 NFKBIZ ZBTB18 GATAD2B RUNX1 PCBD1,BP,157,157 of 662,6.67,23.72,8.132E-31,8.703E-29
GO:0005813,centrosome,Q2KII9(Evidence code:IBA/Database source:PANTHER:PTN000293992)E1BQ19(Evidence code:IEA/Database source:InterPro:IPR029664)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q96GX5)Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q96FJ2|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:A0A024R0F8)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8N157)A2VDZ4(Evidence code:IEA/Database source:UniProtKB:O00444|ens)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138)A2VDN5(Evidence code:IEA/Database source:UniRule:UR000107246)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8TCU4|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)F1MM88(Evidence code:IEA/Database source:UniProtKB:Q8TD19|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BKZ3(Evidence code:IEA/Database source:InterPro:IPR031887)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F1MWN4(Evidence code:IEA/Database source:InterPro:IPR030516)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1BFA7(Evidence code:IEA/Database source:UniProtKB:Q9BVG8|ens)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)E1BC48(Evidence code:IEA/Database source:InterPro:IPR028750)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)G3N2H6(Evidence code:IEA/Database source:UniProtKB:Q0P6D6|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)F1MC03(Evidence code:IEA/Database source:InterPro:IPR029560)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)A5D7P5(Evidence code:IEA/Database source:UniProtKB:Q9BSJ2|ens)E1BLZ4(Evidence code:ISS/Database source:UniProtKB:Q68DK2)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:P18564|ens)P43033(Evidence code:IBA/Database source:PANTHER:PTN000752735)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)Q3T140(Evidence code:IEA/Database source:UniProtKB:Q9NP97|ens)P61420(Evidence code:ISS/Database source:UniProtKB:P61421)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens), DYNC1LI1 NIN PRKAR2A MASTL DYNLL2 PLK3 GPSM2 AHI1 PLK4 PCM1 SPAST ACTR1A ALMS1 KIF23 BRCA2 CDK5RAP2 PCNT NEK9 WRN PPP2R5A DCTN3 RGS14 SDCCAG8 MVB12A PSEN1 SIRT2 SFI1 ARL2 BICD2 CDK6 KIFC3 CDC27 CEP350 CLIC4 PDE4D CCDC15 CKAP5 NUMA1 E2F1 USP20 PRKACB CEP295 BRSK2 GNAI1 DCTN2 TUBGCP2 ZFYVE26 CDK1 ITGB6 PAFAH1B1 CIB1 AXIN2 DYNLRB1 ATP6V0D1 CCT5 VPS4B RANBP2 RAB23 CRMP1 RAD18 PKHD1,CC,61,61 of 99,2.59,61.62,1.063E-29,1.116E-27
GO:0005730,nucleolus,F6RRD7(Evidence code:IEA/Database source:UniProtKB:Q8IXW5|ens)Q3SZ65(Evidence code:IBA/Database source:PANTHER:PTN000618218)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P30291|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:A0A024RDI0)Q1JPD9(Evidence code:IEA/Database source:UniProtKB:A0A024QYX2)F1N397(Evidence code:IEA/Database source:UniProtKB:A0A140VJD0)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:J3KNS1|ens)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)E1B7T1(Evidence code:IEA/Database source:UniProtKB:Q7Z7B0|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)E1BGE2(Evidence code:IEA/Database source:UniProtKB:O75691|ens)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224)P63097(Evidence code:IEA/Database source:UniProtKB:P63096|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)Q3T087(Evidence code:ISS/Database source:UniProtKB:P62913)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)E1BC24(Evidence code:IEA/Database source:UniProtKB:Q9NU22|ens)E1BNA1(Evidence code:IEA/Database source:UniProtKB:Q5JTH9|ens)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q96LA8|ens)Q3MI00(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q9Y4G2|ens)Q2KJ71(Evidence code:IEA/Database source:UniProtKB:Q13595|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens)Q3SZ54(Evidence code:IBA/Database source:PANTHER:PTN000618218)A5D7J3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)Q17QL4(Evidence code:IEA/Database source:UniProtKB:A0A024R9Y7)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)E1BDV5(Evidence code:IEA/Database source:UniProtKB:C9JFV4|ens)E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433607)A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000618218)A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:F8VVT9|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)F1MMU4(Evidence code:IEA/Database source:UniProtKB:Q92522|ens)Q2NL22(Evidence code:IBA/Database source:PANTHER:PTN000618218)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BHN9(Evidence code:IEA/Database source:UniProtKB:Q3TPJ7|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:B0LPF3|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:A0A024R8V6)Q0IIK5(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q9TU47(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28141(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)Q3T0M9(Evidence code:ISS/Database source:UniProtKB:P40617)Q647I9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)P48818(Evidence code:IEA/Database source:UniProtKB:P49748|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q9D4H8|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens), RPAP2 EIF4A2 PARP1 MYO1C SMG6 ACAT2 MOB1B CCT5 BLM WEE1 WDFY3 GPRC5B LRWD1 IKBKAP AGTPBP1 SAPCD2 DDX4 DCTN3 FILIP1 MALT1 PTPN6 UTP20 STAT1 GNAI1 DGCR8 CHD7 RPL11 INTS3 MDN1 RRP12 DDX3X PRMT6 DNAJB1 PLEKHM1 TRA2A TRIM68 BCL9L EIF4A1 KNOP1 ATF6B GCFC2 ADARB1 MAGED2 PPP1CB CPS1 CKAP5 PELP1 GOLGA3 DHX37 RPS9 HSPA9 PPP1CC PLK3 SDCBP2 SUZ12 DDX3Y PLK4 NUDT16 WRN DDX20 AGAP2 ARL2 XPO1 H1FX EIF4A3 TAOK2 ABL1 KANSL3 MIDN SIRT2 GRB2 USP36 DDX1 EIF6 DHX9 OSBP ARFGEF1 ARL4A NLRP5 NF2 RPS19 TSG101 PPID ACADVL ATM GLI2 CUL2 PRKDC,CC,88,88 of 232,3.74,37.93,1.224E-29,1.26E-27
GO:0016043,cellular component organization,E1B718(Evidence code:IEA/Database source:InterPro:IPR010472)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010472)A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010472)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010472)G3N135(Evidence code:IEA/Database source:InterPro:IPR010472), FMNL3 FMNL1 DIAPH3 DAAM1 FMNL2,BP,5,5 of 1191,0.21,0.42,7.427E-29,7.499E-27
GO:0005096,GTPase activator activity,F1MM72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)F1MKZ2(Evidence code:IEA/Database source:InterPro:IPR001164)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR028558)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739)Q0V8A7(Evidence code:IEA/Database source:InterPro:IPR001164)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)A0JN64(Evidence code:IEA/Database source:InterPro:IPR000331|I)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR030772)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR030061)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090250)F1MHG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)E1BP38(Evidence code:IEA/Database source:InterPro:IPR000331|I)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR037776)F1MM21(Evidence code:IEA/Database source:InterPro:IPR037956)F1MJI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR000331|I)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q29RJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR000331|I)Q58DV1(Evidence code:IEA/Database source:InterPro:IPR039093)A7YY57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)E1B800(Evidence code:IBA/Database source:PANTHER:PTN000022879)A7MB27(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR037769)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)F1MGL2(Evidence code:IEA/Database source:InterPro:IPR001164)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776)G3X7P3(Evidence code:IBA/Database source:PANTHER:PTN000090250)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)F1N746(Evidence code:IEA/Database source:InterPro:IPR033185)F1MTH3(Evidence code:IEA/Database source:UniProtKB:Q6ZPF3|ens)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037884)A6QNV8(Evidence code:IEA/Database source:InterPro:IPR030409)F1N2I0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)G3MYM2(Evidence code:IEA/Database source:InterPro:IPR033564)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR037858)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)G3MXN3(Evidence code:IEA/Database source:InterPro:IPR037745)F1MD62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0343)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR028557)E1BIQ2(Evidence code:IEA/Database source:InterPro:IPR001164), ARHGAP22 ASAP2 TBC1D12 MYO9A RAPGEF2 ARFGAP1 LARS GARNL3 ARHGAP6 ARHGAP26 AXIN1 ARHGAP21 RALGAPA1 RASAL1 RGS6 SRGAP3 DAB2IP TSC2 TBC1D22B TBC1D24 SIPA1L1 RP2 ARHGAP29 MTSS1L SYNGAP1 RASAL2 ARHGAP36 LRRK2 BCR RACGAP1 AGAP1 RGS14 AXIN2 ARHGAP35 RANBP2 RABGAP1 TIAM2 ARHGEF12 RGS1 CHML TBC1D2 TBC1D4 ARAP3 ECT2 SGSM2 ARHGAP20 MYO9B AGAP2,MF,48,48 of 54,2.04,88.89,1.035E-28,1.025E-26
GO:0046982,protein heterodimerization activity,E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1MUD2(Evidence code:IEA/Database source:InterPro:IPR009072)E1BGN3(Evidence code:IEA/Database source:InterPro:IPR009072)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)F1MV26(Evidence code:IEA/Database source:InterPro:IPR009072)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR009072)Q32L48(Evidence code:IEA/Database source:InterPro:IPR009072)Q2KII5(Evidence code:IEA/Database source:InterPro:IPR009072)G3MYD7(Evidence code:IEA/Database source:InterPro:IPR009072)G3N068(Evidence code:IEA/Database source:InterPro:IPR009072)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q5E9F8(Evidence code:IEA/Database source:InterPro:IPR009072)E1BGW2(Evidence code:IEA/Database source:InterPro:IPR009072)P55156(Evidence code:ISS/Database source:UniProtKB:P55157)G8JL00(Evidence code:IEA/Database source:InterPro:IPR009072)F2Z4E8(Evidence code:IEA/Database source:InterPro:IPR009072)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)E1BJF4(Evidence code:IEA/Database source:UniProtKB:P33609|ens)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A7MAZ4(Evidence code:IEA/Database source:InterPro:IPR009072)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)E1BM22(Evidence code:IEA/Database source:InterPro:IPR009072)G3N053(Evidence code:IEA/Database source:InterPro:IPR009072)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BJI4(Evidence code:IEA/Database source:InterPro:IPR009072)A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR009072)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR009072)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR009072)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)E1B8G9(Evidence code:IEA/Database source:InterPro:IPR009072)G3MZR4(Evidence code:IEA/Database source:InterPro:IPR009072)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR009072)A6QQ14(Evidence code:IEA/Database source:InterPro:IPR009072)E1BL49(Evidence code:IEA/Database source:InterPro:IPR009072)E1BC18(Evidence code:IEA/Database source:InterPro:IPR009072)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1N5F3(Evidence code:IEA/Database source:InterPro:IPR009072)A0A0A0MP90(Evidence code:IEA/Database source:InterPro:IPR009072)A5PK61(Evidence code:IEA/Database source:InterPro:IPR009072)E1BH22(Evidence code:IEA/Database source:InterPro:IPR009072)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)G3N2P2(Evidence code:IEA/Database source:InterPro:IPR009072)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR009072)G3N3L9(Evidence code:IEA/Database source:InterPro:IPR009072)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR009072)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)P67774(Evidence code:ISS/Database source:UniProtKB:P67775)F1N453(Evidence code:IEA/Database source:InterPro:IPR009072)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens), TENM3 HIST2H2BF HIST2H3D MEIS1 IKBKG LOC525433 SDCBP2 PEF1 HIST1H2AJ HIST1H2BN HIST1H2BI LOC100297725 LOC614378 MAPK4 NCOA3 H3F3B HIST1H2BJ MTTP LOC104975684 HIST1H2BB SIM2 POLA1 TENM2 SOX17 TAF8 SRI LOC100300167 HIST1H2BA NAE1 FLOT1 BTBD11 EXT1 H2AFZ HIST3H2A NFKB1 LOC619094 ZHX3 HIST3H2BB LOC523702 PKNOX1 TAF4B POLE4 LOC614206 LOC617043 TOP2B LOC615183 HIST1H2AC H3F3C HIST2H2AB SPTA1 LOC613345 TXLNG H2AFJ LOC613363 LOC614881 TCF7L2 PPP2CA HIST2H2BE ITGB1 CUL3,MF,60,60 of 103,2.55,58.25,2.833E-28,2.756E-26
GO:0032502,developmental process,F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745)E1BJB4(Evidence code:IEA/Database source:InterPro:IPR031136), PPP2R2A RPGRIP1L,BP,2,2 of 1033,0.08,0.19,3.263E-28,3.118E-26
GO:0016567,protein ubiquitination,A3KN22(Evidence code:IEA/Database source:GO:0004842)E1BL52(Evidence code:IEA/Database source:GO:0061630)A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6)Q0V7P2(Evidence code:IEA/Database source:InterPro:IPR031227)E1BAK9(Evidence code:IEA/Database source:InterPro:IPR032832)Q32PG9(Evidence code:IEA/Database source:UniPathway:UPA00143)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens)Q3SZD5(Evidence code:IEA/Database source:InterPro:IPR038914)Q3SX45(Evidence code:IEA/Database source:UniPathway:UPA00143)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR027139|I)Q32PF3(Evidence code:IEA/Database source:InterPro:IPR029169)A2VE03(Evidence code:IEA/Database source:UniPathway:UPA00143)A7Z061(Evidence code:IEA/Database source:UniPathway:UPA00143)F1MBS7(Evidence code:IEA/Database source:GO:0004842)E1BK47(Evidence code:IEA/Database source:GO:0004842)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)A7MBJ7(Evidence code:IEA/Database source:GO:0004842)Q3ZC24(Evidence code:IEA/Database source:UniPathway:UPA00143)E1B7Q7(Evidence code:IEA/Database source:UniPathway:UPA00143)F1MNJ8(Evidence code:IEA/Database source:GO:0004842)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR003613|I)Q08DF2(Evidence code:IEA/Database source:UniPathway:UPA00143)Q08DB6(Evidence code:IEA/Database source:GO:0004842)Q17QG5(Evidence code:IEA/Database source:UniPathway:UPA00143)Q32PG4(Evidence code:IEA/Database source:GO:0004842)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q6PDX6)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670)F2Y8Y4(Evidence code:IEA/Database source:InterPro:IPR039087)G3MX28(Evidence code:IEA/Database source:GO:0004842)E1BG23(Evidence code:IEA/Database source:UniProtKB:Q8C0E3|ens)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)A7E320(Evidence code:IEA/Database source:UniPathway:UPA00143)Q864U1(Evidence code:IEA/Database source:UniPathway:UPA00143)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)A5PJF0(Evidence code:IEA/Database source:InterPro:IPR033097)Q08DE9(Evidence code:IEA/Database source:GO:0061630)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)Q29RU0(Evidence code:IEA/Database source:UniPathway:UPA00143)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)F1MUH4(Evidence code:IEA/Database source:InterPro:IPR003613)G5E639(Evidence code:IEA/Database source:UniProtKB:P0C2W1|ens)Q3ZCF3(Evidence code:IEA/Database source:UniPathway:UPA00143)G3MX12(Evidence code:IEA/Database source:InterPro:IPR010606)E1BE13(Evidence code:IEA/Database source:GO:0004842)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)E1BB00(Evidence code:IEA/Database source:UniPathway:UPA00143)F1N1C5(Evidence code:IEA/Database source:GO:0061630)Q0VD59(Evidence code:IEA/Database source:UniPathway:UPA00143)F1N1X8(Evidence code:IEA/Database source:GO:0061630)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A6QNU0(Evidence code:IEA/Database source:GO:0004842)A8WFQ1(Evidence code:IEA/Database source:InterPro:IPR037299)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)Q1RMX2(Evidence code:IEA/Database source:UniPathway:UPA00143)P61085(Evidence code:IEA/Database source:UniPathway:UPA00143)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR010606)A7MBG4(Evidence code:IEA/Database source:InterPro:IPR030563)A5PJZ4(Evidence code:IEA/Database source:GO:0004842)F1MDC0(Evidence code:IEA/Database source:InterPro:IPR031127)G3N1V7(Evidence code:IEA/Database source:GO:0004842)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)E1BM69(Evidence code:IEA/Database source:GO:0004842)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)G8JKY1(Evidence code:IEA/Database source:UniPathway:UPA00143)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens), UBE2M LOC780968 CAND1 PJA1 SYVN1 FBXL12 CUL1 DCAF15 ASB2 TRAF6 PCNP ITCH CDC27 MALT1 KLHL35 RBX1 KLHL18 MARCH5 TRIP12 KLHL26 UBE4B RNF112 HERC4 UBE2G2 NEDD4L RNF220 CUL3 RC3H2 VCPIP1 KLHDC7A TRIM47 MYCBP2 UHRF1 BRCA1 PINK1 BARD1 CUL2 CBLC RNF128 UBE2L3 RNF139 STUB1 FBXO45 SKP1 HERC2 BIRC6 NFE2L2 ASB10 FBXO40 MARCH8 UBE2Z NEDD4 RNF31 TRIM37 WWTR1 UBE2D2 UBE2K MIB2 KEAP1 HECTD3 ANKIB1 KLHL34 TRIM23 LOC516599 KLHL13 ASB14 ARRDC1,BP,67,67 of 137,2.85,48.91,5.833E-28,5.476E-26
GO:0003774,motor activity,E1BBN7(Evidence code:IEA/Database source:UniRule:UR000401007)E1BA80(Evidence code:IEA/Database source:InterPro:IPR001609)E1BGB0(Evidence code:IEA/Database source:UniRule:UR000401007)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q0II58(Evidence code:IEA/Database source:UniRule:UR000401007)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR001609|I)A7MBA1(Evidence code:IEA/Database source:UniRule:UR000401007)F1MNK8(Evidence code:IEA/Database source:UniRule:UR000401007)F1MG13(Evidence code:IEA/Database source:InterPro:IPR001609)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR001609|I)G3MXV5(Evidence code:IEA/Database source:UniRule:UR000401007)E1BFA7(Evidence code:IEA/Database source:UniRule:UR000401007)Q17R14(Evidence code:IEA/Database source:InterPro:IPR001609|I)A7E3C1(Evidence code:IEA/Database source:UniRule:UR000401007)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)F1ME41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR001609|I)G3N1E4(Evidence code:IEA/Database source:UniRule:UR000401007)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)P10568(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MX93(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)A5D7N6(Evidence code:IEA/Database source:UniRule:UR000401007)Q3MHR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)G5E5S3(Evidence code:IEA/Database source:UniRule:UR000401007)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)E1BC41(Evidence code:IEA/Database source:UniRule:UR000401007)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)Q27966(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)Q32WS5(Evidence code:IEA/Database source:InterPro:IPR002928)G5E5V6(Evidence code:IEA/Database source:InterPro:IPR002928)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MM57(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MMC7(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q3MHM9(Evidence code:IEA/Database source:UniRule:UR000401007)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I), KIF1B MYO18B KIF13B MYO5A KIF5C MYO9B KIFC1 KIF26B MYO15A MYH11 KIF13A KIFC3 MYO1D KIF5A DYNC1I2 LOC101902172 MYO6 KIF26A DYNLRB1 MYO1A MYO5C MYO18A KIF23 DYNLL2 KIF14 DYNLT1 KIF15 DYNLL1 MYO1C LOC101905447 CGN CGNL1 MYO9A MYH14 MYO7B MYO1F KIF5B DCTN2 MYO5B,MF,39,39 of 29,1.66,134.48,6.932E-28,6.396E-26
GO:0003779,actin binding,A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010472|I)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1MLR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)P10568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)A6QLN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)G3MXG3(Evidence code:IEA/Database source:InterPro:IPR027717)E1BGT8(Evidence code:IEA/Database source:InterPro:IPR029901|I)A2VDK6(Evidence code:IEA/Database source:InterPro:IPR003124)Q0III9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q56JV6(Evidence code:IEA/Database source:InterPro:IPR002108|I)F1MCY2(Evidence code:IEA/Database source:InterPro:IPR029984)E1BKQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MX93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MT60(Evidence code:IEA/Database source:InterPro:IPR013998)F1MMC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)O46385(Evidence code:IEA/Database source:InterPro:IPR003128|I)F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222)E1BA80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MM57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR002108)E1BDP6(Evidence code:IEA/Database source:InterPro:IPR003128|I)A5PK55(Evidence code:IEA/Database source:InterPro:IPR028433)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)E1BL04(Evidence code:IEA/Database source:InterPro:IPR012510|I)F6Q0K7(Evidence code:IBA/Database source:PANTHER:PTN002204142)Q17R14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BE25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q32LP2(Evidence code:IEA/Database source:InterPro:IPR008954|I)E1B718(Evidence code:IEA/Database source:InterPro:IPR010472|I)F1MGT3(Evidence code:IEA/Database source:InterPro:IPR030059|I)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737)F1MG13(Evidence code:IEA/Database source:InterPro:IPR035487)G3MZH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010472|I)F1MKE9(Evidence code:IEA/Database source:InterPro:IPR016343)F1MMQ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)G3N3E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BLT3(Evidence code:IEA/Database source:InterPro:IPR016343)A5D7L9(Evidence code:IEA/Database source:InterPro:IPR013998)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939)B6Z9Q5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q1JP79(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)F1N611(Evidence code:IEA/Database source:InterPro:IPR008379)E1BIG2(Evidence code:IEA/Database source:InterPro:IPR008954|I)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)Q28046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)G3N135(Evidence code:IEA/Database source:InterPro:IPR010472)G3MXH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010472|I)E1BNV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BET5(Evidence code:IEA/Database source:InterPro:IPR026648)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BPK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0009)E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922)F1N643(Evidence code:IEA/Database source:InterPro:IPR030494), DIAPH3 ARPC5L GIPC1 MYO7B EPS8L1 MYO1A MYH11 CCDC88A SPIRE1 WASF2 ACTN3 MYO1C TWF1 PHACTR4 MYO18A MYO5C NEB MYO1F SVIL EPS8 MYO18B ACTN2 MYH14 DSTN VILL PARVA UTRN TRPM7 XIRP2 SPATA32 MYO1D FLNC RDX FMNL3 MTSS1L SYN1 CORO7 MYO15A MYO5A DAAM1 SPTB MYO5B SPTBN5 SPTBN4 NRAP MICAL2 SHROOM2 LRRK2 ARPC1A EPB41L1 NF2 KCNMA1 MKL1 SCIN FMNL2 MYO9A MICAL3 FMNL1 MYO9B SSFA2 CYFIP1 MYO6 SSH2 SHROOM3,MF,64,64 of 124,2.72,51.61,8.56E-28,7.763E-26
GO:0005768,endosome,Q1RMW2(Evidence code:ISS/Database source:UniProtKB:Q3UFJ6)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56817)A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q58CS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q1RMR9(Evidence code:IBA/Database source:PANTHER:PTN000860688)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A5PK00(Evidence code:ISS/Database source:UniProtKB:Q86VN1)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)Q17R14(Evidence code:ISS/Database source:UniProtKB:F1PRN2)G5E657(Evidence code:IEA/Database source:UniProtKB:Q9NQE7|ens)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)P11456(Evidence code:ISS/Database source:UniProtKB:P20645)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A6QQ47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q08DI5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635134)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)E1BK71(Evidence code:IBA/Database source:PANTHER:PTN000860688)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q08DN8(Evidence code:ISS/Database source:UniProtKB:O75955)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)Q0VD59(Evidence code:ISS/Database source:UniProtKB:Q5T0T0)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635134)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0967)A6QLR4(Evidence code:ISS/Database source:UniProtKB:Q14254)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)P11019(Evidence code:ISS/Database source:UniProtKB:P50518)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), TMEM184A TMEM59 BACE1 SNX12 SNX8 RAPGEF2 PKN1 VPS41 SNX3 CHMP3 RAB3A PTPRN SNX27 CHMP1B VTA1 CFTR PACSIN2 ZFYVE27 PTPN23 VPS4B VPS36 ABHD17C CD63 SH3GL1 STEAP4 VPS25 VPS28 ASTN1 STX7 RNF112 MYO1D PRSS16 UBXN6 TOM1 M6PR TSG101 VPS35 ARL8B MVB12A SPAST VPS29 VPS51 RAP2C RAB26 BIRC6 HPS6 CUBN PACSIN3 NPC1 LRRK2 CPNE6 FLOT1 RAB4A TMEM106B TLR4 SORL1 ANKFY1 CHMP2B VPS26A ITM2B CHMP4A ITGB1 MARCH8 RAB37 LAMP1 FLOT2 GRB2 CHMP4B ATP6V1E1 ARF6 TFRC DGKQ,CC,72,72 of 165,3.06,43.64,1.59E-27,1.418E-25
GO:0006508,proteolysis,P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)G3MZT7(Evidence code:IEA/Database source:InterPro:IPR001590)Q5E998(Evidence code:IEA/Database source:InterPro:IPR000668)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MF35(Evidence code:IEA/Database source:InterPro:IPR001506|I)Q3T0Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08DY9(Evidence code:IEA/Database source:InterPro:IPR001309|I)A5D7S6(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BL29(Evidence code:IEA/Database source:InterPro:IPR004134)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q29RY7(Evidence code:IEA/Database source:GO:0008233)Q3ZC89(Evidence code:IEA/Database source:InterPro:IPR002468)F1MCT1(Evidence code:IEA/Database source:InterPro:IPR000209|I)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9TT92(Evidence code:IEA/Database source:InterPro:IPR001590)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q3T0X5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q1LZ81(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q5E9Z2(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR001375|I)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BFV4(Evidence code:IEA/Database source:InterPro:IPR001590)F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens)G5E657(Evidence code:IEA/Database source:InterPro:IPR008758)G5E5C6(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR001096)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR001590)E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180|I)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR000668)Q3SZH7(Evidence code:IEA/Database source:InterPro:IPR001930)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR001309|I)F1MQD1(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR001590)P42891(Evidence code:IEA/Database source:InterPro:IPR000718|I)E1BEQ4(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q2HJ40(Evidence code:IEA/Database source:InterPro:IPR001461|I)A1A4Q9(Evidence code:IEA/Database source:GO:0008235)P80227(Evidence code:IEA/Database source:InterPro:IPR001375|I)F2Y8Y4(Evidence code:IEA/Database source:GO:0004843)F1MRA8(Evidence code:IEA/Database source:InterPro:IPR001590)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN001124099)Q2HJH1(Evidence code:IEA/Database source:InterPro:IPR001948)Q08D90(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q24K02(Evidence code:IEA/Database source:InterPro:IPR001431)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9TT93(Evidence code:IEA/Database source:InterPro:IPR001590)A6QQ95(Evidence code:IEA/Database source:InterPro:IPR001254|I)F1MKS6(Evidence code:IEA/Database source:InterPro:IPR000834)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BIX3(Evidence code:IEA/Database source:InterPro:IPR001300|I)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1B9Z9(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q1LZE9(Evidence code:IEA/Database source:InterPro:IPR001254|I)P12820(Evidence code:IEA/Database source:InterPro:IPR001548)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MWW8(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q0III2(Evidence code:IEA/Database source:InterPro:IPR001193|I)P81425(Evidence code:IEA/Database source:InterPro:IPR001375|I)Q27971(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0Q2(Evidence code:IEA/Database source:GO:0004175)G3X743(Evidence code:IEA/Database source:InterPro:IPR001930)E1BP91(Evidence code:IEA/Database source:InterPro:IPR001930)Q08E55(Evidence code:IEA/Database source:InterPro:IPR000209|I)A4FUF1(Evidence code:IEA/Database source:InterPro:IPR001254|I)F1N152(Evidence code:IEA/Database source:InterPro:IPR001940)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BI31(Evidence code:IEA/Database source:InterPro:IPR001375|I)F1N2M2(Evidence code:IEA/Database source:InterPro:IPR001590)Q5E9K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BER3(Evidence code:IEA/Database source:InterPro:IPR000834)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BBU4(Evidence code:IEA/Database source:InterPro:IPR001590)Q0IIA3(Evidence code:IBA/Database source:PANTHER:PTN000021568)P12661(Evidence code:IEA/Database source:InterPro:IPR005151)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)B7TCH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MBS7(Evidence code:IEA/Database source:InterPro:IPR001309), PSMB3 SPCS3 LOC531521 CTSV PSMB8 TLL2 PSMA2 CASP3 PEF1 PSMB10 BLMH PSMB4 FGL2 METAP2 PCSK6 USP5 ADAMTS5 CAPN11 PSMA1 PDCD6 HABP2 PREP USP13 XPNPEP1 ADAMTS14 NAALAD2 PRSS16 ACR PIGK ADAMTS18 DPEP3 TINAGL1 LTA4H TMPRSS2 CASP6 CAPN5 ADAMTS12 ECE1 LOC505658 BACE1 NUDT16 APEH VCPIP1 ADAM7 CBLC DNPEP KLK7 IDE PSMB9 ADAMTS4 KLK6 AGTPBP1 OTUB1 CAPN7 USP20 TMPRSS9 PRSS23 ACE PSMA3 TMPRSS6 PSMA7 MBTPS2 DPP4 CAPN2 MMP19 PSEN1 TMEM59 RNPEP NPEPPS MBTPS1 LOC100125946 HTRA1 BRCC3 DPP9 ADAMTS7 PSMB2 CPXM2 SEC11A ADAM15 SRI RBP3 PSMA4 USP9Y MALT1,BP,84,84 of 230,3.57,36.52,1.764E-27,1.548E-25
GO:0006366,transcription by RNA polymerase II,F1MKW9(Evidence code:IEA/Database source:GO:0001205)A2VDR9(Evidence code:IEA/Database source:GO:0001077)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BAD4(Evidence code:IEA/Database source:GO:0001228)F1MIK5(Evidence code:IEA/Database source:GO:0001077)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)Q32KX6(Evidence code:IEA/Database source:GO:0001228)F1MBH4(Evidence code:IEA/Database source:GO:0001228)E1BCF7(Evidence code:IEA/Database source:GO:0001228)Q32PE0(Evidence code:ISS/Database source:UniProtKB:P61218)F1MXR2(Evidence code:IEA/Database source:GO:0001077)E1B8D8(Evidence code:IEA/Database source:GO:0001077)E1BGF3(Evidence code:IEA/Database source:GO:0001205)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000684)A7MB06(Evidence code:IEA/Database source:GO:0001077)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BDX4(Evidence code:IEA/Database source:GO:0001228)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1BGZ3(Evidence code:IEA/Database source:GO:0001228)Q0VCF8(Evidence code:IEA/Database source:GO:0001077)A4FUE0(Evidence code:IEA/Database source:GO:0001077)F1MCY1(Evidence code:IEA/Database source:GO:0001077)E1BLU8(Evidence code:IEA/Database source:GO:0001077)Q7YRX0(Evidence code:IEA/Database source:GO:0001077)A2VDU4(Evidence code:IEA/Database source:GO:0001228)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BC39(Evidence code:IEA/Database source:GO:0001228)Q2KJC1(Evidence code:IEA/Database source:GO:0001228)Q2KIM2(Evidence code:IEA/Database source:GO:0001228)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q2HJ84(Evidence code:IEA/Database source:GO:0001228)E1BD25(Evidence code:IEA/Database source:GO:0001077)A0JNC9(Evidence code:IEA/Database source:GO:0001077)E1B7I2(Evidence code:IEA/Database source:GO:0001077)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BHB8(Evidence code:IEA/Database source:GO:0001077)P17667(Evidence code:IEA/Database source:GO:0001228), NFKB1 ZNF750 LEF1 RUNX1 SOX1 HIVEP1 ERCC2 TFDP2 FOXF1 DLX2 POLR2F ONECUT2 HOXA7 HCFC1 SRF POLR2A SP7 BCL11A ZBTB17 GATA6 ARID3A SOX4 MEIS1 GLI2 POU4F2 RAX2 NR1I2 RREB1 HIVEP3 ESRRG CDC5L EAF2 SALL4 PKNOX1 BCL11B SP1 ETV2 ZNF516 RAX MYF5,BP,40,40 of 34,1.7,117.65,3.366E-27,2.905E-25
GO:0003700,DNA-binding transcription factor activity,A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628)F1ML16(Evidence code:IEA/Database source:InterPro:IPR028424)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR004827|I)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR003309)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)P61635(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1B9X1(Evidence code:IBA/Database source:PANTHER:PTN000383895)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BG94(Evidence code:IEA/Database source:InterPro:IPR003316)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8CJF7|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR003894|I)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR001699|I)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q3UH06|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BE02(Evidence code:IEA/Database source:InterPro:IPR003316)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BK57(Evidence code:IEA/Database source:InterPro:IPR001699|I)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR003316|I)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR039355)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)F1MC99(Evidence code:IEA/Database source:InterPro:IPR001766|I)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)A6QPK5(Evidence code:IBA/Database source:PANTHER:PTN000927455)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR003894|I)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR004827|I)F1MBH4(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1B7I2(Evidence code:IEA/Database source:InterPro:IPR000418)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)Q3MHL6(Evidence code:IEA/Database source:InterPro:IPR000580)A6QLP0(Evidence code:IEA/Database source:InterPro:IPR001766|I)E1BFV5(Evidence code:IEA/Database source:UniProtKB:Q7RTV3|ens)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR001217|I)F1MU40(Evidence code:IBA/Database source:PANTHER:PTN000677913)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR001827|I)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR000327|I)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MU53(Evidence code:IEA/Database source:InterPro:IPR003309)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR030449)F1N281(Evidence code:ISS/Database source:UniProtKB:Q7Z4V0-1)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BPS0(Evidence code:IEA/Database source:InterPro:IPR004827)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)Q95115(Evidence code:IEA/Database source:InterPro:IPR001217|I)F1MKK8(Evidence code:IEA/Database source:InterPro:IPR010578)A6QNN4(Evidence code:IEA/Database source:InterPro:IPR003309)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A6QNK4(Evidence code:IEA/Database source:InterPro:IPR000580)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR026607)E1BGG6(Evidence code:IBA/Database source:PANTHER:PTN000289470)E1BAD4(Evidence code:IEA/Database source:InterPro:IPR008967|I)G3N2N6(Evidence code:IBA/Database source:PANTHER:PTN001225609)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)G3MY92(Evidence code:IBA/Database source:PANTHER:PTN000358347)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR017431|I)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000451|I)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)B0JYL6(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)E1BDX0(Evidence code:IEA/Database source:InterPro:IPR012890)A7Z017(Evidence code:IEA/Database source:InterPro:IPR004827|I)F1ML85(Evidence code:IEA/Database source:InterPro:IPR033348)O02754(Evidence code:IEA/Database source:InterPro:IPR004827)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR000327)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR039355), NR1I2 HIC1 ATF6B ZNF394 SRF STAT3 RAI1 PURA ONECUT2 HIVEP3 E2F1 AHCTF1 Gli3 CBFA2T2 MGA RREB1 GLI2 E2F7 SOX4 TBX3 TFDP2 ZNF516 GATA6 STRN3 INSM1 FOXI3 TAF10 TCF7L2 TAF4B NFE2L2 FOXF1 MKL1 ETV2 PURB TSC22D1 FOXO4 ZNF367 STAT5B MNX1 CTBP1 NR2F6 HOXA7 POU3F1 SALL4 ZNF446 SP1 ZNF438 LEF1 CREBRF BCL3 TCF20 STAT5A SIM2 LOC515042 SOX17 TSC22D3 DMRTC2 RFX5 RUNX1 ZFP37 ZHX3 ASCL4 IRF1 ESRRG NFKB1 ZBTB17 STAT1 ARID3A GCFC2 MAF AHR CEBPA LOC526488 POU4F2 gata4,MF,75,75 of 187,3.19,40.11,9.146E-27,7.769E-25
GO:0006139,nucleobase-containing compound metabolic process,G3X7J6(Evidence code:IEA/Database source:InterPro:IPR002562)F1MUF5(Evidence code:IEA/Database source:InterPro:IPR000850)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002562)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR006555), EXD3 AK9 WRN ERCC2,BP,4,4 of 1068,0.17,0.37,1.596E-26,1.335E-24
GO:0044249,cellular biosynthetic process,Q2HJ58(Evidence code:IEA/Database source:InterPro:IPR000842)Q2NL31(Evidence code:IEA/Database source:InterPro:IPR005251|I)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842), PRPS1 MRI1 PRPS2 PRPS1L1,BP,4,4 of 1045,0.17,0.38,7.932E-26,6.53E-24
GO:0009058,biosynthetic process,E1BDG9(Evidence code:IEA/Database source:InterPro:IPR002376|I)A7YY67(Evidence code:IEA/Database source:InterPro:IPR002376|I)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR004838|I)E1BEN4(Evidence code:IEA/Database source:InterPro:IPR005835)Q2YDJ9(Evidence code:IEA/Database source:InterPro:IPR005835)Q59A32(Evidence code:IEA/Database source:InterPro:IPR002376|I), ALDH1L2 ALDH1L1 TAT GMPPA GMPPB GART,BP,6,6 of 1113,0.25,0.54,1.341E-25,1.087E-23
GO:0018105,peptidyl-serine phosphorylation,P05126(Evidence code:IBA/Database source:PANTHER:PTN000683254)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)P67827(Evidence code:IDA/Database source:)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)E1BFR5(Evidence code:IBA/Database source:PANTHER:PTN000683254)A1A4I4(Evidence code:IBA/Database source:PANTHER:PTN000683254)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)A7E3X2(Evidence code:IEA/Database source:UniProtKB:Q9HCP0|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P39951)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)A4IFM7(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63085)P35509(Evidence code:IBA/Database source:PANTHER:PTN000225966)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)A7MB90(Evidence code:IEA/Database source:UniProtKB:P78368|ens)Q3SYZ2(Evidence code:IEA/Database source:UniProtKB:Q16644|ens)A5PJL3(Evidence code:IEA/Database source:UniProtKB:P53778|ens), PRKCB MYLK4 CAMK2D ATM PINK1 CSNK1A1 MAP3K10 SMTNL1 MYLK3 WNK1 MASTL PKN1 TNKS CAMK2A GSK3A PAK2 CSNK1G1 RPS6KA2 PRKACA CDK1 MARK3 HIPK4 RICTOR DGKQ LMTK2 UHMK1 MYLK2 LRRK2 MAPK9 CAMK2B PRKCI PRKDC MAPK1 CSNK1G3 SMG1 DCLK2 CSNK1G2 MAPKAPK3 MAPK12,BP,39,39 of 40,1.66,97.5,1.262E-24,1.003E-22
GO:0000002,mitochondrial genome maintenance,Q2KIN6(Evidence code:IEA/Database source:UniProtKB:P39210|ens),MPV17,BP,1,1 of 862,0.04,0.12,1.275E-24,1.003E-22
GO:0003723,RNA binding,Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR039109)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q32PB9(Evidence code:IBA/Database source:PANTHER:PTN000103359)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)Q08E07(Evidence code:IEA/Database source:InterPro:IPR034648)G3MZL2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A7MBG9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q56JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)A6QR01(Evidence code:IEA/Database source:InterPro:IPR005146)F1N301(Evidence code:IBA/Database source:PANTHER:PTN000007073)Q58DW0(Evidence code:IBA/Database source:PANTHER:PTN000454620)Q3SZ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433338)A4IFC3(Evidence code:IEA/Database source:InterPro:IPR002004|I)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q3SYT9(Evidence code:IEA/Database source:InterPro:IPR004088|I)E1BQ37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q2KIE4(Evidence code:IEA/Database source:InterPro:IPR002478|I)F1MRK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BM86(Evidence code:IEA/Database source:InterPro:IPR004088|I)G3MZ78(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MHP1(Evidence code:IEA/Database source:InterPro:IPR000061|I)Q5JB60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q32LC3(Evidence code:IEA/Database source:InterPro:IPR006196)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I)Q2YDE6(Evidence code:IEA/Database source:InterPro:IPR004088|I)O19137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q24JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q08DJ3(Evidence code:IEA/Database source:InterPro:IPR004088|I)A5D7S3(Evidence code:IEA/Database source:InterPro:IPR002905)A2VE06(Evidence code:IEA/Database source:InterPro:IPR002942)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)A4FV72(Evidence code:IEA/Database source:InterPro:IPR016304|I)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1N0T4(Evidence code:IEA/Database source:InterPro:IPR002466)P61286(Evidence code:IEA/Database source:InterPro:IPR002004|I)F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103)E1BJV5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MXI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QLG1(Evidence code:IEA/Database source:InterPro:IPR002478|I)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q3T087(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3SYR7(Evidence code:IBA/Database source:PANTHER:PTN000183645)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QLE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR023672)E1B719(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q2KJ71(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q0VC66(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q28165(Evidence code:IEA/Database source:InterPro:IPR034911)F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I)A2VDN6(Evidence code:IEA/Database source:InterPro:IPR000061|I)E1BIA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR002942|I)Q3ZC12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BFI4(Evidence code:IEA/Database source:InterPro:IPR004088|I)F1N6Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A2PYH9(Evidence code:IEA/Database source:InterPro:IPR034126|I)A7Z025(Evidence code:IEA/Database source:InterPro:IPR019582)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)Q0II93(Evidence code:IEA/Database source:InterPro:IPR015245)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q0P5L0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MX04(Evidence code:IEA/Database source:InterPro:IPR003890)Q29RQ2(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q17QV0(Evidence code:IEA/Database source:InterPro:IPR004088|I)P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q0III8(Evidence code:IEA/Database source:InterPro:IPR001568|I)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1B908(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BE82(Evidence code:IEA/Database source:InterPro:IPR001313|I)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2KJ34(Evidence code:IEA/Database source:InterPro:IPR003652|I)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q5E9A3(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q56JX6(Evidence code:IBA/Database source:PANTHER:PTN000080571)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)Q0VCY7(Evidence code:IEA/Database source:InterPro:IPR034520)Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I)A6QR44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q17R11(Evidence code:IEA/Database source:InterPro:IPR033103)E1BNB4(Evidence code:IEA/Database source:InterPro:IPR002004|I)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)P10881(Evidence code:IEA/Database source:InterPro:IPR002344|I)G3N065(Evidence code:IBA/Database source:PANTHER:PTN001128910)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)A6QQP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR006536)E1B7G5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MI56(Evidence code:IEA/Database source:InterPro:IPR004088|I)A8NJ74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)O97764(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MVN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)P06623(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q08DM8(Evidence code:IEA/Database source:InterPro:IPR033956)P68102(Evidence code:IEA/Database source:InterPro:IPR011488)A1A4K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q17QN3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)F1MS84(Evidence code:IEA/Database source:InterPro:IPR004088|I)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0694)Q2YDI4(Evidence code:IEA/Database source:InterPro:IPR004088|I), RPL30 DDX1 RPL38 TRUB1 CELF3 RBM28 AARS WBSCR1 RPL35A RPS18 LRRC47 RPL22 RPL4 EIF4A1 IMPDH2 DHX8 PABPC4 AGO4 GPKOW SAMHD1 DHX34 PCBP2 SFPQ TDRD9 MCTS1 SPEN PRPF40A RANBP2 MEX3B CSTF2T U2SURP NCL EIF1AX PUS3 HDLBP CPSF4 RPL23A FUBP1 TRMT1L RPS4Y1 PURB PPIE EIF4A3 ADARB1 PABPC1 PUS10 ZNF638 SNRPE MATR3 LOC515358 DHX37 RPL11 RPL9 PURA SYNJ1 EIF3K EIF4A2 TDRD7 PNPT1 RPL8 ANKHD1 TRA2A CTU1 NUDT16 PABPN1 EIF5A2 SF3A1 CLUH RPS9 EIF3G IGF2BP2 SETD1B Msi1 PRPF8 LRPPRC NXF3 DXO RBM42 EIF4G1 KHDRBS1 PCBP3 DHFR RNASET2 SUZ12 PABPN1L PUM1 DHX9 UHMK1 HBP1 EIF4H PCBP1 RPS28 MARS EIF4E1B EIF3B SRSF1 SNRNP70 RPUSD2 DGCR8 DZIP3 PABPC1L AGO3 DICER1 SSB ZNF385C LSM4 MYEF2 HNRNPL RBM12B ANKRD17 RBM34 CRYZ ESRP1 CNP AARS2 TSN EIF2S1 NSUN2 SNRPN SMG6 NOVA2 CDC5L MEX3C,MF,123,123 of 520,5.23,23.65,1.319E-24,1.023E-22
GO:0008152,metabolic process,Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)P48644(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q3SZD3(Evidence code:IEA/Database source:InterPro:IPR002504|I)F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR015590|I)F1MPW1(Evidence code:IEA/Database source:InterPro:IPR000873)P31754(Evidence code:IEA/Database source:InterPro:IPR011060)A6QPY4(Evidence code:IEA/Database source:InterPro:IPR000917|I)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR017438)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR005811)A7YY67(Evidence code:IEA/Database source:InterPro:IPR015590|I)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR016039)Q17QK4(Evidence code:IEA/Database source:InterPro:IPR006439)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139)E1BPZ8(Evidence code:IEA/Database source:InterPro:IPR017849|I)F1MHR3(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q3ZBF9(Evidence code:IEA/Database source:InterPro:IPR006349)A5PKM0(Evidence code:IEA/Database source:InterPro:IPR003081)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q3MHK8(Evidence code:IEA/Database source:InterPro:IPR013216)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR016035)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)F1MFF6(Evidence code:IEA/Database source:InterPro:IPR002213)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)F1MUX5(Evidence code:IEA/Database source:InterPro:IPR003081)F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139)P16386(Evidence code:IEA/Database source:InterPro:IPR002168|I)F1MIU7(Evidence code:IEA/Database source:InterPro:IPR000873)E1BM45(Evidence code:IEA/Database source:InterPro:IPR017849|I)Q0VCR6(Evidence code:IEA/Database source:InterPro:IPR002123)Q0VCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)F1MLE1(Evidence code:IEA/Database source:InterPro:IPR000873)A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)E1BFI2(Evidence code:IEA/Database source:InterPro:IPR001017)A7E3D9(Evidence code:IEA/Database source:InterPro:IPR000873)A8E657(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)E1BJM1(Evidence code:IEA/Database source:InterPro:IPR017438)Q17QI3(Evidence code:IEA/Database source:InterPro:IPR002155|I)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q95JH2(Evidence code:IEA/Database source:InterPro:IPR002123)A7YWF1(Evidence code:IEA/Database source:InterPro:IPR000873)A6QNL8(Evidence code:IEA/Database source:InterPro:IPR016035)F1MLW9(Evidence code:IEA/Database source:InterPro:IPR002123)Q08DD1(Evidence code:IEA/Database source:InterPro:IPR000917|I)Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)H7BWW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)G3N337(Evidence code:IEA/Database source:InterPro:IPR002618)A6QLY4(Evidence code:IEA/Database source:InterPro:IPR000868|I)Q5I598(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)A7MBJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)A1A4J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)P11181(Evidence code:IEA/Database source:InterPro:IPR001078|I)A5D9G1(Evidence code:IEA/Database source:InterPro:IPR002618), FUCA1 GART ALDH1A1 NADK CTBP1 ALDH9A1 DIP2A UMPS SGSH DGKQ ACLY ALDH1L1 PFKP HMGCS1 EPHX2 PHGDH PIGO ALDH1A3 PDXP GSTM2 PFKM METTL7A PNPLA2 SAMHD1 UGT2B10 HYAL1 LOC100295687 GRHPR LIPE SLC27A3 PIGN TMEM68 ATIC DIP2B GALK1 IDE DHTKD1 ACSL4 AASS SPAST LYZ1 SPHK2 ACAT2 ALDH1L2 AGPAT1 ACSS2 MCAT GPAT2 ARSA PAH MAN1A2 LYZ DNPH1 HEXB UAP1L1 ISOC1 MTHFR PAK1 MAN1B1 EDEM2 PFKL DBT UAP1,BP,63,63 of 2613,2.68,2.41,5.277E-24,4.034E-22
GO:0000786,nucleosome,E1BC18(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3N053(Evidence code:IEA/Database source:InterPro:IPR000558|I)P0C0S4(Evidence code:IEA/Database source:InterPro:IPR002119|I)F1N5F3(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3N2P2(Evidence code:IEA/Database source:InterPro:IPR000164|I)A0A0A0MP93(Evidence code:IEA/Database source:InterPro:IPR002119|I)A7MAZ5(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1BH22(Evidence code:IEA/Database source:InterPro:IPR002119|I)G3MYD7(Evidence code:IEA/Database source:InterPro:IPR000164|I)A5PK61(Evidence code:IEA/Database source:InterPro:IPR000164|I)E1BGW2(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q3ZBX9(Evidence code:IEA/Database source:InterPro:IPR002119|I)E1BGN3(Evidence code:IEA/Database source:InterPro:IPR000164|I)G3N3L9(Evidence code:IEA/Database source:InterPro:IPR000558|I)F2Z4E8(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1MV26(Evidence code:IEA/Database source:InterPro:IPR000558|I)G3N068(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q2KII5(Evidence code:IEA/Database source:InterPro:IPR000558|I)F1N453(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BL49(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1B8G9(Evidence code:IEA/Database source:InterPro:IPR000558|I)A0A0A0MP90(Evidence code:IEA/Database source:InterPro:IPR002119|I)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818|I)G3MZR4(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR001951|I)G8JL00(Evidence code:IEA/Database source:InterPro:IPR002119|I)F1MUD2(Evidence code:IEA/Database source:InterPro:IPR000558|I)Q32L48(Evidence code:IEA/Database source:InterPro:IPR000558|I)E1BM22(Evidence code:IEA/Database source:InterPro:IPR000558|I)A4IFU5(Evidence code:IEA/Database source:InterPro:IPR002119|I)A5PK20(Evidence code:IEA/Database source:InterPro:IPR005818|I)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818|I)A0A0A0MPA2(Evidence code:IEA/Database source:InterPro:IPR002119|I)Q5E9F8(Evidence code:IEA/Database source:InterPro:IPR000164|I), LOC617043 HIST1H2BA H2AFZ LOC615183 LOC613345 LOC614881 HIST1H1D HIST2H2AB LOC100297725 H3F3C HIST1H2BJ H2AFJ HIST2H3D LOC613363 HIST1H2BB LOC525433 LOC614378 HIST1H2BI HIST2H2BE LOC614206 HIST3H2BB HIST1H2AC HIST1H1A LOC523702 LOC619094 LOC104975684 HIST2H2BF HIST1H2BN LOC100300167 HIST3H2A HIST1H1E H1FX HIST1H2AJ H3F3B,CC,34,34 of 28,1.44,121.43,1.231E-23,9.276E-22
GO:0006412,translation,P0C2B7(Evidence code:IDA/Database source:)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)Q3ZC12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)P68102(Evidence code:ISS/Database source:UniProtKB:Q6ZWX6)Q32LC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3T076(Evidence code:IEA/Database source:InterPro:IPR001971|I)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672)Q58DW0(Evidence code:IEA/Database source:InterPro:IPR002136|I)Q5E938(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592|I)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)Q5E966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)Q3T087(Evidence code:IEA/Database source:InterPro:IPR002132|I)Q3T057(Evidence code:IEA/Database source:InterPro:IPR000218|I)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3SZ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)Q3T0V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q0VCX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A7MB16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR005710)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR011035)Q32KZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR011035)F1MN49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)E1BLZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)Q2KJG3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530)Q3T148(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR001266|I)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592|I)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)A7YW98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A6QLR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)Q3T099(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q76I82(Evidence code:IEA/Database source:InterPro:IPR000630|I)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)F1N030(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A7MBC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0648)A6QLN9(Evidence code:IEA/Database source:InterPro:IPR020592), MRPL52 RPL9 EIF3G EIF4A2 EIF2S1 EIF1AX RPS14 RPL28 RPL4 EIF1 MARS RPS27 RPL27 EIF3I RPS7 RPL11 RPL23 MRPL3 EIF4G1 AIMP2 EIF6 EIF4A1 RPS17 EIF3K ETF1 RARS2 EIF3B RPS9 AARS RPS4Y1 EIF4H EPRS MTIF3 QARS EIF5A2 RPL38 RPS18 RPL22 EIF3F RPL30 NARS LOC511302 EIF3M RPS19 RPS27L RPL23A RARS RPS4X AARS2 LARS RPL35A WARS2 RPS15A RPL8 MCTS1 RPS28 EIF4E1B IARS VWA1,BP,59,59 of 130,2.51,45.38,1.431E-23,1.063E-21
GO:0005887,integral component of plasma membrane,Q3ZC83(Evidence code:IEA/Database source:InterPro:IPR030195)F1MJZ6(Evidence code:IBA/Database source:PANTHER:PTN001060286)F1MEX4(Evidence code:IEA/Database source:InterPro:IPR027689)F1N5R0(Evidence code:IBA/Database source:PANTHER:PTN000177662)F1MJ94(Evidence code:IBA/Database source:PANTHER:PTN001932250)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR002438)O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)O97711(Evidence code:IEA/Database source:InterPro:IPR028371)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)F1MP51(Evidence code:IBA/Database source:PANTHER:PTN000025348)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN001060286)E1B749(Evidence code:IBA/Database source:PANTHER:PTN000213391)E1BAW2(Evidence code:IBA/Database source:PANTHER:PTN000757746)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658000)Q2KJ41(Evidence code:IBA/Database source:PANTHER:PTN001060286)Q05037(Evidence code:ISS/Database source:UniProtKB:P22459)F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN000660491)O18875(Evidence code:IEA/Database source:InterPro:IPR002984)E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001173583)P47803(Evidence code:IEA/Database source:UniProtKB:Q9Z2B3|ens)F1MUC1(Evidence code:IBA/Database source:PANTHER:PTN002384094)F1MN60(Evidence code:IBA/Database source:PANTHER:PTN000642960)F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens)F1MIU3(Evidence code:IEA/Database source:InterPro:IPR038900)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR016257)F1N4L1(Evidence code:IBA/Database source:PANTHER:PTN000894242)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)G3N152(Evidence code:IBA/Database source:PANTHER:PTN001932250)F1MMU8(Evidence code:IEA/Database source:InterPro:IPR038900)F1N5Z0(Evidence code:IBA/Database source:PANTHER:PTN000440615)E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN000642960)Q32PI9(Evidence code:IEA/Database source:InterPro:IPR029870)Q6BBL6(Evidence code:IEA/Database source:UniProtKB:O14493|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q0VCU9(Evidence code:IEA/Database source:InterPro:IPR038900)G3MW11(Evidence code:IBA/Database source:PANTHER:PTN002384094)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)G3N2I5(Evidence code:IEA/Database source:UniProtKB:D3W0D1|ens)E1BAI2(Evidence code:IBA/Database source:PANTHER:PTN000039495)Q58CZ7(Evidence code:IBA/Database source:PANTHER:PTN001060286)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752)Q1JQB3(Evidence code:IBA/Database source:PANTHER:PTN000660850)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000642960)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982)E1BMA2(Evidence code:IBA/Database source:PANTHER:PTN000025348)E1BDL0(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)F1MEC8(Evidence code:IBA/Database source:PANTHER:PTN001932250)G3MW09(Evidence code:IBA/Database source:PANTHER:PTN002384094)Q9GL65(Evidence code:IBA/Database source:PANTHER:PTN000687652)Q0VCP0(Evidence code:IBA/Database source:PANTHER:PTN000299690)A5D7F4(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q3ZC26(Evidence code:IBA/Database source:PANTHER:PTN000213391)F1MSN2(Evidence code:IBA/Database source:PANTHER:PTN001799275)E1BJW2(Evidence code:IBA/Database source:PANTHER:PTN000369696)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR027689)A7YY44(Evidence code:IBA/Database source:PANTHER:PTN000660850)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)A5D7H9(Evidence code:IBA/Database source:PANTHER:PTN000177662), SLC29A1 TSPAN9 TENM2 SLC6A5 PCDHA13 SLC6A20 TRPC1 RTN4R CDON HAS2 PTH1R KCNH5 PTK7 CD63 SLC5A9 LRRC32 ABCC3 TSPAN14 KCNA4 RXFP3 SLC6A8 GRM7 RGR LOC515333 ATP2B2 TMEM2 TMC5 EPHB4 SLC4A2 HCN1 BCAP31 PCDHB8 TMC3 AQP5 ADORA2A LRRC26 TRPC2 PSEN1 ATP2B3 MPZL1 CLDN4 NPC1 TMC6 LOC523126 BACE1 KLRF2 KL TSPAN2 LGR4 C5AR1 GPR4 ABCA1 ATP13A5 BOC KCNH6 LOC786512 FCER1G ALCAM TFRC VAMP5 PCDH8 LOC509854 TLR4 SLC33A1 PCDHGC3 SLC5A11 TACSTD2 STEAP4 TENM3 F2R CFTR NLGN2 SLC6A14,CC,73,73 of 209,3.1,34.93,3.213E-23,2.355E-21
GO:0006950,response to stress,Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404),TRAP1,BP,1,1 of 762,0.04,0.13,1.208E-21,8.738E-20
GO:0005840,ribosome,Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592)Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)Q76I82(Evidence code:IEA/Database source:InterPro:IPR000630|I)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592)A6QLN9(Evidence code:IEA/Database source:InterPro:IPR020592)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)Q3T076(Evidence code:IEA/Database source:InterPro:IPR001971|I)A6QLG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q56JX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q3T087(Evidence code:IEA/Database source:InterPro:IPR002132|I)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)Q3T057(Evidence code:IEA/Database source:InterPro:IPR000218|I)E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530)A6QL80(Evidence code:IEA/Database source:UniProtKB:Q922H1|ens)Q58DW0(Evidence code:IEA/Database source:InterPro:IPR002136|I)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR001266|I)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)P68102(Evidence code:IBA/Database source:PANTHER:PTN000063907)P0C2B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0689)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672), RPS27 RPL35A RPS4X RPS7 RPL30 RPS28 RPS15A RPS27L VWA1 RPL23A RPS17 RPS18 RPS14 RPS9 RPS25 RPL11 RPL9 RPL27 RPL38 RPL23 LOC511302 PRMT3 RPL4 RPS19 RPL22 RPL8 RPS4Y1 EIF2S1 MRPL52 MRPL3 RPL28,CC,31,31 of 26,1.32,119.23,1.529E-21,1.091E-19
GO:0000287,magnesium ion binding,E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:P60487)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539)A5PJL6(Evidence code:IEA/Database source:InterPro:IPR012000)A5PJL3(Evidence code:IEA/Database source:UniProtKB:P53778|ens)F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539)Q2HJ58(Evidence code:IEA/Database source:InterPro:IPR000842|I)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)B3IVN4(Evidence code:IEA/Database source:InterPro:IPR001697|I)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR001697|I)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens)E1BN61(Evidence code:IEA/Database source:InterPro:IPR016239)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128)F1MS56(Evidence code:IEA/Database source:InterPro:IPR016066)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR016239)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842|I)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)Q08DW2(Evidence code:IEA/Database source:InterPro:IPR005946)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)E1BH93(Evidence code:IEA/Database source:InterPro:IPR015022)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR005946)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)Q5EAC2(Evidence code:ISS/Database source:UniProtKB:P48637)E1BN72(Evidence code:IEA/Database source:UniProtKB:Q8IY84|ens)A7MBG0(Evidence code:IEA/Database source:UniRule:UR000106960)F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR016239)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR017164)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842|I)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens), DYRK2 PDXP GNAI1 ATP8B1 HACL1 MAPK12 ATP11A PRPS1 RAN DXO PKM PKLR TDG PRKACA PDCD6 RPS6KA5 BRSK2 COMT PGM3 RPS6KA2 PRPS2 ABL1 WRN IMPA1 PRPSAP1 NUDT16 MAST4 PRPSAP2 PRKACB GSS NIM1K ADSS ENO4 RPS6KA4 WEE1 PRPS1L1 STK3 STK26 PINK1 RAP2A,MF,40,40 of 58,1.7,68.97,2.275E-21,1.602E-19
GO:0005576,extracellular region,A6QQN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q95106(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)G3N183(Evidence code:IEA/Database source:InterPro:IPR000471)Q28084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6YT15(Evidence code:IEA/Database source:InterPro:IPR000827|I)Q95MI6(Evidence code:IEA/Database source:InterPro:IPR000187|I)E1BFV4(Evidence code:IEA/Database source:UniProtKB:B2RXX5|ens)Q7SIB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A5PJL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0767)P02459(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P46161(Evidence code:IEA/Database source:InterPro:IPR001855|I)P56830(Evidence code:IEA/Database source:InterPro:IPR000471)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QR60(Evidence code:IEA/Database source:InterPro:IPR018244)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BF06(Evidence code:IEA/Database source:InterPro:IPR008064)F2FB42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1N152(Evidence code:IEA/Database source:InterPro:IPR000867)Q32S24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)P60986(Evidence code:IEA/Database source:InterPro:IPR007990)Q7SIB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q27967(Evidence code:IEA/Database source:InterPro:IPR010892)Q28083(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P23206(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q29RY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)P07507(Evidence code:IEA/Database source:InterPro:IPR000294|I)P23389(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q9GKN8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens)P46169(Evidence code:IEA/Database source:InterPro:IPR001855|I)A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens)P56831(Evidence code:IEA/Database source:InterPro:IPR000471)Q2WGK0(Evidence code:IEA/Database source:InterPro:IPR001400|I)A4IFB5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P98167(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q2HJH1(Evidence code:IBA/Database source:PANTHER:PTN002004887)Q0VCP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P12661(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q28038(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P58754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F1MLJ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q1RMH5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A7MB18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)A6QLN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR001811|I)F1MD40(Evidence code:IEA/Database source:UniProtKB:Q8C6K9|ens)P02668(Evidence code:IEA/Database source:InterPro:IPR000117)P37141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P01175(Evidence code:IEA/Database source:InterPro:IPR000981|I)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P26917(Evidence code:IEA/Database source:InterPro:IPR004250|I)P02465(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305)P81282(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P0C6R3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q29442(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BH09(Evidence code:IEA/Database source:UniProtKB:Q70UZ7|ens)P20959(Evidence code:IEA/Database source:InterPro:IPR000867|I)Q95LI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P13608(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P03968(Evidence code:IEA/Database source:InterPro:IPR028210)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BLS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)P46165(Evidence code:IEA/Database source:InterPro:IPR001855|I)Q8MJ29(Evidence code:IEA/Database source:InterPro:IPR000471)A7E2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)F1MJR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0964)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)C6KGD8(Evidence code:IEA/Database source:InterPro:IPR030773), SMPDL3B CD63 BDNF LOC104968438 COL4A3 CCL28 CRH ADAMTS14 COL4A2 C1QTNF5 CHGA SFTPD COL2A1 DEFB3 IFNT2 HABP2 CRISPLD1 DPP4 TNFSF15 MUC5B HTRA1 COL11A2 NPC1 PIP COL4A1 SPP2 COL11A1 COL10A1 FGL2 PDGFC MGP CHGB PRSS23 PRELP PROK1 DEFB11 KLK6 IFNT3 PRP8 TECTB SSPO DNPEP OLFML3 RBP3 MIA LY96 IDE SLIT2 C1QC NTN4 VWA1 MYDGF ADAMTS4 CXCL12 COL6A5 CSN3 GPX3 OXT ADAMTS5 SST COL1A2 NDNF RNPEP VCAN CES4A COL4A4 VWA2 IGFBP3 VIT HYAL1 ACAN FGF1 LIPF ACE COPA ITM2B EMILIN1 DEFB7 IFNT C1QTNF6 TFRC COL8A2 HMCN1 HSTN,CC,84,84 of 300,3.57,28,3.021E-21,2.1E-19
GO:0004842,ubiquitin-protein transferase activity,Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)G3MX28(Evidence code:IBA/Database source:PANTHER:PTN001973695)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q6PDX6)Q08DB6(Evidence code:IEA/Database source:InterPro:IPR000569|I)P61085(Evidence code:ISS/Database source:UniProtKB:P61086)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR026254)A5PJZ4(Evidence code:IEA/Database source:InterPro:IPR000569|I)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917)F1MDC0(Evidence code:IEA/Database source:InterPro:IPR031127)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BG23(Evidence code:IEA/Database source:UniProtKB:Q8C0E3|ens)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001973695)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR024162)G3MX12(Evidence code:IEA/Database source:InterPro:IPR000569|I)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)E1BNY9(Evidence code:IEA/Database source:InterPro:IPR000569|I)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)Q17R11(Evidence code:IEA/Database source:UniProtKB:Q86Y13|ens)E1B7Q7(Evidence code:IEA/Database source:InterPro:IPR000569|I)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364)A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)Q32PG4(Evidence code:IEA/Database source:InterPro:IPR000569|I)A2VE03(Evidence code:IEA/Database source:InterPro:IPR000569|I)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR027139|I)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)Q1RMX2(Evidence code:ISS/Database source:UniProtKB:P62837)E1BBN5(Evidence code:IEA/Database source:InterPro:IPR010606|I)A7MBJ7(Evidence code:IBA/Database source:PANTHER:PTN001973695)F1MUH4(Evidence code:IEA/Database source:InterPro:IPR003613)F1MJ10(Evidence code:IEA/Database source:InterPro:IPR000569|I)G3N1V7(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BK47(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BB00(Evidence code:IBA/Database source:PANTHER:PTN001194385)A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BE13(Evidence code:IEA/Database source:InterPro:IPR022103)Q0VD59(Evidence code:ISS/Database source:UniProtKB:Q5T0T0)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR003613), UBE2G2 KLHDC7A RNF220 HERC4 UBE2K RNF31 HECTD3 UHRF1 LOC516599 ANKIB1 RC3H2 CUL3 TRIM47 KLHL26 CBLC HERC2 RNF139 BCOR ASB14 HUWE1 TRIM23 MALT1 DZIP3 TRIP12 BRCA1 UBE2M MARCH5 KLHL13 UBE2L3 NEDD4L ITCH TRAF6 TRIM68 UBE2D2 MIB2 KLHL18 STUB1 NEDD4 KLHL34 KLHL35 ASB10 KEAP1 BIRC6 MARCH8 UBE4B,MF,45,45 of 81,1.91,55.56,4.904E-21,3.364E-19
GO:0031090,organelle membrane,P67810(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SEC11A HPS6 SPCS3,CC,3,3 of 830,0.13,0.36,5.717E-21,3.828E-19
GO:0016070,RNA metabolic process,Q08DM8(Evidence code:IEA/Database source:InterPro:IPR033956),TSN,BP,1,1 of 737,0.04,0.14,5.723E-21,3.828E-19
GO:0019901,protein kinase binding,E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)E1B847(Evidence code:IEA/Database source:UniProtKB:Q13233|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q2TBI4(Evidence code:IEA/Database source:UniProtKB:Q12931|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q6UVK1|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)A6QQM1(Evidence code:IEA/Database source:InterPro:IPR012399)F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)P04695(Evidence code:IDA/Database source:)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1BB52(Evidence code:IEA/Database source:UniProtKB:Q69ZA1|ens)E1BBI6(Evidence code:IEA/Database source:InterPro:IPR012399)E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q96KP1|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)P81948(Evidence code:IEA/Database source:UniProtKB:P68366|ens)F1MVV5(Evidence code:IEA/Database source:UniProtKB:Q6P5G0|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)Q0VCF3(Evidence code:IEA/Database source:UniProtKB:Q9BRV8|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)E1BMW2(Evidence code:IEA/Database source:UniProtKB:P17426|ens)F1MM88(Evidence code:IEA/Database source:UniProtKB:Q8TD19|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens), TCL1A PTPN23 DUSP3 TPCN2 LCK MAP3K1 RICTOR PPP1CC TRAF6 TRAP1 CDK5RAP2 WNK1 GCN1L1 GATA6 RPS19 DLG1 KIF14 CSPG4 UTRN CCNY SLC12A2 ITGB2 JAK2 GNAT1 PDCD10 CADPS SASH1 CDK13 CCNYL1 EXOC2 GRB2 RACGAP1 TUBA4A MAPK4 DCTN2 DAB2IP PTPN6 DNM1 SIKE1 RFFL DPYSL2 PAK2 AP2A1 NEK9 BAG5 STAT3 NBEA FRMD5 KIF13B ZBTB4,MF,50,50 of 106,2.12,47.17,8.268E-21,5.462E-19
GO:0055085,transmembrane transport,E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)Q8MII5(Evidence code:IEA/Database source:InterPro:IPR013657)Q1JQC7(Evidence code:IEA/Database source:InterPro:IPR005828)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)F1MG24(Evidence code:IEA/Database source:InterPro:IPR026082)G3N271(Evidence code:IEA/Database source:InterPro:IPR006042|I)E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006042|I)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR005821)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)G3MW09(Evidence code:IEA/Database source:InterPro:IPR011527)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR005821)E1BI45(Evidence code:IEA/Database source:InterPro:IPR006043)Q95JC7(Evidence code:IEA/Database source:GO:0015293)Q3ZC26(Evidence code:IEA/Database source:InterPro:IPR001734)F1MS75(Evidence code:IEA/Database source:InterPro:IPR004841)G3MW11(Evidence code:IEA/Database source:InterPro:IPR011527)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR011527|I)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR005821)P35071(Evidence code:IEA/Database source:InterPro:IPR011527)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR005821)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR005821)E1BM97(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR005821)P02722(Evidence code:IEA/Database source:InterPro:IPR002067|I)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005821)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR005821)E1BF03(Evidence code:IEA/Database source:GO:0022829)Q28204(Evidence code:IEA/Database source:InterPro:IPR005821)A5D7H9(Evidence code:IEA/Database source:GO:0015293)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR005821)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR011527)G3MW12(Evidence code:IEA/Database source:InterPro:IPR011527)F1MD64(Evidence code:IEA/Database source:GO:0008381)O18784(Evidence code:IEA/Database source:InterPro:IPR005821)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)O62826(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821)E1BA07(Evidence code:IEA/Database source:InterPro:IPR011701)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP51(Evidence code:IEA/Database source:InterPro:IPR005821)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR005292|I)Q08DK7(Evidence code:IEA/Database source:InterPro:IPR002067)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR005821)E1B749(Evidence code:IEA/Database source:InterPro:IPR001734)F1MS08(Evidence code:IEA/Database source:InterPro:IPR004841)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR005821)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR026082)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP22(Evidence code:IEA/Database source:InterPro:IPR005821)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)Q1LZD6(Evidence code:IEA/Database source:GO:0042626)A6QR09(Evidence code:IEA/Database source:InterPro:IPR002067)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR005821)F1N5Z0(Evidence code:IEA/Database source:InterPro:IPR000425)A1A4L2(Evidence code:IEA/Database source:GO:0015293)E1B968(Evidence code:IEA/Database source:InterPro:IPR002293)G3MYG6(Evidence code:IEA/Database source:InterPro:IPR003689)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821), KCNC4 CACNA1D SLC35B1 SLC22A23 CACNA1H ABCA1 LOC100337457 LOC100298868 ITPR1 KCNC3 CACNA1B LOC509854 ITPR2 SLC23A1 SLC1A5 SLC5A11 SLC12A1 LOC523126 LOC515333 KCNH6 CFTR SCN11A CACNA1S HCN1 RYR2 SLC25A4 TRPC3 SCN10A PANX3 KCNMA1 SLC6A14 CACNA1A SCN5A LOC100299180 LOC100337053 PIEZO1 TRPC1 KCNG4 TRPC2 SCN3A SLC17A8 KCNF1 KCNH5 KCNG2 ABCC3 SLC25A29 TPCN2 SLC5A9 SLC12A2 RYR1 ABCA7 CACNA1C TRPM4 CACNA1E TRPM7 ABCC5 SLC25A26 KCNA4 SCN8A AQP5 SLC6A20 SLC7A2 SLC39A6 CACNA1F,BP,64,64 of 183,2.72,34.97,1.291E-20,8.428E-19
GO:0000978,RNA polymerase II proximal promoter sequence-specific DNA binding,E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:P70661)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)Q7YRX0(Evidence code:IEA/Database source:UniProtKB:Q96IS3|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BGG6(Evidence code:IBA/Database source:PANTHER:PTN000289470)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:O00570|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:Q05925|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q8K1A6|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:Q9Y2V3|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q12837|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens), RUNX1 BCL11B RREB1 INSM1 CHD7 DHX9 LEF1 GLI2 GLI1 CUX2 RAX2 ETV2 TCF7L2 SOX4 SUZ12 MEIS1 RFX5 HOXA7 SOX1 EN1 ZFHX3 GCFC2 GATA6 ZNF750 E2F7 AEBP2 TBX3 LITAF CC2D1A RAX SP7 SRF MYF5 POU4F2 SP1 ONECUT2 ZBTB17,MF,37,37 of 51,1.57,72.55,2.018E-20,1.301E-18
GO:0050896,response to stimulus,P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)P22571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)Q8WN91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)Q7YRX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0716), GNAT1 OR51Q1 PDE6H RGR LOC614090 LOC531090 LOC788626 OR13C3 RRH CDHR1 RAX2 OR5M11 GNAT2,BP,13,13 of 1151,0.55,1.13,3.627E-20,2.311E-18
GO:0007155,cell adhesion,E1BDL0(Evidence code:IEA/Database source:InterPro:IPR020894)A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)Q29442(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR000633|I)Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)Q29423(Evidence code:IEA/Database source:InterPro:IPR000538|I)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR020894)Q2TA30(Evidence code:IEA/Database source:InterPro:IPR007007)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR020894|I)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)F1MQP6(Evidence code:IEA/Database source:InterPro:IPR020894)Q01107(Evidence code:IEA/Database source:InterPro:IPR020894)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR020894|I)F1MMH2(Evidence code:IEA/Database source:InterPro:IPR000413)P81282(Evidence code:IEA/Database source:InterPro:IPR000538)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)E1BLS8(Evidence code:IBA/Database source:PANTHER:PTN000396109)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)P61625(Evidence code:IEA/Database source:InterPro:IPR000413)F1MKY3(Evidence code:IEA/Database source:InterPro:IPR000538)G3N152(Evidence code:IEA/Database source:InterPro:IPR020894)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028443)A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)O97711(Evidence code:IBA/Database source:PANTHER:PTN000530809)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR020894)E1BF53(Evidence code:IEA/Database source:InterPro:IPR020894)P53710(Evidence code:IEA/Database source:InterPro:IPR000413)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR020894)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR020894|I)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR020894)P80746(Evidence code:IEA/Database source:InterPro:IPR000413)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)A6QQ97(Evidence code:IEA/Database source:InterPro:IPR000413)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR020894)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)Q28084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR000633|I)P31836(Evidence code:IEA/Database source:InterPro:IPR009138)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)F1MUC5(Evidence code:IEA/Database source:InterPro:IPR039070)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN000445299)Q29RN1(Evidence code:IEA/Database source:InterPro:IPR028510)P13608(Evidence code:IEA/Database source:InterPro:IPR000538)Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)A5PK55(Evidence code:IEA/Database source:InterPro:IPR028433)F1N416(Evidence code:IEA/Database source:InterPro:IPR020894)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR020894)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR020894)F1N2J5(Evidence code:IEA/Database source:InterPro:IPR000538)P98167(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)V6F7Z2(Evidence code:IEA/Database source:InterPro:IPR033029)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR010307)A6QLR4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0130)P32592(Evidence code:IEA/Database source:InterPro:IPR015439), LOC786512 NLGN2 COL4A4 CTNNA1 ALCAM CD44 CDH11 NINJ1 SRC EPHB4 PCDH8 MPDZ DCHS2 DSC1 PCDHGC3 ITGA9 VCAN ITGB1 EMILIN1 ITGB6 ITGAL SUSD5 PCDHB8 PKP4 ITGB7 HAS2 NRXN1 CDHR1 CDH7 ITGA2 PCDH1 PCDH12 FAT1 ITGAV TOR1A ITGAD PCDH20 CD97 DPP4 HEPACAM COL4A3 CTNNA2 NCAM1 PSEN1 COL15A1 CD63 SORBS3 ACAN F11R CIB1 PARVA CDH22 PCDHA13 FAT2 HAPLN4 SSPO TINAGL1 DSCAML1 LAMA3 FLOT2 ITGB2,BP,61,61 of 171,2.59,35.67,4.433E-20,2.791E-18
GO:0031625,ubiquitin protein ligase binding,P23956(Evidence code:IEA/Database source:UniProtKB:P27449|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)F1MYD0(Evidence code:IEA/Database source:InterPro:IPR001373|I)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)E1BIN5(Evidence code:IEA/Database source:InterPro:IPR001373|I)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629506)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens)Q2KJ77(Evidence code:IEA/Database source:UniProtKB:Q9NZL4|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q58DU5(Evidence code:IEA/Database source:UniProtKB:P25788|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)P61085(Evidence code:ISS/Database source:UniProtKB:P61086)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38646|ens)A3KN22(Evidence code:IBA/Database source:PANTHER:PTN000630367)Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629506)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)E1BB00(Evidence code:IBA/Database source:PANTHER:PTN001194385)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)P11181(Evidence code:IEA/Database source:UniProtKB:P11182|ens)A7MBA2(Evidence code:IEA/Database source:UniProtKB:Q99460|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)F1N1X8(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q1KZG4(Evidence code:IEA/Database source:UniProtKB:P49789|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)Q08DE9(Evidence code:IEA/Database source:InterPro:IPR001373|I)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q5EA61(Evidence code:IEA/Database source:UniProtKB:P12277|ens), ATP6V0C PRKAR2A SPG20 PINK1 BTBD11 CUL1 TSG101 BAG5 AXIN2 CUL3 PCBP2 UBE2G2 LRPPRC OTUB1 HSPBP1 DDX58 PSMA3 AXIN1 UBE2K TRAF6 BTBD3 SPOPL USP13 BTBD6 PRKACB HSPA9 UBE2M UBE2V2 NAE1 PIAS1 IKBKG ARRDC1 ASB10 UBXN1 DBT PSMD1 RAD18 UBE2Z FHIT RFFL ASB14 CUL2 UBE2V1 CKB,MF,44,44 of 83,1.87,53.01,5.212E-20,3.243E-18
GO:0051252,regulation of RNA metabolic process,F1MS84(Evidence code:IEA/Database source:UniProtKB:A0A1W2P872),NOVA2,BP,1,1 of 703,0.04,0.14,6.587E-20,4.052E-18
GO:0015629,actin cytoskeleton,F1N6V1(Evidence code:IEA/Database source:UniProtKB:O54834|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q69Z38|ens)E1BP80(Evidence code:IEA/Database source:InterPro:IPR030637)P68138(Evidence code:IEA/Database source:UniProtKB:P68133|ens)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR000633)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1B8E3(Evidence code:IEA/Database source:UniProtKB:Q86SG2|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR017904|I)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)E1B8H4(Evidence code:IEA/Database source:UniProtKB:Q9ULE3|ens)Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I)E1BQ32(Evidence code:IEA/Database source:UniProtKB:Q64010|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)E1B7T1(Evidence code:IEA/Database source:UniProtKB:Q7Z7B0|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR000633), ARHGAP6 PEAK1 ZNF185 ACTA1 ARHGAP21 MYLK3 DDX58 ARPC1A NDC1 PDXP CTNNA1 ARHGAP35 ONECUT2 ABL1 DHX9 ANKRD23 TWF1 DSTN BAIAP2L1 DENND2A ARPC5L CRK TAX1BP3 FILIP1 TAOK2 KNTC1 BAIAP2 CTNNA2,CC,28,28 of 23,1.19,121.74,9.396E-20,5.677E-18
GO:1903561,extracellular vesicle,Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens),ARRDC1,CC,1,1 of 696,0.04,0.14,9.442E-20,5.677E-18
GO:0016887,ATPase activity,Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P35998)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR006544)A4IFE6(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1N724(Evidence code:IEA/Database source:InterPro:IPR011704)G3MW11(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q3SZ65(Evidence code:IEA/Database source:UniProtKB:Q14240|ens)E1BGB0(Evidence code:IBA/Database source:PANTHER:PTN000648413)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR003439|I)A2VDN5(Evidence code:IBA/Database source:PANTHER:PTN000553509)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)P35071(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)E1BC41(Evidence code:IBA/Database source:PANTHER:PTN000648413)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR011704)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR011704)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)A1A4M8(Evidence code:IEA/Database source:UniProtKB:Q9H497|ens)F1MNE5(Evidence code:IBA/Database source:PANTHER:PTN000553509)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)A5D7N6(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR030088)P05630(Evidence code:IEA/Database source:UniProtKB:P30049|ens)Q2NL05(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BAN2(Evidence code:IBA/Database source:PANTHER:PTN000553509)Q4ZJV8(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR003439|I)Q0VD48(Evidence code:IBA/Database source:PANTHER:PTN000553509)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)G3N1E4(Evidence code:IBA/Database source:PANTHER:PTN000649056)E1BFA7(Evidence code:IBA/Database source:PANTHER:PTN000648413)F1MG24(Evidence code:IEA/Database source:InterPro:IPR003439|I)E1BC24(Evidence code:IEA/Database source:InterPro:IPR011704|I)A7MBA1(Evidence code:IBA/Database source:PANTHER:PTN000648413)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR011704)F1MIM5(Evidence code:IEA/Database source:InterPro:IPR011704)Q28141(Evidence code:IDA/Database source:)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR003439|I)F1MY45(Evidence code:IEA/Database source:InterPro:IPR031046)G3MW09(Evidence code:IEA/Database source:InterPro:IPR003439|I)G3MW12(Evidence code:IEA/Database source:InterPro:IPR003439|I)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens), PSMC2 ATP13A5 ABCE1 DNAH11 LOC523126 EIF4A2 KIF13B LOC515333 SPAST BLM CFTR DDX4 KIF15 LOC100299180 TDRD9 DNAH5 DNAH10 KIF14 KIF1B MYO9B ATP1A2 WRN TOR3A FIGNL1 TOR1B KIF23 INO80 SMARCA2 ATP5D KIF2A KATNAL2 ABCG8 ABCC3 VPS4B PTPA KIF26A KIFC3 ABCA1 MDN1 KIFC1 TOR1A DYNC1H1 VWA8 DHX9 ABCA7 CARNS1 LOC509854 LOC100337053 RUVBL1,MF,49,49 of 110,2.08,44.55,1.294E-19,7.693E-18
GO:0046777,protein autophosphorylation,E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P68102(Evidence code:IEA/Database source:UniProtKB:Q6ZWX6|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)F1N3K4(Evidence code:IEA/Database source:UniProtKB:P80192|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:Q13554)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens), PEAK1 LRRK2 ZAP70 CAMK2G MAPKAPK3 TRPM7 HIPK4 SRC SLK PASK PAK2 CAMK2A AAK1 UHMK1 PRKACA EPHB4 KIT PAK1 ABL1 EIF2S1 STK26 MAP3K9 SMG1 LMTK2 ATM CAMK2B TAOK3 MYLK2,BP,28,28 of 24,1.19,116.67,1.901E-19,1.118E-17
GO:0061630,ubiquitin protein ligase activity,E1BBN5(Evidence code:IEA/Database source:UniProtKB:Q8R516|ens)E1B7Q7(Evidence code:IBA/Database source:PANTHER:PTN000134256)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129805)Q17R11(Evidence code:IEA/Database source:InterPro:IPR033103)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)E1BIN5(Evidence code:IBA/Database source:PANTHER:PTN000231993)F1N2S5(Evidence code:IEA/Database source:UniProtKB:Q8TEJ3|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BAK9(Evidence code:IEA/Database source:InterPro:IPR032832)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629506)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)F1N1C5(Evidence code:IEA/Database source:InterPro:IPR031890)P61085(Evidence code:IBA/Database source:PANTHER:PTN000629506)A2VE03(Evidence code:IEA/Database source:InterPro:IPR024928)E1BP63(Evidence code:IBA/Database source:PANTHER:PTN000280277)Q08DE9(Evidence code:IBA/Database source:PANTHER:PTN000231993)Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629506)F1MYD0(Evidence code:IBA/Database source:PANTHER:PTN000231993)Q0V7P2(Evidence code:IEA/Database source:InterPro:IPR031227)F1N1X8(Evidence code:IBA/Database source:PANTHER:PTN000629506)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)E1BNY9(Evidence code:IBA/Database source:PANTHER:PTN000134256)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)E1BCW1(Evidence code:IEA/Database source:InterPro:IPR039164)A3KN22(Evidence code:IBA/Database source:PANTHER:PTN000630367)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens), MIB2 TRIP12 LOC780968 DZIP3 MYCBP2 ANKIB1 RNF112 CUL3 SH3RF3 NEDD4 SYVN1 TRAF6 UHRF1 UBE4B UBE2G2 UBE2V1 RAD18 FBXO40 UBE2K ITCH RNF139 CUL2 UBE2V2 CUL1 PJA1 UBE2Z RNF165 HUWE1 RFFL UBR2 UBE2M CBLC MARCH8,MF,33,33 of 41,1.4,80.49,2.385E-19,1.387E-17
GO:0003777,microtubule motor activity,Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752|I)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752|I)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1N724(Evidence code:IEA/Database source:InterPro:IPR004273|I)Q2KII9(Evidence code:IEA/Database source:InterPro:IPR008467)G3N1E4(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q2HJJ0(Evidence code:IEA/Database source:InterPro:IPR002151)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR004273|I)F1N1K6(Evidence code:IEA/Database source:InterPro:IPR004273|I)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR004273|I)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR004273|I)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752|I)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR004273|I), KIF5B KIF23 KIF14 DNAH11 DYNC1LI1 KIF26A KIF5C KIF13B KIF1B KIF5A KLC4 KIFC3 DYNC1H1 DNHD1 DNAH7 KIF2A KIF26B DNAH5 KIF13A KIF15 KIFC1 DNAH10,MF,22,22 of 9,0.93,244.44,2.429E-19,1.398E-17
GO:0014069,postsynaptic density,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)F1MJ11(Evidence code:IEA/Database source:UniProtKB:Q68FH0|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)A5PKD9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q8CIN4|ens)Q2KHT7(Evidence code:IEA/Database source:UniProtKB:P42677|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BB27(Evidence code:IEA/Database source:UniProtKB:Q9D415|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0R1(Evidence code:IEA/Database source:UniProtKB:P62269|ens)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens), RPS19 RNF112 SYNGAP1 PKP4 RGS14 TSC2 ABHD17C SHANK1 SYN2 PAK2 RPS27 VPS35 SCRIB BSN PLEKHA5 DNM2 LIN7B DLGAP1 DLG1 CAMK2A CAMK2G PAK3 PALM LIN7A LIN7C RPS18 RPL30 BCR FBXO45,CC,29,29 of 28,1.23,103.57,3.491E-19,1.987E-17
GO:0008233,peptidase activity,E1BFV4(Evidence code:IEA/Database source:InterPro:IPR010909)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q5E9K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1N2M2(Evidence code:IEA/Database source:InterPro:IPR010909)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)B7TCH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MF35(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P42891(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08DI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3ZC89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)G5E5C6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9TT93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR010909)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BEQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BIX3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3SZH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q08D90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens)P67810(Evidence code:IEA/Database source:InterPro:IPR001733)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q5E998(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9TT92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR010909)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653)Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR001096)F1MQD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A6QQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)F1MXQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A4FUF1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q9XTA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q8R016|ens)F1MCT1(Evidence code:IEA/Database source:InterPro:IPR010909)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q29RY7(Evidence code:IEA/Database source:InterPro:IPR033083)Q3T0Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645)Q3T0X5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0645), ADAMTS14 PSMB4 MBTPS2 PSMB2 ADAMTS7 TMPRSS2 DPP4 CASP6 USP9Y TLL2 ACE ECE1 PSMA3 MMP19 CASP3 METAP2 ACR ADAMTS4 CAPN2 MALT1 ADAMTS18 NPEPPS PSMB8 LOC505658 DPEP3 TMPRSS6 USP5 CAPN7 LTA4H KLK7 NAALAD2 SEC11A BACE1 PSMB10 HTRA1 PSMA4 DNPEP HABP2 USP13 CTSV IDE ADAMTS5 ADAMTS12 PSMA7 BRCC3 PSMB9 SPCS3 PIGK CAPN5 KLK6 XPNPEP1 PSMB3 CAPN11 TMPRSS9 LOC100125946 PSEN1 PREP OTUB1 BLMH PCSK6 PRSS23 USP20 FGL2 PSMA2 PSMA1,MF,65,65 of 205,2.76,31.71,4.131E-19,2.327E-17
GO:0034645,cellular macromolecule biosynthetic process,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens),EIF4G1,BP,1,1 of 670,0.04,0.15,4.415E-19,2.461E-17
GO:0044267,cellular protein metabolic process,Q3SZH7(Evidence code:IEA/Database source:UniProtKB:P09960|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), LTA4H PSEN1,BP,2,2 of 715,0.08,0.28,4.641E-19,2.56E-17
GO:1903506,regulation of nucleic acid-templated transcription,E1BEZ8(Evidence code:IEA/Database source:GO:0003712),PTPN14,BP,1,1 of 663,0.04,0.15,6.524E-19,3.562E-17
GO:2001141,regulation of RNA biosynthetic process,F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens),NCOA3,BP,1,1 of 666,0.04,0.15,6.811E-19,3.681E-17
GO:0003682,chromatin binding,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)F1MME0(Evidence code:IBA/Database source:PANTHER:PTN000388531)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)E1BLK1(Evidence code:IEA/Database source:InterPro:IPR001025)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)A5PK20(Evidence code:IDA/Database source:)E1BBH8(Evidence code:IEA/Database source:UniProtKB:Q96DN6|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)A5PJQ1(Evidence code:IBA/Database source:PANTHER:PTN000336336)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P52632)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)E1BGA4(Evidence code:IEA/Database source:InterPro:IPR001025)E1B9J3(Evidence code:IBA/Database source:PANTHER:PTN000286904)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)F1MM81(Evidence code:IEA/Database source:InterPro:IPR001025)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MNH3(Evidence code:IEA/Database source:UniProtKB:A2AVA0|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BKC4(Evidence code:IEA/Database source:InterPro:IPR033031), GATA6 TAF2 POU4F2 SUZ12 LRWD1 SRF PKN1 PRKCB SHMT2 TNRC18 TSHZ1 HIST1H1E MBD6 DLX2 TOP2B SIRT2 MEIS1 PRDM13 DEK STAT5B HCFC1 PRMT6 POLG PLAC8 CDK1 MB21D1 ASH1L RAD21L1 DDX1 SIRT6 KMT2A ARID3A NFKB1 BAHCC1 BRD2 SFPQ PYGO2 ATRX ZMYND8 POLQ ANKRD17 GLI1 CHD8 TCF7L2 LEF1 SVEP1 TPR GLI2 NIPBL,MF,49,49 of 116,2.08,42.24,7.335E-19,3.857E-17
GO:0008017,microtubule binding,E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB:Q5KU39|ens)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170013)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752)E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1N1R8(Evidence code:IBA/Database source:PANTHER:PTN000347035)O02675(Evidence code:IEA/Database source:InterPro:IPR030615)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752)Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752)E1BC48(Evidence code:IEA/Database source:InterPro:IPR028750)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752)Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170013)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776|I)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752)P43033(Evidence code:IDA/Database source:)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170013)E1BI79(Evidence code:IEA/Database source:InterPro:IPR009234)A8E641(Evidence code:IEA/Database source:InterPro:IPR030626)E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752)E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens)E1BAN2(Evidence code:IEA/Database source:UniRule:UR000107529)G3N1E4(Evidence code:IEA/Database source:InterPro:IPR001752)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752)F1N3M8(Evidence code:IEA/Database source:InterPro:IPR015656|I)E1BF73(Evidence code:IEA/Database source:UniProtKB:Q3UHI0|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), KIFC3 RACGAP1 VPS41 DNM2 CDK5RAP2 KIF5C EML2 GLI1 EML4 DPYSL2 KIF13B KIF5B CEP350 KIF14 DNM1 KIF23 RGS14 KIF2A PAFAH1B1 PRNP KIF13A KIF1B MX2 APC2 DPYSL5 KIF15 NAV3 KATNAL2 KIF26A KIFC1 MAP1A CCSER2 NUMA1 KIF5A KIF26B SPAST,MF,36,36 of 55,1.53,65.45,7.352E-19,3.857E-17
GO:0030496,midbody,E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O95785|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q14145|ens)P27214(Evidence code:ISS/Database source:UniProtKB:P50995)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QQY2(Evidence code:IBA/Database source:PANTHER:PTN000697893)G3X6L5(Evidence code:IEA/Database source:UniProtKB:Q96BM9|ens)F1MF87(Evidence code:IEA/Database source:UniProtKB:Q96AY4|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)P63097(Evidence code:ISS/Database source:UniProtKB:P63096)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)Q32LM0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MWR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)E1BLZ4(Evidence code:ISS/Database source:UniProtKB:Q68DK2)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P06493), APC2 SEPT6 PIN1 WIZ PKN1 PDXP SEPT2 CTNND1 KEAP1 ANXA11 CHMP4B CHMP4A RACGAP1 SPAST PPP1CC SIRT2 SPG20 DNM2 CRMP1 SVIL KLHL13 ARL8A TTC28 PKP4 GNAI1 BCL3 SH3GLB1 SEPT7 BIRC6 DCTN3 MICAL3 KIF14 CLIC4 ZFYVE26 KIF23 CDK1,CC,36,36 of 55,1.53,65.45,7.352E-19,3.857E-17
GO:0007399,nervous system development,Q2HJ58(Evidence code:IEA/Database source:UniProtKB:P60891|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)P98167(Evidence code:IEA/Database source:InterPro:IPR030119)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MKK8(Evidence code:IBA/Database source:PANTHER:PTN000548801)A8E641(Evidence code:IEA/Database source:InterPro:IPR030626)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MEC8(Evidence code:IBA/Database source:PANTHER:PTN001932250)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000686332)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MIK5(Evidence code:IEA/Database source:InterPro:IPR031268)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)A5D7F4(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q28053(Evidence code:IEA/Database source:InterPro:IPR028866)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN002389359)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000686332)Q3T0P7(Evidence code:IBA/Database source:PANTHER:PTN000103178)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)E1BER6(Evidence code:IEA/Database source:InterPro:IPR030624)F1MJ94(Evidence code:IBA/Database source:PANTHER:PTN001932250)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0524)Q08DH7(Evidence code:IEA/Database source:InterPro:IPR027703), PRPS1 RAPGEF2 PURA SSPO CAMK2D SPAST SIM2 DPYSL5 NDRG2 SCRIB KIF2A PCDH8 TAOK3 PHACTR4 CAMK2B SOX1 INSM1 DLG1 PAFAH1B1 PCDHGC3 APP DYNLT1 CAMK2A DPYSL2 TAOK2 ITM2B CYFIP1 CRMP1 PCDHA13 RNF112 INA,BP,31,31 of 36,1.32,86.11,7.501E-19,3.897E-17
GO:0023051,regulation of signaling,A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR024162),CBLC,BP,1,1 of 654,0.04,0.15,1.5E-18,7.719E-17
GO:0097367,carbohydrate derivative binding,Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR001347)F1MZY2(Evidence code:IEA/Database source:InterPro:IPR001347), GFPT2 GFPT1,MF,2,2 of 686,0.08,0.29,3.312E-18,1.688E-16
GO:0043565,sequence-specific DNA binding,A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001628)Q7YRX0(Evidence code:IEA/Database source:InterPro:IPR017970)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)F1MME0(Evidence code:IBA/Database source:PANTHER:PTN000388531)G5E655(Evidence code:IEA/Database source:InterPro:IPR000232)E1BHB8(Evidence code:IEA/Database source:InterPro:IPR017970)F1MC99(Evidence code:IEA/Database source:InterPro:IPR001766|I)Q32LE6(Evidence code:IEA/Database source:InterPro:IPR001275|I)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BLU8(Evidence code:IEA/Database source:InterPro:IPR001387|I)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001628)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR000679)A6QLP0(Evidence code:IEA/Database source:InterPro:IPR001766|I)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BL97(Evidence code:IEA/Database source:InterPro:IPR029547)E1B7I2(Evidence code:IEA/Database source:InterPro:IPR000418)E1BDU9(Evidence code:IEA/Database source:InterPro:IPR000679)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1BJK0(Evidence code:IEA/Database source:InterPro:IPR017970)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q32LB3(Evidence code:ISS/Database source:UniProtKB:Q7LFL8)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR017970)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR017970)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)E1BLB9(Evidence code:IEA/Database source:InterPro:IPR017970)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q08DM8(Evidence code:IEA/Database source:InterPro:IPR002848|I)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MT17(Evidence code:IEA/Database source:InterPro:IPR017970)F1MU40(Evidence code:IEA/Database source:InterPro:IPR017970)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1B8D8(Evidence code:IEA/Database source:InterPro:IPR017970)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BAI9(Evidence code:IEA/Database source:InterPro:IPR017970)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q1MW18(Evidence code:IEA/Database source:InterPro:IPR017970)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR017970)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BGG6(Evidence code:IEA/Database source:UniProtKB:P48382|ens)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BCF7(Evidence code:IEA/Database source:InterPro:IPR017970)A0JN76(Evidence code:ISS/Database source:UniProtKB:Q99592)E1BD77(Evidence code:IEA/Database source:InterPro:IPR017970)F1MBH4(Evidence code:IEA/Database source:InterPro:IPR001766|I)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR000679)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001628), NR1I2 RAX2 ZBTB4 MYF5 TAF2 LOC526488 RAX FOXI3 DMRTC2 SP1 GLI2 POU4F2 ESRRG GATA6 FOXO4 SOX17 BCL11B SOX13 ETV2 GATAD2B SNAPC4 SUZ12 IRX1 BCL11A CXXC5 PKNOX1 POU3F1 ZFHX3 HIC1 HIVEP3 NFKB1 SHOX2 LEF1 TSN TBX3 MEIS1 CUX2 MNX1 CDC5L HOXA7 ZNF516 E2F1 SOX1 KDM6B ANHX RREB1 LHX4 EN1 HIVEP1 RFX5 SALL4 DLX2 ZBTB18 ZFHX2 FOXF1 gata4 SRF NR2F6,MF,58,58 of 173,2.46,33.53,3.687E-18,1.861E-16
GO:0035556,intracellular signal transduction,Q08E45(Evidence code:IBA/Database source:PANTHER:PTN000680267)Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR002219)A1A4I4(Evidence code:IBA/Database source:PANTHER:PTN000683254)E1BN72(Evidence code:IBA/Database source:PANTHER:PTN000678822)Q28021(Evidence code:IEA/Database source:InterPro:IPR002219)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR016251)F1MY16(Evidence code:IEA/Database source:InterPro:IPR002219)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR016251|I)E1BN32(Evidence code:IEA/Database source:InterPro:IPR003533|I)A5D793(Evidence code:IEA/Database source:InterPro:IPR001331)Q4TVR5(Evidence code:IBA/Database source:PANTHER:PTN000357044)E1BB00(Evidence code:IEA/Database source:InterPro:IPR036036)F1N657(Evidence code:IEA/Database source:InterPro:IPR001331)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR001331)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR001331)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR001331)Q29450(Evidence code:IEA/Database source:InterPro:IPR001054|I)P08487(Evidence code:IEA/Database source:InterPro:IPR001192|I)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR016251|I)Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR006019)E1BA57(Evidence code:IEA/Database source:InterPro:IPR000591)E1B9B6(Evidence code:IBA/Database source:PANTHER:PTN000678822)F1MVZ2(Evidence code:IBA/Database source:PANTHER:PTN000678822)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR012234)A5PKC1(Evidence code:IEA/Database source:InterPro:IPR002219)G8JKY1(Evidence code:IEA/Database source:InterPro:IPR036036)Q1JQD5(Evidence code:IEA/Database source:InterPro:IPR028749)A7YY57(Evidence code:IEA/Database source:InterPro:IPR002219)P05126(Evidence code:IEA/Database source:InterPro:IPR002219)E1BP72(Evidence code:IEA/Database source:InterPro:IPR002219)F1N6T8(Evidence code:IEA/Database source:InterPro:IPR001331|I)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001192|I)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR002219)E1BLC5(Evidence code:IEA/Database source:InterPro:IPR003533|I)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR002219|I)F1MQE1(Evidence code:IEA/Database source:InterPro:IPR016239)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR002219)G3X7G7(Evidence code:IEA/Database source:InterPro:IPR002219)E1BPZ4(Evidence code:IBA/Database source:PANTHER:PTN000395915)A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR001054|I)A7YVE7(Evidence code:IEA/Database source:InterPro:IPR002219)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR028558)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR002219)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)F1MK99(Evidence code:IEA/Database source:InterPro:IPR002219)Q3SX45(Evidence code:IEA/Database source:InterPro:IPR036036)F1MP30(Evidence code:IEA/Database source:InterPro:IPR002219)F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens)E1BFR5(Evidence code:IBA/Database source:PANTHER:PTN000683254)E1BN61(Evidence code:IEA/Database source:InterPro:IPR016239)E1BPX7(Evidence code:IEA/Database source:InterPro:IPR000591)F1N6C1(Evidence code:IBA/Database source:PANTHER:PTN000584058)F1MNR5(Evidence code:IEA/Database source:InterPro:IPR016239)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776)A4IFM7(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR001562)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR001562)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BJP2(Evidence code:IEA/Database source:InterPro:IPR002219)F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR000591|I)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q6UVK1|ens), CAMK2A PSEN1 GNA12 PRKCI PKN1 NIM1K ROCK2 TYK2 AKAP13 PTPN6 JAK1 RP1L1 ECT2 DSTYK ASB10 SPATA13 ARHGEF12 TIAM2 LRRK2 BCR ADCY7 PLCG1 JAK2 SHC1 DEPDC1 NUAK1 BRSK2 ZAP70 CDC42BPA ASB14 OXSR1 ARHGAP29 PRKCB CDC42BPB VAV2 GNA13 PLCB3 DGKQ DCLK2 MYLK4 STK3 MYO9B RPS6KA4 MYLK3 UNC13C PLEKHM1 PPP1R1C GUCY1A3 CIT MYO9A MAP3K4 PINK1 CAMK2D BRAF WNK1 UNC13A ASB2 UNC13B SH2B2 MASTL RPS6KA5 RAPGEF4 LRRK1 RPS6KA2 KIT RGS14 MYLK2 TEC SRC RASAL1 CAMK2B RACGAP1 PREX1 CSPG4,BP,74,74 of 275,3.14,26.91,3.753E-18,1.877E-16
GO:0018108,peptidyl-tyrosine phosphorylation,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)Q95M13(Evidence code:IEA/Database source:GO:0004713)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)E1BG90(Evidence code:IEA/Database source:GO:0004713)E1B8H0(Evidence code:IEA/Database source:GO:0004715)Q58D16(Evidence code:IEA/Database source:GO:0004713)Q56JV6(Evidence code:IEA/Database source:GO:0004713)A3KMY9(Evidence code:IEA/Database source:GO:0004713)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)E1BIE4(Evidence code:IEA/Database source:GO:0004713)F1MRU0(Evidence code:IEA/Database source:GO:0004713)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)Q4TVR5(Evidence code:IEA/Database source:GO:0004713)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MTD8(Evidence code:IEA/Database source:GO:0004713)F1MQH2(Evidence code:IEA/Database source:GO:0004713)F1N758(Evidence code:IEA/Database source:GO:0004713)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens), LCK fgfr3 TEC DYRK2 PEAK1 MATK TWF1 JAK1 ABL1 KIT EPHB4 FLT3 WEE1 ZAP70 DSTYK SRC HCK EPHA6 ERBB4 ABI1 PTPN6,BP,21,21 of 10,0.89,210,7.304E-18,3.619E-16
GO:0005874,microtubule,A5D7N6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)O02675(Evidence code:ISS/Database source:UniProtKB:Q16555)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)Q3MHM9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1BAN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q3MHR3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F1N3M8(Evidence code:IEA/Database source:InterPro:IPR015656|I)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR000217|I)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)P81948(Evidence code:IEA/Database source:InterPro:IPR000217|I)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR000217|I)F1ME41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)A5D7P5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1B953(Evidence code:IEA/Database source:InterPro:IPR000217|I)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR000217|I)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1BFA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F6RP72(Evidence code:IEA/Database source:InterPro:IPR000217|I)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR027188)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR000217|I)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)A7E3C1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A7MBA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q0II58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)E1B7A3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q2HJJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0493)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR000217|I), KIF23 DPYSL2 HSPH1 KIF5B KATNAL2 DCLK2 TEKT4 DYNLT1 TUBA1D DYNLL2 CCT5 NDRG1 MAP1A TUBB4A TUBA3E CCT3 TUBA4A SPAST TUBB1 LOC101902172 DNM1 TUBGCP2 LOC533307 TUBA1A TUBA8 DLG1 FKBP4 KIFC3 DYNLL1 SIRT2 LOC100295712 DNM2 LRPPRC LOC100141266 KIF14 KIF2A KIF5A DYNLRB1 CDK5RAP2 KIFC1 DCTN2 KIF5C PAFAH1B1 DYNC1I2 LOC101905447 KLC4 TUBB3,CC,47,47 of 114,2,41.23,7.845E-18,3.851E-16
GO:0006470,protein dephosphorylation,A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000242|I)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000242|I)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens)G5E526(Evidence code:IEA/Database source:GO:0008138)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR020405|I)Q3ZCM0(Evidence code:IEA/Database source:GO:0004722)P11064(Evidence code:IEA/Database source:InterPro:IPR002115|I)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000242|I)P48452(Evidence code:ISS/Database source:UniProtKB:Q08209)Q3ZBF9(Evidence code:IDA/Database source:)E1BD03(Evidence code:IEA/Database source:InterPro:IPR015655)P61287(Evidence code:ISS/Database source:UniProtKB:P63087)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000242)Q58DC0(Evidence code:IEA/Database source:GO:0004721)Q0P594(Evidence code:IEA/Database source:GO:0004721)A5D980(Evidence code:IEA/Database source:InterPro:IPR000242|I)P67774(Evidence code:IEA/Database source:GO:0004721)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000242)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)A6QLS1(Evidence code:IEA/Database source:InterPro:IPR008343|I)A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR020422)Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens)F1MG56(Evidence code:IEA/Database source:UniProtKB:P63151|ens)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000242), PTPN5 PTPN14 CTDSP1 PTP4A1 DUSP3 LCK ACP1 PTPRA PPP3CA PDXP PPM1D PPP1CC PPP2R5A PTPN23 CPPED1 PPP2CB PTPN6 PPP2CA PTPRM PPP1CB DUSP7 PPP3CC SSH2 PHPT1 PPP2R2A PTPRZ1,BP,26,26 of 24,1.1,108.33,1.157E-17,5.629E-16
GO:0006351,"transcription, DNA-templated",Q32PE0(Evidence code:IEA/Database source:InterPro:IPR006110|I)G5E5M1(Evidence code:IEA/Database source:InterPro:IPR003618|I)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QLP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A5D7F6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q0VCF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q7YRX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BLU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BC39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)B0JYL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000722|I)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q5NUA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q32S26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q9TUM3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7Z017(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A5PJW1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BAD4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3Y4E1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MVD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q9BE45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A2VDU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A0JND4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q0VCJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MU53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MKK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A8QQK8(Evidence code:IEA/Database source:InterPro:IPR005570)E1BEP4(Evidence code:IBA/Database source:PANTHER:PTN000063846)G3N2D1(Evidence code:IEA/Database source:InterPro:IPR007759)F1MT17(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q95115(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2T9N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3SYX4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BBQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)O02754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q95KU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P61635(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BG94(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QPH9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3MHL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3MHP1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1N4U8(Evidence code:IEA/Database source:InterPro:IPR007759)G3MYR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F6RRD7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MXR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1ML85(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A6QNT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G3MWI7(Evidence code:IEA/Database source:UniRule:UR000400705)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BKB7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)P17667(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BJP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)F1N3S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)G3MYE7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q9GL32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)E1BK57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q32KX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0804), POLR2F PHF3 MCTS1 FOXO4 MAML2 SOX4 RAX2 PTPRN POU4F2 ESRRG STAT1 ERCC2 SAP18 BCL3 POLR2A INSM1 AEBP2 PRKCB IRF1 PAXIP1 NFE2L2 BRD2 RUVBL2 STAT5B DDX1 MAF CDC5L VPS25 INO80 PRMT6 TAF10 RUNX1 MMS19 ZNF148 NCOA3 NFKBIZ DHX9 NR1I2 SBNO2 ZBTB8A ZNF446 PCBD1 SIM2 POLR2H ASH2L ASXL3 CUX2 STAT5A HDAC5 ZNF394 ZBTB18 IKBKAP ZNF750 CIDEC CEBPA IKBKG PARP1 STAT3 E2F1 ZMYM5 VPS36 CHD8 TSC22D1 UBE2L3 ASXL1 POU3F1 RPAP2 DYNLL1 KMT2A UHRF1 PKN1 ONECUT2 AHR FAM120B DMRTC2 ZFPM1 HBP1 MGA CPNE1 GTF3C6 MYF5 PRMT5 BRCA1 SRF NR2F6 E2F7 MECP2 HEYL MAPK13 RUVBL1 EGR4 TBX3 TFDP2 TAF8 FHIT,BP,95,95 of 435,4.04,21.84,1.443E-17,6.958E-16
GO:0006811,ion transport,P31404(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)F1MS16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP51(Evidence code:IEA/Database source:InterPro:IPR005821)F1MS08(Evidence code:IEA/Database source:InterPro:IPR002443|I)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)P23956(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P11019(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)O62826(Evidence code:IEA/Database source:InterPro:IPR005821)F1MN60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)E1BM97(Evidence code:IEA/Database source:InterPro:IPR005821)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR005821)O18784(Evidence code:IEA/Database source:InterPro:IPR004729|I)P02715(Evidence code:IEA/Database source:InterPro:IPR002394|I)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR005821)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR005821)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR005821)A2VDL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005821)Q08DA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)A6H7B0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR005821)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001508)Q28204(Evidence code:IEA/Database source:InterPro:IPR005821)P05630(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)F1N1D4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P31408(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001508)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001508)P31407(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR005821)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)P35071(Evidence code:IEA/Database source:InterPro:IPR009147)F1MP22(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR005821)F1MMF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)Q08E50(Evidence code:IEA/Database source:InterPro:IPR001390|I)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001508)P21282(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR005821)F1N4L1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)P61420(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR005821)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)Q3T0E0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)O46563(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)O18875(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR005821)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR005821)F1MS75(Evidence code:IEA/Database source:InterPro:IPR002443|I)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001508)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0406), ATP6V1A KCNG4 ATP2B3 SCN8A KCNH5 SLC12A2 SCN3A KCNC4 ATP6V0C ATP6V1E1 TRPC2 ATP2B2 KCNG2 HCN1 SCN10A TRPC1 CHRNE RYR1 ITPR2 CACNA1C TPCN2 ATP1A2 TRPC3 ATP1A1 PLLP KCNH6 GRIA2 KCNMA1 ATP5D SLC5A11 TTYH3 KCNF1 BEST3 ATP6V1B2 PANX3 CLDN4 CLIC4 KCNA4 CACNA1B GRIA3 GRIK4 ATP6V1B1 CACNA1F CLIC1 RYR2 CACNA1D CFTR CACNA1E ITPR1 ATP2C2 GABRA5 CLIC6 ATP2B4 KCNC3 WNK1 TRPM7 GRIA1 ATP6V1C1 TRPM4 SLC4A2 ATP6V0D1 CACNA1A SCN5A CACNA1H ATOX1 ATP6V1H SLC6A8 SCN11A LETM1 CACNA1S SLC12A1 GRIN3B CLCC1,BP,73,73 of 278,3.1,26.26,1.882E-17,8.994E-16
GO:0016324,apical plasma membrane,P31404(Evidence code:IEA/Database source:UniProtKB:P50516|ens)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)P81425(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7YY70(Evidence code:IEA/Database source:UniProtKB:Q06495|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)P35071(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MS08(Evidence code:IBA/Database source:PANTHER:PTN000930541)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P11019(Evidence code:ISS/Database source:UniProtKB:P50518)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q61146|ens)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)E1B9W1(Evidence code:IEA/Database source:UniProtKB:Q9D563|ens)Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5)Q17QL5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX1)Q3ZC83(Evidence code:IEA/Database source:UniProtKB:Q99808|ens)F1MS75(Evidence code:IBA/Database source:PANTHER:PTN000930541)A2VE13(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens), ATP6V1A ATP6V1B1 STK26 DPP4 SLC34A1 RAPGEF2 CUBN FAT1 CIB1 AKR1A1 ATP8B1 CFTR SLC12A2 SLC23A1 MYO1A C1QTNF5 ATP6V1E1 PRKCI OCLN CD44 PKHD1 AQP5 KCNMA1 TMEM114 SEPT7 TMEM30A DSTYK SLC29A1 SLC12A1 MAL2 MPDZ AMOTL1 RAB17 PFKM TJP1,CC,35,35 of 60,1.49,58.33,3.189E-17,1.51E-15
GO:0004713,protein tyrosine kinase activity,E1BIM8(Evidence code:IEA/Database source:InterPro:IPR020635)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR020635)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR020635)Q58D16(Evidence code:IEA/Database source:InterPro:IPR020635)E1BPI3(Evidence code:IEA/Database source:InterPro:IPR020635)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0829)F1MSH3(Evidence code:IEA/Database source:InterPro:IPR020635)A7MB57(Evidence code:IEA/Database source:InterPro:IPR020635)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR020635)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)P43481(Evidence code:IEA/Database source:InterPro:IPR020635)A7MBC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0829)F1N758(Evidence code:IEA/Database source:InterPro:IPR016245)Q3ZCM0(Evidence code:IEA/Database source:InterPro:IPR020635)Q95M13(Evidence code:IEA/Database source:InterPro:IPR020635)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR020635)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR020635|I)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR020635)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR020635)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR020635)F1MTD8(Evidence code:IEA/Database source:InterPro:IPR020635), SRC JAK1 TYK2 MATK FRK DSTYK TEC YES1 JAK2 DYRK2 TWF1 KIT WEE1 ERBB4 LCK fgfr3 EPHA6 ABL1 FLT3 ZAP70 EPHB4 HCK,MF,22,22 of 14,0.93,157.14,3.261E-17,1.531E-15
GO:0045892,"negative regulation of transcription, DNA-templated",E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)A5D7H2(Evidence code:ISS/Database source:UniProtKB:Q13033-2)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)P62194(Evidence code:IEA/Database source:UniProtKB:P62196|ens)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)A0JN76(Evidence code:ISS/Database source:UniProtKB:Q9WUK6)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1N281(Evidence code:ISS/Database source:UniProtKB:Q7Z4V0-1)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR013289)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)Q1RMU0(Evidence code:IEA/Database source:InterPro:IPR006989)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR033277)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q3UH06|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)E1BA57(Evidence code:IEA/Database source:UniProtKB:Q5TB30|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q60749|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749), HOXA7 BCOR SBNO2 CUX2 PDCD4 SFPQ TFDP2 CTBP1 STRN3 MT3 PSMC5 COPS2 ZBTB18 SMARCA2 CHD8 ZNF438 NIPBL FAM129B EMILIN1 IRF1 CBFA2T2 SIRT6 NAB2 GON4L E2F1 CHMP1A ZHX3 CCAR2 SIM2 MAP3K10 ZBTB4 TMPRSS6 LEF1 CEBPA ARHGAP35 RREB1 TBX3 SIRT2 PRMT6 GATA6 FZD1 SPEN PURB DEPDC1 RPS6KA5 NR1I2 PURA LANCL2 ATP8B1 TRAF6 SMTNL1 DAB2IP KHDRBS1 NACC1 TSG101 NFKB1 BCL3,BP,57,57 of 178,2.42,32.02,3.856E-17,1.794E-15
GO:0070588,calcium ion transmembrane transport,D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408|I)O62826(Evidence code:IEA/Database source:InterPro:IPR002153|I)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000699)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR000699)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005445)F1MPF0(Evidence code:IEA/Database source:GO:0005262)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MS16(Evidence code:IEA/Database source:InterPro:IPR006408)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR002153|I)F1MN60(Evidence code:IEA/Database source:InterPro:IPR006408)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000699)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR000699)F1MRN7(Evidence code:IEA/Database source:GO:0005388)O18784(Evidence code:IEA/Database source:InterPro:IPR002153|I)F1MWI8(Evidence code:IEA/Database source:GO:0005262)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)E1BNX9(Evidence code:IEA/Database source:GO:0005262)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR030334)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR002077|I)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005447)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR002077|I)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002077|I)Q9XT97(Evidence code:IEA/Database source:GO:0005262)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR000699), ATP2B4 TRPC2 ITPR2 RYR2 CACNA1H TRPM7 CACNA1S ATP2B3 CACNA1E TRPC3 ATP2B2 ITPR1 RYR1 ATP13A5 TRPC1 GRIN3B ANO6 TRPM4 CACNA1F ATP2C2 CACNA1D CACNA1A CACNA1C CACNA1B PSEN1 RYR3,BP,26,26 of 26,1.1,100,4.119E-17,1.9E-15
GO:0000502,proteasome complex,Q3T0B2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)Q3T112(Evidence code:IEA/Database source:InterPro:IPR035705)A4FUZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3T0T1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q17QP9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3T108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q1JP95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q2KJ25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q2KIW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P35998)Q58DU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)P56701(Evidence code:IEA/Database source:InterPro:IPR016643)Q2NKS3(Evidence code:IBA/Database source:PANTHER:PTN001257301)P33672(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q5E9K0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)A7MBA2(Evidence code:IEA/Database source:InterPro:IPR016642)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3SZC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q5E964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3T0Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647)Q3T0X5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0647), PSMD6 PSMC5 PSMB8 PSMC1 PSMB10 PSMD14 PSMB4 PSMA7 PSMC3 PSMD12 PSMC6 PSMC2 PSMA3 PSMD2 PSMG3 PSMB3 PSMB2 PSMD1 PSMA4 UBXN1 RAD23B PSMB9 PSMD13 PSMA2 PSMA1,CC,25,25 of 23,1.06,108.7,4.613E-17,2.11E-15
GO:0005604,basement membrane,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)F1MDD5(Evidence code:IEA/Database source:UniProtKB:Q61789|ens)E1BH09(Evidence code:IEA/Database source:InterPro:IPR030755)Q29442(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)F1MF97(Evidence code:IEA/Database source:UniProtKB:O88322|ens)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)E1BN52(Evidence code:IEA/Database source:InterPro:IPR032825)E1B7H2(Evidence code:IEA/Database source:UniProtKB:Q63870|ens)A7MB18(Evidence code:IEA/Database source:UniProtKB:Q9JI33|ens)E1BJW3(Evidence code:IEA/Database source:UniProtKB:A6H6E2|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:P55268|ens)A6QLN9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)Q7SIB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)Q28084(Evidence code:IEA/Database source:UniProtKB-KW:KW-0084)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)F1MUC5(Evidence code:IEA/Database source:InterPro:IPR039070), COL2A1 COL4A1 LAMA3 VWA2 COL4A4 COL4A6 NID2 FRAS1 FREM1 COL7A1 NTN4 MMRN2 LAMB2 VWA1 HMCN1 LAMB1 COL4A2 COL4A5 LAMC3 COL4A3 FREM2 COL15A1,CC,22,22 of 15,0.93,146.67,7.518E-17,3.409E-15
GO:0051015,actin filament binding,E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR031244)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR008989)E1BP80(Evidence code:IEA/Database source:InterPro:IPR030637)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)F1MF57(Evidence code:IEA/Database source:UniProtKB:O76041|ens)Q28046(Evidence code:IEA/Database source:InterPro:IPR007122|I)E1BDP6(Evidence code:IEA/Database source:InterPro:IPR007122)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR008989)E1BE25(Evidence code:IEA/Database source:InterPro:IPR032461)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)E1BET5(Evidence code:IEA/Database source:UniProtKB:P28290|ens)F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR008989)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR001033|I)O46385(Evidence code:IEA/Database source:InterPro:IPR007122|I)F1MX93(Evidence code:IEA/Database source:InterPro:IPR008989)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)F1N643(Evidence code:IEA/Database source:InterPro:IPR014800|I)B6Z9Q5(Evidence code:IEA/Database source:InterPro:IPR014800|I)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR008989)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR008989)Q5E963(Evidence code:IBA/Database source:PANTHER:PTN000291131)Q5E9D5(Evidence code:ISS/Database source:UniProtKB:P60981)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR001033|I)Q1JP79(Evidence code:IBA/Database source:PANTHER:PTN000076207)P85091(Evidence code:IDA/Database source:)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens), MYO18A MYO7B ZNF185 IQGAP2 SYNE3 NEBL SCIN VILL FERMT2 MICALL2 ABL1 MYO6 FLNC MYBPC3 SSFA2 MYO5B MYO1A CTNNA2 SVIL MYO5C MYO1D SHROOM3 SHROOM2 FMNL1 MYO5A MYH11 ARPC5L DSTN CTNNA1 ARPC1A CYFIP1 MYH14,MF,32,32 of 50,1.36,64,9.78E-17,4.398E-15
GO:0006334,nucleosome assembly,A5PK61(Evidence code:IBA/Database source:PANTHER:PTN000152096)Q2KII5(Evidence code:IBA/Database source:PANTHER:PTN000603808)E1B8G9(Evidence code:IBA/Database source:PANTHER:PTN000603808)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)A6H767(Evidence code:IEA/Database source:InterPro:IPR002164)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)Q2TA40(Evidence code:IEA/Database source:InterPro:IPR002164)F1MUD2(Evidence code:IBA/Database source:PANTHER:PTN000603808)G3MYD7(Evidence code:IBA/Database source:PANTHER:PTN000152096)A5PK20(Evidence code:IEA/Database source:InterPro:IPR005818|I)F1N453(Evidence code:IBA/Database source:PANTHER:PTN000603808)E1BC18(Evidence code:IBA/Database source:PANTHER:PTN000603808)E1BGW2(Evidence code:IBA/Database source:PANTHER:PTN000603808)G3MZR4(Evidence code:IBA/Database source:PANTHER:PTN000603808)E1BL49(Evidence code:IBA/Database source:PANTHER:PTN000603808)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR019809)F1MV26(Evidence code:IBA/Database source:PANTHER:PTN000603808)A7MAZ5(Evidence code:IEA/Database source:InterPro:IPR005818|I)G3N3L9(Evidence code:IBA/Database source:PANTHER:PTN000603808)G3N131(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1BGN3(Evidence code:IBA/Database source:PANTHER:PTN000152096)G3N068(Evidence code:IBA/Database source:PANTHER:PTN000603808)Q32L48(Evidence code:IBA/Database source:PANTHER:PTN000603808)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)F1MMU4(Evidence code:IEA/Database source:InterPro:IPR005818|I)E1BM22(Evidence code:IBA/Database source:PANTHER:PTN000603808), H3F3C HIST1H2BI HIST3H2BB BRD2 HIST1H2BA NAP1L1 ATRX NAP1L4 HIST2H2BF LOC100297725 HIST1H1E HIST2H2BE LOC617043 HIST1H2BJ LOC523702 LOC614206 LOC619094 LOC525433 HIST1H1D LOC613363 HIST1H1A HIST2H3D LOC614378 HIST1H2BN H3F3B H1FX LOC100300167,BP,27,27 of 33,1.15,81.82,3.101E-16,1.383E-14
GO:0048856,anatomical structure development,F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), AMER3 GLI2,BP,2,2 of 617,0.08,0.32,3.708E-16,1.64E-14
GO:0006886,intracellular protein transport,Q3T0M0(Evidence code:IBA/Database source:PANTHER:PTN000122547)E1BME2(Evidence code:IEA/Database source:InterPro:IPR002553)E1B8Q9(Evidence code:IEA/Database source:InterPro:IPR001494|I)P63009(Evidence code:IEA/Database source:InterPro:IPR002553|I)G5E567(Evidence code:IEA/Database source:InterPro:IPR001494)E1BBK9(Evidence code:IEA/Database source:InterPro:IPR010911)A4IFB8(Evidence code:IEA/Database source:InterPro:IPR001494)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR006012)Q3B7N3(Evidence code:IEA/Database source:InterPro:IPR001494)A3KN15(Evidence code:IEA/Database source:InterPro:IPR000547)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q3T0T7(Evidence code:IEA/Database source:InterPro:IPR006687)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q5E9F1(Evidence code:IEA/Database source:InterPro:IPR008417)E0AE16(Evidence code:IEA/Database source:InterPro:IPR028644|I)Q08DL9(Evidence code:IEA/Database source:InterPro:IPR002014)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR028667|I)E1B8Q8(Evidence code:IEA/Database source:InterPro:IPR001494)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR002553|I)A0JN39(Evidence code:IEA/Database source:InterPro:IPR002553|I)A5PK10(Evidence code:IEA/Database source:InterPro:IPR002014|I)E1BFV0(Evidence code:IEA/Database source:InterPro:IPR001494)P81127(Evidence code:IEA/Database source:InterPro:IPR000744)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)P63171(Evidence code:TAS/Database source:)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)E1BE98(Evidence code:IEA/Database source:InterPro:IPR001494)Q2HJG5(Evidence code:IBA/Database source:PANTHER:PTN000120819)Q3SYU7(Evidence code:IEA/Database source:InterPro:IPR001494)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q2KI57(Evidence code:IEA/Database source:InterPro:IPR001494)F1MPE5(Evidence code:IEA/Database source:InterPro:IPR001494)A1A4I8(Evidence code:IEA/Database source:InterPro:IPR001494)F1N2I0(Evidence code:IEA/Database source:InterPro:IPR001738)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR002553|I)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR028642|I)E1BGE5(Evidence code:IEA/Database source:InterPro:IPR001494|I)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)P35604(Evidence code:IEA/Database source:InterPro:IPR000804)Q2HJE9(Evidence code:IEA/Database source:InterPro:IPR005678)A6QP06(Evidence code:IEA/Database source:InterPro:IPR010911)Q5BIP4(Evidence code:IEA/Database source:InterPro:IPR002014|I)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)A2VE21(Evidence code:IEA/Database source:InterPro:IPR002553|I)P04973(Evidence code:IEA/Database source:InterPro:IPR000996)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q0VD53(Evidence code:IBA/Database source:PANTHER:PTN000260563)Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)Q3ZC13(Evidence code:IEA/Database source:InterPro:IPR001392|I)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR000804)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR000804)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692|I), VPS29 AP3B2 IPO8 AP2B1 IPO9 SYTL1 IPO4 STX7 RANBP6 VPS41 TBC1D22B SAR1B SEC23A SEC24C BCAP31 SNX9 STAM TBC1D2 SNX27 XPOT AP2A2 COPB1 TOM1L2 KPNB1 NAPG SEC23B DYNLT1 SGSM2 XPO1 VPS35 TNPO1 COPB2 SEC24D TNPO2 IPO5 XPO7 CHML AP2B1 SNX33 IPO7 PDCD6 COPZ1 TIMM17B SYTL2 TOM1 TBC1D12 COPG2 CLTA SEC24A AP2A1 VPS26A SNX8 RABGAP1 CTTN AP2M1 AP2S1 AP1S1 COPA,BP,58,58 of 196,2.46,29.59,3.926E-16,1.722E-14
GO:0016459,myosin complex,F1MMQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MMC7(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BA80(Evidence code:IEA/Database source:InterPro:IPR001609)F1MLR9(Evidence code:IEA/Database source:InterPro:IPR001609)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR001609)P85100(Evidence code:IEA/Database source:UniProtKB-KW:KW-0518)F1MG13(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q27966(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q17R14(Evidence code:IEA/Database source:InterPro:IPR001609|I)F1MM57(Evidence code:IEA/Database source:InterPro:IPR001609|I)A0JNJ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0518)Q32WS5(Evidence code:IEA/Database source:InterPro:IPR002928)F1MX93(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR001609|I)P10568(Evidence code:IEA/Database source:InterPro:IPR001609|I)E1BPK6(Evidence code:IEA/Database source:InterPro:IPR001609|I)G5E5V6(Evidence code:IEA/Database source:InterPro:IPR002928)G3MZH3(Evidence code:IEA/Database source:InterPro:IPR001609|I)Q0P571(Evidence code:IEA/Database source:UniProtKB-KW:KW-0518)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR001609)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000934383)A6QLN6(Evidence code:IEA/Database source:InterPro:IPR001609|I), MYO5B MYO1F MYO18B MYO7B MYO9A MYL3 MYO15A MYO1C MYO1D MYH14 MYL1 CGN MYO5C MYO18A MYO1A MYO6 CGNL1 MYO5A MYLPF MYO9B DYNLL2 MYH11,CC,22,22 of 18,0.93,122.22,7.432E-16,3.233E-14
GO:0007420,brain development,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)O02675(Evidence code:IEA/Database source:InterPro:IPR030615)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)Q2YDD2(Evidence code:ISS/Database source:UniProtKB:Q9DB90)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR016362)Q3ZBA8(Evidence code:IBA/Database source:PANTHER:PTN000112095)Q5EA61(Evidence code:ISS/Database source:UniProtKB:P07335)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)Q29460(Evidence code:IBA/Database source:PANTHER:PTN000220758)Q3MHH4(Evidence code:ISS/Database source:UniProtKB:P47897)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9Z2J0)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens), PYGO2 CDK5RAP2 PRKDC EXT1 DPYSL2 CHD8 SMG9 COL4A1 PSEN1 POU3F1 NDRG2 CKB NF2 SPHK2 PAFAH1B3 QARS SLC23A1 STK36 BCR BRCA2 HYDIN ARL6 NIPBL RPGRIP1L RAX,BP,25,25 of 28,1.06,89.29,9.588E-16,4.137E-14
GO:0007275,multicellular organism development,Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q0VD00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)Q08DH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q0VCP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1N5R9(Evidence code:IEA/Database source:InterPro:IPR000747)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN001364370)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens)F1MT17(Evidence code:IBA/Database source:PANTHER:PTN001019067)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)G3X812(Evidence code:IEA/Database source:InterPro:IPR011656)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BLB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)O02754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P03968(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)A0JN76(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)A7MBJ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)A2VDU1(Evidence code:IEA/Database source:InterPro:IPR007875)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BMA1(Evidence code:IEA/Database source:InterPro:IPR033011)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN001364370)E1B8D8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BHB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217)P17667(Evidence code:IEA/Database source:UniProtKB-KW:KW-0217), HEYL INSM1 ZNF516 KCTD15 PHACTR4 RREB1 INA TDRD5 OLFML3 VAMP5 DDX4 EN1 ARVCF ZMYM5 CYFIP1 CDK3 HYDIN CUX2 LGR4 NOTCH4 AIMP2 HIVEP1 TSHZ1 SPAST SHOX2 NDRG2 CEBPA FGF1 TAF8 BRAF ZBTB18 HIVEP3 MTURN LRP6 DDX1 FZD1 RAPGEF2 SPRY4 MGP PAFAH1B1 PRTG LFNG KIF2A DPYSL2 ZMYM4 HOXA7 CDK6 RAX MYF5,BP,49,49 of 145,2.08,33.79,1.004E-15,4.3E-14
GO:0015031,protein transport,Q5BIP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q32L63(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P61763(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A6QQ47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3SX42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A6QP64(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A3KN51(Evidence code:IEA/Database source:InterPro:IPR008883)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P10948(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q08DR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3ZC43(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P35605(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)Q2HJG5(Evidence code:IEA/Database source:InterPro:IPR005378)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P83437(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR016635)Q3T178(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A4IFN6(Evidence code:IEA/Database source:InterPro:IPR014536)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR008883)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0VD53(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BME2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR016635)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR014536)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P10949(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A5PK10(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR017104)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P63009(Evidence code:IEA/Database source:InterPro:IPR016342)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR017104)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A4IF89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P81127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q9TTK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)F1MV07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0V8C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A6QLD1(Evidence code:IEA/Database source:InterPro:IPR007191)E0AE16(Evidence code:IEA/Database source:InterPro:IPR014536)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q0P5B1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P26882(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q29RR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A6QR35(Evidence code:IEA/Database source:InterPro:IPR007273)Q3SYU7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q58CS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR016342)E1BIU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)E1BC70(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)A7YY62(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0653), TOM1 VTA1 COPZ1 RANBP2 STXBP1 VPS51 LIN7B SNX3 CHMP4A CHMP2B VPS36 VPS37B SEC13 TSG101 CHMP1B RAB3B COPE ARCN1 LIN7C SNF8 CD63 VPS41 EXOC7 COPB2 FRAS1 VPS35 VAMP3 COG5 COPA SNX27 MVB12A CORO7 AP1S1 VPS28 AP2M1 COPB1 ARFGEF1 VPS29 SNX18 UEVLD SNX8 VPS26A AP3B2 RAB4A COPG2 LIN7A AP2S1 MYO1C SNX33 SEC24A RAB3C TOM1L2 AP2A1 RAB39B AP2B1 AP2A2 VPS25 EXOC8 NAPG LYST SEC24D EXOC3 EXOC4 SNX9 SEC23B ARL6 SAR1B PSEN1 PEX13 PPID RAB26 TIMM17B SCAMP2 TNPO1 CHMP3 VPS4B ARRDC1 RAN AP2B1 SEC24C RAB25 VPS37C SEC23A FAM160A2 RAB3A,BP,85,85 of 394,3.61,21.57,1.154E-15,4.903E-14
GO:0031965,nuclear membrane,Q08DB4(Evidence code:IEA/Database source:UniProtKB:B0QZ18|ens)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)E1BLK1(Evidence code:IEA/Database source:UniProtKB:O15417|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)Q32L41(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MS27(Evidence code:IEA/Database source:UniProtKB:A0A140VJR0)E1BJE7(Evidence code:IEA/Database source:UniProtKB:O60318|ens)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)P80227(Evidence code:IEA/Database source:UniProtKB:A0A024R2U9)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BIJ4(Evidence code:IEA/Database source:UniProtKB:A0A024RBB9)Q0VCU9(Evidence code:IEA/Database source:UniProtKB:Q7Z403|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)P43033(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CPNE1 CLIC1 NDC1 XPO1 PCM1 IPO5 HOXA7 TPR DNAJB2 TNRC18 SPAST GATA6 ANKRD17 RIF1 RANBP2 KPNB1 MYO6 PRNP TNKS GCHFR PDE4D MCM3AP TXLNG SYNE3 INA IPO4 SHISA5 TOR1A APEH TNPO1 LEMD3 TMC6 PSEN1 TNPO3 AHCTF1 PAFAH1B1,CC,36,36 of 75,1.53,48,1.234E-15,5.201E-14
GO:0016607,nuclear speck,E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BI51(Evidence code:IEA/Database source:UniProtKB:Q4ZHG4|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)A7YY70(Evidence code:IEA/Database source:UniProtKB:A0A024R7R9)E1BB50(Evidence code:ISS/Database source:UniProtKB:Q3MJK5)Q28165(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)A2VDN6(Evidence code:IEA/Database source:UniProtKB:A0A024R1K8)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q14004)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q12837|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1N2Q3(Evidence code:IEA/Database source:UniProtKB:P49842|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:A2ABF8|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)Q32S26(Evidence code:IEA/Database source:UniProtKB:P25440|ens)F1MZQ1(Evidence code:IEA/Database source:UniProtKB:Q9H0E3|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:A0A024R8V6)E1B7Q7(Evidence code:IEA/Database source:UniProtKB:Q14669|ens)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q9H3U1|ens)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens)G3N0D9(Evidence code:IEA/Database source:UniProtKB:A0A024R4V5)Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979)Q2NL22(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9BYH8|ens)P67827(Evidence code:ISS/Database source:UniProtKB:P48729)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q8CHI8|ens)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), E2F7 SNRNP70 FNDC1 FOXO4 PIN1 DGKQ SLC34A1 CDK12 PABPN1 PCBP1 SF3A1 MAML2 SRSF1 CDK13 PACSIN2 POU4F2 GLI2 STK19 EHMT2 PUM1 BRD2 SAP130 RREB1 SDCBP2 PRPF40A USP36 TRIP12 UNC45A BDNF BRD1 SAP18 WRN UHMK1 EIF4A3 PPP1CC NFKBIZ CSNK1A1 EP400 AP5Z1 SYF2 CDC5L,CC,41,41 of 103,1.74,39.81,2.352E-15,9.832E-14
GO:0032268,regulation of cellular protein metabolic process,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 539,0.04,0.19,2.685E-15,1.114E-13
GO:0043025,neuronal cell body,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)E1BID8(Evidence code:IEA/Database source:UniProtKB:Q8JZW4|ens)E1BCA5(Evidence code:IEA/Database source:UniProtKB:O35684|ens)A8E641(Evidence code:IEA/Database source:UniProtKB:Q9EQF6|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P50114|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB:Q9Z2M7|ens), VPS35 SYT4 CPNE5 SERPINI1 DPYSL5 S100B FABP7 BRINP1 DNER PTPRN CACNA1B DENND1A HCFC1 RTN4R RAB17 LRP6 SEZ6L2 TUBB3 PSEN1 PURA CIB1 GRIN3B MYO1D DAB2IP SPTBN4 LRRK2 RAPGEF2 DPYSL2 TUBB4A PMM2,CC,30,30 of 50,1.27,60,3.123E-15,1.286E-13
GO:0098793,presynapse,F1MKZ3(Evidence code:IEA/Database source:GO:0016079)A5D7F2(Evidence code:IEA/Database source:GO:0048791)E1BBK9(Evidence code:IEA/Database source:GO:0048791)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1MME2(Evidence code:IEA/Database source:GO:0048488)Q2KIB6(Evidence code:IEA/Database source:GO:0007269)Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens)E1BGL9(Evidence code:IEA/Database source:GO:0048791)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)Q0P5F3(Evidence code:IEA/Database source:GO:0007269)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)Q9TU34(Evidence code:IDA/Database source:)E1BBX9(Evidence code:IEA/Database source:UniProtKB:Q8K0T7|ens)Q9XT97(Evidence code:IEA/Database source:GO:0016080)E1BMQ1(Evidence code:IEA/Database source:GO:0016079)Q32LM6(Evidence code:IEA/Database source:GO:0007269)F1MS16(Evidence code:IEA/Database source:GO:0099509)O18964(Evidence code:IEA/Database source:GO:0048488)E1BGA9(Evidence code:IEA/Database source:UniProtKB:Q6P5E8|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q99961|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)F1MNU6(Evidence code:IEA/Database source:GO:1905413)A6QP06(Evidence code:IEA/Database source:GO:0048791), CADPS SYT4 SYTL1 UNC13A BACE1 GIPC1 DENND1A LIN7B SEPT6 SYT6 FBXO45 LIN7C UNC13B ITPR1 UNC13C PSEN1 OTOF LIN7A ATP2B3 SYNJ1 DGKQ SH3GL1 DNAJC5 BSN BAIAP3 SYTL2,CC,26,26 of 34,1.1,76.47,3.367E-15,1.375E-13
GO:0005769,early endosome,F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN000634601)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)Q9GL65(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8NFT8|ens)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q8K3H0|ens)E1BBN5(Evidence code:IEA/Database source:UniProtKB:Q8R516|ens)P61420(Evidence code:IEA/Database source:UniProtKB:P51863|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92), RAB17 CHMP1A TFRC VPS41 SNX3 STX7 MAPK1 TLR4 CFTR RIN3 DNER VPS29 VPS26A SNX12 TOM1 SORL1 TSG101 VPS35 LRP6 FLOT1 WASF2 APPL1 MIB2 ATP6V0D1 CLN3 PTPN23 ANKFY1 BACE1 NF2 LMTK2 SNX27,CC,31,31 of 55,1.32,56.36,3.965E-15,1.607E-13
GO:0000139,Golgi membrane,A6QNT8(Evidence code:IEA/Database source:GO:0090110)Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens)Q32LM0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7I4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens)E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens)Q3ZCC9(Evidence code:IEA/Database source:GO:0090110)Q3SZN2(Evidence code:IEA/Database source:GO:0090114)P35605(Evidence code:ISS/Database source:UniProtKB:O35142)Q3SYY2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)E1BIN5(Evidence code:IEA/Database source:GO:0048208)Q2YDM1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MXQ8(Evidence code:IBA/Database source:PANTHER:PTN000201534)Q27954(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VE21(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35604(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKQ6(Evidence code:IEA/Database source:GO:0048194)A5D7S6(Evidence code:IEA/Database source:GO:0048208)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1MV07(Evidence code:IEA/Database source:GO:0090110)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N7I5(Evidence code:IEA/Database source:InterPro:IPR026650)F6PW02(Evidence code:IEA/Database source:GO:0048208)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793)A2VDL8(Evidence code:IEA/Database source:GO:0090110)P53619(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225)A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XT97(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BB48(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MT17(Evidence code:IBA/Database source:PANTHER:PTN000361901)E1BIU0(Evidence code:IEA/Database source:GO:0090110)Q28104(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A3KMX1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1LZ81(Evidence code:IEA/Database source:GO:0048208)Q1RMW9(Evidence code:IEA/Database source:GO:0048194)Q2KJ92(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)P67827(Evidence code:IDA/Database source:)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P83437(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SEC24A RAB26 SH3GLB1 EXT1 BCAP31 MAN1A2 SEC13 SEC23B COPB2 TPST2 OSBP CUL3 ARL1 CORO7 POMGNT1 MAN1B1 COPA ARFGEF1 B3GALT4 TMEM59 COPG2 COPZ1 MYO18A PEF1 MAPK8IP3 SEC24D SERINC3 NUMA1 TFG ARFIP1 SEC23A ARCN1 SCAP COPB1 PSEN1 ITM2B GALNT2 CUX2 SEC24C COPE CHST14 PDCD6 GOLPH3 LFNG TRIM23 CSNK1A1 GALNT7 COG5,CC,48,48 of 147,2.04,32.65,5.675E-15,2.283E-13
GO:0005216,ion channel activity,A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005821)P02715(Evidence code:IEA/Database source:InterPro:IPR002394|I)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR005821)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR005821)Q05037(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR005821)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001508)E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001508)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR005821)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR005821)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR005821)Q28204(Evidence code:IEA/Database source:InterPro:IPR005821)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001508)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR005821)F1ML52(Evidence code:IEA/Database source:InterPro:IPR005821)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR005821)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR005821)E1BC13(Evidence code:IEA/Database source:InterPro:IPR005821)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR005821)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR005821)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP51(Evidence code:IEA/Database source:InterPro:IPR005821)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001508)O18784(Evidence code:IEA/Database source:InterPro:IPR004729|I)O62826(Evidence code:IEA/Database source:InterPro:IPR005821)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001508)A4FV89(Evidence code:IEA/Database source:InterPro:IPR005821)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR005821)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR005821)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR005821)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR005821)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005821)Q08E50(Evidence code:IEA/Database source:InterPro:IPR001390|I)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR005821)F1MP22(Evidence code:IEA/Database source:InterPro:IPR005821)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR005821)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR005821)E1BM97(Evidence code:IEA/Database source:InterPro:IPR005821), CACNA1A CHRNE CACNA1S KCNG2 KCNA4 SCN11A GRIN3B GRIA3 TPCN2 ITPR1 SCN8A CACNA1B KCNMA1 GRIA2 TRPC3 RYR2 KCNG4 SCN3A KCNC4 KCNC3 KCNH6 CACNA1C RYR1 KCNH5 GRIA1 TRPC1 TRPC2 GRIK4 KCNF1 SCN5A TRPM7 CACNA1F CACNA1D CACNA1H GABRA5 SCN10A CACNA1E ITPR2 TRPM4 HCN1,MF,40,40 of 101,1.7,39.6,5.812E-15,2.321E-13
GO:0001701,in utero embryonic development,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens)E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)F1MV07(Evidence code:IEA/Database source:UniProtKB:Q6NXL1|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)E1BIU0(Evidence code:IEA/Database source:UniProtKB:G3X972|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MSK0(Evidence code:IEA/Database source:UniProtKB:A2A690|ens)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)P08487(Evidence code:ISS/Database source:UniProtKB:Q62077)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q6PDM2|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)Q5E9I4(Evidence code:IEA/Database source:UniProtKB:P27808|ens)A6H7B5(Evidence code:IEA/Database source:UniProtKB:O88543|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens), GATA6 PYGO2 CHD8 SYF2 INPP5B CUL3 SEC24D SRF MYO18B SEC24C RPGRIP1L ETV2 GLI2 TANC2 GNA12 GNA13 TBX3 PLCG1 SALL4 SRSF1 CHD7 MGAT1 COPS3 FOXF1 MAPK8IP3 KEAP1,BP,26,26 of 36,1.1,72.22,8.819E-15,3.496E-13
GO:0007283,spermatogenesis,E1BJ75(Evidence code:IEA/Database source:UniProtKB:Q9CYD3|ens)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8K1H1)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)F1MS56(Evidence code:IEA/Database source:UniProtKB:Q9CYR6|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens)Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens)F6Q0K7(Evidence code:IEA/Database source:InterPro:IPR029297)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)E1B970(Evidence code:IEA/Database source:InterPro:IPR033288)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54728|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)G5E5Q8(Evidence code:IEA/Database source:UniProtKB:Q6ZPE2|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)E1BDZ4(Evidence code:IEA/Database source:UniProtKB:Q86W24|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q8VCB1|ens)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0744)Q29460(Evidence code:ISS/Database source:UniProtKB:Q61205)E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496), CRTAP TDRD7 CCNYL1 TDRD1 PGM3 UBR2 RAD21L1 SEPT7 CIB1 PUM1 CELF3 SPATA32 GLI1 KIT TDRD5 GOLGA3 RAD23B BRCA2 SEPT2 RACGAP1 SBF1 HIST1H1A NLRP14 TDRD9 PIWIL2 ATRX NDC1 BCAP31 SEPT6 PAFAH1B3 INPP5B LGR4 SOX17 DDX4,BP,34,34 of 72,1.44,47.22,1.077E-14,4.222E-13
GO:0005089,Rho guanyl-nucleotide exchange factor activity,F1MHU4(Evidence code:IEA/Database source:InterPro:IPR000219)E1BG38(Evidence code:IEA/Database source:InterPro:IPR000219|I)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR000219|I)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)F1MY16(Evidence code:IEA/Database source:InterPro:IPR000219)F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR000219)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR000219)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR000219)F1MQ44(Evidence code:IEA/Database source:InterPro:IPR000219)F1N657(Evidence code:IEA/Database source:InterPro:IPR000219)Q58CS5(Evidence code:IEA/Database source:InterPro:IPR000219)A5D793(Evidence code:IEA/Database source:InterPro:IPR000219)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000219)F1N6T8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MRP8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MSU8(Evidence code:IEA/Database source:InterPro:IPR000219), PLEKHG3 ARHGEF1 ARHGEF12 EPS8L1 AKAP13 PREX1 TIAM2 BCR MCF2L2 SPATA13 FGD3 ECT2 TRIO VAV2 PLEKHG1 PLEKHG2,MF,16,16 of 6,0.68,266.67,1.081E-14,4.222E-13
GO:0008022,protein C-terminus binding,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)Q08DF4(Evidence code:IPI/Database source:UniProtKB:P20488)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:O75970|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)P63026(Evidence code:IPI/Database source:UniProtKB:F1N348), DLG1 NUMA1 TAX1BP3 ABL1 TOP2B BRCA2 PEX1 SDCBP2 SNF8 NPAT BANF1 MYO1C NIPBL SASH1 SRC PFKM DNM1 PPP2CA TERF2 MPDZ VPS4B ERCC2 LCK GPSM2 SP1 VAMP2,MF,26,26 of 37,1.1,70.27,1.403E-14,5.44E-13
GO:0030425,dendrite,F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)Q9BH13(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)E1BB14(Evidence code:IEA/Database source:UniProtKB:Q61011|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)A8E641(Evidence code:IEA/Database source:UniProtKB:Q9EQF6|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)Q32L41(Evidence code:IEA/Database source:UniProtKB:P30047|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)Q2KHY1(Evidence code:ISS/Database source:UniProtKB:Q9Z140)F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q27971(Evidence code:ISS/Database source:UniProtKB:Q07009)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens), MARK3 ALCAM PURA GNB3 RGS14 DPYSL5 BSN GCHFR LRRK2 SYT4 DENND1A CACNA1B PRNP HCN1 TUBB3 SHANK1 GRM7 ZFYVE27 PSEN1 BRINP1 DPYSL2 DNER CPNE6 GPHN MAPK8IP3 CAPN2 TRAPPC4 GABRA5 RAB17,CC,29,29 of 50,1.23,58,1.714E-14,6.6E-13
GO:0030424,axon,Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)A2VE99(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BHM6(Evidence code:IEA/Database source:UniProtKB:Q9R053|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)Q05037(Evidence code:ISS/Database source:UniProtKB:P15385)Q2KHY1(Evidence code:ISS/Database source:UniProtKB:Q9Z140)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q9TU34(Evidence code:IDA/Database source:)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens)P56722(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)A4FUY1(Evidence code:IEA/Database source:UniProtKB:Q14CZ8|ens), ALCAM SEPT11 SCN11A BACE1 SETX TUBB3 PINK1 UHMK1 BSN KCNA4 CPNE6 SYT4 ZFYVE27 DPYSL2 UNC13A LRRK2 DAB2IP MYO1D SNAP25 ITPR1 GARS PSEN1 MAPK8IP3 SPTBN4 TAOK2 KIF13B HCN1 PTPRN MYH14 HEPACAM,CC,30,30 of 56,1.27,53.57,3E-14,1.147E-12
GO:0051641,cellular localization,Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0),MYO1D,BP,1,1 of 509,0.04,0.2,3.113E-14,1.181E-12
GO:0008013,beta-catenin binding,E1BPF3(Evidence code:IEA/Database source:InterPro:IPR015668)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)E1BI79(Evidence code:IEA/Database source:InterPro:IPR009224|I)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)E1BJ93(Evidence code:IEA/Database source:InterPro:IPR028769)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1B8K0(Evidence code:IEA/Database source:InterPro:IPR015668)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F1MPU1(Evidence code:IEA/Database source:InterPro:IPR021989)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens), BCL9 CHD8 AMER3 PSEN1 ASH2L TAX1BP3 APC2 CTNNA1 LEF1 KDM6B FOXO4 BCL9L PIN1 MED12L AXIN1 SOX17,MF,16,16 of 7,0.68,228.57,3.324E-14,1.252E-12
GO:0004715,non-membrane spanning protein tyrosine kinase activity,Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)A3KMY9(Evidence code:IEA/Database source:InterPro:IPR016251|I)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR017164)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)A7MB57(Evidence code:IEA/Database source:EC:2.7.10.2)Q58D16(Evidence code:IEA/Database source:EC:2.7.10.2)Q3ZCM0(Evidence code:IEA/Database source:EC:2.7.10.2)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR016251|I)F1MSH3(Evidence code:IEA/Database source:EC:2.7.10.2)E1BPI3(Evidence code:IEA/Database source:EC:2.7.10.2)F1MXG8(Evidence code:IEA/Database source:InterPro:IPR015015)F1MTD8(Evidence code:IEA/Database source:EC:2.7.10.2)F1MCX4(Evidence code:IEA/Database source:InterPro:IPR016251)E1BIM8(Evidence code:IEA/Database source:EC:2.7.10.2)E1BMP9(Evidence code:IEA/Database source:InterPro:IPR012234|I), GRB2 JAK1 WEE1 PEAK1 YES1 MATK LCK JAK2 TEC FRK ABL1 HCK TYK2 SRC ZAP70,MF,15,15 of 5,0.64,300,3.518E-14,1.316E-12
GO:0009986,cell surface,E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)F1MP76(Evidence code:IBA/Database source:PANTHER:PTN000099415)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:O95183|ens)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q3UUY6|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)F1MPW1(Evidence code:IEA/Database source:UniProtKB:Q14689|ens)F1MQD1(Evidence code:IEA/Database source:UniProtKB:O15484|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q29RY7(Evidence code:ISS/Database source:UniProtKB:Q8MIP7)G3X812(Evidence code:IEA/Database source:UniProtKB:Q99466|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q68SA9|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)Q95J79(Evidence code:ISS/Database source:UniProtKB:O43914)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8QZY6|ens)F1MP51(Evidence code:IEA/Database source:UniProtKB:Q8NCM2|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens), BSN SDC3 IQGAP2 HIST1H1A VAMP5 PROM2 ITGB1 LAMP1 DIP2A CAPN5 PSEN1 TFRC PRNP CLIC4 FGL2 NOTCH4 ADAMTS7 ADAM15 ITGB7 FZD1 TYROBP IDE BACE1 HFE2 LRP6 TSPAN14 KCNH5 ITGB2 PCSK6 FCER1G DPP4 PROM1 CD63 PDGFC RTN4R KIT RC3H2,CC,37,37 of 94,1.57,39.36,6.755E-14,2.51E-12
GO:0006996,organelle organization,A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens), HPS6 TOR1A,BP,2,2 of 532,0.08,0.38,8.333E-14,3.075E-12
GO:0015630,microtubule cytoskeleton,E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q3SZ20(Evidence code:IEA/Database source:UniProtKB:P34897|ens)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680687)E1B9B6(Evidence code:IEA/Database source:UniProtKB:A0A024RBL3)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens)E1BF73(Evidence code:IEA/Database source:UniProtKB:Q3UHI0|ens)Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)P81948(Evidence code:IEA/Database source:UniProtKB:P68366|ens)E1BB08(Evidence code:IBA/Database source:PANTHER:PTN000347035)F1N1R8(Evidence code:IBA/Database source:PANTHER:PTN000347035)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB:Q5KU39|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q2HJB8(Evidence code:IEA/Database source:UniProtKB:Q9NY65|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:Q71U36|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN001016925), APC2 SHMT2 DCLK2 NUAK1 TUBB3 CCSER2 LYST ACTR1A CLIC4 TUBA4A EML2 EML4 PIK3R4 VPS41 SPAST TUBA8 TUBA1A PRKCI TACC1,CC,19,19 of 16,0.81,118.75,9.578E-14,3.51E-12
GO:0030900,forebrain development,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q64511|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens), SRF POU3F1 ATRX SOX1 ARHGAP35 fgfr3 FRS2 E2F1 TOP2B ARID1A MAPK8IP3 SRC PSEN1 MKL1,BP,14,14 of 4,0.59,350,1.087E-13,3.931E-12
GO:0035335,peptidyl-tyrosine dephosphorylation,P56722(Evidence code:IEA/Database source:GO:0004725)P11064(Evidence code:IEA/Database source:GO:0004725)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)A6QLS1(Evidence code:IEA/Database source:GO:0004725)E1BIU7(Evidence code:IEA/Database source:GO:0004725)E1BPN5(Evidence code:IEA/Database source:GO:0004725)A6QQD4(Evidence code:IEA/Database source:GO:0004725)E1BEZ8(Evidence code:IEA/Database source:GO:0004725)G5E526(Evidence code:IEA/Database source:GO:0004725)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)E1BPU9(Evidence code:IEA/Database source:GO:0005001)E1BPA0(Evidence code:IEA/Database source:GO:0004725)E1BFE6(Evidence code:IEA/Database source:GO:0004725), PTPRN ACP1 DUSP3 DUSP7 PTPN23 SSH2 PTPN5 PTPN14 PTP4A1 PTPN6 PTPRZ1 PTPRM PTPRA MTMR1,BP,14,14 of 4,0.59,350,1.087E-13,3.931E-12
GO:0003676,nucleic acid binding,D3IVZ2(Evidence code:IEA/Database source:InterPro:IPR011545)A6QQP0(Evidence code:IEA/Database source:InterPro:IPR000504|I)A2PYH9(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BFI4(Evidence code:IEA/Database source:InterPro:IPR000504|I)A4FV57(Evidence code:IEA/Database source:InterPro:IPR013087)A5D7S3(Evidence code:IEA/Database source:InterPro:IPR013087)G3MY13(Evidence code:IEA/Database source:InterPro:IPR013087)G5E631(Evidence code:IEA/Database source:InterPro:IPR011545)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR004365)G3N065(Evidence code:IEA/Database source:InterPro:IPR003604|I)E1BAR2(Evidence code:IEA/Database source:InterPro:IPR001878|I)G3X7J6(Evidence code:IEA/Database source:InterPro:IPR002562|I)A4IFC3(Evidence code:IEA/Database source:InterPro:IPR000504|I)K7N846(Evidence code:IEA/Database source:InterPro:IPR013087)E1BGF9(Evidence code:IEA/Database source:InterPro:IPR013087)Q08DJ3(Evidence code:IEA/Database source:InterPro:IPR004087|I)F1MEM4(Evidence code:IEA/Database source:InterPro:IPR003029)A6H727(Evidence code:IEA/Database source:InterPro:IPR013087)E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR035979)Q3SZ54(Evidence code:IEA/Database source:InterPro:IPR011545)E1BPV9(Evidence code:IEA/Database source:InterPro:IPR003604|I)Q28165(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BFV5(Evidence code:IEA/Database source:InterPro:IPR013087)E1BJE7(Evidence code:IEA/Database source:InterPro:IPR035979)A7MB16(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q6T5B7(Evidence code:IEA/Database source:InterPro:IPR003165|I)F1N281(Evidence code:IEA/Database source:InterPro:IPR013087)Q0P5L0(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MBK6(Evidence code:IEA/Database source:InterPro:IPR013087)F1MKU1(Evidence code:IEA/Database source:InterPro:IPR011545)E1BD77(Evidence code:IEA/Database source:InterPro:IPR003604|I)F1MCY1(Evidence code:IEA/Database source:InterPro:IPR013087)Q9GL32(Evidence code:IEA/Database source:InterPro:IPR013087)Q2NL22(Evidence code:IEA/Database source:InterPro:IPR011545)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR002121|I)E1B908(Evidence code:IEA/Database source:InterPro:IPR000504|I)G3MWI7(Evidence code:IEA/Database source:InterPro:IPR013087)E1BML0(Evidence code:IEA/Database source:InterPro:IPR036397)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR000504|I)A6QNU0(Evidence code:IEA/Database source:InterPro:IPR013087)F1MLT5(Evidence code:IEA/Database source:InterPro:IPR000504|I)A4FV72(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1B719(Evidence code:IEA/Database source:InterPro:IPR004087)Q0IIK5(Evidence code:IEA/Database source:InterPro:IPR011545)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR011545|I)F1MNA1(Evidence code:IEA/Database source:InterPro:IPR011545)F1MX93(Evidence code:IEA/Database source:InterPro:IPR013087)Q08E07(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1B7E6(Evidence code:IEA/Database source:InterPro:IPR003165|I)E1BM86(Evidence code:IEA/Database source:InterPro:IPR004087)Q3SYT9(Evidence code:IEA/Database source:InterPro:IPR004087)G3MZL2(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MVN3(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR011545)F1ML16(Evidence code:IEA/Database source:InterPro:IPR013087)Q5E9A3(Evidence code:IEA/Database source:InterPro:IPR004087)G3N2N6(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BNM4(Evidence code:IEA/Database source:InterPro:IPR001909|I)O18964(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006172|I)G3N2D0(Evidence code:IEA/Database source:InterPro:IPR013087)F1MU53(Evidence code:IEA/Database source:InterPro:IPR001909|I)F1MI56(Evidence code:IEA/Database source:InterPro:IPR004087)A6QL80(Evidence code:IEA/Database source:InterPro:IPR013087)Q0II93(Evidence code:IEA/Database source:InterPro:IPR035979)E1BC37(Evidence code:IEA/Database source:InterPro:IPR000467|I)G3MY25(Evidence code:IEA/Database source:InterPro:IPR004875)A7MB06(Evidence code:IEA/Database source:InterPro:IPR013087)Q3Y4E1(Evidence code:IEA/Database source:InterPro:IPR013087)F1MWZ3(Evidence code:IEA/Database source:InterPro:IPR013087)A6QNZ1(Evidence code:IEA/Database source:InterPro:IPR013087)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR013087)P61286(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BDX4(Evidence code:IEA/Database source:InterPro:IPR013087)E1BJV5(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1N312(Evidence code:IEA/Database source:InterPro:IPR013087)F1MS84(Evidence code:IEA/Database source:InterPro:IPR004087)F1MFQ4(Evidence code:IEA/Database source:InterPro:IPR013087)Q5JB60(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MRW7(Evidence code:IEA/Database source:InterPro:IPR011545)A8NJ74(Evidence code:IEA/Database source:InterPro:IPR000504|I)F2Z4H6(Evidence code:IEA/Database source:InterPro:IPR013087)F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MLJ0(Evidence code:IEA/Database source:InterPro:IPR013087)Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR011545)E1BNB4(Evidence code:IEA/Database source:InterPro:IPR000504|I)A7YWM6(Evidence code:IEA/Database source:InterPro:IPR001427)E1BP84(Evidence code:IEA/Database source:InterPro:IPR013087)E1BGQ4(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BJZ5(Evidence code:IEA/Database source:InterPro:IPR013087)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR006555)Q29RQ2(Evidence code:IEA/Database source:InterPro:IPR004087)F1MHP1(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BK83(Evidence code:IEA/Database source:InterPro:IPR002775|I)Q28141(Evidence code:IEA/Database source:InterPro:IPR011545)E1BCC3(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1B7G5(Evidence code:IEA/Database source:InterPro:IPR000504|I)A6H7J1(Evidence code:IEA/Database source:InterPro:IPR013087)E1BHU5(Evidence code:IEA/Database source:InterPro:IPR013087)Q1RMR2(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BQ01(Evidence code:IEA/Database source:InterPro:IPR013087)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR018165)E1BCS0(Evidence code:IEA/Database source:InterPro:IPR013087)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002121|I)O19137(Evidence code:IEA/Database source:InterPro:IPR001878|I)F1MXK6(Evidence code:IEA/Database source:InterPro:IPR003165|I)E1B928(Evidence code:IEA/Database source:InterPro:IPR013087)Q17QV0(Evidence code:IEA/Database source:InterPro:IPR004087)Q2YDE6(Evidence code:IEA/Database source:InterPro:IPR004087)E1BCA0(Evidence code:IEA/Database source:InterPro:IPR013087)F1MGC2(Evidence code:IEA/Database source:InterPro:IPR001427)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR010979)Q17QR0(Evidence code:IEA/Database source:InterPro:IPR013087)F1MMF1(Evidence code:IEA/Database source:InterPro:IPR013087)A0JN76(Evidence code:IEA/Database source:InterPro:IPR013087)P68102(Evidence code:IEA/Database source:InterPro:IPR003029)Q2KJ71(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q3ZC12(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MRK2(Evidence code:IEA/Database source:InterPro:IPR000504|I)Q0VCY7(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MGZ7(Evidence code:IEA/Database source:InterPro:IPR013087)Q2YDI4(Evidence code:IEA/Database source:InterPro:IPR004087)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)F1MXI4(Evidence code:IEA/Database source:InterPro:IPR000504|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR003156|I)E1BCS5(Evidence code:IEA/Database source:InterPro:IPR013087)E1BQ37(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1N0D7(Evidence code:IEA/Database source:InterPro:IPR013087)E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR003029|I)Q3SYX4(Evidence code:IEA/Database source:InterPro:IPR001909|I)E1BD25(Evidence code:IEA/Database source:InterPro:IPR013087)A7MBG9(Evidence code:IEA/Database source:InterPro:IPR000504|I)P10881(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BN14(Evidence code:IEA/Database source:InterPro:IPR000467)A5D7T6(Evidence code:IEA/Database source:InterPro:IPR013087)G3MZ78(Evidence code:IEA/Database source:InterPro:IPR000504|I)F1MLP0(Evidence code:IEA/Database source:InterPro:IPR013087)F1MI25(Evidence code:IEA/Database source:InterPro:IPR003604|I)Q1JPH6(Evidence code:IEA/Database source:InterPro:IPR000504|I)E1BN44(Evidence code:IEA/Database source:InterPro:IPR013087)E1BNQ2(Evidence code:IEA/Database source:InterPro:IPR011545)Q0VCJ6(Evidence code:IEA/Database source:InterPro:IPR013087)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR013087)E1BH78(Evidence code:IEA/Database source:InterPro:IPR011545)F1MNG4(Evidence code:IEA/Database source:InterPro:IPR013087)Q5W5U4(Evidence code:IEA/Database source:InterPro:IPR011545)F1MIB3(Evidence code:IEA/Database source:InterPro:IPR013087)E1BNL0(Evidence code:IEA/Database source:InterPro:IPR013087)E1BDH6(Evidence code:IEA/Database source:InterPro:IPR001374|I), DDX3Y MYEF2 Msi1 IGF2BP2 AEBP2 TRMT1L TSHZ1 DDX3X NARS ZNF385C ZCCHC6 EXD3 PABPC4 KLF7 ZHX3 FUBP1 DHX8 GLI1 LEMD3 EIF4A1 ZFHX3 PABPN1 ZNF367 MCM3AP EIF3B AGO3 ZNF438 RBM42 HIVEP3 DDX58 ZFHX2 GLI2 EGR4 EIF4A3 BLM PABPN1L ZFPM1 PAN2 HNRNPL RNF31 TNRC6C PPIE ANKHD1 DDX1 POLQ TDRD9 MYO5C CELF3 PIWIL2 MEX3B PCBP2 RBM28 ESRP1 DICER1 HIC1 PCBP1 ZFP37 ZNF282 SYNJ1 POLA1 ZNF469 ZNF446 ANKRD17 PRMT3 NXF3 GPATCH8 TIGD5 SP7 ZNF148 ZNF827 FIZ1 Gli3 PABPC1 ZBTB17 ZNF638 ZNF608 NOVA2 ZBTB4 NCL DDX20 RBM34 TRIM23 SETD1B WIZ EIF4A2 PABPC1L RNASE13 ZNF512B ZNF316 SALL4 ERCC2 KHDRBS1 U2SURP RPP25 DHX9 UHMK1 RBM12B INSM1 ZBTB32 SNRNP70 ZNF687 AARS2 ZNF366 WRN CPSF4 AGO4 ZNF598 PCBP3 HDLBP ZNF516 RNASE2 RPS18 BCL11A PRDM13 ZBTB18 EIF2S1 TRA2A EIF3G SPEN SRSF1 ZNF384 MEX3C SAMHD1 MATR3 AARS ZBTB47 SFPQ ZIC2 PNPT1 ZNF394 BCL11B WBSCR1 SSB GPKOW YY1 CSTF2T ZBTB22 HIVEP1 EIF4H RREB1 DHX37 ZBTB8A SP1 SNRNP200 ZNF280D DDX4 ZNF462 ZNF142 R3HDM1,MF,149,149 of 989,6.33,15.07,1.138E-13,4.088E-12
GO:0007049,cell cycle,Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A7Z052(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q5E9L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3MHQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P63097(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR004582)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3MHY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2TA37(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A6QQY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BKC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q3T0N5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q32PF3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR015648)Q2NKY7(Evidence code:IEA/Database source:InterPro:IPR008113)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0131)F1N746(Evidence code:IEA/Database source:InterPro:IPR033185), KIF2A CSNK1A1 WDR6 PIN1 DCTN3 E2F7 MAPK1 VPS4B SEPT7 BRINP1 NCAPH HEPACAM SEPT6 ZFYVE26 PPP1CC GNAI1 MASTL UHRF1 RAD17 CLTA SPAST SEPT11 CHMP1B DYNLT1 TERF1 RAN CDK1 ARL2 INSM1 PPP1CB KLHL13 NIPBL MAPK13 PCNP BRCC3 ARL8B CDC5L BRCA1 ANXA11 TFDP2 SEPT2 CIB1 CDK6 PAFAH1B1 MCTS1 RABGAP1,BP,46,46 of 151,1.95,30.46,1.599E-13,5.665E-12
GO:0006816,calcium ion transport,G3N0E5(Evidence code:IEA/Database source:InterPro:IPR013333|I)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR013333|I)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR006413)Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)F1MN60(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493|I)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)E1BIB9(Evidence code:IBA/Database source:PANTHER:PTN001295293)O18784(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493|I)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)O62826(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)F1MS16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR013333|I)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0109), RYR3 ATP2B4 RYR2 PPP3CA TRPM4 PSEN1 CAMK2G CACNA1E ATP2C2 LETM1 ATP2B2 ITPR2 CAMK2A TPCN2 TRPC1 ITPR1 CACNA1B SRI TRPC2 CACNA1C CACNA1S TRPM7 ATP2B3 CACNA1F RYR1 PRKCB CACNA1D,BP,27,27 of 47,1.15,57.45,1.594E-13,5.665E-12
GO:0051260,protein homooligomerization,P02668(Evidence code:IDA/Database source:)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q0VCA3(Evidence code:ISS/Database source:UniProtKB:Q9Z2I0)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)A4FUH1(Evidence code:IEA/Database source:UniProtKB:Q5JU69|ens)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003131)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q0VD00(Evidence code:IEA/Database source:InterPro:IPR003131)E1B905(Evidence code:IEA/Database source:InterPro:IPR003131)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P30273|ens)Q05037(Evidence code:IEA/Database source:InterPro:IPR003131)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003131)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1BH09(Evidence code:IEA/Database source:UniProtKB:Q5GFL6|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)P62964(Evidence code:IDA/Database source:)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003131)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003131)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)P10279(Evidence code:IEA/Database source:InterPro:IPR000817|I)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003131), CSN3 NACC1 PNPT1 TOR1A CHMP2A PDCD6IP LETM1 CRYAB TOR2A KCNC3 POLQ CLDN3 TOR1B FIS1 KCTD15 KCTD16 FCER1G KCNA4 KCNMA1 PRTG KCNC4 FLOT1 CHMP4A SPAST VWA2 IDE BLM CRABP1 KCNF1 KCNG4 CHMP4B RASEF PRNP TAF10 KCNG2,BP,35,35 of 88,1.49,39.77,2.449E-13,8.62E-12
GO:0009966,regulation of signal transduction,A2VDU1(Evidence code:IEA/Database source:InterPro:IPR007875)Q17R10(Evidence code:IEA/Database source:InterPro:IPR030115)E1BE13(Evidence code:IBA/Database source:PANTHER:PTN000005165)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), SPRY4 AFAP1L2 BIRC6 CRK,BP,4,4 of 593,0.17,0.67,2.802E-13,9.799E-12
GO:0005635,nuclear envelope,Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)G5E567(Evidence code:IBA/Database source:PANTHER:PTN000108134)P61283(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)Q5E9B7(Evidence code:IEA/Database source:UniProtKB:O00299|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000308195)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)A5PJQ6(Evidence code:IEA/Database source:UniProtKB:O15173|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)P27214(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)Q3T054(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)E1BGE5(Evidence code:IBA/Database source:PANTHER:PTN000108134)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens), CHMP4B TOR1A IPO9 BANF1 RANBP2 CLIC1 SEC13 SYNE3 SPAG4 TPR CHMP2A PGRMC2 NPC1 TOR1B KPNB1 ANXA11 PARP1 RAN WDFY3 IPO7 IPO8 BICD2,CC,22,22 of 28,0.93,78.57,2.961E-13,1.029E-11
GO:0050793,regulation of developmental process,G3X812(Evidence code:IEA/Database source:InterPro:IPR008297),NOTCH4,BP,1,1 of 473,0.04,0.21,3.191E-13,1.102E-11
GO:0006974,cellular response to DNA damage stimulus,Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q864U1(Evidence code:IEA/Database source:InterPro:IPR031099)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)A5PJJ9(Evidence code:IEA/Database source:UniProtKB:Q00526|ens)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)Q95KU9(Evidence code:ISS/Database source:UniProtKB:Q9Y6K9)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)G5E639(Evidence code:IEA/Database source:UniProtKB:P0C2W1|ens)P84798(Evidence code:IEA/Database source:UniProtKB-KW:KW-0227)F1N2G1(Evidence code:IEA/Database source:UniProtKB:Q8NFC6|ens), CDC5L BRCA2 RIF1 LIG1 ZBTB4 ETAA1 ABL1 SFPQ UHRF1 POLQ OTUB1 TRIP12 PLK3 SAMHD1 DYRK2 INTS3 NIPBL TRAF6 PAXIP1 ASH2L MMS19 RAD23B RUVBL1 ZFYVE26 WRN BRCA1 PARP1 TAOK3 E2F7 SETX BCL3 CIB1 MB21D1 ATM SMARCAL1 CDK3 RUVBL2 BLM TAOK2 IKBKG PSEN1 ALKBH2 RAD18 MASTL BRCC3 PRMT6 MCTS1 ERCC2 FBXO45 POLD3 BOD1L1,BP,51,51 of 188,2.17,27.13,3.536E-13,1.213E-11
GO:0005244,voltage-gated ion channel activity,F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851), SCN8A HCN1 CACNA1E CACNA1B ANO6 SCN11A KCNA4 CACNA1C SCN3A CACNA1F KCNG4 KCNC4 KCNMA1 CACNA1D KCNG2 SCN5A KCNH6 KCNF1 SCN10A CLIC6 CLIC1 KCNC3 KCNH5 CLIC4 CACNA1S,MF,25,25 of 41,1.06,60.98,4.602E-13,1.569E-11
GO:0001726,ruffle,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)P85091(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:Q15735|ens)P31408(Evidence code:IEA/Database source:UniProtKB:P62814|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)P08487(Evidence code:ISS/Database source:UniProtKB:P19174)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), WASF2 CYFIP1 ARF6 SH2B2 NF2 S100B MYO1C BAIAP2 CTTN INPP5J ATP6V1B2 CDK6 ARAP3 MTSS1L TRPM7 PAK1 PLCG1 MYO6 ITGB1,CC,19,19 of 19,0.81,100,6.82E-13,2.295E-11
GO:0005201,extracellular matrix structural constituent,F1MJY9(Evidence code:IEA/Database source:InterPro:IPR001442|I)P81282(Evidence code:IBA/Database source:PANTHER:PTN001105676)Q32S24(Evidence code:IEA/Database source:InterPro:IPR000885)Q7SIB3(Evidence code:IEA/Database source:InterPro:IPR001442|I)F1N474(Evidence code:IEA/Database source:InterPro:IPR001442|I)P13608(Evidence code:IBA/Database source:PANTHER:PTN001105676)F1MZD0(Evidence code:IEA/Database source:InterPro:IPR011398)Q29442(Evidence code:IEA/Database source:InterPro:IPR001442|I)Q148M4(Evidence code:IEA/Database source:InterPro:IPR000885)P07507(Evidence code:IBA/Database source:PANTHER:PTN000011588)F1MJQ6(Evidence code:IEA/Database source:InterPro:IPR000885)F1N2Y2(Evidence code:IEA/Database source:InterPro:IPR000885)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)P02459(Evidence code:IEA/Database source:InterPro:IPR000885)Q9GKN8(Evidence code:IEA/Database source:InterPro:IPR027216)P02465(Evidence code:IEA/Database source:InterPro:IPR000885)F1N2J5(Evidence code:IBA/Database source:PANTHER:PTN001105676)Q7SIB2(Evidence code:IEA/Database source:InterPro:IPR001442|I)Q28084(Evidence code:IEA/Database source:InterPro:IPR001442|I), COL4A6 VCAN COL11A2 COL4A2 COL4A5 ACAN FBN3 COL4A4 COL27A1 MGP COL5A3 COL5A2 LAMB1 COL2A1 PRELP COL1A2 HAPLN4 COL4A1 COL4A3,MF,19,19 of 19,0.81,100,6.82E-13,2.295E-11
GO:0031982,vesicle,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q0III3(Evidence code:ISS/Database source:UniProtKB:Q13409)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)E1BJQ7(Evidence code:IBA/Database source:PANTHER:PTN000956809)P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)P63026(Evidence code:ISS/Database source:UniProtKB:P63027)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)A7YY70(Evidence code:IBA/Database source:PANTHER:PTN001293650)G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q9HBX8|ens)G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60880|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)Q3ZCF0(Evidence code:ISS/Database source:UniProtKB:Q13561)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens), SRI VPS26A STX7 DYNC1I2 LAMP1 GIPC1 RAB3C VAMP2 MVB12A SLC34A1 LGR6 HIST1H1A RAB4A CHMP4B SNAP25 NPC1 RAB3B DCTN2 SYT4,CC,19,19 of 1000,0.81,1.9,7.304E-13,2.443E-11
GO:0008134,transcription factor binding,E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)Q05B89(Evidence code:IEA/Database source:UniProtKB:Q9GZT8|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)A7MBG4(Evidence code:IEA/Database source:InterPro:IPR030563)Q32LB3(Evidence code:ISS/Database source:UniProtKB:Q7LFL8)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR028314)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BHY2(Evidence code:IEA/Database source:InterPro:IPR028319)E1B793(Evidence code:IEA/Database source:UniProtKB:Q9NRP7|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens), TAF4B CDK13 NIF3L1 MAPK9 NAB2 NFKB1 PTPRN GLI2 CTBP1 SNF8 KEAP1 CXXC5 HOXA7 PPID E2F1 ZBTB17 SRF PURA SOX17 SIRT2 PURB BCOR FOXO4 TFDP2 BCL3 CDK12 PSMC5 PRKDC PIAS1 LEF1 PPP1R13B STK36 HYAL1 SP1 GATA6 SALL4,MF,36,36 of 98,1.53,36.73,7.539E-13,2.506E-11
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,F1MQP6(Evidence code:IEA/Database source:InterPro:IPR002126)F1MJ94(Evidence code:IEA/Database source:InterPro:IPR002126)G3X6Y5(Evidence code:IEA/Database source:InterPro:IPR002126)F1N416(Evidence code:IEA/Database source:InterPro:IPR000233|I)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)A5D7F4(Evidence code:IEA/Database source:InterPro:IPR002126)G3N152(Evidence code:IEA/Database source:InterPro:IPR002126)F1MPF3(Evidence code:IEA/Database source:InterPro:IPR002126)A4IFK1(Evidence code:IEA/Database source:InterPro:IPR002126)E1BDL0(Evidence code:IEA/Database source:InterPro:IPR002126)F1MEC8(Evidence code:IEA/Database source:InterPro:IPR002126)E1BF53(Evidence code:IEA/Database source:InterPro:IPR000233|I)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR002126|I)E1BKL9(Evidence code:IEA/Database source:InterPro:IPR002126)A2VDQ6(Evidence code:IEA/Database source:InterPro:IPR000233|I)Q01107(Evidence code:IEA/Database source:InterPro:IPR000233|I)Q8WN91(Evidence code:IEA/Database source:InterPro:IPR002126), DCHS2 PCDHA13 PCDH20 CDH22 PTPRM SDK2 PCDHGC3 PCDHB8 FAT2 PCDH1 LOC786512 PCDH8 CDH7 PCDH12 FAT1 CDH11 DSC1 CDHR1,BP,18,18 of 16,0.76,112.5,7.627E-13,2.519E-11
GO:0001784,phosphotyrosine residue binding,A6QQD4(Evidence code:IEA/Database source:UniProtKB:P54829|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:P52735|ens)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR024159)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens), PTPN5 VAV2 CBLC YES1 CRKL LCK CRK IRS1 ZAP70 ABL1 GRB2 PTPN6,MF,12,12 of 2,0.51,600,7.926E-13,2.602E-11
GO:0005938,cell cortex,Q647I9(Evidence code:IDA/Database source:)Q58DA7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q06002(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P03968(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens)Q28046(Evidence code:IDA/Database source:)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604)P43033(Evidence code:IBA/Database source:PANTHER:PTN000752735)Q2NKY7(Evidence code:ISS/Database source:UniProtKB:Q9DE33)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604)G3MWR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)P63097(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), NLRP5 GLRX3 TRAF6 BFSP1 FGF1 CTTN MYO9B HMCN1 PSEN1 GIPC1 SCIN GPSM2 FRY PAFAH1B1 SEPT2 NEDD4 GRM7 FRYL MICAL3 RYR1 NUMA1 GNAI1 ARF6,CC,23,23 of 34,0.98,67.65,8.053E-13,2.628E-11
GO:0031410,cytoplasmic vesicle,A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)A2VDN5(Evidence code:IEA/Database source:UniProtKB:Q9UBP0|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q08DS7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A2VE21(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q8WN96(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)Q29455(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q9NZM1|ens)Q9TU34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E0AE16(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)P35605(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)P10897(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A0JN39(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P23389(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q0V8F1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P35604(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P62194(Evidence code:IEA/Database source:UniProtKB:P62195|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0968)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens), DYSF PIGT SPAST SNX18 CLINT1 LRP6 SEC24A AP2B1 ARCN1 COPG2 MYO1C ITPR2 OCLN CHMP4A AP1S1 SNX3 VAMP1 RIN3 ARRDC1 HYAL1 MARCH8 CPNE6 BDNF FLOT1 TMEM184A CLN3 FNDC3A TAOK2 CADPS DNAJC5 CLTA RAB25 MYOF ITPR1 COPE SNX9 RAB39B ATP2C2 SEC23B PDCD6 BACE1 VPS41 RNF112 COPA PRKACA TBC1D2 COPB2 VAMP2 MYO1D CYB561 DBH COPB1 ATP7B GIPC1 SNX33 AMOTL1 SEC23A TMEM30A CHGB BICD2 COPS4 CORO7 SH3GLB1 SCAP DNM2 TFRC MYO6 LRRK2 SEC13 COPZ1 CHGA PSEN1 PSMC5 ATM PTPRN MPDZ,CC,76,76 of 379,3.23,20.05,9.77E-13,3.168E-11
GO:0008536,Ran GTPase binding,E1B8Q9(Evidence code:IEA/Database source:InterPro:IPR001494)G5E567(Evidence code:IEA/Database source:InterPro:IPR001494)E1BGE5(Evidence code:IEA/Database source:InterPro:IPR001494)A1A4I8(Evidence code:IEA/Database source:InterPro:IPR001494)Q2KI57(Evidence code:IEA/Database source:InterPro:IPR001494)E1BFV0(Evidence code:IEA/Database source:InterPro:IPR001494)Q3B7N3(Evidence code:IEA/Database source:InterPro:IPR001494)Q3SYU7(Evidence code:IEA/Database source:InterPro:IPR001494)E1BE98(Evidence code:IEA/Database source:InterPro:IPR001494)A4IFB8(Evidence code:IEA/Database source:InterPro:IPR001494)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)F1MPE5(Evidence code:IEA/Database source:InterPro:IPR001494)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566730)E1B8Q8(Evidence code:IEA/Database source:InterPro:IPR001494), IPO8 IPO9 IPO7 XPO7 TNPO2 KPNB1 RANBP6 TNPO1 XPO1 IPO4 MYCBP2 IPO5 RANBP2 XPOT,MF,14,14 of 6,0.59,233.33,1.207E-12,3.892E-11
GO:0005923,bicellular tight junction,F1MTP9(Evidence code:IEA/Database source:InterPro:IPR005419)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q3B7N4(Evidence code:IEA/Database source:InterPro:IPR003552|I)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)F1N2D3(Evidence code:IEA/Database source:InterPro:IPR005417|I)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)A4IFM4(Evidence code:IEA/Database source:InterPro:IPR003926|I)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)Q29RS2(Evidence code:IEA/Database source:InterPro:IPR005417|I)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)E1BEQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796)Q6BBL6(Evidence code:IEA/Database source:InterPro:IPR003550|I)Q765N9(Evidence code:IEA/Database source:InterPro:IPR003549|I)E1B7V9(Evidence code:IEA/Database source:InterPro:IPR030033)A2VE81(Evidence code:IEA/Database source:InterPro:IPR002958)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0796), TJP2 DDX58 CLDN7 LIN7C C1QTNF5 TJP1 MICALL2 CLDN8 RAP2C TJP3 LIN7B AMOTL1 RAPGEF2 LIN7A CLDN4 CLDN3 MAGI1 OCLN DLG1 MPDZ F11R,CC,21,21 of 30,0.89,70,4.898E-12,1.57E-10
GO:0008285,negative regulation of cell proliferation,Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)G3X749(Evidence code:IEA/Database source:UniProtKB:Q96F45|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR031215)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q96AV8)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)Q28046(Evidence code:ISS/Database source:UniProtKB:Q9Y6U3)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)O46414(Evidence code:ISS/Database source:UniProtKB:Q8TD27)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens)Q2YDE9(Evidence code:ISS/Database source:UniProtKB:Q9UGI8)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens)Q58DD3(Evidence code:ISS/Database source:UniProtKB:P25686)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens), AIMP2 RNF139 BCL11B CIB1 fgfr3 TSG101 SMARCA2 INSM1 STK3 FAM129B ZNF503 IRF1 E2F7 TAX1BP3 SCIN SIRT2 ALOX15B KMT2A FTH1 AXIN2 EEF1E1 IGFBP3 PHF14 TES SOX4 SH3BP4 SIRT6 ADARB1 ZBTB17 DAB2IP F2R NF2 RAPGEF2 CEBPA COPS8 DNAJB2 FOXO4 PTPN14,BP,38,38 of 119,1.61,31.93,5.862E-12,1.867E-10
GO:0031098,stress-activated protein kinase signaling cascade,G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000684825)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825), PAK2 MAP3K8 PAK3 MAP3K4 PAK1 STK25 MAP3K1 PAK4 PAK6 STK26 SLK TAOK3 MAP2K4 MAP3K14 TAOK2 STK3,BP,16,16 of 13,0.68,123.08,6.18E-12,1.957E-10
GO:0007605,sensory perception of sound,F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)F1MG13(Evidence code:IEA/Database source:InterPro:IPR035487)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)P31407(Evidence code:ISS/Database source:UniProtKB:P15313)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens), ATP2B2 NAV2 NIPBL CRYM KCNMA1 CACNA1D ALMS1 MYO1A GRM7 MYO15A SPTBN4 TJP1 ATP6V1B1 POU4F2 COL2A1 CHD7 DNM1 ATP8B1 GABRA5,BP,19,19 of 23,0.81,82.61,6.596E-12,2.076E-10
GO:0008021,synaptic vesicle,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)P10949(Evidence code:IEA/Database source:UniProtKB:P62823|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)A0JNA0(Evidence code:IEA/Database source:InterPro:IPR030529)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN001530779)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN001530779)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)F1N159(Evidence code:IEA/Database source:InterPro:IPR001359)P17599(Evidence code:IEA/Database source:InterPro:IPR001359)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens), TOR1A TRAPPC4 COPS5 RNF112 RAB3C SEPT6 DNAJC5 APBA2 RAB3A MT3 PTPRN RAB3B RAB37 RAB26 LAMP1 SYN2 SYN1 SNAP25 COPS4 GIPC1 LRRK2,CC,21,21 of 31,0.89,67.74,7.682E-12,2.404E-10
GO:0006464,cellular protein modification process,Q08E58(Evidence code:IEA/Database source:InterPro:IPR004344)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR008883)A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081)A3KN51(Evidence code:IEA/Database source:InterPro:IPR008883)P15246(Evidence code:IEA/Database source:InterPro:IPR000682), TTLL12 UEVLD UBE2M TSG101 PCMT1,BP,5,5 of 565,0.21,0.88,9.178E-12,2.855E-10
GO:0030036,actin cytoskeleton organization,O02811(Evidence code:IBA/Database source:PANTHER:PTN000006021)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BGT8(Evidence code:IEA/Database source:UniProtKB:Q08AE8|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q28021(Evidence code:IEA/Database source:InterPro:IPR020684)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BL04(Evidence code:IEA/Database source:InterPro:IPR012510|I)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010473)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010473|I)Q1RMR9(Evidence code:IEA/Database source:InterPro:IPR028521|I)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR030133)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR030061)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326)A2VDK6(Evidence code:IEA/Database source:InterPro:IPR028288)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)E1B718(Evidence code:IEA/Database source:InterPro:IPR010473)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010473)E1BP72(Evidence code:IEA/Database source:InterPro:IPR033232)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens), PI4KA PAK6 SPIRE1 SPTA1 PHACTR4 PAK2 ROCK2 PAK4 XIRP2 FMNL1 SH2B2 SRF DIAPH3 PACSIN2 MKL1 TMOD3 ARHGAP26 ABL1 CLN3 PAK1 WASF2 BCR FMNL3 TAOK2 DAAM1 CDC42BPB PAK3 NF2,BP,28,28 of 64,1.19,43.75,9.351E-12,2.892E-10
GO:0007165,signal transduction,G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MZM7(Evidence code:IEA/Database source:InterPro:IPR000198|I)F1MS27(Evidence code:IEA/Database source:InterPro:IPR002073|I)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR000198|I)A4FUC9(Evidence code:IEA/Database source:InterPro:IPR011072)Q29450(Evidence code:IBA/Database source:PANTHER:PTN000228924)E1BB77(Evidence code:IEA/Database source:InterPro:IPR008936)F1MDL4(Evidence code:IEA/Database source:InterPro:IPR003116)E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR000198|I)F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)P04695(Evidence code:IEA/Database source:InterPro:IPR011025)Q32PI9(Evidence code:IEA/Database source:InterPro:IPR029870)E1BPZ4(Evidence code:IEA/Database source:InterPro:IPR008466)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR009471)E1BKZ0(Evidence code:IEA/Database source:InterPro:IPR028745)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001711)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR000159)E1BD25(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BNV7(Evidence code:IEA/Database source:InterPro:IPR000159|I)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)Q1JQB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BLK3(Evidence code:IEA/Database source:UniProtKB:Q9JJA9|ens)E1BJP2(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1BB73(Evidence code:IEA/Database source:InterPro:IPR000198|I)E1BIM3(Evidence code:IEA/Database source:InterPro:IPR000198|I)Q3SZ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)P38408(Evidence code:IEA/Database source:InterPro:IPR011025)P04696(Evidence code:IEA/Database source:InterPro:IPR011025)A2VDZ0(Evidence code:IEA/Database source:InterPro:IPR002554)P63217(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)G3MWT9(Evidence code:IEA/Database source:InterPro:IPR001573)Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR029586)P08487(Evidence code:IEA/Database source:InterPro:IPR001711|I)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR001217|I)Q8SQA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1BNQ3(Evidence code:IEA/Database source:InterPro:IPR020849)A7Z090(Evidence code:IEA/Database source:InterPro:IPR000488)A7YY57(Evidence code:IEA/Database source:InterPro:IPR000198|I)F1N2Q9(Evidence code:IEA/Database source:InterPro:IPR020849)G3MXH2(Evidence code:IEA/Database source:InterPro:IPR020849)Q95115(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR011025)F1MRH8(Evidence code:IEA/Database source:InterPro:IPR030520|I)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR000157)E1BF06(Evidence code:IEA/Database source:InterPro:IPR008064)E1B7Q8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)G5E5D0(Evidence code:IEA/Database source:InterPro:IPR000159)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR003116)B0JYL6(Evidence code:IEA/Database source:InterPro:IPR001217|I)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1B801(Evidence code:IEA/Database source:InterPro:IPR000198|I)A6H7H0(Evidence code:IEA/Database source:InterPro:IPR008936)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR000159|I)A5PKD6(Evidence code:IEA/Database source:InterPro:IPR016346)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)A7MB27(Evidence code:IEA/Database source:InterPro:IPR000198|I)P30671(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)P63097(Evidence code:IEA/Database source:InterPro:IPR011025)Q3SYX0(Evidence code:IBA/Database source:PANTHER:PTN000867215)Q58DL5(Evidence code:IEA/Database source:InterPro:IPR028849)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR011025)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR012227)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MM72(Evidence code:IEA/Database source:InterPro:IPR000198|I)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR000198|I)A0JN96(Evidence code:IEA/Database source:InterPro:IPR011524)Q2TBH2(Evidence code:IEA/Database source:InterPro:IPR020849)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MBI8(Evidence code:IEA/Database source:InterPro:IPR008936)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR000488)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)G3MXH1(Evidence code:IEA/Database source:InterPro:IPR000159)Q673L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR011025)Q3ZBA8(Evidence code:IBA/Database source:PANTHER:PTN000867215)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR008936)E1BMN4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MJI3(Evidence code:IEA/Database source:InterPro:IPR000198|I)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR011025)A7YY44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)Q1RMI6(Evidence code:IEA/Database source:InterPro:IPR000159)A6QPG6(Evidence code:IBA/Database source:PANTHER:PTN000296773)A6QLJ4(Evidence code:IBA/Database source:PANTHER:PTN001004344)F1MHG5(Evidence code:IEA/Database source:InterPro:IPR000198|I)A5D7A4(Evidence code:IEA/Database source:InterPro:IPR020849)A4FV68(Evidence code:IEA/Database source:InterPro:IPR002554)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR003116)E1B714(Evidence code:IEA/Database source:InterPro:IPR029797)Q2YDG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR000159)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)P63026(Evidence code:IMP/Database source:)E1BGE5(Evidence code:IBA/Database source:PANTHER:PTN000108192)E1BB14(Evidence code:IEA/Database source:InterPro:IPR016346)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR000159)Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN000385798)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108192)Q08DI5(Evidence code:IEA/Database source:InterPro:IPR020849)A1A4I4(Evidence code:IEA/Database source:InterPro:IPR011072)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR000159|I)P04896(Evidence code:IEA/Database source:InterPro:IPR011025)E1BA57(Evidence code:IEA/Database source:InterPro:IPR008936)E1BLE8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MS53(Evidence code:IEA/Database source:InterPro:IPR000159)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BKU0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1B800(Evidence code:IEA/Database source:InterPro:IPR008936)P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)E1B7G7(Evidence code:IEA/Database source:InterPro:IPR000159)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)F1MD62(Evidence code:IEA/Database source:InterPro:IPR000159|I)P61635(Evidence code:IEA/Database source:InterPro:IPR001217|I)F1MJ20(Evidence code:IEA/Database source:InterPro:IPR000198|I)Q1LZF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0807)F1MTR1(Evidence code:IEA/Database source:InterPro:IPR008936), OR5M11 SYDE2 PDE4D LOC788626 ARHGAP6 RHPN2 ADCY7 DAB2IP BRAF LOC531090 OR13C3 ARHGAP26 RRH GNAT1 MPZL1 PPP1R1C TENM3 PCNT PLCB3 SNX27 BCL11B MYO9B LOC614090 GPR4 CDK6 LGR4 GRASP RACGAP1 INPP5B ARHGAP11A GNG10 GNA14 GNAT2 PPP2R5A GNG5 AKAP12 SHC1 PLCG1 STAT5B CD97 RAP2A ANK3 ARHGAP29 DIRAS2 HRAS STAT5A GNA12 SH2B2 TLR4 TNFSF15 PTH2R RIN3 TIAM2 STAT1 OR51Q1 ARHGAP35 IQGAP3 ARAP3 GNB4 HIVEP1 ARHGAP36 GNG7 GNAI1 NDRG1 BCAR3 GNA13 TRAF6 ZNF516 ARHGAP22 BCR STK3 RRAS PTPRM HIVEP3 SYNGAP1 CDK3 FCER1G NFKB1 RREB1 MYO9A C5AR1 GNAL NDRG2 RASAL1 NMBR SRGAP3 GNAT3 F2R RASSF4 LANCL2 CDC42SE2 ARHGAP21 RIT1 PPP2R5E RGS14 AXIN1 GPRC5C Grb10 BCL11A VAMP2 IPO7 GNB3 RAPGEF2 CRH IPO8 RAP2C PKN1 DGKQ GNAS DEPDC1 GRM7 RAPGEF6 SALL4 ADORA2A RASAL2 RGR PLEKHH3 IMPA1 ARHGAP20 STAT3 ARHGAP28 PTH1R IQGAP2,BP,123,123 of 809,5.23,15.2,9.462E-12,2.91E-10
GO:0006796,phosphate-containing compound metabolic process,P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens),IMPA1,BP,1,1 of 417,0.04,0.24,1.031E-11,3.151E-10
GO:0006511,ubiquitin-dependent protein catabolic process,E1BMF7(Evidence code:IEA/Database source:InterPro:IPR018200)Q3ZCF3(Evidence code:IEA/Database source:InterPro:IPR001232|I)F1MF37(Evidence code:IEA/Database source:InterPro:IPR018200)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629793)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)G5E639(Evidence code:IEA/Database source:UniProtKB:P0C2W1|ens)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR000426)F1MYD0(Evidence code:IEA/Database source:InterPro:IPR001373|I)E1BIN5(Evidence code:IEA/Database source:InterPro:IPR001373|I)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR018200)Q08DE9(Evidence code:IEA/Database source:InterPro:IPR001373|I)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)Q3T0X5(Evidence code:IEA/Database source:InterPro:IPR000426)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)G5E630(Evidence code:IEA/Database source:InterPro:IPR018200)A7Z056(Evidence code:IEA/Database source:InterPro:IPR018200)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)Q0P568(Evidence code:IEA/Database source:InterPro:IPR004854)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR000426)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)B7TCH8(Evidence code:IEA/Database source:InterPro:IPR018200)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR000426)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q3UE37|ens)A2VE03(Evidence code:IEA/Database source:InterPro:IPR024928)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)F1N0A8(Evidence code:IEA/Database source:InterPro:IPR018200)E1BGW4(Evidence code:IEA/Database source:InterPro:IPR018200)E1BND0(Evidence code:IEA/Database source:InterPro:IPR018200)A1L548(Evidence code:IEA/Database source:InterPro:IPR018200)Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR019474)Q3T0Y5(Evidence code:IEA/Database source:InterPro:IPR000426)A6H7B5(Evidence code:IBA/Database source:PANTHER:PTN000079485)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P35998)E1BG52(Evidence code:IEA/Database source:InterPro:IPR018200), USP13 SKP1 USP31 NEDD4 UBE2G2 TRIP12 FBXO45 PSMA3 CUL1 CUL3 SYVN1 USP32 CUL2 UBR2 PSMA1 RFFL USP9X USP20 RANBP2 UFD1L PSMA4 PSMD13 CBLC USP9Y PSMA7 UBE2Z ITCH UHRF1 USP34 USP36 USP24 USP5 ARRDC1 UBE4B PSMA2 COPS3 PSMC2 USP35,BP,38,38 of 122,1.61,31.15,1.082E-11,3.29E-10
GO:0007186,G-protein coupled receptor signaling pathway,Q1JQB3(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BLE8(Evidence code:IEA/Database source:InterPro:IPR000162|I)F1MR98(Evidence code:IEA/Database source:InterPro:IPR000276|I)P04896(Evidence code:IEA/Database source:InterPro:IPR000367|I)F1MLX5(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)E1BMN4(Evidence code:IEA/Database source:InterPro:IPR000276|I)G3X6G8(Evidence code:IEA/Database source:InterPro:IPR002131)E1B9D3(Evidence code:IEA/Database source:InterPro:IPR017978)Q1JPD9(Evidence code:IEA/Database source:InterPro:IPR017978)Q2YDG0(Evidence code:IEA/Database source:InterPro:IPR017978)G3X8A9(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR000832|I)P63217(Evidence code:IEA/Database source:InterPro:IPR001770|I)E1BMY3(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469|I)E1BKU0(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367|I)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F1MM21(Evidence code:IEA/Database source:InterPro:IPR015898|I)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)Q673L2(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)F1MG76(Evidence code:IEA/Database source:InterPro:IPR000276)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR000832|I)P38408(Evidence code:IEA/Database source:InterPro:IPR000654|I)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR000832|I)P47803(Evidence code:IEA/Database source:InterPro:IPR000276|I)F1MSU3(Evidence code:IEA/Database source:InterPro:IPR000276)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q3SZ98(Evidence code:IEA/Database source:InterPro:IPR001770|I)G3N0Y0(Evidence code:IEA/Database source:InterPro:IPR000276|I)P04695(Evidence code:IEA/Database source:InterPro:IPR001019|I)A7MB15(Evidence code:IEA/Database source:GO:0004930)P30671(Evidence code:IEA/Database source:InterPro:IPR001770|I)P05131(Evidence code:IEA/Database source:InterPro:IPR039083)P63097(Evidence code:IEA/Database source:InterPro:IPR001019|I)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037801|I)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469|I)P04696(Evidence code:IEA/Database source:InterPro:IPR001019|I)E1BMX7(Evidence code:IEA/Database source:InterPro:IPR000276|I)G3X828(Evidence code:IEA/Database source:InterPro:IPR000276|I)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019|I)E1BEB2(Evidence code:IEA/Database source:InterPro:IPR000276|I), GPR4 GRM7 RRH GNAS LGR4 BAIAP3 NMBR LGR6 GPR179 GPRC5B GPRC5C OR5M11 CD97 GNG5 LOC614090 GNA12 ADORA2A PREX1 GNAL DGKQ RGS6 RAPGEF2 C5AR1 ABCA1 GPR75 PTH2R GNA14 PTH1R RGR RXFP3 F2R GNG10 LOC788626 GNAT1 FZD1 GNG7 PRKACB GNAI1 ARHGEF12 GNA13 GNAT2 OR51Q1 OR13C3 GNAT3 LOC531090,BP,45,45 of 168,1.91,26.79,1.141E-11,3.448E-10
GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357), TEC SRC SNAP25 LCK TYK2 FERMT2 RACGAP1 JAK2 SNX18 ABL1 YES1 GRB2 FRK ALOX15 ZAP70,CC,15,15 of 11,0.64,136.36,1.179E-11,3.545E-10
GO:0005581,collagen trimer,F1N0Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q28083(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)P02465(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)P23206(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)E1BLS8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)A7E2Z1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)F1MJR6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q32S24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)A5D9D7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q7SIB3(Evidence code:IEA/Database source:InterPro:IPR001442|I)P02459(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)F1MUC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q29442(Evidence code:IEA/Database source:InterPro:IPR001442|I)Q1RMH5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q7SIB2(Evidence code:IEA/Database source:InterPro:IPR001442|I)F1N474(Evidence code:IEA/Database source:InterPro:IPR001442|I)F1MJY9(Evidence code:IEA/Database source:InterPro:IPR001442|I)A5PJL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0176)Q28084(Evidence code:IEA/Database source:InterPro:IPR001442|I), COLEC10 COL11A1 COL1A2 SFTPD COL5A2 COL10A1 EMILIN1 C1QTNF6 COL8A2 COL11A2 PLOD3 COL4A2 COL2A1 COL15A1 COL4A4 C1QC COL4A1 COL4A5 COL4A6 C1QTNF5 COL4A3,CC,21,21 of 32,0.89,65.62,1.19E-11,3.556E-10
GO:0031594,neuromuscular junction,G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q62288)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)E1B7T7(Evidence code:IEA/Database source:UniProtKB:Q8R1C0|ens)E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)F1MRT9(Evidence code:IEA/Database source:UniProtKB:E9Q6R7|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens)P02715(Evidence code:IEA/Database source:UniProtKB:P20782|ens), CRKL SPOCK1 UNC13A KCNC4 DLGAP3 COL4A5 LAMB2 F2R UNC13B DNAJC5 PRKACA DLG1 PSEN1 UTRN TUBA1A CHRNE,CC,16,16 of 14,0.68,114.29,1.239E-11,3.684E-10
GO:0005764,lysosome,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q08DD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)G5E657(Evidence code:IEA/Database source:UniProtKB:Q9NQE7|ens)Q3SZJ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)Q5E998(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q0VD59(Evidence code:ISS/Database source:UniProtKB:Q5T0T0)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens)Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q05204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q2KJA5(Evidence code:IEA/Database source:InterPro:IPR018397)A3KN15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q3T0Q2(Evidence code:ISS/Database source:UniProtKB:Q9BXS4)P11456(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8BWC0|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-KW:KW-0458)Q0VD53(Evidence code:IEA/Database source:UniProtKB:O75436|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), SRC LARS SEC13 TSC2 LRRK2 HYAL1 RAB9A CD63 ARSA PRSS16 LAMP2 fgfr3 CTSV VPS35 TINAGL1 ARL8B MARCH8 CAPN2 CHMP2B CLN3 NEU4 FUCA1 UBXN6 LAMP1 LAPTM5 VPS41 TMEM59 M6PR TPCN2 STX7 TMEM106B VPS26A NPC1,CC,33,33 of 93,1.4,35.48,1.392E-11,4.114E-10
GO:0043209,myelin sheath,Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)P31404(Evidence code:IEA/Database source:UniProtKB:P50516|ens)P02722(Evidence code:IEA/Database source:UniProtKB:P48962|ens)P81127(Evidence code:IEA/Database source:UniProtKB:Q9CWZ7|ens)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61164|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:P53810|ens)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P80316|ens)P31408(Evidence code:IEA/Database source:UniProtKB:P62814|ens)A5PKD6(Evidence code:IEA/Database source:UniProtKB:P29387|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q8BHJ6|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)Q5EA61(Evidence code:IEA/Database source:UniProtKB:Q04447|ens)Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens), TUBB4A MYO1D ARF6 ATP6V1A SLC25A4 NAPG ACTR1A SYN2 TUBA1A DNM1 CCT3 PITPNA CCT5 ATP6V1B2 GNB4 SNAP25 HSPA9 CRYAB SIRT2 PDCD6IP INA SERINC5 CNP DPYSL2 TSPAN2 CKB FAM213B ATP1A2 MYH14,CC,29,29 of 71,1.23,40.85,1.526E-11,4.471E-10
GO:0032559,adenyl ribonucleotide binding,P58108(Evidence code:IEA/Database source:InterPro:IPR039166),PRKAG1,MF,1,1 of 412,0.04,0.24,1.529E-11,4.471E-10
GO:0008284,positive regulation of cell proliferation,E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)Q95M13(Evidence code:IEA/Database source:InterPro:IPR016248)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)F1MN49(Evidence code:IEA/Database source:UniProtKB:Q9GZV4|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979), PURA TRPM4 fgfr3 PKHD1 TCL1A PAK1 CDK6 ASH2L RAB25 DLG1 NACC1 CRKL SAPCD2 KIF14 KIT GLI1 PTPN6 DPP4 CIB1 PDGFC NUDT16 PROK1 DOT1L STAT1 SOX4 PLAC8 RPS9 BIRC6 LEF1 STAT5B FGF1 PDCD10 TBX3 RPS15A EIF4G1 STAT5A SPHK2 EIF5A2 MARCH7 F2R WWTR1 SUZ12 GLI2 CDK3,BP,44,44 of 164,1.87,26.83,1.822E-11,5.299E-10
GO:0005515,protein binding,O02675(Evidence code:IPI/Database source:UniProtKB:Q8N3F8)F1MWD3(Evidence code:IPI/Database source:UniProtKB:Q2NKZ1)Q3SYU7(Evidence code:IPI/Database source:UniProtKB:P52293)P81948(Evidence code:IPI/Database source:UniProtKB:P90521)P61763(Evidence code:IPI/Database source:UniProtKB:P32850)Q27954(Evidence code:IPI/Database source:UniProtKB:P35605)Q1RMR3(Evidence code:IPI/Database source:UniProtKB:F1MUI0)P63026(Evidence code:IPI/Database source:UniProtKB:F1N348)P02639(Evidence code:IPI/Database source:UniProtKB:Q9CXW3)P63097(Evidence code:IPI/Database source:UniProtKB:P62871)P48452(Evidence code:IPI/Database source:UniProtKB:P63099)G3MZY8(Evidence code:IPI/Database source:UniProtKB:A5PJW8)Q0VCK5(Evidence code:IPI/Database source:UniProtKB:Q61548)P63171(Evidence code:IPI/Database source:UniProtKB:P02699)P00515(Evidence code:IPI/Database source:UniProtKB:Q6XGM8)P02638(Evidence code:IPI/Database source:UniProtKB:Q9CXW3)A2VDL6(Evidence code:IPI/Database source:UniProtKB:Q3SZX0)Q2NKZ1(Evidence code:IPI/Database source:UniProtKB:F1MWD3)P13608(Evidence code:IPI/Database source:UniProtKB:P49747)P03968(Evidence code:IPI/Database source:UniProtKB:P21802)P0C7Q4(Evidence code:IPI/Database source:UniProtKB:P02699)Q08DF4(Evidence code:IPI/Database source:UniProtKB:F1N548)P26882(Evidence code:IPI/Database source:UniProtKB:P02639)E1BHE1(Evidence code:IPI/Database source:UniProtKB:Q89582)P32592(Evidence code:IPI/Database source:UniProtKB:Q7BHI8)Q17QQ3(Evidence code:IPI/Database source:UniProtKB:Q704P2)P04695(Evidence code:IPI/Database source:UniProtKB:Q28181)A6QLP2(Evidence code:IPI/Database source:UniProtKB:Q9GL77)Q29455(Evidence code:IPI/Database source:UniProtKB:Q80TN5)Q9TRY0(Evidence code:IPI/Database source:UniProtKB:P02639)Q2TA37(Evidence code:IPI/Database source:UniProtKB:Q28205)P04973(Evidence code:IPI/Database source:UniProtKB:O00291)O19137(Evidence code:IPI/Database source:UniProtKB:P03120)B0JYL6(Evidence code:IPI/Database source:UniProtKB:Q4VW77)P61625(Evidence code:IPI/Database source:UniProtKB:Q7BHI8)P61286(Evidence code:IPI/Database source:UniProtKB:P15170)P02510(Evidence code:IPI/Database source:UniProtKB:P02470)O46385(Evidence code:IPI/Database source:UniProtKB:P35579)F1MQ85(Evidence code:IPI/Database source:UniProtKB:Q89582)Q0P594(Evidence code:IPI/Database source:UniProtKB:Q28205)Q0IIE2(Evidence code:IPI/Database source:UniProtKB:Q9QYY0)P02668(Evidence code:IPI/Database source:UniProtKB:Q9RA63)F1MSG6(Evidence code:IPI/Database source:UniProtKB:Q02248)P43033(Evidence code:IPI/Database source:UniProtKB:O35264)Q08DA1(Evidence code:IPI/Database source:UniProtKB:Q3SZX0)P42891(Evidence code:IPI/Database source:UniProtKB:Q95N27)P35605(Evidence code:IPI/Database source:UniProtKB:Q27954)P53619(Evidence code:IPI/Database source:UniProtKB:P23514)P10279(Evidence code:IPI/Database source:UniProtKB:P04156)P08487(Evidence code:IPI/Database source:UniProtKB:P48025)P00517(Evidence code:IPI/Database source:UniProtKB:P63251)Q28104(Evidence code:IPI/Database source:UniProtKB:Q27954), DPYSL2 CCT5 TNPO1 TUBA4A STXBP1 COPA CTTN VAMP2 S100A1 GNAI1 PPP3CA POLR2A AP2A2 DYNLT1 PRKAR2A S100B ATP1A2 CCT7 ACAN FGF1 GNAT3 DNM1 PPID TAOK3 ITGB2 SNAP25 GNAT1 AHCYL2 DNAJC5 FKBP4 ARL2 CLTA CPSF4 STAT1 ITGAL PABPC1 CRYAB SVIL ATRX PPP2CB SHC1 CSN3 RAPGEF2 PAFAH1B1 ATP1A1 ECE1 COPB2 ARCN1 PRNP PLCG1 PRKACA COPE,MF,52,52 of 1669,2.21,3.12,1.948E-11,5.636E-10
GO:0005262,calcium channel activity,Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000699)E1BHV1(Evidence code:IEA/Database source:InterPro:IPR000699)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F1MHV0(Evidence code:IEA/Database source:InterPro:IPR002153|I)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)O62826(Evidence code:IEA/Database source:InterPro:IPR002153|I)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)O18784(Evidence code:IEA/Database source:InterPro:IPR002153|I)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR000699)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000699)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR000699)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0107), ITPR2 RYR2 PSEN1 TRPC3 CACNA1S TRPC2 TRPM7 GRIN3B CACNA1C TRPC1 CACNA1E CACNA1D TRPM4 RYR1 CACNA1B ITPR1 RYR3 CACNA1F,MF,18,18 of 22,0.76,81.82,2.629E-11,7.564E-10
GO:0008360,regulation of cell shape,E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)A7E3X2(Evidence code:IBA/Database source:PANTHER:PTN000225966)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)E1B718(Evidence code:IEA/Database source:InterPro:IPR027655)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0133)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)P35509(Evidence code:IBA/Database source:PANTHER:PTN000225966)F1N3Q4(Evidence code:IEA/Database source:InterPro:IPR004965)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR027657)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)P67827(Evidence code:IBA/Database source:PANTHER:PTN000225966)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q8BKX1)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0133)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000225966), SYNE3 CSNK1G1 SPTA1 KIT ARAP3 GNA12 FMNL3 CDC42SE2 TAOK2 CSNK1G3 PALM FMNL1 GNA13 CSNK1A1 CRK DLG1 ARHGAP35 SEMA3E STRIP2 BAIAP2 PRPF40A CYFIP1 CSNK1G2,BP,23,23 of 43,0.98,53.49,2.879E-11,8.238E-10
GO:0000413,protein peptidyl-prolyl isomerization,P26882(Evidence code:IEA/Database source:InterPro:IPR002130)P48820(Evidence code:IEA/Database source:InterPro:IPR002130)Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210)A4FV72(Evidence code:IEA/Database source:InterPro:IPR002130)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)Q32PA9(Evidence code:IEA/Database source:GO:0003755)G3X8B1(Evidence code:IEA/Database source:InterPro:IPR002130)Q2KJC8(Evidence code:IEA/Database source:GO:0003755)Q5BIN5(Evidence code:IEA/Database source:GO:0003755)Q29RZ2(Evidence code:IEA/Database source:InterPro:IPR002130)Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212)Q2KJ44(Evidence code:IEA/Database source:GO:0003755), PPID RANBP2 FKBP5 PPIE FKBP1B FKBP2 LOC613401 FKBP9 PIN1 PPWD1 FKBP4 PTPA,BP,12,12 of 5,0.51,240,4.435E-11,1.262E-09
GO:0007229,integrin-mediated signaling pathway,P53712(Evidence code:IEA/Database source:InterPro:IPR027071)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P32592(Evidence code:IEA/Database source:InterPro:IPR015439)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)A7MB21(Evidence code:IEA/Database source:InterPro:IPR037837|I)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)A6QQ97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)P53710(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)F1MMH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0401)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens), ITGB1 ABL1 ITGB2 ITGB6 ITGAV FERMT2 TEC ITGAD ITGB7 ITGA2 SRC ADAM15 FCER1G ITGAL ITGA9 CUL3,BP,16,16 of 16,0.68,100,4.487E-11,1.27E-09
GO:0003743,translation initiation factor activity,Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR037583)Q3SZ54(Evidence code:IEA/Database source:InterPro:IPR037583)F1MX04(Evidence code:IEA/Database source:InterPro:IPR037584)Q3T148(Evidence code:IEA/Database source:InterPro:IPR027528)Q5E966(Evidence code:IEA/Database source:InterPro:IPR027525)E1BLZ8(Evidence code:IBA/Database source:PANTHER:PTN000056988)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)P68102(Evidence code:IEA/Database source:InterPro:IPR011488)A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q32LC3(Evidence code:IEA/Database source:InterPro:IPR001253|I)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)Q3T0V3(Evidence code:ISS/Database source:UniProtKB:Q9UBQ5)Q32KZ1(Evidence code:IEA/Database source:InterPro:IPR001288|I)Q5E938(Evidence code:IEA/Database source:InterPro:IPR001950|I)A7MB16(Evidence code:ISS/Database source:UniProtKB:P55884)Q32LJ9(Evidence code:IEA/Database source:InterPro:IPR001950|I)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)Q3ZC12(Evidence code:ISS/Database source:UniProtKB:O75821), EIF4A2 EIF4A1 EIF4G1 EIF3M EIF3I EIF3F EIF6 EIF2S1 WBSCR1 MCTS1 EIF1AX EIF4H EIF4E1B EIF3K MTIF3 EIF1 EIF3B EIF1B EIF2B5 EIF3G,MF,20,20 of 31,0.85,64.52,4.559E-11,1.284E-09
GO:0035023,regulation of Rho protein signal transduction,F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR000219)F1MHU4(Evidence code:IEA/Database source:InterPro:IPR000219)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR000219)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)F1MQ44(Evidence code:IEA/Database source:InterPro:IPR000219)Q58CS5(Evidence code:IEA/Database source:InterPro:IPR000219)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR000219)A6QLJ4(Evidence code:IEA/Database source:InterPro:IPR039056)F1N657(Evidence code:IEA/Database source:InterPro:IPR000219)F1MSU8(Evidence code:IEA/Database source:InterPro:IPR000219)A5D793(Evidence code:IEA/Database source:InterPro:IPR000219)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)E1BG38(Evidence code:IEA/Database source:InterPro:IPR000219)F1N6T8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR000219)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)F1MY16(Evidence code:IEA/Database source:InterPro:IPR000219|I)F1MRP8(Evidence code:IEA/Database source:InterPro:IPR000219)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR000219), PREX1 PLEKHG3 TRIO MYO9B MCF2L2 FGD3 ARHGEF12 CDC42SE2 SPATA13 PLEKHG2 ECT2 EPS8L1 ARHGEF1 VAV2 TIAM2 FLOT1 AKAP13 PLEKHG1 BCR,BP,19,19 of 27,0.81,70.37,4.694E-11,1.315E-09
GO:0051174,regulation of phosphorus metabolic process,F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens),FAM20C,BP,1,1 of 394,0.04,0.25,4.922E-11,1.372E-09
GO:0005085,guanyl-nucleotide exchange factor activity,A5D793(Evidence code:IEA/Database source:InterPro:IPR001331|I)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR001895)F1N6T8(Evidence code:IEA/Database source:InterPro:IPR001331)F1MQ43(Evidence code:IEA/Database source:InterPro:IPR026791|I)G3MXA5(Evidence code:IEA/Database source:InterPro:IPR033360)F1N657(Evidence code:IEA/Database source:InterPro:IPR001331)E1BK77(Evidence code:IEA/Database source:InterPro:IPR026791|I)A6QQZ8(Evidence code:IEA/Database source:InterPro:IPR028570)E1BPX7(Evidence code:IEA/Database source:InterPro:IPR001895|I)Q5E9S7(Evidence code:IEA/Database source:InterPro:IPR001895|I)F1MBT5(Evidence code:IEA/Database source:InterPro:IPR001331)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR001331|I)F1MTH3(Evidence code:IEA/Database source:InterPro:IPR001331)Q32P83(Evidence code:IEA/Database source:InterPro:IPR007515)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)F1MS53(Evidence code:IEA/Database source:InterPro:IPR001895)Q58DL5(Evidence code:IEA/Database source:InterPro:IPR001895|I)O46382(Evidence code:IEA/Database source:UniProtKB-KW:KW-0344)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)E1B7C4(Evidence code:IEA/Database source:InterPro:IPR026791)F1N1Q7(Evidence code:IEA/Database source:InterPro:IPR001331), ECT2 RAPGEF2 VAV2 DOCK9 TIAM1 SPATA13 DOCK6 TRIO RAPGEF4 RASGEF1A BCR ARHGEF12 TIAM2 RABIF EIF2B5 RAPGEF6 BCAR3 ARFGEF1 MYCBP2 DOCK10 PREX1,MF,21,21 of 36,0.89,58.33,6.098E-11,1.691E-09
GO:0005911,cell-cell junction,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8N157)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q86SQ7|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28827|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:Q14517|ens)A4FUY1(Evidence code:IEA/Database source:UniProtKB:Q14CZ8|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1PBJ0)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q9R1N9|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)A5D7V2(Evidence code:IEA/Database source:InterPro:IPR030720)Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN001019267)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), AHI1 FABP7 TWF1 PTK7 PACSIN2 SDCCAG8 OCLN FLOT1 PTPN6 TJP1 CLIC4 PKP4 ZAP70 WASF2 CTNND1 LIN7C LIN7B PAK1 PTPRM MICALL2 GRB2 FAT1 HEPACAM SCRIB RAPGEF2 COL13A1 DLG1 PCDH12 LIN7A FRS2 KIT,CC,31,31 of 88,1.32,35.23,6.536E-11,1.803E-09
GO:0030054,cell junction,P02715(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BAI0(Evidence code:IEA/Database source:UniProtKB:A0A024RD41)Q01107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q2YDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q9XT56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BEQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)Q28146(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A4IFM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3MHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1N2D3(Evidence code:IEA/Database source:UniProtKB:G3V1L9|ens)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1B968(Evidence code:IEA/Database source:UniProtKB:P52569|ens)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q3SZA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1MJ11(Evidence code:IEA/Database source:UniProtKB:Q99569|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A6QP29(Evidence code:ISS/Database source:UniProtKB:Q9BYX2)E1BQ03(Evidence code:IEA/Database source:UniProtKB:A0A024R7E0)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)Q765N9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q9XT97(Evidence code:IEA/Database source:UniProtKB:A0A024R6A3)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BL04(Evidence code:IEA/Database source:InterPro:IPR012510)Q4TVR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q28046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)P17599(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0965)E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens), CHRNE RAPGEF2 OSBP PTPRN CLDN7 RAB23 DSC1 RNF112 LIN7C CDK5RAP2 SEPT11 ITGB1 TES F11R AMOTL1 S100A14 PANX3 OCLN NRXN1 DPP4 UTRN LIN7B CLDN8 CYFIP1 GRIA3 CTNNA1 TJP1 VAMP2 SLC7A2 SVIL COPS4 CLDN4 PKP4 SH3GL1 TBC1D2 NACC1 PRUNE1 VAMP1 DNM2 CLDN3 PSEN1 VAMP3 XIRP2 DSTYK GRIA1 MAGI1 ITGAV FAT1 GRIA2 ITGB6 PAK1 ABHD17C SCIN LIN7A SCRIB CAMK2B ARHGAP21 GABRA5 ABCA7 SYN1 SNAP25 HMCN1 DLG1,CC,63,63 of 315,2.68,20,6.894E-11,1.892E-09
GO:0007507,heart development,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)Q2YDD2(Evidence code:ISS/Database source:UniProtKB:Q9DB90)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)F1MF74(Evidence code:ISS/Database source:UniProtKB:F1RA39)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)E1BL04(Evidence code:IEA/Database source:InterPro:IPR030072|I)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens), RPS6KA2 PTK7 CRKL SMG9 NIPBL MICAL2 POU4F2 PRKDC PSEN1 BCOR MTHFD1 FOXF1 SRF SOX4 DNAH11 GLI2 SALL4 DNAH5 XIRP2 FREM2,BP,20,20 of 32,0.85,62.5,6.929E-11,1.892E-09
GO:0016491,oxidoreductase activity,Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P00435(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MF74(Evidence code:ISS/Database source:UniProtKB:O94851)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR015590|I)A7YY67(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR015875)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I)Q0P5I1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q58DM4(Evidence code:IEA/Database source:InterPro:IPR005123)Q17QK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P37141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q28007(Evidence code:IEA/Database source:InterPro:IPR023753)Q4JIJ2(Evidence code:IEA/Database source:InterPro:IPR001433|I)Q5EAD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)O46414(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MXW0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MMK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3T0Z7(Evidence code:IEA/Database source:InterPro:IPR020904)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR015590|I)Q32L93(Evidence code:IEA/Database source:InterPro:IPR015875)P48034(Evidence code:IEA/Database source:InterPro:IPR002346|I)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)F1MEU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR013328)Q3MHF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P56560(Evidence code:IEA/Database source:InterPro:IPR001613|I)F1MB84(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR028614)Q27995(Evidence code:IEA/Database source:InterPro:IPR001433|I)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)O62768(Evidence code:IEA/Database source:InterPro:IPR001100|I)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A8E657(Evidence code:IEA/Database source:InterPro:IPR005097)E1BL62(Evidence code:IEA/Database source:InterPro:IPR002346|I)P16116(Evidence code:IEA/Database source:InterPro:IPR018170|I)O77769(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR005123)A5PJM4(Evidence code:IEA/Database source:InterPro:IPR000103|I)Q3T046(Evidence code:IEA/Database source:InterPro:IPR020904)Q3ZCJ2(Evidence code:IEA/Database source:InterPro:IPR018170|I)P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001236)Q58D31(Evidence code:IEA/Database source:InterPro:IPR002328|I)Q32L99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q2KHX6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q5I598(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P10897(Evidence code:IBA/Database source:PANTHER:PTN000010357)Q148K4(Evidence code:IEA/Database source:InterPro:IPR006094)Q3MHW4(Evidence code:IEA/Database source:InterPro:IPR023753)Q59A28(Evidence code:IEA/Database source:InterPro:IPR020843)Q32LH7(Evidence code:IEA/Database source:InterPro:IPR001433|I)Q2KJE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)A6QP05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR002328|I)F1MYP4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)O97764(Evidence code:IEA/Database source:InterPro:IPR002364|I)F1MHR3(Evidence code:IEA/Database source:InterPro:IPR015590|I)E1BBS6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR000262|I)E1BJA2(Evidence code:IEA/Database source:InterPro:IPR016156|I)P48644(Evidence code:IEA/Database source:InterPro:IPR015590|I)E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P48818(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0560)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR005123), PAH GPX1 MICAL2 ALDH1L2 ALDH1L1 IMPDH2 LOC100295883 CRYL1 CYP2R1 ALKBH2 SPR GPX3 DPYD MTRR PHGDH FTH1 ALOX15B G6PD QDPR ALDH9A1 GMPR2 AOX1 MICAL3 LOC540627 GPD1L HSD3B7 MAOB GRHPR TSTA3 NOS2 CAT TXNRD1 DBH AASS AOX4 AKR1B1 DHRS3 EGLN3 AIFM2 BDH2 AKR1A1 NDUFS3 DHFR UEVLD SORD PTGR2 CRYM MTHFR CYB561 LDHD SQRDL CRYZL1 CYB5R4 GAPDHS FAM213B DHRS12 ADH5 CTBP1 CRYZ ALDH1A3 QSOX2 HAO2 AIFM1 ALDH1A1 CYP7A1 CYP2J2 ACADVL ALOX15 P4HA2,MF,69,69 of 361,2.93,19.11,7.105E-11,1.93E-09
GO:0017137,Rab GTPase binding,A6QP06(Evidence code:IEA/Database source:InterPro:IPR010911|I)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)F6REL8(Evidence code:IEA/Database source:InterPro:IPR028563)G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)A7E3D4(Evidence code:IEA/Database source:InterPro:IPR037789)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BBK9(Evidence code:IEA/Database source:InterPro:IPR010911)F1N2I0(Evidence code:IEA/Database source:UniRule:UR000859759)E1BKQ2(Evidence code:IEA/Database source:InterPro:IPR037789)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens)F1N746(Evidence code:IEA/Database source:UniProtKB:Q9Y3P9|ens)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)E1BDC9(Evidence code:IBA/Database source:PANTHER:PTN000367098)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561), SYTL2 TBC1D2 MICALL2 RIN3 ANKFY1 RAB11FIP2 DENND1A SYTL1 CHML RAB11FIP1 BICD2 HPS6 RABGAP1 TBC1D12 SGSM2 RIMS1 VPS52 TBC1D22B,MF,18,18 of 24,0.76,75,7.179E-11,1.94E-09
GO:0004721,phosphoprotein phosphatase activity,P11064(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)P67774(Evidence code:IEA/Database source:EC:3.1.3.16)F6RRD7(Evidence code:IEA/Database source:EC:3.1.3.16)P61287(Evidence code:IEA/Database source:EC:3.1.3.16)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:Q9D7X3|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)F1MGK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)Q3SWW9(Evidence code:IEA/Database source:EC:3.1.3.16)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)A6QQD4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)A6QLS1(Evidence code:IEA/Database source:EC:3.1.3.16)A5D980(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)Q0P594(Evidence code:IEA/Database source:EC:3.1.3.16)E1BPU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)E1BDE3(Evidence code:IBA/Database source:PANTHER:PTN000258719)P48452(Evidence code:IEA/Database source:EC:3.1.3.16)E1BPA0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)Q58DC0(Evidence code:IEA/Database source:EC:3.1.3.16)E1BD03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)A5D7T5(Evidence code:IEA/Database source:EC:3.1.3.16)Q32PA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0904)Q3ZBF9(Evidence code:IDA/Database source:), ACP1 PPP2CA RPAP2 PPP1CC DUSP3 PTPN14 PTPRZ1 PPP1CB PPP2R5A PTPN5 DUSP7 PTPN6 PPP2CB PTPRM CTDSP1 PPP3CA PTPRA CPPED1 PPM1D PPP3CC PHPT1 PDXP,MF,22,22 of 41,0.93,53.66,7.327E-11,1.97E-09
GO:0022008,neurogenesis,Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q62288)E1BD25(Evidence code:IBA/Database source:PANTHER:PTN001905569)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN001905569)E1BP55(Evidence code:IEA/Database source:InterPro:IPR039041)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579503)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN001229949)P43033(Evidence code:IBA/Database source:PANTHER:PTN000522053)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)G3X736(Evidence code:IBA/Database source:PANTHER:PTN000073673)F1MHF3(Evidence code:IEA/Database source:InterPro:IPR039041), SPOCK1 BCL11B CDK5RAP2 BCL11A NAV3 SALL4 PRDM13 BTBD6 PAFAH1B1 FABP7 PSEN1 COPS2 NAV2,BP,13,13 of 8,0.55,162.5,8.165E-11,2.184E-09
GO:1902531,regulation of intracellular signal transduction,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997),LEMD3,BP,1,1 of 382,0.04,0.26,1.074E-10,2.858E-09
GO:0050821,protein stabilization,E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O95785|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)Q05204(Evidence code:ISS/Database source:UniProtKB:P11438)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:B1AQJ2|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BJ75(Evidence code:IEA/Database source:UniProtKB:O75718|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)P02668(Evidence code:IBA/Database source:PANTHER:PTN000895253), SYVN1 BAG5 SOX4 CCT5 SOX17 CRYAB USP9X AAK1 MT3 USP13 WIZ HCFC1 LAMP1 PINK1 USP36 PIN1 CRTAP CCT3 PDCD10 MARCH7 FLOT1 STK3 CSN3,BP,23,23 of 47,0.98,48.94,1.13E-10,2.993E-09
GO:0048365,Rac GTPase binding,E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)F1MJI3(Evidence code:IBA/Database source:PANTHER:PTN001021265)P85091(Evidence code:IDA/Database source:)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326), PAK3 PAK1 SRGAP3 CYFIP1 FMNL1 PKN1 NCKAP1 MTSS1L PAK6 IQGAP2 PAK2 PAK4,MF,12,12 of 6,0.51,200,1.247E-10,3.287E-09
GO:0032991,protein-containing complex,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)F1MSL9(Evidence code:IEA/Database source:UniProtKB:Q9NYU1|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BJ75(Evidence code:ISS/Database source:UniProtKB:Q90830)A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:P11274|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q92598|ens)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q2YDE9(Evidence code:IEA/Database source:UniProtKB:Q9UGI8|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)P62964(Evidence code:IDA/Database source:)E1BAH0(Evidence code:IEA/Database source:UniProtKB:O75420|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)Q3SZD5(Evidence code:IEA/Database source:UniProtKB:Q66K64|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)E1BAD4(Evidence code:IDA/Database source:)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB:Q9Y4Z0|ens)F1MDV3(Evidence code:IEA/Database source:UniProtKB:Q13884|ens), FIS1 UGGT2 CKAP5 PAK1 BRCA2 GPSM2 UBE2D2 HCFC1 KEAP1 KPNB1 MALT1 ACR E2F1 CRTAP IPO4 PPP1CC BCR HSPH1 EPS8L1 PRKDC TES XPO1 PSEN1 CRABP1 GIGYF1 H3F3B DCAF15 MPP5 MIER1 RYR1 SASH1 DOT1L RNF165 UBQLN1 SALL4 PCM1 PLCB3 CRK POLG STK3 PRKAR2A TJP1 RUNX1 ZBTB17 TRAF6 RAPGEF2 BCL3 NCOA3 ABL1 WASF2 NUMA1 TCL1A PTPN6 UTRN LSM4 SNTB1,CC,56,56 of 1693,2.38,3.31,1.542E-10,4.045E-09
GO:0005200,structural constituent of cytoskeleton,F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR002452)E1B953(Evidence code:IEA/Database source:InterPro:IPR002453)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR002452)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR002453)F1MKE9(Evidence code:IEA/Database source:InterPro:IPR016343)F1N611(Evidence code:IBA/Database source:PANTHER:PTN001150527)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR030634)P81948(Evidence code:IEA/Database source:InterPro:IPR002452)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR002452)F6RP72(Evidence code:IEA/Database source:InterPro:IPR002452)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR002453)F1MGE1(Evidence code:IBA/Database source:PANTHER:PTN001150527)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR002453)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR002452)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR002452)E1BLT3(Evidence code:IEA/Database source:InterPro:IPR016343)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085), TUBA1A LOC533307 TUBA1D TUBB1 SPTB EPB41L1 SYNM TUBA4A LOC100141266 LOC100295712 TUBB3 FRMD5 TUBB4A TUBA8 TUBA3E SPTBN4 TUBGCP2,MF,17,17 of 22,0.72,77.27,1.74E-10,4.541E-09
GO:0007409,axonogenesis,E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)A2VDN5(Evidence code:IEA/Database source:UniRule:UR000107246)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)P02638(Evidence code:NAS/Database source:)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q64511|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN000689595)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:P53810|ens), PAK3 TAOK2 RTN4R SPAST BCL11B SPTBN4 PTPRZ1 S100B FLOT1 TOP2B CNP POU4F2 RAB3A PRELP RNF165 PITPNA,BP,16,16 of 19,0.68,84.21,2.485E-10,6.455E-09
GO:0033554,cellular response to stress,Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173),GCN1L1,BP,1,1 of 375,0.04,0.27,2.539E-10,6.564E-09
GO:0060271,cilium assembly,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)Q0IIM2(Evidence code:ISS/Database source:UniProtKB:Q9H0F7)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223362)P61420(Evidence code:ISS/Database source:UniProtKB:Q6PGV1)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR028770)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462267)F1MQV5(Evidence code:IEA/Database source:InterPro:IPR033561)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223362)E1BK86(Evidence code:IEA/Database source:UniProtKB:E9PZ36|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:Q9H0T7|ens)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223362)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)Q2NKY7(Evidence code:ISS/Database source:UniProtKB:P42208)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223362)Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), AHI1 ARL6 DYNLL1 ATP6V0D1 ALMS1 C1H21ORF2 PTPN23 IQUB STK36 TEKT4 FBF1 LOC101905447 PKHD1 WWTR1 RAB17 PCM1 DYNLL2 ONECUT2 SEPT2 RAB23 LOC101902172 SEPT7 PCNT RPGRIP1L,BP,24,24 of 55,1.02,43.64,2.838E-10,7.301E-09
GO:0090263,positive regulation of canonical Wnt signaling pathway,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q38SD2|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q5VTB9)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), TRPM4 LGR4 LRRK2 TNKS VPS35 LRRK1 NFKB1 RNF220 SRC CCAR2 RUVBL1 PTK7 WNK1 PIN1 SOX4,BP,15,15 of 16,0.64,93.75,3.299E-10,8.447E-09
GO:0004386,helicase activity,Q9TTA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)F1MEM4(Evidence code:IEA/Database source:InterPro:IPR007502)E1BNQ2(Evidence code:IEA/Database source:InterPro:IPR007502)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)Q3SZ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q28141(Evidence code:IEA/Database source:InterPro:IPR007502)E1BJ90(Evidence code:IEA/Database source:InterPro:IPR007502)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)F1MNA1(Evidence code:IEA/Database source:InterPro:IPR007502)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)G5E631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q0V8H0(Evidence code:IEA/Database source:InterPro:IPR007502)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)D3IVZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0347), SMARCAL1 DHX8 DHX37 CHD8 BLM EIF4A1 RUVBL1 DHX9 DHX34 WRN DDX4 RUVBL2 TDRD9 EIF4A3 ERCC2 EIF4A2 DDX3X DHX57 DDX1 DDX3Y DICER1,MF,21,21 of 41,0.89,51.22,3.764E-10,9.546E-09
GO:0005770,late endosome,Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)A6QR68(Evidence code:IEA/Database source:UniProtKB:Q8K211|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)A5PK00(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)Q3T0Q2(Evidence code:ISS/Database source:UniProtKB:Q9BXS4)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05204(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P11456(Evidence code:IEA/Database source:UniProtKB:P24668|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2HJG5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens), BACE1 PIK3R4 SLC31A1 CHMP2B VPS36 ATP7B CLN3 TMEM59 SRC STX7 MAPK1 RAPGEF2 VAMP5 VPS41 LAMP1 M6PR TSG101 RAB9A VPS29 VPS35 EXOC8,CC,21,21 of 41,0.89,51.22,3.764E-10,9.546E-09
GO:0007018,microtubule-based movement,F1N724(Evidence code:IEA/Database source:InterPro:IPR004273|I)Q0III3(Evidence code:IEA/Database source:InterPro:IPR025956)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR004273|I)Q2NL05(Evidence code:IEA/Database source:InterPro:IPR001752|I)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR004273|I)E1BGB0(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q3T140(Evidence code:IEA/Database source:InterPro:IPR016561)F1MNK8(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q0II58(Evidence code:IEA/Database source:InterPro:IPR001752|I)G3N1E4(Evidence code:IBA/Database source:PANTHER:PTN000649056)A7E3C1(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q2KII9(Evidence code:IEA/Database source:InterPro:IPR008467)G5E5S3(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BC41(Evidence code:IEA/Database source:InterPro:IPR001752|I)Q3MHM9(Evidence code:IEA/Database source:InterPro:IPR001752|I)A5D7N6(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR001752|I)A7MBA1(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR004273|I)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR004273|I)F1N1K6(Evidence code:IEA/Database source:InterPro:IPR004273|I)G3MXV5(Evidence code:IEA/Database source:InterPro:IPR001752|I)E1BBN7(Evidence code:IEA/Database source:InterPro:IPR001752|I), DNAH11 DYNC1I2 DNAH7 KIF2A BICD2 DNAH10 KIF13B DYNLRB1 KIF26B KIF5C KIF26A KIF5A DYNC1LI1 KIF14 KIF15 KIF5B KIF23 KIFC3 KIFC1 DYNC1H1 DNAH5 DNHD1 KIF13A KIF1B,BP,24,24 of 56,1.02,42.86,3.79E-10,9.565E-09
GO:0001843,neural tube closure,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1N643(Evidence code:IEA/Database source:InterPro:IPR030494)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens)A6H769(Evidence code:IEA/Database source:UniProtKB:P62082|ens), TRAF6 SCRIB ARHGAP35 SALL4 SHROOM3 LRP6 MTHFD1 ABL1 PTK7 PRKACA ARID1A PHACTR4 PRKACB RPS7,BP,14,14 of 13,0.59,107.69,3.946E-10,9.866E-09
GO:0030286,dynein complex,P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)F1N5R7(Evidence code:IEA/Database source:InterPro:IPR004273)Q3T140(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)F1ME41(Evidence code:IEA/Database source:InterPro:IPR001372|I)Q0III3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0243)F1N1K6(Evidence code:IEA/Database source:InterPro:IPR004273)Q3MHR3(Evidence code:IEA/Database source:InterPro:IPR001372|I)E1BMG2(Evidence code:IEA/Database source:InterPro:IPR004273)P61285(Evidence code:IEA/Database source:InterPro:IPR001372|I)E1B7A3(Evidence code:IEA/Database source:InterPro:IPR001372|I)F1MSP8(Evidence code:IEA/Database source:InterPro:IPR004273)E1BDX8(Evidence code:IEA/Database source:InterPro:IPR004273)F1N724(Evidence code:IEA/Database source:InterPro:IPR004273), DYNLT1 DNAH7 DYNLRB1 DCTN2 LOC101902172 DYNC1I2 DNHD1 DYNLL2 DNAH5 DYNLL1 LOC101905447 DNAH10 DYNC1H1 DNAH11,CC,14,14 of 13,0.59,107.69,3.946E-10,9.866E-09
GO:0008237,metallopeptidase activity,F1N2M2(Evidence code:IEA/Database source:InterPro:IPR024079)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR024079)E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)E1BP91(Evidence code:IEA/Database source:InterPro:IPR014782)F1MRA8(Evidence code:IEA/Database source:InterPro:IPR024079)P42891(Evidence code:IEA/Database source:InterPro:IPR024079)E1BFV4(Evidence code:IEA/Database source:InterPro:IPR024079)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)Q3SZH7(Evidence code:IEA/Database source:InterPro:IPR014782|I)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)G3X743(Evidence code:IEA/Database source:InterPro:IPR014782|I)Q9TT92(Evidence code:IEA/Database source:InterPro:IPR024079)E1BBU4(Evidence code:IEA/Database source:InterPro:IPR024079)G3MZT7(Evidence code:IEA/Database source:InterPro:IPR024079)Q9TT93(Evidence code:IEA/Database source:InterPro:IPR024079)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR024079)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR006026|I)Q24K02(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)F1MF35(Evidence code:IEA/Database source:InterPro:IPR006026|I)Q2HJH1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0482)P12820(Evidence code:IEA/Database source:InterPro:IPR001548), ADAMTS7 XPNPEP1 ADAMTS12 DPEP3 NPEPPS ADAM7 ECE1 ADAMTS14 BRCC3 LTA4H MBTPS2 RNPEP ADAMTS5 ADAM15 LOC531521 ADAMTS4 COPS5 ADAMTS18 MMP19 IDE TLL2 DNPEP ACE,MF,23,23 of 51,0.98,45.1,3.973E-10,9.889E-09
GO:0007266,Rho protein signal transduction,E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037801)Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens), GNA12 PAK4 PAK1 EPS8L1 PAK6 GNA13 PHACTR4 ARHGEF12 ROCK2 COL1A2 PAK3 PAK2 TAX1BP3,BP,13,13 of 10,0.55,130,4.028E-10,9.934E-09
GO:0006342,chromatin silencing,A0A0A0MPA2(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BH22(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)E1BLK1(Evidence code:IBA/Database source:PANTHER:PTN000968522)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR021169)A0A0A0MP93(Evidence code:IBA/Database source:PANTHER:PTN000604564)G8JL00(Evidence code:IBA/Database source:PANTHER:PTN000604564)A0A0A0MP90(Evidence code:IBA/Database source:PANTHER:PTN000604564)F1MM81(Evidence code:IBA/Database source:PANTHER:PTN000968522)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens)P0C0S4(Evidence code:IBA/Database source:PANTHER:PTN000604564)Q3ZBX9(Evidence code:IBA/Database source:PANTHER:PTN000604564)A4IFU5(Evidence code:IBA/Database source:PANTHER:PTN000604564), HIST1H2AJ HIST2H2AB UBR2 TNRC18 DOT1L LOC614881 LOC104975684 HIST1H2AC BAHCC1 PPM1D H2AFZ H2AFJ HIST3H2A,BP,13,13 of 10,0.55,130,4.028E-10,9.934E-09
GO:0030117,membrane coat,Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR002553|I)P63009(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q0IIM2(Evidence code:IDA/Database source:)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR000804)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692)E1BME2(Evidence code:IEA/Database source:InterPro:IPR002553)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR000804)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)P35604(Evidence code:IEA/Database source:InterPro:IPR000804)A0JN39(Evidence code:IEA/Database source:InterPro:IPR002553)A2VE21(Evidence code:IEA/Database source:InterPro:IPR002553|I)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR002553|I), AP2A2 CHMP4B AP2A1 AP2B1 ARL6 AP2S1 DNM1 COPB2 COPA AP3B2 AP1S1 CHMP2A COPZ1 COPB1 COPG2 CHMP4A AP2B1,CC,17,17 of 24,0.72,70.83,4.526E-10,1.111E-08
GO:0009898,cytoplasmic side of plasma membrane,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)G5E526(Evidence code:IEA/Database source:UniProtKB:Q93096|ens)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569), LITAF TRAF6 DLG1 G6PD CHMP4B fgfr3 CHMP4A PPP3CA PTP4A1 ATP2C2 PKP4,CC,11,11 of 5,0.47,220,4.6E-10,1.114E-08
GO:0051959,dynein light intermediate chain binding,P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491), DYNLL1 BICD2 DNAH7 LOC101905447 DNAH5 DYNLL2 LOC101902172 DNAH10 DYNC1H1 DNAH11 DNHD1,MF,11,11 of 5,0.47,220,4.6E-10,1.114E-08
GO:0045505,dynein intermediate chain binding,F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q3T140(Evidence code:IBA/Database source:PANTHER:PTN002244005)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491), DNAH11 LOC101905447 DYNLL2 DNAH5 DYNC1H1 DYNLL1 DYNLRB1 LOC101902172 DNAH7 DNAH10 DNHD1,MF,11,11 of 5,0.47,220,4.6E-10,1.114E-08
GO:0016477,cell migration,E1B718(Evidence code:IEA/Database source:InterPro:IPR027655)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)F1MP76(Evidence code:IBA/Database source:PANTHER:PTN000099415)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN001231165)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)Q5E9S7(Evidence code:IEA/Database source:UniProtKB:Q8N9B8|ens)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q5E963(Evidence code:IBA/Database source:PANTHER:PTN000974138)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN001231165)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)G3MXG3(Evidence code:IEA/Database source:InterPro:IPR027717)A4FUD6(Evidence code:IEA/Database source:InterPro:IPR030713)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)E1BP72(Evidence code:IEA/Database source:InterPro:IPR033232)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN001231165)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)G5E630(Evidence code:IBA/Database source:PANTHER:PTN001163006)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN001231165)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN001231165), FMNL3 PAK6 LCK ARHGAP35 SDC3 YES1 PAK2 PRPF40A CUL3 PTK7 RASGEF1A TYK2 PAK3 VAV2 GSK3A EMILIN1 SCRIB ARPC5L MYO18A PAK1 PAK4 JAK2 WWC1 CCDC88A ELMO2 GOLPH3 ADAMTS12 CDC42BPB FRK CD63 USP9X STRIP2 GRB2 PEAK1 ASTN1 CLN3 SRC ZAP70,BP,38,38 of 143,1.61,26.57,5.05E-10,1.217E-08
GO:0003714,transcription corepressor activity,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens)E1BGF9(Evidence code:IBA/Database source:PANTHER:PTN001435424)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8)F1MJ18(Evidence code:IEA/Database source:InterPro:IPR013289)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR033277)Q3MI00(Evidence code:ISS/Database source:UniProtKB:P0DMV8)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q66L42|ens)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens), TSG101 TCF7L2 WWTR1 AEBP2 ZHX3 NPAT PRMT5 CBFA2T2 CTBP1 GON4L DNAJB1 E2F7 ZNF366 BCOR MAP3K10 CRYM COPS2 POU4F2 SIRT6,MF,19,19 of 33,0.81,57.58,5.779E-10,1.387E-08
GO:0034765,regulation of ion transmembrane transport,F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q9TTA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MP22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3N3N2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)G3MZ07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)F1MTK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1B9S9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0851), SCN8A KCNG4 CLIC4 KCNF1 SCN10A KCNH5 KCNA4 CLIC1 KCNC4 CACNA1B CACNA1E SCN5A CACNA1C KCNMA1 KCNH6 CACNA1S NEDD4 SCN11A SCN3A KCNC3 KCNG2 CACNA1D HCN1 CACNA1F CLIC6,BP,25,25 of 63,1.06,39.68,5.965E-10,1.425E-08
GO:0045087,innate immune response,F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)E1BGE5(Evidence code:IEA/Database source:UniProtKB:Q9EPL8|ens)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)P58754(Evidence code:IEA/Database source:InterPro:IPR039217)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)A4FUZ5(Evidence code:ISS/Database source:UniProtKB:Q13530)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)P05059(Evidence code:NAS/Database source:)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0399)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1B719(Evidence code:IBA/Database source:PANTHER:PTN001506277), TEC IFNT3 MALT1 ZAP70 IFNT2 IPO7 ABL1 LY96 MX2 MB21D1 SRC LOC516599 SERINC5 NFKB1 ANKRD17 SERINC3 DDX58 TYK2 CHGA LCK YES1 JAK2 IRF1 LOC104968438 LGR4 SAMHD1 GRB2 TRIM14 ADAM15 DHX9 TLR4 PIK3CD SFTPD FCER1G FRK ANKHD1,BP,36,36 of 131,1.53,27.48,6.573E-10,1.563E-08
GO:0005902,microvillus,P31408(Evidence code:IEA/Database source:UniProtKB:P62814|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q3UQ44|ens)Q29423(Evidence code:ISS/Database source:UniProtKB:P15379)A6QLD1(Evidence code:IEA/Database source:UniProtKB:O35382|ens)F1MLR9(Evidence code:IEA/Database source:UniProtKB:Q6PIF6|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens)F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)Q32LP2(Evidence code:ISS/Database source:UniProtKB:P26043)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6)P31404(Evidence code:IEA/Database source:UniProtKB:P50516|ens), ATP6V1B2 LRRK2 IQGAP2 CD44 EXOC4 MYO7B AQP5 STARD10 RDX CLIC4 MYO1C MYO1A ATP6V1B1 ATP6V1A,CC,14,14 of 14,0.59,100,7.391E-10,1.75E-08
GO:0030097,hemopoiesis,F1MRU0(Evidence code:IEA/Database source:InterPro:IPR030118)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BDL2(Evidence code:IEA/Database source:UniProtKB:Q8BGB2|ens)F1MS56(Evidence code:IEA/Database source:UniProtKB:Q9CYR6|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q14004)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens), FLT3 RUNX1 KIT BRCA2 ETV2 MEIS1 TTC7A PGM3 PKNOX1 SPTA1 CDK6 CDK13 ASXL1,BP,13,13 of 11,0.55,118.18,8.234E-10,1.941E-08
GO:0045893,"positive regulation of transcription, DNA-templated",E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1N1M2(Evidence code:IEA/Database source:InterPro:IPR008013)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)E1BAD4(Evidence code:IEA/Database source:UniRule:UR000461770)A6QLP0(Evidence code:IEA/Database source:UniProtKB:Q9WVH3|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)Q95KV6(Evidence code:IEA/Database source:InterPro:IPR008013)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q5NUA6(Evidence code:IBA/Database source:PANTHER:PTN000696756)E1BNH7(Evidence code:IEA/Database source:UniProtKB:Q9BZ95|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)Q05B89(Evidence code:IEA/Database source:UniProtKB:Q9GZT8|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MBK6(Evidence code:IEA/Database source:UniProtKB:Q5T1R4|ens)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914), BLM GATA6 F2R EMILIN1 BRCA1 RUNX1 FOXO4 ZBTB17 ZNF516 POU3F1 RAI1 STAT3 CHD8 AXIN1 E2F1 SOX4 ESRRG ARID1A gata4 EAF2 NR1I2 FOXF1 BRCA2 PSEN1 GLI2 NFKB1 MKL1 KMT2A GLI1 STAT1 LEF1 NFE2L2 WHSC1L1 ZFHX3 SRF CDK5RAP2 SOX17 SP1 ERCC2 MT3 BCL3 FZD1 TBX3 AFAP1L2 NPAT LRP6 SMARCA2 NIF3L1 FAM129B TAF8 HCFC1 HIVEP3 IRF1,BP,53,53 of 255,2.25,20.78,8.756E-10,2.055E-08
GO:0016579,protein deubiquitination,F1N0A8(Evidence code:IEA/Database source:InterPro:IPR001394)E1BND0(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BG52(Evidence code:IEA/Database source:InterPro:IPR001394)F1MF37(Evidence code:IEA/Database source:InterPro:IPR001394)B7TCH8(Evidence code:IEA/Database source:InterPro:IPR001394)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BGW4(Evidence code:IEA/Database source:InterPro:IPR001394)A7Z056(Evidence code:IEA/Database source:InterPro:IPR001394)F1MWQ8(Evidence code:IBA/Database source:PANTHER:PTN000364080)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR001394)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR001394)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)A1L548(Evidence code:IEA/Database source:InterPro:IPR001394|I)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)Q3T0Y1(Evidence code:IEA/Database source:InterPro:IPR016615|I)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:O00303|ens)G5E630(Evidence code:IEA/Database source:InterPro:IPR001394), USP34 USP24 USP35 USP31 USP9Y USP13 USP36 USP20 DMWD USP32 USP39 OTUD7B USP5 STAMBP COPS5 OTUB1 EIF3F USP9X,BP,18,18 of 30,0.76,60,9.95E-10,2.325E-08
GO:0003713,transcription coactivator activity,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)E1BNH7(Evidence code:IEA/Database source:UniProtKB:Q9BZ95|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)E1BGK7(Evidence code:IBA/Database source:PANTHER:PTN000388601)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)E1BPF3(Evidence code:IEA/Database source:InterPro:IPR015668)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P53566)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR009110|I)E1B8K0(Evidence code:IEA/Database source:InterPro:IPR015668)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens), WWTR1 NPAT POU3F1 DHX9 LPIN2 RAP2C WHSC1L1 TAF10 MKL1 UBE2L3 MAML2 SOX4 SMARCA2 TAF4B HCFC1 BRCA1 FAM129B BCL9 SOX17 CEBPA RUVBL1 NCOA3 BCL9L WWC1 ASXL1,MF,25,25 of 65,1.06,38.46,1.003E-09,2.334E-08
GO:0000790,nuclear chromatin,A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)A0A0A0MP93(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BH22(Evidence code:IBA/Database source:PANTHER:PTN000604564)G3N131(Evidence code:IEA/Database source:UniProtKB:Q02539|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)P0C0S4(Evidence code:IBA/Database source:PANTHER:PTN000604564)A7E320(Evidence code:ISS/Database source:UniProtKB:Q8VDF2)A5PK20(Evidence code:IDA/Database source:)A4IFU5(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)G8JL00(Evidence code:IBA/Database source:PANTHER:PTN000604564)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q3ZBX9(Evidence code:IBA/Database source:PANTHER:PTN000604564)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens)A0A0A0MP90(Evidence code:IBA/Database source:PANTHER:PTN000604564)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)A0A0A0MPA2(Evidence code:IBA/Database source:PANTHER:PTN000604564), IPO4 RIF1 SMARCA2 LOC614881 HIST2H2AB HIST1H1A SP1 H2AFZ UHRF1 HIST1H1E HIST3H2A E2F1 LOC104975684 SRF CCAR2 H2AFJ TTC21B HIST1H2AC NCOA3 ARID1A HIST1H2AJ,CC,21,21 of 44,0.89,47.73,1.015E-09,2.352E-08
GO:0006897,endocytosis,P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)F1N7K7(Evidence code:IEA/Database source:UniProtKB:Q60754|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)E0AE16(Evidence code:IEA/Database source:InterPro:IPR028644|I)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)A6H7I5(Evidence code:IEA/Database source:InterPro:IPR027188)F1MX23(Evidence code:IEA/Database source:InterPro:IPR028501|I)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)P35509(Evidence code:IBA/Database source:PANTHER:PTN000226268)Q08DF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR028642|I)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)Q2KJA1(Evidence code:IEA/Database source:InterPro:IPR028501)O02675(Evidence code:ISS/Database source:UniProtKB:Q16555)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)Q2KHV6(Evidence code:IBA/Database source:PANTHER:PTN000058569)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)E1BMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)O18964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0254)A7E3X2(Evidence code:IBA/Database source:PANTHER:PTN000226268)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000226268)A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)Q1RMH8(Evidence code:IBA/Database source:PANTHER:PTN000058569)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens), AP2B1 MARCO CLINT1 AP2S1 SNX9 NPC1 MYO6 AP2A2 WASF2 DNM2 SH3GL3 CLN3 CSNK1G3 DNM1 SNX33 DENND1A SH3GL1 DPYSL2 AP2M1 SNX8 AAK1 AP2A1 SYNJ1 USP20 CSNK1G1 LRRK2 CSNK1G2 SNX12 SNX3 SNX18,BP,30,30 of 96,1.27,31.25,1.375E-09,3.172E-08
GO:0006281,DNA repair,Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1B8X8(Evidence code:IEA/Database source:InterPro:IPR015525)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR018982)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)Q864U1(Evidence code:IEA/Database source:InterPro:IPR011364|I)Q05B83(Evidence code:IBA/Database source:PANTHER:PTN000186209)Q4VE16(Evidence code:IEA/Database source:InterPro:IPR001126|I)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)Q29RK4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A4IF83(Evidence code:IEA/Database source:InterPro:IPR003310|I)E1B7Q7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)E1BGK8(Evidence code:IBA/Database source:PANTHER:PTN000485246)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)F1MBL6(Evidence code:IBA/Database source:PANTHER:PTN000124197)Q08DI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR004582|I)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)E1BMC0(Evidence code:IEA/Database source:UniProtKB:Q8CGS6|ens)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)Q32LH8(Evidence code:IEA/Database source:InterPro:IPR006642)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR018982)P84798(Evidence code:IEA/Database source:UniProtKB-KW:KW-0228)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234)Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR030101)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR037706)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0234), ALKBH2 BRCA2 RUVBL2 WRN PAXIP1 BRCA1 RFC2 POLI CDK1 RAD23B BRCC3 ZFYVE26 TDG TRIP12 UHRF1 DOT1L PRMT6 SMG1 ETAA1 RAD17 INO80 POLQ MMS19 SAMHD1 ERCC2 RAD18 PARP1 LIG1 ATM BLM POLD3 INTS3 RUVBL1 SMARCAL1 PRKDC CDC5L,BP,36,36 of 136,1.53,26.47,1.534E-09,3.523E-08
GO:0043066,negative regulation of apoptotic process,P48734(Evidence code:ISS/Database source:UniProtKB:P06493)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q5E9C2(Evidence code:IEA/Database source:UniProtKB:P61804|ens)P02510(Evidence code:ISS/Database source:UniProtKB:P02511)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q04760|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens)E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens), CDK1 BIRC6 SRC BCL3 CHD8 AGO4 PSEN1 LEF1 STAT5B STAT5A PRKDC DSTYK SETX TCL1A GATA6 ALMS1 BCL11B MYO18A COPS5 PRNP PLK3 TBX3 FAM129B GOLPH3 DAD1 CRYAB BRAF MT3 FIGNL1 AHI1 KIF14 PDCD10 GLI2 PLAC8 PAK2 GLO1 MYDGF ASNS AGAP2 PKHD1 CAT CIB1 ANKLE2,BP,43,43 of 186,1.83,23.12,1.547E-09,3.538E-08
GO:0038083,peptidyl-tyrosine autophosphorylation,E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357), ZAP70 GRB2 JAK2 TYK2 TEC ABL1 SRC YES1 LCK FRK,BP,10,10 of 4,0.42,250,1.652E-09,3.762E-08
GO:0045211,postsynaptic membrane,E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens)F1MCW8(Evidence code:IEA/Database source:UniProtKB:Q8BMF5|ens)F1MBY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)G0T3G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)F1MRT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens)E1BGZ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)Q08DF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628)P02715(Evidence code:IEA/Database source:InterPro:IPR002394)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0628), KCTD16 DLG1 KCNMA1 LIN7B GABRA5 DNM2 GPHN GRIK4 GRIA2 GRIA1 SCRIB F2R UTRN SHANK1 PCDHB8 GRIA3 RNF112 ABHD17C LIN7A CHRNE SHANK2 LIN7C,CC,22,22 of 51,0.93,43.14,1.819E-09,4.124E-08
GO:0003824,catalytic activity,Q75WB5(Evidence code:IEA/Database source:InterPro:IPR003692)Q2KIH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR015813)Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR013785)A6QPG6(Evidence code:IEA/Database source:InterPro:IPR012341)E1BD03(Evidence code:IEA/Database source:InterPro:IPR001932)Q17QI3(Evidence code:IEA/Database source:InterPro:IPR016039)F1MI35(Evidence code:IEA/Database source:InterPro:IPR011041)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR001093|I)Q32L93(Evidence code:IEA/Database source:InterPro:IPR001093|I)E1BCH6(Evidence code:IEA/Database source:InterPro:IPR018294)Q24K02(Evidence code:IEA/Database source:InterPro:IPR011249)A7E3D9(Evidence code:IEA/Database source:InterPro:IPR000873)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR015955)Q3T0S5(Evidence code:IEA/Database source:InterPro:IPR013785)Q148D3(Evidence code:IEA/Database source:InterPro:IPR008948|I)P15101(Evidence code:IEA/Database source:InterPro:IPR008977)F1MLE1(Evidence code:IEA/Database source:InterPro:IPR000873)Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR000845|I)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)A7YY67(Evidence code:IEA/Database source:InterPro:IPR011034)Q1RMX7(Evidence code:IEA/Database source:InterPro:IPR013785)E1BI49(Evidence code:IEA/Database source:InterPro:IPR012341)A7YWF1(Evidence code:IEA/Database source:InterPro:IPR000873)Q17QK4(Evidence code:IEA/Database source:InterPro:IPR000639)Q148K4(Evidence code:IEA/Database source:InterPro:IPR004113|I)F1MPW1(Evidence code:IEA/Database source:InterPro:IPR000873)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR006047|I)E1BCW3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)E1BM12(Evidence code:IEA/Database source:InterPro:IPR001045)E1BPZ8(Evidence code:IEA/Database source:InterPro:IPR002591|I)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR010997)Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR015421|I)A3KN12(Evidence code:IEA/Database source:InterPro:IPR008948|I)Q0IIG5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)F1MWT0(Evidence code:IEA/Database source:InterPro:IPR011013|I)A5PK51(Evidence code:IEA/Database source:InterPro:IPR013785)E1BM45(Evidence code:IEA/Database source:InterPro:IPR002591|I)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR015421)Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR001509)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR005811)A1A4J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)A2VDS1(Evidence code:IEA/Database source:InterPro:IPR015421|I)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)Q5E985(Evidence code:IEA/Database source:InterPro:IPR013785)A6QLY4(Evidence code:IEA/Database source:InterPro:IPR000868|I)E1BP41(Evidence code:IEA/Database source:InterPro:IPR015421)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR004838|I)P31754(Evidence code:IEA/Database source:InterPro:IPR011060|I)Q2YDJ4(Evidence code:IEA/Database source:InterPro:IPR011146)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR010997)Q1KZG4(Evidence code:IEA/Database source:InterPro:IPR011146)E1B7K0(Evidence code:IEA/Database source:InterPro:IPR013785)A6QPY4(Evidence code:IEA/Database source:InterPro:IPR017849|I)G3MXQ8(Evidence code:IEA/Database source:InterPro:IPR012341)A8E657(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)F1MJ90(Evidence code:IEA/Database source:InterPro:IPR008928)Q28007(Evidence code:IEA/Database source:InterPro:IPR013785)Q5I598(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)F1MIU7(Evidence code:IEA/Database source:InterPro:IPR000873)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0511)A5PJL6(Evidence code:IEA/Database source:InterPro:IPR011766)Q08DD1(Evidence code:IEA/Database source:InterPro:IPR017849|I)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR011034)Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR016193)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0021)B3IVN4(Evidence code:IEA/Database source:InterPro:IPR015813)A4FUD0(Evidence code:IEA/Database source:InterPro:IPR020867)Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR016039)Q5EA61(Evidence code:IEA/Database source:InterPro:IPR014746)A7MBJ3(Evidence code:IEA/Database source:InterPro:IPR012341), OPLAH PAH PKLR HAO2 LANCL2 PPM1D ACAT2 HHIPL1 IMPDH2 GMPR2 ISPD IDE ACSL4 UEVLD ALDOB FH DBH DIP2B MTAP PAK1 ALDH1L1 NANS MAN1A2 ACSS2 EPHX2 LDHD DIP2A GBE1 PFKP SRM PIGO SAMHD1 WRN SHMT2 ADSL PFKM MAN2C1 NAPRT PIGN LYZ1 PDXDC1 TSTA3 ACLY PFKL SCLY LYZ HYAL1 ISOC1 CSAD TAT UMPS HINT3 BLM FHIT GALC SGSH MAN1B1 AASS PHKB DPYD MTHFR SLC27A3 GART HACL1 ARSA ALDH1L2 ATIC SPAST PKM MTHFD1 HMGCS1 CKB EDEM2,MF,73,73 of 1952,3.1,3.74,1.863E-09,4.206E-08
GO:0001077,"transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding",Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:O95948|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)E1BHB8(Evidence code:IEA/Database source:UniProtKB:Q9Y2V3|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)Q7YRX0(Evidence code:IEA/Database source:UniProtKB:Q96IS3|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens), SOX4 SP7 TCF7L2 ETV2 ZNF750 LEF1 GLI2 ONECUT2 POU4F2 RAX BCL11B ZBTB17 SOX1 MEIS1 RAX2 HOXA7 SP1 SRF,MF,18,18 of 32,0.76,56.25,2.151E-09,4.837E-08
GO:0018107,peptidyl-threonine phosphorylation,E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63085)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN000680267)E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680267)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN000680267)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens), MAP3K10 MAPK1 CAMK2B LRRK2 TNKS MYLK2 CAMK2D DCLK2 LMTK2 CAMK2A MYLK3 MYLK4 CDK1 PRKACA,BP,14,14 of 16,0.59,87.5,2.35E-09,5.261E-08
GO:0090630,activation of GTPase activity,A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)G3MXA5(Evidence code:IEA/Database source:InterPro:IPR033360)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)E1BP38(Evidence code:IBA/Database source:PANTHER:PTN000006983)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens), TBC1D22B TIAM1 TBC1D2 SCRIB MTSS1L TBC1D12 APC2 RABGAP1 RALGAPA1 SGSM2 TAX1BP3,BP,11,11 of 7,0.47,157.14,2.946E-09,6.569E-08
GO:0072686,mitotic spindle,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)P46196(Evidence code:ISS/Database source:UniProtKB:P26696)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)P61285(Evidence code:ISS/Database source:UniProtKB:P63167)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)A7YY70(Evidence code:IEA/Database source:UniProtKB:A0A024R7R9), NUMA1 TPR KIF23 EML2 RACGAP1 IKBKG CDK1 MAPK1 SIRT2 DYNLL1 PKHD1 PKP4 SLC34A1,CC,13,13 of 13,0.55,100,3.011E-09,6.686E-08
GO:1902476,chloride transmembrane transport,E1BF90(Evidence code:IEA/Database source:GO:0005254)Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295)F1MS75(Evidence code:IEA/Database source:GO:0015377)Q08E50(Evidence code:IEA/Database source:GO:0005254)Q5E9B7(Evidence code:IBA/Database source:PANTHER:PTN000136443)F1N1D4(Evidence code:IEA/Database source:GO:0005254)F1MS08(Evidence code:IEA/Database source:GO:0015377)Q6BBL6(Evidence code:IEA/Database source:GO:0005254)Q1LZF8(Evidence code:IEA/Database source:GO:0005254)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443)P35071(Evidence code:ISS/Database source:UniProtKB:P13569), BEST3 CLIC4 ANO6 SLC12A1 GABRA5 CLIC1 TTYH3 SLC12A2 CLDN4 CLCC1 CLIC6 CFTR,BP,12,12 of 10,0.51,120,3.351E-09,7.409E-08
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)E1B7Y9(Evidence code:IEA/Database source:UniProtKB:Q6IQ16|ens)Q3T0B2(Evidence code:IBA/Database source:PANTHER:PTN000365348)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)Q2KJ25(Evidence code:IBA/Database source:PANTHER:PTN000091582)P33672(Evidence code:IEA/Database source:InterPro:IPR033811)P61085(Evidence code:IBA/Database source:PANTHER:PTN000629609)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BP63(Evidence code:IBA/Database source:PANTHER:PTN000280277)P62194(Evidence code:ISS/Database source:UniProtKB:P62195)A6QNS2(Evidence code:IEA/Database source:UniProtKB:O95155|ens)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596256)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)F1MJP2(Evidence code:IBA/Database source:PANTHER:PTN000280277)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN000697161)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR015360|I)A7MBA2(Evidence code:IBA/Database source:PANTHER:PTN000101661)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens), PCBP2 SPOPL PSMD6 CUL3 GSK3A PPP2CB PSMD12 PSMB3 UBE2K BTBD11 RNF139 PSMC5 UBE4B NSFL1C BTBD6 RNF165 FBXO45 BTBD3 KEAP1 RAD23B PSMD1 RFFL PSMD2 SIRT2 NFE2L2 KIF14,BP,26,26 of 76,1.1,34.21,3.526E-09,7.763E-08
GO:0042592,homeostatic process,Q2KIN6(Evidence code:IEA/Database source:UniProtKB:P39210|ens),MPV17,BP,1,1 of 330,0.04,0.3,3.561E-09,7.808E-08
GO:0010033,response to organic substance,E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)P68107(Evidence code:ISA/Database source:UniProtKB:P97534)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979), CDK6 FKBP1B CDK3,BP,3,3 of 408,0.13,0.74,3.617E-09,7.899E-08
GO:0046907,intracellular transport,P48820(Evidence code:IEA/Database source:InterPro:IPR000156)A3KN15(Evidence code:IEA/Database source:InterPro:IPR016902), RANBP2 VPS41,BP,2,2 of 369,0.08,0.54,3.843E-09,8.359E-08
GO:0086010,membrane depolarization during action potential,E1B9S9(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MHP0(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MTK5(Evidence code:IBA/Database source:PANTHER:PTN000004140)E1BIB9(Evidence code:IBA/Database source:PANTHER:PTN000004140)E1BHM6(Evidence code:IBA/Database source:PANTHER:PTN000004140)G3MYM1(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MP22(Evidence code:IBA/Database source:PANTHER:PTN000004140)F1MMU9(Evidence code:IBA/Database source:PANTHER:PTN000004140), CACNA1F SCN5A CACNA1D TPCN2 SCN11A SCN10A CACNA1E SCN8A,BP,8,8 of 1,0.34,800,3.879E-09,8.403E-08
GO:0004004,ATP-dependent RNA helicase activity,Q3SZ65(Evidence code:IEA/Database source:InterPro:IPR037583)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN000618218)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q28141(Evidence code:IBA/Database source:PANTHER:PTN000433338)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433338)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000618218)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q3SZ54(Evidence code:IEA/Database source:InterPro:IPR037583)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)Q0IIK5(Evidence code:IBA/Database source:PANTHER:PTN000618218), EIF4A2 DDX4 DDX20 DHX8 DHX9 DHX37 DDX3Y TDRD9 EIF4A3 DDX3X EIF4A1 DHX34 SNRNP200 DDX1,MF,14,14 of 17,0.59,82.35,4.014E-09,8.625E-08
GO:0071805,potassium ion transmembrane transport,Q05037(Evidence code:ISS/Database source:UniProtKB:P22459)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q17QQ3(Evidence code:IEA/Database source:GO:0005249)E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)G3N279(Evidence code:IEA/Database source:GO:0005249)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169)A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1N4T0(Evidence code:IEA/Database source:GO:0005249)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631), KCNA4 KCNG2 SNAP25 KCNC4 KCNQ5 HCN1 KCNF1 KCNH5 LRRC26 KCNH6 KCNT2 KCNG4 KCNMA1 KCNC3,BP,14,14 of 17,0.59,82.35,4.014E-09,8.625E-08
GO:0000977,RNA polymerase II regulatory region sequence-specific DNA binding,F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BL97(Evidence code:IEA/Database source:UniProtKB:Q04891|ens)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q6S7F2|ens)F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)G3MY92(Evidence code:IBA/Database source:PANTHER:PTN000358347)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q8CGN4|ens)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens), ZBTB4 LMO2 LEF1 GATA6 NR1I2 SP1 ARHGAP35 PURB NFKB1 CDC5L TFDP2 EHMT2 SOX13 ZMYND8 ARID3A FOXF1 E2F7 CUX2 ASCL4 RREB1 EAF2 DLX2 GLI1 RUNX1 BCOR ESRRG,MF,26,26 of 77,1.1,33.77,4.408E-09,9.359E-08
GO:0006813,potassium ion transport,E1BMA2(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q28204(Evidence code:IEA/Database source:InterPro:IPR003929|I)Q08DA1(Evidence code:IEA/Database source:InterPro:IPR005775)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003968|I)G3N279(Evidence code:IEA/Database source:InterPro:IPR028325)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003968|I)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1MP51(Evidence code:IEA/Database source:InterPro:IPR003938|I)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1BM97(Evidence code:IEA/Database source:InterPro:IPR003938)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1N4T0(Evidence code:IEA/Database source:InterPro:IPR003929)Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)Q05037(Evidence code:IEA/Database source:InterPro:IPR003968|I)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775), KCNH6 KCNMA1 ATP1A1 KCNC3 KCNQ5 KCNC4 KCNF1 KCNH5 KCNG2 HCN1 KCNG4 KCNT2 VPS4B KCNA4 ATP1A2,BP,15,15 of 21,0.64,71.43,4.398E-09,9.359E-08
GO:0017124,SH3 domain binding,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)O46631(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)A4FUD6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)A4IFC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0729)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens), GRB2 PTPN6 CBLC WASF2 SIRPA ADAM15 AFAP1L2 CRK ABL1 ELMO2 DAB2IP ABI1 SH3BGRL2 MVB12A DENND1A,MF,15,15 of 21,0.64,71.43,4.398E-09,9.359E-08
GO:0030027,lamellipodium,P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P0C1G6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P08487(Evidence code:ISS/Database source:UniProtKB:P19174)P68138(Evidence code:ISS/Database source:UniProtKB:P08023)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0), ITGB1 SWAP70 PHACTR4 DPP4 NF2 FLOT1 IQGAP2 MTSS1L CYFIP1 ARAP3 CTTN WASF2 PLCG1 ACTA1 AMOTL1 FAT1 CIB1 ABI1 PTPRM PDXP,CC,20,20 of 44,0.85,45.45,4.834E-09,1.018E-07
GO:0051082,unfolded protein binding,A1A4P5(Evidence code:IEA/Database source:InterPro:IPR002777)Q3ZCH0(Evidence code:IEA/Database source:InterPro:IPR012725)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)Q3T084(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3ZBA6(Evidence code:IEA/Database source:InterPro:IPR008971)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)F1MWD3(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q2NKZ1(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3MI00(Evidence code:IEA/Database source:InterPro:IPR008971)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR001305|I)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404)Q3ZCI9(Evidence code:IEA/Database source:InterPro:IPR002194|I)F1MGK3(Evidence code:IEA/Database source:UniProtKB:Q96DZ1|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)Q3T0K2(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q2KIT4(Evidence code:IEA/Database source:InterPro:IPR008971)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q32L40(Evidence code:IEA/Database source:InterPro:IPR002194|I), PFDN2 HSPA9 CRYAB CCT6B DNAJB11 SYVN1 CCT5 CCT7 DNAJB1 DZIP3 DNAJA2 UGGT2 TRAP1 CCT8 ERLEC1 TOR1A CCT3 DNAJB4 DNAJB2 TCP1,MF,20,20 of 44,0.85,45.45,4.834E-09,1.018E-07
GO:0007160,cell-matrix adhesion,F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q5TAT6|ens)F1MJQ6(Evidence code:IEA/Database source:UniProtKB:Q9JLI2|ens)F1MF97(Evidence code:IEA/Database source:InterPro:IPR003886)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)E1BN52(Evidence code:IEA/Database source:InterPro:IPR032825)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)P32592(Evidence code:IEA/Database source:InterPro:IPR015439), ADAMTS12 COL13A1 COL5A3 NID2 EMILIN1 FERMT2 FREM1 ITGB1 ITGB7 SRF CD63 ITGB6 ITGB2,BP,13,13 of 14,0.55,92.86,5.441E-09,1.142E-07
GO:0006887,exocytosis,Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)Q3ZC43(Evidence code:IEA/Database source:InterPro:IPR004140)A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)A5D7F2(Evidence code:IEA/Database source:InterPro:IPR028683)E1BBK9(Evidence code:IEA/Database source:InterPro:IPR028378)A4IF89(Evidence code:IEA/Database source:InterPro:IPR033961)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)A6QP06(Evidence code:IEA/Database source:InterPro:IPR027006)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR009976|I)A6QQU0(Evidence code:IEA/Database source:InterPro:IPR019160)A6QLT7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)P11023(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0268)P63026(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q0V8C2(Evidence code:IEA/Database source:InterPro:IPR010326)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885), PAK1 RIMS1 EXOC7 EXOC4 LIN7B VAMP1 SYT4 SYTL1 EXOC8 VAMP5 LIN7C SYTL2 LIN7A EXOC5 EXOC1 EXOC6 RAB3A MICAL3 VAMP2 EXOC3 VAMP3,BP,21,21 of 50,0.89,42,6.121E-09,1.279E-07
GO:0004843,thiol-dependent ubiquitin-specific protease activity,A7Z056(Evidence code:IEA/Database source:InterPro:IPR006615)Q3T0Y1(Evidence code:IEA/Database source:InterPro:IPR030298)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR006615)A1L548(Evidence code:IEA/Database source:InterPro:IPR016652)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)F2Y8Y4(Evidence code:IEA/Database source:InterPro:IPR039087)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:O00303|ens)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR016652)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens)F1MF37(Evidence code:IEA/Database source:UniProtKB:Q70CQ4|ens)E1BG52(Evidence code:IEA/Database source:UniProtKB:Q9P2H5|ens)G3N2I1(Evidence code:IEA/Database source:UniProtKB:Q5VV17|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens), USP20 OTUB1 USP36 BRCC3 USP32 USP5 STAMBP VCPIP1 EIF3F USP13 COPS5 OTUD4 USP31 USP35 OTUD1 OTUD7B,MF,16,16 of 26,0.68,61.54,6.417E-09,1.336E-07
GO:0007224,smoothened signaling pathway,Q2NKY7(Evidence code:ISS/Database source:UniProtKB:P42208)A6H727(Evidence code:IEA/Database source:InterPro:IPR032850)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), SEPT2 GLI1 GLI2 Gli3 BOC MAP3K10 C1H21ORF2 IQUB TTC21B DYRK2 CDON FOXF1,BP,12,12 of 11,0.51,109.09,6.566E-09,1.357E-07
GO:0008286,insulin receptor signaling pathway,F1MYE0(Evidence code:IEA/Database source:InterPro:IPR039011)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)F1MXR0(Evidence code:IBA/Database source:PANTHER:PTN001022094)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18052|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000037430)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)F1MGG8(Evidence code:IEA/Database source:InterPro:IPR039011)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)Q5EAD0(Evidence code:IBA/Database source:PANTHER:PTN001022094)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens), IRS1 GSK3A BAIAP2L1 PTPRA FOXO4 SHC1 KL IRS4 SH2B2 GRB2 BAIAP2 APPL1,BP,12,12 of 11,0.51,109.09,6.566E-09,1.357E-07
GO:0004725,protein tyrosine phosphatase activity,E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000242|I)P56722(Evidence code:ISS/Database source:UniProtKB:Q60673)A6QLS1(Evidence code:IEA/Database source:EC:3.1.3.48)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000242|I)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000242|I)A5D980(Evidence code:IEA/Database source:InterPro:IPR000242|I)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR016130)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000242|I)G5E526(Evidence code:IBA/Database source:PANTHER:PTN000596945)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000242|I)A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000242|I)P11064(Evidence code:IEA/Database source:InterPro:IPR017867)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR016130)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR016130), PTPN23 PTPRN DUSP7 PTPRZ1 PTPRA PTPN6 DUSP3 PTPRM PTP4A1 PTPN14 PTPN5 ACP1 SSH2 MTMR1,MF,14,14 of 18,0.59,77.78,6.683E-09,1.375E-07
GO:0010469,regulation of signaling receptor activity,P56831(Evidence code:IEA/Database source:GO:0005125)P56830(Evidence code:IEA/Database source:GO:0005125)P26917(Evidence code:IEA/Database source:GO:0005179)Q95106(Evidence code:IEA/Database source:GO:0008083)Q28038(Evidence code:IEA/Database source:GO:0008083)Q8MJ29(Evidence code:IEA/Database source:GO:0005125)Q27954(Evidence code:IEA/Database source:GO:0005179)A4FV80(Evidence code:IEA/Database source:GO:0008083)A6YT15(Evidence code:IEA/Database source:GO:0005125)E1BF06(Evidence code:IEA/Database source:GO:0005125)P03968(Evidence code:IEA/Database source:GO:0008083)G3N183(Evidence code:IEA/Database source:GO:0005125)E1BJY4(Evidence code:IEA/Database source:GO:0008083)Q2WGK0(Evidence code:IEA/Database source:GO:0005179)P01175(Evidence code:IEA/Database source:GO:0005179), IFNT3 IFNT2 SST BDNF MIA IFNT COPA FBRS CCL28 TNFSF15 FGF1 LOC104968438 PDGFC PRP8 OXT,BP,15,15 of 22,0.64,68.18,6.926E-09,0.000000142
GO:0000165,MAPK cascade,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MDL4(Evidence code:IEA/Database source:GO:0004709)F1MVV5(Evidence code:IEA/Database source:GO:0004707)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)E1B7J7(Evidence code:IEA/Database source:GO:0004708)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR038786)Q3SWY6(Evidence code:IEA/Database source:GO:0008349)Q28165(Evidence code:ISS/Database source:UniProtKB:Q8CCS6)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR038785)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN001553005)F1N5W5(Evidence code:IEA/Database source:GO:0008349)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F1N3T0(Evidence code:IEA/Database source:GO:0004709)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens)P46196(Evidence code:IEA/Database source:GO:0004707), LRRK2 BRAF MAPK4 POU4F2 PAK3 MAPK12 STK25 PABPN1 MAPK13 MAPKAPK3 STK26 TAOK3 SETX MAP3K4 fgfr3 MAP2K4 MAPK1,BP,17,17 of 31,0.72,54.84,7.969E-09,1.628E-07
GO:0032270,positive regulation of cellular protein metabolic process,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens),EIF4G1,BP,1,1 of 322,0.04,0.31,8.179E-09,1.664E-07
GO:0016323,basolateral plasma membrane,Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658318)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)A4IFM4(Evidence code:IEA/Database source:UniProtKB:Q9Z260|ens)Q3B7N4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX1)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q3ZC83(Evidence code:IEA/Database source:UniProtKB:Q99808|ens)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32LM6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), C5AR1 SCRIB ABCC3 CNNM2 DLG1 ATP7B CLDN8 CLDN7 ATP6V1B1 LIN7C RAB17 MYO1A MYO1D DSTYK FLOT1 TFRC SLC29A1 LIN7B LIN7A,CC,19,19 of 41,0.81,46.34,9.079E-09,0.000000184
GO:0005249,voltage-gated potassium channel activity,E1BM97(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q28204(Evidence code:IEA/Database source:InterPro:IPR028325)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1N4T0(Evidence code:IEA/Database source:UniProtKB:Q6UVM3|ens)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)F1MP51(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q17QQ3(Evidence code:IEA/Database source:InterPro:IPR039077)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003968|I)G3N279(Evidence code:IEA/Database source:InterPro:IPR028325)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1BMA2(Evidence code:IEA/Database source:InterPro:IPR003938|I)Q05037(Evidence code:IEA/Database source:InterPro:IPR003968|I), HCN1 KCNMA1 KCNF1 KCNT2 LRRC26 KCNH5 SNAP25 KCNC3 KCNQ5 KCNG2 KCNC4 KCNG4 KCNH6 KCNA4,MF,14,14 of 19,0.59,73.68,1.087E-08,2.195E-07
GO:0006888,ER to Golgi vesicle-mediated transport,A6H7F7(Evidence code:IEA/Database source:InterPro:IPR006722)Q2TBL9(Evidence code:IBA/Database source:PANTHER:PTN000583159)Q28104(Evidence code:IBA/Database source:PANTHER:PTN000086687)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q27954(Evidence code:IBA/Database source:PANTHER:PTN000458798)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)P35605(Evidence code:IBA/Database source:PANTHER:PTN000458798)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)A0JN39(Evidence code:IBA/Database source:PANTHER:PTN000067242)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)F6PW02(Evidence code:IEA/Database source:InterPro:IPR033512)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895|I)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens), TRAPPC2L TRAPPC4 COPE PEF1 SEC24D SEC24C COPA SPAST COPB2 SEC23B SEC23A COPB1 PDCD6 CUL3 TFG SEC24A BCAP31,BP,17,17 of 32,0.72,53.12,1.142E-08,2.297E-07
GO:0032266,phosphatidylinositol-3-phosphate binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)A5PK00(Evidence code:IEA/Database source:InterPro:IPR021648)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR028730)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR028667|I), DAB2IP LANCL2 SH3PXD2A SNX19 VPS36 SNX3 ZFYVE26 DENND1A PLEKHA5 SNX27,MF,10,10 of 6,0.42,166.67,1.163E-08,2.323E-07
GO:0032508,DNA duplex unwinding,Q0P5I4(Evidence code:IEA/Database source:GO:0003678)A6QLJ0(Evidence code:IEA/Database source:GO:0043139)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)F1MLB2(Evidence code:IEA/Database source:GO:0003678)F1MFY4(Evidence code:IEA/Database source:GO:0004003)Q2TBU9(Evidence code:IEA/Database source:GO:0004003)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q28141(Evidence code:IDA/Database source:)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)A7MBG8(Evidence code:IEA/Database source:GO:0004003), MCM4 ERCC2 DDX1 CHD8 HELB RUVBL2 WRN DHX9 BLM RUVBL1,BP,10,10 of 6,0.42,166.67,1.163E-08,2.323E-07
GO:0017048,Rho GTPase binding,F1MGX4(Evidence code:IEA/Database source:InterPro:IPR010473)A2VDK3(Evidence code:IEA/Database source:InterPro:IPR010473|I)Q28021(Evidence code:IEA/Database source:InterPro:IPR015008)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)E1B718(Evidence code:IEA/Database source:InterPro:IPR010473)Q0VCF3(Evidence code:IEA/Database source:UniProtKB:Q9BRV8|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)A7E3A9(Evidence code:IEA/Database source:InterPro:IPR010473|I)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)A6QLJ4(Evidence code:IEA/Database source:InterPro:IPR039056), FMNL1 DAAM1 ROCK2 MYO9B PAK3 FMNL3 SIKE1 IQGAP2 STRN3 DIAPH3 LRRK2 CDC42SE2,MF,12,12 of 12,0.51,100,1.231E-08,2.449E-07
GO:0043231,intracellular membrane-bounded organelle,E1BP22(Evidence code:IEA/Database source:UniProtKB:A0A024R899)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)A6QR35(Evidence code:IEA/Database source:UniProtKB:A0A140VK92)E1BCG1(Evidence code:IBA/Database source:PANTHER:PTN000442469)F1MKS6(Evidence code:IEA/Database source:UniProtKB:J3KNS1|ens)P67810(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)P31408(Evidence code:IEA/Database source:UniProtKB:A0A140VK65)A2VDT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:A0A024R1Y6)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)Q1LZF8(Evidence code:IEA/Database source:UniProtKB:A0A024R0G0)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q17QB7(Evidence code:IEA/Database source:UniProtKB:A8K5R1|ens)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q9Y4G2|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens)Q1JPD9(Evidence code:IEA/Database source:UniProtKB:A0A024QYX2)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)Q5EA65(Evidence code:IEA/Database source:UniProtKB:Q9H3H5|ens)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)E1B718(Evidence code:IEA/Database source:UniProtKB:Q8IVF7|ens)E1BJM1(Evidence code:IEA/Database source:UniProtKB:A0A024QZH5)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MNM7(Evidence code:IEA/Database source:UniProtKB:Q96Q06|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BKQ2(Evidence code:IEA/Database source:UniProtKB:Q6WKZ4|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:A0A140VJD0)Q2KJ71(Evidence code:IEA/Database source:UniProtKB:Q13595|ens)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0492)A5D7F2(Evidence code:IEA/Database source:UniProtKB:Q9H2B2|ens)O19137(Evidence code:IEA/Database source:UniProtKB:O95639|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens)E1BMN0(Evidence code:IBA/Database source:PANTHER:PTN000066595)Q2KHV6(Evidence code:IEA/Database source:UniProtKB:Q9Y5X2|ens)A0JN39(Evidence code:IEA/Database source:UniProtKB:P53618|ens)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q92968|ens)E1BH40(Evidence code:IEA/Database source:UniProtKB:O75592|ens)F1N0J3(Evidence code:IEA/Database source:UniProtKB:P98196|ens)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)E1BJV5(Evidence code:IEA/Database source:UniProtKB:Q14966|ens)A7MBC2(Evidence code:IEA/Database source:UniProtKB:Q6P996|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:A0A024QYT6)F1MN49(Evidence code:IEA/Database source:UniProtKB:Q9GZV4|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q9NZM1|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)A4IFC8(Evidence code:IEA/Database source:UniProtKB:P18858|ens)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN000642960)E1BQ03(Evidence code:IEA/Database source:UniProtKB:A0A024R7E0)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)Q0VC12(Evidence code:IEA/Database source:UniProtKB:Q9GZM5|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB:A0A0S2Z5H3)A5D7C4(Evidence code:IEA/Database source:UniProtKB:A0A024R794)E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q9H8M5|ens)P68107(Evidence code:ISA/Database source:UniProtKB:P97534)F1MFF6(Evidence code:IBA/Database source:PANTHER:PTN000230403)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)Q3ZCK9(Evidence code:IEA/Database source:UniProtKB:P25789|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q9UJQ4|ens)F1MN60(Evidence code:IBA/Database source:PANTHER:PTN000642960)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000642960), RC3H2 XPO1 SCAMP2 ABCA7 AGTPBP1 SEC11A TOR1A CAT ATP6V1B2 HPS6 MAP3K14 PALM TAX1BP3 CLCC1 SEC13 GOLPH3 RAB30 PLEKHM1 CTTN ACSS2 ANKFY1 DENND1A GPRC5B NUP214 DPAGT1 AHCYL2 EPS15 RUNX1 ABCA1 ARID3A FMNL3 SPHK2 LRRK2 PLIN4 PRNP RAB11FIP1 LRWD1 TRA2A SPCS3 SYT4 CPSF4 DOT1L NEU4 SNX8 COPB1 DNAJC13 PEX13 MYCBP2 ATP11A DBH ZNF638 PDXDC1 SMARCA2 AP1S1 EIF5A2 GOLGA4 MYOF BCL3 LIG1 ATP2B3 NACC1 PACSIN2 YIPF3 CLINT1 TNPO3 CNNM2 FKBP1B UGT2B10 KANSL3 PSMA4 PIK3R4 LITAF SALL4 ATP2B2 ATP13A5,CC,75,75 of 1927,3.19,3.89,1.474E-08,2.921E-07
GO:0006915,apoptotic process,E1BHY2(Evidence code:IEA/Database source:InterPro:IPR028319)A4FUD6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR037554)P46196(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)E1BE13(Evidence code:IEA/Database source:InterPro:IPR022103)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR031215)Q1KZG4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)E1BF06(Evidence code:IEA/Database source:InterPro:IPR008064)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)Q9TU34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)Q08DY9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q3MHP3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P37359(Evidence code:IEA/Database source:GO:0043027)F1MN90(Evidence code:IEA/Database source:InterPro:IPR003508)P62248(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens)P26882(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0053), PPP1R13B ELMO2 PDCD6 CASP6 MAPK1 BIRC6 SH3GLB1 NOA1 AIFM1 IRF1 FHIT CYFIP2 CDK1 CIB1 TNFSF15 TAF10 ITPR1 DAD1 PRKCB PSEN1 SLC5A11 EGLN3 CASP3 FIS1 SHISA5 PAK1 AIFM2 S100A14 DYNLL1 MT3 CIDEC MYDGF CUL1 PPID AIMP2 CYCS,BP,36,36 of 151,1.53,23.84,1.567E-08,3.093E-07
GO:0007411,axon guidance,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q2T9S0(Evidence code:ISS/Database source:UniProtKB:Q9ERD7)Q32LG4(Evidence code:IEA/Database source:InterPro:IPR032985)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BER6(Evidence code:IEA/Database source:InterPro:IPR030624)A8E641(Evidence code:IEA/Database source:InterPro:IPR030626)E1BCH6(Evidence code:IEA/Database source:UniProtKB:Q5RJG7|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)O02675(Evidence code:IEA/Database source:InterPro:IPR030615)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506), MAPK8IP3 TUBB3 ROBO2 EXT1 ARHGAP35 CRMP1 DPYSL5 ISPD LAMB2 POU4F2 DPYSL2 GLI2 BOC SLIT2 CXCL12,BP,15,15 of 24,0.64,62.5,1.63E-08,3.207E-07
GO:0032147,activation of protein kinase activity,E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q1JPD9(Evidence code:IEA/Database source:GO:0030295)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BN63(Evidence code:IEA/Database source:GO:0030295)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825), PAK6 PRNP TRAF6 MAP2K4 DLG1 MAP3K4 SLK PAK3 KIF14 GPRC5B STK3 MAP3K14 MAP3K1 PAK4 WNK1 PAK2 AXIN1 MAP3K8 PAK1,BP,19,19 of 43,0.81,44.19,1.664E-08,3.262E-07
GO:0017112,Rab guanyl-nucleotide exchange factor activity,G5E5Q8(Evidence code:IEA/Database source:UniProtKB:O95248|ens)F1N1V1(Evidence code:IEA/Database source:UniProtKB:Q9H6A0|ens)A5D7B4(Evidence code:IEA/Database source:UniProtKB:P78524|ens)G5E5D0(Evidence code:IEA/Database source:UniProtKB:Q8TB24|ens)F1MLZ5(Evidence code:IEA/Database source:UniProtKB:A2RT67|ens)E1B8H4(Evidence code:IEA/Database source:UniProtKB:Q9ULE3|ens)Q2TBL9(Evidence code:IBA/Database source:PANTHER:PTN000583159)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)E1BJE1(Evidence code:IEA/Database source:UniProtKB:Q7Z401|ens), SBF1 DENND2D ST5 RIN3 DENND3 DENND2A TRAPPC4 DENND1A DENND4A,MF,9,9 of 4,0.38,225,1.736E-08,0.000000339
GO:0005819,spindle,G3MWR8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P04973(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P63171(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BP36(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P48734(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P43033(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:O43566|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)P27214(Evidence code:ISS/Database source:UniProtKB:P50995)Q2NL05(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P46196(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BAN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KI07(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), MICAL3 DCTN3 CLTA DYNLT1 SEPT7 MMS19 CDK1 PAFAH1B1 KIF23 RGS14 RPS6KA2 SEPT6 ERCC2 SIRT2 ANXA11 KIF2A MAPK1 KATNAL2 ARL8B SEPT2 SPAST,CC,21,21 of 54,0.89,38.89,0.000000018,3.503E-07
GO:0036459,thiol-dependent ubiquitinyl hydrolase activity,F1N0A8(Evidence code:IEA/Database source:InterPro:IPR001394|I)G5E630(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)Q3T0Y1(Evidence code:IEA/Database source:EC:3.4.19.12)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)A1L548(Evidence code:IEA/Database source:InterPro:IPR001394|I)B7TCH8(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BMF7(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BG52(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BND0(Evidence code:IEA/Database source:InterPro:IPR001394|I)E1BGW4(Evidence code:IEA/Database source:InterPro:IPR001394|I)F1MF37(Evidence code:IEA/Database source:InterPro:IPR001394|I)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)F1N3S5(Evidence code:IEA/Database source:InterPro:IPR001394|I)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR001394)A7Z056(Evidence code:IEA/Database source:InterPro:IPR001394|I), USP34 USP9X OTUD7B OTUB1 PSMD14 USP5 USP9Y USP13 USP35 USP24 USP36 USP31 BRCC3 USP32 USP39 USP20,MF,16,16 of 29,0.68,55.17,2.045E-08,3.964E-07
GO:0031463,Cul3-RING ubiquitin ligase complex,A7MBJ7(Evidence code:IBA/Database source:PANTHER:PTN001973695)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1B7Y9(Evidence code:IEA/Database source:UniProtKB:Q6IQ16|ens)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)E1BK47(Evidence code:IBA/Database source:PANTHER:PTN001973695)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)A7MBG4(Evidence code:IEA/Database source:InterPro:IPR030563)G3MX28(Evidence code:IBA/Database source:PANTHER:PTN001973695)G3N1V7(Evidence code:IBA/Database source:PANTHER:PTN001973695), KLHL18 PDCD6 SPOPL KLHL26 CUL3 PEF1 KLHL13 KLHL35 LOC780968 KEAP1 KLHDC7A KLHL34,CC,12,12 of 13,0.51,92.31,2.219E-08,4.271E-07
GO:0005905,clathrin-coated pit,P63009(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)E1BMW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)F1MH24(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168)Q17QC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0168), AP2B1 DNM2 CUBN AP2A2 EPS15 AP1S1 CLTA AP2A1 TFRC AAK1 AP2M1 AP2S1,CC,12,12 of 13,0.51,92.31,2.219E-08,4.271E-07
GO:0042393,histone binding,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)E1BGE5(Evidence code:IEA/Database source:UniProtKB:Q9EPL8|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1B7N2(Evidence code:IBA/Database source:PANTHER:PTN000826174)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)A5PJQ1(Evidence code:IEA/Database source:UniProtKB:P35659|ens)E1BCP6(Evidence code:IEA/Database source:InterPro:IPR020693)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:P55198|ens)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR029295)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88), PRMT6 CHD8 ATRX PRKCB IPO7 LEF1 LOC619094 PYGO2 PKN1 DEK JAK2 ZMYND8 TNKS BRD1 MLLT6 SMARCA2 HIST1H2BA UHRF1,MF,18,18 of 39,0.76,46.15,2.323E-08,4.455E-07
GO:0004222,metalloendopeptidase activity,Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)E1BFV4(Evidence code:IEA/Database source:InterPro:IPR001590)F1MRA8(Evidence code:IEA/Database source:InterPro:IPR001590)E1B8S3(Evidence code:IEA/Database source:InterPro:IPR001590)E1BBU4(Evidence code:IEA/Database source:InterPro:IPR001590|I)P42891(Evidence code:IEA/Database source:InterPro:IPR000718|I)Q24K02(Evidence code:IEA/Database source:InterPro:IPR001431)F1MF35(Evidence code:IEA/Database source:InterPro:IPR001506|I)Q0III2(Evidence code:IEA/Database source:InterPro:IPR001193|I)F1MBP8(Evidence code:IEA/Database source:InterPro:IPR037740)G3MZT7(Evidence code:IEA/Database source:InterPro:IPR001590)Q9TT93(Evidence code:IEA/Database source:InterPro:IPR001590)Q9TT92(Evidence code:IEA/Database source:InterPro:IPR001590)F1MXQ0(Evidence code:IEA/Database source:InterPro:IPR001590)F1N2M2(Evidence code:IEA/Database source:InterPro:IPR001590), MMP19 ADAMTS14 ADAM7 ADAMTS18 ADAM15 ECE1 IDE TLL2 MBTPS2 COPS5 LOC531521 ADAMTS4 ADAMTS5 ADAMTS12 ADAMTS7,MF,15,15 of 25,0.64,60,2.443E-08,4.668E-07
GO:0044212,transcription regulatory region DNA binding,E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1MBK6(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)E1BCA0(Evidence code:IBA/Database source:PANTHER:PTN000579295)O02754(Evidence code:ISS/Database source:UniProtKB:P49715)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)F1MI25(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579295)E1B8T3(Evidence code:IBA/Database source:PANTHER:PTN000383895)E1BJZ5(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BD25(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1B9X1(Evidence code:IBA/Database source:PANTHER:PTN000383895)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BN44(Evidence code:IBA/Database source:PANTHER:PTN000579295)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR001346), CDK13 SP1 ASH2L SMARCA2 GLI1 HIVEP3 KMT2A GATA6 BCOR CDC5L ATF6B ZNF516 CEBPA TAF2 SFPQ HIVEP1 RUNX1 BCL11A TCF20 SALL4 NFKB1 FOXF1 SOX17 BCL11B GLI2 RAI1 CDK12 LEF1 RREB1 CDK5RAP2 SNAPC4 E2F1 IRF1,MF,33,33 of 133,1.4,24.81,2.676E-08,5.042E-07
GO:0001501,skeletal system development,P13608(Evidence code:IBA/Database source:PANTHER:PTN001105676)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)F1N2J5(Evidence code:IBA/Database source:PANTHER:PTN001105676)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)P81282(Evidence code:IBA/Database source:PANTHER:PTN001105676)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), ACAN GLI2 ASH1L RAI1 HAPLN4 TBX3 CHD7 FAM20C COL1A2 COL5A2 VCAN COL2A1 SOX4,BP,13,13 of 17,0.55,76.47,2.672E-08,5.042E-07
GO:0019905,syntaxin binding,A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001285)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000752023)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)G3X6A9(Evidence code:IEA/Database source:InterPro:IPR026183)P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q5T7P8|ens)P63026(Evidence code:IPI/Database source:UniProtKB:Q3SWZ3)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285), SYTL2 STX7 VAMP1 ABCA1 VPS52 SYTL1 TXLNG NAPG ABL1 BAIAP3 SYT6 VAMP2 SYT4,MF,13,13 of 17,0.55,76.47,2.672E-08,5.042E-07
GO:0010941,regulation of cell death,P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q8NC60), CRYAB NOA1,BP,2,2 of 342,0.08,0.58,2.661E-08,5.042E-07
GO:0032154,cleavage furrow,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)Q32LP2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q96GX5)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), NF2 ARF6 STAMBP PDXP RDX RACGAP1 MASTL PPP1CC SEPT6 SEPT2 SVIL PKN1 DCTN3 SEPT7,CC,14,14 of 21,0.59,66.67,2.703E-08,5.056E-07
GO:0016363,nuclear matrix,A0JNA8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8CJF7|ens)O46382(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B8Q8(Evidence code:IBA/Database source:PANTHER:PTN000409486)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1)A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888), PAXIP1 CLIC4 AHCTF1 ARFGEF1 XPOT SPTBN4 SFPQ DNMT3A UHRF1 BLM CAD PRPF40A NUMA1 CHMP1A,CC,14,14 of 21,0.59,66.67,2.703E-08,5.056E-07
GO:0055037,recycling endosome,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:Q71U36|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)A6QR68(Evidence code:IEA/Database source:UniProtKB:Q8K211|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000538677)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q8BU31|ens)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N0J3(Evidence code:IEA/Database source:UniProtKB:P98196|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens), STX7 VPS51 SNF8 TUBA1A SORL1 LMTK2 SLC31A1 MICALL2 RAB17 TBC1D12 VPS52 RAP2C ITGB1 ATP11A RAP2A TFRC,CC,16,16 of 30,0.68,53.33,2.935E-08,5.453E-07
GO:0012505,endomembrane system,Q29RU0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)E1BF03(Evidence code:IBA/Database source:PANTHER:PTN001039730)F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)A5PJQ6(Evidence code:IBA/Database source:PANTHER:PTN000031541)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN000445299)P31408(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349)Q3SZN2(Evidence code:IEA/Database source:UniProtKB:Q15437|ens), RNF128 ATF6B PANX3 RABGAP1 CHMP1A VAMP5 LARS TBC1D2 PGRMC2 TBC1D22B CD63 ATP6V1B2 SGSM2 NBEA STX7 SEC23B,CC,16,16 of 30,0.68,53.33,2.935E-08,5.453E-07
GO:0003729,mRNA binding,F1MX04(Evidence code:IEA/Database source:InterPro:IPR037584)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)Q0II93(Evidence code:IEA/Database source:InterPro:IPR030216)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359236)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)P00376(Evidence code:ISS/Database source:UniProtKB:P00374)Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q6PHQ9|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8NHU6)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)Q08DM8(Evidence code:IEA/Database source:UniProtKB:Q62348|ens)Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)E1BIA7(Evidence code:IEA/Database source:UniProtKB:O75153|ens)G3MZ78(Evidence code:IBA/Database source:PANTHER:PTN000566843)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)E1BFI4(Evidence code:IEA/Database source:InterPro:IPR028743), EIF4G1 PURB NXF3 ESRP1 SNRNP70 DHX9 DHFR DXO RC3H2 PABPC4 NUDT16 TDRD7 TPR PPIE TSN PCBP1 CLUH CSTF2T PIWIL2 SRSF1 EIF4A3 IGF2BP2,MF,22,22 of 62,0.93,35.48,3.178E-08,5.884E-07
GO:0016757,"transferase activity, transferring glycosyl groups",F1MSM4(Evidence code:IEA/Database source:InterPro:IPR002495)E1BMM8(Evidence code:IEA/Database source:UniProtKB:Q6IQX7|ens)O97711(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)E1B8R5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR003378)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q5EA65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q5E9I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q0P582(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q3MHF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q5E9E7(Evidence code:IEA/Database source:InterPro:IPR002495)Q32LF7(Evidence code:IEA/Database source:InterPro:IPR003859)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)P18493(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)A5PK45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)F1MFF6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)F1MX31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q5EAB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)Q2HJA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)F1MCK0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0328)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR004263|I), GYG2 CHPF HAS2 pofut2 UMPS TNKS LFNG GALNT7 DPAGT1 MGAT1 PARP14 MTAP GLT8D1 B4GALT4 GALNT2 PARP1 COLGALT1 UGT2B10 ST8SIA3 POMGNT1 B3GALT4 PARP8 EXT1,MF,23,23 of 69,0.98,33.33,4.037E-08,7.449E-07
GO:0005802,trans-Golgi network,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P61212)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)P11456(Evidence code:IBA/Database source:PANTHER:PTN000824899)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56818)Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737)A7Z035(Evidence code:TAS/Database source:)O46382(Evidence code:ISS/Database source:UniProtKB:D4A631)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens), GOLPH3 ATP7B BIRC6 ARL1 SORL1 LRRK2 SNAP25 GCC2 M6PR NBEA RAB30 MYO18A BACE1 CORO7 CLINT1 ARFGEF1 OSBP,CC,17,17 of 36,0.72,47.22,4.357E-08,8.012E-07
GO:0032456,endocytic recycling,F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)F6REL8(Evidence code:IEA/Database source:InterPro:IPR028563)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens), LMTK2 PTPN23 RAB17 VPS51 ARF6 VPS52 DENND1A MICALL2 SNF8,BP,9,9 of 5,0.38,180,4.563E-08,8.362E-07
GO:0016055,Wnt signaling pathway,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592)A7E3X2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1BEQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)A7MB90(Evidence code:IBA/Database source:PANTHER:PTN000226268)E1B714(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)F1MDE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1B8R5(Evidence code:IEA/Database source:InterPro:IPR028731)Q2KJ34(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)E1BI79(Evidence code:IEA/Database source:InterPro:IPR009223|I)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)E1BJ93(Evidence code:IEA/Database source:InterPro:IPR024940|I)P35509(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:Q9H0F7|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0879)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)A7MB15(Evidence code:IEA/Database source:InterPro:IPR026548), CUL3 PTK7 CSNK1G1 AMOTL1 CSNK1G2 AXIN1 CHD8 LRP6 CSNK1A1 LGR4 TNKS HBP1 NDRG2 APC2 ETV2 LEF1 CSNK1G3 ARL6 AXIN2 FERMT2 FZD1,BP,21,21 of 58,0.89,36.21,4.879E-08,0.000000891
GO:0007080,mitotic metaphase plate congression,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)A7MBA1(Evidence code:IEA/Database source:UniProtKB:Q9BW19|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens), CUL3 KPNB1 CHMP2A KIF14 KIFC1 VPS4B CHMP4B CHMP1A CHMP4A CHMP2B CHMP6,BP,11,11 of 11,0.47,100,5.049E-08,9.067E-07
GO:0030663,COPI-coated vesicle membrane,A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28104(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53619(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35604(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35605(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q27954(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VE21(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), COPB1 COPE ARCN1 COPZ1 COPB2 COPA COPG2,CC,7,7 of 1,0.3,700,5.066E-08,9.067E-07
GO:0021772,olfactory bulb development,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), AGTPBP1 DLX2 KIF14 EXT1 RPGRIP1L CHD7 LRRK2,BP,7,7 of 1,0.3,700,5.066E-08,9.067E-07
GO:0060384,innervation,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens), CHD7 RNF165 GABRA5 UNC13A ADARB1 FBXO45 UNC13B,BP,7,7 of 1,0.3,700,5.066E-08,9.067E-07
GO:0033290,eukaryotic 48S preinitiation complex,Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107)Q3ZC12(Evidence code:IEA/Database source:UniRule:UR000106306)Q5E966(Evidence code:IEA/Database source:UniRule:UR000107081)P68102(Evidence code:IBA/Database source:PANTHER:PTN000063908)E1BLZ8(Evidence code:IEA/Database source:UniRule:UR000106280)Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134)A7MB16(Evidence code:IEA/Database source:UniRule:UR000106119), EIF3K EIF3G EIF3I EIF2S1 EIF3F EIF3M EIF3B,CC,7,7 of 1,0.3,700,5.066E-08,9.067E-07
GO:0008569,"ATP-dependent microtubule motor activity, minus-end-directed",E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BFA7(Evidence code:IEA/Database source:InterPro:IPR027325)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491), DNAH5 DNHD1 KIFC3 DNAH10 DNAH7 DNAH11 DYNC1H1,MF,7,7 of 1,0.3,700,5.066E-08,9.067E-07
GO:0001228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding",E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BC39(Evidence code:IEA/Database source:UniProtKB:P62509|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q62431|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), LEF1 ZBTB17 SRF DLX2 EAF2 CDC5L RUNX1 MYF5 LMO2 TFDP2 GATA6 RREB1 ESRRG ARID3A FOXF1 POU4F2 PKNOX1 NR1I2 SOX17,MF,19,19 of 47,0.81,40.43,5.153E-08,9.191E-07
GO:0065003,protein-containing complex assembly,Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)F1N7B7(Evidence code:IEA/Database source:UniProtKB:Q86UR5|ens), AIMP2 KMT2A PPID RIMS1,BP,4,4 of 397,0.17,1.01,5.367E-08,9.541E-07
GO:0005245,voltage-gated calcium channel activity,A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005447)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)F1MTK5(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002077|I)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR002077)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR002077|I)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR002077|I)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005445)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR028798)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002077|I), CACNA1A RYR1 CACNA1D CACNA1E CACNA1F CACNA1C CACNA1S CACNA1H TPCN2 CACNA1B,MF,10,10 of 8,0.42,125,5.596E-08,9.869E-07
GO:0005871,kinesin complex,E1BBN7(Evidence code:IBA/Database source:PANTHER:PTN000648413)G5E5S3(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BGB0(Evidence code:IBA/Database source:PANTHER:PTN000648413)Q2NL05(Evidence code:IBA/Database source:PANTHER:PTN000648413)A7MBA1(Evidence code:IBA/Database source:PANTHER:PTN000648413)Q2HJJ0(Evidence code:IEA/Database source:InterPro:IPR002151)E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens)A5D7N6(Evidence code:IBA/Database source:PANTHER:PTN000648413)E1BC41(Evidence code:IBA/Database source:PANTHER:PTN000648413)G3N1E4(Evidence code:IBA/Database source:PANTHER:PTN000648413), KIF1B KIF14 KIF13B KIF2A KIFC1 KLC4 KIFC3 KIF23 KIF15 KIF26A,CC,10,10 of 8,0.42,125,5.596E-08,9.869E-07
GO:0042325,regulation of phosphorylation,F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), RICTOR PSEN1,BP,2,2 of 330,0.08,0.61,5.606E-08,9.869E-07
GO:0047485,protein N-terminus binding,Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q9D4H1|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)A6QLD1(Evidence code:IEA/Database source:UniProtKB:Q96A65|ens), VPS25 NIPBL ARF6 CHMP6 BANF1 PDCD10 TRAF6 ATM NCOA3 SNF8 NPAT EXOC2 PPP1CC EXOC4,MF,14,14 of 23,0.59,60.87,6.243E-08,0.000001094
GO:0045503,dynein light chain binding,E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000743491)E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277823)Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277823)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1MSP8(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N724(Evidence code:IBA/Database source:PANTHER:PTN000743491)F1N5R7(Evidence code:IBA/Database source:PANTHER:PTN000743491), DNAH5 DYNC1H1 WDR78 DYNC1I2 DNHD1 DNAH10 DNAH11 DNAH7,MF,8,8 of 3,0.34,266.67,6.277E-08,0.000001094
GO:0017101,aminoacyl-tRNA synthetase multienzyme complex,Q2T9L8(Evidence code:ISS/Database source:UniProtKB:P56192)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q8BMJ2|ens)A7YW98(Evidence code:ISS/Database source:UniProtKB:P54136)Q3MHH4(Evidence code:ISS/Database source:UniProtKB:P47897)Q3SZ15(Evidence code:IEA/Database source:UniProtKB:Q9D1M4|ens)A7MBC5(Evidence code:IEA/Database source:UniProtKB:P41252|ens)Q0II26(Evidence code:ISS/Database source:UniProtKB:Q13155), MARS EPRS LARS RARS QARS EEF1E1 IARS AIMP2,CC,8,8 of 3,0.34,266.67,6.277E-08,0.000001094
GO:0005901,caveola,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)P16386(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P63086)P63026(Evidence code:IDA/Database source:)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)A6QLR4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05204(Evidence code:IDA/Database source:)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), KCNMA1 FLOT1 MYOF IRS1 LIPE F2R LRP6 MAPK1 VAMP2 PACSIN2 FLOT2 LAMP1 SRC,CC,13,13 of 19,0.55,68.42,6.806E-08,0.000001182
GO:0045184,establishment of protein localization,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens), ABL1 RAP2A KPNB1 CHMP2A KIF14,BP,5,5 of 416,0.21,1.2,7.291E-08,0.000001263
GO:0061077,chaperone-mediated protein folding,Q32PA9(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q9TRY0(Evidence code:ISS/Database source:UniProtKB:Q02790)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q99KD5|ens)Q3T0K2(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q2KJC8(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q32L40(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3ZCI9(Evidence code:IBA/Database source:PANTHER:PTN000143677)P68107(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q29RL2(Evidence code:ISS/Database source:UniProtKB:Q9D1P4)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)F1MWD3(Evidence code:IBA/Database source:PANTHER:PTN000143677)E1BJ75(Evidence code:ISS/Database source:UniProtKB:Q90830)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)Q2NKZ1(Evidence code:IBA/Database source:PANTHER:PTN000143677), FKBP2 FKBP4 PPID UNC45A CCT3 CCT6B FKBP9 TCP1 CCT8 FKBP1B CHORDC1 DNAJB2 TOR1A CCT5 CRTAP DNAJC5 CCT7,BP,17,17 of 38,0.72,44.74,8.064E-08,0.000001392
GO:0002020,protease binding,P81425(Evidence code:ISS/Database source:UniProtKB:P27487)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MPR9(Evidence code:IEA/Database source:UniProtKB:Q6P4R8|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)A5PK65(Evidence code:IEA/Database source:UniProtKB:O35215|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens), DPP4 PINK1 NFRKB COL1A2 KIT FLOT1 BRCA2 DDT RFFL MALT1 RNF139 PRNP RYR1 SH3PXD2A SRI POLG,MF,16,16 of 33,0.68,48.48,8.133E-08,0.000001395
GO:0008104,protein localization,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512256)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512256)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)F1MF64(Evidence code:IEA/Database source:UniProtKB:Q9EPN1|ens)E1BJG8(Evidence code:IEA/Database source:UniProtKB:Q9H2F9|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens), MAPK8IP3 MAL2 PLLP DLG1 SCRIB NBEA CCDC68 PALM,BP,8,8 of 497,0.34,1.61,8.134E-08,0.000001395
GO:0044325,ion channel binding,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)F1ML52(Evidence code:IEA/Database source:UniProtKB:Q8TDN1|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q9Z0F4|ens)F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens), PDE4D LRRC26 KCNG4 GPD1L SCN10A S100A10 YES1 SRC DLG1 LRRK2 CIB1 RIMS1 FKBP1B PHPT1,MF,14,14 of 24,0.59,58.33,9.259E-08,0.000001578
GO:0042147,"retrograde transport, endosome to Golgi",F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)Q3T0M0(Evidence code:IEA/Database source:InterPro:IPR028661)Q08DW1(Evidence code:IBA/Database source:PANTHER:PTN001178525)E1B8H4(Evidence code:IEA/Database source:UniProtKB:Q9ULE3|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3)Q2HJG5(Evidence code:IEA/Database source:InterPro:IPR005378)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:P61967|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q2KJD2(Evidence code:ISS/Database source:UniProtKB:Q15836)E1BDC9(Evidence code:IBA/Database source:PANTHER:PTN000367098)Q2KHV6(Evidence code:IEA/Database source:InterPro:IPR028662)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens), ANKFY1 VPS26A VPS29 RAB9A DENND2A VPS51 VPS35 ARL1 AP1S1 BAIAP3 VAMP3 VPS52 SNX8 GCC2,BP,14,14 of 24,0.59,58.33,9.259E-08,0.000001578
GO:0019003,GDP binding,Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:Q9H0T7|ens)A7Z031(Evidence code:IEA/Database source:UniProtKB:Q8IZ41|ens)P04695(Evidence code:IMP/Database source:)Q2TA37(Evidence code:IEA/Database source:UniProtKB:Q9D0J4|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)Q2TBH7(Evidence code:ISS/Database source:UniProtKB:P20338), RAB9A RAP2C RAP2A TRIM23 RAB3B RAB17 RASEF GNAT1 ARL2 GNAI1 RRAS DYNC1LI1 RAB4A,MF,13,13 of 20,0.55,65,1.052E-07,0.000001788
GO:0001764,neuron migration,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q62288)F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q8BL48|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q64511|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens), SRF FBXO45 NDNF SPOCK1 UNK PCM1 SOX1 ASTN1 TOP2B RAPGEF2 PSEN1 PEX13 USP9X MKL1 SDCCAG8,BP,15,15 of 29,0.64,51.72,1.074E-07,0.000001796
GO:0043621,protein self-association,E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1MRU0(Evidence code:IEA/Database source:UniProtKB:P36888|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)Q28165(Evidence code:IDA/Database source:), GPSM2 SMTNL1 TCF7L2 RNF112 FLT3 MALT1 ZFYVE27 SGTA CRK TDG PTH1R PABPN1,MF,12,12 of 16,0.51,75,1.069E-07,0.000001796
GO:0008076,voltage-gated potassium channel complex,G3N279(Evidence code:IEA/Database source:InterPro:IPR028325)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens)Q05037(Evidence code:IEA/Database source:InterPro:IPR003968|I)A4FV89(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1B7T7(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1N4T0(Evidence code:IBA/Database source:PANTHER:PTN000002873)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)P63026(Evidence code:ISS/Database source:UniProtKB:P63045)F1ML52(Evidence code:IEA/Database source:InterPro:IPR003968|I)E1BC13(Evidence code:IEA/Database source:InterPro:IPR003968|I)F1MJA9(Evidence code:IEA/Database source:InterPro:IPR003968|I)Q28204(Evidence code:IEA/Database source:InterPro:IPR028325), KCNQ5 LRRC26 KCNA4 KCNF1 KCNC4 KCNT2 CTTN VAMP2 KCNG4 KCNC3 KCNG2 KCNMA1,CC,12,12 of 16,0.51,75,1.069E-07,0.000001796
GO:0000159,protein phosphatase type 2A complex,E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)F1MG56(Evidence code:IEA/Database source:InterPro:IPR000009)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)A4FV68(Evidence code:IEA/Database source:InterPro:IPR002554)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)A2VDZ0(Evidence code:IEA/Database source:InterPro:IPR002554)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens), STRN4 PPP2CB PPP2R2A STRN3 PPP2R5E PPP2CA IER5 PPP2R5A PTPA,CC,9,9 of 6,0.38,150,1.071E-07,0.000001796
GO:0034446,substrate adhesion-dependent cell spreading,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q2KJD2(Evidence code:ISS/Database source:UniProtKB:P63024)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens), KIF14 VAMP3 ABL1 FERMT2 SRC PEAK1 ITGB7 MICALL2 LAMB1,BP,9,9 of 6,0.38,150,1.071E-07,0.000001796
GO:0005868,cytoplasmic dynein complex,Q2KII9(Evidence code:IEA/Database source:InterPro:IPR008467)Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q9D0M5|ens)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223362)Q0III3(Evidence code:IEA/Database source:InterPro:IPR025956)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223362)E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000072732)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)P63171(Evidence code:ISS/Database source:UniProtKB:Q5XI90)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223362)Q3T140(Evidence code:IEA/Database source:InterPro:IPR016561), DYNC1LI1 DYNLL2 LOC101902172 DYNC1I2 LOC101905447 DYNC1H1 TPR DYNLT1 DYNLL1 DYNLRB1,CC,10,10 of 9,0.42,111.11,1.108E-07,0.000001842
GO:0000281,mitotic cytokinesis,A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E0AE16(Evidence code:IEA/Database source:InterPro:IPR028644|I)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR028642|I), SNX18 RACGAP1 SPAST SNX9 CHMP4B KIF23 BRCA2 STAMBP PDCD6IP SNX33,BP,10,10 of 9,0.42,111.11,1.108E-07,0.000001842
GO:0016462,pyrophosphatase activity,Q5E9Y6(Evidence code:IEA/Database source:InterPro:IPR004097),PRUNE1,MF,1,1 of 277,0.04,0.36,1.158E-07,0.000001913
GO:0022414,reproductive process,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,BP,1,1 of 277,0.04,0.36,1.158E-07,0.000001913
GO:0005615,extracellular space,P37141(Evidence code:ISS/Database source:UniProtKB:P22352)E1BJ75(Evidence code:IEA/Database source:UniProtKB:O75718|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)A5PK65(Evidence code:IEA/Database source:UniProtKB:O35215|ens)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)E1BGU5(Evidence code:IEA/Database source:InterPro:IPR027881)F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)Q8MJ29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)E1BBS6(Evidence code:IBA/Database source:PANTHER:PTN000528008)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)P58754(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000163972)F1MYW3(Evidence code:IBA/Database source:PANTHER:PTN000744245)G3N183(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)G8JKW7(Evidence code:IEA/Database source:InterPro:IPR000215)Q08D90(Evidence code:IEA/Database source:UniProtKB:P49862|ens)Q5EA61(Evidence code:ISS/Database source:UniProtKB:P05122)G3X743(Evidence code:IEA/Database source:InterPro:IPR015571)Q5E998(Evidence code:IBA/Database source:PANTHER:PTN000274640)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)E1BN05(Evidence code:IEA/Database source:UniProtKB:Q8BMF8|ens)A6YT15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)A6QQ02(Evidence code:IEA/Database source:InterPro:IPR000215)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)A4FV80(Evidence code:IEA/Database source:UniProtKB:Q8R089|ens)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274640)E1BJW3(Evidence code:IEA/Database source:UniProtKB:Q9H8L6|ens)E1BF06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P06623(Evidence code:IEA/Database source:UniProtKB:P09543|ens)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)G3MYK9(Evidence code:IBA/Database source:PANTHER:PTN000744245)E1BCA5(Evidence code:IEA/Database source:InterPro:IPR000215)Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287)Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens)E1BH09(Evidence code:IEA/Database source:InterPro:IPR030755)F1N160(Evidence code:IBA/Database source:PANTHER:PTN000587099)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685978)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q969H8)P02668(Evidence code:IDA/Database source:)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q08629)F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q9Y6Z7|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P35246(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3X894(Evidence code:IEA/Database source:InterPro:IPR000215)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)P98167(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QQN6(Evidence code:IEA/Database source:InterPro:IPR017064)P01175(Evidence code:IDA/Database source:)P26917(Evidence code:IBA/Database source:PANTHER:PTN000059370)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN001224703)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)P05059(Evidence code:IDA/Database source:), GPX3 CRTAP HFE2 DDT IFNT3 SOGA3 FUCA2 DBH IFNT QSOX2 TMPRSS6 LY96 IDE CPXM2 SEMA3E LOC104968438 SERPINA3 KLK7 CKB RNPEP CTSV FAM20A FGF1 FAM20C GLDN CCL28 LOC617406 PDGFC DNAJB11 FBRS KL TINAGL1 MMRN2 TNFSF15 CNP IGFBP3 LAMB1 SEMA3G SERPINI1 ITM2B CRH VWA2 VPREB1 KIT TACSTD2 LYZ1 PCSK6 MYDGF CSN3 COL1A2 IFNT2 SPOCK1 COLEC10 SLIT2 C1QTNF5 SFTPD LOC786263 EMILIN1 COL2A1 SSPO SMPDL3B OXT SST HYAL1 PRELP SORL1 CHGA,CC,67,67 of 426,2.85,15.73,1.256E-07,0.000002068
GO:0043524,negative regulation of neuron apoptotic process,Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)Q17QR2(Evidence code:IEA/Database source:UniProtKB:Q9CQ26|ens)Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), BDNF STAMBP DNAJC5 SYNGAP1 BRAF CLN3 AARS MT3 PRKCI GABRA5 KIF14 EN1 NDNF F2R PINK1,BP,15,15 of 30,0.64,50,1.508E-07,0.000002476
GO:0022624,proteasome accessory complex,Q5E964(Evidence code:ISS/Database source:UniProtKB:Q9WVJ2)Q2KJ25(Evidence code:ISS/Database source:UniProtKB:Q9D8W5)A7MBA2(Evidence code:IEA/Database source:UniRule:UR000777776)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O35593|ens)Q0P5A6(Evidence code:ISS/Database source:UniProtKB:Q8BJY1)Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P46471)Q2KIW6(Evidence code:ISS/Database source:UniProtKB:P62334)P62194(Evidence code:ISS/Database source:UniProtKB:P62196)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62192|ens)P56701(Evidence code:ISS/Database source:UniProtKB:Q8VDM4)Q3T0B2(Evidence code:ISS/Database source:UniProtKB:Q99JI4), PSMD13 PSMD12 PSMD1 PSMD14 PSMD5 PSMC2 PSMC6 PSMC5 PSMC1 PSMD2 PSMD6,CC,11,11 of 13,0.47,84.62,1.571E-07,0.000002572
GO:0046914,transition metal ion binding,P35466(Evidence code:IEA/Database source:InterPro:IPR034325)F1N226(Evidence code:IEA/Database source:InterPro:IPR011178|I), S100A4 APLP2,MF,2,2 of 309,0.08,0.65,1.643E-07,0.000002681
GO:0000920,cell separation after cytokinesis,Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens), CHMP1A CHMP6 CHMP4B CHMP2A CHMP4A VPS4B PDCD6IP CHMP2B,BP,8,8 of 4,0.34,200,1.769E-07,0.000002878
GO:0035725,sodium ion transmembrane transport,E1BHM6(Evidence code:IEA/Database source:GO:0005248)A7YY70(Evidence code:IEA/Database source:GO:0005436)E1BI45(Evidence code:IEA/Database source:GO:0015081)F1MHP0(Evidence code:IEA/Database source:GO:0005248)E1BHR8(Evidence code:IEA/Database source:GO:0005248)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)F1MMU9(Evidence code:IEA/Database source:GO:0005248)E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens)G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169), SCN11A SLC34A1 SLC23A1 SCN5A SCN3A ANO6 SCN8A SCN2B SCN10A HCN1,BP,10,10 of 10,0.42,100,0.000000208,0.000003373
GO:0030879,mammary gland development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)G3X812(Evidence code:IEA/Database source:UniProtKB:Q99466|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), GLI2 TBX3 ARHGAP35 NOTCH4 LEF1 PYGO2 STAT5A,BP,7,7 of 2,0.3,350,2.144E-07,0.000003466
GO:0005891,voltage-gated calcium channel complex,F1MTK5(Evidence code:IEA/Database source:InterPro:IPR002077|I)M5FK87(Evidence code:IEA/Database source:InterPro:IPR005445)Q9TTA4(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR002077|I)G3N3N2(Evidence code:IEA/Database source:InterPro:IPR002077|I)A5ACB6(Evidence code:IEA/Database source:InterPro:IPR005447)G3MZ07(Evidence code:IEA/Database source:InterPro:IPR002077|I)F1MP22(Evidence code:IEA/Database source:InterPro:IPR002077|I), CACNA1D CACNA1H CACNA1B PDE4D CACNA1F CACNA1C CACNA1A CACNA1S CACNA1E,CC,9,9 of 7,0.38,128.57,2.298E-07,0.000003693
GO:0032467,positive regulation of cytokinesis,A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)A2VDN5(Evidence code:IEA/Database source:UniProtKB:Q9UBP0|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028443)F1MSU3(Evidence code:IEA/Database source:UniProtKB:Q9NSD7|ens)O46385(Evidence code:IMP/Database source:), KIF23 SPAST CUL3 GIPC1 KIF14 RACGAP1 PKP4 RXFP3 SVIL,BP,9,9 of 7,0.38,128.57,2.298E-07,0.000003693
GO:0051301,cell division,P04973(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)Q3T054(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens)P63171(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)E1BFR5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q3MHQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P48734(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q2NKY7(Evidence code:IEA/Database source:InterPro:IPR008113)Q5E994(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P27214(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)A6QQY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132)P63097(Evidence code:ISS/Database source:UniProtKB:P63096)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0132), CLTA KIF14 RAN ARL8B SPG20 DYNLT1 SEPT11 PPP1CC MASTL CSNK1A1 NCAPH CDK1 SPAST SEPT7 KIF2A ZFYVE26 SEPT2 CHMP1B CHMP1A VPS4B ANXA11 RGS14 BRCC3 KLHL13 DCTN3 SEPT6 PAFAH1B1 CIB1 GNAI1 PPP1CB,BP,30,30 of 126,1.27,23.81,2.363E-07,0.000003786
GO:0030426,growth cone,A4IF89(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q99KJ8|ens)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q17QQ3(Evidence code:IDA/Database source:), EXOC8 RTN4R USP9X INPP5J LRRK2 DCTN2 NDRG2 DNM2 CIB1 PSEN1 MYH14 SETX SNAP25,CC,13,13 of 22,0.55,59.09,0.000000238,0.000003802
GO:0005815,microtubule organizing center,Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P48734(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P63097(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2NL05(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SYX0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P43033(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6H769(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens)A2VDN5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A7Z056(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28141(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IFE3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)Q32L40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:A0A024R7C0)P67827(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MGF7(Evidence code:IEA/Database source:InterPro:IPR012943)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BFR5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0S5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KIJ6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28021(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)P46196(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QE5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), DCTN3 CDK1 GNAI1 KIF2A TUBGCP2 FLOT1 CAMK2B NDRG1 PAFAH1B1 DCTN2 RPS7 ZFYVE26 RPP25 SPAST USP20 DHX9 ACTR1B NSFL1C BIRC6 TCP1 DBH KEAP1 CSNK1A1 CDK5RAP2 MVB12A MASTL ALDOB UBXN6 ROCK2 PCNT ARL2 CHMP1A MAPK1 CCT8 CIB1,CC,35,35 of 164,1.49,21.34,2.475E-07,0.000003942
GO:0070062,extracellular exosome,Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1JPD9(Evidence code:IEA/Database source:UniProtKB:Q9NZH0|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)A5D7A2(Evidence code:IEA/Database source:UniProtKB:Q9CZD3|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN000689792)Q5E9B7(Evidence code:IEA/Database source:UniProtKB:O00299|ens)Q3T0P7(Evidence code:IBA/Database source:PANTHER:PTN000103178)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q12791)F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens), RAB4A CD63 GPRC5B TFRC ADAM15 PDCD6IP PROM1 GARS SNX18 PRELP CLIC1 ITM2B TSG101 KCNMA1 CUBN SRI SORD,CC,17,17 of 691,0.72,2.46,2.743E-07,0.000004356
GO:0031902,late endosome membrane,Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KI07(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E994(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDY3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q58CS7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SX42(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T178(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0N1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)A5PK00(Evidence code:IBA/Database source:PANTHER:PTN000319648)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q3ZC25(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), UBXN6 TMEM59 ARL8B CHMP1B CHMP4A CHMP3 CHMP2B VPS28 MVB12A VPS41 VPS36 CD63 SNF8 VPS4B BAIAP3 TMEM106B,CC,16,16 of 37,0.68,43.24,2.771E-07,0.000004388
GO:0005765,lysosomal membrane,Q3SZJ7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MX24(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P63026(Evidence code:IDA/Database source:)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)P10897(Evidence code:IBA/Database source:PANTHER:PTN001297406)E1BIB9(Evidence code:IEA/Database source:InterPro:IPR028798)A7MBJ6(Evidence code:IEA/Database source:UniProtKB:Q6PJI9|ens)Q05204(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC9(Evidence code:ISS/Database source:UniProtKB:P55735)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)Q2KJA5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZC25(Evidence code:ISS/Database source:UniProtKB:Q9NUM4)F2Z4H6(Evidence code:IEA/Database source:UniProtKB:P36406|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)P11456(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)O46563(Evidence code:IBA/Database source:PANTHER:PTN000842131)P31404(Evidence code:IBA/Database source:PANTHER:PTN001032512)P21282(Evidence code:IBA/Database source:PANTHER:PTN000806076)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens)Q2KI07(Evidence code:ISS/Database source:UniProtKB:Q9NVJ2)Q0VD59(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), LAMP2 CLN3 VAMP2 HPS6 TMEM59 CD63 CYB561 TPCN2 WDR59 LAMP1 SEC13 VPS41 ATP6V0D1 LAPTM5 TMEM106B TRIM23 PSEN1 M6PR ATP6V1H ATP6V1A ATP6V1C1 UBXN6 LITAF ARL8B MARCH8,CC,25,25 of 92,1.06,27.17,2.882E-07,0.000004549
GO:0043065,positive regulation of apoptotic process,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)P20959(Evidence code:ISS/Database source:UniProtKB:P17936)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)A7YY65(Evidence code:IBA/Database source:PANTHER:PTN001324730)A5PJF0(Evidence code:IEA/Database source:InterPro:IPR033097)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622311)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q9H832|ens)E1B9H3(Evidence code:IEA/Database source:InterPro:IPR028811)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)E1B7H4(Evidence code:IBA/Database source:PANTHER:PTN000584371)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q28046(Evidence code:ISS/Database source:UniProtKB:Q9Y6U3)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens), E2F1 IGFBP3 AIFM2 EEF1E1 DAB2IP PPID ALDH1A3 SLIT2 ATM ABL1 SCRIB SAP18 ANO6 SOX4 PRKDC MTCH1 BARD1 UNC13B MAPK9 UBE2Z CCAR2 KCNMA1 MAP3K10 DDX20 fgfr3 PTPA PSEN1 SCIN STK3,BP,29,29 of 121,1.23,23.97,3.297E-07,0.000005189
GO:0008180,COP9 signalosome,P08487(Evidence code:ISS/Database source:UniProtKB:P19174)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q8IY63|ens)A6QQ21(Evidence code:IEA/Database source:InterPro:IPR033859)G3X736(Evidence code:IEA/Database source:InterPro:IPR037750)A6H7B5(Evidence code:IEA/Database source:InterPro:IPR037753)A4FV74(Evidence code:IEA/Database source:InterPro:IPR033205)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)F1MBP8(Evidence code:IEA/Database source:InterPro:IPR037740)Q3SZA0(Evidence code:IEA/Database source:InterPro:IPR037754)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens), PLCG1 AMOTL1 COPS6 COPS2 COPS3 COPS8 FLOT1 COPS5 COPS4 GRB2,CC,10,10 of 11,0.42,90.91,3.726E-07,0.00000583
GO:0050852,T cell receptor signaling pathway,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q9BE45(Evidence code:ISS/Database source:UniProtKB:Q9EST8)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens), BRAF NFKBIZ PSEN1 WNK1 TRAF6 PDE4D RC3H2 ZAP70 EIF2B5 MALT1,BP,10,10 of 11,0.42,90.91,3.726E-07,0.00000583
GO:0006606,protein import into nucleus,Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:Q80U93|ens)A5D7C4(Evidence code:IEA/Database source:UniProtKB:Q9Y5L0|ens)E1BGE5(Evidence code:IEA/Database source:UniProtKB:Q9EPL8|ens)Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)E1BF47(Evidence code:IEA/Database source:InterPro:IPR012929)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)P61635(Evidence code:ISS/Database source:UniProtKB:P40763)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)G5E567(Evidence code:IBA/Database source:PANTHER:PTN000108134)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens), MBTPS1 NUP214 TNPO3 IPO7 RAN TPR POM121L2 PTTG1IP IPO8 RANBP2 STAT3 PPP3CA IPO9 KPNB1,BP,14,14 of 28,0.59,50,3.899E-07,0.000006082
GO:0030154,cell differentiation,F1MRU0(Evidence code:IEA/Database source:InterPro:IPR030118)E1BLV9(Evidence code:IBA/Database source:PANTHER:PTN001126776)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P98167(Evidence code:IEA/Database source:InterPro:IPR030119)A6QLP0(Evidence code:IBA/Database source:PANTHER:PTN001371846)E1B7I2(Evidence code:IBA/Database source:PANTHER:PTN000218930)Q08DB4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q2NL05(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q08DH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)F1MBH4(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)A7MAZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BPH3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A0JND4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN002389359)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A6QNT4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MSG6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3MU93(Evidence code:IEA/Database source:InterPro:IPR010660)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MXR2(Evidence code:IBA/Database source:PANTHER:PTN001422142)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BAF6(Evidence code:IBA/Database source:PANTHER:PTN000361728)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)Q0II26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)P03968(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)P17667(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)A6H7J1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)A2VDN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MC99(Evidence code:IBA/Database source:PANTHER:PTN001371846)A2VDR9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)O02675(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)G3X812(Evidence code:IEA/Database source:InterPro:IPR008297|I)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)A6H769(Evidence code:IEA/Database source:UniProtKB:P62082|ens)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)A6QLE1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0221)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens), FLT3 KIAA1522 CIB1 SSPO FOXO4 ETV2 CPNE1 KIF2A INA PAFAH1B1 MGP CYFIP1 CAMK2B FOXF1 TEC PURB TAF8 TDRD5 SBNO2 CAMK2A SNAPC4 SEPT7 SEPT2 FAM120B FRK TYK2 RAPGEF2 TSG101 LGR4 VAMP5 Notch1 ABL1 ONECUT2 BRAF PRRC2A GNA13 DMRTC2 NDRG2 CAMK2D GATA6 AIMP2 PURA CDC5L FGF1 GNA12 DLX2 CAND1 PSMB8 CPNE6 MYF5 PTPN6 INSM1 SPAST SEPT6 ZAP70 GLI2 FOXI3 ZNF750 DPYSL2 DDX4 NOTCH4 YES1 RPS7 CDK1 TDRD7 GRB2,BP,66,66 of 434,2.8,15.21,4.217E-07,0.000006559
GO:0072659,protein localization to plasma membrane,E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635134)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635134)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)E1BDL2(Evidence code:IEA/Database source:UniProtKB:Q9ULT0|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1B9D3(Evidence code:IEA/Database source:UniProtKB:E9PY61|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens), RAB37 TSPAN14 RAB26 CLN3 PALM LRP6 ZFYVE27 F11R TTC7A S100A10 FCER1G ATP2C2 DLG1 GPR179 RAPGEF2 RAP2A FLOT1,BP,17,17 of 44,0.72,38.64,4.269E-07,0.000006571
GO:0055038,recycling endosome membrane,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)P35071(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PKD9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)A6QR35(Evidence code:IEA/Database source:UniProtKB:O15127|ens), ARF6 RAB17 ZFYVE27 RAP2A BAIAP3 CFTR ABHD17C RAB4A RAP2C PACSIN2 SCAMP2,CC,11,11 of 15,0.47,73.33,4.279E-07,0.000006571
GO:0007608,sensory perception of smell,E1BEB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)G3N0Y0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)G3X828(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1BMX7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1BI89(Evidence code:IEA/Database source:InterPro:IPR034433)G3X8A9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552)E1BMY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0552), LOC531090 LOC788626 NAV2 OR13C3 OR51Q1 LOC101908058 OR5M11 LOC614090,BP,8,8 of 5,0.34,160,4.322E-07,0.000006571
GO:0030127,COPII vesicle coat,Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596)F1MV07(Evidence code:IEA/Database source:InterPro:IPR006895|I)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR006895|I)A6QNT8(Evidence code:IEA/Database source:InterPro:IPR006895|I)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR006895|I)E1BIU0(Evidence code:IEA/Database source:InterPro:IPR006895|I), PDCD6 SEC13 SEC24D SEC23A SEC24A PEF1 SEC23B SEC24C,CC,8,8 of 5,0.34,160,4.322E-07,0.000006571
GO:0034260,negative regulation of GTPase activity,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens)F1MLJ7(Evidence code:IEA/Database source:GO:0005095)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), ARFGEF1 ARL2 DAB2IP SH3BP4 WNK1 SLIT2 F11R LRRK2,BP,8,8 of 5,0.34,160,4.322E-07,0.000006571
GO:0016327,apicolateral plasma membrane,A4IFM4(Evidence code:IEA/Database source:UniProtKB:Q9Z260|ens)Q3B7N4(Evidence code:IEA/Database source:UniProtKB:Q9Z261|ens)Q6BBL6(Evidence code:IEA/Database source:UniProtKB:O35054|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)E1B9W1(Evidence code:IEA/Database source:UniProtKB:Q9D563|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:O75970|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q61146|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens), CLDN8 CLDN7 CLDN4 TJP1 TMEM114 MPDZ OCLN CLDN3,CC,8,8 of 5,0.34,160,4.322E-07,0.000006571
GO:0000145,exocyst,Q0V8C2(Evidence code:IEA/Database source:InterPro:IPR010326)A6QLT7(Evidence code:IEA/Database source:InterPro:IPR007225)Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR033960)A6QQU0(Evidence code:IEA/Database source:InterPro:IPR019160)A4IF89(Evidence code:IEA/Database source:InterPro:IPR033961)A6QLD1(Evidence code:IEA/Database source:InterPro:IPR007191)E1BDW9(Evidence code:IEA/Database source:InterPro:IPR029175)Q3ZC43(Evidence code:IEA/Database source:InterPro:IPR004140), EXOC3 EXOC6 EXOC5 EXOC1 EXOC8 EXOC4 EXOC2 EXOC7,CC,8,8 of 5,0.34,160,4.322E-07,0.000006571
GO:0070273,phosphatidylinositol-4-phosphate binding,F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)Q1RMW9(Evidence code:IEA/Database source:InterPro:IPR008628)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492), PLEKHA5 DAB2IP LANCL2 SH3PXD2A GOLPH3 ARFIP1 OSBP SNX3,MF,8,8 of 5,0.34,160,4.322E-07,0.000006571
GO:0008305,integrin complex,A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)P61625(Evidence code:IEA/Database source:InterPro:IPR000413)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)P32592(Evidence code:IEA/Database source:InterPro:IPR015439)A6QQ97(Evidence code:IEA/Database source:InterPro:IPR000413)P80746(Evidence code:IEA/Database source:InterPro:IPR000413)F1MMH2(Evidence code:IEA/Database source:InterPro:IPR000413)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)P53710(Evidence code:IEA/Database source:InterPro:IPR000413), ITGB7 ITGAL ITGB1 ITGB2 ITGAD ITGAV ITGA9 ITGB6 ITGA2,CC,9,9 of 8,0.38,112.5,4.586E-07,0.000006951
GO:0016311,dephosphorylation,E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000387|I)A5D980(Evidence code:IEA/Database source:InterPro:IPR000387|I)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR000340|I)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR000387|I)Q5E9Y6(Evidence code:IEA/Database source:GO:0016791)A1A4Q9(Evidence code:IEA/Database source:GO:0098519)G5E526(Evidence code:IEA/Database source:InterPro:IPR000340|I)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000387|I)E1BCN1(Evidence code:IEA/Database source:GO:0008195)A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000387|I)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000387|I)A6QLS1(Evidence code:IEA/Database source:InterPro:IPR000340|I)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR000340|I)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000387)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000387|I)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), PTPRM PTPN6 SSH2 MTMR1 PRUNE1 NUDT16 PTP4A1 PTPN14 LPIN2 PTPN5 PTPRZ1 DUSP7 DUSP3 PTPN23 PTPRA PPP3CA,BP,16,16 of 39,0.68,41.03,0.000000487,0.000007361
GO:0017111,nucleoside-triphosphatase activity,Q28141(Evidence code:IDA/Database source:),DHX9,MF,1,1 of 257,0.04,0.39,5.549E-07,0.000008364
GO:0051865,protein autoubiquitination,A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)F1N2S5(Evidence code:IEA/Database source:UniProtKB:Q8TEJ3|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)Q08DV5(Evidence code:ISS/Database source:UniProtKB:Q6PDX6)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens), UHRF1 BRCA1 SH3RF3 RNF112 UBE4B TRIM68 MARCH5 RNF220 MARCH7 UBE2D2 TRAF6 RAD18,BP,12,12 of 20,0.51,60,0.000000613,0.000009162
GO:0004812,aminoacyl-tRNA ligase activity,G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000738|I)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR000738|I)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001412|I)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR012947)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001412|I)A6QLT9(Evidence code:IEA/Database source:InterPro:IPR012947)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR000738|I)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I), EPRS MARS WARS2 LARS RARS AARS2 QARS RARS2 AARS GARS IARS NARS,MF,12,12 of 20,0.51,60,0.000000613,0.000009162
GO:0042826,histone deacetylase binding,F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR031169)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), TOP2B HIC1 LEF1 TRAF6 SP1 MIER1 SIRT2 BCOR DDX20 PKN1 SFPQ NIPBL,MF,12,12 of 20,0.51,60,0.000000613,0.000009162
GO:0006821,chloride transport,Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q5E9B7(Evidence code:IEA/Database source:InterPro:IPR030259)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q08E50(Evidence code:IEA/Database source:InterPro:IPR005435)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)F1N1D4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869), CLCC1 BEST3 ANO6 CLDN4 CLIC1 CLIC4 GABRA5 CLIC6 TTYH3 CFTR,BP,10,10 of 12,0.42,83.33,6.411E-07,0.000009529
GO:0005643,nuclear pore,Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0906)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q8VCB1|ens)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)A1A4I8(Evidence code:IEA/Database source:UniProtKB:Q9UIA9|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0906), MYO1C BICD2 RANBP2 PIK3R4 TPR NDC1 XPOT AHCTF1 XPO7 SEC13,CC,10,10 of 12,0.42,83.33,6.411E-07,0.000009529
GO:0019774,"proteasome core complex, beta-subunit complex",Q5E9K0(Evidence code:ISS/Database source:UniProtKB:P23724)Q3T112(Evidence code:ISS/Database source:UniProtKB:P23724)Q3T108(Evidence code:ISS/Database source:UniProtKB:P23724)Q3T0T1(Evidence code:ISS/Database source:UniProtKB:P23724)Q3SZC2(Evidence code:ISS/Database source:UniProtKB:P23724)P33672(Evidence code:IEA/Database source:InterPro:IPR033811), PSMB2 PSMB8 PSMB4 PSMB10 PSMB9 PSMB3,CC,6,6 of 1,0.25,600,6.519E-07,0.000009583
GO:0001732,formation of cytoplasmic translation initiation complex,E1BLZ8(Evidence code:IEA/Database source:UniRule:UR000106280)Q3ZC12(Evidence code:IEA/Database source:UniRule:UR000106306)Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134)Q5E966(Evidence code:IEA/Database source:UniRule:UR000107081)A7MB16(Evidence code:IEA/Database source:UniRule:UR000106119)Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107), EIF3F EIF3G EIF3M EIF3I EIF3B EIF3K,BP,6,6 of 1,0.25,600,6.519E-07,0.000009583
GO:0035235,ionotropic glutamate receptor signaling pathway,F1MCW8(Evidence code:IEA/Database source:GO:0004970)F1MWI8(Evidence code:IEA/Database source:GO:0004970)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MBY1(Evidence code:IEA/Database source:GO:0004971)E1BGZ0(Evidence code:IEA/Database source:GO:0004971)G0T3G6(Evidence code:IEA/Database source:GO:0004970), GRIK4 GRIN3B CLN3 GRIA2 GRIA3 GRIA1,BP,6,6 of 1,0.25,600,6.519E-07,0.000009583
GO:0046835,carbohydrate phosphorylation,A6QP44(Evidence code:IEA/Database source:UniProtKB:Q7TMC8|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)A6H768(Evidence code:IEA/Database source:InterPro:IPR000705)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens)Q0IIG5(Evidence code:IEA/Database source:GO:0008443)E1BNF8(Evidence code:IEA/Database source:UniProtKB:Q96C11|ens), FUK GCK GALK1 HK2 PFKM FGGY,BP,6,6 of 1,0.25,600,6.519E-07,0.000009583
GO:0039702,viral budding via host ESCRT complex,A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens), CHMP4A CHMP4B PDCD6IP CHMP2B CHMP2A VPS4B CHMP6,BP,7,7 of 3,0.3,233.33,6.722E-07,0.000009855
GO:0005623,cell,Q0II43(Evidence code:IEA/Database source:GO:0045454)E1BDL2(Evidence code:IEA/Database source:GO:0006879)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)F1N3Q4(Evidence code:IDA/Database source:)B6Z9Q5(Evidence code:IEA/Database source:GO:0032401)G3MXV5(Evidence code:IEA/Database source:GO:0072383)E1BHV1(Evidence code:IEA/Database source:GO:0006874)G3N0E5(Evidence code:IEA/Database source:GO:0006874)E1BNF8(Evidence code:IEA/Database source:GO:0070050)F1MF57(Evidence code:IDA/Database source:)A5PKI0(Evidence code:IDA/Database source:), TXNL1 TTC7A FAM20A PALM SHROOM2 KIF13A RYR2 RYR3 FGGY NEBL APPL1,CC,11,11 of 16,0.47,68.75,6.772E-07,0.000009901
GO:0009890,negative regulation of biosynthetic process,Q32L41(Evidence code:IEA/Database source:InterPro:IPR009112|I),GCHFR,BP,1,1 of 253,0.04,0.4,8.534E-07,0.00001244
GO:0001756,somitogenesis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MEC8(Evidence code:IEA/Database source:UniProtKB:Q7TSK3|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens), PSEN1 AXIN2 LEF1 PCDH8 PRKDC MYF5 LFNG FOXF1 ABI1,BP,9,9 of 9,0.38,100,8.612E-07,0.00001245
GO:0031532,actin cytoskeleton reorganization,F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR030770)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)A5PK55(Evidence code:IEA/Database source:InterPro:IPR028433), MICALL2 KIT PAK1 SIPA1L1 RAP2A PTK7 BRSK2 RICTOR PARVA,BP,9,9 of 9,0.38,100,8.612E-07,0.00001245
GO:0000186,activation of MAPKK activity,E1B7H4(Evidence code:IEA/Database source:GO:0004709)F1MDL4(Evidence code:IEA/Database source:GO:0004709)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1BHE1(Evidence code:IEA/Database source:GO:0004709)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1N3K4(Evidence code:IEA/Database source:GO:0004709)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens), MAP3K10 BRAF F2R TAOK3 MAP3K4 LRRK2 PSEN1 MAP3K9 TAOK2,BP,9,9 of 9,0.38,100,8.612E-07,0.00001245
GO:0005516,calmodulin binding,Q27995(Evidence code:IEA/Database source:InterPro:IPR012144)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)A5D7H2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR013543)A4IFM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)Q08E45(Evidence code:IEA/Database source:InterPro:IPR013543)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1MJ90(Evidence code:IEA/Database source:InterPro:IPR008734)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR013543)P10568(Evidence code:IEA/Database source:UniProtKB-KW:KW-0112)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR013543)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens), NOS2 MYO9B MAPKAPK3 ATP2B4 SMTNL1 IQGAP2 MYO1D STRN3 CAMK2G MYLK2 CAMK2A CDK5RAP2 PHKB PPP3CA MYO1C CAMK2D MYO1A CAMK2B PLCB3,MF,19,19 of 59,0.81,32.2,9.013E-07,0.00001292
GO:0043087,regulation of GTPase activity,E1B801(Evidence code:IBA/Database source:PANTHER:PTN000571279)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1BB77(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1MZM7(Evidence code:IBA/Database source:PANTHER:PTN000571279)F1N6T8(Evidence code:IEA/Database source:UniProtKB:P52735|ens)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens)G5E5Q8(Evidence code:IEA/Database source:InterPro:IPR030574)E1BJP2(Evidence code:IBA/Database source:PANTHER:PTN000571279)F1N746(Evidence code:IEA/Database source:UniProtKB:Q9Y3P9|ens)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR030770)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR001936|I)E1B800(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1MTR1(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1MBI8(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR030772)A6H7H0(Evidence code:IEA/Database source:InterPro:IPR001936|I)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens), ARHGAP35 CRK DAB2IP SYDE2 VAV2 PROM2 SBF1 RACGAP1 RABGAP1 SIPA1L1 RASAL1 RASAL2 IQGAP2 SYNGAP1 ARHGAP6 IQGAP3 RICTOR,BP,17,17 of 47,0.72,36.17,0.0000009,0.00001292
GO:0098794,postsynapse,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q96FJ2|ens)E1BPU0(Evidence code:IEA/Database source:GO:0060079)Q3ZC13(Evidence code:IEA/Database source:GO:0098884)Q3ZBG0(Evidence code:IEA/Database source:UniProtKB:Q9Z2U0|ens)E1BKU0(Evidence code:IEA/Database source:GO:0060080)F1MN60(Evidence code:IEA/Database source:GO:0099566)E1BGA9(Evidence code:IEA/Database source:UniProtKB:Q6P5E8|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens), GIPC1 INA SNAP25 VPS35 DYNLL2 LRRK2 AP2M1 PSMA7 ADORA2A ATP2B2 DGKQ PURA,CC,12,12 of 21,0.51,57.14,9.031E-07,0.00001292
GO:0030433,ubiquitin-dependent ERAD pathway,Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)E1BAK9(Evidence code:IEA/Database source:InterPro:IPR032832)F1MGK3(Evidence code:IBA/Database source:PANTHER:PTN000395729)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)G3MXQ8(Evidence code:IEA/Database source:UniProtKB:Q9UKM7|ens)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765)Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)A6QNS2(Evidence code:IBA/Database source:PANTHER:PTN000358161)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens), PSMC2 SYVN1 ERLEC1 PSMC5 MAN1B1 PSMC6 DZIP3 SGTA UBE2G2 UBE4B PSMC1 UBQLN1,BP,12,12 of 21,0.51,57.14,9.031E-07,0.00001292
GO:0071339,MLL1 complex,E1BKB7(Evidence code:IEA/Database source:InterPro:IPR037935)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR037927)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q91X20|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230)E1BGF3(Evidence code:IEA/Database source:InterPro:IPR037854)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)E1BEJ7(Evidence code:IEA/Database source:InterPro:IPR037932), MGA KMT2A ASH2L RUVBL1 RUVBL2 HCFC1 CHD8 HCFC2,CC,8,8 of 6,0.34,133.33,9.477E-07,0.00001352
GO:0016874,ligase activity,A6QLR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q3T099(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q6PWM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q3ZBF0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A7MBG0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q2KJG3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A7MBC5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR014042)E1BE47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863)A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q3MHH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)A7YW98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)Q08E58(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436)F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0436), LARS WARS2 PFAS RARS2 GART AARS MARS NADSYN1 ADSS NARS IARS GSS MGRN1 ITCH LIG1 ASNS QARS NAPRT RARS TTLL12 AARS2,MF,21,21 of 72,0.89,29.17,9.517E-07,0.00001354
GO:0004298,threonine-type endopeptidase activity,Q5E9K0(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3T0Y5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T108(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T0X5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR001353|I)P33672(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3T112(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR001353|I), PSMB2 PSMA2 PSMB4 PSMA3 PSMA7 PSMA1 PSMA4 PSMB10 PSMB3 PSMB8 PSMB9,MF,11,11 of 17,0.47,64.71,0.000001046,0.00001473
GO:0090090,negative regulation of canonical Wnt signaling pathway,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A0JN59(Evidence code:IEA/Database source:UniProtKB:Q9Y283|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)E1BI79(Evidence code:IEA/Database source:InterPro:IPR026837)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens), FZD1 SOX17 INVS STK3 CTNND1 APC2 GLI1 AXIN2 DAB2IP AXIN1 WWTR1,BP,11,11 of 17,0.47,64.71,0.000001046,0.00001473
GO:0007286,spermatid development,F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551)E1B7M8(Evidence code:IEA/Database source:UniProtKB:Q5QNQ6|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BF83(Evidence code:IEA/Database source:UniProtKB:Q3TY65|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BFJ4(Evidence code:IEA/Database source:UniProtKB:Q99MV7|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), KLHL26 OSBP2 PYGO2 TDRD5 EHMT2 ICA1L FNDC3A ALMS1 RNF17 CIB1 KIT,BP,11,11 of 17,0.47,64.71,0.000001046,0.00001473
GO:0006096,glycolytic process,E1BME6(Evidence code:IEA/Database source:InterPro:IPR019807)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR001697|I)Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR000023|I)A1A4J1(Evidence code:IEA/Database source:InterPro:IPR000023|I)A6QR34(Evidence code:IEA/Database source:InterPro:IPR019807)Q32KN6(Evidence code:IEA/Database source:InterPro:IPR001576|I)F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941)Q3T0S5(Evidence code:IEA/Database source:InterPro:IPR000741)B3IVN4(Evidence code:IEA/Database source:InterPro:IPR001697|I)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR000023|I)Q2KJE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0324), HK2 PKLR PFKM PFKL GCK PGK2 ENO4 ALDOB PKM PFKP GAPDHS,BP,11,11 of 17,0.47,64.71,0.000001046,0.00001473
GO:0010501,RNA secondary structure unwinding,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)Q3SZ65(Evidence code:IBA/Database source:PANTHER:PTN000618218)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q2NL22(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q3SZ54(Evidence code:IBA/Database source:PANTHER:PTN000618218)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q0IIK5(Evidence code:IBA/Database source:PANTHER:PTN000618218)F1MRW7(Evidence code:IBA/Database source:PANTHER:PTN000618218)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000618218), AGO4 EIF4A2 DDX3X EIF4A3 DDX4 EIF4A1 DHX9 DDX1 DDX20 DDX3Y,BP,10,10 of 13,0.42,76.92,0.000001064,0.00001491
GO:0009791,post-embryonic development,E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), STK36 RAB3A RC3H2 ASH1L MAPK8IP3 KMT2A PYGO2 PSEN1 ABL1 BCL11B,BP,10,10 of 13,0.42,76.92,0.000001064,0.00001491
GO:0016818,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I), BLM ERCC2,MF,2,2 of 281,0.08,0.71,0.000001073,0.000015
GO:0000398,"mRNA splicing, via spliceosome",Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)Q2KJ71(Evidence code:IEA/Database source:UniProtKB:Q13595|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)F1MS84(Evidence code:IEA/Database source:InterPro:IPR033087)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)A7Z025(Evidence code:IEA/Database source:InterPro:IPR012591|I)F1MRK2(Evidence code:IBA/Database source:PANTHER:PTN000573351)Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q9UMS4)A4FUI2(Evidence code:IEA/Database source:InterPro:IPR027078)Q3ZBK6(Evidence code:IEA/Database source:InterPro:IPR034101)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)A2VDN6(Evidence code:ISS/Database source:UniProtKB:Q15459), SNRNP70 GPKOW PPIE TRA2A DHX8 SNRNP200 NOVA2 PRPF40A SYF2 PRPF8 SPEN CDC5L SNRPE LSM4 SNRPN SF3A1,BP,16,16 of 43,0.68,37.21,0.000001381,0.0000192
GO:0000776,kinetochore,Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)P61285(Evidence code:ISS/Database source:UniProtKB:P63167)P43033(Evidence code:IBA/Database source:PANTHER:PTN000752735)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0995)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens), DCTN3 SEC13 TPR LRWD1 DYNC1LI1 SEPT6 XPO1 SEPT7 SEPT2 DYNLL1 PAFAH1B1 DCTN2 CSNK1A1 PPP1CC PSEN1 CKAP5,CC,16,16 of 43,0.68,37.21,0.000001381,0.0000192
GO:0020037,heme binding,F1MP20(Evidence code:IEA/Database source:InterPro:IPR012292)A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR038158)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)P00432(Evidence code:IEA/Database source:InterPro:IPR002226|I)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)P62894(Evidence code:IEA/Database source:InterPro:IPR002327|I)E1BEL8(Evidence code:IEA/Database source:InterPro:IPR000971|I)A5PJQ6(Evidence code:IBA/Database source:PANTHER:PTN000031653)A7MBF5(Evidence code:IEA/Database source:InterPro:IPR000898|I)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q32LH7(Evidence code:IEA/Database source:InterPro:IPR018506)Q27995(Evidence code:IEA/Database source:InterPro:IPR012144), ADGB GUCY1A3 JAK2 CAT DGCR8 CYP7A1 LOC540627 SRC CYCS HBE1 PGRMC2 IDO1 CYP2J2 CYP2R1 LOC100295883 CYB5R4 NOS2,MF,17,17 of 49,0.72,34.69,0.000001439,0.00001995
GO:0031648,protein destabilization,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens), SRC PRKDC SIRT6 CUL3 SOX17 PRNP RNF139 PEX2 VPS35,BP,9,9 of 10,0.38,90,0.000001537,0.00002119
GO:0031683,G-protein beta/gamma-subunit complex binding,A6QPN4(Evidence code:IEA/Database source:InterPro:IPR000367|I)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR001019)P04696(Evidence code:IEA/Database source:InterPro:IPR001019|I)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019|I)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR001019)P38408(Evidence code:IEA/Database source:InterPro:IPR001019)P04695(Evidence code:IEA/Database source:InterPro:IPR001019|I)P04896(Evidence code:IEA/Database source:InterPro:IPR000367|I)P63097(Evidence code:IEA/Database source:InterPro:IPR001019|I), GNAL GNA12 GNAT2 GNAT3 GNA13 GNA14 GNAT1 GNAS GNAI1,MF,9,9 of 10,0.38,90,0.000001537,0.00002119
GO:0005839,proteasome core complex,Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q3T0X5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3T112(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q3T108(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q5E9K0(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3T0Y5(Evidence code:IEA/Database source:InterPro:IPR001353)P33672(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR001353)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR001353|I), PSMB10 PSMA1 PSMA4 PSMB8 PSMB4 PSMB2 PSMA2 PSMB3 PSMB9 PSMA7 PSMA3,CC,11,11 of 18,0.47,61.11,0.000001581,0.00002169
GO:0007417,central nervous system development,P13608(Evidence code:IBA/Database source:PANTHER:PTN001105676)V6F7Z2(Evidence code:IEA/Database source:InterPro:IPR033029)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8NFT8|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)F1N2J5(Evidence code:IBA/Database source:PANTHER:PTN001105676)P81282(Evidence code:IBA/Database source:PANTHER:PTN001105676), ACAN DSCAML1 DNER STK3 COL2A1 AHI1 ANKLE2 CHD7 SRC HAPLN4 VCAN,BP,11,11 of 18,0.47,61.11,0.000001581,0.00002169
GO:0016853,isomerase activity,P26882(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q5BIN5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3T105(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q9TRY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q0P563(Evidence code:IEA/Database source:InterPro:IPR007721|I)Q17QA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)F1MU48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q2KJC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3SZJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3SZI0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q32PA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)F1MS56(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3SX07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)G3X8B1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)P68107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q3MHF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413)Q2KJ44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0413), PPID PIN1 GALE FKBP4 MRI1 FUOM FKBP5 TOP2B FKBP9 PPWD1 PTGES3 PMM2 MPI FKBP2 PGM3 PUS3 PPIE LOC613401 FKBP1B HSD3B7 PTPA,MF,21,21 of 75,0.89,28,0.000001649,0.00002257
GO:0043197,dendritic spine,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)A2VE99(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BFV9(Evidence code:IEA/Database source:UniProtKB:Q0QWG9|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)A5PKD9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P48452(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), PRKACA SEPT11 GRID2IP CAMK2A GIPC1 ABHD17C PPP3CA SHANK2 RGS14 SHANK1,CC,10,10 of 14,0.42,71.43,0.000001712,0.00002338
GO:0016079,synaptic vesicle exocytosis,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MKZ3(Evidence code:IEA/Database source:InterPro:IPR033227)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1BBX9(Evidence code:IEA/Database source:UniProtKB:Q8K0T7|ens)E1BMQ1(Evidence code:IEA/Database source:InterPro:IPR029996)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens), UNC13A CADPS RAB3A UNC13C OTOF SNAP25 UNC13B,BP,7,7 of 4,0.3,175,0.000001739,0.00002344
GO:0004707,MAP kinase activity,A4FV00(Evidence code:IEA/Database source:InterPro:IPR003527|I)A5PJL3(Evidence code:IEA/Database source:InterPro:IPR003527|I)Q3T0N5(Evidence code:IEA/Database source:InterPro:IPR003527|I)G3X793(Evidence code:IEA/Database source:InterPro:IPR003527)P46196(Evidence code:IEA/Database source:InterPro:IPR003527|I)Q2KI72(Evidence code:IEA/Database source:InterPro:IPR003527|I)F1MVV5(Evidence code:IEA/Database source:InterPro:IPR008350), MAPK10 MAPK12 MAPK13 MAPK11 MAPK1 MAPK9 MAPK4,MF,7,7 of 4,0.3,175,0.000001739,0.00002344
GO:0042169,SH2 domain binding,Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), AFAP1L2 CRK JAK2 PTPN6 LCK ABL1 SRC,MF,7,7 of 4,0.3,175,0.000001739,0.00002344
GO:0000338,protein deneddylation,Q3SZA0(Evidence code:ISS/Database source:UniProtKB:Q9BT78)A6H7B5(Evidence code:IEA/Database source:UniProtKB:Q9UNS2|ens)A4FV74(Evidence code:IEA/Database source:InterPro:IPR033205)A6QQ21(Evidence code:IEA/Database source:InterPro:IPR033859)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)G3X736(Evidence code:IEA/Database source:UniProtKB:P61201|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens), COPS4 COPS3 COPS8 COPS6 COPS5 COPS2 TOR1A,BP,7,7 of 4,0.3,175,0.000001739,0.00002344
GO:0004198,calcium-dependent cysteine-type endopeptidase activity,A5D7S6(Evidence code:IBA/Database source:PANTHER:PTN000021568)Q0IIA3(Evidence code:IBA/Database source:PANTHER:PTN000021568)E1BIX3(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q1LZ81(Evidence code:IBA/Database source:PANTHER:PTN000021568)F1MQD1(Evidence code:IEA/Database source:InterPro:IPR001300|I)F1MXQ5(Evidence code:IEA/Database source:InterPro:IPR001300|I)Q27971(Evidence code:IEA/Database source:InterPro:IPR001300|I), PEF1 SRI CAPN7 PDCD6 CAPN5 CAPN11 CAPN2,MF,7,7 of 4,0.3,175,0.000001739,0.00002344
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR001824)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BIE4(Evidence code:IEA/Database source:InterPro:IPR001426|I)F1N758(Evidence code:IEA/Database source:InterPro:IPR006211|I)F1MQH2(Evidence code:IEA/Database source:InterPro:IPR001426)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)P43481(Evidence code:IEA/Database source:InterPro:IPR001824)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357), CSPG4 ZAP70 AHI1 FLT3 FRK ABL1 TYK2 JAK2 TEC FRS2 EPHB4 ERBB4 EPHA6 YES1 GRB2 KIT BDNF LCK,BP,18,18 of 56,0.76,32.14,0.000001765,0.00002373
GO:0016788,"hydrolase activity, acting on ester bonds",Q29458(Evidence code:IEA/Database source:InterPro:IPR025483),LIPF,MF,1,1 of 240,0.04,0.42,0.00000177,0.00002374
GO:0007030,Golgi organization,Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257)E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens)A6QQ47(Evidence code:IBA/Database source:PANTHER:PTN000409559)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P61212)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens)E1BPC3(Evidence code:IBA/Database source:PANTHER:PTN001184364), NSFL1C KIFC3 VPS51 BAG5 LRRK2 ARL1 MYO18A GOLPH3 ARFGEF1 RAB30 ARHGAP21 ATP8B1,BP,12,12 of 23,0.51,52.17,0.000001867,0.00002498
GO:0050885,neuromuscular process controlling balance,E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens), POU4F2 KCNMA1 ABL1 CLN3 ALDH1A3 BCR SHANK1 AARS,BP,8,8 of 7,0.34,114.29,0.000001908,0.00002521
GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), RREB1 CRKL BRAF CIB1 S100A10 PREX1 ABL1 CRK,BP,8,8 of 7,0.34,114.29,0.000001908,0.00002521
GO:0007416,synapse assembly,E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens)E1BMN9(Evidence code:IEA/Database source:InterPro:IPR030627)G3N152(Evidence code:IBA/Database source:PANTHER:PTN000617834)F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)E1BDL0(Evidence code:IBA/Database source:PANTHER:PTN000617834)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens), SHANK2 VPS35 BDNF BSN PCDHB8 SDK2 LOC786512 CRKL,BP,8,8 of 7,0.34,114.29,0.000001908,0.00002521
GO:0043507,positive regulation of JUN kinase activity,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), MAPK8IP3 SASH1 TRAF6 MAP3K10 MAP3K4 PAK1 TAOK3 DAB2IP,BP,8,8 of 7,0.34,114.29,0.000001908,0.00002521
GO:0070830,bicellular tight junction assembly,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens)Q2TA37(Evidence code:IDA/Database source:)E1BIQ8(Evidence code:IEA/Database source:InterPro:IPR031185)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A2VE81(Evidence code:IEA/Database source:InterPro:IPR002958)Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens), PDCD6IP ARL2 MPP5 MICALL2 SRF OCLN CLDN3 DLG1,BP,8,8 of 7,0.34,114.29,0.000001908,0.00002521
GO:0016604,nuclear body,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens)Q29RZ2(Evidence code:IEA/Database source:UniProtKB:Q96BP3|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1B8T3(Evidence code:IEA/Database source:UniProtKB:Q9UGU0|ens)F1MI25(Evidence code:IEA/Database source:UniProtKB:P15822|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)F1MUU2(Evidence code:IEA/Database source:UniProtKB:Q8TDR2|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q2L6I0|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)E1BQ03(Evidence code:IEA/Database source:UniProtKB:Q96RE7|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:A4LAA3|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q14190|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)G5E5Q8(Evidence code:IEA/Database source:UniProtKB:O95248|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:F1D8P9|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens)F1N0D7(Evidence code:IEA/Database source:UniProtKB:A0A024RDY6), AGO4 ZBTB4 RIF1 CELF3 PPWD1 DHX9 RGS14 TCF20 HIVEP1 SUZ12 STK35 PPP1R10 WWTR1 ZFHX3 INO80 NACC1 ABL1 ATRX MYO1C SIM2 DHX8 SETX TNKS S100A14 SBF1 NR1I2 PTPN23 TERF2 RNF112 GTF3C6 RAD18 LARS ESRP1 ZIC2,CC,34,34 of 171,1.44,19.88,0.000001917,0.00002526
GO:0042995,cell projection,Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)Q28046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A2VDK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A2VDU1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens)F1MCY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A2VE99(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q5E963(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)P48452(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)O46385(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P56722(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A5PKD9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q08E52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q58DW6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A4IF89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A8E4N3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZBA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q5EAD0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P0C1G6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P85091(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0966), KCNA4 SEPT6 FABP7 SCIN WASF2 SPRY4 MAGI1 PHACTR4 SEPT11 SEPT2 ALCAM ARPC5L DPP4 CD44 PPP3CA TUBB4A CSPG4 SORD CCT8 SVIL PTPRN ABHD17C DNM2 PAK1 CDC42SE2 ZFYVE27 RAB25 EXOC8 PRKACA CPNE6 RDX RSPH3 PROM2 SH3GL1 NDRG2 SEPT7 TEKT4 C1QTNF5 MYO1C GNAT1 PDXP ATP2B4 MICAL3 ARL6 CSNK1A1 BAIAP2 SWAP70 CIB1 PLCG1 CYFIP1 ITGB1,CC,51,51 of 317,2.17,16.09,0.000001998,0.00002627
GO:1903861,positive regulation of dendrite extension,Q2KHY1(Evidence code:IEA/Database source:UniProtKB:O95741|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:Q9H2B2|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q9UPW8|ens)F1N7B7(Evidence code:IEA/Database source:UniProtKB:Q86UR5|ens)E1BPM0(Evidence code:IEA/Database source:UniProtKB:O95294|ens)E1BID8(Evidence code:IEA/Database source:UniProtKB:Q9HCH3|ens), CPNE6 SYT4 UNC13A RIMS1 RASAL1 CPNE5,BP,6,6 of 2,0.25,300,0.000002455,0.00003181
GO:0000815,ESCRT III complex,Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888), CHMP6 CHMP2A CHMP2B CHMP4A CHMP4B CHMP1A,CC,6,6 of 2,0.25,300,0.000002455,0.00003181
GO:0034399,nuclear periphery,Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MNL8(Evidence code:IBA/Database source:PANTHER:PTN001854329)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens)E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427), TNPO1 IPO5 IPO4 AHCTF1 TPR KPNB1,CC,6,6 of 2,0.25,300,0.000002455,0.00003181
GO:0042800,histone methyltransferase activity (H3-K4 specific),F1MYZ3(Evidence code:IEA/Database source:InterPro:IPR037877)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569|I)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569)E1BEP4(Evidence code:IBA/Database source:PANTHER:PTN000063846), KMT2C KMT2A SETD1B ASH1L KMT2B ASH2L,MF,6,6 of 2,0.25,300,0.000002455,0.00003181
GO:0007095,mitotic G2 DNA damage checkpoint,P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:Q9WVH3|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), CDK1 TAOK3 SYF2 FOXO4 TAOK2 BLM,BP,6,6 of 2,0.25,300,0.000002455,0.00003181
GO:0003950,NAD+ ADP-ribosyltransferase activity,E1B7S1(Evidence code:IEA/Database source:InterPro:IPR012317)E1BCF8(Evidence code:IEA/Database source:InterPro:IPR012317)P18493(Evidence code:IEA/Database source:InterPro:IPR004102|I)Q0P582(Evidence code:IEA/Database source:InterPro:IPR012317)F1MCK0(Evidence code:IEA/Database source:InterPro:IPR012317)E1B8R5(Evidence code:IEA/Database source:InterPro:IPR012317|I), PARP12 ZC3HAV1 PARP1 PARP14 PARP8 TNKS,MF,6,6 of 2,0.25,300,0.000002455,0.00003181
GO:0019866,organelle inner membrane,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,CC,1,1 of 231,0.04,0.43,0.000002506,0.00003239
GO:0003755,peptidyl-prolyl cis-trans isomerase activity,P48820(Evidence code:IEA/Database source:InterPro:IPR002130|I)Q5BIN5(Evidence code:IEA/Database source:InterPro:IPR000297)Q2KJC8(Evidence code:IEA/Database source:EC:5.2.1.8)G3X8B1(Evidence code:IEA/Database source:InterPro:IPR002130|I)Q2KJ44(Evidence code:IEA/Database source:EC:5.2.1.8)Q32PA9(Evidence code:IEA/Database source:EC:5.2.1.8)A4FV72(Evidence code:IEA/Database source:InterPro:IPR002130|I)P26882(Evidence code:IEA/Database source:InterPro:IPR002130|I)P68107(Evidence code:IEA/Database source:EC:5.2.1.8)Q29RZ2(Evidence code:IEA/Database source:InterPro:IPR002130|I)Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212)Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210), RANBP2 PIN1 FKBP9 LOC613401 PTPA FKBP2 PPIE PPID FKBP1B PPWD1 FKBP4 FKBP5,MF,12,12 of 24,0.51,50,0.000002626,0.00003354
GO:0007040,lysosome organization,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q14703|ens)Q3ZC25(Evidence code:IEA/Database source:UniProtKB:Q80X71|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612)Q9TTK4(Evidence code:IEA/Database source:InterPro:IPR030464), ABCA1 VPS35 MBTPS1 TMEM106B LRRK2 TPCN2 CLN3 FAM160A2 LYST,BP,9,9 of 11,0.38,81.82,0.000002623,0.00003354
GO:0010824,regulation of centrosome duplication,Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q29RL2(Evidence code:ISS/Database source:UniProtKB:Q9D1P4)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens)E1BK86(Evidence code:IEA/Database source:InterPro:IPR028839)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), CHMP2B PDCD6IP CHMP1A CHMP2A CHORDC1 VPS4B XPO1 PKHD1 CHMP4B,BP,9,9 of 11,0.38,81.82,0.000002623,0.00003354
GO:0030324,lung development,P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens)F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P53566)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BI45(Evidence code:IEA/Database source:UniProtKB:Q9Z2J0|ens)Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), FGF1 SIM2 GLI1 CEBPA FOXF1 SLC23A1 CRH RAB3A GLI2,BP,9,9 of 11,0.38,81.82,0.000002623,0.00003354
GO:0030276,clathrin binding,Q5BIP4(Evidence code:IEA/Database source:UniProtKB:O60784|ens)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)P63009(Evidence code:IEA/Database source:InterPro:IPR016342)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q5T7P8|ens)A7Z035(Evidence code:IEA/Database source:UniProtKB:Q14677|ens)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR016342)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285), TOM1 SYTL2 LRRK2 AP2B1 SYT6 CLINT1 AP2B1 SYT4 SYTL1,MF,9,9 of 11,0.38,81.82,0.000002623,0.00003354
GO:0030145,manganese ion binding,Q1JPJ2(Evidence code:ISS/Database source:UniProtKB:Q9NQW7)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1)P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q8IXL6|ens), XPNPEP1 DYRK2 ABL1 POMGNT1 NUDT16 IMPA1 WRN PRKACA GALNT2 FAM20C,MF,10,10 of 15,0.42,66.67,0.000002679,0.00003405
GO:0016328,lateral plasma membrane,E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q3B7N4(Evidence code:IEA/Database source:UniProtKB:Q9Z261|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6)Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens)Q2TA37(Evidence code:IDA/Database source:)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens), AXIN1 MYO1A DLG1 CLDN7 MYO1C C1QTNF5 ATP6V1B1 CLDN3 ARL2 TACSTD2,CC,10,10 of 15,0.42,66.67,0.000002679,0.00003405
GO:0000922,spindle pole,E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BAN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)P67774(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)A5PJP6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), KNTC1 CDK5RAP2 NUMA1 DYNC1LI1 VPS4B KATNAL2 TUBGCP2 PPP2CA CKAP5 KIF2A BIRC6 BRCC3 PKP4 IKBKG PPP2CB,CC,15,15 of 40,0.64,37.5,0.000002706,0.00003431
GO:0019904,protein domain specific binding,Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)E1BB27(Evidence code:IBA/Database source:PANTHER:PTN000270003)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)Q2KIB6(Evidence code:IEA/Database source:UniProtKB:Q9HAP6|ens)E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q2YDM1(Evidence code:IEA/Database source:UniProtKB:P40616|ens)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR010504)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)E1BF83(Evidence code:IEA/Database source:InterPro:IPR010504)E1BBJ2(Evidence code:IBA/Database source:PANTHER:PTN000270003)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens), TFDP2 PRKDC CTBP1 DLGAP1 CHMP2B SRC NEDD4 GRB2 ABL1 MPP5 PRKAR2A LIN7C TJP1 LIN7B OSBP KPNB1 STAMBP CHMP2A ARL1 ARFIP1 NUMA1 CHMP1A GPSM2 IKBKG KHDRBS1 PRKACA ICA1L DLGAP3 OCLN LAMP1,MF,30,30 of 145,1.27,20.69,0.000002902,0.0000367
GO:0008565,protein transporter activity,G5E567(Evidence code:IEA/Database source:UniProtKB:Q96P70|ens)F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)E1BGE5(Evidence code:IBA/Database source:PANTHER:PTN000108134)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens)Q0VD53(Evidence code:IBA/Database source:PANTHER:PTN000260563)Q2HJG5(Evidence code:IBA/Database source:PANTHER:PTN000120819)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P56371|ens)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1B8Q9(Evidence code:IBA/Database source:PANTHER:PTN000108134)Q3T0M0(Evidence code:IBA/Database source:PANTHER:PTN000122547)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR027156), IPO9 IPO5 KPNB1 IPO7 IPO4 XPO1 VPS26A VPS35 RAB4A TNPO3 TNPO1 IPO8 VPS29 AP2S1,MF,14,14 of 35,0.59,40,0.000003157,0.00003985
GO:0034622,cellular protein-containing complex assembly,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens), TAF10 AXIN1,BP,2,2 of 262,0.08,0.76,0.000003229,0.00004065
GO:0005811,lipid droplet,A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)Q2KI18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0551)F1MNM7(Evidence code:IEA/Database source:UniProtKB:Q96Q06|ens)P16386(Evidence code:ISS/Database source:UniProtKB:P54310)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)P02694(Evidence code:ISS/Database source:UniProtKB:P09455)Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q3MHF2(Evidence code:IEA/Database source:UniProtKB:Q9H2F3|ens)F1MN90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0551), SPG20 PNPLA2 PLIN4 LIPE AIFM2 RBP1 TRAF6 BCAP31 ALOX15 HSD3B7 CIDEC,CC,11,11 of 20,0.47,55,0.000003405,0.00004237
GO:0032465,regulation of cytokinesis,Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)A6QQY2(Evidence code:ISS/Database source:UniProtKB:Q9P2N7)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)E1BLZ4(Evidence code:ISS/Database source:UniProtKB:Q68DK2)E1BE13(Evidence code:IEA/Database source:InterPro:IPR022103)G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207), PDXP PIK3R4 KLHL13 PLK3 BRCA2 AHCTF1 PIN1 PRPF40A ZFYVE26 BIRC6 CCP110,BP,11,11 of 20,0.47,55,0.000003405,0.00004237
GO:0000724,double-strand break repair via homologous recombination,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)E1B8X8(Evidence code:IEA/Database source:InterPro:IPR015187|I)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR028730)E1BQ04(Evidence code:IBA/Database source:PANTHER:PTN000344874)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)E1BEE6(Evidence code:IBA/Database source:PANTHER:PTN000344874), RAD21L1 AP5Z1 SFPQ BRCA2 PSMD14 ZFYVE26 BLM SAMHD1 INO80 BRCA1 WRN,BP,11,11 of 20,0.47,55,0.000003405,0.00004237
GO:0032587,ruffle membrane,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QE5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BKS0(Evidence code:IEA/Database source:UniProtKB:Q8TE68|ens)A2VDU1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0), TWF1 DDX58 PAK1 CIB1 EPS8L1 SPRY4 ITGB1 SRC WWC1 MTSS1L PDXP,CC,11,11 of 20,0.47,55,0.000003405,0.00004237
GO:0005834,heterotrimeric G-protein complex,P38408(Evidence code:IBA/Database source:PANTHER:PTN000026392)Q3SZ98(Evidence code:IEA/Database source:InterPro:IPR001770)P63217(Evidence code:IEA/Database source:InterPro:IPR001770)P63097(Evidence code:IBA/Database source:PANTHER:PTN000026392)E1BIL1(Evidence code:IBA/Database source:PANTHER:PTN000026392)P30671(Evidence code:IEA/Database source:InterPro:IPR001770)P04896(Evidence code:IBA/Database source:PANTHER:PTN000026392)P04696(Evidence code:IBA/Database source:PANTHER:PTN000026392)G5E6P3(Evidence code:IBA/Database source:PANTHER:PTN000026392)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026392)P04695(Evidence code:IBA/Database source:PANTHER:PTN000026392), GNA14 GNG10 GNG5 GNAI1 GNA12 GNG7 GNAS GNAT2 GNA13 GNAT3 GNAT1,CC,11,11 of 20,0.47,55,0.000003405,0.00004237
GO:0007269,neurotransmitter secretion,Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)F1N159(Evidence code:IEA/Database source:InterPro:IPR001359)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q32LM6(Evidence code:IEA/Database source:UniProtKB:Q8JZS0|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:O88952|ens)P17599(Evidence code:IEA/Database source:InterPro:IPR001359|I)Q2KIB6(Evidence code:IEA/Database source:UniProtKB:O88951|ens), CACNA1B SYN2 SYT4 LIN7A SNAP25 LIN7C SYN1 LIN7B,BP,8,8 of 8,0.34,100,0.000003587,0.00004443
GO:0030234,enzyme regulator activity,P56701(Evidence code:IEA/Database source:InterPro:IPR016643)Q3T0B2(Evidence code:IEA/Database source:InterPro:IPR035268)A7MBA2(Evidence code:IEA/Database source:InterPro:IPR016642|I), PSMD2 PSMD6 PSMD1,MF,3,3 of 293,0.13,1.02,0.000003579,0.00004443
GO:0009607,response to biotic stimulus,Q0P559(Evidence code:IEA/Database source:InterPro:IPR007593),IFITM1,BP,1,1 of 225,0.04,0.44,0.000003676,0.00004542
GO:0045595,regulation of cell differentiation,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028)A4FV32(Evidence code:IBA/Database source:PANTHER:PTN001023612), SOX17 RUNX1 PLEKHB2,BP,3,3 of 296,0.13,1.01,0.000003796,0.0000468
GO:0030514,negative regulation of BMP signaling pathway,F1N152(Evidence code:IEA/Database source:UniProtKB:Q9R118|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)E1BIJ4(Evidence code:IEA/Database source:UniProtKB:Q9Y2U8|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), HTRA1 ABL1 TMPRSS6 HFE2 LEMD3 SPG20 FZD1,BP,7,7 of 5,0.3,140,0.000003925,0.00004784
GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1MI25(Evidence code:IEA/Database source:UniProtKB:F8VPM9|ens)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens), NR2F6 H3F3B KMT2A NFKB1 HIVEP1 ATF6B SFPQ,MF,7,7 of 5,0.3,140,0.000003925,0.00004784
GO:1990841,promoter-specific chromatin binding,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens), CHD7 SUZ12 ZNF750 EHMT2 DHX9 POU4F2 GLI2,MF,7,7 of 5,0.3,140,0.000003925,0.00004784
GO:0000132,establishment of mitotic spindle orientation,P63171(Evidence code:ISS/Database source:UniProtKB:P51807)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)P43033(Evidence code:IEA/Database source:UniRule:UR000107004)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q9D818|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens), DYNLT1 NUMA1 PAFAH1B1 GPSM2 NSFL1C SAPCD2 CDK5RAP2,BP,7,7 of 5,0.3,140,0.000003925,0.00004784
GO:0031941,filamentous actin,E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:A4UGR9|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5), MYO18B MYO1C APC2 XIRP2 MYO6 IQGAP2 MYO1A,CC,7,7 of 5,0.3,140,0.000003925,0.00004784
GO:0001669,acrosomal vesicle,F1MXQ5(Evidence code:IEA/Database source:UniProtKB:Q6J756|ens)E1BF83(Evidence code:IEA/Database source:UniProtKB:Q3TY65|ens)Q5EA42(Evidence code:IEA/Database source:UniProtKB:Q9QXM0|ens)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)E1BDI1(Evidence code:IEA/Database source:UniProtKB:Q9DA79|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens)G5E5C6(Evidence code:IEA/Database source:InterPro:IPR012267), CAPN11 ICA1L ABHD2 IQUB DPEP3 PRKACA FNDC3A MROH2B RAB3A ACR,CC,10,10 of 16,0.42,62.5,0.000004085,0.00004968
GO:0008236,serine-type peptidase activity,F1MWW8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)E1B9Z9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR001375)E1BI31(Evidence code:IEA/Database source:InterPro:IPR001375)A6QQ95(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P81425(Evidence code:IEA/Database source:InterPro:IPR001375)G5E657(Evidence code:IEA/Database source:InterPro:IPR008758)Q1LZE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)A4FUF1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)Q5E9Z2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P80227(Evidence code:IEA/Database source:InterPro:IPR001375)Q08D90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)E1BEQ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)F1MCT1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P67810(Evidence code:IEA/Database source:InterPro:IPR019756|I)G5E5C6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)P12661(Evidence code:IEA/Database source:InterPro:IPR005151)A2VDV7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720)F1N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-0720), TMPRSS6 TMPRSS9 PREP DPP9 KLK6 DPP4 PRSS16 PRSS23 LOC100125946 HABP2 APEH KLK7 LOC505658 PCSK6 SEC11A ACR RBP3 TMPRSS2 HTRA1,MF,19,19 of 67,0.81,28.36,0.000004317,0.00005239
GO:0031901,early endosome membrane,Q1RMW2(Evidence code:ISS/Database source:UniProtKB:Q3UFJ6)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773)Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2)Q0VD59(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P35071(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)Q2TBH7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5PKA5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), TMEM184A SNX19 HPS6 SNX8 MARCH8 CFTR DNAJC13 UBXN6 RAB4A SH3GL1 SNX3 STX7 SNX27,CC,13,13 of 31,0.55,41.94,0.000004672,0.00005644
GO:0045766,positive regulation of angiogenesis,A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q969H8)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)G5E5G9(Evidence code:IEA/Database source:UniProtKB:O96013|ens)Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4)E1BME6(Evidence code:IEA/Database source:UniProtKB:P52789|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P68404), SP1 FGF1 GATA6 MYDGF RRAS PAK4 C5AR1 PDCD6 SASH1 HYAL1 EMC10 HK2 PRKCB,BP,13,13 of 31,0.55,41.94,0.000004672,0.00005644
GO:0010976,positive regulation of neuron projection development,Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:P08413)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O43439|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q8VEK0|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492), CAMK2B DAB2IP RAPGEF2 PRKCI PTK7 NDNF SETX CBFA2T2 ARHGAP35 TMEM30A SNX3,BP,11,11 of 21,0.47,52.38,0.000004868,0.00005853
GO:0001650,fibrillar center,Q1KZG4(Evidence code:IEA/Database source:UniProtKB:A0A024R366)E1BGK7(Evidence code:IEA/Database source:UniProtKB:J3KTH2|ens)A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q6P1N0|ens)Q0VD10(Evidence code:IEA/Database source:UniProtKB:O15446|ens)E1BBH8(Evidence code:IEA/Database source:UniProtKB:A0A024RBA3)Q2NL31(Evidence code:IEA/Database source:UniProtKB:Q9BV20|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)E1B9B6(Evidence code:IEA/Database source:UniProtKB:A0A024RBL3)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens), FHIT TAF4B CC2D1A CD3EAP MBD6 MRI1 TAX1BP3 RREB1 MAP3K14 NUAK1 MALT1,CC,11,11 of 21,0.47,52.38,0.000004868,0.00005853
GO:0071222,cellular response to lipopolysaccharide,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q61823|ens)Q28165(Evidence code:ISS/Database source:UniProtKB:Q8CCS6)P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens), DAB2IP SBNO2 PDE4D PDCD4 PABPN1 LY96 NFKB1 ABL1 ABCA1 BCR LITAF TRAF6,BP,12,12 of 26,0.51,46.15,0.000004995,0.00005993
GO:0043005,neuron projection,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q2KJD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)P63026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)Q32LM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622286)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622286)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2KIB6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q08E45(Evidence code:IBA/Database source:PANTHER:PTN002389359)Q17QQ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)E1BID8(Evidence code:IEA/Database source:UniProtKB:Q8JZW4|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0771)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q2HJF7(Evidence code:IBA/Database source:PANTHER:PTN002389359)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)A6QLP2(Evidence code:IEA/Database source:UniProtKB:Q68FL4|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)Q3MHJ9(Evidence code:IBA/Database source:PANTHER:PTN002389359), BRAF VAMP3 SHANK1 VAMP2 LIN7A MAPK10 CYFIP1 RAPGEF2 VAMP1 MAPK9 CIB1 VPS35 MYO1D LRRK2 LIN7B RTN4R CAMK2A SNAP25 CPNE5 LIN7C SYT4 CAMK2D TENM3 NF2 TAOK2 TENM2 AHCYL2 BCL11B ABI1 SHANK2 CAMK2B,CC,31,31 of 154,1.32,20.13,0.000005223,0.00006252
GO:0043207,response to external biotic stimulus,P01175(Evidence code:IDA/Database source:),OXT,BP,1,1 of 219,0.04,0.46,0.00000539,0.00006438
GO:0019752,carboxylic acid metabolic process,E1BP41(Evidence code:IEA/Database source:InterPro:IPR002129)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001557)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR002129), CSAD UEVLD PDXDC1,BP,3,3 of 290,0.13,1.03,0.000005423,0.00006463
GO:0035091,phosphatidylinositol binding,A4IFN6(Evidence code:IEA/Database source:InterPro:IPR001683|I)Q2KHV6(Evidence code:IEA/Database source:InterPro:IPR001683|I)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q96RG2|ens)Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881)Q08DX0(Evidence code:IEA/Database source:InterPro:IPR001683|I)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR001683|I)A6QR61(Evidence code:IEA/Database source:InterPro:IPR001683|I)Q1RMH8(Evidence code:IEA/Database source:InterPro:IPR001683|I)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)E0AE16(Evidence code:IEA/Database source:InterPro:IPR001683|I)M5FK25(Evidence code:IEA/Database source:InterPro:IPR001683|I)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens)E1BKW9(Evidence code:IEA/Database source:InterPro:IPR001683|I)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR001683|I)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), SNX18 SNX8 PASK ITPR1 SNX29 SNX33 SNX12 SNX3 TNFAIP8L3 SNX9 NOXO1 PITPNA SNX19 SH3PXD2A SNX27 NUMA1,MF,16,16 of 49,0.68,32.65,0.000005505,0.00006546
GO:0022627,cytosolic small ribosomal subunit,A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)A2VE06(Evidence code:IBA/Database source:PANTHER:PTN000171891)Q56JX6(Evidence code:ISS/Database source:UniProtKB:Q6QAT1)E1BCB7(Evidence code:IBA/Database source:PANTHER:PTN000217533)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)A5PK63(Evidence code:IBA/Database source:PANTHER:PTN000077142)Q3T0B7(Evidence code:IBA/Database source:PANTHER:PTN000174285)A6QLG1(Evidence code:IBA/Database source:PANTHER:PTN000513830)Q2KHT7(Evidence code:IEA/Database source:UniProtKB:P42677|ens)Q3T0R1(Evidence code:ISS/Database source:UniProtKB:P62269), RPS9 RPS7 RPS19 RPS4Y1 RPS28 LOC511302 MCTS1 RPS15A RPS17 RPS27L LOC515358 RPS27 RPS18,CC,13,13 of 32,0.55,40.62,0.000006159,0.00007308
GO:0006879,cellular iron ion homeostasis,O46415(Evidence code:IEA/Database source:InterPro:IPR001519|I)P31404(Evidence code:ISS/Database source:UniProtKB:P38606)P61420(Evidence code:ISS/Database source:UniProtKB:P61421)E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q7TQ32|ens)O46414(Evidence code:IEA/Database source:InterPro:IPR001519|I)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q9DBI0|ens)E1BDL2(Evidence code:IEA/Database source:UniProtKB:Q8BGB2|ens), FTL ATP6V1A ATP6V0D1 TFRC HFE2 FTH1 TMPRSS6 TTC7A,BP,8,8 of 9,0.34,88.89,0.000006368,0.00007539
GO:0005975,carbohydrate metabolic process,Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)F1MMK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)Q3T105(Evidence code:IEA/Database source:InterPro:IPR008089)Q32LF7(Evidence code:IEA/Database source:InterPro:IPR003859)F1N5H2(Evidence code:IEA/Database source:InterPro:IPR000933|I)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR004193|I)A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I)F1MS56(Evidence code:IEA/Database source:InterPro:IPR005844|I)A6H768(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)Q2KIM0(Evidence code:IEA/Database source:InterPro:IPR000933|I)Q17QE7(Evidence code:IEA/Database source:InterPro:IPR005076)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR000577|I)F1MJ90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR001360)Q0IID9(Evidence code:IEA/Database source:InterPro:IPR000577|I)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312|I)F1MSV5(Evidence code:IEA/Database source:InterPro:IPR000577|I)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006109)Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR015955)F1MWT0(Evidence code:IEA/Database source:InterPro:IPR011013|I)Q2TBQ8(Evidence code:IEA/Database source:InterPro:IPR005900|I)A3KMX1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0119)Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR001250)Q5E985(Evidence code:IEA/Database source:InterPro:IPR018155)H7BWW2(Evidence code:IEA/Database source:InterPro:IPR015883|I)E1BNF8(Evidence code:IEA/Database source:InterPro:IPR000577|I)Q17QL1(Evidence code:IEA/Database source:InterPro:IPR006148), PPP1CB PPP1CC G6PD GALE B4GALT4 FUCA2 GBE1 GCK PGM3 GALK1 FUCA1 GBGT1 LOC538702 PHKB KL GK HK2 GK2 GPD1L pofut2 UEVLD MAN2C1 PGLS CHST14 MPI HYAL1 HEXB FGGY GNPDA2,BP,29,29 of 144,1.23,20.14,0.000006585,0.00007778
GO:0003697,single-stranded DNA binding,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)Q08DM8(Evidence code:IEA/Database source:InterPro:IPR033956)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)G8JKZ3(Evidence code:IBA/Database source:PANTHER:PTN000056764)Q5E9A3(Evidence code:ISS/Database source:UniProtKB:Q15365)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)A6QQP0(Evidence code:IEA/Database source:InterPro:IPR034632)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens), BLM TSN DHX9 PRIM1 PCBP1 LRPPRC MYEF2 PURB BRCA2 SAMHD1 PURA,MF,11,11 of 22,0.47,50,0.00000685,0.00008035
GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",E1B7E6(Evidence code:IEA/Database source:GO:0004521)Q6TUI4(Evidence code:IEA/Database source:GO:0004525)E1BFK4(Evidence code:IEA/Database source:GO:0004521)A6QR44(Evidence code:IEA/Database source:GO:0004525)E1BK83(Evidence code:IEA/Database source:GO:0004526)Q6T5B7(Evidence code:IEA/Database source:GO:0004521)E1BFB5(Evidence code:IEA/Database source:GO:0004526)Q0III8(Evidence code:IEA/Database source:GO:0033897)O19137(Evidence code:IEA/Database source:GO:0004521), PIWIL2 DICER1 SMG6 DGCR8 RPP25 AGO3 KIAA0391 RNASET2 CPSF4,BP,9,9 of 13,0.38,69.23,0.000006853,0.00008035
GO:0050790,regulation of catalytic activity,P56701(Evidence code:IEA/Database source:GO:0030234)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)Q5BIS9(Evidence code:IEA/Database source:InterPro:IPR039160)E1BIX7(Evidence code:IEA/Database source:GO:0005092)A7MBA2(Evidence code:IEA/Database source:GO:0030234)Q3T0B2(Evidence code:IEA/Database source:GO:0030234)F1N2I0(Evidence code:IEA/Database source:GO:0005092), PSMD2 SH3BP4 PRKAB1 GPSM2 PSMD1 PSMD6 CHML,BP,7,7 of 388,0.3,1.8,0.00000682,0.00008035
GO:0035855,megakaryocyte development,A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens), MEIS1 ABI1 KIT SRF PTPN6 WASF2,BP,6,6 of 3,0.25,200,0.000006937,0.00008035
GO:0001518,voltage-gated sodium channel complex,E1BHR8(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1B757(Evidence code:IEA/Database source:InterPro:IPR029873)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR001696|I)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR001696|I), SCN3A SCN2B SCN11A SCN5A SCN10A SCN8A,CC,6,6 of 3,0.25,200,0.000006937,0.00008035
GO:1902902,negative regulation of autophagosome assembly,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens), EHMT2 PINK1 LRRK2 CHMP4A CHMP4B SCFD1,BP,6,6 of 3,0.25,200,0.000006937,0.00008035
GO:0048786,presynaptic active zone,E1BMN9(Evidence code:IEA/Database source:InterPro:IPR030627)E1BPW2(Evidence code:IEA/Database source:InterPro:IPR019323)F1N7B7(Evidence code:IEA/Database source:InterPro:IPR030630|I)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)E1BBX9(Evidence code:IBA/Database source:PANTHER:PTN000826129)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens), BSN ERC1 RIMS1 UNC13A UNC13C UNC13B,CC,6,6 of 3,0.25,200,0.000006937,0.00008035
GO:0046875,ephrin receptor binding,F1MHL2(Evidence code:IEA/Database source:InterPro:IPR033637)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1MXV4(Evidence code:IEA/Database source:UniProtKB:Q8C0T5|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), ANKS1A ABL1 SIPA1L1 SRC GRB2 CRK,MF,6,6 of 3,0.25,200,0.000006937,0.00008035
GO:0004709,MAP kinase kinase kinase activity,F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)F1N3K4(Evidence code:IEA/Database source:InterPro:IPR016231)E1B7H4(Evidence code:IEA/Database source:InterPro:IPR015785|I)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN001554601)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN001554601), BRAF MAP3K4 MAP3K9 MAP3K10 TAOK3 TAOK2,MF,6,6 of 3,0.25,200,0.000006937,0.00008035
GO:0005215,transporter activity,F1MS75(Evidence code:IEA/Database source:InterPro:IPR002443|I)Q1RMW2(Evidence code:IBA/Database source:PANTHER:PTN000603211)G3N271(Evidence code:IEA/Database source:InterPro:IPR006042)A5D7H9(Evidence code:IBA/Database source:PANTHER:PTN000177662)F1MS08(Evidence code:IEA/Database source:InterPro:IPR002443|I)E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006042)P63009(Evidence code:TAS/Database source:)A1A4L2(Evidence code:IBA/Database source:PANTHER:PTN000177662), SLC12A1 TMEM184A LOC100337457 SLC6A14 SLC12A2 LOC100298868 AP2B1 SLC6A20,MF,8,8 of 411,0.34,1.95,0.000007834,0.00009053
GO:1901998,toxin transport,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P80316|ens)F1MDE1(Evidence code:IEA/Database source:GO:0019534)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8BRF7|ens)P35604(Evidence code:IEA/Database source:UniProtKB:P61924|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens), CCT3 CCT5 LRP6 DNM1 SCFD1 COPZ1 ARID1A,BP,7,7 of 6,0.3,116.67,0.000008,0.00009206
GO:0008139,nuclear localization sequence binding,E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MH31(Evidence code:IBA/Database source:PANTHER:PTN000573960)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)A5D7C4(Evidence code:IBA/Database source:PANTHER:PTN000270925), KPNB1 TNPO1 NUP214 IPO4 POM121L2 IPO5 TNPO3,MF,7,7 of 6,0.3,116.67,0.000008,0.00009206
GO:0019898,extrinsic component of membrane,E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1MM21(Evidence code:IEA/Database source:UniProtKB:P49758|ens)Q2KHV6(Evidence code:IBA/Database source:PANTHER:PTN000058569)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023)Q1RMH8(Evidence code:IBA/Database source:PANTHER:PTN000058569), WDFY3 PACSIN2 TPR SEC23A ALOX15B RNF112 RGS6 SNX8 SNX33 SNX12 UBXN6 ATG2B SNX3,CC,13,13 of 33,0.55,39.39,0.000008048,0.00009242
GO:0007257,activation of JUN kinase activity,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)F1N3K4(Evidence code:IBA/Database source:PANTHER:PTN001147668)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1B7H4(Evidence code:IBA/Database source:PANTHER:PTN001147668), AXIN1 MAP3K9 MAPK8IP3 DAB2IP MAP3K10,BP,5,5 of 1,0.21,500,0.000008223,0.00009361
GO:0035255,ionotropic glutamate receptor binding,E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793), SHANK2 DLG1 SHANK1 SCRIB GNAS,MF,5,5 of 1,0.21,500,0.000008223,0.00009361
GO:0045332,phospholipid translocation,Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q8VEK0|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)F1N0J3(Evidence code:IEA/Database source:GO:0004012)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), TMEM30A ATP8B1 ATP11A ABCA7 ABCA1,BP,5,5 of 1,0.21,500,0.000008223,0.00009361
GO:0071007,U2-type catalytic step 2 spliceosome,F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens), DHX8 CDC5L SYF2 PPIE PRPF8,CC,5,5 of 1,0.21,500,0.000008223,0.00009361
GO:0003735,structural constituent of ribosome,Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)A2VE06(Evidence code:IEA/Database source:InterPro:IPR000876)Q3T0L7(Evidence code:IEA/Database source:InterPro:IPR002672)Q32PD5(Evidence code:IEA/Database source:InterPro:IPR001266|I)Q3T087(Evidence code:IEA/Database source:InterPro:IPR002132|I)Q56JY1(Evidence code:IEA/Database source:InterPro:IPR001780|I)Q3ZBX6(Evidence code:IEA/Database source:InterPro:IPR000597|I)Q58DW0(Evidence code:IEA/Database source:InterPro:IPR002136|I)Q3T057(Evidence code:IEA/Database source:InterPro:IPR000218|I)Q2XW10(Evidence code:IEA/Database source:InterPro:IPR000876)Q3T0R1(Evidence code:IEA/Database source:InterPro:IPR001892|I)Q2KHT7(Evidence code:IEA/Database source:InterPro:IPR000592)P61356(Evidence code:IEA/Database source:InterPro:IPR001141|I)A6H769(Evidence code:IEA/Database source:InterPro:IPR000554)Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR002171|I)Q24JY1(Evidence code:IEA/Database source:InterPro:IPR012678|I)P0C2B7(Evidence code:IEA/Database source:InterPro:IPR034596)Q3T0B7(Evidence code:IEA/Database source:InterPro:IPR000592)A6QLN9(Evidence code:IEA/Database source:InterPro:IPR020592)Q3T076(Evidence code:IEA/Database source:InterPro:IPR001971|I)Q56JX6(Evidence code:IEA/Database source:InterPro:IPR000289)Q32PB9(Evidence code:IEA/Database source:InterPro:IPR002675)F1N301(Evidence code:IEA/Database source:InterPro:IPR002671)Q3T0D5(Evidence code:IEA/Database source:InterPro:IPR000231)Q76I82(Evidence code:IEA/Database source:InterPro:IPR000630|I)A5PK63(Evidence code:IEA/Database source:InterPro:IPR001210|I)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR005710)E1BCB7(Evidence code:IEA/Database source:InterPro:IPR000530), RPL9 RPS4Y1 RPL28 RPS19 RPL11 RPL35A MRPL3 RPL4 RPL23 RPS4X RPS18 RPS27 RPL27 RPS7 RPL8 RPL23A MRPL52 RPS27L VWA1 RPS14 RPS28 RPL38 RPL22 RPL30 RPS15A RPS17 RPS9 LOC511302,MF,28,28 of 138,1.19,20.29,0.000008314,0.00009446
GO:0031175,neuron projection development,E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens)Q17QM6(Evidence code:IEA/Database source:UniProtKB:Q9D4J1|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000958636)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000958636), UHMK1 PTPRM TOR1A CYFIP2 EFHD1 SRF FRY UBE4B RAPGEF2 NEDD4 LAMB1 MKL1 LAMB2 ZFYVE27 MICALL2 FRYL,BP,16,16 of 51,0.68,31.37,0.000008375,0.00009495
GO:0000981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)F1MC99(Evidence code:IBA/Database source:PANTHER:PTN001371846)A5PKI6(Evidence code:IBA/Database source:PANTHER:PTN000317389)M5FMX2(Evidence code:IEA/Database source:InterPro:IPR031265)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A0JNC9(Evidence code:IBA/Database source:PANTHER:PTN001145452)A6QPH9(Evidence code:ISS/Database source:UniProtKB:Q9UJ78)F1MKK8(Evidence code:IBA/Database source:PANTHER:PTN000548738)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)F1MU53(Evidence code:IBA/Database source:PANTHER:PTN000003381)E1B7I2(Evidence code:IBA/Database source:PANTHER:PTN000218930)A7MB06(Evidence code:IBA/Database source:PANTHER:PTN001145452)A6QLP0(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MVT7(Evidence code:IBA/Database source:PANTHER:PTN000192346)A6QQP0(Evidence code:IEA/Database source:InterPro:IPR034632)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)F1MHR5(Evidence code:IBA/Database source:PANTHER:PTN000192346)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q12837|ens)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)Q32KX6(Evidence code:IBA/Database source:PANTHER:PTN000284480), LMO2 TCF7L2 FOXI3 CC2D1A SOX8 SOX17 SP1 ZMYM5 SIM2 CDC5L ZNF446 ETV2 SP7 FOXO4 EPM2AIP1 MYEF2 GATA6 ZMYM4 POU4F2 NFKB1 SNAPC4 RUNX1 E2F1 TFDP2,MF,24,24 of 107,1.02,22.43,0.000008469,0.00009581
GO:0045121,membrane raft,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)A2VE13(Evidence code:IEA/Database source:InterPro:IPR033240)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512256)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)P81425(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)Q05204(Evidence code:IDA/Database source:)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)P10279(Evidence code:ISS/Database source:UniProtKB:P35052)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BGZ3(Evidence code:IEA/Database source:UniProtKB:Q99856|ens)Q08DN8(Evidence code:ISS/Database source:UniProtKB:O75955)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN001124099), NPC1 MAL2 PLLP S100A10 ABCA1 DPP4 ZAP70 LAMP1 CAPN2 PRNP DLG1 LRRK2 ARID3A FLOT1 BACE1 LCK MYO1C PSEN1 CBLC,CC,19,19 of 71,0.81,26.76,0.000008717,0.0000984
GO:0042383,sarcolemma,E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)A6QQP7(Evidence code:ISS/Database source:UniProtKB:Q9ESD7)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:E9Q6R7|ens)Q08DA1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIS6(Evidence code:IEA/Database source:UniProtKB:Q70IV5|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)P48452(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens), FLNC DYSF ATP1A2 UTRN ATP1A1 ITGB1 SYNM CIB1 CAMK2D FLOT1 PPP3CA LAMP1,CC,12,12 of 28,0.51,42.86,0.000009064,0.0001021
GO:0032259,methylation,Q7YRV8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)Q3MHK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)G3MZP6(Evidence code:IEA/Database source:InterPro:IPR002877)P10950(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A6QL80(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A1A4K2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489), DNMT3A METTL7A PRMT5 CMTR2 ASMT WHSC1L1 KMT2A PCMT1 KMT2B PRMT3 NSUN2 KMT2C PRMT6 COMT ASH1L TRMT1L DOT1L,BP,17,17 of 58,0.72,29.31,0.000009392,0.0001056
GO:0009968,negative regulation of signal transduction,F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)G3N1E4(Evidence code:IEA/Database source:UniProtKB:Q52KG5|ens), BRAF KIF26A,BP,2,2 of 245,0.08,0.82,0.000009805,0.00011
GO:0006357,regulation of transcription by RNA polymerase II,P61635(Evidence code:ISS/Database source:UniProtKB:P42227)Q32KX6(Evidence code:IBA/Database source:PANTHER:PTN000284480)F1MC99(Evidence code:IEA/Database source:GO:0000981)A0JNC9(Evidence code:IEA/Database source:InterPro:IPR030449)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)E1BJ93(Evidence code:IEA/Database source:InterPro:IPR028769)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens)Q5NUA6(Evidence code:IBA/Database source:PANTHER:PTN000696756)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028)E1BDD9(Evidence code:IBA/Database source:PANTHER:PTN001480141)B0JYL6(Evidence code:IEA/Database source:GO:0000982)G3MYR6(Evidence code:IEA/Database source:InterPro:IPR016362)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)E1BFV5(Evidence code:IEA/Database source:UniProtKB:Q7RTV3|ens)F1MKW9(Evidence code:IEA/Database source:InterPro:IPR030503)F1MPU1(Evidence code:IEA/Database source:InterPro:IPR019035)Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)F1MVT7(Evidence code:IEA/Database source:GO:0000981)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440)Q9BE45(Evidence code:IBA/Database source:PANTHER:PTN001538048)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q9CPU0|ens)F1MU40(Evidence code:IBA/Database source:PANTHER:PTN000677913)M5FMX2(Evidence code:IEA/Database source:GO:0000981)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens)G3MY92(Evidence code:IEA/Database source:InterPro:IPR015660)A6QQP0(Evidence code:IEA/Database source:GO:0000981)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens)F1MHR5(Evidence code:IEA/Database source:GO:0000981)P05126(Evidence code:ISS/Database source:UniProtKB:P05771)P62194(Evidence code:IEA/Database source:UniProtKB:P62195|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F1MKK8(Evidence code:IBA/Database source:PANTHER:PTN000548738)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q7Z4L5|ens)E1B7I2(Evidence code:IBA/Database source:PANTHER:PTN000218930)E1BGG6(Evidence code:IEA/Database source:InterPro:IPR033486)A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)F1MU53(Evidence code:IEA/Database source:GO:0000981)A6QPH9(Evidence code:IEA/Database source:GO:0000981), STAT3 TFDP2 FOXI3 SP1 PKN1 LEF1 NIPBL PKNOX1 SP7 NFE2L2 EHMT2 RUNX1 MKL1 STAT1 POU3F1 SMARCAL1 ZNF367 NFKB1 MED12L BRCA1 EPM2AIP1 BRD2 NFKBIZ GLO1 MNX1 SOX8 DLX2 SNF8 CUL3 RUVBL2 CDC5L TSHZ1 HIST1H1D ASCL4 MYEF2 CTDSP1 ZMYM4 PRKCB PSMC5 IKBKAP SNAPC4 DGKQ SIM2 TTC21B ETV2 RFX5 RUVBL1 RAI1 ATF6B ZNF446 ZMYM5,BP,51,51 of 336,2.17,15.18,0.00001001,0.000112
GO:0044255,cellular lipid metabolic process,F1MLW9(Evidence code:IEA/Database source:InterPro:IPR022284)Q3SZH7(Evidence code:IBA/Database source:PANTHER:PTN000164255), GPAT2 LTA4H,BP,2,2 of 247,0.08,0.81,0.00001008,0.0001126
GO:0001932,regulation of protein phosphorylation,E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)P00515(Evidence code:IEA/Database source:InterPro:IPR012198)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens), CCNYL1 PIN1 PRKAR2A RICTOR,BP,4,4 of 304,0.17,1.32,0.00001012,0.0001128
GO:0030018,Z disc,E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)F1MF57(Evidence code:ISS/Database source:UniProtKB:O76041)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)Q3ZC55(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)Q58DA7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)P48452(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), MYO18B SRI NEBL FKBP1B XIRP2 ACTN2 CACNA1D CRYAB PSEN1 PPP2R5A GLRX3 MYBPC3 PPP3CA,CC,13,13 of 34,0.55,38.24,0.00001043,0.000116
GO:0060070,canonical Wnt signaling pathway,Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024458)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MDE1(Evidence code:IEA/Database source:InterPro:IPR017049)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)E1B8K0(Evidence code:IEA/Database source:InterPro:IPR015668)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BPF3(Evidence code:IEA/Database source:InterPro:IPR015668), PSEN1 LEF1 LRP6 GLI1 BCL9L FZD1 SOX17 PYGO2 BCL9,BP,9,9 of 14,0.38,64.29,0.00001057,0.0001167
GO:0002039,p53 binding,F1N413(Evidence code:IEA/Database source:InterPro:IPR038034)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)G3N065(Evidence code:IBA/Database source:PANTHER:PTN000552321)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9D3J3|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens), EHMT2 CHD8 ZNF385C BLM PTTG1IP BCL2L12 RFFL PLK3 NUAK1,MF,9,9 of 14,0.38,64.29,0.00001057,0.0001167
GO:0000049,tRNA binding,F1MKA6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)Q0VC66(Evidence code:IEA/Database source:InterPro:IPR000541)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q2T9L8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)Q56JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0820)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR033709), AARS2 XPOT AARS CTU1 SSB MARS TRMT1L RPL35A IARS,MF,9,9 of 14,0.38,64.29,0.00001057,0.0001167
GO:0001725,stress fiber,A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)F1MF57(Evidence code:ISS/Database source:UniProtKB:O76041)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q8BPM0|ens)P68138(Evidence code:ISS/Database source:UniProtKB:P68133)E1BL04(Evidence code:IEA/Database source:UniProtKB:A4UGR9|ens)A2VE99(Evidence code:IEA/Database source:UniProtKB:Q9NVA2|ens), FERMT2 MYH14 MICALL2 NEBL SH2B2 DAAM1 ACTA1 XIRP2 SEPT11,CC,9,9 of 14,0.38,64.29,0.00001057,0.0001167
GO:0030904,retromer complex,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)Q0VD53(Evidence code:IEA/Database source:UniProtKB:O75436|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens)Q3T0M0(Evidence code:IEA/Database source:InterPro:IPR028661)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2)P11456(Evidence code:IEA/Database source:UniProtKB:P20645|ens), SNX3 VPS26A ANKFY1 VPS29 VPS35 SNX27 SNX8 M6PR,CC,8,8 of 10,0.34,80,0.00001077,0.0001181
GO:0035264,multicellular organism growth,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens), ATRX ADARB1 WWTR1 RC3H2 CLIC4 PDE4D TAF10 EN1,BP,8,8 of 10,0.34,80,0.00001077,0.0001181
GO:0001772,immunological synapse,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens), DLG1 PDCD6IP ALCAM STX7 ZAP70 SNX27 LCK DUSP3,CC,8,8 of 10,0.34,80,0.00001077,0.0001181
GO:0006338,chromatin remodeling,A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR030088)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)A7Z075(Evidence code:IEA/Database source:InterPro:IPR029523)E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR021906)A5PJQ1(Evidence code:IBA/Database source:PANTHER:PTN000336336)E1B925(Evidence code:IEA/Database source:InterPro:IPR021906|I), RUVBL1 CHD7 SMARCA2 KDM6B RUVBL2 INO80 INO80B PABPC1L ATRX ARID1B DEK ARID1A,BP,12,12 of 29,0.51,41.38,0.00001202,0.0001315
GO:0005929,cilium,P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)F1N307(Evidence code:IEA/Database source:GO:0035721)Q3ZCI9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)F6PR93(Evidence code:IEA/Database source:GO:0035721)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)A8E4N3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)F2Z4K0(Evidence code:IEA/Database source:UniProtKB:P05214|ens)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)Q58D31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:Q9H0F7|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0969), PRKACA TTC21A CCT8 TTC21B TUBB4A SEPT7 RSPH3 DNAH7 SEPT2 TUBA3E TEKT4 ATP2B4 SORD ARL6 GLI1 GLI2 PKHD1 AHI1 SEPT6,CC,19,19 of 73,0.81,26.03,0.00001217,0.0001329
GO:0000209,protein polyubiquitination,Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)E1BP63(Evidence code:IBA/Database source:PANTHER:PTN000280277)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q17R11(Evidence code:IEA/Database source:InterPro:IPR033103)Q17QG5(Evidence code:IBA/Database source:PANTHER:PTN000629793)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)P61085(Evidence code:IBA/Database source:PANTHER:PTN000629609)E1BAK9(Evidence code:IBA/Database source:PANTHER:PTN000280277)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens), UBE2D2 RNF139 ANKIB1 RC3H2 TRAF6 SASH1 DZIP3 UBE2G2 UBE2L3 RNF165 UBE4B CUL3 UBE2K SYVN1 TNKS HUWE1,BP,16,16 of 53,0.68,30.19,0.00001251,0.0001363
GO:0004930,G-protein coupled receptor activity,Q673L2(Evidence code:IEA/Database source:InterPro:IPR000276)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)A7MB15(Evidence code:IBA/Database source:PANTHER:PTN000139394)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR000832|I)F1MR98(Evidence code:IEA/Database source:InterPro:IPR000276|I)G3X828(Evidence code:IEA/Database source:InterPro:IPR000276)E1BLE8(Evidence code:IEA/Database source:InterPro:IPR000337|I)F1MSU3(Evidence code:IEA/Database source:InterPro:IPR000276)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR000832|I)Q1JPD9(Evidence code:IEA/Database source:InterPro:IPR017978)F1MG76(Evidence code:IEA/Database source:InterPro:IPR000276)G3X8A9(Evidence code:IEA/Database source:InterPro:IPR000276)Q2YDG0(Evidence code:IEA/Database source:InterPro:IPR017978)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BMX7(Evidence code:IEA/Database source:InterPro:IPR000276)E1BEB2(Evidence code:IEA/Database source:InterPro:IPR000276)G3N0Y0(Evidence code:IEA/Database source:InterPro:IPR000276)P47803(Evidence code:IEA/Database source:InterPro:IPR000276|I)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR000832|I)E1B9D3(Evidence code:IEA/Database source:InterPro:IPR017978)Q1JQB3(Evidence code:IEA/Database source:InterPro:IPR000276|I)E1BMY3(Evidence code:IEA/Database source:InterPro:IPR000276)E1BMN4(Evidence code:IEA/Database source:InterPro:IPR000276)E1BKU0(Evidence code:IEA/Database source:InterPro:IPR000276), C5AR1 LGR4 FZD1 PTH2R RRH OR13C3 GRM7 RXFP3 CD97 GPRC5B GPR75 OR5M11 GPRC5C F2R OR51Q1 LOC531090 LOC788626 RGR PTH1R GPR179 GPR4 LOC614090 NMBR ADORA2A,MF,24,24 of 110,1.02,21.82,0.00001259,0.000137
GO:0042645,mitochondrial nucleoid,E1BFB5(Evidence code:IEA/Database source:UniProtKB:Q8JZY4|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens)E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens)F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)P11181(Evidence code:IEA/Database source:UniProtKB:P11182|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q9Y2S7|ens)P48818(Evidence code:IEA/Database source:UniProtKB:P49748|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38646|ens), KIAA0391 SHMT2 FASTKD2 POLG CPS1 LRPPRC DBT POLDIP2 ACADVL HSPA9,CC,10,10 of 19,0.42,52.63,0.00001274,0.000138
GO:0000278,mitotic cell cycle,A4IFN6(Evidence code:IEA/Database source:InterPro:IPR014536)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)A7MBC3(Evidence code:IEA/Database source:InterPro:IPR017164)E0AE16(Evidence code:IEA/Database source:InterPro:IPR014536)E1BHK6(Evidence code:IEA/Database source:InterPro:IPR014536)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR028314), SNX18 CUL3 DCTN2 RGS14 PPP2R2A MASTL WEE1 SNX9 SNX33 TFDP2,BP,10,10 of 19,0.42,52.63,0.00001274,0.000138
GO:1901135,carbohydrate derivative metabolic process,F1MZY2(Evidence code:IEA/Database source:InterPro:IPR001347)Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR001347), GFPT1 GFPT2,BP,2,2 of 240,0.08,0.83,0.00001429,0.0001545
GO:0048538,thymus development,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens), BCL11B ASXL1 SRF PSEN1 BRAF ABL1 CRKL,BP,7,7 of 7,0.3,100,0.00001505,0.0001624
GO:0030165,PDZ domain binding,F1MN60(Evidence code:IBA/Database source:PANTHER:PTN001184752)A7YY57(Evidence code:IEA/Database source:UniProtKB:Q52LW3|ens)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN001184752)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)A6QLD1(Evidence code:IEA/Database source:UniProtKB:O35382|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens), ATP2B2 ARHGAP29 ATP2B3 F11R RAPGEF2 EXOC4 KIF14 PSEN1 FZD1,MF,9,9 of 15,0.38,60,0.00001589,0.0001704
GO:0071230,cellular response to amino acid stimulus,E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02463|ens)P02465(Evidence code:IEA/Database source:UniProtKB:Q01149|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)Q27971(Evidence code:ISS/Database source:UniProtKB:O08529), PDGFC COL4A1 COL1A2 LARS COL4A6 IPO5 SH3BP4 COL5A2 CAPN2,BP,9,9 of 15,0.38,60,0.00001589,0.0001704
GO:0048306,calcium-dependent protein binding,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1BC70(Evidence code:IEA/Database source:UniProtKB:A5D8V6|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens), PDCD6IP PEF1 CLN3 VPS37C S100B PDCD6 SYT6 MYO1D TSG101,MF,9,9 of 15,0.38,60,0.00001589,0.0001704
GO:1903543,positive regulation of exosomal secretion,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q08DL9(Evidence code:IEA/Database source:UniProtKB:Q92783|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens), TSG101 SNF8 CHMP2A VPS4B STAM PDCD6IP,BP,6,6 of 4,0.25,150,0.00001634,0.0001745
GO:0005248,voltage-gated sodium channel activity,F1MMU9(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR001696|I)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BHR8(Evidence code:IEA/Database source:InterPro:IPR001696|I), SCN8A SCN5A SCN10A HCN1 SCN11A SCN3A,MF,6,6 of 4,0.25,150,0.00001634,0.0001745
GO:0030336,negative regulation of cell migration,Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)Q5EA42(Evidence code:ISS/Database source:UniProtKB:Q9QXM0)E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:Q80ZJ1|ens)F1MJI3(Evidence code:IBA/Database source:PANTHER:PTN001021265)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10833|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens)F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), RAP2C CLIC4 DUSP3 ADAM15 STK26 ABHD2 ARAP3 RAP2A SRGAP3 RRAS ADARB1 BCR NAV3 ZMYND8 SLIT2,BP,15,15 of 48,0.64,31.25,0.00001648,0.0001757
GO:0006898,receptor-mediated endocytosis,Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)A2VDV7(Evidence code:IEA/Database source:GO:0005044)Q0V7N1(Evidence code:IEA/Database source:GO:0005044)E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513)E1B9M8(Evidence code:IEA/Database source:GO:0005044)E1B813(Evidence code:IEA/Database source:GO:0005044)F1MI35(Evidence code:IEA/Database source:GO:0005044)F1MDR7(Evidence code:IBA/Database source:PANTHER:PTN001181218)B6ULZ4(Evidence code:IEA/Database source:GO:0005044)F1N7K7(Evidence code:IEA/Database source:GO:0005044)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)E1B9H1(Evidence code:IEA/Database source:GO:0005044), DNM1 DNM2 TMPRSS2 SUSD2 TFRC SCARF2 LOC786796 HHIPL1 DNAJC13 WC1 MARCO CUBN TINAGL1,BP,13,13 of 36,0.55,36.11,0.00001711,0.000182
GO:0051209,release of sequestered calcium ion into cytosol,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)E1BHV1(Evidence code:IEA/Database source:GO:0005219)Q8WN96(Evidence code:IBA/Database source:PANTHER:PTN001416417)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8BWC0|ens)G3N0E5(Evidence code:IEA/Database source:GO:0005219)Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881), FKBP1B RYR2 ITPR2 RYR1 F2R TPCN2 RYR3 ITPR1,BP,8,8 of 11,0.34,72.73,0.00001749,0.000185
GO:0045335,phagocytic vesicle,F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)G3X7D3(Evidence code:IEA/Database source:UniProtKB:Q14964|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens), FMNL1 SNX3 ABCA1 RAB9A RAB23 RAB39A LAMP1 MYO1C,CC,8,8 of 11,0.34,72.73,0.00001749,0.000185
GO:0070536,protein K63-linked deubiquitination,E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens)E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens)G3N2I1(Evidence code:IEA/Database source:UniProtKB:Q5VV17|ens)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995), OTUD7B OTUD4 SHMT2 BRCC3 PSMD14 OTUD1 USP20 USP13,BP,8,8 of 11,0.34,72.73,0.00001749,0.000185
GO:0034707,chloride channel complex,F1N1D4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)P35071(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q5E9B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q6BBL6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869), TTYH3 CLIC6 CFTR ANO6 CLIC4 BEST3 CLCC1 CLIC1 CLDN4 GABRA5,CC,10,10 of 20,0.42,50,0.00001794,0.000189
GO:0006418,tRNA aminoacylation for protein translation,G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000738|I)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR001412|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR002312|I)A5D7A2(Evidence code:IEA/Database source:InterPro:IPR000738|I)Q3T099(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001412|I)Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR000738|I), EPRS LARS IARS RARS QARS NARS GARS WARS2 RARS2 MARS,BP,10,10 of 20,0.42,50,0.00001794,0.000189
GO:0030308,negative regulation of cell growth,E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens)A3KN28(Evidence code:IEA/Database source:UniProtKB:Q8K4P7|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)P23709(Evidence code:ISS/Database source:UniProtKB:O75489)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)Q58DD3(Evidence code:ISS/Database source:UniProtKB:P25686)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), CCAR2 SOX17 EAF2 ST7L SMARCA2 NDUFS3 ADAM15 MT3 HYAL1 SH3BP4 DNAJB2 SLIT2,BP,12,12 of 31,0.51,38.71,0.00002053,0.0002158
GO:0023014,signal transduction by protein phosphorylation,E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MP51(Evidence code:IEA/Database source:GO:0000155)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825), PAK3 MAP3K14 PAK4 MAP3K8 PAK2 MAP3K1 MAP2K4 MAP3K4 PAK6 SLK KCNH5 STK3 PAK1,BP,13,13 of 37,0.55,35.14,0.00002168,0.0002275
GO:0005741,mitochondrial outer membrane,P56560(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47)E1BME6(Evidence code:IEA/Database source:UniProtKB:P52789|ens)Q5E9M9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q2HJF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q3T0I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P63087|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-1000), MAOB MARCH5 HK2 RHOT2 SPG20 LRRK2 RHOT1 FIS1 CPT1B GK SH3GLB1 MFN2 PINK1 PPP1CC AIFM2,CC,15,15 of 50,0.64,30,0.00002457,0.0002573
GO:0048513,animal organ development,Q00KA9(Evidence code:IEA/Database source:InterPro:IPR030799),LRP4,BP,1,1 of 199,0.04,0.5,0.00002548,0.0002663
GO:0004252,serine-type endopeptidase activity,Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR002470|I)Q5E9Z2(Evidence code:IEA/Database source:InterPro:IPR001254|I)P80227(Evidence code:IEA/Database source:InterPro:IPR002471)A4FUF1(Evidence code:IEA/Database source:InterPro:IPR001254|I)F1MCT1(Evidence code:IEA/Database source:InterPro:IPR000209|I)Q08E55(Evidence code:IEA/Database source:InterPro:IPR000209|I)Q1LZE9(Evidence code:IEA/Database source:InterPro:IPR001254|I)A6QQ95(Evidence code:IEA/Database source:InterPro:IPR001254|I)Q08D90(Evidence code:IEA/Database source:InterPro:IPR001254|I)G5E5C6(Evidence code:IEA/Database source:InterPro:IPR001254|I)P81425(Evidence code:IEA/Database source:InterPro:IPR002471)F1MWW8(Evidence code:IEA/Database source:InterPro:IPR001254|I)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001254|I)E1B9Z9(Evidence code:IEA/Database source:InterPro:IPR001254|I)E1BEQ4(Evidence code:IEA/Database source:InterPro:IPR001254|I)F1N152(Evidence code:IEA/Database source:InterPro:IPR001940), PREP HABP2 APEH LOC100125946 PCSK6 MBTPS1 PRSS23 KLK6 KLK7 ACR DPP4 TMPRSS6 TMPRSS2 TMPRSS9 LOC505658 HTRA1,MF,16,16 of 57,0.68,28.07,0.00002654,0.0002733
GO:0008540,"proteasome regulatory particle, base subcomplex",A7MBA2(Evidence code:IEA/Database source:UniRule:UR000777776)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q0P5A6(Evidence code:IBA/Database source:PANTHER:PTN000339132), PSMD1 PSMC1 PSMD2 PSMC5 PSMC6 PSMC2 PSMD5,CC,7,7 of 8,0.3,87.5,0.00002655,0.0002733
GO:0008146,sulfotransferase activity,F1MX20(Evidence code:IEA/Database source:UniProtKB:Q9H3Q3|ens)E1B729(Evidence code:IEA/Database source:InterPro:IPR000863|I)F1N638(Evidence code:IEA/Database source:InterPro:IPR000863)P50227(Evidence code:IEA/Database source:InterPro:IPR000863)A3KMX1(Evidence code:IEA/Database source:InterPro:IPR005331|I)Q0VCB5(Evidence code:IEA/Database source:InterPro:IPR000863|I)F1ME12(Evidence code:IEA/Database source:InterPro:IPR000863), GAL3ST2 HS3ST6 SULT1C4 SULT1A1 CHST14 HS3ST1 DSEL,MF,7,7 of 8,0.3,87.5,0.00002655,0.0002733
GO:0030126,COPI vesicle coat,P35604(Evidence code:IEA/Database source:UniProtKB:P61923|ens)Q28104(Evidence code:IDA/Database source:)A0JN39(Evidence code:IEA/Database source:InterPro:IPR011710)P35605(Evidence code:ISS/Database source:UniProtKB:P35606)A2VE21(Evidence code:IEA/Database source:InterPro:IPR013040|I)Q27954(Evidence code:IEA/Database source:InterPro:IPR010714)P53619(Evidence code:IEA/Database source:InterPro:IPR027059), COPZ1 COPE COPB1 COPB2 COPG2 COPA ARCN1,CC,7,7 of 8,0.3,87.5,0.00002655,0.0002733
GO:0006904,vesicle docking involved in exocytosis,E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635132)A6QLT7(Evidence code:IEA/Database source:InterPro:IPR007225)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635132)A6QLD1(Evidence code:IEA/Database source:InterPro:IPR007191)A3KMZ0(Evidence code:IEA/Database source:InterPro:IPR001619|I)P61763(Evidence code:IEA/Database source:InterPro:IPR001619|I)E1BG76(Evidence code:IEA/Database source:InterPro:IPR001619|I), RAB37 EXOC6 RAB26 EXOC4 STXBP3 STXBP1 SCFD1,BP,7,7 of 8,0.3,87.5,0.00002655,0.0002733
GO:0043195,terminal bouton,F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8)E1BBX9(Evidence code:IBA/Database source:PANTHER:PTN000826129)F1MP30(Evidence code:IBA/Database source:PANTHER:PTN000826129)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:P61967|ens)F1MK99(Evidence code:IBA/Database source:PANTHER:PTN000826129), AAK1 UNC13C UNC13B KCNMA1 RAB3A AP1S1 UNC13A,CC,7,7 of 8,0.3,87.5,0.00002655,0.0002733
GO:0030326,embryonic limb morphogenesis,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), LEF1 PSEN1 SALL4 MEGF8 FRAS1 EN1 SHOX2,BP,7,7 of 8,0.3,87.5,0.00002655,0.0002733
GO:0032515,negative regulation of phosphoprotein phosphatase activity,F1MRI6(Evidence code:IEA/Database source:GO:0004864)A7Z026(Evidence code:IEA/Database source:GO:0004864)E1BPZ4(Evidence code:IEA/Database source:GO:0004865)F1N1P8(Evidence code:IEA/Database source:GO:0004864)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens), LMTK2 PPP1R37 PPP1R1C PPP1R26 PTPA MASTL FKBP1B,BP,7,7 of 8,0.3,87.5,0.00002655,0.0002733
GO:0005838,proteasome regulatory particle,A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62192|ens)Q2KJ25(Evidence code:IEA/Database source:UniProtKB:Q9D8W5|ens)P62194(Evidence code:IEA/Database source:UniProtKB:P62196|ens)Q3T0B2(Evidence code:IBA/Database source:PANTHER:PTN000365350)P56701(Evidence code:IEA/Database source:UniProtKB:Q8VDM4|ens), PSMC1 PSMD12 PSMC5 PSMD6 PSMD2,CC,5,5 of 2,0.21,250,0.00002715,0.0002767
GO:0032839,dendrite cytoplasm,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)E1BQ37(Evidence code:IEA/Database source:GO:0098963)E1BMW9(Evidence code:IEA/Database source:GO:0098963)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens), LRRK2 ABHD12 SFPQ PURA UHMK1,CC,5,5 of 2,0.21,250,0.00002715,0.0002767
GO:0090110,cargo loading into COPII-coated vesicle,F1MV07(Evidence code:IEA/Database source:UniProtKB:O94855|ens)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)E1BIU0(Evidence code:IEA/Database source:UniProtKB:P53992|ens)A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)A6QNT8(Evidence code:ISS/Database source:UniProtKB:O95486), SEC24D SEC13 SEC24C SEC23A SEC24A,BP,5,5 of 2,0.21,250,0.00002715,0.0002767
GO:0000813,ESCRT I complex,Q3T0N1(Evidence code:IEA/Database source:InterPro:IPR018798)E1BC70(Evidence code:IEA/Database source:InterPro:IPR037859)A6QP64(Evidence code:IEA/Database source:InterPro:IPR037859)Q3T178(Evidence code:IEA/Database source:InterPro:IPR007143)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens), MVB12A VPS37C VPS37B VPS28 TSG101,CC,5,5 of 2,0.21,250,0.00002715,0.0002767
GO:0005790,smooth endoplasmic reticulum,Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), MYO1D PSEN1 RYR1 MAPK8IP3 SYVN1,CC,5,5 of 2,0.21,250,0.00002715,0.0002767
GO:0005913,cell-cell adherens junction,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8WU20|ens)F1MPF3(Evidence code:IEA/Database source:UniProtKB:Q9NYQ8|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens), FLOT1 FRS2 FAT2 SCRIB PTPRM MPP5 TJP1 TNKS1BP1,CC,8,8 of 12,0.34,66.67,0.0000274,0.0002782
GO:0032947,protein-containing complex scaffold activity,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1B7V9(Evidence code:IEA/Database source:InterPro:IPR030033)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BKZ0(Evidence code:IEA/Database source:InterPro:IPR028745)Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens)E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens), DLG1 MAGI1 WWC1 SASH1 AXIN1 PCNT AIMP2 OTUD4,MF,8,8 of 12,0.34,66.67,0.0000274,0.0002782
GO:0006413,translational initiation,Q32LC3(Evidence code:IEA/Database source:InterPro:IPR001253|I)F1N030(Evidence code:IEA/Database source:InterPro:IPR001040|I)P68102(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q5E966(Evidence code:ISS/Database source:UniProtKB:Q13347)Q1JPH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)F1MX04(Evidence code:IEA/Database source:GO:0003743)A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q3SZ65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q32LJ9(Evidence code:IEA/Database source:InterPro:IPR001950|I)Q3T148(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q3T0V3(Evidence code:ISS/Database source:UniProtKB:Q9UBQ5)E1BLZ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)Q9TU47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)Q3SZ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0396)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)Q32KZ1(Evidence code:IEA/Database source:InterPro:IPR001288|I)Q5E938(Evidence code:IEA/Database source:InterPro:IPR001950|I)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)Q3ZC12(Evidence code:ISS/Database source:UniProtKB:O75821), EIF1AX EIF4E1B EIF2S1 EIF3I EIF4H EIF4G1 EIF3B ABCE1 EIF4A2 EIF1B EIF3M EIF3K EIF3F DDX3X EIF6 MCTS1 EIF4A1 EIF2B5 MTIF3 EIF1 DDX3Y EIF3G,BP,22,22 of 101,0.93,21.78,0.00002886,0.0002925
GO:0090305,nucleic acid phosphodiester bond hydrolysis,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)A7YWM6(Evidence code:IEA/Database source:GO:0004519)F1MGC2(Evidence code:IEA/Database source:GO:0004519)Q08DM8(Evidence code:IEA/Database source:GO:0004518)Q2QDE9(Evidence code:IEA/Database source:GO:0004518)A5PJT8(Evidence code:IEA/Database source:GO:0004518)G3X7J6(Evidence code:IEA/Database source:GO:0008408)E1BPX9(Evidence code:IEA/Database source:GO:0004519)E1BEE6(Evidence code:IEA/Database source:GO:0008408)Q6T5B7(Evidence code:IEA/Database source:GO:0004518)Q0II50(Evidence code:IEA/Database source:GO:0004518)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens)E1BMC0(Evidence code:IEA/Database source:GO:0008409)E1BML0(Evidence code:IEA/Database source:GO:0004518)E1BDI3(Evidence code:IEA/Database source:GO:0008408), DXO RNASE13 RNASE2 TSN DNASE1L1 DNASE1L2 EXD3 LRPPRC WRN AGO3 USB1 DDX1 POLQ PAN2 POLG,BP,15,15 of 51,0.64,29.41,0.0000298,0.0003014
GO:0006814,sodium ion transport,E1BHR8(Evidence code:IEA/Database source:InterPro:IPR001696|I)F1MHP0(Evidence code:IEA/Database source:InterPro:IPR001696|I)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0739)O18875(Evidence code:IEA/Database source:UniProtKB-KW:KW-0739)Q08DA1(Evidence code:IEA/Database source:InterPro:IPR005775)G3MYM1(Evidence code:IEA/Database source:InterPro:IPR001696|I)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775)F1MMU9(Evidence code:IEA/Database source:InterPro:IPR001696|I)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)E1B749(Evidence code:IBA/Database source:PANTHER:PTN001371381)E1BHM6(Evidence code:IEA/Database source:InterPro:IPR001696|I), SCN3A SCN5A SLC5A11 SLC6A8 ATP1A1 SCN10A ATP1A2 SCN8A SLC23A1 SLC5A9 SCN11A,BP,11,11 of 27,0.47,40.74,0.00003097,0.0003127
GO:0005930,axoneme,P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q8VD65|ens)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)Q0IIM2(Evidence code:IDA/Database source:)Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:P04350|ens), PRKAR2A GLI2 GLI1 PIK3R4 DNAH5 ARL6 SEPT7 DNAH11 TUBB4A,CC,9,9 of 17,0.38,52.94,0.00003351,0.0003318
GO:0003705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MBH4(Evidence code:IBA/Database source:PANTHER:PTN000215836)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), PKNOX1 MYF5 MEIS1 LEF1 FOXF1 GLI1 SOX17 GATA6 SRF,MF,9,9 of 17,0.38,52.94,0.00003351,0.0003318
GO:0031434,mitogen-activated protein kinase kinase binding,E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MDL4(Evidence code:IBA/Database source:PANTHER:PTN002356460)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens), TAOK2 DLG1 BRAF DAB2IP MAPK8IP3 PIN1,MF,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0035176,social behavior,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1BFN9(Evidence code:IEA/Database source:UniProtKB:Q9P2S2|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens), EN1 PCM1 SHANK1 NRXN2 SHANK2 CHD8,BP,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0043198,dendritic shaft,Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens), CACNA1B PSEN1 INPP5J SYNGAP1 GIPC1 RTN4R,CC,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0070403,NAD+ binding,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)A5D7K6(Evidence code:IEA/Database source:InterPro:IPR003000)C6K7D2(Evidence code:IEA/Database source:InterPro:IPR003000)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR022694)F6QK60(Evidence code:IEA/Database source:InterPro:IPR003000)E1BMI4(Evidence code:IEA/Database source:UniProtKB:Q8NBZ7|ens), ALDH1A3 SIRT6 Sirt1 CRYL1 SIRT2 UXS1,MF,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0004683,calmodulin-dependent protein kinase activity,Q2HJF7(Evidence code:IEA/Database source:InterPro:IPR013543|I)Q08E45(Evidence code:IEA/Database source:InterPro:IPR013543|I)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens)Q3MHJ9(Evidence code:IEA/Database source:InterPro:IPR013543|I)F1MVF1(Evidence code:IEA/Database source:InterPro:IPR013543|I), CAMK2D CAMK2A MAPKAPK3 MYLK3 CAMK2B CAMK2G,MF,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:1901673,regulation of mitotic spindle assembly,Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens), CHMP4B TPR VPS4B CHMP2A CHMP2B CHMP1A,BP,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0098869,cellular oxidant detoxification,P00432(Evidence code:IEA/Database source:GO:0004096)Q58CY6(Evidence code:IEA/Database source:GO:0016209)F1MHF7(Evidence code:IEA/Database source:GO:0004601)P00435(Evidence code:IEA/Database source:GO:0004602)O62768(Evidence code:IEA/Database source:GO:0004791)P37141(Evidence code:IEA/Database source:GO:0004602), CAT FAM213B TXNDC17 GPX1 TXNRD1 GPX3,BP,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0007140,male meiotic nuclear division,F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)E1BDI1(Evidence code:IEA/Database source:UniProtKB:Q9DA79|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens), FIGNL1 AGO4 DPEP3 DDX4 UBR2 TDRD9,BP,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0005070,SH3/SH2 adaptor activity,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR035036)Q58DL5(Evidence code:IBA/Database source:PANTHER:PTN001023064)F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), GRB2 KHDRBS1 Grb10 BCAR3 SH2B2 CRK,MF,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0031011,Ino80 complex,A7Z075(Evidence code:IEA/Database source:InterPro:IPR006880|I)F1MPR9(Evidence code:IEA/Database source:InterPro:IPR024867)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR027238|I)E1BAN8(Evidence code:IEA/Database source:InterPro:IPR031047)G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR027238|I), INO80B NFRKB RUVBL1 INO80 ACTR5 RUVBL2,CC,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0046718,viral entry into host cell,Q5E985(Evidence code:IEA/Database source:GO:0001618)P80746(Evidence code:IEA/Database source:GO:0001618)P53712(Evidence code:IEA/Database source:GO:0001618)Q8SQB8(Evidence code:IEA/Database source:GO:0001618)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens), HYAL1 ITGAV ITGB1 ITGB6 NPC1 EPS15,BP,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0003007,heart morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), NIPBL CHD7 COL2A1 MYBPC3 ASXL1 TBX3,BP,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0070840,dynein complex binding,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)A5PKJ3(Evidence code:IEA/Database source:InterPro:IPR027663)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)G3N3P0(Evidence code:IEA/Database source:InterPro:IPR018477)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)P43033(Evidence code:IEA/Database source:UniRule:UR000107004), NUMA1 DCTN1 TPR BICD2 GPSM2 PAFAH1B1,MF,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0007528,neuromuscular junction development,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02463|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens), UNC13A COL4A1 LRRK2 LAMB2 COL4A5 UNC13B,BP,6,6 of 5,0.25,120,0.00003385,0.0003318
GO:0043069,negative regulation of programmed cell death,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 191,0.04,0.52,0.00003631,0.0003552
GO:0060341,regulation of cellular localization,Q2HJF7(Evidence code:ISS/Database source:UniProtKB:Q13557),CAMK2D,BP,1,1 of 194,0.04,0.52,0.00003793,0.0003704
GO:0031047,gene silencing by RNA,Q6T5B7(Evidence code:IEA/Database source:InterPro:IPR028603)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)E1B7E6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0943)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)P61286(Evidence code:ISS/Database source:UniProtKB:P29341), AGO3 DICER1 PIWIL2 DDX4 AGO4 DHX9 TDRD1 PABPC1,BP,8,8 of 13,0.34,61.54,0.00004161,0.0004048
GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",P27479(Evidence code:ISS/Database source:UniProtKB:P16050)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)Q28046(Evidence code:IDA/Database source:)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668), ALOX15 MTSS1L SCIN SDCBP2 TWF1 SH3PXD2A SNX18 AMER3,MF,8,8 of 13,0.34,61.54,0.00004161,0.0004048
GO:0006260,DNA replication,P84798(Evidence code:IEA/Database source:InterPro:IPR019038)Q05B83(Evidence code:IEA/Database source:InterPro:IPR008921)G8JKZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR012532|I)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR015088)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR001098|I)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR018982)E1BDI3(Evidence code:IEA/Database source:InterPro:IPR001098|I)A4IFC8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR018525)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0235), POLD3 RFC2 PRIM1 BLM DHX9 POLA1 POLQ WRN POLG LIG1 MCM4 SAMHD1,BP,12,12 of 34,0.51,35.29,0.00004297,0.0004173
GO:0008234,cysteine-type peptidase activity,Q27971(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR000668|I)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)Q5E998(Evidence code:IEA/Database source:InterPro:IPR000668|I)Q08DY9(Evidence code:IEA/Database source:InterPro:IPR015917)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)F1MXQ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)A7Z056(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)E1BL29(Evidence code:IBA/Database source:PANTHER:PTN001621808)E1BIX3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)F1MQD1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR015917)A1L548(Evidence code:IEA/Database source:UniProtKB-KW:KW-0788), CAPN2 USP13 TINAGL1 OTUD7B CTSV CASP3 OTUB1 PIGK CAPN11 USP20 BLMH CAPN7 CAPN5 CASP6 USP5,MF,15,15 of 53,0.64,28.3,0.00004326,0.0004193
GO:0005844,polysome,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575)Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q9C0B0|ens), DHX9 WBSCR1 PIWIL2 VBP1 EIF4H EIF4G1 UNK,CC,7,7 of 9,0.3,77.78,0.00004442,0.000429
GO:0042475,odontogenesis of dentin-containing tooth,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), DLX2 GLI2 LEF1 NF2 LRP6 BCL11B TRAF6,BP,7,7 of 9,0.3,77.78,0.00004442,0.000429
GO:0030139,endocytic vesicle,F1MKV7(Evidence code:IEA/Database source:UniProtKB:O60494|ens)A2VE81(Evidence code:IEA/Database source:UniProtKB:Q61146|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A6QLR4(Evidence code:ISS/Database source:UniProtKB:Q14254)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN000634696)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens), CUBN OCLN RAPGEF2 ABCA1 DAB2IP FLOT2 DPP4 ARF6 RAB17 STX7,CC,10,10 of 23,0.42,43.48,0.00004573,0.0004409
GO:0030136,clathrin-coated vesicle,A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)Q1RMR3(Evidence code:IDA/Database source:)F1MH24(Evidence code:ISS/Database source:UniProtKB:F1SPM8)A7Z035(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens), VPS41 SNX3 CPNE6 SNX18 CTTN AAK1 CLINT1 EPS15 DENND1A,CC,9,9 of 18,0.38,50,0.00004721,0.0004536
GO:0000187,activation of MAPK activity,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000037430)E1B7J7(Evidence code:IEA/Database source:GO:0004708)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens)P22571(Evidence code:IEA/Database source:UniProtKB:P61249|ens), FRS2 SHC1 PAK3 KIT PROK1 FGF1 LRRK2 CSPG4 PDE6H,BP,9,9 of 18,0.38,50,0.00004721,0.0004536
GO:0016192,vesicle-mediated transport,Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q8BHC1)A2VDL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q1JQ98(Evidence code:IEA/Database source:InterPro:IPR000804)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q2KJD2(Evidence code:IEA/Database source:InterPro:IPR001388)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)A0JN39(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q2TBL9(Evidence code:IEA/Database source:InterPro:IPR007233)Q17QC5(Evidence code:IEA/Database source:InterPro:IPR000804)O46382(Evidence code:IBA/Database source:PANTHER:PTN000070561)P81127(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)A2VE21(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR002553|I)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR010989)A6QNT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)P61763(Evidence code:IEA/Database source:InterPro:IPR001619|I)P63009(Evidence code:IEA/Database source:InterPro:IPR002553|I)P53619(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q0V7N0(Evidence code:IEA/Database source:InterPro:IPR001388)P35604(Evidence code:IEA/Database source:InterPro:IPR000804)Q28104(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)P04973(Evidence code:IEA/Database source:InterPro:IPR000996)P63026(Evidence code:IEA/Database source:InterPro:IPR001388)E1BG76(Evidence code:IEA/Database source:InterPro:IPR001619|I)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q09YL9(Evidence code:IEA/Database source:InterPro:IPR001388)A3KMZ0(Evidence code:IEA/Database source:InterPro:IPR001619|I)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR002553|I)E1BGT8(Evidence code:IEA/Database source:InterPro:IPR029901|I)A7Z035(Evidence code:IEA/Database source:InterPro:IPR030544)Q3ZC13(Evidence code:IEA/Database source:InterPro:IPR001392|I)A6H7F7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692|I)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0931)E1BME2(Evidence code:IEA/Database source:InterPro:IPR002553|I)A3KN15(Evidence code:IEA/Database source:InterPro:IPR000547)Q2KHY2(Evidence code:IEA/Database source:InterPro:IPR001388), CHMP1A AHI1 RAB39B SEC23A AP2A1 AP1S1 SEC23B VAMP3 COPB2 COPB1 TRAPPC4 AP2S1 ARFGEF1 NAPG COPG2 AP2A2 ZFYVE27 STX7 SEC24A STXBP1 AP2B1 ARCN1 VAMP1 COPZ1 COPE CLTA VAMP2 SCFD1 SEC13 MAPK8IP3 STXBP5 STXBP3 AP2B1 SPIRE1 CLINT1 AP2M1 TRAPPC2L COPA SAR1B AP3B2 VPS41 VAMP5,BP,42,42 of 277,1.78,15.16,0.00004778,0.0004582
GO:0031514,motile cilium,P00517(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)D3K0R6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)Q58D31(Evidence code:ISS/Database source:UniProtKB:Q64442)F1MSL8(Evidence code:IEA/Database source:UniProtKB:Q8CDK3|ens)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0282)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), PRKACA ATP2B4 SORD IQUB SEPT6 SEPT7 SEPT2 TEKT4 DAAM1 DNAH11 GLI2,CC,11,11 of 29,0.47,37.93,0.00005239,0.0005006
GO:0007034,vacuolar transport,F1MX24(Evidence code:IBA/Database source:PANTHER:PTN000104831)Q58CS7(Evidence code:IEA/Database source:InterPro:IPR005024)Q148L0(Evidence code:IEA/Database source:InterPro:IPR005024)P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)Q5E994(Evidence code:IEA/Database source:InterPro:IPR005024)Q3SZ37(Evidence code:IEA/Database source:InterPro:IPR005024)Q08E32(Evidence code:IEA/Database source:InterPro:IPR005024)Q3SX42(Evidence code:IEA/Database source:InterPro:IPR005024)A2VDY3(Evidence code:IEA/Database source:InterPro:IPR005024)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR005024)Q3T0U5(Evidence code:IEA/Database source:InterPro:IPR005024), CLN3 CHMP3 CHMP6 ATP6V0D1 CHMP1B CHMP5 CHMP4B CHMP2B CHMP4A CHMP1A CHMP2A,BP,11,11 of 29,0.47,37.93,0.00005239,0.0005006
GO:0042327,positive regulation of phosphorylation,E1BMG1(Evidence code:IEA/Database source:GO:0019209)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), MOB1B PSEN1,BP,2,2 of 214,0.08,0.93,0.00006074,0.0005793
GO:1902533,positive regulation of intracellular signal transduction,P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens), FGF1 LRRK1,BP,2,2 of 217,0.08,0.92,0.00006222,0.0005924
GO:0070006,metalloaminopeptidase activity,G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q3SZH7(Evidence code:IEA/Database source:UniProtKB:P09960|ens)Q3ZC89(Evidence code:IEA/Database source:UniRule:UR000111476)Q2HJH1(Evidence code:IBA/Database source:PANTHER:PTN002004858)Q1JPJ2(Evidence code:IEA/Database source:InterPro:IPR033740)E1BP91(Evidence code:IBA/Database source:PANTHER:PTN000164249), RNPEP LTA4H METAP2 DNPEP XPNPEP1 NPEPPS,MF,6,6 of 6,0.25,100,0.00006378,0.0006019
GO:0021766,hippocampus development,E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), DCLK2 DLX2 NF2 KIF14 LEF1 SRF,BP,6,6 of 6,0.25,100,0.00006378,0.0006019
GO:0005795,Golgi stack,Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)E1BB36(Evidence code:IEA/Database source:InterPro:IPR007754)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PLK3 MBTPS1 GALNT2 MGAT2 TRAPPC4 NSFL1C,CC,6,6 of 6,0.25,100,0.00006378,0.0006019
GO:0006284,base-excision repair,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens)A4IFC8(Evidence code:IEA/Database source:UniProtKB:P18858|ens), SIRT6 WRN TDG POLQ HUWE1 LIG1,BP,6,6 of 6,0.25,100,0.00006378,0.0006019
GO:0009925,basal plasma membrane,E1BI45(Evidence code:IEA/Database source:UniProtKB:Q9Z2J0|ens)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)F1MMH2(Evidence code:IEA/Database source:UniProtKB:B8JK39|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens), SLC23A1 MYO1A MYO1C TACSTD2 ITGA9 AQP5,CC,6,6 of 6,0.25,100,0.00006378,0.0006019
GO:0070374,positive regulation of ERK1 and ERK2 cascade,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens), ABL1 CRKL DSTYK ALOX15 RAPGEF2 PDGFC SRC F2R MT3 TNFAIP8L3 CIB1 BRAF C5AR1,BP,13,13 of 42,0.55,30.95,0.00006426,0.0006054
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q6UVK1|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)O46405(Evidence code:IEA/Database source:UniProtKB:P33681|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), RICTOR CSPG4 YES1 ABL1 PAK2 TEC LRRK1 PRNP CD80 fgfr3 DGKQ SRC,BP,12,12 of 36,0.51,33.33,0.00006771,0.0006302
GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001485)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001285), RIMS1 SYTL1 SYTL2 SYT4 SYT6,BP,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0035987,endodermal cell differentiation,E1B7H2(Evidence code:IEA/Database source:UniProtKB:Q02388|ens)F1MDD5(Evidence code:IEA/Database source:UniProtKB:Q16787|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), COL7A1 LAMA3 LAMB1 ITGB2 GATA6,BP,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0060325,face morphogenesis,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)A6QR60(Evidence code:IEA/Database source:UniProtKB:Q9H336|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens), LEF1 NIPBL CRISPLD1 LRP6 RRAS,BP,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0071773,cellular response to BMP stimulus,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens), GATA6 ADAMTS7 ADAMTS12 COL2A1 HFE2,BP,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0043113,receptor clustering,F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163), SYNGAP1 ITGB2 ITGB7 SCRIB DLG1,BP,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR028770)Q3T178(Evidence code:ISS/Database source:UniProtKB:Q9UK41), TSG101 VPS4B NEDD4 PTPN23 VPS28,BP,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0005388,calcium-transporting ATPase activity,D3K0R6(Evidence code:IEA/Database source:InterPro:IPR006408|I)F1MS16(Evidence code:IEA/Database source:InterPro:IPR006408|I)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000643812)F1MMF3(Evidence code:IEA/Database source:InterPro:IPR006413|I)F1MN60(Evidence code:IEA/Database source:InterPro:IPR006408|I), ATP2B4 ATP2B3 ATP13A5 ATP2C2 ATP2B2,MF,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0004749,ribose phosphate diphosphokinase activity,G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842|I)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR005946)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842|I)Q2HJ58(Evidence code:IEA/Database source:InterPro:IPR000842|I)Q08DW2(Evidence code:IEA/Database source:InterPro:IPR005946), PRPS2 PRPSAP2 PRPS1L1 PRPS1 PRPSAP1,MF,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0070064,proline-rich region binding,Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)G3MZC7(Evidence code:IEA/Database source:UniProtKB:Q9R1C7|ens), BAIAP2 NEDD4 ABL1 BAIAP2L1 PRPF40A,MF,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0032039,integrator complex,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)E1B8S1(Evidence code:IEA/Database source:InterPro:IPR038902)E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)A5PJT2(Evidence code:IEA/Database source:InterPro:IPR026164)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens), NIPBL INTS1 CPSF3L INTS10 INTS3,CC,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0019228,neuronal action potential,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MHP0(Evidence code:IBA/Database source:PANTHER:PTN000798901)G3MYM1(Evidence code:IBA/Database source:PANTHER:PTN000798901)E1BHM6(Evidence code:IBA/Database source:PANTHER:PTN000798901)F1MMU9(Evidence code:IBA/Database source:PANTHER:PTN000798901), KCNMA1 SCN5A SCN10A SCN11A SCN8A,BP,5,5 of 3,0.21,166.67,0.00006831,0.0006302
GO:0007268,chemical synaptic transmission,F1MP30(Evidence code:IEA/Database source:InterPro:IPR027080)F1MK99(Evidence code:IEA/Database source:InterPro:IPR027080)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)G3N152(Evidence code:IBA/Database source:PANTHER:PTN000617834)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)E1BDL0(Evidence code:IBA/Database source:PANTHER:PTN000617834)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR027080|I)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)E1BB27(Evidence code:IEA/Database source:InterPro:IPR030524)A0JNA0(Evidence code:IEA/Database source:InterPro:IPR030529)A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365476)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460), UNC13B UNC13A DLG1 PCDHB8 LRP6 LOC786512 UNC13C SCRIB DLGAP1 APBA2 EXOC4 GIPC1 GRM7 KCNMA1,BP,14,14 of 49,0.59,28.57,0.00007057,0.0006477
GO:0043010,camera-type eye development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens), RPGRIP1L CHD7 RAX PKNOX1 MYF5 ARHGAP35 CRYAB,BP,7,7 of 10,0.3,70,0.00007105,0.0006477
GO:0007368,determination of left/right symmetry,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)F1MCT1(Evidence code:IEA/Database source:UniProtKB:F6XJP7|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), DNAH11 MEGF8 DNAH5 RPGRIP1L AXIN1 PCSK6 FOXF1,BP,7,7 of 10,0.3,70,0.00007105,0.0006477
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)F1N152(Evidence code:IEA/Database source:UniProtKB:Q9R118|ens)E1BIJ4(Evidence code:IEA/Database source:UniProtKB:Q9Y2U8|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens), ONECUT2 STRAP HTRA1 LEMD3 BCL9L EMILIN1 PIN1,BP,7,7 of 10,0.3,70,0.00007105,0.0006477
GO:0060021,roof of mouth development,F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens), LRP6 FRAS1 BCOR COL2A1 TBX3 CHD7 PYGO2,BP,7,7 of 10,0.3,70,0.00007105,0.0006477
GO:0071158,positive regulation of cell cycle arrest,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens), INSM1 DAB2IP ZBTB17 GATA6 BRCA1 PRKACA FOXO4,BP,7,7 of 10,0.3,70,0.00007105,0.0006477
GO:0001540,amyloid-beta binding,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)A0JNA0(Evidence code:IEA/Database source:InterPro:IPR030529)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)Q3T0P7(Evidence code:IBA/Database source:PANTHER:PTN000103178), SORL1 CRYAB DLGAP3 PRNP APBA2 BACE1 ITM2B,MF,7,7 of 10,0.3,70,0.00007105,0.0006477
GO:0042470,melanosome,A6H767(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32L41(Evidence code:IEA/Database source:UniProtKB:P30047|ens)P53712(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T054(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q95JC7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P31408(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P06623(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DN8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)Q29455(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DW1(Evidence code:IEA/Database source:UniProtKB:Q9R0M6|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens)P27214(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), NAP1L1 GCHFR ITGB1 RAN SLC1A5 CD63 ATP6V1B2 CNP FLOT1 LAMP1 DNAJC5 RAB9A RAB17 SGSM2 ANXA11,CC,15,15 of 56,0.64,26.79,0.00007341,0.000668
GO:0040012,regulation of locomotion,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 183,0.04,0.55,0.00008236,0.0007483
GO:0030182,neuron differentiation,F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens)Q05B89(Evidence code:ISS/Database source:UniProtKB:Q9EQ80)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000048336)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)E1BLC5(Evidence code:IBA/Database source:PANTHER:PTN000680687)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000237028)F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5), ATP2B2 NIF3L1 CASP3 PSEN1 EN1 ABL1 POU4F2 DCLK2 RUNX1 PIGT RNF112,BP,11,11 of 31,0.47,35.48,0.00008544,0.0007723
GO:0005814,centriole,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)G3N3M6(Evidence code:IEA/Database source:InterPro:IPR026048)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8TCU4|ens)E1BC48(Evidence code:IEA/Database source:UniProtKB:Q5VT06|ens)E1BJG8(Evidence code:IEA/Database source:UniProtKB:Q9H2F9|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR033700)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207), PCM1 CEP250 ALMS1 CEP350 CCDC68 PCNT PLK4 AHI1 SDCCAG8 SIRT2 CCP110,CC,11,11 of 31,0.47,35.48,0.00008544,0.0007723
GO:0010951,negative regulation of endopeptidase activity,E1BHA8(Evidence code:IEA/Database source:GO:0004866)E1BCA5(Evidence code:IEA/Database source:GO:0004867)P20811(Evidence code:IEA/Database source:GO:0004869)G3X894(Evidence code:IEA/Database source:GO:0004867)Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q08629)E1BE13(Evidence code:IEA/Database source:GO:0004869)Q9BGU1(Evidence code:IEA/Database source:GO:0004869)G8JKW7(Evidence code:IEA/Database source:GO:0004867)F1N226(Evidence code:IEA/Database source:GO:0004867)A6QPK7(Evidence code:IEA/Database source:GO:0004867)E1B7H2(Evidence code:IEA/Database source:GO:0004867), CPAMD8 SERPINI1 CAST LOC786263 SPOCK1 BIRC6 BTHRG SERPINA3 APLP2 PTI COL7A1,BP,11,11 of 31,0.47,35.48,0.00008544,0.0007723
GO:0005506,iron ion binding,P27479(Evidence code:IEA/Database source:InterPro:IPR001885)F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I)P48034(Evidence code:IEA/Database source:InterPro:IPR016208)F1MXW0(Evidence code:IEA/Database source:InterPro:IPR001885)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR006620)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR006620)E1BL62(Evidence code:IEA/Database source:InterPro:IPR016208)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I)O46415(Evidence code:ISS/Database source:UniProtKB:P02792)O46414(Evidence code:IBA/Database source:PANTHER:PTN000153092)E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727), ALOX15 LOC540627 AOX1 ALOX15B P4HA2 CYP2J2 CYP2R1 EGLN3 AOX4 PAH FTL FTH1 LOC100295883 CYP7A1 ABCE1,MF,15,15 of 57,0.64,26.32,0.0000869,0.0007842
GO:0000082,G1/S transition of mitotic cell cycle,A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)F1MVF1(Evidence code:IEA/Database source:UniProtKB:Q923T9|ens), CDK3 RANBP2 CAMK2A PPP3CA CDK6 PLK3 TAF10 CAMK2G,BP,8,8 of 15,0.34,53.33,0.00008862,0.000797
GO:0006997,nucleus organization,Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens), CHMP1A LEMD3 CHMP4A VPS4B CHMP4B CHMP2B CHMP6 CHMP2A,BP,8,8 of 15,0.34,53.33,0.00008862,0.000797
GO:0098609,cell-cell adhesion,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MJ11(Evidence code:IEA/Database source:InterPro:IPR028435)F1MSN2(Evidence code:IBA/Database source:PANTHER:PTN001799275)A4FUD6(Evidence code:IEA/Database source:InterPro:IPR030713)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens)A4IF71(Evidence code:IEA/Database source:InterPro:IPR028435)A7YY26(Evidence code:IEA/Database source:InterPro:IPR028435)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)E1BQ11(Evidence code:IEA/Database source:InterPro:IPR028435|I)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q5TAT6|ens), FOXF1 SCRIB SRF PKP4 TACSTD2 ELMO2 DLG1 FAT1 CYFIP2 PKP2 ARVCF FNDC3A CTNND1 ASTN1 PSEN1 COL13A1,BP,16,16 of 65,0.68,24.62,0.0001004,0.0008826
GO:0051298,centrosome duplication,A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085)E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207), TUBGCP2 CKAP5 BRCA2 CCP110,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0060996,dendritic spine development,Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q8CIN4|ens)G5E5G9(Evidence code:IEA/Database source:UniProtKB:Q8BTW9|ens), CAMK2A PAK3 PAK2 PAK4,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0006610,ribosomal protein import into nucleus,E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)F1MPE5(Evidence code:IEA/Database source:UniProtKB:O00410|ens), KPNB1 TNPO1 IPO4 IPO5,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:2001224,positive regulation of neuron migration,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), MAPK8IP3 NIPBL RAPGEF2 DAB2IP,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0048172,regulation of short-term neuronal synaptic plasticity,F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens), UNC13B KMT2A UNC13A RAB3A,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0048593,camera-type eye morphogenesis,E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)F1MJR6(Evidence code:IEA/Database source:UniProtKB:P25318|ens)E1BMG7(Evidence code:IEA/Database source:UniProtKB:Q9P273|ens)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens), FAT1 COL8A2 TENM3 AQP5,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0002042,cell migration involved in sprouting angiogenesis,E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)E1BJW3(Evidence code:IEA/Database source:UniProtKB:A6H6E2|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens), EPHB4 MMRN2 SLIT2 SRF,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:1990907,beta-catenin-TCF complex,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:O00512|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q9BRQ0|ens), LEF1 BCL9L BCL9 PYGO2,CC,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0044322,endoplasmic reticulum quality control compartment,A7MBJ3(Evidence code:IEA/Database source:GO:0036509)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)G3MXQ8(Evidence code:IEA/Database source:UniProtKB:Q9UKM7|ens)E1BAK9(Evidence code:IBA/Database source:PANTHER:PTN000967687), EDEM2 DZIP3 MAN1B1 SYVN1,CC,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0038191,neuropilin binding,F1MYW3(Evidence code:IBA/Database source:PANTHER:PTN000867406)G3MYK9(Evidence code:IBA/Database source:PANTHER:PTN000867406)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens), SEMA3E SEMA3G ABL1 TAOK2,MF,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0044615,nuclear pore nuclear basket,F1MH31(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573963)P48820(Evidence code:ISS/Database source:UniProtKB:P49792)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), NUP214 POM121L2 RANBP2 TPR,CC,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0043220,Schmidt-Lanterman incisure,E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1MMT3(Evidence code:IEA/Database source:UniProtKB:Q8VBX6|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens), MPP5 SIRT2 MPDZ PRKCI,CC,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0005587,collagen type IV trimer,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)F1N474(Evidence code:IEA/Database source:UniProtKB:Q63ZW6|ens)Q29442(Evidence code:IDA/Database source:), COL4A1 COL4A6 COL4A5 COL4A4,CC,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0060324,face development,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens), SRF CHD7 BRAF ALDH1A3,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0031435,mitogen-activated protein kinase kinase kinase binding,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens), MAPK8IP3 DAB2IP TRAF6 SASH1,MF,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0006491,N-glycan processing,E1BI49(Evidence code:IBA/Database source:PANTHER:PTN000201533)F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)A7MBJ3(Evidence code:IBA/Database source:PANTHER:PTN000201533)G3MXQ8(Evidence code:IBA/Database source:PANTHER:PTN000201533), MAN1A2 ST8SIA3 EDEM2 MAN1B1,BP,4,4 of 1,0.17,400,0.0001009,0.0008826
GO:0005267,potassium channel activity,A4FV89(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q05037(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1B7T7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BMA2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1ML52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)E1BM97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)Q28204(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1MP51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631)F1MJA9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0631), KCNF1 KCNA4 KCNC4 KCNH6 KCNG4 KCNC3 HCN1 KCNMA1 KCNH5 KCNG2,MF,10,10 of 26,0.42,38.46,0.000104,0.0009075
GO:0031122,cytoplasmic microtubule organization,E1BDX8(Evidence code:IBA/Database source:PANTHER:PTN000072732)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens), DYNC1H1 CIB1 AXIN1 TUBGCP2 PCM1 PLK3 SLK,BP,7,7 of 11,0.3,63.64,0.0001094,0.000952
GO:0005852,eukaryotic translation initiation factor 3 complex,A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)Q3T0V3(Evidence code:IEA/Database source:InterPro:IPR009374|I)E1BLZ8(Evidence code:IEA/Database source:InterPro:IPR027531)Q5E966(Evidence code:IEA/Database source:InterPro:IPR027525)Q3T148(Evidence code:IEA/Database source:InterPro:IPR027528)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q3ZC12(Evidence code:IEA/Database source:InterPro:IPR017334), EIF3B EIF3K EIF3F EIF3I EIF3M ABCE1 EIF3G,CC,7,7 of 11,0.3,63.64,0.0001094,0.000952
GO:0016529,sarcoplasmic reticulum,Q2HJF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)P68107(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)Q9N1F0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0703), CAMK2D FKBP1B JSRP1 CAMK2B RYR1 MRVI1,CC,6,6 of 7,0.25,85.71,0.0001116,0.00096
GO:0000228,nuclear chromosome,E1B9J3(Evidence code:IEA/Database source:InterPro:IPR006909)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q6PIW4|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), RAD21L1 SETX H3F3B FIGNL1 BLM ATRX,CC,6,6 of 7,0.25,85.71,0.0001116,0.00096
GO:0021987,cerebral cortex development,G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)F1MQ38(Evidence code:IEA/Database source:UniProtKB:P58545|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN000357964), KIF14 CDON BTBD3 PSEN1 LRP6 TACC1,BP,6,6 of 7,0.25,85.71,0.0001116,0.00096
GO:0042472,inner ear morphogenesis,P31407(Evidence code:ISS/Database source:UniProtKB:P15313)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)F1MG13(Evidence code:IEA/Database source:UniProtKB:Q9QZZ4|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), ATP6V1B1 CHD7 BCR ALDH1A3 MYO15A COL2A1,BP,6,6 of 7,0.25,85.71,0.0001116,0.00096
GO:0002183,cytoplasmic translational initiation,Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134)Q3T0V3(Evidence code:IEA/Database source:UniRule:UR000107107)A7MB16(Evidence code:IEA/Database source:UniRule:UR000106119)E1BLZ8(Evidence code:IEA/Database source:UniRule:UR000106280)Q3ZC12(Evidence code:IEA/Database source:UniRule:UR000106306)Q5E966(Evidence code:IEA/Database source:UniRule:UR000107081), EIF3M EIF3K EIF3B EIF3F EIF3G EIF3I,BP,6,6 of 7,0.25,85.71,0.0001116,0.00096
GO:0004003,ATP-dependent DNA helicase activity,A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)F1MFY4(Evidence code:IEA/Database source:InterPro:IPR027044)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945|I)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244), RUVBL1 HELB BLM WRN ERCC2 RUVBL2,MF,6,6 of 7,0.25,85.71,0.0001116,0.00096
GO:0001947,heart looping,F1MF74(Evidence code:ISS/Database source:UniProtKB:F1RA39)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), MICAL2 SRF AHI1 SOX17 TBX3 PSEN1,BP,6,6 of 7,0.25,85.71,0.0001116,0.00096
GO:0070201,regulation of establishment of protein localization,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 175,0.04,0.57,0.0001149,0.000987
GO:0001568,blood vessel development,E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)P80746(Evidence code:ISS/Database source:UniProtKB:P43406)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SPHK2 COL1A2 RAPGEF2 ITGAV CRKL FOXF1 CHD7 TBX3 PSEN1,BP,9,9 of 21,0.38,42.86,0.0001195,0.001022
GO:0032092,positive regulation of protein binding,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens)Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens), FLOT1 MARK3 LFNG STK3 RAPGEF2 LRRK2 PIN1 PSEN1 SPTA1,BP,9,9 of 21,0.38,42.86,0.0001195,0.001022
GO:0001078,"transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",A5PKI6(Evidence code:IEA/Database source:UniProtKB:Q8K1A6|ens)E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:Q05925|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934)A4FV57(Evidence code:IEA/Database source:UniProtKB:Q9Z248|ens)G3MY13(Evidence code:IBA/Database source:PANTHER:PTN000281113)F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)Q17QR0(Evidence code:IBA/Database source:PANTHER:PTN000579358), CC2D1A GCFC2 EN1 TBX3 POU4F2 AEBP2 TSHZ1 CUX2 BCL11A,MF,9,9 of 21,0.38,42.86,0.0001195,0.001022
GO:0006457,protein folding,Q2TBI4(Evidence code:IEA/Database source:InterPro:IPR001404)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR008971|I)Q3ZCI9(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3T084(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q2NKZ1(Evidence code:IEA/Database source:InterPro:IPR002194|I)A4FV72(Evidence code:IEA/Database source:InterPro:IPR016304|I)A4FUW8(Evidence code:IBA/Database source:PANTHER:PTN000432607)Q3MI00(Evidence code:IEA/Database source:InterPro:IPR008971)P26882(Evidence code:IEA/Database source:InterPro:IPR020892)Q2TBX2(Evidence code:IEA/Database source:InterPro:IPR016655)Q3T0K2(Evidence code:IEA/Database source:InterPro:IPR002194|I)G3X8B1(Evidence code:IEA/Database source:InterPro:IPR020892)Q2KJC8(Evidence code:IEA/Database source:UniProtKB:Q9Z247|ens)P48820(Evidence code:IEA/Database source:InterPro:IPR020892)Q32L40(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3ZBA6(Evidence code:IEA/Database source:InterPro:IPR008971)A1A4P5(Evidence code:IEA/Database source:InterPro:IPR002777|I)F1MWD3(Evidence code:IEA/Database source:InterPro:IPR002194|I)Q3ZCH0(Evidence code:IEA/Database source:InterPro:IPR012725)Q2KIT4(Evidence code:IEA/Database source:InterPro:IPR008971), TRAP1 DNAJA2 CCT8 CCT6B CCT7 PPIE TXNDC11 DNAJB1 PPID VBP1 CCT3 LOC613401 FKBP9 RANBP2 TCP1 DNAJB11 PFDN2 CCT5 HSPA9 DNAJB4,BP,20,20 of 97,0.85,20.62,0.0001242,0.00106
GO:0005044,scavenger receptor activity,E1B9H1(Evidence code:IEA/Database source:InterPro:IPR001212)B6ULZ4(Evidence code:IEA/Database source:InterPro:IPR001190)A2VDV7(Evidence code:IEA/Database source:InterPro:IPR001190)E1B9M8(Evidence code:IEA/Database source:UniProtKB:P59222|ens)F1N7K7(Evidence code:IEA/Database source:InterPro:IPR001190)E1B813(Evidence code:IEA/Database source:InterPro:IPR001190)F1MI35(Evidence code:IEA/Database source:InterPro:IPR001190)Q0V7N1(Evidence code:IEA/Database source:InterPro:IPR001212|I), TINAGL1 WC1 TMPRSS2 SCARF2 MARCO LOC786796 HHIPL1 SUSD2,MF,8,8 of 16,0.34,50,0.000125,0.001065
GO:0006302,double-strand break repair,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)P18493(Evidence code:ISS/Database source:UniProtKB:P09874)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736), DDX1 WRN RAD21L1 POLQ ACTR5 BRCA2 TNKS1BP1 INO80 PRKDC SETX PARP1 BRCC3,BP,12,12 of 39,0.51,30.77,0.0001274,0.001082
GO:0007626,locomotory behavior,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)E1BA03(Evidence code:IEA/Database source:UniProtKB:Q3ULB5|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)F1MG13(Evidence code:IEA/Database source:UniProtKB:Q9QZZ4|ens), PEX13 ASTN1 PAK6 ADORA2A SNAP25 DBH CACNA1B CHD7 ALDH1A3 MEIS1 NAV2 MYO15A,BP,12,12 of 39,0.51,30.77,0.0001274,0.001082
GO:0016772,"transferase activity, transferring phosphorus-containing groups",Q5EA61(Evidence code:IEA/Database source:InterPro:IPR000749|I)A6QP44(Evidence code:IEA/Database source:InterPro:IPR012887)Q3ZBM7(Evidence code:IEA/Database source:InterPro:IPR002745), CKB FUK TRPT1,MF,3,3 of 236,0.13,1.27,0.0001293,0.001097
GO:0016817,"hydrolase activity, acting on acid anhydrides",F1MLB2(Evidence code:IEA/Database source:InterPro:IPR006576)F1N734(Evidence code:IEA/Database source:InterPro:IPR006576)A5PKK5(Evidence code:IEA/Database source:InterPro:IPR006576)E1BPM4(Evidence code:IEA/Database source:InterPro:IPR006576)E1BDZ3(Evidence code:IEA/Database source:InterPro:IPR006576), CHD8 CHD6 SMARCA2 CHD7 CHD9,MF,5,5 of 283,0.21,1.77,0.0001318,0.001116
GO:0051287,NAD binding,P48034(Evidence code:IEA/Database source:InterPro:IPR014313)F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139|I)F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139|I)P48644(Evidence code:ISS/Database source:UniProtKB:Q28399)Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens)P18493(Evidence code:IEA/Database source:InterPro:IPR008288)E1BL62(Evidence code:IEA/Database source:InterPro:IPR014313)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR011128|I)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139|I)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424), AOX1 CTBP1 GRHPR ALDH1A1 SORD PARP1 AOX4 GPD1L PHGDH GAPDHS,MF,10,10 of 27,0.42,37.04,0.0001338,0.001131
GO:0006072,glycerol-3-phosphate metabolic process,A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006168)Q0IID9(Evidence code:IEA/Database source:InterPro:IPR005999)F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens)F1MSV5(Evidence code:IEA/Database source:InterPro:IPR005999)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR005999), GPD1L GK GPAT2 GK2 LOC538702,BP,5,5 of 4,0.21,125,0.000145,0.001212
GO:0075522,IRES-dependent viral translational initiation,Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:O00303|ens)A7MB16(Evidence code:IEA/Database source:UniProtKB:P55884|ens)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens), MCTS1 PCBP2 EIF3F EIF3B SSB,BP,5,5 of 4,0.21,125,0.000145,0.001212
GO:0007175,negative regulation of epidermal growth factor-activated receptor activity,Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB:Q9BRG1|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), CHMP6 CBLC VPS25 TSG101 PSEN1,BP,5,5 of 4,0.21,125,0.000145,0.001212
GO:0050853,B cell receptor signaling pathway,P05126(Evidence code:ISS/Database source:UniProtKB:P68404)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000701114)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens), PRKCB ABL1 LCK PTPN6 TEC,BP,5,5 of 4,0.21,125,0.000145,0.001212
GO:0003151,outflow tract morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), NIPBL TBX3 FZD1 RYR1 SOX17,BP,5,5 of 4,0.21,125,0.000145,0.001212
GO:0008143,poly(A) binding,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9), DDX1 EIF4A3 KHDRBS1 PABPC4 PPIE,MF,5,5 of 4,0.21,125,0.000145,0.001212
GO:0036402,proteasome-activating ATPase activity,Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR035263)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR035254)P62194(Evidence code:IEA/Database source:InterPro:IPR035261)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR035245)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR035244), PSMC6 PSMC3 PSMC5 PSMC2 PSMC1,MF,5,5 of 4,0.21,125,0.000145,0.001212
GO:0016791,phosphatase activity,A6QLS1(Evidence code:IEA/Database source:InterPro:IPR000387)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)E1BIU7(Evidence code:IEA/Database source:InterPro:IPR000387)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR000387)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR000387)E1BEZ8(Evidence code:IEA/Database source:InterPro:IPR000387)E1BPU9(Evidence code:IEA/Database source:InterPro:IPR000387)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)Q3ZBF9(Evidence code:IEA/Database source:InterPro:IPR006349)P61287(Evidence code:ISS/Database source:UniProtKB:P63087)F1MGK5(Evidence code:IEA/Database source:InterPro:IPR000387)E1BPA0(Evidence code:IEA/Database source:InterPro:IPR000387)G5E526(Evidence code:IEA/Database source:InterPro:IPR000387)A5D980(Evidence code:IEA/Database source:InterPro:IPR000387)A6QQD4(Evidence code:IEA/Database source:InterPro:IPR000387)E1BDE3(Evidence code:IEA/Database source:InterPro:IPR011948)E1BPN5(Evidence code:IEA/Database source:InterPro:IPR000387), DUSP7 PRUNE1 PTPN23 MTMR1 DUSP3 PTPN14 PTPRM PPP1CB PDXP PPP1CC PTPRZ1 PTPRA PTP4A1 PTPN6 PTPN5 CTDSP1 SSH2,MF,17,17 of 75,0.72,22.67,0.0001467,0.001223
GO:0008168,methyltransferase activity,A7YW45(Evidence code:IEA/Database source:InterPro:IPR007857|I)E1BGA4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A7MBI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)Q5E9L5(Evidence code:IEA/Database source:InterPro:IPR025799)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)E1BKN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)A6QL80(Evidence code:IEA/Database source:InterPro:IPR025799)E1BNH7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)G3MZP6(Evidence code:IEA/Database source:InterPro:IPR002877)A1A4K2(Evidence code:IEA/Database source:InterPro:IPR001678)P15246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)Q3MHK8(Evidence code:IEA/Database source:InterPro:IPR013216)Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR001525)F1MYZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0489)P10950(Evidence code:IEA/Database source:InterPro:IPR016461), PRMT5 ASH1L COMT TRMT1L PRMT6 DOT1L KMT2B PRMT3 WHSC1L1 CMTR2 NSUN2 PCMT1 METTL7A DNMT3A KMT2C KMT2A ASMT,MF,17,17 of 75,0.72,22.67,0.0001467,0.001223
GO:0007032,endosome organization,Q08DF4(Evidence code:IEA/Database source:UniProtKB:Q05193|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens), DNM1 CHMP2B VPS4B FAM160A2 DNAJC13 SNX33 EXOC8,BP,7,7 of 12,0.3,58.33,0.000163,0.001348
GO:0007613,memory,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BA03(Evidence code:IEA/Database source:UniProtKB:Q3ULB5|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P50114|ens), DBH PAK6 PSEN1 SYT4 KMT2B SHANK2 S100B,BP,7,7 of 12,0.3,58.33,0.000163,0.001348
GO:0017053,transcriptional repressor complex,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)Q08DY2(Evidence code:IEA/Database source:InterPro:IPR031169)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)E1BA57(Evidence code:IEA/Database source:UniProtKB:Q5TB30|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens), INSM1 SPEN MIER1 CTBP1 DEPDC1 DDX20 SP1,CC,7,7 of 12,0.3,58.33,0.000163,0.001348
GO:0043666,regulation of phosphoprotein phosphatase activity,Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)Q3SZC4(Evidence code:IEA/Database source:GO:0019888)F1MCY2(Evidence code:IEA/Database source:GO:0072542)A4FV68(Evidence code:IEA/Database source:GO:0019888)A2VDZ0(Evidence code:IEA/Database source:GO:0019888)F1MG56(Evidence code:IEA/Database source:GO:0019888)P20959(Evidence code:IEA/Database source:GO:0008160), PTPA NSFL1C PHACTR4 PPP2R5E PPP2R5A PPP2R2A IGFBP3,BP,7,7 of 12,0.3,58.33,0.000163,0.001348
GO:0045171,intercellular bridge,P05131(Evidence code:IEA/Database source:UniProtKB:P22694|ens)A5D7N6(Evidence code:IEA/Database source:UniProtKB:E9Q5G3|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q0II50(Evidence code:IEA/Database source:UniProtKB:A0A024R6V6)F1N1T6(Evidence code:IEA/Database source:UniProtKB:A0A024R419), PRKACB KIF23 APC2 PRKCI SETX USB1 FASTKD2,CC,7,7 of 12,0.3,58.33,0.000163,0.001348
GO:0001882,nucleoside binding,E1BJF4(Evidence code:IEA/Database source:InterPro:IPR015088),POLA1,MF,1,1 of 167,0.04,0.6,0.0001651,0.001361
GO:0051223,regulation of protein transport,E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens),SCFD1,BP,1,1 of 167,0.04,0.6,0.0001651,0.001361
GO:2000145,regulation of cell motility,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512),PKN1,BP,1,1 of 168,0.04,0.6,0.0001657,0.001364
GO:0036064,ciliary basal body,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)P67827(Evidence code:ISS/Database source:UniProtKB:Q8BK63)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)F2Z4K0(Evidence code:IEA/Database source:UniProtKB:P05214|ens)A2VDK3(Evidence code:IEA/Database source:UniProtKB:Q9Y4D1|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), PCM1 CSNK1A1 AHI1 ARHGAP35 PTPN23 TUBA3E DAAM1 PKHD1 C1H21ORF2 RPGRIP1L,CC,10,10 of 28,0.42,35.71,0.0001705,0.001401
GO:0006890,"retrograde vesicle-mediated transport, Golgi to ER",A0JN39(Evidence code:IBA/Database source:PANTHER:PTN000067242)P35605(Evidence code:TAS/Database source:)Q1RMW9(Evidence code:IBA/Database source:PANTHER:PTN000294961)Q27954(Evidence code:TAS/Database source:)P35604(Evidence code:TAS/Database source:)P53619(Evidence code:IEA/Database source:InterPro:IPR027059)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)Q28104(Evidence code:IEA/Database source:InterPro:IPR006822), COPB1 COPB2 GOLPH3 COPA COPZ1 ARCN1 BICD2 COPE,BP,8,8 of 17,0.34,47.06,0.0001728,0.001412
GO:0000775,"chromosome, centromeric region",P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)P67827(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q6Q137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q2NKY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q0P594(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0137), PPP2CA CSNK1A1 SEPT7 PPP1CC DCTN3 SEPT2 PPP2CB SEPT6,CC,8,8 of 17,0.34,47.06,0.0001728,0.001412
GO:0051117,ATPase binding,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), ABCA1 RUVBL1 LCK UBXN1 SYVN1 CHMP4A BRSK2 PDE4D,MF,8,8 of 17,0.34,47.06,0.0001728,0.001412
GO:0006891,intra-Golgi vesicle-mediated transport,Q27954(Evidence code:TAS/Database source:)A2VE21(Evidence code:IEA/Database source:UniProtKB:Q9UBF2|ens)Q28104(Evidence code:IDA/Database source:)A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)P35605(Evidence code:ISS/Database source:UniProtKB:P35606)P53619(Evidence code:TAS/Database source:)A0JN39(Evidence code:IBA/Database source:PANTHER:PTN000067242)P35604(Evidence code:IEA/Database source:UniProtKB:P61923|ens), COPA COPG2 COPE RAB33B COPB2 ARCN1 COPB1 COPZ1,BP,8,8 of 17,0.34,47.06,0.0001728,0.001412
GO:0008219,cell death,Q5E9L2(Evidence code:ISS/Database source:UniProtKB:O60477),BRINP1,BP,1,1 of 171,0.04,0.58,0.0001739,0.001418
GO:0006397,mRNA processing,Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)O19137(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)E1BIB4(Evidence code:IEA/Database source:InterPro:IPR006536)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR033809)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q1RMR2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)E1BB50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q28165(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)E1BML0(Evidence code:IEA/Database source:InterPro:IPR030843)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q08E07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0507), STRAP EIF4A3 DDX1 SAP18 CPSF4 HNRNPL USP39 DHX9 CDK13 EFTUD2 PABPC1 SNRNP70 CDC5L CDK12 PABPN1 PPWD1 SF3A1 PPIE PAN2 SNRPE CELF3 LSM4 SRSF1,BP,23,23 of 123,0.98,18.7,0.0001786,0.001455
GO:0040011,locomotion,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), ATP1A2 PSEN1,BP,2,2 of 196,0.08,1.02,0.0001802,0.001465
GO:0019725,cellular homeostasis,Q5E9M9(Evidence code:ISS/Database source:UniProtKB:Q8IXI1)Q2HJF8(Evidence code:ISS/Database source:UniProtKB:Q8IXI2), RHOT2 RHOT1,BP,2,2 of 198,0.08,1.01,0.0001816,0.001475
GO:0045111,intermediate filament cytoskeleton,Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)E1BC24(Evidence code:IEA/Database source:UniProtKB:Q9NU22|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:A0A024R9R7)A2VDU4(Evidence code:IEA/Database source:UniProtKB:F1D8P9|ens)A5PKK5(Evidence code:IEA/Database source:UniProtKB:P51531|ens)Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens), INA MDN1 INO80 NR1I2 SMARCA2 NSFL1C,CC,6,6 of 8,0.25,75,0.000184,0.001476
GO:0000060,"protein import into nucleus, translocation",F1MPE5(Evidence code:IBA/Database source:PANTHER:PTN000055427)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427), IPO5 MT3 IPO4 KPNB1 BCL3 TNPO1,BP,6,6 of 8,0.25,75,0.000184,0.001476
GO:0051721,protein phosphatase 2A binding,E1BFD1(Evidence code:IEA/Database source:InterPro:IPR035007)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens), ANKLE2 MASTL STRN4 DAB2IP STRN3 PTPA,MF,6,6 of 8,0.25,75,0.000184,0.001476
GO:0004693,cyclin-dependent protein serine/threonine kinase activity,P48734(Evidence code:IEA/Database source:EC:2.7.11.22)F1MN42(Evidence code:IBA/Database source:PANTHER:PTN001172753)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623091)E1BB52(Evidence code:IEA/Database source:EC:2.7.11.22)E1BB50(Evidence code:IEA/Database source:EC:2.7.11.22)E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788), CDK1 CDK17 CDK3 CDK13 CDK12 CDK6,MF,6,6 of 8,0.25,75,0.000184,0.001476
GO:0005832,chaperonin-containing T-complex,F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143755)Q3ZCI9(Evidence code:IDA/Database source:)Q2NKZ1(Evidence code:IDA/Database source:)Q32L40(Evidence code:IDA/Database source:)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens), CCT5 CCT6B CCT8 CCT7 TCP1 CCT3,CC,6,6 of 8,0.25,75,0.000184,0.001476
GO:0007369,gastrulation,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens), SOX17 SRF EXT1 ARID1A SYF2 CUL3,BP,6,6 of 8,0.25,75,0.000184,0.001476
GO:0030332,cyclin binding,A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1BB52(Evidence code:IEA/Database source:UniProtKB:Q14004|ens), CDK3 CUL3 CDK1 CDK12 CDK6 CDK13,MF,6,6 of 8,0.25,75,0.000184,0.001476
GO:0051568,histone H3-K4 methylation,E1BEP4(Evidence code:IEA/Database source:InterPro:IPR037353)F1MYZ3(Evidence code:IEA/Database source:GO:0042800)F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR037842)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569)F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569), ASH2L KMT2C SETD1B ASH1L KMT2B KMT2A,BP,6,6 of 8,0.25,75,0.000184,0.001476
GO:0051092,positive regulation of NF-kappaB transcription factor activity,F1MBS7(Evidence code:IEA/Database source:InterPro:IPR033540)P05126(Evidence code:ISS/Database source:UniProtKB:P68404)F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens)Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens), MALT1 PRKCB TRIM14 DHX9 PRKCI RPS6KA5 CAMK2A TRAF6 CIB1 CAT IKBKG,BP,11,11 of 35,0.47,31.43,0.0002067,0.001655
GO:0051087,chaperone binding,Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)A2VE51(Evidence code:IEA/Database source:InterPro:IPR003103|I)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q2KIT4(Evidence code:IEA/Database source:UniProtKB:Q9UDY4|ens)Q2TA08(Evidence code:IEA/Database source:InterPro:IPR003103|I)Q2HJ94(Evidence code:IEA/Database source:UniProtKB:O60884|ens)E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)A6QLM8(Evidence code:IEA/Database source:InterPro:IPR004640), DNAJB2 BAG3 ATP1A2 SYVN1 DNAJB4 BAG5 DNAJA2 USP13 HSCB,MF,9,9 of 23,0.38,39.13,0.0002069,0.001655
GO:0005667,transcription factor complex,Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BG94(Evidence code:IEA/Database source:InterPro:IPR003316)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1BE02(Evidence code:IEA/Database source:InterPro:IPR003316)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR003316|I)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens), LMO2 SNF8 E2F1 PKNOX1 MEIS1 E2F7 WWTR1 PRKDC LEF1 GATA6 POU3F1 SOX17 TFDP2 TCF7L2 CTBP1 ZFHX3,CC,16,16 of 70,0.68,22.86,0.0002088,0.001668
GO:0007219,Notch signaling pathway,Q9XT97(Evidence code:IEA/Database source:UniProtKB-KW:KW-0914)G3X812(Evidence code:IEA/Database source:InterPro:IPR008297|I)Q3ZBY8(Evidence code:ISS/Database source:UniProtKB:Q1LVF8)Q2NL18(Evidence code:IEA/Database source:UniProtKB-KW:KW-0914)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)A5D7F6(Evidence code:IEA/Database source:InterPro:IPR019082)F1MKY3(Evidence code:IEA/Database source:UniProtKB:G3UW60|ens), PSEN1 NOTCH4 GMDS HEYL ETV2 CDK6 MAML2 SUSD5,BP,8,8 of 18,0.34,44.44,0.0002347,0.001872
GO:0044183,protein binding involved in protein folding,Q3ZCI9(Evidence code:IBA/Database source:PANTHER:PTN000143677)A1A4P5(Evidence code:IBA/Database source:PANTHER:PTN000329566)Q32L40(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T0K2(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q2NKZ1(Evidence code:IBA/Database source:PANTHER:PTN000143677)F1MWD3(Evidence code:IBA/Database source:PANTHER:PTN000143677), CCT8 PFDN2 TCP1 CCT3 CCT6B CCT7 CCT5,MF,7,7 of 13,0.3,53.85,0.0002361,0.001877
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42225)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239), STAT1 PDCD6 F2R TNFSF15 AIFM1 EGLN3 LCK,BP,7,7 of 13,0.3,53.85,0.0002361,0.001877
GO:0071013,catalytic step 2 spliceosome,A2VDN6(Evidence code:IEA/Database source:UniProtKB:Q15459|ens)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)F1N607(Evidence code:IEA/Database source:UniProtKB:O95926|ens)Q29RZ2(Evidence code:IEA/Database source:UniProtKB:Q96BP3|ens)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)F1N543(Evidence code:IBA/Database source:PANTHER:PTN000336449)Q2KJC1(Evidence code:IEA/Database source:UniProtKB:Q99459|ens)F1MEM4(Evidence code:IEA/Database source:UniProtKB:Q14562|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens), SF3A1 SNRPN SYF2 PPWD1 SNRNP200 NRDE2 CDC5L DHX8 SRSF1 EIF4A3 PRPF8,CC,11,11 of 36,0.47,30.56,0.0002533,0.002011
GO:0000902,cell morphogenesis,E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)F1N643(Evidence code:IEA/Database source:InterPro:IPR030494)Q3T0T1(Evidence code:IEA/Database source:UniProtKB:O35955|ens)Q58DV1(Evidence code:IEA/Database source:InterPro:IPR016098)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604)E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens), TENM3 ECT2 ASXL1 SHROOM3 PSMB10 RP2 FRY FRYL TENM2 CUL3,BP,10,10 of 30,0.42,33.33,0.0002696,0.002107
GO:0016525,negative regulation of angiogenesis,A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)P05059(Evidence code:TAS/Database source:)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1BB77(Evidence code:IEA/Database source:InterPro:IPR030403)Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens), FOXO4 SEMA3E EMILIN1 PTPRM CHGA STAT1 TCF7L2 DAB2IP GPR4,BP,9,9 of 24,0.38,37.5,0.0002673,0.002107
GO:0031595,nuclear proteasome complex,P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q2KJ25(Evidence code:IBA/Database source:PANTHER:PTN000091582)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMC5 PSMC1 PSMC2 PSMD12 PSMC6,CC,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0006002,fructose 6-phosphate metabolic process,Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR022953)F1MZY2(Evidence code:IBA/Database source:PANTHER:PTN000101302)A1A4J1(Evidence code:IEA/Database source:InterPro:IPR022953)Q08DQ2(Evidence code:IBA/Database source:PANTHER:PTN000101302)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR022953), PFKM GFPT1 PFKL GFPT2 PFKP,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0060173,limb development,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens), RC3H2 RAX EN1 RNF165 CHD7,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0005869,dynactin complex,Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens)A5PKJ3(Evidence code:IEA/Database source:InterPro:IPR027663)A4IFE3(Evidence code:IEA/Database source:InterPro:IPR029909)Q3ZCF0(Evidence code:IEA/Database source:InterPro:IPR028133)F2Z4F0(Evidence code:IEA/Database source:InterPro:IPR029909), DCTN3 DCTN1 ACTR1B DCTN2 ACTR1A,CC,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0071300,cellular response to retinoic acid,F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q13308|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)Q5E9L2(Evidence code:IBA/Database source:PANTHER:PTN001036861)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens), PTK7 ABCA1 SETX BRINP1 YES1,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0045022,early endosome to late endosome transport,A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)F1MDR7(Evidence code:IBA/Database source:PANTHER:PTN001181218)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens), FAM160A2 SNF8 LMTK2 DNAJC13 PTPN23,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0012507,ER to Golgi transport vesicle membrane,Q3SZN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDL8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QNT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QM06(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SEC23B SEC23A SEC24A SEC13 SCAP,CC,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0035115,embryonic forelimb morphogenesis,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), TBX3 NIPBL EN1 RPGRIP1L SHOX2,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0046856,phosphatidylinositol dephosphorylation,F1MHB9(Evidence code:IEA/Database source:InterPro:IPR000300)E1BLB5(Evidence code:IEA/Database source:InterPro:IPR000300)E1BFE6(Evidence code:IEA/Database source:InterPro:IPR030587|I)O18964(Evidence code:IEA/Database source:InterPro:IPR000300|I)E1BB73(Evidence code:IEA/Database source:InterPro:IPR000300), INPP5A INPP5J MTMR1 SYNJ1 INPP5B,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0016242,negative regulation of macroautophagy,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens), PINK1 NPC1 LRRK2 POLDIP2 USP36,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0030010,establishment of cell polarity,A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR033624)A4IFF6(Evidence code:IEA/Database source:UniProtKB:Q9R0A5|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282), WEE1 MARK3 NEK3 SDCCAG8 RICTOR,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0035198,miRNA binding,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187)Q6T5B7(Evidence code:IEA/Database source:UniRule:UR000107558)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens), PUM1 AGO4 AGO3 PNPT1 ZCCHC6,MF,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0030742,GTP-dependent protein binding,P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)P10949(Evidence code:IEA/Database source:UniProtKB:P62823|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens), RAB3B RAB3C RAB3A UNC13B HPS6,MF,5,5 of 5,0.21,100,0.0002737,0.002107
GO:2000582,"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed",E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277824)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361), LOC101905447 DYNLL1 DYNC1I2 LOC101902172 DYNLL2,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0032212,positive regulation of telomere maintenance via telomerase,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)Q0VCK2(Evidence code:IEA/Database source:UniProtKB:Q9C010|ens)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)E1B8R5(Evidence code:IEA/Database source:InterPro:IPR028731), CCT3 MAP3K4 PKIB CCT5 TNKS,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0001569,branching involved in blood vessel morphogenesis,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens), SEMA3E GNA13 COL4A1 SRF LEF1,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0043531,ADP binding,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens)P58108(Evidence code:ISS/Database source:UniProtKB:P80385), MYO9B RUVBL1 MYO18A CHORDC1 PRKAG1,MF,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0004714,transmembrane receptor protein tyrosine kinase activity,F1N758(Evidence code:IEA/Database source:InterPro:IPR006211)F1MRU0(Evidence code:IEA/Database source:InterPro:IPR001824|I)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens)P43481(Evidence code:IEA/Database source:InterPro:IPR001824|I)Q95M13(Evidence code:IEA/Database source:EC:2.7.10.1), ERBB4 FLT3 EPHB4 KIT fgfr3,MF,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0071108,protein K48-linked deubiquitination,E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens)Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)G5E630(Evidence code:IEA/Database source:GO:1990380)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens), OTUD4 OTUB1 USP20 USP9X OTUD7B,BP,5,5 of 5,0.21,100,0.0002737,0.002107
GO:0031290,retinal ganglion cell axon guidance,E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens), PTPRM ALCAM SLIT2 POU4F2,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0009954,proximal/distal pattern formation,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), GLI1 DLX2 EN1 GLI2,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0010314,phosphatidylinositol-5-phosphate binding,A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492), LANCL2 SH3PXD2A PLEKHA5 SNX3,MF,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0097264,self proteolysis,F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)E1BIX3(Evidence code:IEA/Database source:UniProtKB:Q9Y6W3|ens)F1MEX4(Evidence code:IEA/Database source:InterPro:IPR022385)E1BMG7(Evidence code:IEA/Database source:InterPro:IPR022385), TMPRSS6 CAPN7 TENM2 TENM3,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0016018,cyclosporin A binding,Q29RZ2(Evidence code:ISS/Database source:UniProtKB:Q96BP3)A4FV72(Evidence code:ISS/Database source:UniProtKB:Q9UNP9)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens), PPWD1 PPIE PPID PPP3CA,MF,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0090543,Flemming body,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens), VPS4B ARF6 PDCD6IP KIF14,CC,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0008266,poly(U) RNA binding,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens), PNPT1 PABPC4 KHDRBS1 SSB,MF,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0045725,positive regulation of glycogen biosynthetic process,A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens), GCK IRS1 EPM2AIP1 DYRK2,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0045773,positive regulation of axon extension,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q3TXX3)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens), SRF ZFYVE27 POU4F2 GOLGA4,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0035068,micro-ribonucleoprotein complex,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3)F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187)Q6T5B7(Evidence code:IEA/Database source:UniRule:UR000107558), DHX9 DICER1 AGO4 AGO3,CC,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0006004,fucose metabolic process,Q0R340(Evidence code:IEA/Database source:UniProtKB-KW:KW-0294)F1N5H2(Evidence code:IEA/Database source:InterPro:IPR016286)Q2KIM0(Evidence code:IEA/Database source:InterPro:IPR016286)Q0P563(Evidence code:ISS/Database source:UniProtKB:Q8R2K1), pofut2 FUCA2 FUCA1 FUOM,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0017056,structural constituent of nuclear pore,F1MH31(Evidence code:IEA/Database source:UniProtKB:Q80U93|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens), NUP214 TPR POM121L2 NDC1,MF,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0036120,cellular response to platelet-derived growth factor stimulus,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q765P7|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens), HYAL1 SRC MTSS1L YES1,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0048208,COPII vesicle coating,A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)F6PW02(Evidence code:IEA/Database source:InterPro:IPR033512), PEF1 PDCD6 CUL3 TFG,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0048041,focal adhesion assembly,F1N6V1(Evidence code:IEA/Database source:UniProtKB:O54834|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens), ARHGAP6 TAOK2 PEAK1 FERMT2,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0002161,aminoacyl-tRNA editing activity,A6QLT9(Evidence code:IEA/Database source:UniProtKB:P49588|ens)E1B937(Evidence code:IEA/Database source:InterPro:IPR003732)A6QLR2(Evidence code:IEA/Database source:InterPro:IPR009008)A7MBC5(Evidence code:IEA/Database source:InterPro:IPR009008), AARS DTD2 LARS IARS,MF,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0003281,ventricular septum development,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens), SALL4 PTK7 FRS2 XIRP2,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0031954,positive regulation of protein autophosphorylation,E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000908679)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31), TNKS1BP1 PDGFC RAP2A RAP2C,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0010225,response to UV-C,E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens), BCL3 WRN BRCA2 MAP3K4,BP,4,4 of 2,0.17,200,0.0002864,0.002146
GO:0048286,lung alveolus development,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)P35246(Evidence code:ISS/Database source:UniProtKB:P35247)E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens), MAPK8IP3 PHF14 FOXF1 RC3H2 SFTPD MAN1A2,BP,6,6 of 9,0.25,66.67,0.0002889,0.002147
GO:0032007,negative regulation of TOR signaling,E1BB46(Evidence code:IEA/Database source:InterPro:IPR035455)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q8IWV8|ens)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR003913)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001107228), SH3BP4 UBR2 TSC2 GSK3A PDCD6 PREX1,BP,6,6 of 9,0.25,66.67,0.0002889,0.002147
GO:1903078,positive regulation of protein localization to plasma membrane,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens), PRNP ITGB1 CIB1 ARF6 DLG1 PRKCI,BP,6,6 of 9,0.25,66.67,0.0002889,0.002147
GO:0042734,presynaptic membrane,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)Q28146(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MCW8(Evidence code:IEA/Database source:UniProtKB:Q8BMF5|ens)E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001527784), SCRIB SNAP25 KCTD16 NRXN1 GRIK4 GRM7,CC,6,6 of 9,0.25,66.67,0.0002889,0.002147
GO:0048146,positive regulation of fibroblast proliferation,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)A4FV80(Evidence code:IEA/Database source:UniProtKB:Q8R089|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q9NRA1|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), SIRT6 CDK6 FBRS PDGFC E2F1 DHX9,BP,6,6 of 9,0.25,66.67,0.0002889,0.002147
GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789)Q32KW2(Evidence code:ISS/Database source:UniProtKB:Q04323)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4), FHIT UBXN1 GIPC1 BAG5 CCAR2 RPL11,BP,6,6 of 9,0.25,66.67,0.0002889,0.002147
GO:0043022,ribosome binding,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)Q32KZ1(Evidence code:IBA/Database source:PANTHER:PTN000101471)Q9TU47(Evidence code:IEA/Database source:InterPro:IPR002769)Q0VCA3(Evidence code:IEA/Database source:InterPro:IPR033122)P68102(Evidence code:ISS/Database source:UniProtKB:P05198)Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173)F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I)Q3T0V3(Evidence code:IEA/Database source:InterPro:IPR016020), RICTOR MTIF3 EIF6 LETM1 EIF2S1 GCN1L1 EIF5A2 EIF3K,MF,8,8 of 19,0.34,42.11,0.0003137,0.002319
GO:0006909,phagocytosis,A6H7I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)P32592(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)O77775(Evidence code:IEA/Database source:InterPro:IPR034889)A4FUD6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)P61625(Evidence code:IEA/Database source:UniProtKB-KW:KW-0581)P67827(Evidence code:IBA/Database source:PANTHER:PTN000225967), DNM2 CDC42SE2 ABL1 ITGB2 NCF2 ELMO2 ITGAL CSNK1A1,BP,8,8 of 19,0.34,42.11,0.0003137,0.002319
GO:0019882,antigen processing and presentation,F1N3I2(Evidence code:IEA/Database source:InterPro:IPR010579)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I)Q3T112(Evidence code:IEA/Database source:UniProtKB:P28063|ens)P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)A8E4P0(Evidence code:IEA/Database source:InterPro:IPR010579)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P20338|ens)A7YWH4(Evidence code:IEA/Database source:InterPro:IPR010579), LOC788634 RAB3B LOC100848815 PSMB8 RAB3C LOC100125916 RAB4A BoLA,BP,8,8 of 19,0.34,42.11,0.0003137,0.002319
GO:0005884,actin filament,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)P68138(Evidence code:ISS/Database source:UniProtKB:P68133), MYO9B SH2B2 KEAP1 APC2 SRC YES1 CTTN ACTA1,CC,8,8 of 19,0.34,42.11,0.0003137,0.002319
GO:0042552,myelination,Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512260)Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512260)F1N5T9(Evidence code:IEA/Database source:InterPro:IPR029555), TSPAN2 POU3F1 EIF2B5 MAL2 NAB2 PLLP SERINC5,BP,7,7 of 14,0.3,50,0.0003333,0.00246
GO:0006906,vesicle fusion,A6QQP7(Evidence code:ISS/Database source:UniProtKB:Q9ESD7)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001285)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)P63026(Evidence code:IMP/Database source:)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001285)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349), DYSF SYT6 SYTL2 SYTL1 VAMP3 VAMP2 SYT4 VAMP1 VAMP5 STX7,BP,10,10 of 31,0.42,32.26,0.0003349,0.002469
GO:0006486,protein glycosylation,Q5EA65(Evidence code:IEA/Database source:UniPathway:UPA00378)Q3SZI0(Evidence code:IBA/Database source:PANTHER:PTN000034017)E1BCH6(Evidence code:IEA/Database source:UniPathway:UPA00378)F1N4Q3(Evidence code:IEA/Database source:UniPathway:UPA00378)Q2HJA3(Evidence code:IEA/Database source:InterPro:IPR002659)Q5E9I4(Evidence code:IEA/Database source:InterPro:IPR004139)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q3ZC71(Evidence code:IEA/Database source:InterPro:IPR013174)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q5E9C2(Evidence code:ISS/Database source:UniProtKB:E2R4X3)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR004263)F1MSL9(Evidence code:IEA/Database source:InterPro:IPR009448)E1BB48(Evidence code:IEA/Database source:UniPathway:UPA00378)Q5EAB6(Evidence code:IEA/Database source:InterPro:IPR004139)F1MX31(Evidence code:IEA/Database source:InterPro:IPR001675|I), DPAGT1 MPI ISPD GALNT7 B3GALT4 MGAT1 NPC1 DPM3 PSEN1 DAD1 EXT1 UGGT2 GALNT2 POMGNT1 ST8SIA3,BP,15,15 of 66,0.64,22.73,0.0003422,0.002518
GO:0016071,mRNA metabolic process,Q3SZK4(Evidence code:ISS/Database source:UniProtKB:Q969Z0),TBRG4,BP,1,1 of 160,0.04,0.62,0.0003762,0.002765
GO:0008201,heparin binding,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)P43033(Evidence code:IDA/Database source:)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q5TAT6|ens)F1MJQ6(Evidence code:IEA/Database source:UniProtKB:Q9JLI2|ens)F1N226(Evidence code:IEA/Database source:InterPro:IPR015849|I)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)Q9GKN8(Evidence code:IBA/Database source:PANTHER:PTN000689792)G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q1RMW2(Evidence code:IDA/Database source:)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens), SLIT2 PAFAH1B1 PCSK6 COL13A1 COL5A3 APLP2 FGF1 PRELP HIST1H1A RTN4R TMEM184A NDNF NAV2,MF,13,13 of 52,0.55,25,0.000383,0.002811
GO:0022625,cytosolic large ribosomal subunit,Q32PB9(Evidence code:IBA/Database source:PANTHER:PTN000103359)Q58DW0(Evidence code:IBA/Database source:PANTHER:PTN000454620)P61356(Evidence code:IBA/Database source:PANTHER:PTN000052145)Q3T0S6(Evidence code:IBA/Database source:PANTHER:PTN000343558)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q24JY1(Evidence code:IBA/Database source:PANTHER:PTN000178698)Q3T087(Evidence code:IBA/Database source:PANTHER:PTN000242048)Q3T0L7(Evidence code:IBA/Database source:PANTHER:PTN000057380)F1N301(Evidence code:IBA/Database source:PANTHER:PTN000007073)Q3SYR7(Evidence code:IBA/Database source:PANTHER:PTN000183647)Q56JY1(Evidence code:IBA/Database source:PANTHER:PTN000096770)Q3T057(Evidence code:IBA/Database source:PANTHER:PTN000205184), RPL38 RPL4 RPL27 RPL8 RPL30 RPL23A RPL11 RPL28 RPL22 RPL9 RPL35A RPL23,CC,12,12 of 45,0.51,26.67,0.0003873,0.002839
GO:0008283,cell proliferation,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)E1BB54(Evidence code:IEA/Database source:UniProtKB:Q5W0Q7|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)Q1RMW4(Evidence code:IEA/Database source:UniProtKB:Q8NEU8|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)E1BPA9(Evidence code:IEA/Database source:UniProtKB:Q9H190|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)G3N0W8(Evidence code:IEA/Database source:InterPro:IPR030499)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN001016925)F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens), GOLPH3 SCRIB PRKDC DCTN2 COPS2 GNAT1 CUL1 GLI2 USPL1 BRCA2 USP13 AXIN2 APPL2 APPL1 UBE2L3 SDCBP2 PTPN6 CDK1 PTGES3 PURB TACC1 CSPG4,BP,22,22 of 124,0.93,17.74,0.0004139,0.003013
GO:0015991,ATP hydrolysis coupled proton transport,P31407(Evidence code:IEA/Database source:InterPro:IPR005723)O46563(Evidence code:IEA/Database source:InterPro:IPR004908|I)P31408(Evidence code:IEA/Database source:InterPro:IPR005723)P61420(Evidence code:IEA/Database source:InterPro:IPR016727)P31404(Evidence code:IEA/Database source:InterPro:IPR005725)P21282(Evidence code:IEA/Database source:InterPro:IPR004907|I)P11019(Evidence code:IEA/Database source:InterPro:IPR002842)P23956(Evidence code:IEA/Database source:InterPro:IPR000245|I), ATP6V1B1 ATP6V1H ATP6V1B2 ATP6V0D1 ATP6V1A ATP6V1C1 ATP6V1E1 ATP6V0C,BP,8,8 of 20,0.34,40,0.0004131,0.003013
GO:0002181,cytoplasmic translation,A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q58DW0(Evidence code:IBA/Database source:PANTHER:PTN000454620)Q56JY1(Evidence code:IBA/Database source:PANTHER:PTN000096770)Q56JX6(Evidence code:ISS/Database source:UniProtKB:P62857)Q3T0S6(Evidence code:IBA/Database source:PANTHER:PTN000343556)Q3SYR7(Evidence code:IBA/Database source:PANTHER:PTN000183645)F1N301(Evidence code:IBA/Database source:PANTHER:PTN000007073), RPS7 RPL30 RPL4 RPL35A RPS28 RPL8 RPL9 RPL22,BP,8,8 of 20,0.34,40,0.0004131,0.003013
GO:0030175,filopodium,Q5EAD0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)P68138(Evidence code:ISS/Database source:UniProtKB:P08023)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens), BAIAP2 TWF1 PALM UTRN NF2 IQGAP2 ACTA1 FAT1,CC,8,8 of 20,0.34,40,0.0004131,0.003013
GO:0009967,positive regulation of signal transduction,F1N6C4(Evidence code:IEA/Database source:GO:0035591)Q58DL5(Evidence code:IEA/Database source:GO:0005070)Q6U8D5(Evidence code:IEA/Database source:GO:0005070)Q3T0F9(Evidence code:IEA/Database source:GO:0005070)Q29RQ2(Evidence code:IEA/Database source:GO:0005070)F1MRH8(Evidence code:IEA/Database source:GO:0005070)E1BQ32(Evidence code:IEA/Database source:GO:0005070), EPS8 BCAR3 Grb10 GRB2 KHDRBS1 SH2B2 CRK,BP,7,7 of 308,0.3,2.27,0.0004132,0.003013
GO:0007601,visual perception,E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157)Q7YRX0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844)P22571(Evidence code:IEA/Database source:InterPro:IPR006952|I)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)Q8WN91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844)G3MXA9(Evidence code:IEA/Database source:InterPro:IPR032943)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)F1MR98(Evidence code:IEA/Database source:InterPro:IPR002962|I)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)P47803(Evidence code:IEA/Database source:InterPro:IPR001793)P04695(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844)E1B9D3(Evidence code:IEA/Database source:InterPro:IPR032964)P12661(Evidence code:IEA/Database source:InterPro:IPR032956)P04696(Evidence code:IEA/Database source:UniProtKB-KW:KW-0844), CACNA1F RAX2 PDE6H LAMC3 CDHR1 CNGB3 COL2A1 RRH LAMB2 RGR GNAT1 GPR179 RBP3 GNAT2,BP,14,14 of 60,0.59,23.33,0.0004238,0.003081
GO:0071310,cellular response to organic substance,F1MT17(Evidence code:IEA/Database source:UniProtKB:P70298|ens)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622311)F1MVV5(Evidence code:IBA/Database source:PANTHER:PTN000622282)P46196(Evidence code:IBA/Database source:PANTHER:PTN000622282), CUX2 MAPK9 MAPK4 MAPK1,BP,4,4 of 238,0.17,1.68,0.000427,0.003101
GO:0010008,endosome membrane,F1MD79(Evidence code:IEA/Database source:UniProtKB:Q810B6|ens)Q1RMW4(Evidence code:IEA/Database source:UniProtKB:Q8NEU8|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)A3KN15(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)Q5E9A6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)E1BAI0(Evidence code:IBA/Database source:PANTHER:PTN000636003)Q3T0P7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q32L63(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0M0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD53(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05204(Evidence code:ISS/Database source:UniProtKB:P05300)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens), ANKFY1 APPL2 SNX3 DNAJC13 TFRC VPS41 TPCN2 RFFL VPS25 CHMP6 RAB23 ITM2B SNF8 APPL1 VTA1 VPS29 VPS26A LAMP1 VPS35 VPS4B,CC,20,20 of 104,0.85,19.23,0.0004315,0.003129
GO:0048666,neuron development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622286)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622286)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens), GLI2 MAPK9 MAPK10 EN1 PSEN1 GABRA5 TENM3 TENM2 NR2F6,BP,9,9 of 26,0.38,34.62,0.0004322,0.003129
GO:0031338,regulation of vesicle fusion,F1N746(Evidence code:IBA/Database source:PANTHER:PTN000537561)A6QP29(Evidence code:IBA/Database source:PANTHER:PTN000537561)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000537561)A5PJP0(Evidence code:IBA/Database source:PANTHER:PTN000537561)G3MXN3(Evidence code:IBA/Database source:PANTHER:PTN000537561)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens), RABGAP1 TBC1D2 TBC1D12 TBC1D22B SGSM2 SYT4,BP,6,6 of 10,0.25,60,0.0004357,0.003129
GO:0060041,retina development in camera-type eye,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934), AGTPBP1 LAMB2 CHD7 LAMC3 GNAT1 POU4F2,BP,6,6 of 10,0.25,60,0.0004357,0.003129
GO:0007628,adult walking behavior,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), CHD7 SPTBN4 KCNMA1 AGTPBP1 ABHD12 NPC1,BP,6,6 of 10,0.25,60,0.0004357,0.003129
GO:0002102,podosome,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens)O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q28046(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CTTN SRC SH3GL1 SH3PXD2A SVIL SCIN,CC,6,6 of 10,0.25,60,0.0004357,0.003129
GO:0036126,sperm flagellum,Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462268)Q5EA42(Evidence code:IEA/Database source:UniProtKB:P08910|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132)D3K0R6(Evidence code:ISS/Database source:UniProtKB:Q6Q477)E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens), TEKT4 ABHD2 CUL3 PRKACA ATP2B4 MROH2B,CC,6,6 of 10,0.25,60,0.0004357,0.003129
GO:0001889,liver development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)O02754(Evidence code:ISS/Database source:UniProtKB:P53566), RPGRIP1L ARF6 TAF10 GATA6 ONECUT2 CEBPA,BP,6,6 of 10,0.25,60,0.0004357,0.003129
GO:0043130,ubiquitin binding,Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596256)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)A5PK00(Evidence code:IEA/Database source:InterPro:IPR021648|I)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326), NSFL1C SIRT2 NEDD4 MVB12A UBXN1 MARCH7 DNAJB2 USP13 VPS36 TSG101 OTUB1,MF,11,11 of 39,0.47,28.21,0.0004494,0.003224
GO:0006730,one-carbon metabolic process,Q5I598(Evidence code:IBA/Database source:PANTHER:PTN000472667)A6QLP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0554)E1BDG9(Evidence code:IEA/Database source:InterPro:IPR011407)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0554)A7YY67(Evidence code:IEA/Database source:InterPro:IPR011407)A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens), MTHFR AHCYL2 ALDH1L2 SHMT2 DHFR ALDH1L1 MTHFD1,BP,7,7 of 15,0.3,46.67,0.0004601,0.003283
GO:0030509,BMP signaling pathway,Q00KA9(Evidence code:IEA/Database source:InterPro:IPR030799)E1BCY1(Evidence code:IEA/Database source:UniProtKB:A6ND36|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens), LRP4 FAM83G USP9X PDCD4 HFE2 LEF1 MEGF8,BP,7,7 of 15,0.3,46.67,0.0004601,0.003283
GO:0032922,circadian regulation of gene expression,E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)F1MZY2(Evidence code:IEA/Database source:UniProtKB:P47856|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)P61287(Evidence code:ISS/Database source:UniProtKB:P63087)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), RAI1 PPP1CB GFPT1 PRMT5 LGR4 PPP1CC KMT2A,BP,7,7 of 15,0.3,46.67,0.0004601,0.003283
GO:0004177,aminopeptidase activity,Q3ZC89(Evidence code:IEA/Database source:InterPro:IPR002468)Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960)E1BP91(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031)Q2HJH1(Evidence code:IEA/Database source:InterPro:IPR001948|I)P81425(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031)G3X743(Evidence code:IEA/Database source:InterPro:IPR015571)Q1JPJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0031), METAP2 LTA4H NPEPPS DNPEP DPP4 RNPEP XPNPEP1,MF,7,7 of 15,0.3,46.67,0.0004601,0.003283
GO:0005681,spliceosomal complex,E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)A7Z025(Evidence code:IEA/Database source:InterPro:IPR027652)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)E1BN14(Evidence code:IEA/Database source:UniProtKB:Q92917|ens)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0747)A4FUI2(Evidence code:IEA/Database source:InterPro:IPR027078)F1MEM4(Evidence code:IBA/Database source:PANTHER:PTN000433761), SNRNP200 PRPF8 PABPC1 SRSF1 GPKOW LSM4 PPWD1 EFTUD2 EIF4A3 CCAR2 SF3A1 CDC5L SNRNP70 PPIE SNRPE DHX8,CC,16,16 of 76,0.68,21.05,0.0004616,0.003289
GO:0014002,astrocyte development,Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), TSPAN2 LAMC3 EIF2B5 LAMB2 MT3,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:2000300,regulation of synaptic vesicle exocytosis,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens), GIPC1 RIMS1 PRKCB LRRK2 BACE1,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:0061098,positive regulation of protein tyrosine kinase activity,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)G3MZE2(Evidence code:IEA/Database source:GO:0030296)Q0VCW2(Evidence code:IEA/Database source:GO:0030296)Q17R10(Evidence code:IEA/Database source:GO:0030296), PRNP HSPH1 PAK2 ABI1 AFAP1L2,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:0071404,cellular response to low-density lipoprotein particle stimulus,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P09055)P32592(Evidence code:ISS/Database source:UniProtKB:P11835)Q9BDR7(Evidence code:ISS/Database source:UniProtKB:P20491)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens), ABCA1 ITGB1 ITGB2 FCER1G NPC1,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:0048839,inner ear development,Q32LM6(Evidence code:IEA/Database source:UniProtKB:Q8JZS0|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851), LIN7A C1QTNF5 FREM2 COL2A1 fgfr3,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:0030316,osteoclast differentiation,A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens)A4FUZ1(Evidence code:IEA/Database source:UniProtKB:Q9CPU0|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens), SBNO2 GLO1 FCER1G TRAF6 TFRC,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:1902188,positive regulation of viral release from host cell,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens), TSG101 CHMP2A CHMP4B VPS4B CHMP2B,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:0043588,skin development,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:P05997|ens)F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens), PTGES3 BCL11B RYR1 COL5A2 FRAS1,BP,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:0030552,cAMP binding,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)E1BM97(Evidence code:IEA/Database source:InterPro:IPR030169)P00515(Evidence code:IEA/Database source:UniProtKB-KW:KW-0116), RAPGEF2 RAPGEF4 PDE4D HCN1 PRKAR2A,MF,5,5 of 6,0.21,83.33,0.0004736,0.003334
GO:0008380,RNA splicing,E1BB50(Evidence code:ISS/Database source:UniProtKB:Q3MJK5)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q29RZ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q0II50(Evidence code:ISS/Database source:UniProtKB:Q9BQ65)Q3T022(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q2KJC1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A2VDN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A4FUI2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q5E959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A4FV72(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q08E07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)E1B9H3(Evidence code:IEA/Database source:InterPro:IPR028811)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)E1BB52(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)Q3ZBK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)E1BJV5(Evidence code:IEA/Database source:InterPro:IPR033096)A4FUD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0508)A7E3C9(Evidence code:IEA/Database source:InterPro:IPR034585), CDK12 DHX9 PPWD1 USB1 SAP18 CDC5L SF3A1 SRSF1 SNRPE STRAP PPIE PABPC1 CELF3 CCAR2 EIF4A3 CDK13 LSM4 ZNF638 EFTUD2 RP9,BP,20,20 of 106,0.85,18.87,0.0004782,0.003363
GO:0005789,endoplasmic reticulum membrane,Q3T0T7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32PA9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q8WN96(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BM29(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZN2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225)Q8MII5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QNT8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5EA65(Evidence code:ISS/Database source:UniProtKB:P24140)Q9TU34(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VE53(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZU5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q95JH2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P67810(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPZ8(Evidence code:IBA/Database source:PANTHER:PTN000552915)A2VDL8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6Y1E2(Evidence code:IBA/Database source:PANTHER:PTN000512431)Q3SZ26(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9F1(Evidence code:IBA/Database source:PANTHER:PTN000294723)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A4FUW8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9C2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BM45(Evidence code:IEA/Database source:InterPro:IPR007070|I)Q2YDF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3T0A9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5BIM5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256598)P35071(Evidence code:ISS/Database source:UniProtKB:P13569)A5D7I4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9XT97(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZC71(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q29RN8(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SAR1B FKBP2 ITPR2 CYP7A1 SEC23B ATF6B SRI SCAP SLC35B1 PIGK SEC24A DPAGT1 ITPR1 IKBIP SPCS3 AGPAT1 SEC11A PIGO SEC23A PLP2 WRB BCAP31 SEC13 TXNDC11 DAD1 PIGN JSRP1 SHISA5 ZFYVE27 LPIN2 CFTR EXT1 PSEN1 DPM3 SEZ6L2,CC,35,35 of 244,1.49,14.34,0.0004865,0.003417
GO:0032880,regulation of protein localization,Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), RAB9A AAK1 PRNP,BP,3,3 of 211,0.13,1.42,0.0005052,0.003543
GO:0061024,membrane organization,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens), CLN3 MTSS1L,BP,2,2 of 179,0.08,1.12,0.0005299,0.003711
GO:0006518,peptide metabolic process,E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084)Q2HJH1(Evidence code:IBA/Database source:PANTHER:PTN002004858), CPXM2 DNPEP,BP,2,2 of 181,0.08,1.1,0.0005384,0.003766
GO:0051046,regulation of secretion,E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens),MYO6,BP,1,1 of 154,0.04,0.65,0.0005454,0.00381
GO:0051607,defense response to virus,E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)E1B7G0(Evidence code:IEA/Database source:UniProtKB:Q8CGK5|ens)A4FUZ5(Evidence code:ISS/Database source:UniProtKB:Q13530)G3N183(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)Q8MJ29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0051), MB21D1 SAMHD1 LOC516599 IRF1 IFNLR1 SERINC3 LOC104968438 SERINC5 IFNT2 IFNT3 IFNT DDX58 MAP3K14 MX2,BP,14,14 of 62,0.59,22.58,0.0005617,0.003919
GO:0000785,chromatin,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)F1MM81(Evidence code:IBA/Database source:PANTHER:PTN000968522)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q80W00|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BC56(Evidence code:IEA/Database source:InterPro:IPR000079)E1BLK1(Evidence code:IBA/Database source:PANTHER:PTN000968522)E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens), UBR2 AHCTF1 BAHCC1 COPS5 CHMP2A PPP1R10 NEDD4 SFPQ PINK1 LOC785479 TNRC18 KDM3B ANKRD17 CAPN2 NIPBL,CC,15,15 of 70,0.64,21.43,0.0005838,0.004067
GO:0071897,DNA biosynthetic process,E1BMC0(Evidence code:IEA/Database source:GO:0003887)P06526(Evidence code:IEA/Database source:GO:0003887)P84798(Evidence code:IEA/Database source:GO:0003887)A6QQ14(Evidence code:IEA/Database source:GO:0003887)E1BJF4(Evidence code:IEA/Database source:GO:0003887)A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977)E1BDI3(Evidence code:IEA/Database source:GO:0003887), POLQ DNTT POLD3 POLE4 POLA1 LIG1 POLG,BP,7,7 of 16,0.3,43.75,0.0006227,0.004239
GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)F1MBL6(Evidence code:IEA/Database source:InterPro:IPR031559|I)A1A4J7(Evidence code:IEA/Database source:InterPro:IPR019354|I)Q0VCX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0866)P61286(Evidence code:IEA/Database source:UniProtKB-KW:KW-0866)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0866)Q2YDD2(Evidence code:IEA/Database source:InterPro:IPR019354|I), SMG6 SMG1 SMG8 ETF1 PABPC1 EIF4A3 SMG9,BP,7,7 of 16,0.3,43.75,0.0006227,0.004239
GO:0032869,cellular response to insulin stimulus,F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)Q1JPG7(Evidence code:IBA/Database source:PANTHER:PTN000212861)B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0)A6QLN6(Evidence code:IDA/Database source:)G3X6L9(Evidence code:IEA/Database source:UniProtKB:Q8CGC7|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens), PRKCI IRS1 PKLR STAT1 MYH11 EPRS PRKDC,BP,7,7 of 16,0.3,43.75,0.0006227,0.004239
GO:0030218,erythrocyte differentiation,Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000048336)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624), PKNOX1 CASP3 RPS19 KIT ETV2 HSPA9 JAK2,BP,7,7 of 16,0.3,43.75,0.0006227,0.004239
GO:0071456,cellular response to hypoxia,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)E1BP91(Evidence code:IEA/Database source:UniProtKB:P55786|ens)P37359(Evidence code:IEA/Database source:UniProtKB:P25713|ens), GATA6 UBQLN1 SIRT2 NDNF PINK1 NPEPPS MT3,BP,7,7 of 16,0.3,43.75,0.0006227,0.004239
GO:0015914,phospholipid transport,F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539)C3VEX2(Evidence code:IEA/Database source:InterPro:IPR001666)Q17QL5(Evidence code:IEA/Database source:InterPro:IPR030351)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539|I)P55156(Evidence code:ISS/Database source:UniProtKB:P55157)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)Q2HJ54(Evidence code:IEA/Database source:InterPro:IPR001666), ATP11A PITPNM2 TMEM30A ATP8B1 MTTP TNFAIP8L3 PITPNA,BP,7,7 of 16,0.3,43.75,0.0006227,0.004239
GO:0008306,associative learning,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), DBH SRF SNAP25 SHANK1 GABRA5 CLN3,BP,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0030864,cortical actin cytoskeleton,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q5E9D5(Evidence code:ISS/Database source:UniProtKB:Q9R0P5)A6QPG6(Evidence code:IEA/Database source:UniProtKB:Q9NS86|ens), MTSS1L MYO1A NF2 FLOT1 DSTN LANCL2,CC,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0018024,histone-lysine N-methyltransferase activity,E1BGA4(Evidence code:IEA/Database source:InterPro:IPR006560)E1BNH7(Evidence code:IEA/Database source:InterPro:IPR006560)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR021169|I)F1N413(Evidence code:IEA/Database source:InterPro:IPR007728|I)F1MHA1(Evidence code:IEA/Database source:EC:2.1.1.43)F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR037842), ASH1L WHSC1L1 DOT1L EHMT2 KMT2A SETD1B,MF,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0003678,DNA helicase activity,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR010339)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR010339)Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR008047)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), WRN RUVBL2 RUVBL1 MCM4 CHD8 BLM,MF,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0035914,skeletal muscle cell differentiation,G3X736(Evidence code:IEA/Database source:UniProtKB:P61202|ens)F1MBK6(Evidence code:IEA/Database source:UniProtKB:A2A884|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens), COPS2 HIVEP3 BCL9L MYF5 MYLK2 BCL9,BP,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0031297,replication fork processing,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1N2G1(Evidence code:IEA/Database source:UniProtKB:Q8NFC6|ens)Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR030101), WRN BLM BOD1L1 ETAA1 ATRX SMARCAL1,BP,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0071949,FAD binding,G3MWR8(Evidence code:IEA/Database source:InterPro:IPR002938)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)E1BL62(Evidence code:IEA/Database source:InterPro:IPR016166)F1MF74(Evidence code:IEA/Database source:InterPro:IPR002938)Q148K4(Evidence code:IEA/Database source:InterPro:IPR016166)P48034(Evidence code:IEA/Database source:InterPro:IPR016166), MICAL3 AIFM1 AOX4 MICAL2 LDHD AOX1,MF,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:Q9WTX5)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens), RBX1 LOC780968 WWTR1 SKP1 KIF14 CUL1,BP,6,6 of 11,0.25,54.55,0.0006345,0.004239
GO:0080182,histone H3-K4 trimethylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:O43151|ens), KMT2A HIST1H1D KMT2B TET3,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0097016,L27 domain binding,Q32LM6(Evidence code:IEA/Database source:UniProtKB:O14910|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN000362480)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens), LIN7A DLG1 LIN7B LIN7C,MF,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0007250,activation of NF-kappaB-inducing kinase activity,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens)A4FV74(Evidence code:IEA/Database source:UniProtKB:Q99627|ens), TRAF6 MALT1 TNFSF15 COPS8,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0043328,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,Q3T178(Evidence code:IBA/Database source:PANTHER:PTN000309785)Q08DR7(Evidence code:IEA/Database source:UniRule:UR000342799)Q5E9A6(Evidence code:IBA/Database source:PANTHER:PTN000322234)A5PK00(Evidence code:IBA/Database source:PANTHER:PTN000319648), VPS28 SNF8 VPS25 VPS36,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0097320,plasma membrane tubulation,E1BK71(Evidence code:IEA/Database source:InterPro:IPR028523)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q1RMR9(Evidence code:IEA/Database source:InterPro:IPR028521|I)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens), PACSIN3 CHMP4A PACSIN2 SNX33,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0032794,GTPase activating protein binding,E1B718(Evidence code:IEA/Database source:UniProtKB:Q6ZPF4|ens)F1MGX4(Evidence code:IEA/Database source:UniProtKB:O95466|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens), FMNL3 FMNL1 PIN1 RGS14,MF,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0051393,alpha-actinin binding,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens), CACNA1D ALMS1 XIRP2 MAGI1,MF,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0090161,Golgi ribbon formation,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens), GCC2 PRMT5 MYO18A GOLPH3,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0071546,pi-body,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens), PIWIL2 DDX4 TDRD5 TDRD1,CC,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0016082,synaptic vesicle priming,F1MK99(Evidence code:IEA/Database source:InterPro:IPR027082)Q17QQ3(Evidence code:IBA/Database source:PANTHER:PTN000447754)F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens), UNC13A SNAP25 CADPS UNC13B,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0048013,ephrin receptor signaling pathway,F1MQH2(Evidence code:IEA/Database source:GO:0005003)F1MXV4(Evidence code:IEA/Database source:UniProtKB:Q8C0T5|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1BIE4(Evidence code:IEA/Database source:UniProtKB:P54760|ens), EPHA6 SIPA1L1 CRK EPHB4,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0017160,Ral GTPase binding,A6QLD1(Evidence code:IEA/Database source:UniProtKB:Q96A65|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q96KP1|ens), EXOC4 EXOC8 MYO1C EXOC2,MF,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0042789,mRNA transcription by RNA polymerase II,Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), C5AR1 SOX17 LMO2 SRF,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0042405,nuclear inclusion body,Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q28165(Evidence code:ISS/Database source:UniProtKB:Q86U42)E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792), RAD18 PABPN1 TPR RANBP2,CC,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0051019,mitogen-activated protein kinase binding,Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN001553005)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens), MAPKAPK3 ABL1 TPR PPM1D,MF,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0006622,protein targeting to lysosome,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), GCC2 NEDD4 LARS SORL1,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0031468,nuclear envelope reassembly,Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257), CHMP4B SPAST CHMP2A NSFL1C,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0006189,de novo IMP biosynthetic process,Q59A32(Evidence code:IEA/Database source:InterPro:IPR004607|I)Q2HJ26(Evidence code:IEA/Database source:InterPro:IPR000031|I)A3KN12(Evidence code:IEA/Database source:UniPathway:UPA00074)Q0VCK0(Evidence code:IEA/Database source:UniPathway:UPA00074), GART PAICS ADSL ATIC,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0042267,natural killer cell mediated cytotoxicity,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)F1N4S4(Evidence code:IBA/Database source:PANTHER:PTN000422481)A6QQ36(Evidence code:IBA/Database source:PANTHER:PTN000422481)Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698), PTPN6 ULBP11 LOC100850276 LYST,BP,4,4 of 3,0.17,133.33,0.0006321,0.004239
GO:0030335,positive regulation of cell migration,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q9HBX8|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)E1B9K4(Evidence code:IBA/Database source:PANTHER:PTN000539684)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BBQ3(Evidence code:IEA/Database source:UniProtKB:Q7TT37|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)Q32PI9(Evidence code:IEA/Database source:UniProtKB:Q3TEW6|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)E1BE66(Evidence code:IEA/Database source:UniProtKB:O00329|ens)Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)G5E526(Evidence code:IEA/Database source:UniProtKB:Q63739|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens), MYO1C LAMB1 PDGFC LGR6 CIB1 HMCN2 F2R PDCD10 FOXF1 IKBKAP LEF1 PAK1 MPZL1 ONECUT2 PIK3CD CXCL12 FGF1 PTP4A1 PPP3CA,BP,19,19 of 100,0.81,19,0.0006628,0.004422
GO:0005254,chloride channel activity,E1BAI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)E1BF90(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)P35071(Evidence code:IEA/Database source:InterPro:IPR009147)Q6BBL6(Evidence code:ISS/Database source:UniProtKB:O35054)F1N1D4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q9XSA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q5E9B7(Evidence code:IEA/Database source:InterPro:IPR030259)Q1LZF8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869)Q08E50(Evidence code:IEA/Database source:UniProtKB-KW:KW-0869), CLIC6 BEST3 CFTR CLDN4 TTYH3 CLIC4 CLIC1 CLCC1 GABRA5,MF,9,9 of 28,0.38,32.14,0.0006728,0.004483
GO:0007010,cytoskeleton organization,F2Z4C1(Evidence code:IEA/Database source:GO:0005200)G3MZC7(Evidence code:IEA/Database source:UniProtKB:O75400|ens)Q2HJB8(Evidence code:IEA/Database source:GO:0005200)A4FUD6(Evidence code:IEA/Database source:InterPro:IPR030713)E1BIK9(Evidence code:IEA/Database source:UniProtKB:Q9ULQ0|ens)E1BDP6(Evidence code:IEA/Database source:InterPro:IPR003128|I)G3N135(Evidence code:IEA/Database source:InterPro:IPR027656)P81948(Evidence code:IEA/Database source:GO:0005200)F1MHR5(Evidence code:IEA/Database source:UniProtKB:Q5VZL5|ens)F1MNF8(Evidence code:IEA/Database source:GO:0005200)Q2HJ86(Evidence code:IEA/Database source:GO:0005200)Q2T9S0(Evidence code:IEA/Database source:GO:0005200)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens)F1MGX4(Evidence code:IEA/Database source:InterPro:IPR027657)E1BLT3(Evidence code:IEA/Database source:GO:0005200)F1MF74(Evidence code:ISS/Database source:UniProtKB:O94851)F6RP72(Evidence code:IEA/Database source:GO:0005200)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN001364370)E1B718(Evidence code:IEA/Database source:InterPro:IPR027655)Q3ZBU7(Evidence code:IEA/Database source:GO:0005200)E1B953(Evidence code:IEA/Database source:GO:0005200)O46385(Evidence code:IEA/Database source:InterPro:IPR003128|I)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)F2Z4K0(Evidence code:IEA/Database source:GO:0005200)O02675(Evidence code:IEA/Database source:InterPro:IPR030615)F1MKE9(Evidence code:IEA/Database source:GO:0005200), TUBA1A PRPF40A TUBA8 ELMO2 STRIP2 VILL FMNL2 TUBA4A ZMYM4 LOC100141266 TUBA1D TUBB3 SYNE3 FMNL1 SPTBN4 MICAL2 LOC100295712 PALM ZMYM5 FMNL3 TUBB4A LOC533307 SVIL MICAL3 TUBA3E DPYSL2 SPTB,BP,27,27 of 174,1.15,15.52,0.000675,0.004493
GO:0000784,"nuclear chromosome, telomeric region",Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR017357)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)P61287(Evidence code:IEA/Database source:UniProtKB:P36873|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q96QC0|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR017357|I), TERF1 H3F3B TNKS BRCA2 PPP1CC PPP1R10 ATRX TERF2,CC,8,8 of 22,0.34,36.36,0.0006881,0.004574
GO:0042626,"ATPase activity, coupled to transmembrane movement of substances",G3MW12(Evidence code:IEA/Database source:InterPro:IPR011527)E1BCG1(Evidence code:IEA/Database source:InterPro:IPR026082)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR011527)F1MG24(Evidence code:IEA/Database source:InterPro:IPR026082)P35071(Evidence code:IEA/Database source:InterPro:IPR011527)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)G5E5T3(Evidence code:IEA/Database source:InterPro:IPR011527)F1MUC1(Evidence code:IEA/Database source:InterPro:IPR011527|I)G3MW11(Evidence code:IEA/Database source:InterPro:IPR011527)G3MW09(Evidence code:IEA/Database source:InterPro:IPR011527), LOC100337053 ABCA7 ABCC3 ABCA1 CFTR ABCC5 LOC100299180 LOC515333 LOC523126 LOC509854,MF,10,10 of 35,0.42,28.57,0.000742,0.004926
GO:0034067,protein localization to Golgi apparatus,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens), BICD2 RAB33B ARL1 SORL1 GCC2,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0001890,placenta development,E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)F1N152(Evidence code:IEA/Database source:UniProtKB:Q9R118|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens), BIRC6 E2F7 HTRA1 MAP3K4 ETV2,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0031252,cell leading edge,Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:O54988|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens), ABI1 SLK AAK1 ABL1 SCRIB,CC,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0071004,U2-type prespliceosome,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)A2VDN6(Evidence code:IBA/Database source:PANTHER:PTN000393333)Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359237)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760), UHMK1 PRPF40A SF3A1 SNRNP70 SNRPN,CC,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0043046,DNA methylation involved in gamete generation,E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens), TDRD5 TDRD9 TDRD1 DDX4 PIWIL2,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0030032,lamellipodium assembly,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens), KIT WASF2 VAV2 CYFIP1 GOLPH3,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0043001,Golgi to plasma membrane protein transport,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)P63171(Evidence code:IMP/Database source:), GOLPH3 RAB26 VAMP5 GOLGA4 DYNLT1,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0050435,amyloid-beta metabolic process,P80227(Evidence code:IEA/Database source:UniProtKB:P13798|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735)Q2HJ40(Evidence code:ISS/Database source:UniProtKB:P56817), APEH UNC13A PSEN1 IDE BACE1,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0017025,TBP-class protein binding,P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMC5 PSMC1 PSMC2 RUVBL1 PSMC6,MF,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0071260,cellular response to mechanical stimulus,E1B847(Evidence code:IEA/Database source:UniProtKB:Q13233|ens)F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)A5PJP8(Evidence code:IEA/Database source:UniProtKB:P45985|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens), MAP3K1 PIEZO1 NFKB1 MAP2K4 MAP3K14,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0051233,spindle midzone,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)G3X6L5(Evidence code:IEA/Database source:UniProtKB:Q96BM9|ens), RACGAP1 RIF1 KIF14 PKP4 ARL8A,CC,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0019773,"proteasome core complex, alpha-subunit complex",Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR000426)Q3T0Y5(Evidence code:IEA/Database source:InterPro:IPR000426|I)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR000426|I)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR000426)Q3T0X5(Evidence code:IEA/Database source:InterPro:IPR000426|I), PSMA7 PSMA2 PSMA4 PSMA3 PSMA1,CC,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0031116,positive regulation of microtubule polymerization,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens), NUMA1 PAK1 CDK5RAP2 ARL2 NAV3,BP,5,5 of 7,0.21,71.43,0.0007663,0.005006
GO:0001649,osteoblast differentiation,A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), SP7 GLI2 IGFBP3 WWTR1 FIGNL1 LGR4 LEF1 GLI1 SHOX2,BP,9,9 of 29,0.38,31.03,0.0008286,0.005388
GO:0005178,integrin binding,F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens), UTRN FGF1 ADAM15 LAMB2 ITGB6 CXCL12 FRMD5,MF,7,7 of 17,0.3,41.18,0.0008276,0.005388
GO:0008094,DNA-dependent ATPase activity,F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens)F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR020587)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9), CHD6 CHD8 BLM ERCC2 MYO18A INO80 SMARCAL1,MF,7,7 of 17,0.3,41.18,0.0008276,0.005388
GO:0031226,intrinsic component of plasma membrane,Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)Q29RR0(Evidence code:ISS/Database source:UniProtKB:P51156)P58754(Evidence code:ISS/Database source:UniProtKB:Q9Y6Y9), ALCAM CD63 RAB26 LY96,CC,4,4 of 226,0.17,1.77,0.0008281,0.005388
GO:0003887,DNA-directed DNA polymerase activity,E1BDI3(Evidence code:IEA/Database source:InterPro:IPR001098|I)E1BMC0(Evidence code:IBA/Database source:PANTHER:PTN000805918)A6QQ14(Evidence code:IEA/Database source:EC:2.7.7.7)P84798(Evidence code:TAS/Database source:)P06526(Evidence code:IEA/Database source:InterPro:IPR002054)E1BJF4(Evidence code:IEA/Database source:InterPro:IPR006172|I), POLG POLQ POLE4 POLD3 DNTT POLA1,MF,6,6 of 12,0.25,50,0.0008971,0.005805
GO:0000723,telomere maintenance,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR017357)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR017357|I)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519), RIF1 TERF1 PRKDC WRN TERF2 ATM,BP,6,6 of 12,0.25,50,0.0008971,0.005805
GO:0004364,glutathione transferase activity,A5PKM0(Evidence code:IEA/Database source:InterPro:IPR003081)F1MUX5(Evidence code:IEA/Database source:InterPro:IPR003081)Q3SZ15(Evidence code:IBA/Database source:PANTHER:PTN000136167)Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443)Q5E9B7(Evidence code:IBA/Database source:PANTHER:PTN000136443), GSTM2 LOC100295687 EEF1E1 CLIC4 CLIC6 CLIC1,MF,6,6 of 12,0.25,50,0.0008971,0.005805
GO:0006493,protein O-linked glycosylation,F1MS56(Evidence code:IEA/Database source:UniProtKB:O95394|ens)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1)F1N4Q3(Evidence code:IEA/Database source:UniProtKB:Q80VA0|ens)G3MY32(Evidence code:IEA/Database source:InterPro:IPR003342)F1MJY3(Evidence code:IEA/Database source:UniProtKB:O43151|ens)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens), PGM3 POMGNT1 GALNT7 TMTC2 TET3 GALNT2,BP,6,6 of 12,0.25,50,0.0008971,0.005805
GO:0001503,ossification,A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0892)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)P31407(Evidence code:ISS/Database source:UniProtKB:P15313)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0892)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000942785), EXT1 COL2A1 SBNO2 MYF5 TRAF6 ATP6V1B1 MGP ALOX15 RUNX1,BP,9,9 of 30,0.38,30,0.001013,0.006544
GO:0030317,flagellated sperm motility,E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:Q96DT5|ens)D3K0R6(Evidence code:ISS/Database source:UniProtKB:Q6Q477)Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462268)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens)Q58D31(Evidence code:ISS/Database source:UniProtKB:Q64442), INPP5B DNAH11 ATP2B4 TEKT4 CCNYL1 CELF3 SORD,BP,7,7 of 18,0.3,38.89,0.001082,0.006944
GO:0031593,polyubiquitin modification-dependent protein binding,Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q17R11(Evidence code:IEA/Database source:UniProtKB:Q86Y13|ens)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens), RAD18 RAD23B BRCC3 UBXN1 DZIP3 EPS15 UBQLN1,MF,7,7 of 18,0.3,38.89,0.001082,0.006944
GO:0050661,NADP binding,Q28007(Evidence code:IDA/Database source:)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)F1MMK2(Evidence code:IEA/Database source:InterPro:IPR022674|I)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)O97764(Evidence code:IDA/Database source:)Q27995(Evidence code:IEA/Database source:InterPro:IPR012144), DPYD GAPDHS CAT G6PD CRYM CRYZ NOS2,MF,7,7 of 18,0.3,38.89,0.001082,0.006944
GO:0005903,brush border,P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q5SYD0)F1MLR9(Evidence code:IEA/Database source:UniProtKB:Q6PIF6|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)A7YY70(Evidence code:IBA/Database source:PANTHER:PTN001293650), MYO1A MYH14 MYO1D MYO7B CUBN MYO1C SLC34A1,CC,7,7 of 18,0.3,38.89,0.001082,0.006944
GO:0070373,negative regulation of ERK1 and ERK2 cascade,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)A2VDU1(Evidence code:IEA/Database source:InterPro:IPR030790)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens), DUSP3 EMILIN1 SPRY4 PIN1 DAB2IP DLG1 ABL1,BP,7,7 of 18,0.3,38.89,0.001082,0.006944
GO:0003725,double-stranded RNA binding,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q91VR5|ens), AGO4 DGCR8 RC3H2 DDX58 DHX9 TFRC DDX1,MF,7,7 of 18,0.3,38.89,0.001082,0.006944
GO:0035064,methylated histone binding,F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens), ZMYND8 SUZ12 ATRX UHRF1 LRWD1,MF,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0008543,fibroblast growth factor receptor signaling pathway,P03968(Evidence code:IEA/Database source:InterPro:IPR028210)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546)Q95M13(Evidence code:IEA/Database source:InterPro:IPR016248)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens), FGF1 FRS2 KL fgfr3 SETX,BP,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0009636,response to toxic substance,P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens)E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q8R016|ens)A5D7H9(Evidence code:IEA/Database source:UniProtKB:Q9UN76|ens)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens), CNP SLC23A1 BLMH SLC6A14 SCFD1,BP,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0005272,sodium channel activity,G3MYM1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)F1MMU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)E1BHR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)E1BHM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894)F1MHP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0894), SCN10A SCN8A SCN3A SCN11A SCN5A,MF,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0001917,photoreceptor inner segment,P04695(Evidence code:IEA/Database source:UniProtKB:P11488|ens)P04696(Evidence code:IEA/Database source:UniProtKB:P19087|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026521)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens), GNAT1 GNAT2 SHANK2 GNAT3 DNM1,CC,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0005540,hyaluronic acid binding,F1MKY3(Evidence code:IEA/Database source:InterPro:IPR000538)F1N2J5(Evidence code:IEA/Database source:InterPro:IPR000538)P81282(Evidence code:IEA/Database source:InterPro:IPR000538)P13608(Evidence code:IEA/Database source:InterPro:IPR000538)Q29423(Evidence code:IEA/Database source:InterPro:IPR000538), SUSD5 HAPLN4 VCAN ACAN CD44,MF,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0051879,Hsp90 protein binding,Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9UHD1|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)A5PKJ5(Evidence code:IEA/Database source:UniProtKB:Q99KD5|ens), CHORDC1 TSC2 KPNB1 PPID UNC45A,MF,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0001671,ATPase activator activity,Q2HJ94(Evidence code:ISS/Database source:UniProtKB:O60884)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q3MI00(Evidence code:ISS/Database source:UniProtKB:P25685)Q2KIT4(Evidence code:ISS/Database source:UniProtKB:Q9UDY4)A6QLM8(Evidence code:IEA/Database source:InterPro:IPR004640), DNAJA2 DNAJB2 DNAJB1 DNAJB4 HSCB,MF,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0045747,positive regulation of Notch signaling pathway,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8), PDCD10 STAT3 TSPAN14 LFNG AAK1,BP,5,5 of 8,0.21,62.5,0.001175,0.007055
GO:0032433,filopodium tip,Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)P61085(Evidence code:IEA/Database source:UniProtKB:P61087|ens)E1BMW2(Evidence code:IEA/Database source:UniProtKB:P17426|ens), ABI1 CIB1 UBE2K AP2A1,CC,4,4 of 4,0.17,100,0.001196,0.007055
GO:0030331,estrogen receptor binding,E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)P26882(Evidence code:IDA/Database source:)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), ZNF366 TAF10 PPID LEF1,MF,4,4 of 4,0.17,100,0.001196,0.007055
GO:0030033,microvillus assembly,F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens), STK26 RAPGEF2 RAP2A MYO1A,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0005080,protein kinase C binding,P35605(Evidence code:ISS/Database source:UniProtKB:O35142)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), COPB2 TDG TOP2B ABL1,MF,4,4 of 4,0.17,100,0.001196,0.007055
GO:0099738,cell cortex region,P63097(Evidence code:ISS/Database source:UniProtKB:P63096)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)F2Z4F0(Evidence code:IEA/Database source:UniProtKB:P61163|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens), GNAI1 NUMA1 ACTR1A GPSM2,CC,4,4 of 4,0.17,100,0.001196,0.007055
GO:0045199,maintenance of epithelial cell apical/basal polarity,Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q0P5F3(Evidence code:IBA/Database source:PANTHER:PTN001019267)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens)Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN001019267), LIN7B LIN7C PDCD6IP LIN7A,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BBA0(Evidence code:IEA/Database source:InterPro:IPR037858), FERMT2 IQGAP2 RACGAP1 ARAP3,MF,4,4 of 4,0.17,100,0.001196,0.007055
GO:0051497,negative regulation of stress fiber assembly,F1N6V1(Evidence code:IEA/Database source:UniProtKB:O43182|ens)F1MJ20(Evidence code:IEA/Database source:UniProtKB:Q8BN58|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens), ARHGAP6 ARHGAP28 WASF2 TACSTD2,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0045899,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMC6 PSMC5 PSMC1 PSMC2,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0050860,negative regulation of T cell receptor signaling pathway,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), PHPT1 DUSP3 PTPN6 PRNP,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0001731,formation of translation preinitiation complex,A6QLG1(Evidence code:IBA/Database source:PANTHER:PTN000513830)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens)Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859), LOC515358 MCTS1 EIF4H WBSCR1,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0030955,potassium ion binding,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)B3IVN4(Evidence code:IEA/Database source:InterPro:IPR001697|I)Q05037(Evidence code:IEA/Database source:InterPro:IPR012897|I)Q1JPG7(Evidence code:IEA/Database source:InterPro:IPR001697|I), ATP1A2 PKM KCNA4 PKLR,MF,4,4 of 4,0.17,100,0.001196,0.007055
GO:0010842,retina layer formation,F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5), SDK2 ARL6 PTPRM AHI1,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0097025,MPP7-DLG1-LIN7 complex,Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN000362480)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN000362480), LIN7A LIN7C DLG1 LIN7B,CC,4,4 of 4,0.17,100,0.001196,0.007055
GO:0048488,synaptic vesicle endocytosis,F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)O18964(Evidence code:IEA/Database source:InterPro:IPR034972)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens), DENND1A DNM1 SYNJ1 SCRIB,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0033391,chromatoid body,Q5W5U4(Evidence code:IDA/Database source:)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6), DDX4 TDRD1 PIWIL2 TDRD5,CC,4,4 of 4,0.17,100,0.001196,0.007055
GO:0032588,trans-Golgi network membrane,F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens)A6QR35(Evidence code:IEA/Database source:UniProtKB:O15127|ens)A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens), ATP7B SCAMP2 ARFIP1 BAIAP3,CC,4,4 of 4,0.17,100,0.001196,0.007055
GO:0043015,gamma-tubulin binding,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens), RACGAP1 TUBGCP2 BRCA2 CDK5RAP2,MF,4,4 of 4,0.17,100,0.001196,0.007055
GO:0031235,intrinsic component of the cytoplasmic side of the plasma membrane,F1MBI8(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1BPM0(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1B800(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1BB77(Evidence code:IBA/Database source:PANTHER:PTN000022879), SYNGAP1 RASAL1 RASAL2 DAB2IP,CC,4,4 of 4,0.17,100,0.001196,0.007055
GO:0034451,centriolar satellite,E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens), PCNT SDCCAG8 PCM1 FLOT1,CC,4,4 of 4,0.17,100,0.001196,0.007055
GO:0071333,cellular response to glucose stimulus,E1BM29(Evidence code:IEA/Database source:InterPro:IPR030681)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)P00517(Evidence code:IEA/Database source:InterPro:IPR039035), CYP7A1 UNC13B SOX4 PRKACA,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0006607,NLS-bearing protein import into nucleus,F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)E1BFV0(Evidence code:IBA/Database source:PANTHER:PTN000055427)Q3SYU7(Evidence code:IBA/Database source:PANTHER:PTN000055427)A4IFB8(Evidence code:IBA/Database source:PANTHER:PTN000055427), IPO5 KPNB1 TNPO1 IPO4,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:0035329,hippo signaling,E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens), MOB1B STK3 WWTR1 AMOTL1,BP,4,4 of 4,0.17,100,0.001196,0.007055
GO:1990502,dense core granule maturation,P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens), PTPRN BAIAP3 SNX19,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0060397,JAK-STAT cascade involved in growth hormone signaling pathway,Q95115(Evidence code:IEA/Database source:InterPro:IPR035858)Q9TUM3(Evidence code:IEA/Database source:InterPro:IPR035858)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), STAT5A STAT5B STAT3,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:1903772,regulation of viral budding via host ESCRT complex,Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens), MVB12A TSG101 SNF8,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0004385,guanylate kinase activity,F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)P46195(Evidence code:IEA/Database source:InterPro:IPR017665)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163), DLG1 GUK1 SCRIB,MF,3,3 of 1,0.13,300,0.001192,0.007055
GO:0010735,positive regulation of transcription via serum response element binding,E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939), MKL1 SRF MICAL2,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0060216,definitive hemopoiesis,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens), BCR KMT2A MEIS1,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0006048,UDP-N-acetylglucosamine biosynthetic process,G3N337(Evidence code:IBA/Database source:PANTHER:PTN000237224)Q08DQ2(Evidence code:IEA/Database source:UniPathway:UPA00113)F1MS56(Evidence code:IEA/Database source:UniPathway:UPA00113), UAP1L1 GFPT2 PGM3,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0035924,cellular response to vascular endothelial growth factor stimulus,Q0IIE2(Evidence code:IDA/Database source:)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)P08487(Evidence code:IDA/Database source:), SHC1 DAB2IP PLCG1,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0032367,intracellular cholesterol transport,E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), OSBP NPC1 ABCA1,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:1904355,positive regulation of telomere capping,F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)Q0VCK2(Evidence code:IEA/Database source:UniProtKB:Q9C010|ens), MAP3K4 TNKS PKIB,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0043140,ATP-dependent 3-5 DNA helicase activity,Q28141(Evidence code:IDA/Database source:)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR018982)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR018982), DHX9 BLM WRN,MF,3,3 of 1,0.13,300,0.001192,0.007055
GO:0034454,microtubule anchoring at centrosome,E1BJG8(Evidence code:IEA/Database source:UniProtKB:Q9H2F9|ens)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138)E1BQ19(Evidence code:IEA/Database source:InterPro:IPR029664), CCDC68 PCM1 NIN,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0035385,Roundabout signaling pathway,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q32LG4(Evidence code:IEA/Database source:InterPro:IPR032985)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), MYO9B ROBO2 SLIT2,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0060218,hematopoietic stem cell differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens), CDK6 SRF SP7,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0015825,L-serine transport,A4FUZ5(Evidence code:IEA/Database source:GO:0015194)F1N5T9(Evidence code:IEA/Database source:GO:0015194)Q58CW5(Evidence code:IEA/Database source:GO:0015194), SERINC3 SERINC5 SERINC2,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:1904354,negative regulation of telomere capping,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens), ATM TERF2 SMG6,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0043584,nose development,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), ALDH1A3 CHD7 RPGRIP1L,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0005642,annulate lamellae,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens)P48820(Evidence code:ISS/Database source:UniProtKB:P49792), XPO1 BICD2 RANBP2,CC,3,3 of 1,0.13,300,0.001192,0.007055
GO:1903551,regulation of extracellular exosome assembly,Q08DL9(Evidence code:IEA/Database source:UniProtKB:Q92783|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens), STAM PDCD6IP TSG101,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0001736,establishment of planar polarity,E1BJB4(Evidence code:IEA/Database source:InterPro:IPR031136)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592), RPGRIP1L ALMS1 PTK7,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0031005,filamin binding,F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)F1MF57(Evidence code:IEA/Database source:UniProtKB:O76041|ens), MICALL2 CRMP1 NEBL,MF,3,3 of 1,0.13,300,0.001192,0.007055
GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,Q08DA1(Evidence code:IEA/Database source:GO:0005391)A2VDL6(Evidence code:IEA/Database source:GO:0005391)Q8HYW6(Evidence code:IEA/Database source:GO:0005391), ATP1A1 ATP1A2 atp1A3,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0014029,neural crest formation,Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens), PDCD6 LRP6 PEF1,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0045880,positive regulation of smoothened signaling pathway,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens), SHOX2 GLI1 STK36,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0030520,intracellular estrogen receptor signaling pathway,E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q12837)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141), ARID1A POU4F2 SRC,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens), BCAP31 UBQLN1 SGTA,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0021879,forebrain neuron differentiation,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971), DLX2 SOX1 LEF1,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0009597,detection of virus,A4FUZ5(Evidence code:ISS/Database source:UniProtKB:Q13530)F1N5T9(Evidence code:IEA/Database source:UniProtKB:Q86VE9|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), SERINC3 SERINC5 DDX58,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0006047,UDP-N-acetylglucosamine metabolic process,F1MZY2(Evidence code:IBA/Database source:PANTHER:PTN000101302)F1MIL9(Evidence code:IEA/Database source:InterPro:IPR020004)Q08DQ2(Evidence code:IBA/Database source:PANTHER:PTN000101302), GFPT1 GNE GFPT2,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0042921,glucocorticoid receptor signaling pathway,E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens), ARID1A NEDD4 PTGES3,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0001682,tRNA 5-leader removal,E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)E1BFB5(Evidence code:IBA/Database source:PANTHER:PTN001005190), RPP25 SSB KIAA0391,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:2000772,regulation of cellular senescence,E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens), NUAK1 PNPT1 ABL1,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0043422,protein kinase B binding,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), TRAF6 APPL1 PINK1,MF,3,3 of 1,0.13,300,0.001192,0.007055
GO:0005049,nuclear export signal receptor activity,F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)A1A4I8(Evidence code:IEA/Database source:UniProtKB:Q9UIA9|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens), NUP214 XPO7 XPO1,MF,3,3 of 1,0.13,300,0.001192,0.007055
GO:0035371,microtubule plus-end,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens), NUMA1 CKAP5 CDK5RAP2,CC,3,3 of 1,0.13,300,0.001192,0.007055
GO:0031914,negative regulation of synaptic plasticity,F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BBX9(Evidence code:IEA/Database source:UniProtKB:Q8K0T7|ens), UNC13B RGS14 UNC13C,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0001556,oocyte maturation,E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens), PABPC1L BRCA2 RPS6KA2,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0061615,glycolytic process through fructose-6-phosphate,E1BCW3(Evidence code:IEA/Database source:GO:0003872)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)A1A4J1(Evidence code:IEA/Database source:UniProtKB:P12382|ens), PFKP PFKM PFKL,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0090611,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), VPS4B PDCD6IP CHMP4B,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0060430,lung saccule development,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), ASXL1 PTGES3 GATA6,BP,3,3 of 1,0.13,300,0.001192,0.007055
GO:0003951,NAD+ kinase activity,Q3SZD3(Evidence code:IEA/Database source:InterPro:IPR002504|I)E1BGA9(Evidence code:IEA/Database source:InterPro:IPR017438)E1BJM1(Evidence code:IEA/Database source:InterPro:IPR017438), NADK DGKQ SPHK2,MF,3,3 of 1,0.13,300,0.001192,0.007055
GO:0051289,protein homotetramerization,O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)P37141(Evidence code:ISS/Database source:UniProtKB:P22352)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61458|ens)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens), CRYZ SAMHD1 GPX3 ALDH1A3 SHMT2 CAT HCN1 PCBD1 TRPM4,BP,9,9 of 31,0.38,29.03,0.001228,0.007231
GO:0004497,monooxygenase activity,F1MEU8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I)Q2TBK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)E1BHD5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR002403)G3MWR8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)F1MF74(Evidence code:IEA/Database source:UniProtKB-KW:KW-0503)P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I)E1BM29(Evidence code:IEA/Database source:InterPro:IPR002403), LOC540627 PAH CYP2J2 LOC100295883 CYP2R1 MICAL3 MICAL2 DBH CYP7A1,MF,9,9 of 31,0.38,29.03,0.001228,0.007231
GO:0035690,cellular response to drug,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens), TFRC MT3 PPP3CA RAP2A PRNP BRAF,BP,6,6 of 13,0.25,46.15,0.001236,0.007259
GO:0006513,protein monoubiquitination,Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens), RAD18 CUL3 UBE4B HUWE1 RBX1 CUL1,BP,6,6 of 13,0.25,46.15,0.001236,0.007259
GO:0048812,neuron projection morphogenesis,Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000685430)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)A4IFF6(Evidence code:IEA/Database source:UniProtKB:Q9R0A5|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000685430)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)F1MU40(Evidence code:IBA/Database source:PANTHER:PTN001216704)E1BKJ6(Evidence code:IEA/Database source:InterPro:IPR026722), STK25 BDNF NEK3 DAB2IP WEE1 STK26 LRRK2 DNM2 MNX1 NYAP1,BP,10,10 of 38,0.42,26.32,0.001262,0.007402
GO:0030838,positive regulation of actin filament polymerization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)Q5EAD0(Evidence code:IBA/Database source:PANTHER:PTN001022094)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P39654), DLG1 CTTN ARF6 GRB2 BAIAP2 RICTOR BAIAP2L1 ALOX15,BP,8,8 of 25,0.34,32,0.001359,0.007955
GO:0007059,chromosome segregation,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)Q3T0W4(Evidence code:IEA/Database source:UniProtKB:Q3UM45|ens)Q2KI07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0159)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)E1BP36(Evidence code:IEA/Database source:UniProtKB-KW:KW-0159), RGS14 CDK5RAP2 PPP1R7 ARL8B ERCC2 DDX3Y DDX3X MMS19,BP,8,8 of 25,0.34,32,0.001359,0.007955
GO:0045177,apical part of cell,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens), NF2 C5AR1 CLIC4 CUBN PCM1 PRKCI TJP1,CC,7,7 of 19,0.3,36.84,0.001394,0.008155
GO:0007346,regulation of mitotic cell cycle,A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000684825)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1MF87(Evidence code:IEA/Database source:UniProtKB:Q96AY4|ens)G3X696(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000684825)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825), MAP2K4 TAOK3 AFAP1L2 MAP3K14 PAK1 TAOK2 CDK1 PAK2 MAP3K8 PAK6 MAP3K1 STK25 TTC28 SLK PAK3 STK26 PAK4 MAP3K4 STK3,BP,19,19 of 111,0.81,17.12,0.001429,0.008346
GO:0050660,flavin adenine dinucleotide binding,E1BL62(Evidence code:IEA/Database source:InterPro:IPR036318)P48818(Evidence code:IEA/Database source:InterPro:IPR013786|I)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)O62768(Evidence code:IEA/Database source:InterPro:IPR016156)Q148K4(Evidence code:IEA/Database source:InterPro:IPR004113|I)Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q9UBK8)Q27995(Evidence code:IEA/Database source:InterPro:IPR012144)E1BJA2(Evidence code:IEA/Database source:InterPro:IPR016156)P48034(Evidence code:IEA/Database source:InterPro:IPR036318), AOX4 ACADVL AIFM2 TXNRD1 LDHD MTRR NOS2 AIFM1 AOX1,MF,9,9 of 32,0.38,28.12,0.00148,0.008634
GO:0008289,lipid binding,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens)Q2KHV6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)A5PK00(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q09139(Evidence code:IEA/Database source:InterPro:IPR000463|I)P62964(Evidence code:IEA/Database source:InterPro:IPR000463|I)E1BLZ4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)A6QQP7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR000463|I)Q2KJA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q0VCK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)A5PKA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q32LM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q1RMH8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)P55156(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q3SZC4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q2NL34(Evidence code:ISS/Database source:UniProtKB:O75208)F1MIF5(Evidence code:IEA/Database source:InterPro:IPR000463|I)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)A6QQK8(Evidence code:IEA/Database source:InterPro:IPR031468)P02694(Evidence code:IEA/Database source:InterPro:IPR000463|I)A6QNK3(Evidence code:IEA/Database source:InterPro:IPR002913)A7Z035(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)Q2HJ54(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446)F1MXU5(Evidence code:IEA/Database source:InterPro:IPR002913)Q3ZC13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0446), PACSIN2 MVB12A SNX8 VPS36 FABP7 CRABP1 ZFYVE26 DYSF PACSIN3 CHMP4A CRABP2 SH3GL1 AP2A2 SNX27 SH3GLB1 SNX3 MTTP NSFL1C COQ9 RBP7 ALOX15 TEX2 RBP1 STARD7 CLINT1 PITPNA STARD10 AP2M1,MF,28,28 of 190,1.19,14.74,0.001645,0.00959
GO:0007565,female pregnancy,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0635)Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0635)Q17QL4(Evidence code:IEA/Database source:UniProtKB:Q9UNF1|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B IFNT2 CRH IFNT3 MAGED2 STAT5A,BP,6,6 of 14,0.25,42.86,0.001664,0.009691
GO:0031072,heat shock protein binding,Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)P26882(Evidence code:IEA/Database source:UniProtKB:Q08752|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210)Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR001305), FKBP4 DNAJC7 PPID ITGB2 TPR BCOR FKBP5 DNAJA2,MF,8,8 of 26,0.34,30.77,0.001672,0.009713
GO:0031398,positive regulation of protein ubiquitination,Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens)Q2KJ77(Evidence code:IEA/Database source:UniProtKB:Q9NZL4|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens), fgfr3 CUL3 LRRK2 AIMP2 HSPBP1 PTTG1IP MAPK9 UBQLN1,BP,8,8 of 26,0.34,30.77,0.001672,0.009713
GO:1990126,"retrograde transport, endosome to plasma membrane",Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1)E1B7G6(Evidence code:IEA/Database source:UniProtKB:Q9ULJ7|ens)A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)Q3T0M0(Evidence code:ISS/Database source:UniProtKB:Q9UBQ0)Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436), VPS35 ANKRD50 SNX27 VPS29 VPS26A,BP,5,5 of 9,0.21,55.56,0.001726,0.009954
GO:0005528,FK506 binding,Q9TRY0(Evidence code:IEA/Database source:InterPro:IPR031212)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)Q17QA3(Evidence code:IEA/Database source:InterPro:IPR031210)Q2KJC8(Evidence code:IBA/Database source:PANTHER:PTN000054102)Q32PA9(Evidence code:IBA/Database source:PANTHER:PTN000054102), FKBP4 FKBP1B FKBP5 FKBP9 FKBP2,MF,5,5 of 9,0.21,55.56,0.001726,0.009954
GO:0046854,phosphatidylinositol phosphorylation,F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)O02811(Evidence code:IEA/Database source:InterPro:IPR015433)E1BE66(Evidence code:IEA/Database source:InterPro:IPR008290|I)Q0P5F7(Evidence code:IEA/Database source:GO:0016307)P20456(Evidence code:IEA/Database source:InterPro:IPR000760|I), SMG1 PI4KA PIK3CD PIP4K2C IMPA1,BP,5,5 of 9,0.21,55.56,0.001726,0.009954
GO:0008542,visual learning,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), KMT2A SYNGAP1 BRAF DBH ATP1A2,BP,5,5 of 9,0.21,55.56,0.001726,0.009954
GO:0042584,chromaffin granule membrane,Q08DF4(Evidence code:IDA/Database source:)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)P15101(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q29455(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)G3N3N1(Evidence code:IDA/Database source:), DNM1 SRI DBH DNAJC5 ARF6,CC,5,5 of 9,0.21,55.56,0.001726,0.009954
GO:0001954,positive regulation of cell-matrix adhesion,A6YT15(Evidence code:IEA/Database source:UniProtKB:Q9NRJ3|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q2TA30(Evidence code:IEA/Database source:UniProtKB:O70131|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4), CCL28 CDK6 NINJ1 UTRN CIB1,BP,5,5 of 9,0.21,55.56,0.001726,0.009954
GO:0002088,lens development in camera-type eye,P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens), CRYAB DLG1 CDON PYGO2 FRS2,BP,5,5 of 9,0.21,55.56,0.001726,0.009954
GO:0001525,angiogenesis,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997)A1A4M2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)P03968(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)P62248(Evidence code:IEA/Database source:UniProtKB-KW:KW-0037)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR029586), LEMD3 EMC10 FGF1 CLIC4 HOXA7 SOX17 CIB1 GNA13 MYDGF MEIS1 PKNOX1 NDNF WASF2 SHC1,BP,14,14 of 71,0.59,19.72,0.001746,0.01006
GO:0019005,SCF ubiquitin ligase complex,F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens)F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:P63208)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens), CUL1 BTBD3 SPOPL BTBD11 BTBD6 SKP1 RBX1,CC,7,7 of 20,0.3,35,0.001773,0.01017
GO:0006749,glutathione metabolic process,Q9XSA7(Evidence code:IBA/Database source:PANTHER:PTN000136443)P00435(Evidence code:IDA/Database source:)Q3SZ15(Evidence code:IBA/Database source:PANTHER:PTN000136167)Q5E9B7(Evidence code:IBA/Database source:PANTHER:PTN000136443)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)Q75WB5(Evidence code:IBA/Database source:PANTHER:PTN000146326)E1BAI4(Evidence code:IBA/Database source:PANTHER:PTN000136443), CLIC4 GPX1 EEF1E1 CLIC1 G6PD OPLAH CLIC6,BP,7,7 of 20,0.3,35,0.001773,0.01017
GO:0010977,negative regulation of neuron projection development,Q9TRY0(Evidence code:ISS/Database source:UniProtKB:P27124)E1BER6(Evidence code:IEA/Database source:UniProtKB:Q14194|ens)E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q08629)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens), FKBP4 CRMP1 INPP5J CIB1 SPOCK1 RTN4R BAG5,BP,7,7 of 20,0.3,35,0.001773,0.01017
GO:0071347,cellular response to interleukin-1,F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q32MK0|ens), ADAMTS12 MAPK11 DAB2IP HYAL1 ADAMTS7 NFKB1 MYLK3,BP,7,7 of 20,0.3,35,0.001773,0.01017
GO:0006952,defense response,P46169(Evidence code:IEA/Database source:InterPro:IPR001855|I)P56831(Evidence code:IEA/Database source:InterPro:IPR000471)P46161(Evidence code:IEA/Database source:InterPro:IPR001855|I)G3N183(Evidence code:IEA/Database source:InterPro:IPR000471)P56830(Evidence code:IEA/Database source:InterPro:IPR000471)P46165(Evidence code:IEA/Database source:InterPro:IPR001855|I)Q8MJ29(Evidence code:IEA/Database source:InterPro:IPR000471)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR033899), DEFB11 IFNT3 DEFB3 LOC104968438 IFNT2 DEFB7 IFNT CXCL12,BP,8,8 of 300,0.34,2.67,0.001878,0.01076
GO:0010468,regulation of gene expression,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)F1MZQ1(Evidence code:IBA/Database source:PANTHER:PTN001004204)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)A5PJL3(Evidence code:IBA/Database source:PANTHER:PTN000622075)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979)Q2NL22(Evidence code:IBA/Database source:PANTHER:PTN000619776)P46196(Evidence code:IBA/Database source:PANTHER:PTN000622075)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)Q3T0N5(Evidence code:IBA/Database source:PANTHER:PTN000622075)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)Q3SZ54(Evidence code:IBA/Database source:PANTHER:PTN000620029)A4FV00(Evidence code:IBA/Database source:PANTHER:PTN000622075)F1MVV5(Evidence code:IBA/Database source:PANTHER:PTN000622075)G3X793(Evidence code:IBA/Database source:PANTHER:PTN000622075)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)G3MY13(Evidence code:IEA/Database source:InterPro:IPR027008)Q3SZ65(Evidence code:IBA/Database source:PANTHER:PTN000620029)F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BKC4(Evidence code:IEA/Database source:InterPro:IPR033031)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR030487)Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622075)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens), RICTOR CHD8 TAF10 SAP130 KDM6B LRRK2 DDX3Y MAPK12 CDK3 EIF4A3 MAPK1 KMT2A MAPK13 GATA6 EIF4A1 MAPK10 MAPK4 MAPK11 MEGF8 CDK1 COL2A1 DDX3X TSHZ1 EIF4A2 NPAT MAPK8IP3 ASH1L BCL11B PPP2CB PIN1 NIPBL GNB3 MAP3K4 RC3H2 DNMT3A MAPK9 INSM1 EN1 CDK6,BP,39,39 of 870,1.66,4.48,0.001996,0.01142
GO:0007050,cell cycle arrest,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q9ULX5)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens)Q5E9L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0338)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0338), ATM RNF112 IRF1 TSG101 FOXO4 UHMK1 BRINP1 HEPACAM,BP,8,8 of 27,0.34,29.63,0.002039,0.01143
GO:0031201,SNARE complex,Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349)P63026(Evidence code:ISS/Database source:UniProtKB:P63027)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)Q17QQ3(Evidence code:ISS/Database source:UniProtKB:P60880-1)P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241), STX7 VAMP2 VAMP3 VAMP1 VAMP5 SYN2 SNAP25 NAPG,CC,8,8 of 27,0.34,29.63,0.002039,0.01143
GO:0031490,chromatin DNA binding,E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)A6H7J1(Evidence code:ISS/Database source:UniProtKB:P70661)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BIJ4(Evidence code:IBA/Database source:PANTHER:PTN001412149)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P40763)G3N131(Evidence code:IEA/Database source:UniProtKB:Q02539|ens), KDM3B DHX9 INSM1 SRF LEMD3 SUZ12 STAT3 HIST1H1A,MF,8,8 of 27,0.34,29.63,0.002039,0.01143
GO:0001707,mesoderm formation,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)P00517(Evidence code:ISS/Database source:UniProtKB:P05132), SRF NF2 ETV2 PRKACA,BP,4,4 of 5,0.17,80,0.002036,0.01143
GO:0046037,GMP metabolic process,P46195(Evidence code:IEA/Database source:GO:0004385)F1MNQ3(Evidence code:IEA/Database source:GO:0004385)F1N0Y1(Evidence code:IEA/Database source:GO:0004385)Q32L93(Evidence code:ISS/Database source:UniProtKB:Q9P2T1), GUK1 DLG1 SCRIB GMPR2,BP,4,4 of 5,0.17,80,0.002036,0.01143
GO:0009982,pseudouridine synthase activity,F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I), PUS10 TRUB1 RPUSD2 PUS3,MF,4,4 of 5,0.17,80,0.002036,0.01143
GO:0010718,positive regulation of epithelial to mesenchymal transition,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens), WWTR1 LEF1 AXIN2 BCL9L,BP,4,4 of 5,0.17,80,0.002036,0.01143
GO:0031932,TORC2 complex,F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens)Q24JY1(Evidence code:ISS/Database source:UniProtKB:P62751)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MHN4(Evidence code:IEA/Database source:InterPro:IPR028268), TTI1 RPL23A PINK1 RICTOR,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0031258,lamellipodium membrane,Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)P81425(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens)Q3ZBF9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CD44 DPP4 APC2 PDXP,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0034587,piRNA metabolic process,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens)Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496), PIWIL2 TDRD1 TDRD9 DDX4,BP,4,4 of 5,0.17,80,0.002036,0.01143
GO:0071541,"eukaryotic translation initiation factor 3 complex, eIF3m",Q5E966(Evidence code:IEA/Database source:UniProtKB:Q9QZD9|ens)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:Q9DCH4|ens)A7MB16(Evidence code:IEA/Database source:UniProtKB:Q8JZQ9|ens)Q3T148(Evidence code:IEA/Database source:UniRule:UR000107134), EIF3I EIF3F EIF3B EIF3M,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,P48734(Evidence code:IEA/Database source:EC:2.7.11.23)E1BB50(Evidence code:IEA/Database source:EC:2.7.11.23)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)E1BB52(Evidence code:IEA/Database source:EC:2.7.11.23), CDK1 CDK12 ERCC2 CDK13,MF,4,4 of 5,0.17,80,0.002036,0.01143
GO:0008328,ionotropic glutamate receptor complex,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens), SHANK1 DLG1 SCRIB SHANK2,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0007173,epidermal growth factor receptor signaling pathway,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN000544009)Q0IIE2(Evidence code:IBA/Database source:PANTHER:PTN000037430)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141), ABL1 CBLC SHC1 SRC,BP,4,4 of 5,0.17,80,0.002036,0.01143
GO:0005662,DNA replication factor A complex,Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q99459)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens), CDC5L SMARCAL1 PURA PURB,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0071360,cellular response to exogenous dsRNA,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), DDX58 MB21D1 FLOT1 DHX9,BP,4,4 of 5,0.17,80,0.002036,0.01143
GO:0031597,cytosolic proteasome complex,Q2KIW6(Evidence code:IBA/Database source:PANTHER:PTN000553036)A4FUZ3(Evidence code:IBA/Database source:PANTHER:PTN000553036)Q5E9F9(Evidence code:IBA/Database source:PANTHER:PTN000553036)P62194(Evidence code:IBA/Database source:PANTHER:PTN000553036), PSMC6 PSMC1 PSMC2 PSMC5,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0043186,P granule,F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN001053513)Q5W5U4(Evidence code:IBA/Database source:PANTHER:PTN001169089), TDRD1 PIWIL2 TDRD9 DDX4,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0000788,nuclear nucleosome,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)A4IFU5(Evidence code:IEA/Database source:UniProtKB:Q7L7L0|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)E1B7N2(Evidence code:IBA/Database source:PANTHER:PTN000826174), HIST1H2BA HIST3H2A H3F3B LOC619094,CC,4,4 of 5,0.17,80,0.002036,0.01143
GO:0097009,energy homeostasis,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens)E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q8CEE6|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), EIF4G1 AMPD3 PASK STAT3,BP,4,4 of 5,0.17,80,0.002036,0.01143
GO:0010494,cytoplasmic stress granule,E1BFV0(Evidence code:IEA/Database source:UniProtKB:P70168|ens)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)P68102(Evidence code:ISS/Database source:UniProtKB:Q6ZWX6)P61286(Evidence code:ISS/Database source:UniProtKB:P11940), KPNB1 DDX1 PUM1 PABPC4 EIF2S1 PABPC1,CC,6,6 of 15,0.25,40,0.002197,0.01228
GO:0003341,cilium movement,E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277911)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN000072879)F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens)E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens), WDR78 DNAH11 DNHD1 DNAH7 HYDIN DNAH5,BP,6,6 of 15,0.25,40,0.002197,0.01228
GO:0002244,hematopoietic progenitor cell differentiation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BFI2(Evidence code:IEA/Database source:UniProtKB:A2ATU0|ens)E1BI99(Evidence code:IEA/Database source:UniProtKB:Q5QNV8|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)E1B9S6(Evidence code:IEA/Database source:UniProtKB:E9PYY5|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens), PTPN6 PSEN1 DHTKD1 HEATR9 CDK6 WDR78 PTPRZ1,BP,7,7 of 21,0.3,33.33,0.002226,0.01239
GO:0008344,adult locomotory behavior,Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens)Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens), DNM1 EN1 PUM1 SEZ6L2 ATP1A2 ARCN1 CNP,BP,7,7 of 21,0.3,33.33,0.002226,0.01239
GO:0009952,anterior/posterior pattern specification,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)G3MY13(Evidence code:IEA/Database source:UniProtKB:Q5DTH5|ens), CDON Gli3 HOXA7 KMT2A CRKL GLI2 TSHZ1,BP,7,7 of 21,0.3,33.33,0.002226,0.01239
GO:0030217,T cell differentiation,E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)Q2HJ84(Evidence code:IEA/Database source:UniProtKB:O70477|ens)Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), CHD7 LCK PKNOX1 LFNG KIT PREX1 SOX4,BP,7,7 of 21,0.3,33.33,0.002226,0.01239
GO:0070925,organelle assembly,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 127,0.04,0.79,0.002297,0.01278
GO:0007188,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN001954983)P04696(Evidence code:IEA/Database source:InterPro:IPR001408)E1BIL1(Evidence code:IBA/Database source:PANTHER:PTN000026392)P04695(Evidence code:IEA/Database source:InterPro:IPR001408)P38408(Evidence code:IBA/Database source:PANTHER:PTN000026392)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001408)P63097(Evidence code:IEA/Database source:InterPro:IPR001408)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens), PTH1R RXFP3 GNAT2 GNA12 GNAT1 GNA14 CACNA1D GNAT3 GNAI1 GNA13,BP,10,10 of 42,0.42,23.81,0.002379,0.01322
GO:0022857,transmembrane transporter activity,Q1JQC7(Evidence code:IEA/Database source:InterPro:IPR005828)E1BI45(Evidence code:IEA/Database source:InterPro:IPR006043)P02722(Evidence code:IEA/Database source:InterPro:IPR002113)G3N271(Evidence code:IEA/Database source:InterPro:IPR006043)Q3ZC26(Evidence code:IEA/Database source:InterPro:IPR001734)F1N3Y6(Evidence code:IEA/Database source:InterPro:IPR005292)E1BIE9(Evidence code:IEA/Database source:InterPro:IPR006043)E1B749(Evidence code:IEA/Database source:InterPro:IPR001734)E1B968(Evidence code:IEA/Database source:InterPro:IPR002293), SLC22A23 SLC23A1 SLC25A4 LOC100337457 SLC5A11 ABCC3 LOC100298868 SLC5A9 SLC7A2,MF,9,9 of 311,0.38,2.89,0.002418,0.01339
GO:0040018,positive regulation of multicellular organism growth,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), SPTBN4 STAT5B NIPBL STAT5A CHD7,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0007274,neuromuscular synaptic transmission,A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q8VCR8|ens)P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens), MYLK2 CHRNE ADARB1 RAB3A KIF1B,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0030131,clathrin adaptor complex,P63009(Evidence code:IEA/Database source:InterPro:IPR008152|I)Q3ZC13(Evidence code:IEA/Database source:InterPro:IPR001392|I)Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR003164|I)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR003164|I)Q08DS7(Evidence code:IEA/Database source:InterPro:IPR008152|I), AP2B1 AP2M1 AP2A2 AP2A1 AP2B1,CC,5,5 of 10,0.21,50,0.002445,0.01339
GO:0046039,GTP metabolic process,Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59), RAN AMPD3 RAB23 LRRK2 GTPBP1,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0061631,ubiquitin conjugating enzyme activity,P61085(Evidence code:IDA/Database source:)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q9D2M8|ens)F1N1X8(Evidence code:IEA/Database source:UniProtKB:Q3UE37|ens), UBE2K UBE2D2 BIRC6 UBE2V2 UBE2Z,MF,5,5 of 10,0.21,50,0.002445,0.01339
GO:0007098,centrosome cycle,Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)E1BKZ3(Evidence code:IEA/Database source:InterPro:IPR031887)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens), ARL2 CKAP5 SDCCAG8 PCM1 CDK5RAP2,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0043401,steroid hormone mediated signaling pathway,F1N3S3(Evidence code:IEA/Database source:GO:0003707)E1BJ93(Evidence code:IEA/Database source:GO:0030284)A2VDU4(Evidence code:IEA/Database source:GO:0003707)Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)E1BC39(Evidence code:IEA/Database source:GO:0003707), NR2F6 LEF1 NR1I2 ABHD2 ESRRG,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0043967,histone H4 acetylation,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens), LEF1 RUVBL2 RUVBL1 BRCA2 EP400,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0006306,DNA methylation,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens)Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR030487)Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q8C1A3)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), EHMT2 PPM1D DNMT3A MTRR KMT2A,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0035307,positive regulation of protein dephosphorylation,Q3T0W4(Evidence code:IEA/Database source:UniProtKB:Q15435|ens)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)E1BFD1(Evidence code:IEA/Database source:InterPro:IPR035007)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), PPP1R7 PTPA PPP2R5A ANKLE2 PINK1,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0030968,endoplasmic reticulum unfolded protein response,E1BAK9(Evidence code:IBA/Database source:PANTHER:PTN000967687)A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687)A7MBJ3(Evidence code:IBA/Database source:PANTHER:PTN000201758), SYVN1 ATF6B UGGT2 DZIP3 EDEM2,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0033017,sarcoplasmic reticulum membrane,Q2YDF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)Q2HJF7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3MHJ9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens), JSRP1 RYR1 CAMK2D CAMK2B FKBP1B,CC,5,5 of 10,0.21,50,0.002445,0.01339
GO:0051898,negative regulation of protein kinase B signaling,E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), TSC2 PDCD6 CIB1 PKHD1 DLG1,BP,5,5 of 10,0.21,50,0.002445,0.01339
GO:0001227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding",G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens)F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)Q17QV0(Evidence code:IEA/Database source:UniProtKB:P57722|ens)E1BE02(Evidence code:IEA/Database source:UniProtKB:Q6S7F2|ens), PURB ARHGAP35 ZBTB4 NR2F6 HIC1 NFKB1 PCBP3 E2F7,MF,8,8 of 28,0.34,28.57,0.002467,0.0135
GO:0000149,SNARE binding,Q0V8C2(Evidence code:IBA/Database source:PANTHER:PTN000480155)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BIU0(Evidence code:IEA/Database source:UniProtKB:P53992|ens)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q17QQ3(Evidence code:IEA/Database source:InterPro:IPR039077)F1MV07(Evidence code:IEA/Database source:UniProtKB:O94855|ens), EXOC3 LRRK2 SEC24C VAMP3 STX7 VAMP5 BAIAP3 SNAP25 SEC24D,MF,9,9 of 35,0.38,25.71,0.002489,0.0136
GO:0071356,cellular response to tumor necrosis factor,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), NFKB1 CIB1 DAB2IP ADAMTS7 TCL1A ADAMTS12 DHX9,BP,7,7 of 22,0.3,31.82,0.002764,0.0146
GO:0042752,regulation of circadian rhythm,P61287(Evidence code:ISS/Database source:UniProtKB:P36873)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)Q28021(Evidence code:ISS/Database source:UniProtKB:P70336)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8VDP4|ens)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62140)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens), PPP1CC SFPQ ROCK2 CCAR2 PPP1CB MAPK9 PRKDC,BP,7,7 of 22,0.3,31.82,0.002764,0.0146
GO:0000403,Y-form DNA binding,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), WRN RAD18 BLM,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0031209,SCAR complex,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens), WASF2 ABI1 NCKAP1,CC,3,3 of 2,0.13,150,0.002828,0.0146
GO:0090114,COPII-coated vesicle budding,Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596)A2VDL8(Evidence code:IEA/Database source:InterPro:IPR037550)Q3SZN2(Evidence code:IEA/Database source:InterPro:IPR037550), SEC13 SEC23A SEC23B,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0010459,negative regulation of heart rate,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens), FKBP1B SPTBN4 SRI,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0003872,6-phosphofructokinase activity,Q0IIG5(Evidence code:IEA/Database source:InterPro:IPR000023|I)E1BCW3(Evidence code:IEA/Database source:InterPro:IPR000023|I)A1A4J1(Evidence code:IEA/Database source:InterPro:IPR000023|I), PFKM PFKP PFKL,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0030122,AP-2 adaptor complex,Q17QC5(Evidence code:IEA/Database source:InterPro:IPR027156)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)Q0VCK5(Evidence code:IDA/Database source:), AP2S1 EPS15 AP2A2,CC,3,3 of 2,0.13,150,0.002828,0.0146
GO:0004691,cAMP-dependent protein kinase activity,F1MY16(Evidence code:IEA/Database source:InterPro:IPR028852)P00517(Evidence code:IEA/Database source:InterPro:IPR039035)P05131(Evidence code:IEA/Database source:InterPro:IPR039083), AKAP13 PRKACA PRKACB,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0017075,syntaxin-1 binding,A6QLI3(Evidence code:IEA/Database source:InterPro:IPR026198)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q17QQ3(Evidence code:IEA/Database source:InterPro:IPR039077), GOLSYN LRRK2 SNAP25,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0043968,histone H2A acetylation,Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens), RUVBL2 EP400 RUVBL1,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:1904778,positive regulation of protein localization to cell cortex,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P63096)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens), NUMA1 GNAI1 GPSM2,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0004370,glycerol kinase activity,Q0IID9(Evidence code:IEA/Database source:InterPro:IPR005999)F1MSV5(Evidence code:IEA/Database source:InterPro:IPR005999)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR005999), GK GK2 LOC538702,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0016188,synaptic vesicle maturation,P61763(Evidence code:ISS/Database source:UniProtKB:O08599)F1MK99(Evidence code:IEA/Database source:InterPro:IPR027082)P11023(Evidence code:ISS/Database source:UniProtKB:P63011), STXBP1 UNC13A RAB3A,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0000814,ESCRT II complex,Q5E9A6(Evidence code:IEA/Database source:InterPro:IPR008570)A5PK00(Evidence code:IEA/Database source:InterPro:IPR037855)Q08DR7(Evidence code:IEA/Database source:InterPro:IPR016689), VPS25 VPS36 SNF8,CC,3,3 of 2,0.13,150,0.002828,0.0146
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity,A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens), PIK3R4 TNFAIP8L3 VAV2,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0071712,ER-associated misfolded protein catabolic process,A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens), TOR1A UGGT2 UFD1L,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0004687,myosin light chain kinase activity,E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens)A4IFM7(Evidence code:IEA/Database source:EC:2.7.11.18)F1MG18(Evidence code:IBA/Database source:PANTHER:PTN002389378), MYLK3 MYLK2 MYLK4,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0019894,kinesin binding,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)A6QLI3(Evidence code:IEA/Database source:InterPro:IPR026198), TOR1A MAPK8IP3 GOLSYN,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0070198,"protein localization to chromosome, telomeric region",F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), TERF2 TNKS ATRX,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0031016,pancreas development,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), GATA6 ONECUT2 FOXF1,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:1903507,negative regulation of nucleic acid-templated transcription,Q05B89(Evidence code:ISS/Database source:UniProtKB:Q9EQ80)F1MHZ3(Evidence code:IEA/Database source:GO:0003714)A7YW45(Evidence code:IEA/Database source:GO:0003714), NIF3L1 NPAT PRMT5,BP,3,3 of 180,0.13,1.67,0.002715,0.0146
GO:0046167,glycerol-3-phosphate biosynthetic process,F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q0IID9(Evidence code:IBA/Database source:PANTHER:PTN000023394), GK2 LOC538702 GK,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0070493,thrombin-activated receptor signaling pathway,A7YY44(Evidence code:IEA/Database source:InterPro:IPR003912)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens), F2R DGKQ IQGAP2,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0070306,lens fiber cell differentiation,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)A7Z017(Evidence code:IBA/Database source:PANTHER:PTN000014690)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8K1H1), NF2 MAF TDRD7,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0046849,bone remodeling,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)Q27967(Evidence code:IEA/Database source:InterPro:IPR010892)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4), TRAF6 SPP2 LGR4,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0002089,lens morphogenesis in camera-type eye,F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8K1H1), SOX1 MEIS1 TDRD7,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0007520,myoblast fusion,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens)F1N3I4(Evidence code:IEA/Database source:InterPro:IPR029999), CDON CAPN2 MYOF,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0007588,excretion,P31407(Evidence code:ISS/Database source:UniProtKB:P15313)F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens)F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens), ATP6V1B1 MLLT6 GRHPR,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:1990825,sequence-specific mRNA binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q0VCX5(Evidence code:IEA/Database source:UniProtKB:P62495|ens), DHX9 SSB ETF1,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0016558,protein import into peroxisome matrix,Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens), PEX10 PEX1 PEX2,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0008376,acetylgalactosaminyltransferase activity,E1B9D0(Evidence code:IEA/Database source:InterPro:IPR008428)E1BMM8(Evidence code:IEA/Database source:InterPro:IPR008428)F1N0M7(Evidence code:IEA/Database source:InterPro:IPR008428), CHPF2 CHPF B4GALNT3,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0090162,establishment of epithelial cell polarity,F1MQV5(Evidence code:IEA/Database source:InterPro:IPR033561)E1BIQ8(Evidence code:IEA/Database source:InterPro:IPR031185)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens), FBF1 MPP5 ARF6,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0048008,platelet-derived growth factor receptor signaling pathway,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141), ABL1 PDGFC SRC,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0007130,synaptonemal complex assembly,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens), AGO4 EHMT2 RAD21L1,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0000146,microfilament motor activity,E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357)F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens), MYO9B MYO1D MYH14,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0070569,uridylyltransferase activity,G3N337(Evidence code:IEA/Database source:InterPro:IPR002618)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)A5D9G1(Evidence code:IEA/Database source:InterPro:IPR002618), UAP1L1 ZCCHC6 UAP1,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0030213,hyaluronan biosynthetic process,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q9XS26(Evidence code:IEA/Database source:InterPro:IPR026108)O97711(Evidence code:IEA/Database source:InterPro:IPR028371), HYAL1 HAS3 HAS2,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0070016,armadillo repeat domain binding,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens), LEF1 STRN3 STRN4,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0032510,endosome to lysosome transport via multivesicular body sorting pathway,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698), VPS4B UBXN6 LYST,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0005536,glucose binding,A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312), GCK G6PD HK2,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0021549,cerebellum development,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens), AGTPBP1 RPGRIP1L EN1,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0002011,morphogenesis of an epithelial sheet,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q8N3R9|ens), SRF LIN7C MPP5,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0030506,ankyrin binding,E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens), SPTBN4 FLNC CACNA1D,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0030953,astral microtubule organization,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens), NUMA1 DLG1 KPNB1,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0070932,histone H3 deacetylation,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q2T9N9(Evidence code:IEA/Database source:GO:0032041), SFPQ SIRT2 HDAC5,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0002084,protein depalmitoylation,A5PKD9(Evidence code:IEA/Database source:UniProtKB:Q8VCV1|ens)Q3MHR0(Evidence code:IBA/Database source:PANTHER:PTN001639375)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens), ABHD17C LYPLA1 ABHD12,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0060425,lung morphogenesis,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), FOXF1 MAPK8IP3 SRF,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0000812,Swr1 complex,Q2TBU9(Evidence code:ISS/Database source:UniProtKB:Q9Y230)A7MBG8(Evidence code:IEA/Database source:UniProtKB:Q9Y265|ens)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens), RUVBL2 RUVBL1 EP400,CC,3,3 of 2,0.13,150,0.002828,0.0146
GO:0030902,hindbrain development,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), AHI1 EN1 GLI2,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0070577,lysine-acetylated histone binding,F1MY77(Evidence code:IEA/Database source:UniProtKB:Q9ULU4|ens)Q32S26(Evidence code:ISS/Database source:UniProtKB:P25440)F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens), ZMYND8 BRD2 KMT2A,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0031430,M band,A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q6PD03|ens)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens), PPP2R5A MYBPC3 SMTNL1,CC,3,3 of 2,0.13,150,0.002828,0.0146
GO:0035613,RNA stem-loop binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:Q9HBD1|ens), DHX9 EPRS RC3H2,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0005112,Notch binding,F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)F1MH24(Evidence code:ISS/Database source:UniProtKB:Q2M2I8)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens), DNER AAK1 CUL3,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0050501,hyaluronan synthase activity,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)Q9XS26(Evidence code:IEA/Database source:InterPro:IPR026108)O97711(Evidence code:IEA/Database source:InterPro:IPR028371), HYAL1 HAS3 HAS2,MF,3,3 of 2,0.13,150,0.002828,0.0146
GO:0043984,histone H4-K16 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), KMT2A HCFC1 KANSL3,BP,3,3 of 2,0.13,150,0.002828,0.0146
GO:0044295,axonal growth cone,E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)Q9TRY0(Evidence code:ISS/Database source:UniProtKB:Q9QVC8), TAOK2 RTN4R FKBP4,CC,3,3 of 2,0.13,150,0.002828,0.0146
GO:0046961,"proton-transporting ATPase activity, rotational mechanism",P31404(Evidence code:IEA/Database source:InterPro:IPR005725)P21282(Evidence code:IBA/Database source:PANTHER:PTN000015490)O46563(Evidence code:IEA/Database source:InterPro:IPR004908)P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)P23956(Evidence code:IBA/Database source:PANTHER:PTN000813763)P11019(Evidence code:IEA/Database source:InterPro:IPR002842), ATP6V1A ATP6V1C1 ATP6V1H ATP6V0D1 ATP6V0C ATP6V1E1,MF,6,6 of 16,0.25,37.5,0.002848,0.01464
GO:0046330,positive regulation of JNK cascade,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)F1N2S5(Evidence code:IEA/Database source:UniProtKB:Q8TEJ3|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens), STK3 SH3RF3 TAOK3 DAB2IP MAP3K10 TAOK2,BP,6,6 of 16,0.25,37.5,0.002848,0.01464
GO:0000045,autophagosome assembly,E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257)A4FUD7(Evidence code:IEA/Database source:UniProtKB:O35963|ens), ATG2B PSEN1 RAB23 UBQLN1 NSFL1C RAB33B,BP,6,6 of 16,0.25,37.5,0.002848,0.01464
GO:0043407,negative regulation of MAP kinase activity,A2VDU1(Evidence code:IEA/Database source:UniProtKB:Q9WTP2|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens), SPRY4 SORL1 CBLC RGS14 DAB2IP PTPN6,BP,6,6 of 16,0.25,37.5,0.002848,0.01464
GO:0034605,cellular response to heat,P03968(Evidence code:ISS/Database source:UniProtKB:P05230)P00517(Evidence code:ISS/Database source:UniProtKB:P17612)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), FGF1 PRKACA MYOF PDCD6 IER5 TPR,BP,6,6 of 16,0.25,37.5,0.002848,0.01464
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P68404)P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens)Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q99558|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens)Q2KHV3(Evidence code:ISS/Database source:UniProtKB:Q99732), ABL1 F2R ANKRD17 PRKCB S100A4 TRAF6 IKBKG PINK1 MAP3K14 S100B LITAF,BP,11,11 of 51,0.47,21.57,0.002877,0.01478
GO:0051091,positive regulation of DNA-binding transcription factor activity,P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)Q0III2(Evidence code:IEA/Database source:UniProtKB:O43462|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q13188|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens), KIT MBTPS2 STK3 SRF DDX58 PINK1 TRIM14 FZD1 TRAF6 PPP3CA COPS5 LRP6,BP,12,12 of 59,0.51,20.34,0.002891,0.01483
GO:0006878,cellular copper ion homeostasis,A6QR68(Evidence code:IEA/Database source:UniProtKB:Q8K211|ens)A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276)F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens)Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O08997|ens), SLC31A1 SCO1 ATP7B ATOX1,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0042162,telomeric DNA binding,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q3MHY0(Evidence code:IEA/Database source:InterPro:IPR013867|I)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)F1MMS4(Evidence code:IEA/Database source:InterPro:IPR013867|I), SMG6 TERF1 SMG1 TERF2,MF,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0016236,macroautophagy,Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens), UBQLN1 UBXN6 PIK3R4 CLN3,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0098693,regulation of synaptic vesicle cycle,Q29455(Evidence code:IEA/Database source:UniProtKB:P60904|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens), DNAJC5 BSN RAPGEF4 RAB3B,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0044319,"wound healing, spreading of cells",Q29423(Evidence code:ISS/Database source:UniProtKB:P16070)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens), CD44 ARHGAP35 TOR1A PDCD10,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0055007,cardiac muscle cell differentiation,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), KDM6B TBX3 ARID1A GATA6,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0097431,mitotic spindle pole,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens), CDK5RAP2 TNKS GPSM2 NUMA1,CC,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0051973,positive regulation of telomerase activity,Q0VCK2(Evidence code:IEA/Database source:UniProtKB:Q9C010|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens), PKIB TNKS PTGES3 MAP3K4,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0043024,ribosomal small subunit binding,A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q32KZ1(Evidence code:ISS/Database source:UniProtKB:Q9H2K0)Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859), ABCE1 MTIF3 EIF4H WBSCR1,MF,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0042733,embryonic digit morphogenesis,E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens), GNA12 TBX3 GLI2 FREM2,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0000054,ribosomal subunit export from nucleus,A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727)Q3T054(Evidence code:IBA/Database source:PANTHER:PTN000632582)Q9TU47(Evidence code:IEA/Database source:UniRule:UR000107015)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens), ABCE1 RAN EIF6 XPO1,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0005719,nuclear euchromatin,G3N131(Evidence code:IEA/Database source:UniProtKB:Q02539|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)G3MZY8(Evidence code:IEA/Database source:UniProtKB:P08775|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q91X20|ens), HIST1H1A POU4F2 POLR2A ASH2L,CC,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:2000179,positive regulation of neural precursor cell proliferation,A6H767(Evidence code:ISS/Database source:UniProtKB:P28656)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)P63217(Evidence code:IEA/Database source:UniProtKB:Q80SZ7|ens), NAP1L1 CDON INSM1 GNG5,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0060291,long-term synaptic potentiation,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens), RGS14 BRAF SHANK2 SNAP25,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0016572,histone phosphorylation,E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519)E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens), RPS6KA5 CDK1 ATM HIPK4,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0043029,T cell homeostasis,E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), CACNA1F RC3H2 STAT5A STAT5B,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0035278,miRNA mediated inhibition of translation,Q9TU47(Evidence code:ISS/Database source:UniProtKB:P56537)F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187)F1MLT5(Evidence code:IEA/Database source:InterPro:IPR033499)Q6T5B7(Evidence code:ISS/Database source:UniProtKB:Q9H9G7), EIF6 AGO4 TNRC6C AGO3,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0000380,"alternative mRNA splicing, via spliceosome",Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q69ZA1)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens), DHX9 SRSF1 CDK13 SFPQ,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0048536,spleen development,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens), KMT2A RC3H2 ABL1 BCL3,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0048813,dendrite morphogenesis,F1MQ38(Evidence code:IEA/Database source:UniProtKB:P58545|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)Q3ZC25(Evidence code:ISS/Database source:UniProtKB:Q9NUM4)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens), BTBD3 CAMK2A TMEM106B ABI1,BP,4,4 of 6,0.17,66.67,0.003212,0.01617
GO:0045599,negative regulation of fat cell differentiation,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens), ASXL1 AXIN1 SIRT2 E2F1 WWTR1,BP,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0000086,G2/M transition of mitotic cell cycle,A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens)E1BFR5(Evidence code:ISS/Database source:UniProtKB:Q6NTJ3)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens), CCNY TAF2 MASTL BRSK2 PPM1D,BP,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0002062,chondrocyte differentiation,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BAD4(Evidence code:IBA/Database source:PANTHER:PTN000942785), GLI2 COL2A1 SNX19 SHOX2 RUNX1,BP,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0005791,rough endoplasmic reticulum,Q8WN96(Evidence code:IDA/Database source:)Q56JX6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q9TU34(Evidence code:IDA/Database source:)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)P61356(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), ITPR2 RPS28 ITPR1 PSEN1 RPL27,CC,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0006939,smooth muscle contraction,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)E1B9K4(Evidence code:IBA/Database source:PANTHER:PTN000539684)Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8BWC0|ens), FKBP1B HMCN2 ROCK2 PDE4D TPCN2,BP,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0042254,ribosome biogenesis,Q56JX6(Evidence code:ISS/Database source:UniProtKB:P62857)Q3T0R1(Evidence code:IBA/Database source:PANTHER:PTN000093238)Q4PS77(Evidence code:IBA/Database source:PANTHER:PTN000119716)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q32LB9(Evidence code:IBA/Database source:PANTHER:PTN000119716), RPS28 RPS18 MTG1 XPO1 NOA1,BP,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0071944,cell periphery,Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)Q2T9S0(Evidence code:IEA/Database source:UniProtKB:Q9ERD7|ens), FABP7 STK26 AXIN1 CIB1 TUBB3,CC,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0001570,vasculogenesis,O97711(Evidence code:ISS/Database source:UniProtKB:P70312)Q3T099(Evidence code:IEA/Database source:UniProtKB:Q9CYK1|ens)E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), HAS2 WARS2 MYO18B FOXF1 SOX17,BP,5,5 of 11,0.21,45.45,0.003358,0.01674
GO:0033993,response to lipid,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 122,0.04,0.82,0.003359,0.01674
GO:0051493,regulation of cytoskeleton organization,Q27971(Evidence code:IEA/Database source:InterPro:IPR029539),CAPN2,BP,1,1 of 122,0.04,0.82,0.003359,0.01674
GO:0043068,positive regulation of programmed cell death,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 121,0.04,0.83,0.003331,0.01674
GO:0031966,mitochondrial membrane,Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170085)P00423(Evidence code:IEA/Database source:UniProtKB:P19783|ens)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170085)P48818(Evidence code:IEA/Database source:UniProtKB:P49748|ens)P23709(Evidence code:ISS/Database source:UniProtKB:O75489)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170085)Q58D31(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), DNM1 COX4I1 DNM2 ACADVL NDUFS3 MX2 SORD LRRK2,CC,8,8 of 289,0.34,2.77,0.003367,0.01676
GO:0099132,ATP hydrolysis coupled cation transmembrane transport,F1MKI1(Evidence code:IEA/Database source:GO:0019829)D3K0R6(Evidence code:IEA/Database source:GO:0005388)F1MRN7(Evidence code:IEA/Database source:GO:0005388)P05630(Evidence code:IEA/Database source:GO:0046933)F1MMF3(Evidence code:IEA/Database source:GO:0005388)F1MN60(Evidence code:IEA/Database source:GO:0005388)F1MS16(Evidence code:IEA/Database source:GO:0005388), ATP7B ATP2B4 ATP13A5 ATP5D ATP2C2 ATP2B2 ATP2B3,BP,7,7 of 23,0.3,30.43,0.003395,0.01688
GO:0010564,regulation of cell cycle process,G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q9NUQ3|ens),TXLNG,BP,1,1 of 124,0.04,0.81,0.003471,0.01725
GO:0010811,positive regulation of cell-substrate adhesion,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q2TA37(Evidence code:IDA/Database source:)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), EMILIN1 JAK2 ALOX15 ARL2 NDNF FOXF1,BP,6,6 of 17,0.25,35.29,0.003634,0.01797
GO:0042542,response to hydrogen peroxide,F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)P68107(Evidence code:ISA/Database source:UniProtKB:P97534)P00432(Evidence code:IBA/Database source:PANTHER:PTN000157250)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens), STK26 FKBP1B CAT PPP2CB CRYAB PDCD10,BP,6,6 of 17,0.25,35.29,0.003634,0.01797
GO:0046332,SMAD binding,E1BGE5(Evidence code:IEA/Database source:UniProtKB:O95373|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:Q3U962|ens)P02465(Evidence code:IEA/Database source:UniProtKB:Q01149|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens), IPO7 COL5A2 COL1A2 AXIN1 PURB PURA,MF,6,6 of 17,0.25,35.29,0.003634,0.01797
GO:0016605,PML body,Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), PIAS1 SPTBN4 BLM ATRX WDFY3 TDG,CC,6,6 of 17,0.25,35.29,0.003634,0.01797
GO:0030593,neutrophil chemotaxis,F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)F1MMH2(Evidence code:IEA/Database source:UniProtKB:B8JK39|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), PREX1 FCER1G C5AR1 ITGB2 ITGA9 PDE4D,BP,6,6 of 17,0.25,35.29,0.003634,0.01797
GO:0050804,modulation of chemical synaptic transmission,A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)A2VDQ6(Evidence code:IEA/Database source:UniProtKB:P55288|ens)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18052|ens)E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens), NLGN2 PPP3CA DNM1 CDH11 PTPRA RGS14 PRKACA BCR PACSIN2 BACE1,BP,10,10 of 46,0.42,21.74,0.004179,0.02062
GO:0000932,P-body,Q5E9F9(Evidence code:ISS/Database source:UniProtKB:P46471)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MXK6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817)Q3T0Y5(Evidence code:ISS/Database source:UniProtKB:P49722)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)E1BML0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZCK9(Evidence code:ISS/Database source:UniProtKB:Q9R1P0), PSMC2 AGO3 AGO4 LSM4 PSMA2 PUM1 PAN2 PSMA4,CC,8,8 of 31,0.34,25.81,0.004181,0.02062
GO:0004197,cysteine-type endopeptidase activity,E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)F1MBS7(Evidence code:IEA/Database source:InterPro:IPR001309|I)A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)Q5E998(Evidence code:IBA/Database source:PANTHER:PTN000274640)Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR001309|I)E1BL29(Evidence code:IEA/Database source:InterPro:IPR004134)Q08DY9(Evidence code:IEA/Database source:InterPro:IPR001309|I), USP13 TINAGL1 MALT1 USP20 CTSV CASP6 BLMH CASP3,MF,8,8 of 31,0.34,25.81,0.004181,0.02062
GO:0009653,anatomical structure morphogenesis,F1MC99(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MBH4(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)A6QLP0(Evidence code:IBA/Database source:PANTHER:PTN001371846)F1MZD0(Evidence code:IBA/Database source:PANTHER:PTN001170450), FOXI3 FOXF1 ONECUT2 FOXO4 FBN3,BP,5,5 of 217,0.21,2.3,0.004393,0.02165
GO:0008610,lipid biosynthetic process,Q32PF2(Evidence code:ISS/Database source:UniProtKB:P53396)A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9NR19|ens), ACLY ACSS2,BP,2,2 of 142,0.08,1.41,0.004413,0.02173
GO:2000378,negative regulation of reactive oxygen species metabolic process,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), PINK1 BCR MT3 HK2 SIRT2,BP,5,5 of 12,0.21,41.67,0.004493,0.02202
GO:0043966,histone H3 acetylation,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens)A6QQ14(Evidence code:IEA/Database source:UniProtKB:Q9NR33|ens), BRCA2 LEF1 TAF10 BRD1 POLE4,BP,5,5 of 12,0.21,41.67,0.004493,0.02202
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens), ABL1 DAB2IP OTUD7B STAT1 ASH1L,BP,5,5 of 12,0.21,41.67,0.004493,0.02202
GO:0051496,positive regulation of stress fiber assembly,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), PAK1 NF2 BRAF S100A10 ABL1,BP,5,5 of 12,0.21,41.67,0.004493,0.02202
GO:0043473,pigmentation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q8BLY7|ens)Q9TTK4(Evidence code:ISS/Database source:UniProtKB:Q99698), KIT EN1 ARCN1 HPS6 LYST,BP,5,5 of 12,0.21,41.67,0.004493,0.02202
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)Q2KJ77(Evidence code:IEA/Database source:UniProtKB:Q9NZL4|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), PIAS1 LRRK2 PSEN1 ANKIB1 HSPBP1 SIRT2,BP,6,6 of 18,0.25,33.33,0.004569,0.02233
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420), NEDD4 MYDGF F2R CAT PTPN6 PDGFC,BP,6,6 of 18,0.25,33.33,0.004569,0.02233
GO:0031623,receptor internalization,Q9BDR7(Evidence code:ISS/Database source:UniProtKB:P20491)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P09055)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)P32592(Evidence code:ISS/Database source:UniProtKB:P11835), FCER1G NEDD4 TFRC ITGB1 GRB2 ITGB2,BP,6,6 of 18,0.25,33.33,0.004569,0.02233
GO:0034599,cellular response to oxidative stress,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)P68102(Evidence code:IEA/Database source:UniProtKB:Q6ZWX6|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)Q5NUA6(Evidence code:IEA/Database source:InterPro:IPR029845)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), PNPT1 EIF2S1 LRRK2 SETX SIRT2 PINK1 G6PD NFE2L2 MT3,BP,9,9 of 39,0.38,23.08,0.004606,0.02247
GO:0009897,external side of plasma membrane,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506)F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens), FCER1G KIT TFRC CXCL12 ASTN1 LAMP1 ITGB6 KCNMA1 ABCA1,CC,9,9 of 39,0.38,23.08,0.004606,0.02247
GO:0051085,chaperone cofactor-dependent protein refolding,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)A4FUH1(Evidence code:IEA/Database source:InterPro:IPR017378)F1N7H0(Evidence code:IEA/Database source:UniProtKB:Q99615|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR017378), HSPH1 TOR2A DNAJC7 TOR1A,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0070888,E-box binding,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens), SFPQ PRMT5 TCF7L2 LMO2,MF,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)E1B9M8(Evidence code:IEA/Database source:InterPro:IPR033327)F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466), ALCAM TENM3 SCARF2 TENM2,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0005092,GDP-dissociation inhibitor activity,E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776)F1N2I0(Evidence code:IEA/Database source:InterPro:IPR018203)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:Q8VDU0|ens), RGS14 CHML SH3BP4 GPSM2,MF,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0032509,endosome transport via multivesicular body sorting pathway,A5PK00(Evidence code:IEA/Database source:InterPro:IPR037855)Q3T178(Evidence code:IEA/Database source:InterPro:IPR007143)E1BC70(Evidence code:IEA/Database source:InterPro:IPR037859)A6QP64(Evidence code:IEA/Database source:InterPro:IPR037859), VPS36 VPS28 VPS37C VPS37B,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0090307,mitotic spindle assembly,Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085)A7MBA1(Evidence code:IEA/Database source:UniProtKB:Q9BW19|ens), KIF2A KPNB1 TUBGCP2 KIFC1,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0001618,virus receptor activity,P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-1183)Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-1183)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-1183)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), ITGB1 ITGB6 ITGAV HYAL1,MF,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0009953,dorsal/ventral pattern formation,D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), Gli3 GLI1 EN1 GLI2,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0070207,protein homotrimerization,Q95JC7(Evidence code:ISS/Database source:UniProtKB:Q15758)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q9Y6C2|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens), SLC1A5 TCL1A EMILIN1 PNPT1,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0007249,I-kappaB kinase/NF-kappaB signaling,F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q9WUL6|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749), NFKB1 TRAF6 MAP3K14 BCL3,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0001522,pseudouridine synthesis,E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I)F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103), TRUB1 RPUSD2 PUS3 PUS10,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0003785,actin monomer binding,P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)E1BDD9(Evidence code:IEA/Database source:InterPro:IPR029992), MYL3 MTSS1L TWF1 MKL1,MF,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",E1BE02(Evidence code:ISS/Database source:UniProtKB:Q96AV8)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749), E2F7 ATRX MYO6 BCL3,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0086091,regulation of heart rate by cardiac conduction,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1BMA2(Evidence code:IBA/Database source:PANTHER:PTN000025645)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens), SCN2B CACNA1D KCNH6 TRPM4,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0042060,wound healing,F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153), PTK7 ALOX15 SCRIB PAK1,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0003382,epithelial cell morphogenesis,E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q58DW6(Evidence code:ISS/Database source:UniProtKB:Q9WTL2)Q765N9(Evidence code:ISS/Database source:UniProtKB:Q9Z0G9), FAT1 BCL11B RAB25 CLDN3,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0048565,digestive tract development,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), KIT PDGFC CHD8 FOXF1,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0051402,neuron apoptotic process,F1N4W0(Evidence code:IEA/Database source:UniProtKB:Q8BXQ2|ens)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), PIGT NAE1 AIFM1 PSEN1,BP,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0033180,"proton-transporting V-type ATPase, V1 domain",P31408(Evidence code:IEA/Database source:InterPro:IPR005723)P31407(Evidence code:IEA/Database source:InterPro:IPR005723)P31404(Evidence code:IEA/Database source:InterPro:IPR005725)P21282(Evidence code:IEA/Database source:InterPro:IPR004907|I), ATP6V1B2 ATP6V1B1 ATP6V1A ATP6V1C1,CC,4,4 of 7,0.17,57.14,0.004776,0.0229
GO:0016281,eukaryotic translation initiation factor 4F complex,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859), EIF4G1 EIF4H WBSCR1,CC,3,3 of 3,0.13,100,0.005369,0.02477
GO:0048675,axon extension,G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)P85091(Evidence code:ISS/Database source:UniProtKB:Q7L576), USP9X POU4F2 CYFIP1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0043495,protein membrane anchor,Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens)F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000308195), PDCD6 CIB1 SPAG4,MF,3,3 of 3,0.13,100,0.005369,0.02477
GO:1990869,cellular response to chemokine,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens), SLC12A2 CXCL12 WNK1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0097038,perinuclear endoplasmic reticulum,Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens), CAPN2 SYT6 BCAP31,CC,3,3 of 3,0.13,100,0.005369,0.02477
GO:0043589,skin morphogenesis,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SRF COL1A2 PSEN1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0048709,oligodendrocyte differentiation,Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)P06623(Evidence code:IEA/Database source:UniProtKB:P16330|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens), TSPAN2 CNP PTPRZ1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0030970,"retrograde protein transport, ER to cytosol",F1MGK3(Evidence code:IBA/Database source:PANTHER:PTN000395729)Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), ERLEC1 UFD1L SYVN1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0005391,sodium:potassium-exchanging ATPase activity,Q8HYW6(Evidence code:IEA/Database source:EC:3.6.3.9)Q08DA1(Evidence code:IEA/Database source:InterPro:IPR005775)A2VDL6(Evidence code:IEA/Database source:InterPro:IPR005775), atp1A3 ATP1A1 ATP1A2,MF,3,3 of 3,0.13,100,0.005369,0.02477
GO:0021591,ventricular system development,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens), RAPGEF2 TTC21B HYDIN,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0060718,chorionic trophoblast cell differentiation,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)F1N152(Evidence code:IEA/Database source:UniProtKB:Q9R118|ens)F1N3T0(Evidence code:IEA/Database source:UniProtKB:O08648|ens), E2F7 HTRA1 MAP3K4,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0097194,execution phase of apoptosis,F1MN90(Evidence code:ISS/Database source:UniProtKB:Q96AQ7)Q3T0P5(Evidence code:IEA/Database source:GO:0097200)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000825206), CIDEC CASP6 CASP3,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0031584,activation of phospholipase D activity,G3N3N1(Evidence code:IDA/Database source:)G5E6P3(Evidence code:IBA/Database source:PANTHER:PTN000026718)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616), ARF6 GNA13 ARL1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0060561,apoptotic process involved in morphogenesis,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens), LEF1 SCRIB CRYAB,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0036010,protein localization to endosome,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens), ARF6 TMEM30A PACSIN2,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0070971,endoplasmic reticulum exit site,A2VDL8(Evidence code:ISS/Database source:UniProtKB:Q15436)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), SEC23A PDCD6IP PDCD6,CC,3,3 of 3,0.13,100,0.005369,0.02477
GO:0006729,tetrahydrobiopterin biosynthetic process,Q3T0Z7(Evidence code:ISS/Database source:UniProtKB:P11348)Q3ZBD3(Evidence code:IEA/Database source:InterPro:IPR001533|I)Q17QK8(Evidence code:IEA/Database source:InterPro:IPR006393), QDPR PCBD1 SPR,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:2000009,negative regulation of protein localization to cell surface,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:O14907|ens), ARF6 SNX33 TAX1BP3,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0035267,NuA4 histone acetyltransferase complex,A7MBG8(Evidence code:IEA/Database source:InterPro:IPR037938)F1MLB1(Evidence code:IEA/Database source:UniProtKB:Q96L91|ens)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR037942), RUVBL1 EP400 RUVBL2,CC,3,3 of 3,0.13,100,0.005369,0.02477
GO:0006855,drug transmembrane transport,Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:O43520|ens)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334), TMEM30A ATP8B1 ABCC3,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0009298,GDP-mannose biosynthetic process,Q3SZJ9(Evidence code:IEA/Database source:InterPro:IPR005002)Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR016305)Q2YDJ9(Evidence code:ISS/Database source:UniProtKB:Q9Y5P6), PMM2 MPI GMPPB,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0008331,high voltage-gated calcium channel activity,E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)F1MP22(Evidence code:IBA/Database source:PANTHER:PTN000004694), CACNA1F CACNA1D CACNA1E,MF,3,3 of 3,0.13,100,0.005369,0.02477
GO:0043149,stress fiber assembly,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), CUL3 SRC SRF,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0097094,craniofacial suture morphogenesis,E1BN52(Evidence code:IEA/Database source:UniProtKB:Q5H8C1|ens)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:Q7Z7M0|ens), FREM1 RAB23 MEGF8,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0046755,viral budding,Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens), CHMP4B PDCD6IP TSG101,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0010801,negative regulation of peptidyl-threonine phosphorylation,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens), DGKQ SIRT2 EIF4G1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0070863,positive regulation of protein exit from endoplasmic reticulum,F1MPT8(Evidence code:IEA/Database source:UniProtKB:Q3MIR4|ens)Q17QL5(Evidence code:IEA/Database source:UniProtKB:Q9NV96|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), TMEM30B TMEM30A SORL1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0000800,lateral element,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens), BLM RAD21L1 BRCA2,CC,3,3 of 3,0.13,100,0.005369,0.02477
GO:0030220,platelet formation,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), CIB1 PTPN6 SRF,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0072687,meiotic spindle,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)F1N3C9(Evidence code:IEA/Database source:UniProtKB:Q8BS90|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), RPS6KA2 BORA SIRT2,CC,3,3 of 3,0.13,100,0.005369,0.02477
GO:0006825,copper ion transport,Q3T0E0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0187)A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276)F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens), ATOX1 SCO1 ATP7B,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0030296,protein tyrosine kinase activator activity,G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)Q0VCW2(Evidence code:IEA/Database source:InterPro:IPR028456), PAK2 AFAP1L2 ABI1,MF,3,3 of 3,0.13,100,0.005369,0.02477
GO:0048557,embryonic digestive tract morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), NIPBL SHOX2 FOXF1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0008469,histone-arginine N-methyltransferase activity,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q6NZB1)A7YW45(Evidence code:IBA/Database source:PANTHER:PTN000077429)A6QL80(Evidence code:IBA/Database source:PANTHER:PTN000109455), PRMT6 PRMT5 PRMT3,MF,3,3 of 3,0.13,100,0.005369,0.02477
GO:0007099,centriole replication,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)A2VDZ4(Evidence code:IEA/Database source:InterPro:IPR033700)G3N0U3(Evidence code:IEA/Database source:InterPro:IPR033207), CDK5RAP2 PLK4 CCP110,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), FKBP1B PDE4D CHD7,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0048407,platelet-derived growth factor binding,P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens), COL2A1 COL1A2 COL4A1,MF,3,3 of 3,0.13,100,0.005369,0.02477
GO:0034122,negative regulation of toll-like receptor signaling pathway,E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens), OTUD4 LGR4 SMPDL3B,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0045056,transcytosis,A2VE13(Evidence code:IEA/Database source:InterPro:IPR033240)Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens), MAL2 VPS35 RAB17,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0006207,de novo pyrimidine nucleobase biosynthetic process,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR002082|I)F1ML89(Evidence code:IEA/Database source:InterPro:IPR006274)P31754(Evidence code:IEA/Database source:InterPro:IPR001754|I), CAD CPS1 UMPS,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0030137,COPI-coated vesicle,P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)A0JN39(Evidence code:IEA/Database source:UniProtKB:Q9JIF7|ens)Q28104(Evidence code:IEA/Database source:UniProtKB:O89079|ens), ARCN1 COPB1 COPE,CC,3,3 of 3,0.13,100,0.005369,0.02477
GO:0006303,double-strand break repair via nonhomologous end joining,E1BJF4(Evidence code:IBA/Database source:PANTHER:PTN000035348)E1BLB6(Evidence code:IEA/Database source:InterPro:IPR012582)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens), POLA1 PRKDC PSMD14,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0008474,palmitoyl-(protein) hydrolase activity,Q3MHR0(Evidence code:ISS/Database source:UniProtKB:O75608)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)A5PKD9(Evidence code:IEA/Database source:EC:3.1.2.22), LYPLA1 ABHD12 ABHD17C,MF,3,3 of 3,0.13,100,0.005369,0.02477
GO:0031641,regulation of myelination,G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), KIF14 SIRT2 DLG1,BP,3,3 of 3,0.13,100,0.005369,0.02477
GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",E1BDG9(Evidence code:IEA/Database source:InterPro:IPR016163)P48644(Evidence code:IEA/Database source:InterPro:IPR016163)A7YY67(Evidence code:IEA/Database source:InterPro:IPR016163)F1MHR3(Evidence code:IEA/Database source:InterPro:IPR016163)Q2KJH9(Evidence code:IEA/Database source:InterPro:IPR016163)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424|I), ALDH1L2 ALDH1A1 ALDH1L1 ALDH1A3 ALDH9A1 GAPDHS,MF,6,6 of 19,0.25,31.58,0.00567,0.02611
GO:0050770,regulation of axonogenesis,E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000685295)E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922)F1MXV4(Evidence code:IEA/Database source:UniProtKB:Q8C0T5|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000685295), KIF13B PAK1 SSH2 SIPA1L1 ARHGAP35 PAK3,BP,6,6 of 19,0.25,31.58,0.00567,0.02611
GO:0042593,glucose homeostasis,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)O02754(Evidence code:ISS/Database source:UniProtKB:P53566)A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens), SOX4 SIRT6 DBH PFKM ALMS1 STAT3 CEBPA GCK,BP,8,8 of 33,0.34,24.24,0.005752,0.02642
GO:0045444,fat cell differentiation,Q3T112(Evidence code:ISS/Database source:UniProtKB:P28062)O02754(Evidence code:ISS/Database source:UniProtKB:P05554)E1BJW2(Evidence code:IEA/Database source:UniProtKB:Q923B6|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)A6QNT4(Evidence code:IBA/Database source:PANTHER:PTN000410115)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens), PSMB8 CEBPA STEAP4 ALMS1 FAM120B ARL6 PIAS1 NIPBL,BP,8,8 of 33,0.34,24.24,0.005752,0.02642
GO:0019843,rRNA binding,Q3T0R1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)Q3T087(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)Q3SYR7(Evidence code:IEA/Database source:InterPro:IPR000702|I)A6QLG5(Evidence code:IEA/Database source:InterPro:IPR001912|I)Q3T0S6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)Q24JY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699)F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens)A2VE06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0699), RPS18 RPL11 RPL9 RPS9 RPL8 RPL23A FASTKD2 RPS4Y1,MF,8,8 of 33,0.34,24.24,0.005752,0.02642
GO:0032781,positive regulation of ATPase activity,Q3MI00(Evidence code:IEA/Database source:GO:0001671)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q2HJ94(Evidence code:IEA/Database source:GO:0001671)A6QLM8(Evidence code:IEA/Database source:GO:0001671)Q2KIT4(Evidence code:IEA/Database source:GO:0001671), DNAJB1 DNAJB2 DNAJA2 HSCB DNAJB4,BP,5,5 of 13,0.21,38.46,0.005876,0.0269
GO:0000028,ribosomal small subunit assembly,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q3T0B7(Evidence code:IBA/Database source:PANTHER:PTN000174285)Q2KHT7(Evidence code:IBA/Database source:PANTHER:PTN000174285)A5PK63(Evidence code:IBA/Database source:PANTHER:PTN000077142)Q56JX6(Evidence code:IBA/Database source:PANTHER:PTN000080571), RPS19 RPS27L RPS27 RPS17 RPS28,BP,5,5 of 13,0.21,38.46,0.005876,0.0269
GO:0071479,cellular response to ionizing radiation,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q6PIW4|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), GRB2 TNKS1BP1 INO80 FIGNL1 BLM,BP,5,5 of 13,0.21,38.46,0.005876,0.0269
GO:0016234,inclusion body,Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), BAG5 MT3 WDFY3 LRRK2 PRNP,CC,5,5 of 13,0.21,38.46,0.005876,0.0269
GO:0048468,cell development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), LEF1 TRAF6,BP,2,2 of 139,0.08,1.44,0.006335,0.02897
GO:0005788,endoplasmic reticulum lumen,A4FUH1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A1A4M8(Evidence code:IEA/Database source:UniProtKB:Q9ER38|ens)Q0VD36(Evidence code:IEA/Database source:UniProtKB:Q9JHP7|ens)F1MGK3(Evidence code:IEA/Database source:UniProtKB:Q96DZ1|ens)A5PK45(Evidence code:ISS/Database source:UniProtKB:Q8NBJ5)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)F1MBM5(Evidence code:IEA/Database source:UniProtKB:O14657|ens), TOR2A DNAJB11 TOR3A KDELC1 ERLEC1 COLGALT1 TOR1A TOR1B,CC,8,8 of 34,0.34,23.53,0.006689,0.03054
GO:0006541,glutamine metabolic process,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006274)F1ML89(Evidence code:IEA/Database source:InterPro:IPR006274)Q08DQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0315)Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0315), CAD CPS1 GFPT2 ASNS,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0072583,clathrin-dependent endocytosis,Q0VCK5(Evidence code:IEA/Database source:InterPro:IPR017104)P04973(Evidence code:IBA/Database source:PANTHER:PTN000067451)Q08DF4(Evidence code:IEA/Database source:InterPro:IPR027741)E1BMW2(Evidence code:IEA/Database source:InterPro:IPR017104), AP2A2 CLTA DNM1 AP2A1,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0030866,cortical actin cytoskeleton organization,F1N611(Evidence code:IEA/Database source:InterPro:IPR007477)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MGX4(Evidence code:IEA/Database source:UniProtKB:O95466|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), EPB41L1 DLG1 FMNL1 ARF6,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0060348,bone development,A2VDS0(Evidence code:IEA/Database source:UniProtKB:Q8R574|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), PRPSAP2 PDGFC ASXL1 COL2A1,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0014065,phosphatidylinositol 3-kinase signaling,E1BKJ6(Evidence code:IEA/Database source:InterPro:IPR026722)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BE66(Evidence code:IEA/Database source:UniProtKB:O00329|ens)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens), NYAP1 SIRT2 PIK3CD IRS1,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0030282,bone mineralization,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens), AXIN2 ALOX15 LGR4 SBNO2,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0048741,skeletal muscle fiber development,P68138(Evidence code:ISS/Database source:UniProtKB:P68134)F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens), ACTA1 DNER PPP3CA RYR1,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0008589,regulation of smoothened signaling pathway,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens), GLI2 RPGRIP1L ARL6 TTC21B,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0043627,response to estrogen,E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)P01175(Evidence code:IDA/Database source:)E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens), ASH2L GATA6 OXT ZNF366,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0030073,insulin secretion,P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)E1BKW9(Evidence code:IEA/Database source:UniProtKB:Q6P4T1|ens), PTPRN FKBP1B RAPGEF4 SNX19,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0016918,retinal binding,P12661(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845)P02694(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845)Q5PXY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845)P62964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0845), RBP3 RBP1 CRABP2 CRABP1,MF,4,4 of 8,0.17,50,0.006781,0.03054
GO:0043548,phosphatidylinositol 3-kinase binding,F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), IRS4 IRS1 LCK DAB2IP,MF,4,4 of 8,0.17,50,0.006781,0.03054
GO:0004864,protein phosphatase inhibitor activity,F1N1P8(Evidence code:IEA/Database source:InterPro:IPR026130)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens)A7Z026(Evidence code:IEA/Database source:UniProtKB-KW:KW-0650)E1BPZ4(Evidence code:IEA/Database source:InterPro:IPR008466), PPP1R26 LMTK2 PPP1R37 PPP1R1C,MF,4,4 of 8,0.17,50,0.006781,0.03054
GO:0000792,heterochromatin,A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), UHRF1 TOP2B SALL4 ATRX,CC,4,4 of 8,0.17,50,0.006781,0.03054
GO:0042098,T cell proliferation,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens)Q3T0T1(Evidence code:IEA/Database source:UniProtKB:O35955|ens)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens), RC3H2 PSMB10 FKBP1B MALT1,BP,4,4 of 8,0.17,50,0.006781,0.03054
GO:0019841,retinol binding,P62964(Evidence code:IEA/Database source:UniProtKB-KW:KW-0683)Q5PXY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0683)P12661(Evidence code:IBA/Database source:PANTHER:PTN000137261)P02694(Evidence code:IEA/Database source:UniProtKB-KW:KW-0683), CRABP1 CRABP2 RBP3 RBP1,MF,4,4 of 8,0.17,50,0.006781,0.03054
GO:0043014,alpha-tubulin binding,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens), HSPH1 SPAST RACGAP1 INO80,MF,4,4 of 8,0.17,50,0.006781,0.03054
GO:0001822,kidney development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:E9PZ36|ens)Q32LG4(Evidence code:IEA/Database source:InterPro:IPR032985)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), GREB1L GLI2 PKHD1 ROBO2 PYGO2 RPGRIP1L,BP,6,6 of 20,0.25,30,0.006953,0.03126
GO:0070936,protein K48-linked ubiquitination,Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens)Q1RMX2(Evidence code:ISS/Database source:UniProtKB:P62837)P61085(Evidence code:ISS/Database source:UniProtKB:P61086)A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), UBE2G2 RFFL UBE2D2 UBE2K ITCH SYVN1,BP,6,6 of 20,0.25,30,0.006953,0.03126
GO:0042578,phosphoric ester hydrolase activity,O18964(Evidence code:IEA/Database source:InterPro:IPR002013),SYNJ1,MF,1,1 of 108,0.04,0.93,0.006972,0.03132
GO:0004175,endopeptidase activity,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9QY73|ens)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR000426)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR000426|I)Q3T112(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR000426)Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR000243|I)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR000243|I)A7MBA2(Evidence code:IBA/Database source:PANTHER:PTN000101661)P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56818|ens)P42891(Evidence code:IDA/Database source:)Q3T0X5(Evidence code:IEA/Database source:InterPro:IPR000426)P33672(Evidence code:IEA/Database source:InterPro:IPR016050)Q5E9K0(Evidence code:IEA/Database source:InterPro:IPR016050)Q3T108(Evidence code:IEA/Database source:InterPro:IPR016050)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)Q3T0Y5(Evidence code:IEA/Database source:InterPro:IPR000426)E1BIX3(Evidence code:IEA/Database source:UniProtKB:Q9Y6W3|ens), TMEM59 PSMA7 PSMA4 PSMB8 PSMA3 PSMB10 PCSK6 MBTPS1 PSMB9 PSMD1 PSMD2 BACE1 ECE1 PSMA1 PSMB3 PSMB2 PSMB4 PSEN1 PSMA2 CAPN7,MF,20,20 of 139,0.85,14.39,0.006981,0.03134
GO:0050728,negative regulation of inflammatory response,E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens)A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), ADORA2A ASH1L BCR NFKB1 SMPDL3B FOXF1 VPS35,BP,7,7 of 27,0.3,25.93,0.007067,0.03167
GO:0009566,fertilization,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens), SPTBN4 FNDC3A RAD21L1 EHMT2 KLHL26 CLIC4 TDRD9,BP,7,7 of 27,0.3,25.93,0.007067,0.03167
GO:0050778,positive regulation of immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 112,0.04,0.89,0.007247,0.03245
GO:0046580,negative regulation of Ras protein signal transduction,Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)E1B800(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1BB77(Evidence code:IBA/Database source:PANTHER:PTN000022879)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR028555|I)F1MBI8(Evidence code:IEA/Database source:InterPro:IPR037779), STAMBP RASAL2 DAB2IP RASAL1 SYNGAP1,BP,5,5 of 14,0.21,35.71,0.007533,0.03365
GO:0070063,RNA polymerase binding,Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q28165(Evidence code:ISS/Database source:UniProtKB:Q8CCS6)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens), BRCA1 DHX9 PABPN1 NEDD4 TAF10,MF,5,5 of 14,0.21,35.71,0.007533,0.03365
GO:0031492,nucleosomal DNA binding,E1BGN3(Evidence code:IBA/Database source:PANTHER:PTN000152096)E1BC56(Evidence code:IEA/Database source:InterPro:IPR000079)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)A5PK61(Evidence code:IBA/Database source:PANTHER:PTN000152096)G3MYD7(Evidence code:IBA/Database source:PANTHER:PTN000152096), HIST2H3D LOC785479 H3F3B H3F3C LOC100297725,MF,5,5 of 14,0.21,35.71,0.007533,0.03365
GO:0000781,"chromosome, telomeric region",E1BGK8(Evidence code:IEA/Database source:GO:0006348)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)Q3MHY0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0779)E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens), DOT1L ATM TERF1 WRN BLM TNKS TERF2 RIF1,CC,8,8 of 35,0.34,22.86,0.007737,0.0345
GO:0090501,RNA phosphodiester bond hydrolysis,Q0VCA5(Evidence code:IEA/Database source:GO:0004540)F1MGC2(Evidence code:IEA/Database source:GO:0004540)A6QR44(Evidence code:IEA/Database source:GO:0004525)A7YWM6(Evidence code:IEA/Database source:GO:0004540)Q6TUI4(Evidence code:IEA/Database source:GO:0004525)E1BK83(Evidence code:IEA/Database source:GO:0004526)E1BFB5(Evidence code:IEA/Database source:GO:0004526)E1BFK4(Evidence code:IEA/Database source:GO:0004540), SAMHD1 RNASE2 DGCR8 RNASE13 DICER1 RPP25 KIAA0391 SMG6,BP,8,8 of 35,0.34,22.86,0.007737,0.0345
GO:0045995,regulation of embryonic development,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:G5E870)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9WVM1|ens), NIPBL LAMA3 TDG SOX17 TRIP12 RACGAP1,BP,6,6 of 21,0.25,28.57,0.008432,0.03751
GO:0019722,calcium-mediated signaling,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)F1N6C0(Evidence code:IEA/Database source:InterPro:IPR039030)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), TRPM4 ALMS1 PPP3CA CALM1 TPCN2 LRRK2,BP,6,6 of 21,0.25,28.57,0.008432,0.03751
GO:1901800,positive regulation of proteasomal protein catabolic process,Q2KIW6(Evidence code:IEA/Database source:GO:0036402)A4FUZ3(Evidence code:IEA/Database source:GO:0036402)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q5E9F9(Evidence code:IEA/Database source:GO:0036402)P62194(Evidence code:IEA/Database source:GO:0036402)Q1JP95(Evidence code:IEA/Database source:GO:0036402), PSMC6 PSMC1 DAB2IP PSMC2 PSMC5 PSMC3,BP,6,6 of 21,0.25,28.57,0.008432,0.03751
GO:0050918,positive chemotaxis,F1N0Y5(Evidence code:IEA/Database source:GO:0042056)Q0P5I9(Evidence code:IEA/Database source:GO:0042056)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens), COLEC10 CXCL12 SCRIB,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0048268,clathrin coat assembly,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens)Q0VCK5(Evidence code:IC/Database source:GO:0030122), EPS15 CLTA AP2A2,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0032463,negative regulation of protein homooligomerization,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens), SRC VPS35 CRYAB,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:2000778,positive regulation of interleukin-6 secretion,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), F2R DHX9 DDX58,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0008239,dipeptidyl-peptidase activity,P81425(Evidence code:ISS/Database source:UniProtKB:P27487)E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180)G5E657(Evidence code:IBA/Database source:PANTHER:PTN000110021), DPP4 DPEP3 PRSS16,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0035019,somatic stem cell population maintenance,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BPF3(Evidence code:IEA/Database source:UniProtKB:Q9D219|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q67FY2|ens), BRAF BCL9 BCL9L,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0010458,exit from mitosis,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), SPAST CHMP2A CHMP4B,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0070914,UV-damage excision repair,G3N1W1(Evidence code:IEA/Database source:UniProtKB:Q9H9F9|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)A4IFU5(Evidence code:IEA/Database source:UniProtKB:Q7L7L0|ens), ACTR5 INO80 HIST3H2A,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0005154,epidermal growth factor receptor binding,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens), GRB2 CBLC VAV2,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0042612,MHC class I protein complex,A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490), LOC100125916 LOC788634 BoLA,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0035246,peptidyl-arginine N-methylation,A7YW45(Evidence code:IEA/Database source:InterPro:IPR007857)A6QL80(Evidence code:IEA/Database source:GO:0016274)Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q6NZB1), PRMT5 PRMT3 PRMT6,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0030507,spectrin binding,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens), SPTBN4 PTPRN DCTN2,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0072357,PTW/PP1 phosphatase complex,E1BF96(Evidence code:IEA/Database source:UniProtKB:Q80W00|ens)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR037979)P61287(Evidence code:ISS/Database source:UniProtKB:P36873), PPP1R10 PPP1CB PPP1CC,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:1903361,protein localization to basolateral plasma membrane,Q2KIB6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q32LM6(Evidence code:IBA/Database source:PANTHER:PTN001019267)Q0P5F3(Evidence code:IBA/Database source:PANTHER:PTN001019267), LIN7B LIN7A LIN7C,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0007616,long-term memory,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), RGS14 CHD8 SHANK1,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0070578,RISC-loading complex,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3), DHX9 AGO4 DICER1,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0045504,dynein heavy chain binding,E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277823)Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277823)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens), WDR78 DYNC1I2 DYNC1LI1,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0048477,oogenesis,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens), SRC DDX20 PIWIL2,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0042246,tissue regeneration,G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q3UVD5|ens)Q2TA30(Evidence code:IEA/Database source:InterPro:IPR007007)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700439), LGR6 NINJ1 TEC,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0032012,regulation of ARF protein signal transduction,O46382(Evidence code:IEA/Database source:InterPro:IPR000904|I)F1MIM9(Evidence code:IEA/Database source:InterPro:IPR000904|I)G3MZN6(Evidence code:IEA/Database source:InterPro:IPR000904|I), ARFGEF1 IQSEC2 PSD2,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0005086,ARF guanyl-nucleotide exchange factor activity,G3MZN6(Evidence code:IEA/Database source:InterPro:IPR000904|I)F1MIM9(Evidence code:IEA/Database source:InterPro:IPR000904|I)O46382(Evidence code:IEA/Database source:InterPro:IPR000904|I), PSD2 IQSEC2 ARFGEF1,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0016274,protein-arginine N-methyltransferase activity,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens)A6QL80(Evidence code:IEA/Database source:UniProtKB:Q922H1|ens), PRMT5 PRMT6 PRMT3,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0001553,luteinization,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)P56722(Evidence code:ISS/Database source:UniProtKB:Q60673)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B PTPRN STAT5A,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0000242,pericentriolar material,Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens), LCK CDK5RAP2 PCM1,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0033077,T cell differentiation in thymus,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), PRKDC CDK6 BCL11B,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0016235,aggresome,Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens), UBQLN1 PSEN1 EPS15,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0030517,negative regulation of axon extension,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)G3MYK9(Evidence code:IEA/Database source:UniProtKB:Q4LFA9|ens), MT3 RTN4R SEMA3G,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0035116,embryonic hindlimb morphogenesis,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), TBX3 RPGRIP1L CHD7,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0090557,establishment of endothelial intestinal barrier,F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens), RAPGEF2 F11R RAP2C,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0071480,cellular response to gamma radiation,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens), WRN CRYAB ATM,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0045116,protein neddylation,A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)E1B8X4(Evidence code:IEA/Database source:InterPro:IPR030667), UBE2M LOC780968 NAE1,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0090503,"RNA phosphodiester bond hydrolysis, exonucleolytic",E1BML0(Evidence code:IEA/Database source:GO:0004535)E1BIQ0(Evidence code:IEA/Database source:GO:0000175)Q0II50(Evidence code:IEA/Database source:GO:0000175), PAN2 PNPT1 USB1,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0034113,heterotypic cell-cell adhesion,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)E1BN05(Evidence code:IEA/Database source:GO:0086080), ITGB7 ITGB2 GLDN,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0019869,chloride channel inhibitor activity,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P13569), STX7 WNK1 CFTR,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0046329,negative regulation of JNK cascade,A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens), ITCH DUSP3 TAOK3,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0044257,cellular protein catabolic process,F1MLZ5(Evidence code:IEA/Database source:UniProtKB:A2RT67|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens), DENND3 DAB2IP UBE4B,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0030513,positive regulation of BMP signaling pathway,F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000007601), NUMA1 RNF165 GATA6,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0004407,histone deacetylase activity,Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320|I), MIER1 SIRT2 HDAC5,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0021680,cerebellar Purkinje cell layer development,A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens)Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens), AARS SEZ6L2 AGTPBP1,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:2000010,positive regulation of protein localization to cell surface,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens), SNX33 FCER1G GPD1L,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0050919,negative chemotaxis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)G3MYK9(Evidence code:IBA/Database source:PANTHER:PTN000744245)F1MYW3(Evidence code:IBA/Database source:PANTHER:PTN000744245), SLIT2 SEMA3G SEMA3E,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0031054,pre-miRNA processing,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3), AGO4 ZCCHC6 DICER1,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0001921,positive regulation of receptor recycling,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q2KJD2(Evidence code:ISS/Database source:UniProtKB:P63024)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens), PSEN1 VAMP3 SCRIB,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0000794,condensed nuclear chromosome,Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens), CHMP1A LRPPRC RAD21L1,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0051569,regulation of histone H3-K4 methylation,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), PYGO2 KMT2B KMT2A,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0071889,14-3-3 protein binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1BGB0(Evidence code:IEA/Database source:UniProtKB:Q9NQT8|ens)A5PJP0(Evidence code:IEA/Database source:UniProtKB:Q9NU19|ens), DAB2IP KIF13B TBC1D22B,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0035999,tetrahydrofolate interconversion,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens)Q5I598(Evidence code:ISS/Database source:UniProtKB:P42898)Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR001085), MTHFD1 MTHFR SHMT2,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0050908,detection of light stimulus involved in visual perception,P04695(Evidence code:IEA/Database source:UniProtKB:P11488|ens)P04696(Evidence code:IEA/Database source:UniProtKB:P19087|ens)E1B9S9(Evidence code:IEA/Database source:UniProtKB:O60840|ens), GNAT1 GNAT2 CACNA1F,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0031674,I band,P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens), MYL3 RYR1 SMTNL1,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0034453,microtubule anchoring,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)E1BC48(Evidence code:IEA/Database source:InterPro:IPR028750), PCM1 GCC2 CEP350,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0016514,SWI/SNF complex,A5PKK5(Evidence code:IEA/Database source:InterPro:IPR030088)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR038040), SMARCA2 ARID1A ARID1B,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0000185,activation of MAPKKK activity,Q3SWY6(Evidence code:IEA/Database source:GO:0008349)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1N5W5(Evidence code:IEA/Database source:GO:0008349), STK25 DAB2IP STK26,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0060272,embryonic skeletal joint morphogenesis,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens), AXIN1 SHOX2 COL2A1,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:1990111,spermatoproteasome complex,Q3SZC2(Evidence code:ISS/Database source:UniProtKB:P28076)Q3T0T1(Evidence code:ISS/Database source:UniProtKB:O35955)Q3T112(Evidence code:ISS/Database source:UniProtKB:P28063), PSMB9 PSMB10 PSMB8,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0035640,exploration behavior,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), LRRK2 SHANK2 KMT2A,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0006337,nucleosome disassembly,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens)A4IFU5(Evidence code:IEA/Database source:UniProtKB:Q7L7L0|ens), HIST1H2BA ARID1A HIST3H2A,BP,3,3 of 4,0.13,75,0.008921,0.0378
GO:0031527,filopodium membrane,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:O75781|ens)F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), PALM UTRN ARF6,CC,3,3 of 4,0.13,75,0.008921,0.0378
GO:0003810,protein-glutamine gamma-glutamyltransferase activity,A6QP57(Evidence code:IEA/Database source:InterPro:IPR008958|I)P51176(Evidence code:IEA/Database source:InterPro:IPR008958|I)Q6TNF3(Evidence code:IEA/Database source:InterPro:IPR008958|I), TGM3 TGM2 TGM1,MF,3,3 of 4,0.13,75,0.008921,0.0378
GO:0001817,regulation of cytokine production,Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens), F11R LITAF,BP,2,2 of 131,0.08,1.53,0.008833,0.0378
GO:0048037,cofactor binding,Q32PF2(Evidence code:IEA/Database source:InterPro:IPR003781)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens), ACLY LMO2,MF,2,2 of 132,0.08,1.52,0.008874,0.0378
GO:0030658,transport vesicle membrane,Q9TU34(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P05059(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P56722(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QL5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P23389(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P10897(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P15101(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q8WN96(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), ITPR1 CHGA PTPRN TMEM30A CHGB CYB561 DBH TMEM184A ITPR2,CC,9,9 of 44,0.38,20.45,0.008967,0.03796
GO:0033365,protein localization to organelle,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens), PCM1 VPS35,BP,2,2 of 134,0.08,1.49,0.009066,0.03835
GO:0035108,limb morphogenesis,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:Q7Z7M0|ens), RPGRIP1L TBX3 COL2A1 MEGF8,BP,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0070491,repressing transcription factor binding,A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens), SP1 SRI DDX20 CTBP1,MF,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0030173,integral component of Golgi membrane,Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR017374)Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081292)E1BBS6(Evidence code:IBA/Database source:PANTHER:PTN000528008)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1), LFNG SLC35B1 QSOX2 POMGNT1,CC,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0008138,protein tyrosine/serine/threonine phosphatase activity,E1BPN5(Evidence code:IEA/Database source:InterPro:IPR000340|I)G5E526(Evidence code:IEA/Database source:InterPro:IPR000340)Q2T9T7(Evidence code:IEA/Database source:InterPro:IPR000340|I)A6QLS1(Evidence code:IEA/Database source:InterPro:IPR000340|I), SSH2 PTP4A1 DUSP3 DUSP7,MF,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0030216,keratinocyte differentiation,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000048336), TSG101 CLIC4 POU3F1 CASP3,BP,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0001530,lipopolysaccharide binding,Q3T0X5(Evidence code:IEA/Database source:UniProtKB:Q9R1P4|ens)Q9GL65(Evidence code:IBA/Database source:PANTHER:PTN000687407)P58754(Evidence code:IEA/Database source:InterPro:IPR039217)Q3T108(Evidence code:IEA/Database source:UniProtKB:P99026|ens), PSMA1 TLR4 LY96 PSMB4,MF,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0010613,positive regulation of cardiac muscle hypertrophy,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)P18493(Evidence code:ISS/Database source:UniProtKB:P27008)Q2HJF7(Evidence code:ISS/Database source:UniProtKB:Q13557)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), TWF1 PARP1 CAMK2D PPP3CA,BP,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0005328,neurotransmitter:sodium symporter activity,F1N5R0(Evidence code:IEA/Database source:InterPro:IPR000175|I)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR000175|I)A5D7H9(Evidence code:IEA/Database source:InterPro:IPR000175|I)O18875(Evidence code:IEA/Database source:InterPro:IPR000175|I), SLC6A5 SLC6A20 SLC6A14 SLC6A8,MF,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0031489,myosin V binding,P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens)P10949(Evidence code:IEA/Database source:UniProtKB:Q96E17|ens)P11023(Evidence code:IEA/Database source:UniProtKB:P20336|ens)Q58DW6(Evidence code:IEA/Database source:UniProtKB:P57735|ens), RAB3B RAB3C RAB3A RAB25,MF,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:2000352,negative regulation of endothelial cell apoptotic process,F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)G5E5G9(Evidence code:IEA/Database source:UniProtKB:O96013|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens), NDNF PAK4 BRAF ABL1,BP,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0004029,aldehyde dehydrogenase (NAD) activity,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)Q2KJH9(Evidence code:IEA/Database source:EC:1.2.1.3)P48644(Evidence code:IEA/Database source:UniProtKB:P00352|ens)E1BDG9(Evidence code:IBA/Database source:PANTHER:PTN000192421), ALDH1A3 ALDH9A1 ALDH1A1 ALDH1L2,MF,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0007595,lactation,P02668(Evidence code:IBA/Database source:PANTHER:PTN000895253)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), CSN3 STAT5A ATP7B STAT5B,BP,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0005779,integral component of peroxisomal membrane,Q0P5B1(Evidence code:ISS/Database source:UniProtKB:Q92968)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens), PEX13 FIS1 PEX10 PEX2,CC,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0048487,beta-tubulin binding,E1BPX9(Evidence code:IEA/Database source:UniProtKB:P42704|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), LRPPRC RACGAP1 CCT5 SPAST,MF,4,4 of 9,0.17,44.44,0.009273,0.03876
GO:0048646,anatomical structure formation involved in morphogenesis,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens), GLI2 GRB2,BP,2,2 of 135,0.08,1.48,0.009218,0.03876
GO:0001750,photoreceptor outer segment,P04696(Evidence code:IEA/Database source:UniProtKB:P19087|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)P04695(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026521)F1MR98(Evidence code:IBA/Database source:PANTHER:PTN000662150), GNAT2 SHANK2 GNAT1 GNAT3 RRH,CC,5,5 of 15,0.21,33.33,0.00949,0.03949
GO:0097718,disordered domain specific binding,A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)Q3ZC13(Evidence code:IEA/Database source:UniProtKB:P84091|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens), KEAP1 NUMA1 NCOA3 AP2M1 SMTNL1,MF,5,5 of 15,0.21,33.33,0.00949,0.03949
GO:0048863,stem cell differentiation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), KIT FOXO4 HOXA7 PUM1 SOX17,BP,5,5 of 15,0.21,33.33,0.00949,0.03949
GO:0045104,intermediate filament cytoskeleton organization,Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens)G3MXL3(Evidence code:IEA/Database source:UniProtKB:P12035|ens)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR030634)P67827(Evidence code:ISS/Database source:UniProtKB:P48729)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549), INA KRT3 SYNM CSNK1A1 TOR1A,BP,5,5 of 15,0.21,33.33,0.00949,0.03949
GO:0004722,protein serine/threonine phosphatase activity,E1BD03(Evidence code:IEA/Database source:InterPro:IPR015655)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR037979)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745)P61287(Evidence code:IEA/Database source:InterPro:IPR037981), PPM1D PPP1CB LCK PPP2R2A PPP1CC,MF,5,5 of 15,0.21,33.33,0.00949,0.03949
GO:0042476,odontogenesis,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens)F1MNT4(Evidence code:IEA/Database source:UniProtKB:P07942|ens)G3N201(Evidence code:IEA/Database source:UniProtKB:Q8C3L1|ens), AQP5 AXIN2 BCOR LAMB1 SSUH2,BP,5,5 of 15,0.21,33.33,0.00949,0.03949
GO:0019902,phosphatase binding,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q17R11(Evidence code:IEA/Database source:UniProtKB:Q86Y13|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:Q9H254|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens)F1MWN4(Evidence code:IEA/Database source:UniProtKB:A8K8P3|ens)F1N1P8(Evidence code:IBA/Database source:PANTHER:PTN000404500)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens), DLG1 DZIP3 SPTBN4 WNK1 SFI1 PPP1R26 TSC2,MF,7,7 of 29,0.3,24.14,0.009738,0.04049
GO:0006954,inflammatory response,Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)P58754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453991)Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9EST8|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0395)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), TSPAN2 LY96 HIST1H2BA NFKB1 NOS2 NFKBIZ STAT3 KIT CRH C5AR1 JAK2 DHX9 TLR4 ITGB6 PIK3CD AFAP1L2 F2R HYAL1,BP,18,18 of 121,0.76,14.88,0.009866,0.04099
GO:0007610,behavior,A5D7S3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0085),TRMT1L,BP,1,1 of 102,0.04,0.98,0.01009,0.04187
GO:0030178,negative regulation of Wnt signaling pathway,F1MLB2(Evidence code:IEA/Database source:UniRule:UR000369261)F1ML16(Evidence code:IEA/Database source:UniProtKB:Q14526|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BI79(Evidence code:IEA/Database source:InterPro:IPR026818)Q3ZCD3(Evidence code:IEA/Database source:UniProtKB:Q9DBG9|ens)E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943), CHD8 HIC1 SOX17 APC2 TAX1BP3 TSC2,BP,6,6 of 22,0.25,27.27,0.01013,0.04197
GO:0006487,protein N-linked glycosylation,Q5E9C2(Evidence code:IBA/Database source:PANTHER:PTN000076010)Q5EA65(Evidence code:IEA/Database source:InterPro:IPR033895)Q3SZJ9(Evidence code:IBA/Database source:PANTHER:PTN000049281)Q08DQ2(Evidence code:IBA/Database source:PANTHER:PTN000101302)F1MZY2(Evidence code:IBA/Database source:PANTHER:PTN000101302)F1MS56(Evidence code:IEA/Database source:UniProtKB:O95394|ens), DAD1 DPAGT1 PMM2 GFPT2 GFPT1 PGM3,BP,6,6 of 22,0.25,27.27,0.01013,0.04197
GO:2000147,positive regulation of cell motility,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9DAK9|ens),PHPT1,BP,1,1 of 105,0.04,0.95,0.01029,0.04261
GO:0032940,secretion by cell,F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens),PCSK6,BP,1,1 of 106,0.04,0.94,0.01046,0.04328
GO:0006259,DNA metabolic process,E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)P06526(Evidence code:ISS/Database source:UniProtKB:P04053)Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)E1BKQ6(Evidence code:IEA/Database source:InterPro:IPR020587)F1MU48(Evidence code:IEA/Database source:InterPro:IPR013758), WRN DNTT SMARCAL1 MMS19 MYO18A TOP2B,BP,6,6 of 217,0.25,2.76,0.01059,0.04379
GO:0051345,positive regulation of hydrolase activity,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens),WRN,BP,1,1 of 107,0.04,0.93,0.01068,0.04414
GO:0016779,nucleotidyltransferase activity,E1BCH6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)P06526(Evidence code:IEA/Database source:InterPro:IPR019843)E1BEN4(Evidence code:IEA/Database source:InterPro:IPR005835)G3MZY8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)Q2YDJ9(Evidence code:IEA/Database source:InterPro:IPR005835)A6QQ14(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)E1BAR2(Evidence code:IEA/Database source:InterPro:IPR002934)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0548)Q0VC66(Evidence code:IEA/Database source:UniRule:UR000160875), ISPD DNTT GMPPA POLR2A GMPPB POLE4 MB21D1 ZCCHC6 POLA1 CTU1,MF,10,10 of 54,0.42,18.52,0.01085,0.04482
GO:0005543,phospholipid binding,F1MKE9(Evidence code:IEA/Database source:InterPro:IPR001605)F1MP30(Evidence code:IEA/Database source:InterPro:IPR037302)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q8TCU6|ens)Q0IIM2(Evidence code:IDA/Database source:)E1BLT3(Evidence code:IEA/Database source:InterPro:IPR001605)G3MZN6(Evidence code:IEA/Database source:InterPro:IPR001605)E1BBX9(Evidence code:IEA/Database source:InterPro:IPR037302)E1B801(Evidence code:IEA/Database source:UniProtKB:Q9NRY4|ens)E1BPM0(Evidence code:IEA/Database source:InterPro:IPR028555)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)A6QQP7(Evidence code:ISS/Database source:UniProtKB:O75923)F1MK99(Evidence code:IEA/Database source:InterPro:IPR037302)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens)E1BNB7(Evidence code:IEA/Database source:UniProtKB:Q9UNA1|ens), SPTB UNC13B PREX1 ARL6 SPTBN4 PSD2 UNC13C ARHGAP35 RASAL1 BAIAP3 DYSF UNC13A PRKCI MYOF ARHGAP26,MF,15,15 of 94,0.64,15.96,0.01115,0.046
GO:1903508,positive regulation of nucleic acid-templated transcription,A7MBG8(Evidence code:IEA/Database source:GO:0003713)A5PJW1(Evidence code:IEA/Database source:GO:0003713)O02754(Evidence code:IEA/Database source:GO:0003713)Q08DI5(Evidence code:IEA/Database source:GO:0003713)P05126(Evidence code:IEA/Database source:GO:0030374)F1N3I6(Evidence code:IEA/Database source:GO:0003713)Q3MHP1(Evidence code:IEA/Database source:GO:0003713)A1A4I4(Evidence code:IEA/Database source:GO:0030374), RUVBL1 TAF10 CEBPA RAP2C PRKCB WWC1 UBE2L3 PKN1,BP,8,8 of 255,0.34,3.14,0.01301,0.04788
GO:0030198,extracellular matrix organization,P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)A6QLN9(Evidence code:IEA/Database source:UniProtKB:Q8R2Z5|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens), MYF5 BCL3 FOXF1 VWA1 EMILIN1 OLFML2A COL4A6 NDNF,BP,8,8 of 39,0.34,20.51,0.01319,0.04788
GO:0005484,SNAP receptor activity,Q2KHY2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q2KJD2(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q17QQ3(Evidence code:IBA/Database source:PANTHER:PTN000447753)Q0V7N0(Evidence code:IBA/Database source:PANTHER:PTN000473885)P63026(Evidence code:IBA/Database source:PANTHER:PTN000473885)Q3ZBT5(Evidence code:IEA/Database source:InterPro:IPR006012), VAMP5 VAMP3 SNAP25 VAMP1 VAMP2 STX7,MF,6,6 of 23,0.25,26.09,0.01205,0.04788
GO:0005544,calcium-dependent phospholipid binding,A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001283)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001972)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001283)P27214(Evidence code:IEA/Database source:InterPro:IPR001464|I)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens), SYTL2 SYT4 SYTL1 ANXA11 SYT6,MF,5,5 of 16,0.21,31.25,0.01177,0.04788
GO:0032091,negative regulation of protein binding,Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), DNAJB2 PIN1 SORL1 TDG LRRK2,BP,5,5 of 16,0.21,31.25,0.01177,0.04788
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens), ITPR1 DAB2IP AIFM1 BRSK2,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0051893,regulation of focal adhesion assembly,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q9H792|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens), DUSP3 PEAK1 SLK GPM6B,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0034314,Arp2/3 complex-mediated actin nucleation,F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383)Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I)F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens), ACTR3B ARPC1A ARPC5L IQGAP2,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0032743,positive regulation of interleukin-2 production,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BAD4(Evidence code:IEA/Database source:UniProtKB:Q01196|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens), PDE4D TRAF6 RUNX1 MALT1,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0045663,positive regulation of myoblast differentiation,E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)P20959(Evidence code:ISS/Database source:UniProtKB:P17936)E1BB93(Evidence code:IEA/Database source:InterPro:IPR032982), CDON MYF5 IGFBP3 BOC,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0035591,signaling adaptor activity,Q17R10(Evidence code:IEA/Database source:InterPro:IPR030115)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)F1MRH8(Evidence code:IEA/Database source:InterPro:IPR030520|I)F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222), AFAP1L2 DAB2IP SH2B2 EPS8,MF,4,4 of 10,0.17,40,0.01229,0.04788
GO:0010389,regulation of G2/M transition of mitotic cell cycle,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MP51(Evidence code:IEA/Database source:UniProtKB:Q8NCM2|ens)E1BC36(Evidence code:IBA/Database source:PANTHER:PTN000623979)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979), KIF14 KCNH5 CDK6 CDK3,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0035861,site of double-strand break,Q9TTA5(Evidence code:ISS/Database source:UniProtKB:Q9NZC9)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens), SMARCAL1 SAMHD1 RAD18 RIF1,CC,4,4 of 10,0.17,40,0.01229,0.04788
GO:0007569,cell aging,A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens), PDCD4 TBX3 BRCA2 WRN,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0046632,alpha-beta T cell differentiation,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), LEF1 BRAF ABL1 BCL11B,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0000266,mitochondrial fission,Q3T0I5(Evidence code:IEA/Database source:InterPro:IPR016543)Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000902162)Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000902162)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000902162), FIS1 MX2 DNM1 DNM2,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0016180,snRNA processing,E1B7Q9(Evidence code:IEA/Database source:UniProtKB:Q5TA45|ens)A5PJT2(Evidence code:IEA/Database source:InterPro:IPR026164)E1B8S1(Evidence code:IEA/Database source:UniProtKB:Q8N201|ens)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens), CPSF3L INTS10 INTS1 INTS3,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0034389,lipid droplet organization,P26882(Evidence code:ISS/Database source:UniProtKB:Q08752)F1MT41(Evidence code:IEA/Database source:UniProtKB:Q9WV91|ens)F1MN90(Evidence code:ISS/Database source:UniProtKB:Q96AQ7)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens), PPID PTGFRN CIDEC SPG20,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0008333,endosome to lysosome transport,A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)F1MLZ5(Evidence code:IEA/Database source:UniProtKB:A2RT67|ens)A5PKA5(Evidence code:IEA/Database source:UniProtKB:Q3UHD6|ens), FAM160A2 VPS41 DENND3 SNX27,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0005682,U5 snRNP,E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555)A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760), SNRNP200 SNRPE PRPF8 SNRPN,CC,4,4 of 10,0.17,40,0.01229,0.04788
GO:0030501,positive regulation of bone mineralization,A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295)F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)E1BAI2(Evidence code:IEA/Database source:UniProtKB:Q9UEF7|ens), GPM6B ANO6 FAM20C KL,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0051216,cartilage development,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)P07507(Evidence code:IEA/Database source:UniProtKB-KW:KW-0891)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), DLX2 HYAL1 MGP COL2A1,BP,4,4 of 10,0.17,40,0.01229,0.04788
GO:0008327,methyl-CpG binding,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)F1MFQ4(Evidence code:IEA/Database source:UniProtKB:Q9P1Z0|ens), PRMT5 LRWD1 ZBTB4,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,A6QPZ5(Evidence code:IEA/Database source:UniProtKB:Q9ULV8|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:Q9D7X3|ens), CBLC TSG101 DUSP3,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0004697,protein kinase C activity,P05126(Evidence code:IEA/Database source:InterPro:IPR014375)F1MQ96(Evidence code:IEA/Database source:InterPro:IPR034661)A1A4I4(Evidence code:IEA/Database source:EC:2.7.11.13), PRKCB PRKCI PKN1,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0090141,positive regulation of mitochondrial fission,Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)A5PJP5(Evidence code:IBA/Database source:PANTHER:PTN001121970), FIS1 VPS35 PINK1,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0016925,protein sumoylation,P48820(Evidence code:ISS/Database source:UniProtKB:P49792)E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens), RANBP2 TRPM4 PIAS1,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0060079,excitatory postsynaptic potential,P02715(Evidence code:IEA/Database source:GO:0022848)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), CHRNE LRRK2 PPP3CA,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0042130,negative regulation of T cell proliferation,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens), DLG1 MARCH7 PTPN6,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0003374,dynamin family protein polymerization involved in mitochondrial fission,Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170085)Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170085)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170085), MX2 DNM1 DNM2,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), EIF4G1 ANKRD17 HYAL1,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0090136,epithelial cell-cell adhesion,Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BFA7(Evidence code:IEA/Database source:UniProtKB:Q9BVG8|ens), CTNNA1 SRF KIFC3,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0043653,mitochondrial fragmentation involved in apoptotic process,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), FIS1 CCAR2 VPS35,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0006471,protein ADP-ribosylation,P18493(Evidence code:IEA/Database source:InterPro:IPR004102|I)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens), PARP1 TNKS SIRT6,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0045647,negative regulation of erythrocyte differentiation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646), STAT5A STAT5B HSPA9,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0006658,phosphatidylserine metabolic process,A4FUZ5(Evidence code:IEA/Database source:InterPro:IPR029557)Q58CW5(Evidence code:IEA/Database source:InterPro:IPR029554)F1N5T9(Evidence code:IEA/Database source:InterPro:IPR029555), SERINC3 SERINC2 SERINC5,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:2000648,positive regulation of stem cell proliferation,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens)E1BGK7(Evidence code:IEA/Database source:UniProtKB:G5E8Z2|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), SIRT6 TAF4B TBX3,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0043142,single-stranded DNA-dependent ATPase activity,E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250), POLQ RAD18 RFC2,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0043425,bHLH transcription factor binding,A6QPK5(Evidence code:IBA/Database source:PANTHER:PTN000927455)E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens), TCF7L2 MAP3K10 LMO2,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0060292,long term synaptic depression,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BFV9(Evidence code:IEA/Database source:UniProtKB:Q0QWG9|ens), SRF SHANK2 GRID2IP,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0051014,actin filament severing,Q28046(Evidence code:IEA/Database source:InterPro:IPR030012)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR029924), SCIN FMNL1 DSTN,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0051156,glucose 6-phosphate metabolic process,E1BME6(Evidence code:IEA/Database source:GO:0004340)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens)A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens), HK2 G6PD GCK,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0051966,"regulation of synaptic transmission, glutamatergic",E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001173581)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens), GRM7 PSEN1 LRRK2,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0032331,negative regulation of chondrocyte differentiation,F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), ADAMTS7 ADAMTS12 GLI2,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0001824,blastocyst development,Q5E9C2(Evidence code:IEA/Database source:UniProtKB:P61804|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)Q27971(Evidence code:IEA/Database source:UniProtKB:O08529|ens), DAD1 ETV2 CAPN2,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0019855,calcium channel inhibitor activity,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens), PHPT1 PACSIN3 FKBP1B,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0005104,fibroblast growth factor receptor binding,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8WU20|ens)E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens)P03968(Evidence code:IEA/Database source:InterPro:IPR028210), FRS2 KL FGF1,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0006882,cellular zinc ion homeostasis,F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239), ATP7B MT3 LCK,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0031681,G-protein beta-subunit binding,F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)G3N3N1(Evidence code:IDA/Database source:)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558), CCT5 ARF6 F2R,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0034237,protein kinase A regulatory subunit binding,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6)P00517(Evidence code:IEA/Database source:InterPro:IPR039035)P05131(Evidence code:IEA/Database source:InterPro:IPR039083), ARFGEF1 PRKACA PRKACB,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0044548,S100 protein binding,P03968(Evidence code:ISS/Database source:UniProtKB:P05230)P02638(Evidence code:ISS/Database source:UniProtKB:P04271)P27214(Evidence code:ISS/Database source:UniProtKB:P50995), FGF1 S100B ANXA11,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0032281,AMPA glutamate receptor complex,E1BGZ0(Evidence code:IEA/Database source:UniProtKB:Q9Z2W9|ens)Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens)F1MBY1(Evidence code:IBA/Database source:PANTHER:PTN000438080), GRIA3 ABHD12 GRIA2,CC,3,3 of 5,0.13,60,0.01356,0.04788
GO:0046627,negative regulation of insulin receptor signaling pathway,P05126(Evidence code:ISS/Database source:UniProtKB:P68403)Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR035036)E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943), PRKCB Grb10 TSC2,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0032486,Rap protein signal transduction,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:Q80ZJ1|ens), RAPGEF2 RAP2C RAP2A,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)Q2YDF7(Evidence code:IBA/Database source:PANTHER:PTN001474972)P68107(Evidence code:ISA/Database source:UniProtKB:P68106), PDE4D JSRP1 FKBP1B,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:2000251,positive regulation of actin cytoskeleton reorganization,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)Q5EAD0(Evidence code:IBA/Database source:PANTHER:PTN001022094), ABL1 BAIAP2L1 BAIAP2,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0007254,JNK cascade,A4FV00(Evidence code:IBA/Database source:PANTHER:PTN001171982)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens), MAPK10 MAPK8IP3 MAPK9,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0090398,cellular senescence,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens), SRF TBX3 PRMT6,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0042274,ribosomal small subunit biogenesis,Q56JX6(Evidence code:IEA/Database source:UniProtKB:P62857|ens)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), RPS28 RPS7 RPS19,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0015194,L-serine transmembrane transporter activity,F1N5T9(Evidence code:IBA/Database source:PANTHER:PTN000043695)Q58CW5(Evidence code:IBA/Database source:PANTHER:PTN000043695)A4FUZ5(Evidence code:IBA/Database source:PANTHER:PTN000043695), SERINC5 SERINC2 SERINC3,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0016358,dendrite development,E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)Q2TBL9(Evidence code:IEA/Database source:UniProtKB:Q9ES56|ens), PAK3 SYNGAP1 TRAPPC4,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0005523,tropomyosin binding,F1MF57(Evidence code:IEA/Database source:UniProtKB:O76041|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR004934|I), NEBL SMTNL1 TMOD3,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0033627,cell adhesion mediated by integrin,P80746(Evidence code:ISS/Database source:UniProtKB:P06756)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)Q8SQB8(Evidence code:ISS/Database source:UniProtKB:P18564), ITGAV ITGB1 ITGB6,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0016742,"hydroxymethyl-, formyl- and related transferase activity",E1BDG9(Evidence code:IEA/Database source:InterPro:IPR002376|I)A7YY67(Evidence code:IEA/Database source:InterPro:IPR002376|I)Q59A32(Evidence code:IEA/Database source:InterPro:IPR002376|I), ALDH1L2 ALDH1L1 GART,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0035136,forelimb morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens), NIPBL TBX3 RNF165,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0051145,smooth muscle cell differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BDD9(Evidence code:IBA/Database source:PANTHER:PTN000513566), GATA6 FOXF1 MKL1,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0042805,actinin binding,F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens), PROM1 NFKB1 MICALL2,MF,3,3 of 5,0.13,60,0.01356,0.04788
GO:0010719,negative regulation of epithelial to mesenchymal transition,P67774(Evidence code:IEA/Database source:UniProtKB:P67775|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), PPP2CA STRAP DAB2IP,BP,3,3 of 5,0.13,60,0.01356,0.04788
GO:0015026,coreceptor activity,O46405(Evidence code:IEA/Database source:InterPro:IPR037676)E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606), CD80 HFE2,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:2000623,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P61286(Evidence code:ISS/Database source:UniProtKB:P11940)E1BJ90(Evidence code:IEA/Database source:UniProtKB:Q14147|ens), PABPC1 DHX34,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0050473,arachidonate 15-lipoxygenase activity,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)P27479(Evidence code:IEA/Database source:EC:1.13.11.33), ALOX15B ALOX15,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0003910,DNA ligase (ATP) activity,A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I)P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695), LIG1 PARP1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0043995,histone acetyltransferase activity (H4-K5 specific),F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), KANSL3 HCFC1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0006425,glutaminyl-tRNA aminoacylation,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR004514|I), LARS QARS,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0033129,positive regulation of histone phosphorylation,E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens), RPS6KA5 RPS6KA4,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0061578,Lys63-specific deubiquitinase activity,E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens)Q17QP9(Evidence code:IEA/Database source:InterPro:IPR035299), OTUD4 PSMD14,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0046972,histone acetyltransferase activity (H4-K16 specific),E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0033192,calmodulin-dependent protein phosphatase activity,P48452(Evidence code:ISS/Database source:UniProtKB:Q08209)A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens), PPP3CA PPP3CC,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0003923,GPI-anchor transamidase activity,F1N4W0(Evidence code:IBA/Database source:PANTHER:PTN000311103)Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR028361), PIGT PIGK,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:2001271,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens), PAK2 RFFL,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0008568,microtubule-severing ATPase activity,E1BAN2(Evidence code:IEA/Database source:EC:3.6.4.3)A2VDN5(Evidence code:IEA/Database source:InterPro:IPR017179|I), KATNAL2 SPAST,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0072711,cellular response to hydroxyurea,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), BLM ATRX,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:2000394,positive regulation of lamellipodium morphogenesis,E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), RREB1 SRC,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0043219,lateral loop,E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), MPP5 DLG1,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0050847,progesterone receptor signaling pathway,E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens), SRC NEDD4,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0008865,fructokinase activity,A6QR34(Evidence code:IBA/Database source:PANTHER:PTN000455410)E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350), GCK HK2,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0071763,nuclear membrane organization,F1MBM5(Evidence code:IEA/Database source:UniProtKB:Q9ER41|ens)A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens), TOR1B TOR1A,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0016233,telomere capping,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens), TERF2 PRKDC,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0032183,SUMO binding,E1BB54(Evidence code:IEA/Database source:InterPro:IPR028890)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), USPL1 TDG,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0071257,cellular response to electrical stimulus,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens), GNAT1 PALM,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0016618,hydroxypyruvate reductase activity,F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107947)F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens), CTBP1 GRHPR,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:1901315,negative regulation of histone H2A K63-linked ubiquitination,E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669)Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens), TRIP12 OTUB1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0014044,Schwann cell development,G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens), POU3F1 LAMB2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0097487,"multivesicular body, internal vesicle",Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), CD63 LRRK2,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0022028,tangential migration from the subventricular zone to the olfactory bulb,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), LRRK2 SRF,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:1904851,positive regulation of establishment of protein localization to telomere,F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P49368|ens), CCT5 CCT3,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0004560,alpha-L-fucosidase activity,F1N5H2(Evidence code:IEA/Database source:InterPro:IPR000933|I)Q2KIM0(Evidence code:IEA/Database source:InterPro:IPR000933|I), FUCA2 FUCA1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0099074,mitochondrion to lysosome transport,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), PINK1 VPS35,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0001939,female pronucleus,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens), RIF1 TET3,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0045162,clustering of voltage-gated sodium channels,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)E1BN05(Evidence code:IEA/Database source:InterPro:IPR031224), SPTBN4 GLDN,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0051683,establishment of Golgi localization,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens), PDCD10 ARHGAP21,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0006409,tRNA export from nucleus,E1B8Q8(Evidence code:IEA/Database source:UniProtKB:O43592|ens)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens), XPOT SSB,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0006273,lagging strand elongation,P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695)E1BJF4(Evidence code:IBA/Database source:PANTHER:PTN000035348), PARP1 POLA1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0008526,phosphatidylinositol transporter activity,F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens), TNFAIP8L3 PITPNA,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0097440,apical dendrite,E1B7M8(Evidence code:IEA/Database source:UniProtKB:Q5QNQ6|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357), OSBP2 MYO1D,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0072520,seminiferous tubule development,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens), ATRX RAD21L1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0070087,chromo shadow domain binding,F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), ATRX NIPBL,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0015680,intracellular copper ion transport,F1MKI1(Evidence code:IEA/Database source:UniProtKB:Q64446|ens)Q3T0E0(Evidence code:IBA/Database source:PANTHER:PTN001106576), ATP7B ATOX1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0030991,intraciliary transport particle A,F1N307(Evidence code:IBA/Database source:PANTHER:PTN000380174)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens), TTC21A TTC21B,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:1990909,Wnt signalosome,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens), LRRK2 LRP6,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060119,inner ear receptor cell development,E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens), ATP8B1 GABRA5,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0038061,NIK/NF-kappaB signaling,E1BL08(Evidence code:IEA/Database source:GO:0004704)F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216), MAP3K14 NFKB1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0031065,positive regulation of histone deacetylation,F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), CTBP1 NIPBL,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0051292,nuclear pore complex assembly,E1BM06(Evidence code:IEA/Database source:UniProtKB:Q9BTX1|ens)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens), NDC1 AHCTF1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0043276,anoikis,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens), E2F1 TSC2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060575,intestinal epithelial cell differentiation,F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens), CBFA2T2 GATA6,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0042731,PH domain binding,Q3ZBK6(Evidence code:IEA/Database source:UniProtKB:Q9Y4Z0|ens)F1MHB9(Evidence code:IEA/Database source:UniProtKB:Q14642|ens), LSM4 INPP5A,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0001927,exocyst assembly,E1BDW9(Evidence code:IBA/Database source:PANTHER:PTN000315823)A4IF89(Evidence code:IBA/Database source:PANTHER:PTN000484343), EXOC2 EXOC8,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060026,convergent extension,F1MWK8(Evidence code:IEA/Database source:InterPro:IPR033592)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), PTK7 LRP6,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0048846,axon extension involved in axon guidance,Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), ALCAM SLIT2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:2000463,positive regulation of excitatory postsynaptic potential,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298), SHANK1 CUX2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0006415,translational termination,Q0VCX5(Evidence code:IEA/Database source:InterPro:IPR004403)A4IFE6(Evidence code:IBA/Database source:PANTHER:PTN000443727), ETF1 ABCE1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0001841,neural tube formation,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens), SOX4 STK3,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0004340,glucokinase activity,E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350)A6QR34(Evidence code:IEA/Database source:InterPro:IPR039073), HK2 GCK,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0048668,collateral sprouting,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens), ABL1 BDNF,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0031467,Cul7-RING ubiquitin ligase complex,Q3ZCF3(Evidence code:ISS/Database source:UniProtKB:P63208)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806), SKP1 LOC780968,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0031018,endocrine pancreas development,F1MU40(Evidence code:IBA/Database source:PANTHER:PTN000677917)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens), MNX1 ONECUT2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0002315,marginal zone B cell differentiation,Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens), LFNG BCL3,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0035562,negative regulation of chromatin binding,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), PPP3CA TDG,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0036035,osteoclast development,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens), SRC LRRK1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0097449,astrocyte projection,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens), PINK1 SYT4,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0033572,transferrin transport,E1BIG6(Evidence code:IEA/Database source:InterPro:IPR029513|I)F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens), TFRC LMTK2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0071930,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q96AV8)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens), E2F7 E2F1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0097010,eukaryotic translation initiation factor 4F complex assembly,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859)Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859), WBSCR1 EIF4H,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0090103,cochlea morphogenesis,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), GLI2 PTK7,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0005522,profilin binding,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)F1MGX4(Evidence code:IEA/Database source:UniProtKB:Q9JL26|ens), CTTN FMNL1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0043987,histone H3-S10 phosphorylation,F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens), RPS6KA4 RPS6KA5,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:2000321,positive regulation of T-helper 17 cell differentiation,Q9BE45(Evidence code:ISS/Database source:UniProtKB:Q9EST8)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens), NFKBIZ MALT1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0042074,cell migration involved in gastrulation,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:Q7Z7M0|ens), SOX17 MEGF8,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:1902430,negative regulation of amyloid-beta formation,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens), PRNP SORL1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0045794,negative regulation of cell volume,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens), ANO6 KCNMA1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0004396,hexokinase activity,A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312|I)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312|I), GCK HK2,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0005168,neurotrophin TRKA receptor binding,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8WU20|ens), GRB2 FRS2,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0034499,late endosome to Golgi transport,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)G3MXN3(Evidence code:IEA/Database source:UniProtKB:O43147|ens), GCC2 SGSM2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0046833,positive regulation of RNA export from nucleus,Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), KHDRBS1 DHX9,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0004439,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity",E1BB73(Evidence code:IEA/Database source:UniProtKB:P32019|ens)O18964(Evidence code:IEA/Database source:EC:3.1.3.36), INPP5B SYNJ1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060219,camera-type eye photoreceptor cell differentiation,F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)F1MPT4(Evidence code:IEA/Database source:UniProtKB:Q6V4S5|ens), PROM1 SDK2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:2000042,negative regulation of double-strand break repair via homologous recombination,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens)E1BMC0(Evidence code:IEA/Database source:UniProtKB:O75417|ens), RIF1 POLQ,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0097200,cysteine-type endopeptidase activity involved in execution phase of apoptosis,Q3T0P5(Evidence code:IEA/Database source:InterPro:IPR037554)Q08DY9(Evidence code:IBA/Database source:PANTHER:PTN000825206), CASP6 CASP3,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060009,Sertoli cell development,E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), FNDC3A ATRX,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0043988,histone H3-S28 phosphorylation,F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens), RPS6KA4 RPS6KA5,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0038027,apolipoprotein A-I-mediated signaling pathway,F1MG24(Evidence code:IEA/Database source:GO:0034188)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens), ABCA1 ABCA7,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0007398,ectoderm development,E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), ZBTB17 NF2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:2000642,negative regulation of early endosome to late endosome transport,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens), SNX3 SNX12,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0046855,inositol phosphate dephosphorylation,P20456(Evidence code:IEA/Database source:InterPro:IPR033942)F1MHB9(Evidence code:IBA/Database source:PANTHER:PTN000313248), IMPA1 INPP5A,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0046976,histone methyltransferase activity (H3-K27 specific),E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens), SUZ12 EHMT2,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060134,prepulse inhibition,Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens), FABP7 CHD8,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0015871,choline transport,E1BIP2(Evidence code:IEA/Database source:UniProtKB:Q6X893|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), SLC44A1 PSEN1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0016080,synaptic vesicle targeting,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens), PSEN1 SCRIB,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0019919,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine",A6QL80(Evidence code:IEA/Database source:GO:0035242)Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8), PRMT3 PRMT6,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060152,microtubule-based peroxisome localization,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens), PEX13 PEX1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0090286,cytoskeletal anchoring at nuclear membrane,F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000985481)E1BJU6(Evidence code:IEA/Database source:InterPro:IPR030267), SPAG4 SYNE3,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0003310,pancreatic A cell differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0), GATA6 INSM1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0009051,"pentose-phosphate shunt, oxidative branch",Q2TBQ8(Evidence code:IBA/Database source:PANTHER:PTN000114544)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens), PGLS G6PD,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0090527,actin filament reorganization,E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604), FRYL FRY,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0022038,corpus callosum development,G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), RTN4R RPGRIP1L,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0016081,synaptic vesicle docking,F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens), UNC13B UNC13A,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0007252,I-kappaB phosphorylation,E1BPW2(Evidence code:IEA/Database source:UniProtKB:Q8IUD2|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), ERC1 DAB2IP,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0045059,positive thymic T cell selection,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), ZAP70 SRF,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0048312,intracellular distribution of mitochondria,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)E1BIA7(Evidence code:IEA/Database source:InterPro:IPR027523), LRRK2 CLUH,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0019784,NEDD8-specific protease activity,Q3T0Y1(Evidence code:IEA/Database source:UniRule:UR000329326)Q3SZA0(Evidence code:IBA/Database source:PANTHER:PTN000091645), OTUB1 COPS4,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0045176,apical protein localization,E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens)B6Z9Q5(Evidence code:IEA/Database source:InterPro:IPR027686), HCN1 SHROOM2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0005721,pericentric heterochromatin,F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens), LRWD1 ATRX,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:1990023,mitotic spindle midzone,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens), NUMA1 CTTN,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0042471,ear morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens), CHD7 NIPBL,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0004813,alanine-tRNA ligase activity,A6QLT9(Evidence code:IEA/Database source:InterPro:IPR018162|I)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR018162|I), AARS AARS2,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0031436,BRCA1-BARD1 complex,Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)A5PJF0(Evidence code:IEA/Database source:InterPro:IPR033097), BRCA1 BARD1,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0097542,ciliary tip,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens), GLI2 GLI1,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060074,synapse maturation,Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens), SEZ6L2 PALM,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0000938,GARP complex,E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3), VPS52 VPS51,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:2000467,positive regulation of glycogen (starch) synthase activity,F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens), EPM2AIP1 GSK3A,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0043141,ATP-dependent 5-3 DNA helicase activity,Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR027238|I)A7MBG8(Evidence code:IEA/Database source:InterPro:IPR027238|I), RUVBL2 RUVBL1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0070679,"inositol 1,4,5 trisphosphate binding",Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493), ITPR2 ITPR1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:1990745,EARP complex,E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)A6QQ47(Evidence code:ISS/Database source:UniProtKB:Q9UID3), VPS52 VPS51,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0070197,meiotic attachment of telomere to nuclear envelope,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BIJ4(Evidence code:IBA/Database source:PANTHER:PTN001412149), RAD21L1 LEMD3,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0043996,histone acetyltransferase activity (H4-K8 specific),E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:1990712,HFE-transferrin receptor complex,E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606)E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens), HFE2 TFRC,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0048680,positive regulation of axon regeneration,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P68107(Evidence code:ISA/Database source:UniProtKB:P97534), BRAF FKBP1B,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0071233,cellular response to leucine,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q8IWV8|ens), LARS UBR2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0019158,mannokinase activity,E1BME6(Evidence code:IBA/Database source:PANTHER:PTN000455350)A6QR34(Evidence code:IBA/Database source:PANTHER:PTN000455410), HK2 GCK,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0048495,Roundabout binding,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens), SLIT2 MYO9B,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0005658,alpha DNA polymerase:primase complex,E1BJF4(Evidence code:IEA/Database source:UniProtKB:P33609|ens)G8JKZ3(Evidence code:IBA/Database source:PANTHER:PTN000056765), POLA1 PRIM1,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0035701,hematopoietic stem cell migration,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q9C0K0|ens), KIT BCL11B,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0048790,maintenance of presynaptic active zone structure,P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1BMN9(Evidence code:IEA/Database source:GO:0098882), RAB3A BSN,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0019372,lipoxygenase pathway,P27479(Evidence code:IEA/Database source:UniProtKB:P16050|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O35936|ens), ALOX15 ALOX15B,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0001574,ganglioside biosynthetic process,F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)Q2HJA3(Evidence code:IEA/Database source:UniProtKB:O96024|ens), ST8SIA3 B3GALT4,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0014816,skeletal muscle satellite cell differentiation,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q8VCR8|ens), CDON MYLK2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0048617,embryonic foregut morphogenesis,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), SOX17 FOXF1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0006419,alanyl-tRNA aminoacylation,A6QLT9(Evidence code:IEA/Database source:InterPro:IPR018162|I)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR018162|I), AARS AARS2,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0061357,positive regulation of Wnt protein secretion,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens), VPS35 PTPN23,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0000733,DNA strand renaturation,Q9TTA5(Evidence code:IEA/Database source:GO:0036310)E1BQ04(Evidence code:IEA/Database source:GO:0036310), SMARCAL1 BLM,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:1905606,regulation of presynapse assembly,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), EIF4G1 FZD1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0034515,proteasome storage granule,P56701(Evidence code:IBA/Database source:PANTHER:PTN000101661)A7MBA2(Evidence code:IBA/Database source:PANTHER:PTN000101661), PSMD2 PSMD1,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0008349,MAP kinase kinase kinase kinase activity,F1N5W5(Evidence code:IBA/Database source:PANTHER:PTN000685430)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000685430), STK26 STK25,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0045334,clathrin-coated endocytic vesicle,Q2KHY1(Evidence code:IEA/Database source:UniProtKB:Q9Z140|ens)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens), CPNE6 MYO6,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0030267,glyoxylate reductase (NADP) activity,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)F1MYP4(Evidence code:IBA/Database source:PANTHER:PTN000107947), GRHPR CTBP1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0070742,C2H2 zinc finger domain binding,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), EHMT2 LEF1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0090160,Golgi to lysosome transport,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens), LAMP1 ANKFY1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:1990481,mRNA pseudouridine synthesis,Q3SX07(Evidence code:IBA/Database source:PANTHER:PTN000124846)E1BEB7(Evidence code:IEA/Database source:UniProtKB:Q8WWH5|ens), PUS3 TRUB1,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0060412,ventricular septum morphogenesis,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), FZD1 TBX3,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0036449,microtubule minus-end,O46385(Evidence code:IDA/Database source:)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), SVIL NUMA1,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0004360,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR005855)F1MZY2(Evidence code:IEA/Database source:InterPro:IPR005855), GFPT2 GFPT1,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0004819,glutamine-tRNA ligase activity,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR004514|I), LARS QARS,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0008093,cytoskeletal adaptor activity,G3N3P0(Evidence code:IEA/Database source:InterPro:IPR018477)Q5EAD0(Evidence code:IEA/Database source:InterPro:IPR030128), BICD2 BAIAP2,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0005614,interstitial matrix,F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)A6QLN9(Evidence code:IEA/Database source:UniProtKB:Q8R2Z5|ens), NAV2 VWA1,CC,2,2 of 1,0.08,200,0.01322,0.04788
GO:0034057,RNA strand-exchange activity,A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859)Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859), WBSCR1 EIF4H,MF,2,2 of 1,0.08,200,0.01322,0.04788
GO:0051151,negative regulation of smooth muscle cell differentiation,F1MI56(Evidence code:IEA/Database source:UniProtKB:Q99NH0|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens), ANKRD17 FOXO4,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0051013,microtubule severing,E1BAN2(Evidence code:IEA/Database source:UniRule:UR000107529)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), KATNAL2 SPAST,BP,2,2 of 1,0.08,200,0.01322,0.04788
GO:0009117,nucleotide metabolic process,Q32L93(Evidence code:IEA/Database source:InterPro:IPR005993)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0546)A1A4Q9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0546), GMPR2 DNPH1 NUDT16,BP,3,3 of 147,0.13,2.04,0.01378,0.04863
GO:0050776,regulation of immune response,F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q3SZP0(Evidence code:IEA/Database source:InterPro:IPR031215), SH2B2 FCER1G IRF1,BP,3,3 of 148,0.13,2.03,0.01385,0.04885
GO:0007017,microtubule-based process,E1BFA7(Evidence code:IEA/Database source:UniProtKB:O35231|ens)F2Z4K0(Evidence code:IEA/Database source:InterPro:IPR000217|I)F6RP72(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q2HJ86(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:Q9Z0Y1|ens)F1ME41(Evidence code:IEA/Database source:InterPro:IPR001372|I)Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575)Q3ZBU7(Evidence code:IEA/Database source:InterPro:IPR000217|I)E1BJK2(Evidence code:IEA/Database source:InterPro:IPR000217|I)P61285(Evidence code:IEA/Database source:InterPro:IPR001372|I)P81948(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q2HJB8(Evidence code:IEA/Database source:InterPro:IPR000217|I)E1B953(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q3MHR3(Evidence code:IEA/Database source:InterPro:IPR001372|I)E1B7A3(Evidence code:IEA/Database source:InterPro:IPR001372|I)Q3ZCF0(Evidence code:IEA/Database source:InterPro:IPR028133)F1MNF8(Evidence code:IEA/Database source:InterPro:IPR000217|I)P43033(Evidence code:IEA/Database source:UniRule:UR000107004)F2Z4C1(Evidence code:IEA/Database source:InterPro:IPR000217|I)Q2T9S0(Evidence code:IEA/Database source:InterPro:IPR000217|I), KIFC3 TUBA3E LOC100295712 TUBA1D DCTN3 LOC101902172 VBP1 TUBB4A TUBB1 DYNLL1 TUBA4A TUBA8 LOC533307 DYNLL2 LOC101905447 DCTN2 LOC100141266 PAFAH1B1 TUBA1A TUBB3,BP,20,20 of 149,0.85,13.42,0.01396,0.04921
GO:0019888,protein phosphatase regulator activity,F1MG56(Evidence code:IEA/Database source:InterPro:IPR000009)F1MCY2(Evidence code:IEA/Database source:InterPro:IPR029984)A4FV68(Evidence code:IEA/Database source:InterPro:IPR002554)A2VDZ0(Evidence code:IEA/Database source:InterPro:IPR002554)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257), PPP2R2A PHACTR4 PPP2R5E PPP2R5A PTPA NSFL1C,MF,6,6 of 24,0.25,25,0.01421,0.05002
GO:0008144,drug binding,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P00376(Evidence code:ISS/Database source:UniProtKB:P00374)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens), ATP1A2 NR1I2 MT3 DHFR PDE4D PPP3CA,MF,6,6 of 24,0.25,25,0.01421,0.05002
GO:0016798,"hydrolase activity, acting on glycosyl bonds",G3MXQ8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q5E985(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)E1BM28(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q2KIM0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)H7BWW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)A7MBJ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)E1BI49(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0326), MAN1B1 LYZ HYAL1 DNPH1 FUCA1 HEXB EDEM2 MAN1A2 LYZ1,MF,9,9 of 48,0.38,18.75,0.01427,0.05022
GO:0006865,amino acid transport,Q95JC7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0029)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1B968(Evidence code:IEA/Database source:InterPro:IPR004755)A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0029), SLC1A5 CLN3 SLC7A2 SLC6A20 SLC25A29,BP,5,5 of 17,0.21,29.41,0.01439,0.05057
GO:0070613,regulation of protein processing,E1BB73(Evidence code:IEA/Database source:UniProtKB:Q8K337|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens), INPP5B RNF139 PRKACB RPS6KA2 PRKACA,BP,5,5 of 17,0.21,29.41,0.01439,0.05057
GO:0009725,response to hormone,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,BP,1,1 of 96,0.04,1.04,0.01457,0.05109
GO:0098662,inorganic cation transmembrane transport,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens),TRPM4,BP,1,1 of 96,0.04,1.04,0.01457,0.05109
GO:0009888,tissue development,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens),SALL4,BP,1,1 of 96,0.04,1.04,0.01457,0.05109
GO:0051640,organelle localization,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 98,0.04,1.02,0.01468,0.05145
GO:0060627,regulation of vesicle-mediated transport,Q58DW6(Evidence code:IEA/Database source:UniProtKB:P57735|ens),RAB25,BP,1,1 of 100,0.04,1,0.01508,0.0528
GO:0005669,transcription factor TFIID complex,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)E1BGK7(Evidence code:IEA/Database source:InterPro:IPR007900)F1MME0(Evidence code:IEA/Database source:InterPro:IPR037813)A7MAZ4(Evidence code:IEA/Database source:InterPro:IPR037818), TAF10 TAF4B TAF2 TAF8,CC,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0007339,binding of sperm to zona pellucida,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)G5E5C6(Evidence code:IEA/Database source:UniProtKB:P23578|ens)Q08DD1(Evidence code:IEA/Database source:UniProtKB:P50428|ens)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P80316|ens), CCT3 ACR ARSA CCT5,BP,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0016597,amino acid binding,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006130|I)A6QLT9(Evidence code:IBA/Database source:PANTHER:PTN000206950)Q58CZ9(Evidence code:ISS/Database source:UniProtKB:P04694)F1MKA6(Evidence code:IBA/Database source:PANTHER:PTN000206950), CAD AARS TAT AARS2,MF,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0051018,protein kinase A binding,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)F1MZL5(Evidence code:IEA/Database source:UniProtKB:Q2M3C7|ens)G3MWT9(Evidence code:IEA/Database source:InterPro:IPR028540)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens), WASF2 SPHKAP AKAP12 LRRK2,MF,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0031307,integral component of mitochondrial outer membrane,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR021181)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR021181), FIS1 RHOT1 PINK1 RHOT2,CC,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0018279,protein N-linked glycosylation via asparagine,Q17QG5(Evidence code:ISS/Database source:UniProtKB:P60604)F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)E1BB36(Evidence code:IEA/Database source:UniProtKB:Q921V5|ens), UBE2G2 UGGT2 SYVN1 MGAT2,BP,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0005548,phospholipid transporter activity,P55156(Evidence code:ISS/Database source:UniProtKB:P55157)Q2HJ54(Evidence code:IEA/Database source:InterPro:IPR001666)C3VEX2(Evidence code:IEA/Database source:InterPro:IPR001666)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), MTTP PITPNA PITPNM2 ABCA1,MF,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0050873,brown fat cell differentiation,F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)Q3T0M9(Evidence code:IEA/Database source:UniProtKB:P61213|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens), SH2B2 ZNF516 ARL4A PLAC8,BP,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0005685,U1 snRNP,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)G3MZC7(Evidence code:IBA/Database source:PANTHER:PTN000221451)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621), SNRPE PRPF40A SNRPN SNRNP70,CC,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0043679,axon terminus,Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)E1B7T7(Evidence code:IEA/Database source:UniProtKB:Q8R1C0|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:Q02294), SEPT6 PTPRN KCNC4 CACNA1B,CC,4,4 of 11,0.17,36.36,0.01587,0.05522
GO:0007015,actin filament organization,Q0VCF1(Evidence code:IEA/Database source:InterPro:IPR028506)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)Q29RN1(Evidence code:IEA/Database source:InterPro:IPR028510)G5E5V6(Evidence code:IEA/Database source:UniProtKB:Q0VF96|ens)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)F1N6V1(Evidence code:IEA/Database source:InterPro:IPR030772)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens), SORBS1 MYBPC3 SRF PRKCI SORBS3 CGNL1 CTNNA1 ACTR3B FAT1 ARHGAP6 DLG1,BP,11,11 of 63,0.47,17.46,0.0166,0.05769
GO:0042391,regulation of membrane potential,F1N7B7(Evidence code:IBA/Database source:PANTHER:PTN001741737)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)P02715(Evidence code:IEA/Database source:UniProtKB:P20782|ens)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)E1BMA2(Evidence code:IBA/Database source:PANTHER:PTN000025348)F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131)E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)F1MP51(Evidence code:IBA/Database source:PANTHER:PTN000025348), RIMS1 LRRK2 CHRNE KCNMA1 TRPM4 KCNH6 PIEZO1 HCN1 DLG1 NEDD4 KCNH5,BP,11,11 of 63,0.47,17.46,0.0166,0.05769
GO:0006458,de novo protein folding,Q32L40(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3ZCI9(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T0K2(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q3T084(Evidence code:IBA/Database source:PANTHER:PTN000143677)Q2NKZ1(Evidence code:IBA/Database source:PANTHER:PTN000143677)F1MWD3(Evidence code:IBA/Database source:PANTHER:PTN000143677), TCP1 CCT8 CCT3 CCT6B CCT7 CCT5,BP,6,6 of 25,0.25,24,0.01663,0.0577
GO:0031397,negative regulation of protein ubiquitination,Q32KW2(Evidence code:ISS/Database source:UniProtKB:Q04323)Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens)A6QL80(Evidence code:IEA/Database source:UniProtKB:O60678|ens)E1B7Y9(Evidence code:IEA/Database source:UniProtKB:Q6IQ16|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)Q3T178(Evidence code:ISS/Database source:UniProtKB:Q9UK41), UBXN1 BAG5 PRMT3 SPOPL SOX4 VPS28,BP,6,6 of 25,0.25,24,0.01663,0.0577
GO:1990904,ribonucleoprotein complex,Q28165(Evidence code:ISS/Database source:UniProtKB:Q86U42)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q13310|ens)A6QLG5(Evidence code:ISS/Database source:UniProtKB:P46781)P61286(Evidence code:ISS/Database source:UniProtKB:P11940)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q5U4C9|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)P10881(Evidence code:IEA/Database source:InterPro:IPR002344), PABPN1 DDX1 LRPPRC PABPC4 RPS9 PABPC1 DHX9 DYRK2 LRRK2 XPO1 RUVBL1 TDRD1 EPRS SSB,CC,14,14 of 360,0.59,3.89,0.01682,0.05832
GO:0007264,small GTPase mediated signal transduction,F1N2I0(Evidence code:IEA/Database source:InterPro:IPR018203)Q32P83(Evidence code:IEA/Database source:InterPro:IPR007515)Q5E9S7(Evidence code:IEA/Database source:InterPro:IPR001895|I)Q58DL5(Evidence code:IEA/Database source:InterPro:IPR001895|I)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR001895)E1BK77(Evidence code:IEA/Database source:InterPro:IPR026791|I)F1MQ43(Evidence code:IEA/Database source:InterPro:IPR026791|I)E1B7C4(Evidence code:IEA/Database source:InterPro:IPR026791)F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens)E1BPX7(Evidence code:IEA/Database source:InterPro:IPR001895|I)F1MS53(Evidence code:IEA/Database source:InterPro:IPR001895), CHML RABIF RASGEF1A BCAR3 RAPGEF2 DOCK6 DOCK9 DOCK10 VAV2 RAPGEF4 RAPGEF6,BP,11,11 of 64,0.47,17.19,0.01737,0.06012
GO:0010923,negative regulation of phosphatase activity,F1N1P8(Evidence code:IEA/Database source:InterPro:IPR026130)Q17R14(Evidence code:ISS/Database source:UniProtKB:O94832)F1MWN4(Evidence code:IEA/Database source:UniProtKB:A8K8P3|ens)A7Z026(Evidence code:ISS/Database source:UniProtKB:O75864)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens), PPP1R26 MYO1D SFI1 PPP1R37 WNK1,BP,5,5 of 18,0.21,27.78,0.01738,0.06012
GO:0005776,autophagosome,E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000538677)E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q8R317|ens), WDFY3 CLN3 TBC1D12 RAB23 UBQLN1,CC,5,5 of 18,0.21,27.78,0.01738,0.06012
GO:0035097,histone methyltransferase complex,F1MHA1(Evidence code:IEA/Database source:InterPro:IPR016569)E1BKN0(Evidence code:IEA/Database source:InterPro:IPR016569)F1MYZ3(Evidence code:IEA/Database source:UniProtKB:Q8NEZ4|ens)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens)F1N6Y5(Evidence code:IEA/Database source:UniProtKB:Q9UPS6|ens), KMT2A KMT2B KMT2C ASH2L SETD1B,CC,5,5 of 18,0.21,27.78,0.01738,0.06012
GO:0006091,generation of precursor metabolites and energy,A8E657(Evidence code:IBA/Database source:PANTHER:PTN000875283)E1BFI2(Evidence code:IEA/Database source:UniProtKB:Q96HY7|ens), AASS DHTKD1,BP,2,2 of 120,0.08,1.67,0.01761,0.06088
GO:0043085,positive regulation of catalytic activity,F1MF26(Evidence code:IEA/Database source:GO:0016176)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)O77775(Evidence code:IEA/Database source:GO:0016176)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)F1MHN4(Evidence code:IEA/Database source:GO:0008047), SH3PXD2A CIB1 MT3 PHACTR4 NCF2 PSEN1 RICTOR,BP,7,7 of 229,0.3,3.06,0.01817,0.06278
GO:0000226,microtubule cytoskeleton organization,F1MAZ8(Evidence code:IEA/Database source:InterPro:IPR033624)A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259)F1MSQ8(Evidence code:IBA/Database source:PANTHER:PTN001016925)A7MBC3(Evidence code:IEA/Database source:UniProtKB:P47810|ens)E1BER6(Evidence code:IEA/Database source:InterPro:IPR030624)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens)F1N3M8(Evidence code:IEA/Database source:InterPro:IPR015656|I)Q2KII9(Evidence code:IBA/Database source:PANTHER:PTN000293992)E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens)P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens), MARK3 TUBGCP2 TACC1 WEE1 CRMP1 CDK5RAP2 PCNT MAP1A DYNC1LI1 DCLK2 CDK1 APC2,BP,12,12 of 77,0.51,15.58,0.01926,0.06534
GO:0030307,positive regulation of cell growth,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), CIB1 LEF1 INO80 H3F3B EIF4G1 HYAL1,BP,6,6 of 26,0.25,23.08,0.01931,0.06534
GO:0035584,calcium-mediated signaling using intracellular calcium source,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), BCAP31 FIS1 PRNP,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0042572,retinol metabolic process,P02694(Evidence code:ISS/Database source:UniProtKB:Q00915)P48644(Evidence code:IEA/Database source:UniPathway:UPA00912)O77769(Evidence code:IEA/Database source:InterPro:IPR032969), RBP1 ALDH1A1 DHRS3,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0032420,stereocilium,Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)F1MG13(Evidence code:IEA/Database source:UniProtKB:Q9QZZ4|ens)E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens), MYO1C MYO15A ATP8B1,CC,3,3 of 6,0.13,50,0.01932,0.06534
GO:0048701,embryonic cranial skeleton morphogenesis,Q2NL22(Evidence code:ISS/Database source:UniProtKB:P38919)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens), EIF4A3 DLX2 NIPBL,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0048016,inositol phosphate-mediated signaling,F1MHB9(Evidence code:IBA/Database source:PANTHER:PTN000313248)Q9TU34(Evidence code:IEA/Database source:GO:0005220)Q8WN96(Evidence code:IEA/Database source:GO:0005220), INPP5A ITPR1 ITPR2,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0040015,negative regulation of multicellular organism growth,Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q61818|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens), PLAC8 RAI1 ALMS1,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0006183,GTP biosynthetic process,Q3SWY3(Evidence code:IBA/Database source:PANTHER:PTN000226903)A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), IMPDH2 NME3 NME1,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0071782,endoplasmic reticulum tubular network,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)Q29RM3(Evidence code:ISS/Database source:UniProtKB:Q00765), ZFYVE27 KPNB1 REEP5,CC,3,3 of 6,0.13,50,0.01932,0.06534
GO:0001965,G-protein alpha-subunit binding,E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776|I)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)E1BIX7(Evidence code:IEA/Database source:UniProtKB:Q8VDU0|ens), RGS14 F2R GPSM2,MF,3,3 of 6,0.13,50,0.01932,0.06534
GO:0001958,endochondral ossification,Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens)A7YY40(Evidence code:IEA/Database source:UniProtKB:Q9R1N9|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), NAB2 COL13A1 COL2A1,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0001833,inner cell mass cell proliferation,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q9EQH4|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), SALL4 TAF8 BRCA2,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0035024,negative regulation of Rho protein signal transduction,E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens), ARAP3 CUL3 ARHGAP35,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0016442,RISC complex,F1MXK6(Evidence code:IEA/Database source:UniRule:UR000106187)Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN000383724)Q6T5B7(Evidence code:IEA/Database source:UniRule:UR000107558), AGO4 DICER1 AGO3,CC,3,3 of 6,0.13,50,0.01932,0.06534
GO:0035066,positive regulation of histone acetylation,E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens), RPS6KA5 BRCA1 RPS6KA4,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0006020,inositol metabolic process,P20456(Evidence code:IBA/Database source:PANTHER:PTN000465134)F1MNG6(Evidence code:IBA/Database source:PANTHER:PTN000297581)A4FV33(Evidence code:IEA/Database source:UniProtKB:Q8R071|ens), IMPA1 PPIP5K2 ITPKA,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0048188,Set1C/COMPASS complex,F1N6Y5(Evidence code:IEA/Database source:InterPro:IPR037842)E1BGF3(Evidence code:IEA/Database source:InterPro:IPR037854)E1BEP4(Evidence code:IEA/Database source:InterPro:IPR037353), SETD1B HCFC1 ASH2L,CC,3,3 of 6,0.13,50,0.01932,0.06534
GO:0034142,toll-like receptor 4 signaling pathway,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens), TLR4 LY96 S100A14,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0030048,actin filament-based movement,F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)E1BNV7(Evidence code:IEA/Database source:UniProtKB:Q13459|ens), MYH14 WASF2 MYO9B,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0007340,acrosome reaction,Q5EA42(Evidence code:IEA/Database source:UniProtKB:Q9QXM0|ens)G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens)E1BGL9(Evidence code:IEA/Database source:InterPro:IPR028701), ABHD2 ACR SYT6,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0033209,tumor necrosis factor-mediated signaling pathway,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224)F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens), JAK2 STAT1 TXNDC17,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0005158,insulin receptor binding,F1MGG8(Evidence code:IEA/Database source:InterPro:IPR039011)F1MYE0(Evidence code:IEA/Database source:InterPro:IPR039011)Q6U8D5(Evidence code:IEA/Database source:InterPro:IPR035036), IRS4 IRS1 Grb10,MF,3,3 of 6,0.13,50,0.01932,0.06534
GO:0050681,androgen receptor binding,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P05771), PKN1 TRIM68 PRKCB,MF,3,3 of 6,0.13,50,0.01932,0.06534
GO:0007259,JAK-STAT cascade,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT1 STAT5A,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0048873,homeostasis of number of cells within a tissue,Q148D3(Evidence code:IEA/Database source:UniProtKB:P97807|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), FH F2R KMT2A,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0010738,regulation of protein kinase A signaling,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)F1MZL5(Evidence code:IBA/Database source:PANTHER:PTN000027542)G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens), LRRK2 SPHKAP AKAP12,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0046825,regulation of protein export from nucleus,E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:Q8TAS1|ens), PTPN14 XPO1 UHMK1,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0033137,negative regulation of peptidyl-serine phosphorylation,E1BLB5(Evidence code:IEA/Database source:UniProtKB:P59644|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), INPP5J GPD1L PDE4D,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0007031,peroxisome organization,Q0VC07(Evidence code:IEA/Database source:InterPro:IPR025654)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR015342)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens), PEX10 PEX1 PEX2,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens), BRCA2 BCL3 DYRK2,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0005847,mRNA cleavage and polyadenylation specificity factor complex,G3MZ78(Evidence code:IBA/Database source:PANTHER:PTN000566843)O19137(Evidence code:ISS/Database source:UniProtKB:O95639)P67827(Evidence code:ISS/Database source:UniProtKB:P48729), CSTF2T CPSF4 CSNK1A1,CC,3,3 of 6,0.13,50,0.01932,0.06534
GO:0002040,sprouting angiogenesis,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2), SEMA3E LEF1 E2F7,BP,3,3 of 6,0.13,50,0.01932,0.06534
GO:0000777,condensed chromosome kinetochore,Q2NKY7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P61287(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens)Q0P5A1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q3SZN0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q6Q137(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P67827(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SEPT2 PPP1CC AHCTF1 DCTN3 SEPT6 SEPT7 CSNK1A1,CC,7,7 of 34,0.3,20.59,0.01952,0.06598
GO:0006869,lipid transport,F1MG24(Evidence code:IBA/Database source:PANTHER:PTN000442469)P55156(Evidence code:IEA/Database source:InterPro:IPR001747|I)Q17QL5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)A6QQK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)G3X8E8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)A6QQ47(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)E1B7M8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)E1BPW1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0445)E1BCG1(Evidence code:IBA/Database source:PANTHER:PTN000442469), ABCA1 MTTP TMEM30A TEX2 OSBPL10 VPS51 OSBP2 OSBP ABCA7,BP,9,9 of 51,0.38,17.65,0.01956,0.06607
GO:0030030,cell projection organization,Q2TA38(Evidence code:IEA/Database source:UniProtKB-KW:KW-0970)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0970)P61420(Evidence code:IEA/Database source:UniProtKB-KW:KW-0970)P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens), TEKT4 ARL6 ATP6V0D1 MYO1A,BP,4,4 of 164,0.17,2.44,0.01965,0.06634
GO:0006611,protein export from nucleus,Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens)A1A4I8(Evidence code:IEA/Database source:UniProtKB:Q9UIA9|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens), HSPA9 XPO7 NUP214 XPO1,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0006506,GPI anchor biosynthetic process,E1BPZ8(Evidence code:IEA/Database source:InterPro:IPR037675)E1BM45(Evidence code:IEA/Database source:InterPro:IPR007070|I)Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens)Q3MHZ7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0337), PIGO PIGN DPM3 PIGK,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0090314,positive regulation of protein targeting to membrane,Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828), FIS1 MYO1C PRNP CIB1,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0051693,actin filament capping,Q32LP2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0117)E1BLT3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0117)Q28046(Evidence code:IEA/Database source:UniProtKB-KW:KW-0117)F1MKE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0117), RDX SPTBN4 SCIN SPTB,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0017158,regulation of calcium ion-dependent exocytosis,A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000001485)A5D7F2(Evidence code:IBA/Database source:PANTHER:PTN000001972)E1BGL9(Evidence code:IBA/Database source:PANTHER:PTN000001285)E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000001285), SYTL2 SYT4 SYT6 SYTL1,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0030971,receptor tyrosine kinase binding,Q0IIE2(Evidence code:IEA/Database source:InterPro:IPR029586)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens)A6QPZ5(Evidence code:IBA/Database source:PANTHER:PTN000544009), SHC1 DUSP3 PTPN14 CBLC,MF,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0001541,ovarian follicle development,Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P05532)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens), LFNG KMT2B KIT EIF2B5,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789)E1BHY2(Evidence code:IEA/Database source:UniProtKB:Q96KQ4|ens)G3N065(Evidence code:IBA/Database source:PANTHER:PTN000552321), E2F1 FHIT PPP1R13B ZNF385C,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0032008,positive regulation of TOR signaling,Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)A7MBJ6(Evidence code:IEA/Database source:InterPro:IPR037591), SEC13 GOLPH3 RICTOR WDR59,BP,4,4 of 12,0.17,33.33,0.02004,0.06728
GO:0042632,cholesterol homeostasis,A6QNT8(Evidence code:IEA/Database source:UniProtKB:Q3U2P1|ens)E1BM29(Evidence code:IEA/Database source:InterPro:IPR030681)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens), SEC24A CYP7A1 ALMS1 ABCA1 NPC1,BP,5,5 of 19,0.21,26.32,0.02075,0.06945
GO:0042100,B cell proliferation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens), ABL1 IFNT3 IFNT2 LOC104968438 LEF1,BP,5,5 of 19,0.21,26.32,0.02075,0.06945
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), SRC LEF1 CRYAB MKL1 MT3,BP,5,5 of 19,0.21,26.32,0.02075,0.06945
GO:0010595,positive regulation of endothelial cell migration,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P03968(Evidence code:ISS/Database source:UniProtKB:P05230)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q3TAS6)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), ABL1 FGF1 EMC10 SASH1 PDCD6,BP,5,5 of 19,0.21,26.32,0.02075,0.06945
GO:0019827,stem cell population maintenance,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens), RIF1 ARID1A SALL4 TBX3 NIPBL,BP,5,5 of 19,0.21,26.32,0.02075,0.06945
GO:0022618,ribonucleoprotein complex assembly,Q32PB9(Evidence code:IBA/Database source:PANTHER:PTN000103359),RPL38,BP,1,1 of 90,0.04,1.11,0.02102,0.0703
GO:0006644,phospholipid metabolic process,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 91,0.04,1.1,0.02105,0.07034
GO:0000323,lytic vacuole,P11456(Evidence code:IEA/Database source:InterPro:IPR000296),M6PR,CC,1,1 of 93,0.04,1.08,0.02139,0.07146
GO:0048731,system development,F1MXR2(Evidence code:IBA/Database source:PANTHER:PTN001422142),ONECUT2,BP,1,1 of 94,0.04,1.06,0.02172,0.07249
GO:0005875,microtubule associated complex,P61285(Evidence code:IEA/Database source:InterPro:IPR019763)F1ME41(Evidence code:IEA/Database source:InterPro:IPR019763)Q0P5A1(Evidence code:IEA/Database source:UniProtKB:Q9Z0Y1|ens)P43033(Evidence code:IEA/Database source:UniRule:UR000107004)E1B7A3(Evidence code:IEA/Database source:InterPro:IPR019763)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)Q3MHR3(Evidence code:IEA/Database source:InterPro:IPR019763), DYNLL1 LOC101902172 DCTN3 PAFAH1B1 LOC101905447 KIF1B DYNLL2,CC,7,7 of 35,0.3,20,0.02208,0.07363
GO:0050768,negative regulation of neurogenesis,P37359(Evidence code:IEA/Database source:UniProtKB:P28184|ens)P63171(Evidence code:ISS/Database source:UniProtKB:P51807)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens)E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens), MT3 DYNLT1 SORL1 CTDSP1 DNAJB11 PRTG PCM1,BP,7,7 of 35,0.3,20,0.02208,0.07363
GO:0071900,regulation of protein serine/threonine kinase activity,P58108(Evidence code:IEA/Database source:InterPro:IPR039166),PRKAG1,BP,1,1 of 95,0.04,1.05,0.02214,0.07376
GO:0050680,negative regulation of epithelial cell proliferation,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens), DAB2IP CDK6 PEX2 fgfr3 DLG1 STRAP,BP,6,6 of 27,0.25,22.22,0.02228,0.07415
GO:0031032,actomyosin structure organization,Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)E1BP72(Evidence code:IEA/Database source:UniProtKB:Q9Y5S2|ens)F1MGE1(Evidence code:IBA/Database source:PANTHER:PTN001150527)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens)F1N611(Evidence code:IBA/Database source:PANTHER:PTN001150527), F11R CDC42BPB FRMD5 MYO18A TRPM7 EPB41L1,BP,6,6 of 27,0.25,22.22,0.02228,0.07415
GO:0042742,defense response to bacterium,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens)P46169(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044)C6KGD8(Evidence code:IEA/Database source:InterPro:IPR030773)Q06285(Evidence code:IEA/Database source:InterPro:IPR030056)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens)P46161(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453991)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044)F2X047(Evidence code:IEA/Database source:InterPro:IPR030056)P46165(Evidence code:IEA/Database source:UniProtKB-KW:KW-0044), BCL3 ANKRD17 DEFB11 HSTN LYZ1 S100A14 PLAC8 DEFB3 FCER1G NOS2 CHGA LYZ DEFB7,BP,13,13 of 86,0.55,15.12,0.0244,0.07495
GO:0034976,response to endoplasmic reticulum stress,Q5E953(Evidence code:IEA/Database source:UniProtKB:Q9Y3C8|ens)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)P68102(Evidence code:ISS/Database source:UniProtKB:Q6ZWX6)A4FUW8(Evidence code:IBA/Database source:PANTHER:PTN000432607)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)Q08DG0(Evidence code:IEA/Database source:UniProtKB:Q8VCQ3|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P39654)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61961)Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens), UFC1 EIF2B5 EIF2S1 TXNDC11 UBQLN1 NRBF2 FLOT1 ALOX15 UBE4B UFM1 PPP2CB,BP,11,11 of 70,0.47,15.71,0.02441,0.07495
GO:0030141,secretory granule,G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305)E1BEQ4(Evidence code:IBA/Database source:PANTHER:PTN001208501)P56722(Evidence code:ISS/Database source:UniProtKB:Q63259)A5D7A2(Evidence code:IEA/Database source:UniProtKB:Q9CZD3|ens)P05059(Evidence code:IEA/Database source:InterPro:IPR001819|I)Q9TU34(Evidence code:IDA/Database source:)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)A6QQ95(Evidence code:IBA/Database source:PANTHER:PTN001208501)P23389(Evidence code:IEA/Database source:InterPro:IPR001819|I), RNPEP LOC505658 PTPRN GARS CHGA ITPR1 BRCA2 RAB3B KLK6 CHGB,CC,10,10 of 57,0.42,17.54,0.02363,0.07495
GO:0033138,positive regulation of peptidyl-serine phosphorylation,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), GSK3A PDCD10 EIF4G1 TCL1A TNKS1BP1 PAK1 PINK1,BP,7,7 of 36,0.3,19.44,0.02487,0.07495
GO:1901215,negative regulation of neuron death,Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A4FUZ3(Evidence code:IEA/Database source:UniProtKB:P62192|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), CHMP4B PSMC1 SORL1 CHMP4A EN1 LRRK2 VPS35,BP,7,7 of 36,0.3,19.44,0.02487,0.07495
GO:0050808,synapse organization,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q8BHC1)E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023)F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens), PSEN1 RAB39B LAMB2 NLGN2 SEMA3E,BP,5,5 of 20,0.21,25,0.02452,0.07495
GO:0016571,histone methylation,E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)F1MMF1(Evidence code:IEA/Database source:GO:0042054)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1BNH7(Evidence code:IEA/Database source:UniProtKB:Q9BZ95|ens)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q96LA8|ens), SUZ12 PRDM13 EHMT2 WHSC1L1 PRMT6,BP,5,5 of 20,0.21,25,0.02452,0.07495
GO:0048704,embryonic skeletal system morphogenesis,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P02830|ens), MEGF8 DLG1 MYF5 HOXA7,BP,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0046540,U4/U6 x U5 tri-snRNP complex,A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760)A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555)E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens), PRPF8 SNRPN SNRPE SNRNP200,CC,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0030199,collagen fibril organization,E1BFV4(Evidence code:IEA/Database source:UniProtKB:B2RXX5|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:P05997|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens), ADAMTS14 COL1A2 COL5A2 COL2A1,BP,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0010507,negative regulation of autophagy,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens), EIF4G1 SIRT2 MT3 LARS,BP,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0008584,male gonad development,F1MNJ8(Evidence code:IBA/Database source:PANTHER:PTN001561551)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens), KLHL26 KIT GATA6 AGO4,BP,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0001578,microtubule bundle formation,E1BF73(Evidence code:IEA/Database source:UniProtKB:Q3UHI0|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), CCSER2 CDK5RAP2 NUMA1 SPAST,BP,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0007179,transforming growth factor beta receptor signaling pathway,A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens), FERMT2 SRC USP9X COL1A2,BP,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0030168,platelet activation,G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), GNA13 F2R PIK3CD SRF,BP,4,4 of 13,0.17,30.77,0.02483,0.07495
GO:0097255,R2TP complex,A7MBG8(Evidence code:IEA/Database source:InterPro:IPR037938)Q2TBU9(Evidence code:IEA/Database source:InterPro:IPR037942), RUVBL1 RUVBL2,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0017145,stem cell division,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q9JLV5|ens), WWTR1 CUL3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0008420,RNA polymerase II CTD heptapeptide repeat phosphatase activity,F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)E1BDE3(Evidence code:IEA/Database source:UniProtKB:Q9GZU7|ens), RPAP2 CTDSP1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0048821,erythrocyte development,Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR030133)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), TMOD3 SRF,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0051561,positive regulation of mitochondrial calcium ion concentration,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens), BCAP31 FIS1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:1903753,negative regulation of p38MAPK cascade,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens), HSPH1 DLG1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0036089,cleavage furrow formation,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens), SNX33 SNX18,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0051010,microtubule plus-end binding,E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), CKAP5 NUMA1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:1990381,ubiquitin-specific protease binding,E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)Q17R11(Evidence code:IBA/Database source:PANTHER:PTN000967687), SYVN1 DZIP3,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060161,positive regulation of dopamine receptor signaling pathway,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), LRRK2 VPS35,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0006098,pentose-phosphate shunt,F1MMK2(Evidence code:IEA/Database source:UniPathway:UPA00115)Q2TBQ8(Evidence code:IEA/Database source:InterPro:IPR005900), G6PD PGLS,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0008047,enzyme activator activity,F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616), RICTOR ARL1,MF,2,2 of 113,0.08,1.77,0.0246,0.07495
GO:0051256,mitotic spindle midzone assembly,A5D7N6(Evidence code:IEA/Database source:UniProtKB:Q02241|ens)E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens), KIF23 RACGAP1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035032,"phosphatidylinositol 3-kinase complex, class III",A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q8VD65|ens)Q08DG0(Evidence code:IEA/Database source:UniProtKB:Q8VCQ3|ens), PIK3R4 NRBF2,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:2000535,regulation of entry of bacterium into host cell,E1BDW9(Evidence code:IEA/Database source:UniProtKB:Q96KP1|ens)F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens), EXOC2 FUCA2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0070878,primary miRNA binding,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens), SRF DGCR8,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens), TRAF6 FCER1G,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0001758,retinal dehydrogenase activity,P48644(Evidence code:IEA/Database source:EC:1.2.1.36)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens), ALDH1A1 ALDH1A3,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035331,negative regulation of hippo signaling,F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens), WWC1 MARK3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043923,positive regulation by host of viral transcription,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens), LEF1 SP1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0071599,otic vesicle development,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), AHI1 COL2A1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035242,protein-arginine omega-N asymmetric methyltransferase activity,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8)A6QL80(Evidence code:IBA/Database source:PANTHER:PTN000109455), PRMT6 PRMT3,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0042289,MHC class II protein binding,Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens), MARCH8 COL2A1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035050,embryonic heart tube development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), SOX17 TBX3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",Q3SZ15(Evidence code:ISS/Database source:UniProtKB:Q9D1M4)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens), EEF1E1 ATM,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0016303,1-phosphatidylinositol-3-kinase activity,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BE66(Evidence code:IEA/Database source:InterPro:IPR008290), ATM PIK3CD,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0097197,tetraspanin-enriched microdomain,F1MJZ6(Evidence code:IEA/Database source:UniProtKB:O75954|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8QZY6|ens), TSPAN9 TSPAN14,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0071816,tail-anchored membrane protein insertion into ER membrane,Q3SZ26(Evidence code:IEA/Database source:InterPro:IPR028945|I)Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765), WRB SGTA,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060371,regulation of atrial cardiac muscle cell membrane depolarization,G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens)E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens), SCN10A SCN2B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0004415,hyalurononglucosaminidase activity,Q5E985(Evidence code:IEA/Database source:InterPro:IPR018155)F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens), HYAL1 TMEM2,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0032287,peripheral nervous system myelin maintenance,Q3SYX0(Evidence code:IEA/Database source:InterPro:IPR030693)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens), NDRG1 MPP5,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P05126(Evidence code:ISS/Database source:UniProtKB:P68404), MT3 PRKCB,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0002407,dendritic cell chemotaxis,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295), TRPM4 ANO6,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0046007,negative regulation of activated T cell proliferation,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BAW2(Evidence code:IEA/Database source:UniProtKB:G3XA59|ens), PRNP LRRC32,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0033276,transcription factor TFTC complex,F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens), TAF2 TAF10,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0061003,positive regulation of dendritic spine morphogenesis,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:P08413), CUX2 CAMK2B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0000405,bubble DNA binding,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens), BLM WRN,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0010499,proteasomal ubiquitin-independent protein catabolic process,A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q14145|ens)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236), KEAP1 NFE2L2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0010586,miRNA metabolic process,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens), ZCCHC6 AGO4,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:1904263,positive regulation of TORC1 signaling,Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037596)A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens), SEC13 LARS,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:1903751,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), HSPH1 PINK1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0090647,modulation of age-related behavioral decline,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), PRNP PSEN1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0046541,saliva secretion,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens), KCNMA1 AQP5,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0045198,establishment of epithelial cell apical/basal polarity,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens), FOXF1 PTK7,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0031698,beta-2 adrenergic receptor binding,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens), GNAS NEDD4,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0005945,6-phosphofructokinase complex,A1A4J1(Evidence code:IEA/Database source:UniProtKB:P17858|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens), PFKL PFKM,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0044666,MLL3/4 complex,F1MYZ3(Evidence code:IEA/Database source:InterPro:IPR037877)E1BEP4(Evidence code:IEA/Database source:UniProtKB:Q9UBL3|ens), KMT2C ASH2L,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0001754,eye photoreceptor cell differentiation,P61635(Evidence code:ISS/Database source:UniProtKB:P42227)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens), STAT3 AGTPBP1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0034214,protein hexamerization,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)Q0VCA3(Evidence code:ISS/Database source:UniProtKB:Q9Z2I0), SPAST LETM1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0021952,central nervous system projection neuron axonogenesis,F1MLJ7(Evidence code:IBA/Database source:PANTHER:PTN000690515)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens), SLIT2 SPTBN4,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0008340,determination of adult lifespan,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens), LRRK2 IDE,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0034185,apolipoprotein binding,F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), LRP6 ABCA1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0000221,"vacuolar proton-transporting V-type ATPase, V1 domain",O46563(Evidence code:IEA/Database source:InterPro:IPR004908|I)P21282(Evidence code:IBA/Database source:PANTHER:PTN000015490), ATP6V1H ATP6V1C1,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0030906,"retromer, cargo-selective complex",Q2HJG5(Evidence code:IEA/Database source:InterPro:IPR005378)Q0VD53(Evidence code:IEA/Database source:UniProtKB:O75436|ens), VPS35 VPS26A,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035330,regulation of hippo signaling,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens), NF2 WWC1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0016176,superoxide-generating NADPH oxidase activator activity,F1MF26(Evidence code:IBA/Database source:PANTHER:PTN001038805)O77775(Evidence code:IEA/Database source:InterPro:IPR034889), SH3PXD2A NCF2,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0002551,mast cell chemotaxis,P05059(Evidence code:ISS/Database source:UniProtKB:P10645)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens), CHGA KIT,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0006013,mannose metabolic process,Q3SZJ9(Evidence code:IBA/Database source:PANTHER:PTN000049281)F1MWT0(Evidence code:IEA/Database source:InterPro:IPR000602|I), PMM2 MAN2C1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0070885,negative regulation of calcineurin-NFAT signaling cascade,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens), PRNP DYRK2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:1903608,protein localization to cytoplasmic stress granule,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q92499|ens), SSB DDX1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0034116,positive regulation of heterotypic cell-cell adhesion,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens), LCK FLOT1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0070166,enamel mineralization,F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens), FAM20C FAM20A,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens)A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9D3J3|ens), MARCH7 BCL2L12,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0003309,type B pancreatic cell differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0), GATA6 INSM1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0008160,protein tyrosine phosphatase activator activity,P20959(Evidence code:ISS/Database source:UniProtKB:P17936)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens), IGFBP3 PTPA,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:1903077,negative regulation of protein localization to plasma membrane,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens), TMEM59 PPP2R5A,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0030540,female genitalia development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens), CHD7 TBX3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0030950,establishment or maintenance of actin cytoskeleton polarity,F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens), RICTOR ARHGAP35,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0046931,pore complex assembly,Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens), CCT3 ANO6,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060351,cartilage development involved in endochondral bone morphogenesis,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), COL2A1 SHOX2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035418,protein localization to synapse,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens), SHANK1 BSN,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0050321,tau-protein kinase activity,F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)F1MAZ8(Evidence code:IEA/Database source:UniProtKB:P27448|ens), BRSK2 MARK3,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0046543,development of secondary female sexual characteristics,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT5A,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0031996,thioesterase binding,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), TRAF6 ARF6,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0051775,response to redox state,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P11766|ens), FKBP1B ADH5,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0036302,atrioventricular canal development,O97711(Evidence code:ISS/Database source:UniProtKB:P70312)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), HAS2 CHD7,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0071481,cellular response to X-ray,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens), NIPBL ATM,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,E1BJW3(Evidence code:IEA/Database source:UniProtKB:Q9H8L6|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens), MMRN2 PDCD10,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0071547,piP-body,Q5W5U4(Evidence code:ISS/Database source:UniProtKB:Q61496)F1MNA1(Evidence code:IEA/Database source:UniProtKB:Q14BI7|ens), DDX4 TDRD9,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0098911,regulation of ventricular cardiac muscle cell action potential,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), TRPM4 DLG1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035089,establishment of apical/basal cell polarity,F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens), PRKCI SCRIB,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0021522,spinal cord motor neuron differentiation,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), GLI2 SOX4,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0004505,phenylalanine 4-monooxygenase activity,Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61458|ens)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR005961), PCBD1 PAH,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0021846,cell proliferation in forebrain,Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens), FABP7 KIF14,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0032471,negative regulation of endoplasmic reticulum calcium ion concentration,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens), BCAP31 FIS1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0006654,phosphatidic acid biosynthetic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)Q95JH2(Evidence code:IEA/Database source:UniProtKB:Q99943|ens), DGKQ AGPAT1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0032762,mast cell cytokine production,P05059(Evidence code:ISS/Database source:UniProtKB:P10645)P43481(Evidence code:ISS/Database source:UniProtKB:P10721), CHGA KIT,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0051103,DNA ligation involved in DNA repair,A4IFC8(Evidence code:IBA/Database source:PANTHER:PTN000048794)P18493(Evidence code:IBA/Database source:PANTHER:PTN000048695), LIG1 PARP1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:1901509,regulation of endothelial tube morphogenesis,P03968(Evidence code:ISS/Database source:UniProtKB:P05230)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens), FGF1 ADAMTS12,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060394,negative regulation of pathway-restricted SMAD protein phosphorylation,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens), EMILIN1 STRAP,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q2KII9(Evidence code:IEA/Database source:UniProtKB:Q9Y6G9|ens), TPR DYNC1LI1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0097428,protein maturation by iron-sulfur cluster transfer,A6QLM8(Evidence code:IEA/Database source:InterPro:IPR004640)E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76), HSCB MMS19,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0016812,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides",A5PJV3(Evidence code:IEA/Database source:InterPro:IPR005920)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR002195), AMDHD1 CAD,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0016922,nuclear receptor binding,F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens), NCOA3 ARID1A,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0016266,O-glycan processing,E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens)Q5EAB6(Evidence code:ISS/Database source:UniProtKB:Q8WZA1), GALNT2 POMGNT1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0003214,cardiac left ventricle morphogenesis,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), GSK3A FOXF1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0097422,tubular endosome,Q0VD53(Evidence code:ISS/Database source:UniProtKB:O75436)Q2HJG5(Evidence code:ISS/Database source:UniProtKB:Q96QK1), VPS26A VPS35,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0002318,myeloid progenitor cell differentiation,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), BRAF KIT,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens), PPP3CA CIB1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:2000738,positive regulation of stem cell differentiation,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8TDD2|ens), TACSTD2 SP7,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0032009,early phagosome,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens), SNX3 UNC13B,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0070365,hepatocyte differentiation,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens), E2F7 TAF10,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060174,limb bud formation,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), COL2A1 SOX4,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060322,head development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), RPGRIP1L GLI2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0042101,T cell receptor complex,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)Q9BH13(Evidence code:ISS/Database source:UniProtKB:Q13740), ZAP70 ALCAM,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0010592,positive regulation of lamellipodium assembly,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens), WASF2 NCKAP1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0006420,arginyl-tRNA aminoacylation,A7YW98(Evidence code:IEA/Database source:InterPro:IPR001278|I)Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001278|I), RARS RARS2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0097178,ruffle assembly,F1MGT3(Evidence code:IEA/Database source:InterPro:IPR030059)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens), MTSS1L ARF6,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0036477,somatodendritic compartment,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens), SNAP25 SYT4,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0030619,U1 snRNA binding,A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558)Q1RMR2(Evidence code:IEA/Database source:InterPro:IPR034143), PRPF8 SNRNP70,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0070938,contractile ring,F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0), UTRN PDXP,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0070528,protein kinase C signaling,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), FLOT1 DGKQ,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0007076,mitotic chromosome condensation,Q3MHQ9(Evidence code:IEA/Database source:InterPro:IPR022816)Q32KR9(Evidence code:IEA/Database source:InterPro:IPR029888), NCAPH CHMP1A,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0042908,xenobiotic transport,A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334), NR1I2 ABCC3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043497,regulation of protein heterodimerization activity,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), CDON DAB2IP,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0006999,nuclear pore organization,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BM06(Evidence code:IBA/Database source:PANTHER:PTN000327778), TPR NDC1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0007492,endoderm development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens), SOX17 EXT1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043546,molybdopterin cofactor binding,P48034(Evidence code:IEA/Database source:InterPro:IPR022407)F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens), AOX1 GPHN,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0008157,protein phosphatase 1 binding,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)F1MCY2(Evidence code:IEA/Database source:InterPro:IPR029984), SMTNL1 PHACTR4,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0033592,RNA strand annealing activity,Q1JPH6(Evidence code:IBA/Database source:PANTHER:PTN000579859)A7MBG9(Evidence code:IBA/Database source:PANTHER:PTN000579859), EIF4H WBSCR1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0021854,hypothalamus development,E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens), LEF1 RAX,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0090102,cochlea development,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens), RPGRIP1L GABRA5,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0034774,secretory granule lumen,P15101(Evidence code:ISS/Database source:UniProtKB:P09172)E1BCA5(Evidence code:IEA/Database source:UniProtKB:O35684|ens), DBH SERPINI1,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0030976,thiamine pyrophosphate binding,A5PJL6(Evidence code:IEA/Database source:InterPro:IPR011766|I)E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603), HACL1 DHTKD1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0004032,alditol:NADP+ 1-oxidoreductase activity,P16116(Evidence code:IEA/Database source:EC:1.1.1.21)Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens), AKR1B1 AKR1A1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0005412,glucose:sodium symporter activity,E1B749(Evidence code:IBA/Database source:PANTHER:PTN001371381)Q3ZC26(Evidence code:IBA/Database source:PANTHER:PTN001371381), SLC5A9 SLC5A11,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8WWN8|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens), ARAP3 SH3PXD2A,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043985,histone H4-R3 methylation,A7YW45(Evidence code:ISS/Database source:UniProtKB:Q8CIG8)Q5E9L5(Evidence code:IEA/Database source:GO:0044020), PRMT5 PRMT6,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0071253,connexin binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens), SRC TJP1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0004814,arginine-tRNA ligase activity,Q0P5H7(Evidence code:IEA/Database source:InterPro:IPR001278|I)A7YW98(Evidence code:IEA/Database source:InterPro:IPR001278|I), RARS2 RARS,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0017166,vinculin binding,F1MRT9(Evidence code:IEA/Database source:UniProtKB:P46939|ens)E1BIS6(Evidence code:IEA/Database source:UniProtKB:O15061|ens), UTRN SYNM,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0001657,ureteric bud development,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), DLG1 SLIT2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0016255,attachment of GPI anchor to protein,Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR028361)F1N4W0(Evidence code:IEA/Database source:InterPro:IPR007245), PIGK PIGT,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0002188,translation reinitiation,A6QLG1(Evidence code:IBA/Database source:PANTHER:PTN000513830)Q2KIE4(Evidence code:IBA/Database source:PANTHER:PTN000513830), LOC515358 MCTS1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043277,apoptotic cell clearance,F1N7K7(Evidence code:IEA/Database source:UniProtKB:Q60754|ens)P27479(Evidence code:ISS/Database source:UniProtKB:P39654), MARCO ALOX15,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0097284,hepatocyte apoptotic process,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens), ARF6 STK3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0050901,leukocyte tethering or rolling,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens), GOLPH3 ITGB7,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0019788,NEDD8 transferase activity,E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)A3KN22(Evidence code:ISS/Database source:UniProtKB:P61081), LOC780968 UBE2M,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0080025,"phosphatidylinositol-3,5-bisphosphate binding",F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens)Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O70492), PLEKHA5 SNX3,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060510,type II pneumocyte differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens), GATA6 AIMP2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:1990403,embryonic brain development,Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens), RNF112 EN1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0006382,adenosine to inosine editing,F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0), ADARB1 NUDT16,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060997,dendritic spine morphogenesis,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens), SHANK1 PAK3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0032226,"positive regulation of synaptic transmission, dopaminergic",Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), FLOT1 PINK1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0021904,dorsal/ventral neural tube patterning,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), GLI2 PSEN1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0035721,intraciliary retrograde transport,F1N307(Evidence code:IBA/Database source:PANTHER:PTN000380174)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens), TTC21A TTC21B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0090148,membrane fission,Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0), CHMP4B SPAST,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0034452,dynactin binding,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens)P43033(Evidence code:IDA/Database source:), BICD2 PAFAH1B1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0030539,male genitalia development,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens), TBX3 GREB1L,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0005131,growth hormone receptor binding,E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN001231348)F1MCX4(Evidence code:IEA/Database source:UniProtKB:P29597|ens), JAK2 TYK2,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0005068,transmembrane receptor protein tyrosine kinase adaptor activity,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens), FRS2 SH2B2,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens), CIB1 ABL1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), CHMP4A CHMP4B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0048644,muscle organ morphogenesis,P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens), MYF5 SMTNL1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0021510,spinal cord development,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q95LI2(Evidence code:ISS/Database source:UniProtKB:Q8VHI5), SOX4 VIT,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060065,uterus development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), GREB1L SRC,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0032489,regulation of Cdc42 protein signal transduction,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), ABCA1 ABL1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0022011,myelination in peripheral nervous system,G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), POU3F1 SIRT2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0042765,GPI-anchor transamidase complex,F1N4W0(Evidence code:IEA/Database source:InterPro:IPR007245)Q3MHZ7(Evidence code:IEA/Database source:InterPro:IPR028361), PIGT PIGK,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,Q17QR2(Evidence code:IEA/Database source:UniProtKB:O95630|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), STAMBP DAB2IP,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0009314,response to radiation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens), KIT PLK3,BP,2,2 of 114,0.08,1.75,0.02473,0.07495
GO:0045596,negative regulation of cell differentiation,E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens), POU4F2 SUZ12,BP,2,2 of 113,0.08,1.77,0.0246,0.07495
GO:0044351,macropinocytosis,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q3UMW7), SNX33 MAPKAPK3,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0032958,inositol phosphate biosynthetic process,F1MNG6(Evidence code:IBA/Database source:PANTHER:PTN000297581)A4FV33(Evidence code:IEA/Database source:InterPro:IPR005522), PPIP5K2 ITPKA,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0016540,protein autoprocessing,A2VDV7(Evidence code:IEA/Database source:UniProtKB:O15393|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens), TMPRSS2 HFE2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043368,positive T cell selection,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), BRAF BCL11B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,F1N4Q3(Evidence code:IEA/Database source:UniProtKB:Q80VA0|ens)E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens), GALNT7 GALNT2,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:1904288,BAT3 complex binding,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)Q32LM2(Evidence code:IEA/Database source:UniProtKB:O43765|ens), USP13 SGTA,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0046604,positive regulation of mitotic centrosome separation,Q3SZC4(Evidence code:IEA/Database source:UniProtKB:Q9UNZ2|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604), NSFL1C RANBP2,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0033604,negative regulation of catecholamine secretion,A5D7F2(Evidence code:IEA/Database source:UniProtKB:Q9H2B2|ens)P05059(Evidence code:IDA/Database source:), SYT4 CHGA,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0031915,positive regulation of synaptic plasticity,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens)F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens), SNAP25 UNC13A,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0048143,astrocyte activation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)P02638(Evidence code:NAS/Database source:), PSEN1 S100B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0003222,ventricular trabecula myocardium morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens), CHD7 UBE4B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060013,righting reflex,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens), ALDH1A3 SHANK1,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0031462,Cul2-RING ubiquitin ligase complex,E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806)Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q13617|ens), LOC780968 CUL2,CC,2,2 of 2,0.08,100,0.02526,0.07495
GO:1902741,positive regulation of interferon-alpha secretion,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), DDX58 DHX9,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens), PTTG1IP MARCH7,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0001205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding",F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:Q61191|ens), NFKB1 HCFC1,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0036310,annealing helicase activity,Q9TTA5(Evidence code:IEA/Database source:InterPro:IPR030101)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), SMARCAL1 BLM,MF,2,2 of 2,0.08,100,0.02526,0.07495
GO:0008626,granzyme-mediated apoptotic signaling pathway,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:O95155|ens), LAMP1 UBE4B,BP,2,2 of 2,0.08,100,0.02526,0.07495
GO:0060548,negative regulation of cell death,Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), CHMP2A SOX4 RAD18 VPS35 VPS4B CHMP4B,BP,6,6 of 202,0.25,2.97,0.02528,0.07498
GO:0010634,positive regulation of epithelial cell migration,Q58DW6(Evidence code:IEA/Database source:UniProtKB:P57735|ens)E1BIX3(Evidence code:IEA/Database source:UniProtKB:Q9Y6W3|ens)P08487(Evidence code:ISS/Database source:UniProtKB:P19174)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens), RAB25 CAPN7 PLCG1 HYAL1 SRC RREB1,BP,6,6 of 28,0.25,21.43,0.02554,0.07572
GO:0015267,channel activity,F1N5Z0(Evidence code:IEA/Database source:InterPro:IPR000425)E1BF03(Evidence code:IEA/Database source:InterPro:IPR039099), AQP5 PANX3,MF,2,2 of 117,0.08,1.71,0.02564,0.07597
GO:0045987,positive regulation of smooth muscle contraction,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824), SRF CTTN F2R,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0090181,regulation of cholesterol metabolic process,P48818(Evidence code:IEA/Database source:UniProtKB:P50544|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens), ACADVL DGKQ GNB3,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0048240,sperm capacitation,P35071(Evidence code:ISS/Database source:UniProtKB:P26361)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)Q5EA42(Evidence code:IEA/Database source:UniProtKB:P08910|ens), CFTR PRKACA ABHD2,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0001786,phosphatidylserine binding,Q2KHY1(Evidence code:ISS/Database source:UniProtKB:Q9Z140)Q28046(Evidence code:IDA/Database source:)E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q9R0N8|ens), CPNE6 SCIN SYT6,MF,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0019433,triglyceride catabolic process,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)Q2KI18(Evidence code:IEA/Database source:UniPathway:UPA00256)P16386(Evidence code:IEA/Database source:UniPathway:UPA00256), CPS1 PNPLA2 LIPE,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0046676,negative regulation of insulin secretion,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)P05059(Evidence code:IDA/Database source:)A1A4J1(Evidence code:IEA/Database source:UniProtKB:P12382|ens), IRS1 CHGA PFKL,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0006353,"DNA-templated transcription, termination",E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0806), SETX PRMT5 DHX9,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0045453,bone resorption,F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), LRRK1 TRAF6 SRC,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0061014,positive regulation of mRNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens)Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59), PNPT1 ZC3HAV1 GTPBP1,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0071364,cellular response to epidermal growth factor stimulus,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P52632)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)P08487(Evidence code:ISS/Database source:UniProtKB:P19174), STAT5B DUSP3 PLCG1,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0051482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,F1MSU3(Evidence code:IEA/Database source:UniProtKB:Q8BGE9|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)Q1JQB3(Evidence code:IBA/Database source:PANTHER:PTN000660850), RXFP3 F2R GPR4,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0010800,positive regulation of peptidyl-threonine phosphorylation,E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens), TNKS1BP1 GSK3A UBE2K,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0070997,neuron death,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q96QZ7|ens), LRRK2 KLK6 MAGI1,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0045576,mast cell activation,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)Q3SYX0(Evidence code:IEA/Database source:InterPro:IPR030693)P05059(Evidence code:ISS/Database source:UniProtKB:P10645), FCER1G NDRG1 CHGA,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0070498,interleukin-1-mediated signaling pathway,E1BN61(Evidence code:IEA/Database source:UniProtKB:O75582|ens)F1MQE1(Evidence code:IEA/Database source:UniProtKB:O75676|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), RPS6KA5 RPS6KA4 TRAF6,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0006998,nuclear envelope organization,A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)E1BIJ4(Evidence code:IBA/Database source:PANTHER:PTN001412149)F1MZZ8(Evidence code:IBA/Database source:PANTHER:PTN000308195), TOR1A LEMD3 SPAG4,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0000245,spliceosomal complex assembly,E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens)Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596745)A6QQX8(Evidence code:IEA/Database source:InterPro:IPR033809), GCFC2 LSM4 USP39,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0031418,L-ascorbic acid binding,A7MBA0(Evidence code:IEA/Database source:InterPro:IPR006620)P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0847)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR006620), EGLN3 DBH P4HA2,MF,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0006336,DNA replication-independent nucleosome assembly,A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens)F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens)Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens), IPO4 ATRX H3F3B,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0071353,cellular response to interleukin-4,A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q3SWY3(Evidence code:IEA/Database source:UniProtKB:P24547|ens), KEAP1 LEF1 IMPDH2,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:1900745,positive regulation of p38MAPK cascade,F1N3T0(Evidence code:IEA/Database source:UniProtKB:Q9Y6R4|ens)A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q3TAS6)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens), MAP3K4 EMC10 SASH1,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0070584,mitochondrion morphogenesis,A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens), POLDIP2 PNPT1 FIS1,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0043950,positive regulation of cAMP-mediated signaling,P04896(Evidence code:ISS/Database source:UniProtKB:P63092)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884), GNAS RAPGEF2 MB21D1,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0045746,negative regulation of Notch signaling pathway,Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens), ARRDC1 DLX2 CBFA2T2,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0090026,positive regulation of monocyte chemotaxis,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens), CXCL12 ANO6 S100A14,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0030041,actin filament polymerization,Q1RMR3(Evidence code:IEA/Database source:InterPro:IPR015503)Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737)F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens), CTTN CORO7 MICALL2,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0008541,"proteasome regulatory particle, lid subcomplex",Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)Q2KJ25(Evidence code:IBA/Database source:PANTHER:PTN000091582)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens), PSMD13 PSMD12 PSMD14,CC,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens)F1MNQ3(Evidence code:IBA/Database source:PANTHER:PTN001501163)F1N0Y1(Evidence code:IBA/Database source:PANTHER:PTN001501163), FAT1 DLG1 SCRIB,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0490), LOC788634 LOC100125916 BoLA,BP,3,3 of 7,0.13,42.86,0.02622,0.07646
GO:0007154,cell communication,E1BN52(Evidence code:IEA/Database source:InterPro:IPR003644)F1N740(Evidence code:IEA/Database source:InterPro:IPR003644)F1MFH3(Evidence code:IEA/Database source:InterPro:IPR003644), FREM1 FRAS1 FREM2,BP,3,3 of 138,0.13,2.17,0.02684,0.07821
GO:0004857,enzyme inhibitor activity,Q2KJ77(Evidence code:IBA/Database source:PANTHER:PTN001062464)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)F1MYQ7(Evidence code:IEA/Database source:UniProtKB:E9Q8I9|ens), HSPBP1 CCAR2 FRY,MF,3,3 of 139,0.13,2.16,0.02722,0.07929
GO:0045931,positive regulation of mitotic cell cycle,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens)A5D9H9(Evidence code:IEA/Database source:UniProtKB:Q91VA6|ens), BRCA2 STAT5B ABL1 STAT5A DUSP3 ASNS POLDIP2,BP,7,7 of 37,0.3,18.92,0.0279,0.08117
GO:0042493,response to drug,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)E1BL29(Evidence code:IEA/Database source:UniProtKB:Q8R016|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens), SMTNL1 FZD1 BLMH NPC1 PTPRM LCK GATA6,BP,7,7 of 37,0.3,18.92,0.0279,0.08117
GO:0007189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens)Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)P04896(Evidence code:ISS/Database source:UniProtKB:P63092), ADORA2A PTH1R GNA13 ABCA1 GNAS,BP,5,5 of 21,0.21,23.81,0.02871,0.08335
GO:0000387,spliceosomal snRNP assembly,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4)Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596745)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens), SNRPE PRMT5 STRAP LSM4 DDX20,BP,5,5 of 21,0.21,23.81,0.02871,0.08335
GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",Q2NL22(Evidence code:ISS/Database source:UniProtKB:P38919)Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422)Q08E07(Evidence code:IEA/Database source:UniProtKB:Q5SZQ8|ens)E1BIB4(Evidence code:IEA/Database source:UniProtKB:Q8R081|ens)A2VDN6(Evidence code:IBA/Database source:PANTHER:PTN000393333), EIF4A3 SAP18 CELF3 HNRNPL SF3A1,BP,5,5 of 21,0.21,23.81,0.02871,0.08335
GO:0051897,positive regulation of protein kinase B signaling,F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)F1MHN4(Evidence code:IBA/Database source:PANTHER:PTN000329282)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), TNFAIP8L3 MYDGF STK3 RICTOR SRC,BP,5,5 of 21,0.21,23.81,0.02871,0.08335
GO:0045727,positive regulation of translation,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945), EIF6 PIWIL2 PINK1 BCL3 EIF4A3 SOX4,BP,6,6 of 29,0.25,20.69,0.0291,0.08441
GO:0045666,positive regulation of neuron differentiation,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q5E9L2(Evidence code:IEA/Database source:InterPro:IPR033237)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q6NZJ6|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens), TCF7L2 BRINP1 EIF4G1 GLI2 ECT2 CDON,BP,6,6 of 29,0.25,20.69,0.0291,0.08441
GO:0001933,negative regulation of protein phosphorylation,E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens), CTDSP1 INSM1 DAB2IP SLIT2 PRNP CIB1 IGFBP3 PRKDC LRRK2 WWTR1 PSEN1 LRP6 CRKL,BP,13,13 of 91,0.55,14.29,0.0299,0.08668
GO:0032418,lysosome localization,Q3ZC25(Evidence code:ISS/Database source:UniProtKB:Q9NUM4)A2VDT8(Evidence code:IEA/Database source:UniProtKB:Q86YV9|ens)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q7TSI1|ens)Q2KI07(Evidence code:ISS/Database source:UniProtKB:Q9NVJ2), TMEM106B HPS6 PLEKHM1 ARL8B,BP,4,4 of 14,0.17,28.57,0.03024,0.08747
GO:0007519,skeletal muscle tissue development,Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)Q0P571(Evidence code:IEA/Database source:UniProtKB:P97457|ens)A0JN76(Evidence code:ISS/Database source:UniProtKB:Q9WUK6)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens), VAMP5 MYLPF ZBTB18 MYF5,BP,4,4 of 14,0.17,28.57,0.03024,0.08747
GO:0044291,cell-cell contact zone,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens)Q08DI5(Evidence code:IEA/Database source:UniProtKB:Q9Y3L5|ens), FLOT1 PKP4 SCRIB RAP2C,CC,4,4 of 14,0.17,28.57,0.03024,0.08747
GO:0043204,perikaryon,P56722(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), PTPRN SIRT2 CPNE6 LRRK2,CC,4,4 of 14,0.17,28.57,0.03024,0.08747
GO:0019787,ubiquitin-like protein transferase activity,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens),RNF139,MF,1,1 of 85,0.04,1.18,0.03031,0.08763
GO:0051047,positive regulation of secretion,Q28046(Evidence code:IDA/Database source:),SCIN,BP,1,1 of 86,0.04,1.16,0.03048,0.08807
GO:0034613,cellular protein localization,A4FUY1(Evidence code:IEA/Database source:UniProtKB:Q640R3|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens), HEPACAM SPTBN4 AXIN2 NIPBL RAP2A AHI1 LRRK2,BP,7,7 of 215,0.3,3.26,0.03074,0.08877
GO:0051090,regulation of DNA-binding transcription factor activity,E1B793(Evidence code:IEA/Database source:UniProtKB:Q9NRP7|ens),STK36,BP,1,1 of 87,0.04,1.15,0.03079,0.08887
GO:0006812,cation transport,F1MPF0(Evidence code:IEA/Database source:InterPro:IPR029601)E1BF03(Evidence code:IEA/Database source:InterPro:IPR039099)F1MRN7(Evidence code:IEA/Database source:InterPro:IPR006544)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR027256), TRPM7 PANX3 ATP13A5 TRPM4 ANO6 ATP7B,BP,6,6 of 191,0.25,3.14,0.03244,0.09359
GO:0005507,copper ion binding,A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276)P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I)Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O00244|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR006122)P10279(Evidence code:ISS/Database source:UniProtKB:P04156), SCO1 DBH ATOX1 MT3 ATP7B PRNP,MF,6,6 of 30,0.25,20,0.03298,0.09503
GO:0045454,cell redox homeostasis,O62768(Evidence code:IEA/Database source:InterPro:IPR004099)Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)Q0II43(Evidence code:IEA/Database source:InterPro:IPR013766|I)A4FUW8(Evidence code:IEA/Database source:InterPro:IPR013766)Q58DA7(Evidence code:IEA/Database source:InterPro:IPR002109|I)E1BBS6(Evidence code:IEA/Database source:InterPro:IPR013766), TXNRD1 NFE2L2 TXNL1 TXNDC11 GLRX3 QSOX2,BP,6,6 of 30,0.25,20,0.03298,0.09503
GO:0043330,response to exogenous dsRNA,F1MKU1(Evidence code:IEA/Database source:UniProtKB:Q6Q899|ens)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q91VR5|ens)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), DDX58 IFNT3 DDX1 LOC104968438 IFNT2,BP,5,5 of 22,0.21,22.73,0.03331,0.09595
GO:0007166,cell surface receptor signaling pathway,P26917(Evidence code:IBA/Database source:PANTHER:PTN000059370)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR017981)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR017981)Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN001553005)A6QPZ5(Evidence code:IEA/Database source:InterPro:IPR003153|I)F1MJZ6(Evidence code:IBA/Database source:PANTHER:PTN001060286)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN001060286)Q2KJ41(Evidence code:IBA/Database source:PANTHER:PTN001060286)A7MB15(Evidence code:IEA/Database source:InterPro:IPR000539|I)Q9BDR7(Evidence code:IEA/Database source:InterPro:IPR003110)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR017981)P46196(Evidence code:IBA/Database source:PANTHER:PTN001171853)Q58CZ7(Evidence code:IBA/Database source:PANTHER:PTN001060286), SST PTH2R CD97 KHDRBS1 MAPKAPK3 CBLC TSPAN9 CD63 TSPAN14 FZD1 FCER1G PTH1R MAPK1 TSPAN2,BP,14,14 of 344,0.59,4.07,0.03337,0.09604
GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,Q95KU9(Evidence code:IEA/Database source:InterPro:IPR034735)A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens)E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens), IKBKG PRPF8 OTUD7B,MF,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0016575,histone deacetylation,Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320|I), MIER1 SIRT2 HDAC5,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0061512,protein localization to cilium,F1N307(Evidence code:IBA/Database source:PANTHER:PTN000380174)F6PR93(Evidence code:IEA/Database source:UniProtKB:Q7Z4L5|ens)Q0IIM2(Evidence code:IEA/Database source:UniProtKB:Q9H0F7|ens), TTC21A TTC21B ARL6,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0032206,positive regulation of telomere maintenance,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens)E1BF96(Evidence code:IEA/Database source:UniProtKB:Q96QC0|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens), ATRX PPP1R10 SIRT6,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0035145,exon-exon junction complex,Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens)Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens), SRSF1 EIF4A3 SMG6,CC,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0010181,FMN binding,Q4JIJ2(Evidence code:IEA/Database source:InterPro:IPR001094|I)Q3ZBW2(Evidence code:IEA/Database source:InterPro:IPR012133)Q27995(Evidence code:IEA/Database source:InterPro:IPR001094|I), MTRR HAO2 NOS2,MF,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0030042,actin filament depolymerization,G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q7RTP6)F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR017904), MICAL3 MICAL2 DSTN,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0010955,negative regulation of protein processing,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), TMEM59 SNX12 LRRK2,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0009086,methionine biosynthetic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens)Q4JIJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0486)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0486), MTHFD1 MTRR MRI1,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0018149,peptide cross-linking,A6QP57(Evidence code:IEA/Database source:InterPro:IPR001102|I)Q6TNF3(Evidence code:IEA/Database source:InterPro:IPR001102|I)P51176(Evidence code:IEA/Database source:InterPro:IPR001102|I), TGM3 TGM1 TGM2,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0006261,DNA-dependent DNA replication,Q05B83(Evidence code:IBA/Database source:PANTHER:PTN000186208)E1BMC0(Evidence code:IEA/Database source:InterPro:IPR002298)F1MFY4(Evidence code:IEA/Database source:InterPro:IPR027044), RFC2 POLQ HELB,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0000175,3-5-exoribonuclease activity,Q0II50(Evidence code:ISS/Database source:UniProtKB:Q9BQ65)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)E1BML0(Evidence code:IEA/Database source:UniProtKB:Q504Q3|ens), USB1 PNPT1 PAN2,MF,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0007498,mesoderm development,A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), EXT1 PPP2CA FOXF1,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0002931,response to ischemia,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens), CIB1 NDNF CAMK2A,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0047497,mitochondrion transport along microtubule,E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)Q2HJF8(Evidence code:ISS/Database source:UniProtKB:Q8IXI2)Q5E9M9(Evidence code:ISS/Database source:UniProtKB:Q8IXI1), KIF1B RHOT1 RHOT2,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0043539,protein serine/threonine kinase activator activity,F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74), FAM20A TCL1A ETAA1,MF,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0051965,positive regulation of synapse assembly,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens)A4IFI5(Evidence code:IEA/Database source:UniProtKB:Q8BHA1|ens), CUX2 BDNF LRRC24,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0001953,negative regulation of cell-matrix adhesion,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens), SEMA3E ADAM15 HOXA7,BP,3,3 of 8,0.13,37.5,0.03426,0.09767
GO:0005774,vacuolar membrane,P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241)P23956(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), NAPG ATP6V0C,CC,2,2 of 109,0.08,1.83,0.03492,0.09951
GO:0006469,negative regulation of protein kinase activity,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens)F1N1Q7(Evidence code:IBA/Database source:PANTHER:PTN001107228)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q0VCK2(Evidence code:IEA/Database source:InterPro:IPR004171)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)E1BPZ4(Evidence code:IBA/Database source:PANTHER:PTN000395915)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q17QE5(Evidence code:IEA/Database source:GO:0008427), WWTR1 PREX1 NF2 PKIB LRP6 RTN4R PPP1R1C PSEN1 CIB1,BP,9,9 of 52,0.38,17.31,0.03513,0.1
GO:1901137,carbohydrate derivative biosynthetic process,F1MZY2(Evidence code:IEA/Database source:InterPro:IPR005855)Q08DQ2(Evidence code:IEA/Database source:InterPro:IPR005855), GFPT1 GFPT2,BP,2,2 of 110,0.08,1.82,0.03534,0.1006
GO:0006875,cellular metal ion homeostasis,Q0VCA3(Evidence code:IBA/Database source:PANTHER:PTN000360953)P37359(Evidence code:IEA/Database source:UniProtKB:P28184|ens), LETM1 MT3,BP,2,2 of 111,0.08,1.8,0.03588,0.1021
GO:0042054,histone methyltransferase activity,E1B9T7(Evidence code:IBA/Database source:PANTHER:PTN001476056)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q6XZL8|ens)F1MMF1(Evidence code:IEA/Database source:UniProtKB:E9PZZ1|ens)Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8), SUZ12 DOT1L PRDM13 PRMT6,MF,4,4 of 15,0.17,26.67,0.0363,0.103
GO:0051291,protein heterooligomerization,Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB:P61458|ens)A2VE99(Evidence code:IEA/Database source:UniProtKB:Q9NVA2|ens)Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens), CHMP2A PCBD1 SEPT11 CLDN3,BP,4,4 of 15,0.17,26.67,0.0363,0.103
GO:0000077,DNA damage checkpoint,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519)E1BGK8(Evidence code:IBA/Database source:PANTHER:PTN000485246)A6QNK6(Evidence code:IEA/Database source:InterPro:IPR018324), E2F1 ATM DOT1L RAD17,BP,4,4 of 15,0.17,26.67,0.0363,0.103
GO:2000045,regulation of G1/S transition of mitotic cell cycle,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens), KIF14 PTPN6 INO80 E2F1,BP,4,4 of 15,0.17,26.67,0.0363,0.103
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,A0JN39(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P62248(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BLD5(Evidence code:IEA/Database source:UniProtKB:Q96AX2|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens), COPB1 MYDGF RAB37 PROM1,CC,4,4 of 15,0.17,26.67,0.0363,0.103
GO:0016829,lyase activity,E1BP41(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)Q3ZBD3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)Q3T0S5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)Q29450(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)Q148D3(Evidence code:IEA/Database source:InterPro:IPR018951)A5PK65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A2VDS1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A7MBC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A4FUZ1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456)A3KN12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0456), CSAD PCBD1 UMPS ALDOB ADCY7 FH DDT GUCY1A3 SCLY PDXDC1 GLO1 ADSL,MF,12,12 of 83,0.51,14.46,0.03736,0.1059
GO:0036464,cytoplasmic ribonucleoprotein granule,Q5E9A3(Evidence code:IEA/Database source:UniProtKB:Q15365|ens)Q08DH7(Evidence code:IEA/Database source:UniProtKB:Q16352|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:Q71U36|ens)Q5E9F9(Evidence code:IEA/Database source:UniProtKB:A0A140VK70)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)D3IVZ2(Evidence code:IBA/Database source:PANTHER:PTN000619593)F1MW03(Evidence code:IEA/Database source:UniProtKB:Q8NFU3|ens)G5E631(Evidence code:IBA/Database source:PANTHER:PTN000619593)Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9BYH8|ens), PCBP1 INA TUBA1A PSMC2 DHX9 DDX3Y TSTD1 DDX3X NFKBIZ,CC,9,9 of 54,0.38,16.67,0.03788,0.1074
GO:0019903,protein phosphatase binding,E1BHP3(Evidence code:IEA/Database source:UniProtKB:Q6ZSY5|ens)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens)Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens), PPP1R3F CDC27 LCK SNX3 GRB2,MF,5,5 of 23,0.21,21.74,0.03836,0.1075
GO:0001502,cartilage condensation,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens), COL2A1 MYF5,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0031080,nuclear pore outer ring,Q3ZCC9(Evidence code:ISS/Database source:UniProtKB:P55735)F1MNL8(Evidence code:IEA/Database source:UniProtKB:Q8WYP5|ens), SEC13 AHCTF1,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0021884,forebrain neuron development,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens), RAPGEF2 SOX1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0044754,autolysosome,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens), LRRK2 LAMP1,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0002862,negative regulation of inflammatory response to antigenic stimulus,Q3T0X5(Evidence code:IEA/Database source:UniProtKB:Q9R1P4|ens)Q3T108(Evidence code:IEA/Database source:UniProtKB:P99026|ens), PSMA1 PSMB4,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0044020,histone methyltransferase activity (H4-R3 specific),A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8), PRMT5 PRMT6,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0090129,positive regulation of synapse maturation,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:P08413), DAB2IP CAMK2B,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0006526,arginine biosynthetic process,F1MVC0(Evidence code:IBA/Database source:PANTHER:PTN000150223)F1ML89(Evidence code:IBA/Database source:PANTHER:PTN000150223), CAD CPS1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0019673,GDP-mannose metabolic process,Q3ZBY8(Evidence code:IEA/Database source:InterPro:IPR006368)Q2KIT8(Evidence code:IEA/Database source:UniProtKB:Q13630|ens), GMDS TSTA3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0035360,positive regulation of peroxisome proliferator activated receptor signaling pathway,F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O35936|ens), STARD10 ALOX15B,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0060444,branching involved in mammary gland duct morphogenesis,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), TBX3 SRC,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0000164,protein phosphatase type 1 complex,P61287(Evidence code:IEA/Database source:InterPro:IPR037981)Q3SWW9(Evidence code:IEA/Database source:InterPro:IPR037979), PPP1CC PPP1CB,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0033268,node of Ranvier,Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q62288)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), SPOCK1 DLG1,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0070324,thyroid hormone binding,Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens), CRYM ALDH1A3,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0036159,inner dynein arm assembly,F1N5R7(Evidence code:IEA/Database source:UniProtKB:Q8WXX0|ens)F1N1K6(Evidence code:IBA/Database source:PANTHER:PTN001321402), DNAH7 DNHD1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0007004,telomere maintenance via telomerase,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280), PTGES3 SMG6,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q9UKS6|ens), SNX33 PACSIN3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0016581,NuRD complex,Q1RMW4(Evidence code:IEA/Database source:UniProtKB:Q8NEU8|ens)A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens), APPL2 APPL1,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0001135,RNA polymerase II transcription factor recruiting activity,E1BCK9(Evidence code:IBA/Database source:PANTHER:PTN000067606)Q2KJC1(Evidence code:IBA/Database source:PANTHER:PTN000067606), SNAPC4 CDC5L,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0031105,septin complex,Q6Q137(Evidence code:IEA/Database source:InterPro:IPR008115)Q3SZN0(Evidence code:IEA/Database source:InterPro:IPR030644), SEPT7 SEPT6,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0045656,negative regulation of monocyte differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens), CDK6 HOXA7,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0034098,VCP-NPL4-UFD1 AAA ATPase complex,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens)Q0P568(Evidence code:IEA/Database source:UniProtKB:P70362|ens), UBXN1 UFD1L,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0005787,signal peptidase complex,Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653)P67810(Evidence code:IEA/Database source:InterPro:IPR037712), SPCS3 SEC11A,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0048194,Golgi vesicle budding,E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens), MYO18A GOLPH3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0060333,interferon-gamma-mediated signaling pathway,Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224), IRF1 STAT1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0060976,coronary vasculature development,F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens)E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens), PTK7 MEGF8,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0016446,somatic hypermutation of immunoglobulin genes,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q60710)E1BMC0(Evidence code:IEA/Database source:UniProtKB:Q8CGS6|ens), SAMHD1 POLQ,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0030878,thyroid gland development,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), BRAF SRF,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:1904659,glucose transmembrane transport,E1B749(Evidence code:IBA/Database source:PANTHER:PTN001371381)Q3ZC26(Evidence code:IBA/Database source:PANTHER:PTN001371381), SLC5A9 SLC5A11,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0005720,nuclear heterochromatin,A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens), UHRF1 TNKS1BP1,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0009931,calcium-dependent protein serine/threonine kinase activity,Q3SYZ2(Evidence code:IBA/Database source:PANTHER:PTN000681419)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens), MAPKAPK3 CAMK2A,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0016331,morphogenesis of embryonic epithelium,F1MEC8(Evidence code:IEA/Database source:UniProtKB:Q7TSK3|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens), PCDH8 SCRIB,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0043030,regulation of macrophage activation,E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens), MYO18A SLC7A2,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0007220,Notch receptor processing,F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), DNER PSEN1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0007026,negative regulation of microtubule depolymerization,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens), CIB1 NAV3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0006707,cholesterol catabolic process,E1BM29(Evidence code:IEA/Database source:InterPro:IPR030681)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), CYP7A1 MT3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0001964,startle response,Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens), FABP7 CHD8,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0051444,negative regulation of ubiquitin-protein transferase activity,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), ABL1 PSEN1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0035641,locomotory exploration behavior,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens), LRRK2 CRH,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:2000641,regulation of early endosome to late endosome transport,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens), SRC DNAJC13,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0035067,negative regulation of histone acetylation,F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139), CTBP1 BRCA1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0004012,phospholipid-translocating ATPase activity,F1N0J3(Evidence code:IEA/Database source:InterPro:IPR006539)E1BPC3(Evidence code:IEA/Database source:InterPro:IPR006539|I), ATP11A ATP8B1,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0003689,DNA clamp loader activity,A6QNK6(Evidence code:IEA/Database source:InterPro:IPR018324)Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250), RAD17 RFC2,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0030423,targeting of mRNA for destruction involved in RNA interference,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3), DHX9 DICER1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0004525,ribonuclease III activity,A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens)Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR000999|I), DGCR8 DICER1,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0032211,negative regulation of telomere maintenance via telomerase,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), TERF2 SRC,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0010815,bradykinin catabolic process,Q24K02(Evidence code:ISS/Database source:UniProtKB:P14735)Q1JPJ2(Evidence code:ISS/Database source:UniProtKB:Q9NQW7), IDE XPNPEP1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0071285,cellular response to lithium ion,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)Q29450(Evidence code:ISS/Database source:UniProtKB:P51829), GSK3A ADCY7,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0090166,Golgi disassembly,P48734(Evidence code:ISS/Database source:UniProtKB:P39951)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens), CDK1 PLK3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0016139,glycoside catabolic process,F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens)Q2KIM0(Evidence code:IEA/Database source:UniProtKB:P04066|ens), FUCA2 FUCA1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0044208,de novo AMP biosynthetic process,A7MBG0(Evidence code:IEA/Database source:UniPathway:UPA00075)A3KN12(Evidence code:IEA/Database source:UniPathway:UPA00075), ADSS ADSL,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0033622,integrin activation,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens), CXCL12 FERMT2,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0031748,D1 dopamine receptor binding,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793), VPS35 GNAS,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0006166,purine ribonucleoside salvage,Q3MHF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0660)Q17R18(Evidence code:IEA/Database source:InterPro:IPR001805), MTAP ADK,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0070208,protein heterotrimerization,P02465(Evidence code:IEA/Database source:UniProtKB:Q01149|ens)F1MLJ0(Evidence code:IEA/Database source:UniProtKB:O88286|ens), COL1A2 WIZ,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0006809,nitric oxide biosynthetic process,E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens)Q27995(Evidence code:IEA/Database source:InterPro:IPR004030|I), SLC7A2 NOS2,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0036157,outer dynein arm,Q3T140(Evidence code:IBA/Database source:PANTHER:PTN002244005)E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000840538), DYNLRB1 DNAH5,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0001956,positive regulation of neurotransmitter secretion,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens)F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens), UNC13A BAIAP3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0014898,cardiac muscle hypertrophy in response to stress,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), PPP3CA GATA6,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0070061,fructose binding,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)A1A4J1(Evidence code:IEA/Database source:UniProtKB:P17858|ens), PFKM PFKL,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0007129,synapsis,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens)E1BM06(Evidence code:IEA/Database source:UniProtKB:Q8VCB1|ens), RAD21L1 NDC1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0006880,intracellular sequestering of iron ion,O46415(Evidence code:IBA/Database source:PANTHER:PTN000153092)O46414(Evidence code:IBA/Database source:PANTHER:PTN000153092), FTL FTH1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0017147,Wnt-protein binding,F1MDE1(Evidence code:IEA/Database source:InterPro:IPR017049)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), LRP6 FZD1,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0034450,ubiquitin-ubiquitin ligase activity,P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR019474), UBE2K UBE4B,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0030014,CCR4-NOT complex,E1BHL0(Evidence code:IEA/Database source:InterPro:IPR019312)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens), CNOT11 TNKS1BP1,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0005220,"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",Q8WN96(Evidence code:IEA/Database source:InterPro:IPR000493)Q9TU34(Evidence code:IEA/Database source:InterPro:IPR000493), ITPR2 ITPR1,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0000188,inactivation of MAPK activity,A6QLS1(Evidence code:IEA/Database source:GO:0017017)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens), DUSP7 DUSP3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0033630,positive regulation of cell adhesion mediated by integrin,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828), PTPN6 CIB1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0043116,negative regulation of vascular permeability,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens), SLIT2 ARHGAP35,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0021983,pituitary gland development,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), GLI1 GLI2,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0033160,"positive regulation of protein import into nucleus, translocation",Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens), PSEN1 LRRK2,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0033601,positive regulation of mammary gland epithelial cell proliferation,E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens)E1BN44(Evidence code:IEA/Database source:UniProtKB:Q92766|ens), AGAP2 RREB1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0048012,hepatocyte growth factor receptor signaling pathway,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)Q08E52(Evidence code:IEA/Database source:UniProtKB:Q13153|ens), SIRT2 PAK1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:2001222,regulation of neuron migration,Q3MHJ9(Evidence code:ISS/Database source:UniProtKB:Q13554)Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens), CAMK2B CAMK2A,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0002053,positive regulation of mesenchymal cell proliferation,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), SHOX2 FOXF1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:1904357,negative regulation of telomere maintenance via telomere lengthening,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)E1B8R5(Evidence code:IEA/Database source:UniProtKB:O95271|ens), TERF2 TNKS,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0036435,K48-linked polyubiquitin modification-dependent protein binding,Q0P568(Evidence code:IEA/Database source:UniProtKB:P70362|ens)Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens), UFD1L UBXN1,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0030901,midbrain development,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), EN1 LRP6,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0032497,detection of lipopolysaccharide,Q9GL65(Evidence code:ISS/Database source:UniProtKB:O00206)P58754(Evidence code:ISS/Database source:UniProtKB:Q9Y6Y9), TLR4 LY96,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0050774,negative regulation of dendrite morphogenesis,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), RAPGEF2 PPP3CA,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0042088,T-helper 1 type immune response,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), BCL3 TRAF6,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0036295,cellular response to increased oxygen levels,P61420(Evidence code:ISS/Database source:UniProtKB:P61421)P31404(Evidence code:ISS/Database source:UniProtKB:P38606), ATP6V0D1 ATP6V1A,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:1903204,negative regulation of oxidative stress-induced neuron death,F1MTK2(Evidence code:IEA/Database source:UniProtKB:Q8K0P3|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens), TLDC1 FZD1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0032584,growth cone membrane,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7)A6QLD1(Evidence code:IEA/Database source:UniProtKB:O35382|ens), ZFYVE27 EXOC4,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0007042,lysosomal lumen acidification,P23956(Evidence code:IBA/Database source:PANTHER:PTN000813819)F1MX24(Evidence code:IBA/Database source:PANTHER:PTN000104838), ATP6V0C CLN3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0005229,intracellular calcium activated chloride channel activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)F1N1D4(Evidence code:IEA/Database source:UniProtKB:Q9C0H2|ens), ANO6 TTYH3,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:1901621,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens), PRKACA PRKACB,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0033173,calcineurin-NFAT signaling cascade,A5D7T5(Evidence code:IEA/Database source:UniProtKB:P48454|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens), PPP3CC PPP3CA,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway,F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), SASH1 TRAF6,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0030214,hyaluronan catabolic process,F1MNY2(Evidence code:IEA/Database source:UniProtKB:Q9UHN6|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), TMEM2 HYAL1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0030007,cellular potassium ion homeostasis,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens), KCNMA1 ATP1A2,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens), FKBP1B RYR1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0005883,neurofilament,Q08DH7(Evidence code:IEA/Database source:InterPro:IPR027703)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens), INA SHANK2,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0046696,lipopolysaccharide receptor complex,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9), TLR4 LY96,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0042421,norepinephrine biosynthetic process,P15101(Evidence code:ISS/Database source:UniProtKB:P09172)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0), DBH INSM1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0042982,amyloid precursor protein metabolic process,Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), PSEN1 DLG1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0072001,renal system development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q9H6I2|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), SOX17 FOXF1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0002138,retinoic acid biosynthetic process,P02694(Evidence code:IEA/Database source:InterPro:IPR031264)F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens), RBP1 ALDH1A3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0070734,histone H3-K27 methylation,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)E1B9T7(Evidence code:IEA/Database source:GO:0046976), EHMT2 SUZ12,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0046549,retinal cone cell development,P04696(Evidence code:IEA/Database source:UniProtKB:P50149|ens)E1BM97(Evidence code:IEA/Database source:UniProtKB:O88704|ens), GNAT2 HCN1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0002199,zona pellucida receptor complex,F1MWD3(Evidence code:IEA/Database source:UniProtKB:P80316|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens), CCT5 CCT3,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0090036,regulation of protein kinase C signaling,Q29RN8(Evidence code:IEA/Database source:UniProtKB:Q4V9Z5|ens)G3MWT9(Evidence code:IEA/Database source:InterPro:IPR028540), SEZ6L2 AKAP12,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0007263,nitric oxide mediated signal transduction,F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8TB73|ens)Q27995(Evidence code:IBA/Database source:PANTHER:PTN001066032), NDNF NOS2,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0042813,Wnt-activated receptor activity,A7MB15(Evidence code:IEA/Database source:InterPro:IPR026548)F1MDE1(Evidence code:IEA/Database source:InterPro:IPR017049), FZD1 LRP6,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0036091,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), CHD6 MT3,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0008484,sulfuric ester hydrolase activity,Q08DD1(Evidence code:IEA/Database source:InterPro:IPR000917)A6QPY4(Evidence code:IEA/Database source:InterPro:IPR000917), ARSA SGSH,MF,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0031672,A band,P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens), MYL3 MYBPC3,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0045780,positive regulation of bone resorption,E1BIG6(Evidence code:IEA/Database source:UniProtKB:Q62351|ens)G3X7G7(Evidence code:IEA/Database source:UniProtKB:Q7TSI1|ens), TFRC PLEKHM1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0005858,axonemal dynein complex,E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)E1B9S6(Evidence code:IBA/Database source:PANTHER:PTN000277911), DNAH5 WDR78,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0042994,cytoplasmic sequestering of transcription factor,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens)A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN000697161), SRI KEAP1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0016591,"RNA polymerase II, holoenzyme",F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5)E1BPK6(Evidence code:IEA/Database source:UniProtKB:Q9UM54|ens), RPAP2 MYO6,CC,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,A7YY26(Evidence code:IEA/Database source:InterPro:IPR028444)Q01107(Evidence code:TAS/Database source:), ARVCF DSC1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0006348,chromatin silencing at telomere,E1BGK8(Evidence code:IBA/Database source:PANTHER:PTN000485246)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens), DOT1L RIF1,BP,2,2 of 3,0.08,66.67,0.04021,0.1075
GO:0019221,cytokine-mediated signaling pathway,G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)E1B7G0(Evidence code:IBA/Database source:PANTHER:PTN000466212)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)F1MTF9(Evidence code:IEA/Database source:GO:0004896)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens)G3X7E9(Evidence code:IEA/Database source:GO:0004896), RTN4R IFNT2 IFNT3 JAK2 IFNLR1 STAT5B KIT STAT5A IL9R LOC104968438 SH2B2 IL13RA1,BP,12,12 of 86,0.51,13.95,0.04221,0.1127
GO:0006979,response to oxidative stress,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q3T0E0(Evidence code:IBA/Database source:PANTHER:PTN001106576)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074)P37141(Evidence code:IEA/Database source:InterPro:IPR000889)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P37359(Evidence code:IEA/Database source:UniProtKB:P28184|ens)P00432(Evidence code:IEA/Database source:InterPro:IPR018028|I)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)P00435(Evidence code:IEA/Database source:InterPro:IPR000889), PSEN1 ATOX1 WRN ERCC2 GPX3 PINK1 ABL1 MT3 CAT PRNP LRRK2 GPX1,BP,12,12 of 86,0.51,13.95,0.04221,0.1127
GO:0060326,cell chemotaxis,Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)A6YT15(Evidence code:IEA/Database source:UniProtKB:Q9NRJ3|ens)P43481(Evidence code:ISS/Database source:UniProtKB:P10721)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)A4FUD6(Evidence code:ISS/Database source:UniProtKB:Q96JJ3), C5AR1 CXCL12 PIK3CD CCL28 KIT LEF1 ELMO2,BP,7,7 of 41,0.3,17.07,0.04244,0.1133
GO:0005778,peroxisomal membrane,Q0P5B1(Evidence code:ISS/Database source:UniProtKB:Q92968)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR025653)Q0VC07(Evidence code:IBA/Database source:PANTHER:PTN000598603)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens), PEX13 PEX1 PEX10 CAT,CC,4,4 of 16,0.17,25,0.043,0.1142
GO:0051321,meiotic cell cycle,F1N2F6(Evidence code:IEA/Database source:InterPro:IPR013940)P67774(Evidence code:IEA/Database source:UniProtKB-KW:KW-0469)Q5W5U4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0469)A5D7P5(Evidence code:IBA/Database source:PANTHER:PTN000447085), TEX11 PPP2CA DDX4 TUBGCP2,BP,4,4 of 16,0.17,25,0.043,0.1142
GO:0010633,negative regulation of epithelial cell migration,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens), DAB2IP PTPN23 STRAP TACSTD2,BP,4,4 of 16,0.17,25,0.043,0.1142
GO:0031023,microtubule organizing center organization,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens)P43033(Evidence code:IBA/Database source:PANTHER:PTN000752736)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens), GCC2 SDCCAG8 PAFAH1B1 CDK5RAP2,BP,4,4 of 16,0.17,25,0.043,0.1142
GO:0019897,extrinsic component of plasma membrane,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P08207|ens)F1MH24(Evidence code:IDA/Database source:)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), HIST1H2BA S100A10 AAK1 NUMA1,CC,4,4 of 16,0.17,25,0.043,0.1142
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,F1ML16(Evidence code:IEA/Database source:InterPro:IPR028424)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens), HIC1 BRCA2 E2F1 PRKDC,BP,4,4 of 16,0.17,25,0.043,0.1142
GO:0003730,mRNA 3-UTR binding,F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens)Q5E9A3(Evidence code:ISS/Database source:UniProtKB:P11940), CCT5 PUM1 CRYZ PCBP1,MF,4,4 of 16,0.17,25,0.043,0.1142
GO:0060236,regulation of mitotic spindle organization,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)P63097(Evidence code:ISS/Database source:UniProtKB:P63096), NUMA1 GPSM2 GNAI1,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0005665,"RNA polymerase II, core complex",G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000684)Q32PE0(Evidence code:IEA/Database source:InterPro:IPR028363)F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens), POLR2A POLR2F CHD6,CC,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0070129,regulation of mitochondrial translation,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)E1BPX9(Evidence code:IEA/Database source:UniProtKB:Q6PB66|ens)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17), SHMT2 LRPPRC MTG1,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0006367,transcription initiation from RNA polymerase II promoter,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)F1MME0(Evidence code:IEA/Database source:UniProtKB:Q6P1X5|ens), TCF7L2 TAF10 TAF2,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:1901224,positive regulation of NIK/NF-kappaB signaling,A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens)F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens)E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens), PDCD4 SASH1 RC3H2,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0043153,entrainment of circadian clock by photoperiod,F1N3S3(Evidence code:IEA/Database source:UniProtKB:P43136|ens)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62141)P61287(Evidence code:ISS/Database source:UniProtKB:P63087), NR2F6 PPP1CB PPP1CC,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0019933,cAMP-mediated signaling,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), RAPGEF4 RAPGEF2 DGKQ,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0042311,vasodilation,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)P63026(Evidence code:IMP/Database source:)F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens), KCNMA1 VAMP2 CPS1,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0031624,ubiquitin conjugating enzyme binding,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens), TRAF6 ANKIB1 MARCH7,MF,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:2000249,regulation of actin cytoskeleton reorganization,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:Q9Y624|ens)Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens), SEMA3E F11R PHPT1,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0048514,blood vessel morphogenesis,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens), COL4A1 MEIS1 ETV2,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0030516,regulation of axon extension,O02675(Evidence code:IEA/Database source:InterPro:IPR030615)A6H7I5(Evidence code:ISS/Database source:UniProtKB:P39052)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), DPYSL2 DNM2 ABL1,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0045907,positive regulation of vasoconstriction,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens), SMTNL1 F2R DBH,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0045214,sarcomere organization,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q3UIZ8|ens), SRF MYBPC3 MYLK3,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0005537,mannose binding,F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q8CF98|ens)P11456(Evidence code:IEA/Database source:InterPro:IPR000296)G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens), COLEC10 M6PR ACR,MF,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0070301,cellular response to hydrogen peroxide,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), KDM6B SETX ABL1,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0043392,negative regulation of DNA binding,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens), LEF1 ZNF462 E2F1,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0005885,Arp2/3 protein complex,F1N6J8(Evidence code:IEA/Database source:InterPro:IPR015623)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383)Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I), ACTR3B ARPC1A ARPC5L,CC,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0006071,glycerol metabolic process,F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q0IID9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0319), GK2 LOC538702 GK,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0005686,U2 snRNP,A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555)A2VDN6(Evidence code:IEA/Database source:UniProtKB:Q15459|ens)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760), SNRPE SF3A1 SNRPN,CC,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0002026,regulation of the force of heart contraction,Q58DA7(Evidence code:ISS/Database source:UniProtKB:Q9CQM9)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), GLRX3 MYL3 ATP1A2,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0033344,cholesterol efflux,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens), NPC1 ABCA1 ABCA7,BP,3,3 of 9,0.13,33.33,0.04342,0.1142
GO:0030659,cytoplasmic vesicle membrane,A4IFN6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q08DW1(Evidence code:IEA/Database source:UniProtKB:Q9R0M6|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)E0AE16(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q17QU4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q2HJ40(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QQP7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VD59(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1RMW2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q1JQ98(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P04973(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A2VDY3(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SNX18 RAB9A VAMP5 KIF1B SNX9 RAB39B BACE1 DYSF MARCH8 TMEM184A MYO1C SNX33 AP1S1 CLTA VAMP1 CHMP4A,CC,16,16 of 126,0.68,12.7,0.0435,0.1144
GO:0046486,glycerolipid metabolic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 78,0.04,1.28,0.04354,0.1144
GO:0070124,mitochondrial translational initiation,Q32KZ1(Evidence code:IEA/Database source:UniProtKB:Q9H2K0|ens),MTIF3,BP,1,1 of 79,0.04,1.27,0.04359,0.1145
GO:0006914,autophagy,E1BH30(Evidence code:IEA/Database source:InterPro:IPR026849)Q08DG0(Evidence code:IEA/Database source:InterPro:IPR015056)E1BMF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BM69(Evidence code:IEA/Database source:InterPro:IPR032917)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)Q3T0Q2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens)Q17QU4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0072), ATG2B NRBF2 USP13 PSEN1 LOC516599 NPC1 TMEM59 CHMP4B RAB39B,BP,9,9 of 57,0.38,15.79,0.04363,0.1146
GO:0008026,ATP-dependent helicase activity,E1BH78(Evidence code:IEA/Database source:UniProtKB:O75643|ens)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR004589)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR004589)A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR006555)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499), SNRNP200 WRN BLM ERCC2 DDX1,MF,5,5 of 24,0.21,20.83,0.04384,0.115
GO:0050708,regulation of protein secretion,A4IFK6(Evidence code:IEA/Database source:InterPro:IPR030793),ARFIP1,BP,1,1 of 80,0.04,1.25,0.04383,0.115
GO:0050662,coenzyme binding,Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR001509),TSTA3,MF,1,1 of 81,0.04,1.23,0.04425,0.116
GO:0006325,chromatin organization,Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BGK8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)Q5E9L5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)Q32S26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens)A4FV57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens)F1MLB2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)A7E320(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)A5PJP6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)A1A4I4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156)F1MIB3(Evidence code:IEA/Database source:UniProtKB:B1AWL2|ens)M5FK72(Evidence code:IEA/Database source:InterPro:IPR026936)F1MHA1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0156), RUVBL2 ARID1A DOT1L PRMT6 BRD2 PRKCB PRMT5 LRWD1 AEBP2 HDAC5 HIST1H2BA CHD8 UHRF1 BRCC3 PKN1 ZNF462 UBN1 KMT2A,BP,18,18 of 148,0.76,12.16,0.0444,0.1164
GO:0072594,establishment of protein localization to organelle,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 83,0.04,1.2,0.04565,0.1196
GO:0008203,cholesterol metabolic process,E1BM29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0153)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)P16386(Evidence code:IEA/Database source:InterPro:IPR010468)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0153)A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225), CYP7A1 ABCA1 LIPE CAT MBTPS2 SCAP,BP,6,6 of 33,0.25,18.18,0.04654,0.1218
GO:1902600,proton transmembrane transport,P31408(Evidence code:IEA/Database source:InterPro:IPR004100)P31404(Evidence code:IEA/Database source:InterPro:IPR004100|I)P31407(Evidence code:IEA/Database source:InterPro:IPR004100)A5PK67(Evidence code:IEA/Database source:GO:0004129)Q0VCP0(Evidence code:IEA/Database source:GO:0015295)P00423(Evidence code:IEA/Database source:GO:0004129)P05630(Evidence code:IDA/Database source:), ATP6V1B2 ATP6V1A ATP6V1B1 MGC165862 SLC33A1 COX4I1 ATP5D,BP,7,7 of 42,0.3,16.67,0.04671,0.1222
GO:0045859,regulation of protein kinase activity,A1A4J7(Evidence code:ISS/Database source:UniProtKB:Q8ND04)Q0P5L1(Evidence code:IEA/Database source:GO:0019887)E1BBI6(Evidence code:IEA/Database source:UniProtKB:E9Q226|ens)E1BBQ3(Evidence code:IEA/Database source:GO:0008607), SMG8 GCN1L1 CCNYL1 IKBKAP,BP,4,4 of 145,0.17,2.76,0.04798,0.1254
GO:0040008,regulation of growth,Q2KIE4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0341)P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens)Q0IIE2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0341)A4FUY1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0341), MCTS1 IGFBP3 SHC1 HEPACAM,BP,4,4 of 145,0.17,2.76,0.04798,0.1254
GO:0042326,negative regulation of phosphorylation,E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens)P02638(Evidence code:IEA/Database source:GO:0019210), ANKLE2 S100B,BP,2,2 of 102,0.08,1.96,0.04834,0.1263
GO:0071901,negative regulation of protein serine/threonine kinase activity,A6QP24(Evidence code:IEA/Database source:GO:0030291)Q17QE5(Evidence code:IEA/Database source:GO:0030291)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens), FAM212B CIB1 ABL1 DAB2IP LRP6,BP,5,5 of 25,0.21,20,0.04976,0.1298
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)P62894(Evidence code:IBA/Database source:PANTHER:PTN000943712)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116), FIS1 PDCD6 CYCS BCAP31 F2R,BP,5,5 of 25,0.21,20,0.04976,0.1298
GO:0050729,positive regulation of inflammatory response,Q9BE45(Evidence code:IEA/Database source:UniProtKB:Q9BYH8|ens)A5PK65(Evidence code:IEA/Database source:UniProtKB:O35215|ens)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q61823|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), NFKBIZ DDT STAT5B PDCD4 STAT5A,BP,5,5 of 25,0.21,20,0.04976,0.1298
GO:0003707,steroid hormone receptor activity,A2VDU4(Evidence code:IEA/Database source:InterPro:IPR001723)Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)F1N3S3(Evidence code:IEA/Database source:InterPro:IPR001723)E1BC39(Evidence code:IEA/Database source:InterPro:IPR001723|I), NR1I2 ABHD2 NR2F6 ESRRG,MF,4,4 of 17,0.17,23.53,0.05035,0.1311
GO:0003727,single-stranded RNA binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens), DHX9 DDX58 AGO4 DLX2,MF,4,4 of 17,0.17,23.53,0.05035,0.1311
GO:0002027,regulation of heart rate,G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens), SCN10A FKBP1B PDE4D GPD1L,BP,4,4 of 17,0.17,23.53,0.05035,0.1311
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458)A5PJJ9(Evidence code:IBA/Database source:PANTHER:PTN000623979), CDK6 CDK1 CCNL1 CDK3,CC,4,4 of 17,0.17,23.53,0.05035,0.1311
GO:0010970,transport along microtubule,F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223362)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223362)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223362)A5PKJ3(Evidence code:IEA/Database source:InterPro:IPR027663)Q0III3(Evidence code:IBA/Database source:PANTHER:PTN000277824)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223362), LOC101902172 DYNLL1 DYNLL2 DCTN1 DYNC1I2 LOC101905447,BP,6,6 of 34,0.25,17.65,0.05172,0.1345
GO:0060828,regulation of canonical Wnt signaling pathway,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49769)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)Q00KA9(Evidence code:IEA/Database source:InterPro:IPR030799)F1MRJ5(Evidence code:IBA/Database source:PANTHER:PTN001095668), LRRK2 PSEN1 CCNY WWTR1 LRP4 AMER3,BP,6,6 of 34,0.25,17.65,0.05172,0.1345
GO:0005743,mitochondrial inner membrane,A7E3V3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q32LB9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P02722(Evidence code:IEA/Database source:InterPro:IPR002113)P05630(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)P48818(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q2NL34(Evidence code:IBA/Database source:PANTHER:PTN000484410)Q17QM6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)Q2TBI4(Evidence code:ISS/Database source:UniProtKB:Q12931)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q3ZBX6(Evidence code:TAS/Database source:)Q08DK7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276)P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)A6QR09(Evidence code:ISS/Database source:UniProtKB:Q70HW3)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17)Q0VCA3(Evidence code:ISS/Database source:UniProtKB:O95202)P0C2B7(Evidence code:TAS/Database source:)Q9XT97(Evidence code:IBA/Database source:PANTHER:PTN000024431)Q2HJE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)Q2KIN6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999)P00423(Evidence code:IEA/Database source:UniProtKB-KW:KW-0999), IMMT NOA1 SLC25A4 ATP5D PINK1 ACADVL COQ9 EFHD1 SRC TRAP1 LRRK2 MRPL3 SLC25A29 SCO1 NDUFS3 SHMT2 SLC25A26 MTG1 LETM1 MRPL52 PSEN1 TIMM17B MPV17 COX4I1,CC,24,24 of 215,1.02,11.16,0.05276,0.1372
GO:0008307,structural constituent of muscle,Q0P571(Evidence code:IEA/Database source:UniProtKB:P97457|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR030634), MYLPF MYBPC3 SYNM,MF,3,3 of 10,0.13,30,0.05366,0.1383
GO:0043491,protein kinase B signaling,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens), MT3 SIRT2 SETX,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0060048,cardiac muscle contraction,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens)Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q6PDM2|ens)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens), SCN2B SRSF1 MYL3,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0007035,vacuolar acidification,P61420(Evidence code:IBA/Database source:PANTHER:PTN000111953)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)O46563(Evidence code:IBA/Database source:PANTHER:PTN000075631), ATP6V0D1 CLIC4 ATP6V1H,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0045669,positive regulation of osteoblast differentiation,F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens)Q5E9B7(Evidence code:IEA/Database source:UniProtKB:Q9Z1Q5|ens)E1BGF9(Evidence code:IEA/Database source:UniProtKB:Q9H4I2|ens), FAM20C CLIC1 ZHX3,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0005798,Golgi-associated vesicle,A7Z035(Evidence code:TAS/Database source:)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens), CLINT1 LRRK2 STK26,CC,3,3 of 10,0.13,30,0.05366,0.1383
GO:0042622,photoreceptor outer segment membrane,P04695(Evidence code:IDA/Database source:)P04696(Evidence code:IDA/Database source:)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens), GNAT1 GNAT2 PROM1,CC,3,3 of 10,0.13,30,0.05366,0.1383
GO:0010324,membrane invagination,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens), SNX3 CHMP4A CHMP2A,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0016574,histone ubiquitination,E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1BNY9(Evidence code:IEA/Database source:UniProtKB:Q7Z6Z7|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88), SUZ12 HUWE1 UHRF1,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0035025,positive regulation of Rho protein signal transduction,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q9BZR6|ens)Q1JQB3(Evidence code:IBA/Database source:PANTHER:PTN000660850), F2R RTN4R GPR4,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0048643,positive regulation of skeletal muscle tissue development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens), SOX17 CDON FLOT1,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0045806,negative regulation of endocytosis,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens), SNX33 PACSIN3 PACSIN2,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0003746,translation elongation factor activity,F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I)Q3SZ32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251)Q3SZ15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251), EIF5A2 TCEB2 EEF1E1,MF,3,3 of 10,0.13,30,0.05366,0.1383
GO:0032391,photoreceptor connecting cilium,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens)Q17QN7(Evidence code:IEA/Database source:UniProtKB:Q8C6G1|ens), GNAT1 PCDHB8 C1H21ORF2,CC,3,3 of 10,0.13,30,0.05366,0.1383
GO:0031985,Golgi cisterna,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771), SORL1 GOLPH3 RAB30,CC,3,3 of 10,0.13,30,0.05366,0.1383
GO:0006368,transcription elongation from RNA polymerase II promoter,E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)Q3SZ32(Evidence code:IEA/Database source:InterPro:IPR039049)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455), CDK12 TCEB2 CDK13,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0072091,regulation of stem cell proliferation,Q6T5B7(Evidence code:IEA/Database source:InterPro:IPR028603)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), AGO3 NF2 SOX17,BP,3,3 of 10,0.13,30,0.05366,0.1383
GO:0016702,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR013547)P27479(Evidence code:IEA/Database source:InterPro:IPR000907|I)F1MXW0(Evidence code:IEA/Database source:InterPro:IPR000907|I), P4HA2 ALOX15 ALOX15B,MF,3,3 of 10,0.13,30,0.05366,0.1383
GO:0042981,regulation of apoptotic process,A0JN96(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1B7J7(Evidence code:IEA/Database source:InterPro:IPR035065)F1MPW1(Evidence code:IEA/Database source:UniProtKB:Q14689|ens)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN001231382)E1B847(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BL08(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR012227)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624)E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK86(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PJP8(Evidence code:IBA/Database source:PANTHER:PTN000684825)Q3SWY6(Evidence code:IBA/Database source:PANTHER:PTN000684825)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)P26882(Evidence code:IBA/Database source:PANTHER:PTN000869969)E1B9A2(Evidence code:IEA/Database source:InterPro:IPR001315)E1BKM6(Evidence code:IBA/Database source:PANTHER:PTN000684825)F1N6N6(Evidence code:IEA/Database source:InterPro:IPR008477)F1MN90(Evidence code:IBA/Database source:PANTHER:PTN000959605)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)A5PJP5(Evidence code:IBA/Database source:PANTHER:PTN001121970)G3X696(Evidence code:IEA/Database source:UniProtKB:Q9H2G2|ens)G3MZE2(Evidence code:IEA/Database source:InterPro:IPR035065)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000684825)A6QPJ9(Evidence code:IEA/Database source:InterPro:IPR036834)E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)F1N3T0(Evidence code:IBA/Database source:PANTHER:PTN000684825)A5PK70(Evidence code:IBA/Database source:PANTHER:PTN000142983)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)E1BHE1(Evidence code:IBA/Database source:PANTHER:PTN000684825), STK3 PAK3 DIP2A LCK MAP3K1 MAP3K14 TRAF6 PAK1 JAK2 PAK6 MAP3K8 MAP2K4 STK25 BCL3 PPID CARD6 TAOK2 TNFAIP8L3 CIDEC STK26 PINK1 SLK PAK2 PAK4 BCL2L12 FRS2 NF2 MALT1 MAP3K4 NME3 WRN NAE1 TAOK3,BP,33,33 of 317,1.4,10.41,0.05499,0.1413
GO:0009615,response to virus,F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens)E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749)Q3T0Y5(Evidence code:IEA/Database source:UniProtKB:P25787|ens)Q0IIK5(Evidence code:IEA/Database source:UniProtKB:Q91VR5|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:Q6Q899|ens)Q1JQ98(Evidence code:IEA/Database source:UniProtKB:P61966|ens)Q9BDI7(Evidence code:IDA/Database source:)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), CCT5 ZC3HAV1 BCL3 PSMA2 DDX1 DDX58 AP1S1 MX2 CDK6 RPS15A HYAL1,BP,11,11 of 80,0.47,13.75,0.05715,0.1413
GO:0000151,ubiquitin ligase complex,Q3SZ52(Evidence code:ISS/Database source:UniProtKB:Q13404)F1MDC0(Evidence code:IBA/Database source:PANTHER:PTN000188395)E1BB00(Evidence code:IBA/Database source:PANTHER:PTN001194385)Q1RMX2(Evidence code:IEA/Database source:UniProtKB:P62837|ens)E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens)G8JKY1(Evidence code:IBA/Database source:PANTHER:PTN001194385)E1BBN5(Evidence code:IEA/Database source:UniProtKB:Q8R516|ens)E1BG90(Evidence code:IEA/Database source:UniProtKB:Q92630|ens)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens)A6QNS2(Evidence code:IEA/Database source:InterPro:IPR019474)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens), UBE2V1 ANKIB1 ASB10 UBE2D2 UBR2 ASB14 MIB2 DYRK2 CAND1 UBE4B IKBKG,CC,11,11 of 79,0.47,13.92,0.055,0.1413
GO:0030667,secretory granule membrane,P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens)Q8WN96(Evidence code:IDA/Database source:)Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q504M8|ens)Q1RMW2(Evidence code:ISS/Database source:UniProtKB:Q3UFJ6)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN001179253), DBH ITPR2 RAB26 TMEM184A RAB37,CC,5,5 of 26,0.21,19.23,0.05614,0.1413
GO:0018119,peptidyl-cysteine S-nitrosylation,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)Q27995(Evidence code:ISS/Database source:UniProtKB:P29477), ADH5 NOS2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0046621,negative regulation of organ growth,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens), STK3 WWC1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0030123,AP-3 adaptor complex,E1BME2(Evidence code:IEA/Database source:InterPro:IPR026740)A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens), AP3B2 VPS41,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0072673,lamellipodium morphogenesis,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8CBW3|ens), WASF2 ABI1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0019432,triglyceride biosynthetic process,E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565)F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens), LPIN2 GPAT2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0007094,mitotic spindle assembly checkpoint,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens), TPR ATM,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:1904322,cellular response to forskolin,P35071(Evidence code:ISS/Database source:UniProtKB:P13569)P63097(Evidence code:ISS/Database source:UniProtKB:P10824), CFTR GNAI1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0032703,negative regulation of interleukin-2 production,E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), NAV3 PRNP,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0005109,frizzled binding,A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens), FZD1 LRP6,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0030728,ovulation,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens), ALMS1 KMT2B,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0086004,regulation of cardiac muscle cell contraction,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens), PDE4D SRI,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:1904646,cellular response to amyloid-beta,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), PRNP PSEN1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0001875,lipopolysaccharide receptor activity,P58754(Evidence code:ISS/Database source:UniProtKB:Q9Y6Y9)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168), LY96 TLR4,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0008015,blood circulation,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0), CHD7 STAT1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0051601,exocyst localization,A4IF89(Evidence code:IBA/Database source:PANTHER:PTN000484343)Q0V8C2(Evidence code:IBA/Database source:PANTHER:PTN000480155), EXOC8 EXOC3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0008020,G-protein coupled photoreceptor activity,F1MR98(Evidence code:IBA/Database source:PANTHER:PTN001202194)P47803(Evidence code:IBA/Database source:PANTHER:PTN001202194), RRH RGR,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0035234,ectopic germ cell programmed cell death,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), PRKDC KIT,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0035458,cellular response to interferon-beta,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens), PNPT1 UBE2K,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0001779,natural killer cell differentiation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens), CDK1 VPS4B,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0017070,U6 snRNA binding,A7Z025(Evidence code:IEA/Database source:InterPro:IPR019580)Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817), PRPF8 LSM4,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0009880,embryonic pattern specification,F1MKK8(Evidence code:IEA/Database source:UniProtKB:Q61079|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284), SIM2 LRP6,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0051123,RNA polymerase II transcriptional preinitiation complex assembly,E1BGK7(Evidence code:IEA/Database source:GO:0001075)F1MME0(Evidence code:IEA/Database source:GO:0001075), TAF4B TAF2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0006911,"phagocytosis, engulfment",Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens), FCER1G ABCA1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0015278,calcium-release channel activity,E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR033215)Q9TU34(Evidence code:ISS/Database source:UniProtKB:P11881), RYR1 ITPR1,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:1900016,negative regulation of cytokine production involved in inflammatory response,Q29450(Evidence code:ISS/Database source:UniProtKB:P51829)A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q61823|ens), ADCY7 PDCD4,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0030132,clathrin coat of coated pit,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)P04973(Evidence code:IEA/Database source:InterPro:IPR000996), EPS15 CLTA,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0042118,endothelial cell activation,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744), TCF7L2 PRMT5,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0017134,fibroblast growth factor binding,E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), KL RPS19,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0001759,organ induction,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens), FRS2 FGF1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0060563,neuroepithelial cell differentiation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831), ABL1 SOX4,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0019953,sexual reproduction,A7MBG9(Evidence code:IEA/Database source:UniProtKB:Q9WUK2|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), WBSCR1 STAT3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0042755,eating behavior,E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), ADORA2A STAT3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0071438,invadopodium membrane,P81425(Evidence code:ISS/Database source:UniProtKB:P27487)P53712(Evidence code:ISS/Database source:UniProtKB:P05556), DPP4 ITGB1,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0001766,membrane raft polarization,A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512256)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512256), MAL2 PLLP,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0006559,L-phenylalanine catabolic process,Q58CZ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0585)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR005961), TAT PAH,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0009881,photoreceptor activity,P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0600)F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0600), RGR RRH,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0035195,gene silencing by miRNA,F1MLT5(Evidence code:IEA/Database source:UniProtKB:Q9HCJ0|ens)Q9TU47(Evidence code:ISS/Database source:UniProtKB:P56537), TNRC6C EIF6,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0008024,cyclin/CDK positive transcription elongation factor complex,E1BB50(Evidence code:IBA/Database source:PANTHER:PTN000623455)E1BB52(Evidence code:IBA/Database source:PANTHER:PTN000623455), CDK12 CDK13,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0018344,protein geranylgeranylation,P29702(Evidence code:ISS/Database source:UniProtKB:P49354)F1N2I0(Evidence code:IEA/Database source:InterPro:IPR001738), FNTA CHML,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0006895,Golgi to endosome transport,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens)Q0V8F1(Evidence code:ISS/Database source:UniProtKB:P57737), EPS15 CORO7,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048484,enteric nervous system development,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)G3N1E4(Evidence code:IEA/Database source:UniProtKB:Q52KG5|ens), PHACTR4 KIF26A,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0070050,neuron cellular homeostasis,Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)E1BNF8(Evidence code:IEA/Database source:UniProtKB:Q96C11|ens), CHMP2B FGGY,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0030660,Golgi-associated vesicle membrane,Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287)O02811(Evidence code:ISS/Database source:UniProtKB:O08662), ITM2B PI4KA,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0006167,AMP biosynthetic process,Q17R18(Evidence code:IEA/Database source:GO:0004001)A7MBG0(Evidence code:IEA/Database source:InterPro:IPR027529), ADK ADSS,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0030315,T-tubule,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens), ATP1A2 RYR1,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0030898,actin-dependent ATPase activity,F1MM57(Evidence code:IEA/Database source:UniProtKB:Q6URW6|ens)Q17R14(Evidence code:ISS/Database source:UniProtKB:Q63357), MYH14 MYO1D,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0015269,calcium-activated potassium channel activity,F1N4T0(Evidence code:IBA/Database source:PANTHER:PTN000002873)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens), KCNT2 KCNMA1,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0070816,phosphorylation of RNA polymerase II C-terminal domain,E1BB50(Evidence code:ISS/Database source:UniProtKB:Q9NYV4)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q14004), CDK12 CDK13,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0034380,high-density lipoprotein particle assembly,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens), ABCA1 ABCA7,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0000492,box C/D snoRNP assembly,A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244), RUVBL1 RUVBL2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0014003,oligodendrocyte development,A7E331(Evidence code:IBA/Database source:PANTHER:PTN000003938)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens), PRDM8 EIF2B5,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0000243,commitment complex,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979)Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359236), UHMK1 SNRNP70,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",F1MLT5(Evidence code:IEA/Database source:UniProtKB:Q9HCJ0|ens)P61286(Evidence code:ISS/Database source:UniProtKB:P29341), TNRC6C PABPC1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0070411,I-SMAD binding,E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens), AXIN1 AXIN2,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0010744,positive regulation of macrophage derived foam cell differentiation,Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens), MAPK9 ALOX15B,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048048,embryonic eye morphogenesis,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599)F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens), AXIN1 ALDH1A3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0016208,AMP binding,A7YWF1(Evidence code:IEA/Database source:InterPro:IPR011904)P58108(Evidence code:ISS/Database source:UniProtKB:P80385), ACSS2 PRKAG1,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048147,negative regulation of fibroblast proliferation,F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), PEX2 DAB2IP,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0085029,extracellular matrix assembly,O97711(Evidence code:ISS/Database source:UniProtKB:P70312)A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens), HAS2 GPM6B,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0033210,leptin-mediated signaling pathway,P61635(Evidence code:ISS/Database source:UniProtKB:P40763)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), STAT3 MT3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0008045,motor neuron axon guidance,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens), SLIT2 RNF165,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0043274,phospholipase binding,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)P43033(Evidence code:IDA/Database source:), DGKQ PAFAH1B1,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0001702,gastrulation with mouth forming second,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q60821|ens), FRS2 ZBTB17,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0097352,autophagosome maturation,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens), CLN3 UBQLN1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0060411,cardiac septum morphogenesis,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), DNAH11 CHD7,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048743,positive regulation of skeletal muscle fiber development,P17667(Evidence code:IBA/Database source:PANTHER:PTN000898840)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), MYF5 SHOX2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0060087,relaxation of vascular smooth muscle,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q9ERL9|ens), KCNMA1 GUCY1A3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0008544,epidermis development,A2VDR9(Evidence code:ISS/Database source:UniProtKB:Q32MQ0)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens), ZNF750 POU3F1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0071437,invadopodium,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)O46385(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), PAK1 SVIL,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,P04696(Evidence code:IBA/Database source:PANTHER:PTN000026521)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026521), GNAT2 GNAT3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0071439,clathrin complex,A3KN15(Evidence code:IEA/Database source:UniProtKB:P49754|ens)P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens), VPS41 CLTA,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0031119,tRNA pseudouridine synthesis,F1MRD5(Evidence code:IBA/Database source:PANTHER:PTN000490775)Q3SX07(Evidence code:ISS/Database source:UniProtKB:Q9BZE2), PUS10 PUS3,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0047372,acylglycerol lipase activity,Q5EA42(Evidence code:IEA/Database source:EC:3.1.1.23)Q08DW9(Evidence code:IEA/Database source:InterPro:IPR026605), ABHD2 ABHD12,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0070402,NADPH binding,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens)O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens), GRHPR CRYZ,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048168,regulation of neuronal synaptic plasticity,P02638(Evidence code:IEA/Database source:UniProtKB:P50114|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens), S100B CAMK2A,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048009,insulin-like growth factor receptor signaling pathway,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)E1BAH0(Evidence code:IEA/Database source:UniProtKB:Q99MR1|ens), IRS1 GIGYF1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0045182,translation regulator activity,A6QLG5(Evidence code:IEA/Database source:UniProtKB:P46781|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens), RPS9 AARS,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0071354,cellular response to interleukin-6,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens), NFKB1 SBNO2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0060045,positive regulation of cardiac muscle cell proliferation,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens), GLI1 GATA6,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:2000780,negative regulation of double-strand break repair,Q3T0Y1(Evidence code:IEA/Database source:UniProtKB:Q96FW1|ens)E1B7Q7(Evidence code:ISS/Database source:UniProtKB:Q14669), OTUB1 TRIP12,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,F1MLT5(Evidence code:IEA/Database source:UniProtKB:Q9HCJ0|ens)P61286(Evidence code:ISS/Database source:UniProtKB:P29341), TNRC6C PABPC1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0005227,calcium activated cation channel activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581), ANO6 TRPM4,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0001975,response to amphetamine,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens), DBH ADORA2A,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0004862,cAMP-dependent protein kinase inhibitor activity,P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)Q0VCK2(Evidence code:IEA/Database source:InterPro:IPR004171), PRKAR2A PKIB,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:2001275,positive regulation of glucose import in response to insulin stimulus,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens), IRS1 POU4F2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048255,mRNA stabilization,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens), E2F1 AXIN2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens)P68107(Evidence code:ISA/Database source:UniProtKB:P68106), SRI FKBP1B,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0015020,glucuronosyltransferase activity,F1MFF6(Evidence code:IEA/Database source:EC:2.4.1.17)A5D7I4(Evidence code:IEA/Database source:InterPro:IPR027670), UGT2B10 EXT1,MF,2,2 of 4,0.08,50,0.05763,0.1413
GO:0009301,snRNA transcription,E1BCK9(Evidence code:IEA/Database source:InterPro:IPR031282)F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5), SNAPC4 RPAP2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0005952,cAMP-dependent protein kinase complex,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens)P00515(Evidence code:IEA/Database source:InterPro:IPR012198), PRKACA PRKAR2A,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0045843,negative regulation of striated muscle tissue development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens), LEF1 SIRT2,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0035249,"synaptic transmission, glutamatergic",F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens)F1MK99(Evidence code:IEA/Database source:InterPro:IPR027082), UNC13B UNC13A,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0098789,pre-mRNA cleavage required for polyadenylation,G3MZ78(Evidence code:IBA/Database source:PANTHER:PTN000566843)O19137(Evidence code:IBA/Database source:PANTHER:PTN000559780), CSTF2T CPSF4,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:2000480,negative regulation of cAMP-dependent protein kinase activity,Q0VCK2(Evidence code:IBA/Database source:PANTHER:PTN000395870)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens), PKIB PRKAR2A,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0007205,protein kinase C-activating G-protein coupled receptor signaling pathway,E1BGA9(Evidence code:IEA/Database source:InterPro:IPR000756)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824), DGKQ F2R,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0006228,UTP biosynthetic process,A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), NME3 NME1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0048566,embryonic digestive tract development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), GLI2 FOXF1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0061700,GATOR2 complex,A7MBJ6(Evidence code:IEA/Database source:InterPro:IPR037591)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB:P55735|ens), WDR59 SEC13,CC,2,2 of 4,0.08,50,0.05763,0.1413
GO:0090131,mesenchyme migration,P68138(Evidence code:ISS/Database source:UniProtKB:P08023)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens), ACTA1 FOXF1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0021670,lateral ventricle development,E1BMG2(Evidence code:IEA/Database source:UniProtKB:Q8VHE6|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), DNAH5 RPGRIP1L,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:0002385,mucosal immune response,E1B9S7(Evidence code:IEA/Database source:UniProtKB:B2RUR8|ens)E1B7G0(Evidence code:IEA/Database source:UniProtKB:Q8CGK5|ens), OTUD7B IFNLR1,BP,2,2 of 4,0.08,50,0.05763,0.1413
GO:1904115,axon cytoplasm,E1BBN7(Evidence code:IEA/Database source:GO:0008089)A2VDN5(Evidence code:IEA/Database source:GO:0019896)P43033(Evidence code:IEA/Database source:GO:0008090)E1BN82(Evidence code:IEA/Database source:GO:0099641), KIF1B SPAST PAFAH1B1 MAPK8IP3,CC,4,4 of 18,0.17,22.22,0.05834,0.1427
GO:0032088,negative regulation of NF-kappaB transcription factor activity,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens)A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863), DAB2IP PKHD1 CAT ITCH,BP,4,4 of 18,0.17,22.22,0.05834,0.1427
GO:0006446,regulation of translational initiation,Q5E938(Evidence code:IEA/Database source:UniProtKB:P41567|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)A7MB16(Evidence code:ISS/Database source:UniProtKB:P55884)Q3T0V3(Evidence code:IEA/Database source:InterPro:IPR016020), EIF1 EIF4G1 EIF3B EIF3K,BP,4,4 of 18,0.17,22.22,0.05834,0.1427
GO:0006641,triglyceride metabolic process,F1MSV5(Evidence code:IBA/Database source:PANTHER:PTN000023394)Q0IID9(Evidence code:IBA/Database source:PANTHER:PTN000023394)P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens)Q2NKZ8(Evidence code:IBA/Database source:PANTHER:PTN000023394), GK2 GK CAT LOC538702,BP,4,4 of 18,0.17,22.22,0.05834,0.1427
GO:0006352,"DNA-templated transcription, initiation",E1BGK7(Evidence code:IEA/Database source:InterPro:IPR007900)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)E1B7N2(Evidence code:IEA/Database source:InterPro:IPR004823)A5PJW1(Evidence code:IEA/Database source:InterPro:IPR003923), TAF4B TCF7L2 LOC619094 TAF10,BP,4,4 of 18,0.17,22.22,0.05834,0.1427
GO:0007052,mitotic spindle organization,E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens)Q3ZCF0(Evidence code:IBA/Database source:PANTHER:PTN000394123)Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens), GPSM2 DCTN2 KIF2A PCNT,BP,4,4 of 18,0.17,22.22,0.05834,0.1427
GO:0001666,response to hypoxia,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q765N9(Evidence code:IEA/Database source:UniProtKB:O15551|ens)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens), MT3 CLDN3 PRKCB RYR1 SRF EGLN3 KCNMA1 CRYAB,BP,8,8 of 50,0.34,16,0.0585,0.143
GO:0031253,cell projection membrane,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,CC,1,1 of 72,0.04,1.39,0.06248,0.1527
GO:0030031,cell projection assembly,F1N6T8(Evidence code:IEA/Database source:UniProtKB:Q60992|ens),VAV2,BP,1,1 of 73,0.04,1.37,0.06256,0.1528
GO:0016570,histone modification,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 74,0.04,1.35,0.0629,0.1535
GO:0005777,peroxisome,Q0P5B1(Evidence code:IEA/Database source:InterPro:IPR007223|I)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q3ZBW2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0576)Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR015342)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0576), PEX13 IDE HAO2 FIS1 PEX1 CAT,CC,6,6 of 36,0.25,16.67,0.0631,0.1539
GO:0030176,integral component of endoplasmic reticulum membrane,E1BFD1(Evidence code:IEA/Database source:UniProtKB:Q86XL3|ens)A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens)Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081292)Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens)Q9TU34(Evidence code:IDA/Database source:)Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4), ANKLE2 EXT1 SLC35B1 DPM3 ITPR1 ZFYVE27,CC,6,6 of 36,0.25,16.67,0.0631,0.1539
GO:0032388,positive regulation of intracellular transport,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,BP,1,1 of 75,0.04,1.33,0.06348,0.1548
GO:0030162,regulation of proteolysis,F1MQ38(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1BJI4(Evidence code:IBA/Database source:PANTHER:PTN000698504)A1A4N2(Evidence code:IBA/Database source:PANTHER:PTN000698504)E1B7Y9(Evidence code:IBA/Database source:PANTHER:PTN000698504), BTBD3 BTBD11 BTBD6 SPOPL,BP,4,4 of 139,0.17,2.88,0.06425,0.1566
GO:0004866,endopeptidase inhibitor activity,E1BHA8(Evidence code:IEA/Database source:InterPro:IPR002890),CPAMD8,MF,1,1 of 76,0.04,1.32,0.06432,0.1566
GO:0098797,plasma membrane protein complex,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,CC,1,1 of 76,0.04,1.32,0.06432,0.1566
GO:0005925,focal adhesion,E1BL04(Evidence code:IEA/Database source:UniProtKB:A4UGR9|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens)E1B8H0(Evidence code:IEA/Database source:UniProtKB:Q69Z38|ens)P53712(Evidence code:ISS/Database source:UniProtKB:P05556)Q08E52(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)P80746(Evidence code:ISS/Database source:UniProtKB:P06756)Q8SQB8(Evidence code:ISS/Database source:UniProtKB:P18564)Q2YDE9(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)P46196(Evidence code:IBA/Database source:PANTHER:PTN002372930)A7MB21(Evidence code:IEA/Database source:UniProtKB:Q96AC1|ens), XIRP2 ARL2 PEAK1 ITGB1 PAK1 PRUNE1 NUP214 JAK2 ITGAV ITGB6 TES MAPK1 FERMT2,CC,13,13 of 103,0.55,12.62,0.06462,0.1572
GO:0031640,killing of cells of other organism,P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0295)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), CHGA RPL30 RPS19,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0071560,cellular response to transforming growth factor beta stimulus,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens), SRC YES1 CRKL,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0051489,regulation of filopodium assembly,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens), ARF6 CLN3 RAB17,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0007585,respiratory gaseous exchange,E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0305), MAN1A2 MAPK8IP3 SFTPD,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0014704,intercalated disc,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens), SPTBN4 VAMP5 TJP1,CC,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0071320,cellular response to cAMP,E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens)P35071(Evidence code:ISS/Database source:UniProtKB:P26361)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7), HCN1 CFTR RAPGEF2,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0005771,multivesicular body,Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)Q9XSK2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens), BACE1 CD63 LAMP1,CC,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)P05059(Evidence code:IDA/Database source:), RPL30 RPS19 CHGA,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0032728,positive regulation of interferon-beta production,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P10914)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens), DDX58 IRF1 FLOT1,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0045740,positive regulation of DNA replication,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)F1MCY1(Evidence code:IEA/Database source:UniProtKB:P10070|ens)A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens), DHX9 GLI2 GLI1,BP,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0034719,SMN-Sm protein complex,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens), SNRPE STRAP DDX20,CC,3,3 of 11,0.13,27.27,0.06495,0.1573
GO:0001085,RNA polymerase II transcription factor binding,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)F1N1M2(Evidence code:IBA/Database source:PANTHER:PTN000801139)F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), TBX3 GATA6 SPEN SRF,MF,4,4 of 19,0.17,21.05,0.06696,0.1618
GO:0004601,peroxidase activity,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0575)P37141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0575)P00435(Evidence code:IEA/Database source:UniProtKB-KW:KW-0575)F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens), CAT GPX3 GPX1 TXNDC17,MF,4,4 of 19,0.17,21.05,0.06696,0.1618
GO:0071277,cellular response to calcium ion,E1BPM0(Evidence code:IEA/Database source:InterPro:IPR037776)P27479(Evidence code:ISS/Database source:UniProtKB:P16050)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9Y696|ens)Q2KHY1(Evidence code:IEA/Database source:UniProtKB:Q9Z140|ens), RASAL1 ALOX15 CLIC4 CPNE6,BP,4,4 of 19,0.17,21.05,0.06696,0.1618
GO:0005876,spindle microtubule,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)P48734(Evidence code:ISS/Database source:UniProtKB:P06493)Q2NL05(Evidence code:ISS/Database source:UniProtKB:O00139)A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens), NUMA1 CDK1 KIF2A CDC27,CC,4,4 of 19,0.17,21.05,0.06696,0.1618
GO:0023052,signaling,E1BB27(Evidence code:IEA/Database source:InterPro:IPR005026)E1BBJ2(Evidence code:IEA/Database source:InterPro:IPR005026), DLGAP1 DLGAP3,BP,2,2 of 95,0.08,2.11,0.06688,0.1618
GO:0004519,endonuclease activity,E1BPX9(Evidence code:IBA/Database source:PANTHER:PTN000755749)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)F1MGC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)A5PJT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255)A7YWM6(Evidence code:IBA/Database source:PANTHER:PTN000153528)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0255), LRPPRC AGO3 RNASE2 DNASE1L2 DNASE1L1 TSN RNASE13 DICER1,MF,8,8 of 53,0.34,15.09,0.06731,0.1625
GO:0046873,metal ion transmembrane transporter activity,G3MYG6(Evidence code:IEA/Database source:InterPro:IPR003689)A7MBI9(Evidence code:IEA/Database source:InterPro:IPR001046), SLC39A6 SLC11A2,MF,2,2 of 97,0.08,2.06,0.06785,0.1638
GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",A5PJV3(Evidence code:IEA/Database source:InterPro:IPR011059)E1BER6(Evidence code:IEA/Database source:InterPro:IPR011059)A8E641(Evidence code:IEA/Database source:InterPro:IPR011059)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR011059)F1MLX9(Evidence code:IEA/Database source:InterPro:IPR011059)O02675(Evidence code:IEA/Database source:InterPro:IPR011059), AMDHD1 CRMP1 DPYSL5 CAD GDA DPYSL2,MF,6,6 of 37,0.25,16.22,0.06929,0.1672
GO:0007611,learning or memory,P02638(Evidence code:ISS/Database source:UniProtKB:P50114)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens), S100B PSEN1 PRNP PTPRZ1 DNAH11,BP,5,5 of 28,0.21,17.86,0.07022,0.1693
GO:0031012,extracellular matrix,F1MGK5(Evidence code:IEA/Database source:UniProtKB:B9EKR1|ens)E1BJW3(Evidence code:IBA/Database source:PANTHER:PTN000396081)F1MD94(Evidence code:IEA/Database source:UniProtKB:O35701|ens)F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens)E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens)A6QLN9(Evidence code:IEA/Database source:UniProtKB:Q8R2Z5|ens)Q08DI9(Evidence code:IEA/Database source:InterPro:IPR001818|I)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens)F1MF97(Evidence code:IEA/Database source:UniProtKB:O88322|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)P07507(Evidence code:IEA/Database source:InterPro:IPR027118)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)F1MD40(Evidence code:IEA/Database source:UniProtKB:A6NMZ7|ens)F1MZD0(Evidence code:IBA/Database source:PANTHER:PTN001170450)F1N2E4(Evidence code:IBA/Database source:PANTHER:PTN000396081)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens), PTPRZ1 MMRN2 MATN3 NAV2 OLFML2A VWA1 MMP19 FGF1 NID2 COL2A1 MGP EMILIN1 COL6A5 FBN3 EMILIN3 NDNF,CC,16,16 of 137,0.68,11.68,0.07652,0.1782
GO:0006164,purine nucleotide biosynthetic process,A7MBG0(Evidence code:IEA/Database source:InterPro:IPR001114)Q2HJ26(Evidence code:IEA/Database source:InterPro:IPR018236)Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR005990)A3KN12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0658)Q59A32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0658)Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR002695)A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens)Q2HJ58(Evidence code:IEA/Database source:UniProtKB:P60891|ens), ADSS PAICS IMPDH2 ADSL GART ATIC MTHFD1 PRPS1,BP,8,8 of 55,0.34,14.55,0.07463,0.1782
GO:0043039,tRNA aminoacylation,A6QLT9(Evidence code:IEA/Database source:InterPro:IPR012947)Q3MHH4(Evidence code:IEA/Database source:InterPro:IPR000924|I)G3X6L9(Evidence code:IEA/Database source:InterPro:IPR000924|I)F1MKA6(Evidence code:IEA/Database source:InterPro:IPR012947), AARS QARS EPRS AARS2,BP,4,4 of 20,0.17,20,0.0762,0.1782
GO:0006836,neurotransmitter transport,O18875(Evidence code:IEA/Database source:InterPro:IPR000175|I)A1A4L2(Evidence code:IEA/Database source:InterPro:IPR000175|I)F1N5R0(Evidence code:IEA/Database source:InterPro:IPR000175)A5D7H9(Evidence code:IEA/Database source:InterPro:IPR000175), SLC6A8 SLC6A20 SLC6A5 SLC6A14,BP,4,4 of 20,0.17,20,0.0762,0.1782
GO:0005801,cis-Golgi network,E1BPF3(Evidence code:IEA/Database source:UniProtKB:O00512|ens)Q17QB7(Evidence code:ISS/Database source:UniProtKB:Q15771)E1BG76(Evidence code:IEA/Database source:UniProtKB:Q8WVM8|ens), BCL9 RAB30 SCFD1,CC,3,3 of 12,0.13,25,0.07722,0.1782
GO:0032024,positive regulation of insulin secretion,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)A6QR34(Evidence code:IEA/Database source:InterPro:IPR039073), PFKM SOX4 GCK,BP,3,3 of 12,0.13,25,0.07722,0.1782
GO:0043542,endothelial cell migration,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)P81425(Evidence code:ISS/Database source:UniProtKB:P27487), GIPC1 ABL1 DPP4,BP,3,3 of 12,0.13,25,0.07722,0.1782
GO:0032204,regulation of telomere maintenance,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens), SMG6 SMG1 TERF2,BP,3,3 of 12,0.13,25,0.07722,0.1782
GO:0034704,calcium channel complex,Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), PTPA FKBP1B PDE4D,CC,3,3 of 12,0.13,25,0.07722,0.1782
GO:0015485,cholesterol binding,A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)E1B7M8(Evidence code:IEA/Database source:UniProtKB:Q969R2|ens), SCAP NPC1 OSBP2,MF,3,3 of 12,0.13,25,0.07722,0.1782
GO:0010596,negative regulation of endothelial cell migration,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), SLIT2 PTPRM DAB2IP,BP,3,3 of 12,0.13,25,0.07722,0.1782
GO:0030544,Hsp70 protein binding,P26882(Evidence code:IDA/Database source:)P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens), PPID CDK1 DNAJB2,MF,3,3 of 12,0.13,25,0.07722,0.1782
GO:0030374,nuclear receptor transcription coactivator activity,P05126(Evidence code:ISS/Database source:UniProtKB:P05771)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR017426|I)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512), PRKCB NCOA3 PKN1,MF,3,3 of 12,0.13,25,0.07722,0.1782
GO:0043171,peptide catabolic process,E1BP91(Evidence code:IBA/Database source:PANTHER:PTN000164249)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960), NPEPPS RNPEP LTA4H,BP,3,3 of 12,0.13,25,0.07722,0.1782
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens), ABL1 F2R SRI,BP,3,3 of 12,0.13,25,0.07722,0.1782
GO:0034198,cellular response to amino acid starvation,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)A7MBJ6(Evidence code:IEA/Database source:UniProtKB:Q6PJI9|ens)P68102(Evidence code:ISS/Database source:UniProtKB:Q6ZWX6), LARS WDR59 EIF2S1,BP,3,3 of 12,0.13,25,0.07722,0.1782
GO:0005657,replication fork,E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88), WRN RAD18 UHRF1,CC,3,3 of 12,0.13,25,0.07722,0.1782
GO:0021915,neural tube development,E1BJZ5(Evidence code:IEA/Database source:UniProtKB:Q8BX22|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens), SALL4 GLI2,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0031588,nucleotide-activated protein kinase complex,P58108(Evidence code:ISS/Database source:UniProtKB:P80385)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens), PRKAG1 PRKAR2A,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0022617,extracellular matrix disassembly,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)A4IF89(Evidence code:IEA/Database source:UniProtKB:Q8IYI6|ens), FLOT1 EXOC8,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0042744,hydrogen peroxide catabolic process,P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0376)P00435(Evidence code:IDA/Database source:), CAT GPX1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0097345,mitochondrial outer membrane permeabilization,Q2HJF8(Evidence code:ISS/Database source:UniProtKB:Q8IXI2)Q5E9M9(Evidence code:ISS/Database source:UniProtKB:Q8IXI1), RHOT1 RHOT2,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0055003,cardiac myofibril assembly,E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680821)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), MYLK3 SRF,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0035098,ESC/E(Z) complex,E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q15022|ens)A4FV57(Evidence code:ISS/Database source:UniProtKB:Q6ZN18), SUZ12 AEBP2,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0042629,mast cell granule,P05059(Evidence code:IEA/Database source:GO:0043303)P43481(Evidence code:IEA/Database source:GO:0043303), CHGA KIT,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0001662,behavioral fear response,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q6NZJ6|ens)Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens), EIF4G1 GABRA5,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0030318,melanocyte differentiation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773), KIT HPS6,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0019369,arachidonic acid metabolic process,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)P27479(Evidence code:IEA/Database source:UniProtKB:P16050|ens), ALOX15B ALOX15,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0005851,eukaryotic translation initiation factor 2B complex,E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens)P68102(Evidence code:ISS/Database source:UniProtKB:P05198), EIF2B5 EIF2S1,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0010737,protein kinase A signaling,P00517(Evidence code:IEA/Database source:InterPro:IPR039035)E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens), PRKACA MROH2B,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0051457,maintenance of protein location in nucleus,Q2TA37(Evidence code:ISS/Database source:UniProtKB:P36404)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens), ARL2 TAF8,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0014912,negative regulation of smooth muscle cell migration,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens), SLIT2 IGFBP3,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0070531,BRCA1-A complex,Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349139)A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860), BRCA1 BRCC3,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0003351,epithelial cilium movement,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens)E1B793(Evidence code:IEA/Database source:UniProtKB:Q69ZM6|ens), DNAH11 STK36,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0032790,ribosome disassembly,Q32KZ1(Evidence code:ISS/Database source:UniProtKB:Q9H2K0)Q2KIE4(Evidence code:IEA/Database source:UniProtKB:Q9ULC4|ens), MTIF3 MCTS1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0005452,inorganic anion exchanger activity,F1MCB5(Evidence code:IEA/Database source:InterPro:IPR003020|I)F1N4L1(Evidence code:IEA/Database source:InterPro:IPR001717|I), SLC4A7 SLC4A2,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0086002,cardiac muscle cell action potential involved in contraction,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens)E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens), CACNA1D SCN2B,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0016500,protein-hormone receptor activity,F1MLX5(Evidence code:IEA/Database source:InterPro:IPR002131)G3X6G8(Evidence code:IEA/Database source:InterPro:IPR002131), LGR4 LGR6,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0045579,positive regulation of B cell differentiation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0000050,urea cycle,F1MVC0(Evidence code:IBA/Database source:PANTHER:PTN000150222)F1ML89(Evidence code:IBA/Database source:PANTHER:PTN000150222), CAD CPS1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0070300,phosphatidic acid binding,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens)F1MSG6(Evidence code:IEA/Database source:UniProtKB:Q9Y4G8|ens), PACSIN2 RAPGEF2,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)Q0III2(Evidence code:IEA/Database source:UniProtKB:O43462|ens), ATF6B MBTPS2,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0019908,nuclear cyclin-dependent protein kinase holoenzyme complex,E1BB50(Evidence code:ISS/Database source:UniProtKB:Q3MJK5)E1BB52(Evidence code:ISS/Database source:UniProtKB:Q69ZA1), CDK12 CDK13,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0071569,protein ufmylation,Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)Q5E953(Evidence code:ISS/Database source:UniProtKB:Q9Y3C8), UFM1 UFC1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0071203,WASH complex,A5PKA5(Evidence code:ISS/Database source:UniProtKB:Q96L92)F1MDR7(Evidence code:IEA/Database source:UniProtKB:O75165|ens), SNX27 DNAJC13,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0001963,"synaptic transmission, dopaminergic",E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens), ADORA2A CRH,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0006085,acetyl-CoA biosynthetic process,A7YWF1(Evidence code:IEA/Database source:UniProtKB:Q9QXG4|ens)Q32PF2(Evidence code:IEA/Database source:InterPro:IPR014608), ACSS2 ACLY,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0031295,T cell costimulation,P81425(Evidence code:ISS/Database source:UniProtKB:P27487)O46405(Evidence code:IEA/Database source:InterPro:IPR037676), DPP4 CD80,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0051491,positive regulation of filopodium assembly,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:O75781|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), PALM SRF,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0050772,positive regulation of axonogenesis,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens), BRAF SHOX2,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0043981,histone H4-K5 acetylation,E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0035162,embryonic hemopoiesis,P43481(Evidence code:ISS/Database source:UniProtKB:P05532)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), KIT KMT2A,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0015279,store-operated calcium channel activity,O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230)O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230), TRPC2 TRPC1,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0045086,positive regulation of interleukin-2 biosynthetic process,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT5A,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0008385,IkappaB kinase complex,E1BPW2(Evidence code:IEA/Database source:UniProtKB:Q8IUD2|ens)Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens), ERC1 IKBKG,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:1990592,protein K69-linked ufmylation,Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)Q5E953(Evidence code:ISS/Database source:UniProtKB:Q9Y3C8), UFM1 UFC1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0045830,positive regulation of isotype switching,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q6PR54|ens), TFRC RIF1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0031402,sodium ion binding,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens), TDG ATP1A2,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0043303,mast cell degranulation,P05059(Evidence code:ISS/Database source:UniProtKB:P10645)P43481(Evidence code:ISS/Database source:UniProtKB:P10721), CHGA KIT,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0032506,cytokinetic process,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0)P27214(Evidence code:ISS/Database source:UniProtKB:P50995), SPAST ANXA11,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0021795,cerebral cortex cell migration,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), PEX13 PSEN1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0001972,retinoic acid binding,P62964(Evidence code:IEA/Database source:InterPro:IPR031279)Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281), CRABP1 CRABP2,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0015701,bicarbonate transport,F1N4L1(Evidence code:IEA/Database source:GO:0008510)P35071(Evidence code:ISS/Database source:UniProtKB:P13569), SLC4A2 CFTR,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0030665,clathrin-coated vesicle membrane,Q08DS7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens), AP2B1 DENND1A,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0032148,activation of protein kinase B activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)P03968(Evidence code:ISS/Database source:UniProtKB:P05230), MT3 FGF1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0048148,behavioral response to cocaine,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)F1MFI5(Evidence code:IEA/Database source:UniProtKB:Q3UH53|ens), EHMT2 SDK1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765), PSEN1 SGTA,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0019509,L-methionine salvage from methylthioadenosine,Q3MHF7(Evidence code:IEA/Database source:UniPathway:UPA00904)Q2NL31(Evidence code:IEA/Database source:UniPathway:UPA00904), MTAP MRI1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0010259,multicellular organism aging,E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens), WRN RNF165,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0008409,5-3 exonuclease activity,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)E1BMC0(Evidence code:IBA/Database source:PANTHER:PTN000805918), DXO POLQ,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0098519,"nucleotide phosphatase activity, acting on free nucleotides",A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0)Q3ZBF9(Evidence code:IBA/Database source:PANTHER:PTN000445841), NUDT16 PDXP,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0050702,interleukin-1 beta secretion,Q9GL65(Evidence code:ISS/Database source:UniProtKB:Q9QUK6)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), TLR4 ABCA1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0071803,positive regulation of podosome assembly,Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), MAPK9 SRC,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0042135,neurotransmitter catabolic process,F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens)A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128), NAALAD2 COMT,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,Q6BBL6(Evidence code:ISS/Database source:UniProtKB:Q9Z0G9)Q765N9(Evidence code:IEA/Database source:UniProtKB:Q9Z0G9|ens), CLDN4 CLDN3,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0008553,"proton-exporting ATPase activity, phosphorylative mechanism",P61420(Evidence code:IEA/Database source:UniProtKB:P51863|ens)P21282(Evidence code:IEA/Database source:UniProtKB:Q9Z1G3|ens), ATP6V0D1 ATP6V1C1,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0006012,galactose metabolic process,Q3T105(Evidence code:IEA/Database source:InterPro:IPR005886)A6H768(Evidence code:IEA/Database source:InterPro:IPR000705), GALE GALK1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0018298,protein-chromophore linkage,P47803(Evidence code:IEA/Database source:UniProtKB-KW:KW-0157)F1MR98(Evidence code:IEA/Database source:UniProtKB-KW:KW-0157), RGR RRH,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0006509,membrane protein ectodomain proteolysis,Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768), BACE1 PSEN1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:1900746,regulation of vascular endothelial growth factor signaling pathway,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962), TCF7L2 CD63,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0006465,signal peptide processing,Q3SZU5(Evidence code:IEA/Database source:InterPro:IPR007653)P67810(Evidence code:IEA/Database source:InterPro:IPR001733|I), SPCS3 SEC11A,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0016601,Rac protein signal transduction,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens), WASF2 NCKAP1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0070182,DNA polymerase binding,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens), SMG6 PTGES3,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0032801,receptor catabolic process,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q99570|ens), NEDD4 PIK3R4,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0071565,nBAF complex,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR038040), ARID1A ARID1B,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0030836,positive regulation of actin filament depolymerization,Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0)Q5E9D5(Evidence code:IEA/Database source:InterPro:IPR029924), PDXP DSTN,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0014032,neural crest cell development,A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens), PEF1 PDCD6,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0002230,positive regulation of defense response to virus by host,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884), DDX58 MB21D1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0005671,Ada2/Gcn5/Ada3 transcription activator complex,A6QQ14(Evidence code:IEA/Database source:UniProtKB:Q9NR33|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), POLE4 HCFC1,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:0003016,respiratory system process,P11023(Evidence code:ISS/Database source:UniProtKB:P63011)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens), RAB3A ADH5,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0051764,actin crosslink formation,Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q8BKX1)F1MXR0(Evidence code:IBA/Database source:PANTHER:PTN001022094), BAIAP2 BAIAP2L1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0097067,cellular response to thyroid hormone stimulus,Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), LMO2 KIT,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0030247,polysaccharide binding,Q0V7N1(Evidence code:IEA/Database source:InterPro:IPR001212|I)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR001212), SUSD2 TINAGL1,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0019911,structural constituent of myelin sheath,A2VE13(Evidence code:IBA/Database source:PANTHER:PTN000512260)A6H7B0(Evidence code:IBA/Database source:PANTHER:PTN000512260), MAL2 PLLP,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0006388,"tRNA splicing, via endonucleolytic cleavage and ligation",Q3ZBM7(Evidence code:IEA/Database source:InterPro:IPR002745)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499), TRPT1 DDX1,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0048708,astrocyte differentiation,P61635(Evidence code:ISS/Database source:UniProtKB:P42227)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens), STAT3 EIF2B5,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0043982,histone H4-K8 acetylation,E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens), HCFC1 KANSL3,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0080111,DNA demethylation,F1MJY3(Evidence code:IEA/Database source:UniProtKB:Q8BG87|ens)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens), TET3 TDG,BP,2,2 of 5,0.08,40,0.07711,0.1782
GO:0070552,BRISC complex,A5PJP6(Evidence code:IEA/Database source:InterPro:IPR033860)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897), BRCC3 SHMT2,CC,2,2 of 5,0.08,40,0.07711,0.1782
GO:1990380,Lys48-specific deubiquitinase activity,E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens)G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens), OTUD7B USP9X,MF,2,2 of 5,0.08,40,0.07711,0.1782
GO:0008033,tRNA processing,Q0VC66(Evidence code:IEA/Database source:InterPro:IPR035107)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819)E1BFB5(Evidence code:IEA/Database source:InterPro:IPR033495)P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens)Q3SX07(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819)A5D7S3(Evidence code:IEA/Database source:InterPro:IPR002905)Q3ZBM7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0819), CTU1 DDX1 KIAA0391 SSB PUS3 TRMT1L TRPT1,BP,7,7 of 43,0.3,16.28,0.08072,0.1861
GO:0051262,protein tetramerization,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)F1MPF0(Evidence code:IEA/Database source:InterPro:IPR032415|I)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)E1BMI4(Evidence code:IEA/Database source:UniProtKB:Q8NBZ7|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)E1BC13(Evidence code:IEA/Database source:UniProtKB:Q14003|ens), SHMT2 RPS19 TRPM7 DNM1 UXS1 CAT KCNC3,BP,7,7 of 43,0.3,16.28,0.08072,0.1861
GO:0030672,synaptic vesicle membrane,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens)F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens)P63026(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0V7N0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), SLC17A8 SYN2 VAMP2 VAMP1,CC,4,4 of 21,0.17,19.05,0.08604,0.198
GO:0009611,response to wounding,A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)Q5EA42(Evidence code:ISS/Database source:UniProtKB:Q9QXM0)A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens), MAP2K4 F2R ABHD2 GLI1,BP,4,4 of 21,0.17,19.05,0.08604,0.198
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,A6QQM1(Evidence code:IEA/Database source:InterPro:IPR012399)E1BBI6(Evidence code:IEA/Database source:InterPro:IPR012399)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1BJ67(Evidence code:IEA/Database source:InterPro:IPR015431), CCNY CCNYL1 BLM CCNL1,BP,4,4 of 21,0.17,19.05,0.08604,0.198
GO:0048754,branching morphogenesis of an epithelial tube,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153), SLIT2 GLI2 CLIC4 PAK1,BP,4,4 of 21,0.17,19.05,0.08604,0.198
GO:0005882,intermediate filament,Q9TU47(Evidence code:IEA/Database source:UniProtKB:O55135|ens)Q08DH7(Evidence code:IEA/Database source:InterPro:IPR001664|I)G3MXL3(Evidence code:IEA/Database source:InterPro:IPR001664)F1MFW9(Evidence code:IEA/Database source:InterPro:IPR001664)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0403)Q0P5J7(Evidence code:IEA/Database source:InterPro:IPR001664)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR001664|I), EIF6 INA KRT3 KRT24 BFSP1 KRT35 SYNM,CC,7,7 of 45,0.3,15.56,0.08674,0.1995
GO:0009116,nucleoside metabolic process,P31754(Evidence code:IEA/Database source:InterPro:IPR000836)Q2HJ58(Evidence code:IEA/Database source:InterPro:IPR000836)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000836)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000836)E1BM28(Evidence code:IEA/Database source:UniRule:UR000107503)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR000836)Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR000845|I), UMPS PRPS1 PRPS1L1 PRPS2 DNPH1 PRPSAP2 MTAP,BP,7,7 of 45,0.3,15.56,0.08674,0.1995
GO:0015631,tubulin binding,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens), LRRK2 AGTPBP1 TPR VBP1 NUMA1 PRNP CDK5RAP2 KIF14 EML2 PRUNE1,MF,10,10 of 77,0.42,12.99,0.08694,0.1998
GO:0016747,"transferase activity, transferring acyl groups other than amino-acyl groups",Q17QI3(Evidence code:IEA/Database source:InterPro:IPR002155|I),ACAT2,MF,1,1 of 66,0.04,1.52,0.08947,0.2056
GO:0005773,vacuole,P23956(Evidence code:IEA/Database source:UniProtKB-KW:KW-0926)A3KN15(Evidence code:IEA/Database source:UniRule:UR000570763)F1MWT0(Evidence code:IBA/Database source:PANTHER:PTN000176583), ATP6V0C VPS41 MAN2C1,CC,3,3 of 109,0.13,2.75,0.08971,0.2058
GO:0098655,cation transmembrane transport,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363)G3MXA9(Evidence code:IEA/Database source:InterPro:IPR032943)F1MD64(Evidence code:IEA/Database source:GO:0005261), CHRNE CNGB3 PIEZO1,BP,3,3 of 109,0.13,2.75,0.08971,0.2058
GO:0097190,apoptotic signaling pathway,Q08DY9(Evidence code:IEA/Database source:GO:0097199),CASP3,BP,1,1 of 67,0.04,1.49,0.08961,0.2058
GO:0006163,purine nucleotide metabolic process,Q32L93(Evidence code:IEA/Database source:UniRule:UR000200031)P46195(Evidence code:IEA/Database source:InterPro:IPR017665)Q1KZG4(Evidence code:ISS/Database source:UniProtKB:P49789), GMPR2 GUK1 FHIT,BP,3,3 of 110,0.13,2.73,0.08993,0.2063
GO:0005881,cytoplasmic microtubule,Q05B70(Evidence code:IEA/Database source:UniProtKB:Q96HH9|ens)F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens)E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens), GRAMD3 TUBA1A APC2,CC,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0001654,eye development,E1B8S3(Evidence code:IEA/Database source:UniProtKB:Q8TE60|ens)Q2YDD2(Evidence code:ISS/Database source:UniProtKB:Q9DB90)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens), ADAMTS18 SMG9 FREM2,BP,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0033613,activating transcription factor binding,E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), HCFC1 ZNF516 DGKQ,MF,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0030016,myofibril,A1A4J8(Evidence code:IEA/Database source:UniProtKB:O75880|ens)A0JNJ5(Evidence code:IEA/Database source:UniProtKB:P05976|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens), SCO1 MYL1 TWF1,CC,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0046677,response to antibiotic,Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens), PPP2CB HYAL1 JAK2,BP,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0070534,protein K63-linked ubiquitination,Q3ZCC3(Evidence code:ISS/Database source:UniProtKB:P70196)Q3SZ52(Evidence code:ISS/Database source:UniProtKB:Q13404)Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629507), TRAF6 UBE2V1 UBE2V2,BP,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0009409,response to cold,E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)P48818(Evidence code:IEA/Database source:UniProtKB:P50544|ens)Q3ZCB2(Evidence code:IEA/Database source:UniProtKB:Q9JI48|ens), ZNF516 ACADVL PLAC8,BP,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0008375,acetylglucosaminyltransferase activity,A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens)Q5EAB6(Evidence code:IEA/Database source:InterPro:IPR004139)Q5E9I4(Evidence code:IEA/Database source:InterPro:IPR004139), EXT1 POMGNT1 MGAT1,MF,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0006301,postreplication repair,Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335)Q3SZ52(Evidence code:IBA/Database source:PANTHER:PTN000629507)Q3SZ43(Evidence code:IBA/Database source:PANTHER:PTN000629507), RAD18 UBE2V1 UBE2V2,BP,3,3 of 13,0.13,23.08,0.09041,0.2065
GO:0006399,tRNA metabolic process,E1B937(Evidence code:IBA/Database source:PANTHER:PTN000049487),DTD2,BP,1,1 of 68,0.04,1.47,0.09009,0.2065
GO:0001819,positive regulation of cytokine production,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)Q95JH2(Evidence code:IEA/Database source:UniProtKB:Q99943|ens), FLOT1 AGPAT1,BP,2,2 of 88,0.08,2.27,0.09241,0.211
GO:0010506,regulation of autophagy,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9D8B3|ens)E1BGU5(Evidence code:IEA/Database source:InterPro:IPR027881)Q17QU4(Evidence code:ISS/Database source:UniProtKB:Q96DA2)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BMF7(Evidence code:ISS/Database source:UniProtKB:Q92995)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens), LRRK2 CHMP4B SOGA3 RAB39B ATM USP13 TPCN2,BP,7,7 of 47,0.3,14.89,0.09435,0.2152
GO:0006310,DNA recombination,A4IFC8(Evidence code:IEA/Database source:InterPro:IPR000977|I)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR004589)E1BQ04(Evidence code:IEA/Database source:InterPro:IPR004589)A0JNA8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233)Q2TBU9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233)A7MBG8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0233), LIG1 WRN BLM PAXIP1 BRCA1 RUVBL2 RUVBL1,BP,7,7 of 47,0.3,14.89,0.09435,0.2152
GO:0007596,blood coagulation,A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)A7YY44(Evidence code:IEA/Database source:InterPro:IPR000935|I)Q2TBQ1(Evidence code:IEA/Database source:UniProtKB:Q07968|ens), HPS6 ANO6 PDGFC F2R F13B,BP,5,5 of 31,0.21,16.13,0.09462,0.2157
GO:0051603,proteolysis involved in cellular protein catabolic process,Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR000243|I)F1N2M2(Evidence code:IEA/Database source:UniProtKB:Q9UKP4|ens)Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR000243|I)E1B9H1(Evidence code:IBA/Database source:PANTHER:PTN000274687)Q3T0Y5(Evidence code:IEA/Database source:InterPro:IPR001353)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens)Q3T0X5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T112(Evidence code:IEA/Database source:InterPro:IPR000243|I)Q5E9K0(Evidence code:IEA/Database source:InterPro:IPR001353|I)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)Q5E998(Evidence code:IBA/Database source:PANTHER:PTN000274640)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)P33672(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q58DU5(Evidence code:IEA/Database source:InterPro:IPR001353)Q3ZBG0(Evidence code:IEA/Database source:InterPro:IPR001353)Q3T108(Evidence code:IEA/Database source:InterPro:IPR001353|I)Q3ZCK9(Evidence code:IEA/Database source:InterPro:IPR001353|I), PSMB10 ADAMTS7 PSMB9 TINAGL1 PSMA2 CAPN2 PSMA1 PSMB8 PSMB2 ADAMTS12 CTSV IDE PSMB3 PSMA3 PSMA7 PSMB4 PSMA4,BP,17,17 of 157,0.72,10.83,0.1291,0.2165
GO:0034220,ion transmembrane transport,E1BGZ0(Evidence code:IEA/Database source:GO:0005216)F1MD64(Evidence code:IEA/Database source:GO:0005261)F1MMU9(Evidence code:IEA/Database source:GO:0005216)F1MHP0(Evidence code:IEA/Database source:GO:0005216)F1N5Z0(Evidence code:IBA/Database source:PANTHER:PTN000440615)E1BHM6(Evidence code:IEA/Database source:GO:0005216)E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)Q08E50(Evidence code:IEA/Database source:InterPro:IPR006028|I)F1MPF0(Evidence code:IEA/Database source:GO:0005216)P02715(Evidence code:IEA/Database source:InterPro:IPR006201)E1BHR8(Evidence code:IEA/Database source:GO:0005216)G0T3G6(Evidence code:IEA/Database source:GO:0005216)F1MWI8(Evidence code:IEA/Database source:GO:0005216)F1MBY1(Evidence code:IEA/Database source:GO:0005216)F1MCW8(Evidence code:IEA/Database source:GO:0005216)F1N1D4(Evidence code:IEA/Database source:GO:0005229), GRIA3 PIEZO1 SCN8A SCN5A AQP5 SCN11A TRPM4 GABRA5 TRPM7 CHRNE SCN3A GRIA1 GRIN3B GRIA2 GRIK4 TTYH3,BP,16,16 of 139,0.68,11.51,0.1064,0.2165
GO:0001664,G-protein coupled receptor binding,F1MZA2(Evidence code:IEA/Database source:InterPro:IPR037884)A7Z056(Evidence code:IEA/Database source:UniProtKB:Q9Y2K6|ens)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR000469)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR000469)P63097(Evidence code:ISS/Database source:UniProtKB:P10824)P38408(Evidence code:IEA/Database source:InterPro:IPR000654)P04695(Evidence code:IPI/Database source:UniProtKB:P02699)P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026392)F1N7K7(Evidence code:IEA/Database source:UniProtKB:Q9UEW3|ens)P04696(Evidence code:IBA/Database source:PANTHER:PTN000026392)F1MN36(Evidence code:IBA/Database source:PANTHER:PTN001050425), ARHGEF12 USP20 GNA12 GNA13 GNAI1 GNA14 GNAT1 GNAT3 MARCO GNAT2 PROK1,MF,11,11 of 88,0.47,12.5,0.105,0.2165
GO:0006874,cellular calcium ion homeostasis,E1BHV1(Evidence code:IEA/Database source:InterPro:IPR009460)F1MRN7(Evidence code:IBA/Database source:PANTHER:PTN000643505)E1BDQ4(Evidence code:IEA/Database source:InterPro:IPR009460)E1BIB9(Evidence code:IEA/Database source:UniProtKB:Q8NHX9|ens)D3K0R6(Evidence code:ISS/Database source:UniProtKB:Q6Q477)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F1MN60(Evidence code:IBA/Database source:PANTHER:PTN000643846)F1MS16(Evidence code:IBA/Database source:PANTHER:PTN000643846)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)G3N0E5(Evidence code:IEA/Database source:InterPro:IPR009460), RYR2 ATP13A5 RYR1 TPCN2 ATP2B4 PSEN1 PKHD1 ATP2B2 ATP2B3 PRKCB RYR3,BP,11,11 of 87,0.47,12.64,0.1026,0.2165
GO:0044297,cell body,Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q3T0K2(Evidence code:IEA/Database source:UniProtKB:P80318|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q09139(Evidence code:IEA/Database source:UniProtKB:P51880|ens)F1MWD3(Evidence code:IEA/Database source:UniProtKB:P80316|ens)P68138(Evidence code:ISS/Database source:UniProtKB:P08023), GABRA5 RNF112 PINK1 BRAF CCT3 NF2 FABP7 CCT5 ACTA1,CC,9,9 of 68,0.38,13.24,0.1063,0.2165
GO:0002250,adaptive immune response,G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-1064)E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000799655)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), LOC104968438 IFNT3 ALCAM MARCH8 PRKCB PIK3CD IFNT2,BP,7,7 of 52,0.3,13.46,0.1199,0.2165
GO:0045732,positive regulation of protein catabolic process,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), NEDD4 AXIN1 SNF8 DAB2IP SORL1 SOX17,BP,6,6 of 38,0.25,15.79,0.1209,0.2165
GO:0051028,mRNA transport,P48820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q0VCY7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q3ZCC9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q27966(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0509), RANBP2 SRSF1 SEC13 MYO1C EIF4A3 DHX9,BP,6,6 of 40,0.25,15,0.129,0.2165
GO:0015293,symporter activity,A1A4L2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)Q95JC7(Evidence code:IEA/Database source:InterPro:IPR001991|I)A5D7H9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)O18875(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769)F1N5R0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0769), SLC6A20 SLC5A11 SLC1A5 SLC6A14 SLC6A8 SLC6A5,MF,6,6 of 39,0.25,15.38,0.1247,0.2165
GO:0051536,iron-sulfur cluster binding,A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0411)Q28007(Evidence code:IEA/Database source:InterPro:IPR009051)E1BL62(Evidence code:IEA/Database source:InterPro:IPR001041|I)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0411)P48034(Evidence code:IEA/Database source:InterPro:IPR001041|I)Q58DA7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0411), ERCC2 DPYD AOX4 POLA1 AOX1 GLRX3,MF,6,6 of 40,0.25,15,0.129,0.2165
GO:0050890,cognition,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens)F1MT17(Evidence code:IEA/Database source:UniProtKB:O14529|ens)Q3SX42(Evidence code:IEA/Database source:UniProtKB:Q9UQN3|ens)F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens), NIPBL CHD7 CUX2 CHMP2B KMT2A,BP,5,5 of 32,0.21,15.62,0.1036,0.2165
GO:0050829,defense response to Gram-negative bacterium,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q3T0D5(Evidence code:IEA/Database source:UniProtKB:P62888|ens)Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685984)P05059(Evidence code:IDA/Database source:), TLR4 RPS19 RPL30 LYZ1 CHGA,BP,5,5 of 32,0.21,15.62,0.1036,0.2165
GO:0044853,plasma membrane raft,P10568(Evidence code:IEA/Database source:UniProtKB:O88329|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens), MYO1A FLOT1 PRKAR2A ITGB2,CC,4,4 of 24,0.17,16.67,0.119,0.2165
GO:0036503,ERAD pathway,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)Q2KIJ6(Evidence code:ISS/Database source:UniProtKB:Q9BZV1)F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens)E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens), RNF139 UBXN6 BRSK2 SYVN1,BP,4,4 of 24,0.17,16.67,0.119,0.2165
GO:0045216,cell-cell junction organization,A2VE81(Evidence code:IEA/Database source:UniProtKB:Q16625|ens)E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), OCLN XIRP2 PRKCI NF2,BP,4,4 of 24,0.17,16.67,0.119,0.2165
GO:0008637,apoptotic mitochondrial changes,Q0P594(Evidence code:IEA/Database source:UniProtKB:P62715|ens)P02722(Evidence code:IEA/Database source:UniProtKB:P48962|ens)A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens), PPP2CB SLC25A4 AIFM2 HK2,BP,4,4 of 25,0.17,16,0.131,0.2165
GO:0030183,B cell differentiation,G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)A6QNS1(Evidence code:IEA/Database source:InterPro:IPR033277)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), LOC104968438 IFNT3 GON4L IFNT2,BP,4,4 of 24,0.17,16.67,0.119,0.2165
GO:0004521,endoribonuclease activity,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens)Q6T5B7(Evidence code:ISS/Database source:UniProtKB:Q9H9G7)O19137(Evidence code:IBA/Database source:PANTHER:PTN000559726), SMG6 PIWIL2 AGO3 CPSF4,MF,4,4 of 24,0.17,16.67,0.119,0.2165
GO:0032868,response to insulin,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135)F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)F1MVT7(Evidence code:IEA/Database source:UniProtKB:Q8VEH5|ens)P20959(Evidence code:IDA/Database source:), EIF6 IRS1 EPM2AIP1 IGFBP3,BP,4,4 of 25,0.17,16,0.131,0.2165
GO:0032580,Golgi cisterna membrane,E1B9D0(Evidence code:IEA/Database source:InterPro:IPR008428)E1BMM8(Evidence code:IEA/Database source:InterPro:IPR008428)F1N0M7(Evidence code:IEA/Database source:InterPro:IPR008428)Q3T0T7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), CHPF2 CHPF B4GALNT3 SAR1B,CC,4,4 of 22,0.17,18.18,0.09647,0.2165
GO:0002286,T cell activation involved in immune response,G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), LOC104968438 PSEN1 IFNT3 IFNT2,BP,4,4 of 25,0.17,16,0.131,0.2165
GO:0005132,type I interferon receptor binding,P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT2 IFNT3 LOC104968438,MF,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0042641,actomyosin,E1BP72(Evidence code:IEA/Database source:UniProtKB:Q9Y5S2|ens)E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens), CDC42BPB MYO18A PDCD6IP,CC,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0046426,negative regulation of JAK-STAT cascade,E1BCE6(Evidence code:IEA/Database source:UniProtKB:P20749|ens)G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens), BCL3 RTN4R NF2,BP,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0008408,3-5 exonuclease activity,G3X7J6(Evidence code:IEA/Database source:InterPro:IPR002562|I)E1BDI3(Evidence code:IBA/Database source:PANTHER:PTN000030201)E1BEE6(Evidence code:IEA/Database source:InterPro:IPR002562), EXD3 POLG WRN,MF,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0051017,actin filament bundle assembly,F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q8BKX1)F1MXR0(Evidence code:IBA/Database source:PANTHER:PTN001022094), EPS8 BAIAP2 BAIAP2L1,BP,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0051225,spindle assembly,E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)E1BJK2(Evidence code:IEA/Database source:UniProtKB:A2AQ07|ens)E1B8R5(Evidence code:IEA/Database source:InterPro:IPR028731), INO80 TUBB1 TNKS,BP,3,3 of 15,0.13,20,0.1193,0.2165
GO:0031113,regulation of microtubule polymerization,Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q2TA37(Evidence code:IEA/Database source:UniProtKB:P36404|ens), PRUNE1 ABL1 ARL2,BP,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0002323,natural killer cell activation involved in immune response,P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT3 IFNT2 LOC104968438,BP,3,3 of 15,0.13,20,0.1193,0.2165
GO:0060415,muscle tissue morphogenesis,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens)P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens), SHOX2 ADARB1 MYF5,BP,3,3 of 15,0.13,20,0.1193,0.2165
GO:0005088,Ras guanyl-nucleotide exchange factor activity,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)Q5E9S7(Evidence code:IEA/Database source:UniProtKB:Q8N9B8|ens)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7), RAPGEF4 RASGEF1A RAPGEF2,MF,3,3 of 15,0.13,20,0.1193,0.2165
GO:0015698,inorganic anion transport,F1N4L1(Evidence code:IEA/Database source:GO:0005452)F1MCB5(Evidence code:IEA/Database source:GO:0005452)E1BF90(Evidence code:IEA/Database source:UniProtKB:Q6H1V1|ens), SLC4A2 SLC4A7 BEST3,BP,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0034968,histone lysine methylation,E1BNH7(Evidence code:IEA/Database source:GO:0018024)F1N413(Evidence code:IEA/Database source:InterPro:IPR007728)E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens), WHSC1L1 EHMT2 KMT2B,BP,3,3 of 15,0.13,20,0.1193,0.2165
GO:0043292,contractile fiber,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)A5PJQ1(Evidence code:IEA/Database source:UniProtKB:Q7TNV0|ens), SMTNL1 CRYAB DEK,CC,3,3 of 14,0.13,21.43,0.1045,0.2165
GO:0071383,cellular response to steroid hormone stimulus,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O35604|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens)Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036), NPC1 ATP1A2 UBE2L3,BP,3,3 of 15,0.13,20,0.1193,0.2165
GO:0045860,positive regulation of protein kinase activity,F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), RAPGEF2 PSEN1,BP,2,2 of 83,0.08,2.41,0.128,0.2165
GO:0015934,large ribosomal subunit,Q3T0S6(Evidence code:IEA/Database source:InterPro:IPR023672)P61356(Evidence code:ISS/Database source:UniProtKB:A1XQU5), RPL8 RPL27,CC,2,2 of 92,0.08,2.17,0.09513,0.2165
GO:0051016,barbed-end actin filament capping,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)F1N6C4(Evidence code:IEA/Database source:InterPro:IPR030222), TWF1 EPS8,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0005164,tumor necrosis factor receptor binding,E1BF06(Evidence code:IEA/Database source:InterPro:IPR006052|I)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR027139|I), TNFSF15 TRAF6,MF,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0006623,protein targeting to vacuole,A3KN15(Evidence code:IBA/Database source:PANTHER:PTN000289375)A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471), VPS41 PIK3R4,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0006828,manganese ion transport,O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230)O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230), TRPC1 TRPC2,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0001755,neural crest cell migration,E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7), LEF1 PHACTR4,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0043536,positive regulation of blood vessel endothelial cell migration,E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens), AMOTL1 SP1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0032210,regulation of telomere maintenance via telomerase,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens), ATM TERF2,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0008199,ferric iron binding,O46415(Evidence code:IEA/Database source:InterPro:IPR001519|I)O46414(Evidence code:IEA/Database source:InterPro:IPR001519|I), FTL FTH1,MF,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0003143,embryonic heart tube morphogenesis,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens), MEGF8 SOX17,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0048592,eye morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1N2Y2(Evidence code:IEA/Database source:UniProtKB:P05997|ens), NIPBL COL5A2,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0004383,guanylate cyclase activity,A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR011645)Q29450(Evidence code:IBA/Database source:PANTHER:PTN000229249), GUCY1A3 ADCY7,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0030686,90S preribosome,A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)E1BGE2(Evidence code:IBA/Database source:PANTHER:PTN000427367), RPS7 UTP20,CC,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:1900006,positive regulation of dendrite development,Q3ZC25(Evidence code:IEA/Database source:UniProtKB:Q80X71|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens), TMEM106B DAB2IP,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0034394,protein localization to cell surface,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)Q3MHZ7(Evidence code:IBA/Database source:PANTHER:PTN000243120), ARF6 PIGK,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0042573,retinoic acid metabolic process,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens)P02694(Evidence code:IEA/Database source:UniProtKB:Q00915|ens), ALDH1A3 RBP1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0031143,pseudopodium,Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735)Q27971(Evidence code:IEA/Database source:UniProtKB:P17655|ens), RAB25 CAPN2,CC,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0016471,vacuolar proton-transporting V-type ATPase complex,P31407(Evidence code:ISS/Database source:UniProtKB:P15313)P61420(Evidence code:IEA/Database source:UniProtKB:P61421|ens), ATP6V1B1 ATP6V0D1,CC,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:2000679,positive regulation of transcription regulatory region DNA binding,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens), TRAF6 FAM129B,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0016857,"racemase and epimerase activity, acting on carbohydrates and derivatives",Q0P563(Evidence code:ISS/Database source:UniProtKB:Q8R2K1)Q3T105(Evidence code:IEA/Database source:InterPro:IPR008089), FUOM GALE,MF,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0051984,positive regulation of chromosome segregation,Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens), RAD18 NUMA1,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0031210,phosphatidylcholine binding,Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens), CHMP2A PITPNA,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0051403,stress-activated MAPK cascade,G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens), MAPK11 TAOK2,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0035269,protein O-linked mannosylation,E1BCH6(Evidence code:ISS/Database source:UniProtKB:A4D126)Q3ZC71(Evidence code:IBA/Database source:PANTHER:PTN000419487), ISPD DPM3,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0005640,nuclear outer membrane,E1BJU6(Evidence code:IEA/Database source:InterPro:IPR030267)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens), SYNE3 PSEN1,CC,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0032401,establishment of melanosome localization,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)B6Z9Q5(Evidence code:IEA/Database source:InterPro:IPR027686), RAB17 SHROOM2,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0000791,euchromatin,A7E320(Evidence code:ISS/Database source:UniProtKB:Q96T88)Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1), UHRF1 DNMT3A,CC,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0001765,membrane raft assembly,P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens), S100A10 FLOT1,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0045948,positive regulation of translational initiation,Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens), KHDRBS1 UHMK1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0004806,triglyceride lipase activity,Q29458(Evidence code:IEA/Database source:InterPro:IPR039097)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033903), LIPF PNPLA2,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0016272,prefoldin complex,A1A4P5(Evidence code:IEA/Database source:InterPro:IPR002777|I)Q2TBX2(Evidence code:IEA/Database source:InterPro:IPR016655), PFDN2 VBP1,CC,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:2000637,positive regulation of gene silencing by miRNA,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), PUM1 DHX9,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0016486,peptide hormone processing,F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens)P42891(Evidence code:IEA/Database source:InterPro:IPR029733), PCSK6 ECE1,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0031115,negative regulation of microtubule polymerization,Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:P04350|ens)E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens), TUBB4A EML2,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0045648,positive regulation of erythrocyte differentiation,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P51692)P61635(Evidence code:ISS/Database source:UniProtKB:P40763), STAT5B STAT3,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0002092,positive regulation of receptor internalization,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5), CD63 AHI1,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0004712,protein serine/threonine/tyrosine kinase activity,Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)Q4TVR5(Evidence code:IEA/Database source:EC:2.7.12.1), MAPK9 DSTYK,MF,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0050771,negative regulation of axonogenesis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens), PSEN1 SYNGAP1,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:1990090,cellular response to nerve growth factor stimulus,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386), CIB1 RAPGEF2,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens)E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2), CTDSP1 E2F7,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens), CCAR2 CXCL12,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0097546,ciliary base,P05131(Evidence code:IEA/Database source:UniProtKB:P68181|ens)P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens), PRKACB PRKACA,CC,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0001656,metanephros development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens)E1BJK0(Evidence code:IEA/Database source:UniProtKB:P81068|ens), GREB1L IRX1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:2000785,regulation of autophagosome assembly,A4FUD7(Evidence code:IBA/Database source:PANTHER:PTN001178308)F1MRD8(Evidence code:IBA/Database source:PANTHER:PTN000538677), RAB33B TBC1D12,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0006820,anion transport,F1N4L1(Evidence code:IEA/Database source:InterPro:IPR001717|I)F1MCB5(Evidence code:IEA/Database source:InterPro:IPR003020|I), SLC4A2 SLC4A7,BP,2,2 of 86,0.08,2.33,0.1313,0.2165
GO:0016578,histone deubiquitination,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens), TAF10 USP36,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0071322,cellular response to carbohydrate stimulus,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens), RPS6KA2 PRKCB,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0010569,regulation of double-strand break repair via homologous recombination,F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q6PIW4|ens)A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens), FIGNL1 SIRT6,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0005159,insulin-like growth factor receptor binding,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793), IRS1 GNAS,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,E1BAK9(Evidence code:IEA/Database source:UniProtKB:Q86TM6|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), SYVN1 LRRK2,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0009435,NAD biosynthetic process,A5PK51(Evidence code:IEA/Database source:InterPro:IPR036068)Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003694|I), NAPRT NADSYN1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0071539,protein localization to centrosome,Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q13561|ens)E1BC93(Evidence code:IEA/Database source:InterPro:IPR024138), DCTN2 PCM1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0033674,positive regulation of kinase activity,Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3)Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173), DSTYK GCN1L1,BP,2,2 of 92,0.08,2.17,0.09513,0.2165
GO:0035035,histone acetyltransferase binding,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens), SIRT2 TRIM68,MF,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0045822,negative regulation of heart contraction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens), ATP1A2 PDE4D,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0032797,SMN complex,Q5E959(Evidence code:ISS/Database source:UniProtKB:Q9Y3F4)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9UHI6|ens), STRAP DDX20,CC,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0061564,axon development,Q58CZ7(Evidence code:IEA/Database source:UniProtKB:Q922J6|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens), TSPAN2 MAPK8IP3,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0009416,response to light stimulus,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens)P04695(Evidence code:IDA/Database source:), KMT2A GNAT1,BP,2,2 of 81,0.08,2.47,0.1274,0.2165
GO:0005796,Golgi lumen,A4FUD7(Evidence code:IEA/Database source:UniProtKB:O35963|ens)P02668(Evidence code:IDA/Database source:), RAB33B CSN3,CC,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0002098,tRNA wobble uridine modification,E1BBQ3(Evidence code:IEA/Database source:InterPro:IPR006849)Q0VC66(Evidence code:IEA/Database source:InterPro:IPR000541), IKBKAP CTU1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0060760,positive regulation of response to cytokine stimulus,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), DDX58 DHX9,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0032461,positive regulation of protein oligomerization,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens), IDE TCL1A,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0006241,CTP biosynthetic process,A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), NME3 NME1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0004526,ribonuclease P activity,E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens)E1BFB5(Evidence code:IBA/Database source:PANTHER:PTN001005190), RPP25 KIAA0391,MF,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0032402,melanosome transport,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens)Q3ZCF0(Evidence code:IEA/Database source:UniProtKB:Q99KJ8|ens), RAB17 DCTN2,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0001102,RNA polymerase II activating transcription factor binding,Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens), LMO2 TBX3,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0043011,myeloid dendritic cell differentiation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), PSEN1 TRAF6,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0051930,regulation of sensory perception of pain,A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)E1BHM6(Evidence code:IEA/Database source:UniProtKB:Q9R053|ens), F2R SCN11A,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0010165,response to X-ray,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), BLM BRCA2,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:1905515,non-motile cilium assembly,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens), RPGRIP1L PCM1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0000729,DNA double-strand break processing,Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q15819|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), UBE2V2 BLM,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0009584,detection of visible light,P47803(Evidence code:IEA/Database source:GO:0008020)F1MR98(Evidence code:IEA/Database source:GO:0008020), RGR RRH,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,P22571(Evidence code:IEA/Database source:UniProtKB:P61249|ens)Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens), PDE6H AFAP1L2,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0070628,proteasome binding,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens), USP13 PSMD14,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0042116,macrophage activation,E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168), SLC7A2 TLR4,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0050766,positive regulation of phagocytosis,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens), BCR FCER1G,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0006414,translational elongation,Q3SZ15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251)Q3SZ32(Evidence code:IEA/Database source:UniProtKB-KW:KW-0251), EEF1E1 TCEB2,BP,2,2 of 83,0.08,2.41,0.128,0.2165
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,F1MNU6(Evidence code:IEA/Database source:UniProtKB:O94812|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens), BAIAP3 SRI,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0004435,phosphatidylinositol phospholipase C activity,P08487(Evidence code:IEA/Database source:InterPro:IPR001711|I)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001711|I), PLCG1 PLCB3,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0046653,tetrahydrofolate metabolic process,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)P00376(Evidence code:ISS/Database source:UniProtKB:P00374), SHMT2 DHFR,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0071498,cellular response to fluid shear stress,Q5NUA6(Evidence code:ISS/Database source:UniProtKB:Q16236)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), NFE2L2 SRC,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0060707,trophoblast giant cell differentiation,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2)A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702), E2F7 PLK4,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0031369,translation initiation factor binding,A7MB16(Evidence code:IEA/Database source:InterPro:IPR011400)E1BLZ8(Evidence code:IEA/Database source:UniProtKB:Q9DCH4|ens), EIF3B EIF3F,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0045717,negative regulation of fatty acid biosynthetic process,Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398)P48818(Evidence code:IEA/Database source:UniProtKB:P50544|ens), BRCA1 ACADVL,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0050786,RAGE receptor binding,P35466(Evidence code:IEA/Database source:UniProtKB:P26447|ens)P02638(Evidence code:IEA/Database source:UniProtKB:P04271|ens), S100A4 S100B,MF,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0031526,brush border membrane,E1BIL1(Evidence code:IBA/Database source:PANTHER:PTN000026689)G5E6P3(Evidence code:IBA/Database source:PANTHER:PTN000026689), GNA12 GNA13,CC,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0008074,"guanylate cyclase complex, soluble",A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q02108|ens)Q29450(Evidence code:IBA/Database source:PANTHER:PTN000229249), GUCY1A3 ADCY7,CC,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0006805,xenobiotic metabolic process,A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens)F1ML85(Evidence code:IEA/Database source:InterPro:IPR039091), NR1I2 AHR,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0009113,purine nucleobase biosynthetic process,Q59A32(Evidence code:IEA/Database source:InterPro:IPR000115|I)A4FUD0(Evidence code:IBA/Database source:PANTHER:PTN001598237), GART MTHFD1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0050856,regulation of T cell receptor signaling pathway,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)E1B9S9(Evidence code:IEA/Database source:InterPro:IPR030157), MALT1 CACNA1F,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0007021,tubulin complex assembly,P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)Q2TBX2(Evidence code:IBA/Database source:PANTHER:PTN000274575), CRYAB VBP1,BP,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0071276,cellular response to cadmium ion,Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), MAPK9 MT3,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0042623,"ATPase activity, coupled",Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BPU3(Evidence code:IEA/Database source:InterPro:IPR025653), VPS4B PEX1,MF,2,2 of 86,0.08,2.33,0.1313,0.2165
GO:0044344,cellular response to fibroblast growth factor stimulus,Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3)E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens), DSTYK SETX,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0010765,positive regulation of sodium ion transport,F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens), MLLT6 GPD1L,BP,2,2 of 7,0.08,28.57,0.1209,0.2165
GO:0000974,Prp19 complex,Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q9UMS4)F1N607(Evidence code:IBA/Database source:PANTHER:PTN000327519), CDC5L SYF2,CC,2,2 of 6,0.08,33.33,0.09829,0.2165
GO:0070307,lens fiber cell development,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens),FRS2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004516,nicotinate phosphoribosyltransferase activity,A5PK51(Evidence code:IEA/Database source:InterPro:IPR006405),NAPRT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017045,corticotropin-releasing hormone activity,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN000385798),CRH,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046847,filopodium assembly,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens),RAB17,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061153,trachea gland development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017121,phospholipid scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens),ANO6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035909,aorta morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008295,spermidine biosynthetic process,E1BM12(Evidence code:IEA/Database source:UniProtKB:P19623|ens),SRM,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002265,astrocyte activation involved in immune response,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0098821,BMP receptor activity,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090024,negative regulation of neutrophil chemotaxis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042276,error-prone translesion synthesis,E1BF32(Evidence code:IBA/Database source:PANTHER:PTN000035411),KIAA2022,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1900260,negative regulation of RNA-directed 5-3 RNA polymerase activity,Q3SZ65(Evidence code:IEA/Database source:UniProtKB:Q14240|ens),EIF4A2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060339,negative regulation of type I interferon-mediated signaling pathway,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902510,regulation of apoptotic DNA fragmentation,E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens),AIFM1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019290,siderophore biosynthetic process,Q3T046(Evidence code:ISS/Database source:UniProtKB:Q8JZV9),BDH2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061676,importin-alpha family protein binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009994,oocyte differentiation,E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens),KMT2B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005859,muscle myosin complex,Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569),MYBPC3,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010918,positive regulation of mitochondrial membrane potential,E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens),TCL1A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061030,epithelial cell differentiation involved in mammary gland alveolus development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051903,S-(hydroxymethyl)glutathione dehydrogenase activity,Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR014183),ADH5,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019871,sodium channel inhibitor activity,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000032,cell wall mannoprotein biosynthetic process,Q3SZI0(Evidence code:IBA/Database source:PANTHER:PTN000034017),MPI,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017113,dihydropyrimidine dehydrogenase (NADP+) activity,Q28007(Evidence code:IEA/Database source:EC:1.3.1.2),DPYD,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003365,establishment of cell polarity involved in ameboidal cell migration,E1BEQ5(Evidence code:IEA/Database source:UniProtKB:Q9D4H4|ens),AMOTL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097070,ductus arteriosus closure,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097286,iron ion import,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens),TFRC,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016743,carboxyl- or carbamoyltransferase activity,F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006130|I),CAD,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021773,striatal medium spiny neuron differentiation,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032275,luteinizing hormone secretion,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens),TBX3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003912,DNA nucleotidylexotransferase activity,P06526(Evidence code:IEA/Database source:InterPro:IPR027292),DNTT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061386,closure of optic fissure,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7),PHACTR4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097324,melanocyte migration,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005964,phosphorylase kinase complex,F1MJ90(Evidence code:IBA/Database source:PANTHER:PTN000844181),PHKB,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035963,cellular response to interleukin-13,P27479(Evidence code:ISS/Database source:UniProtKB:P16050),ALOX15,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017096,acetylserotonin O-methyltransferase activity,P10950(Evidence code:IEA/Database source:EC:2.1.1.4),ASMT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031697,beta-1 adrenergic receptor binding,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035735,intraciliary transport involved in cilium assembly,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens),PCM1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,A7Z061(Evidence code:IEA/Database source:UniProtKB:P30260|ens),CDC27,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030242,autophagy of peroxisome,A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043697,cell dedifferentiation,E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788),CDK6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048672,positive regulation of collateral sprouting,Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens),BDNF,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051164,L-xylitol metabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060372,regulation of atrial cardiac muscle cell membrane repolarization,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens),CACNA1D,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000715,"nucleotide-excision repair, DNA damage recognition",Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens),RAD23B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043931,ossification involved in bone maturation,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens),RYR1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990452,Parkin-FBXW7-Cul1 ubiquitin ligase complex,F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q13616|ens),CUL1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016191,synaptic vesicle uncoating,Q2KJA1(Evidence code:IEA/Database source:UniProtKB:Q62419|ens),SH3GL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005740,mitochondrial envelope,P05630(Evidence code:IDA/Database source:),ATP5D,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015881,creatine transmembrane transport,O18875(Evidence code:ISS/Database source:UniProtKB:P48029),SLC6A8,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042609,CD4 receptor binding,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens),LCK,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031076,embryonic camera-type eye development,F1MHR3(Evidence code:IEA/Database source:UniProtKB:Q9JHW9|ens),ALDH1A3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0098719,sodium ion import across plasma membrane,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens),TRPM4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901639,XDP catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032447,protein urmylation,Q0VC66(Evidence code:IEA/Database source:UniRule:UR000160875),CTU1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006015,5-phosphoribose 1-diphosphate biosynthetic process,Q2HJ58(Evidence code:IEA/Database source:UniPathway:UPA00087),PRPS1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902823,negative regulation of late endosome to lysosome transport,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0044547,DNA topoisomerase binding,Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q07955|ens),SRSF1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904888,cranial skeletal system development,F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q9Y6Z7|ens),COLEC10,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005020,stem cell factor receptor activity,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031427,response to methotrexate,P00376(Evidence code:IEA/Database source:UniProtKB-KW:KW-0487),DHFR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042756,drinking behavior,F1N5R9(Evidence code:IEA/Database source:UniProtKB:P09065|ens),EN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1900028,negative regulation of ruffle assembly,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens),TACSTD2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902938,regulation of intracellular calcium activated chloride channel activity,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904294,positive regulation of ERAD pathway,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016035,zeta DNA polymerase complex,E1BF32(Evidence code:IBA/Database source:PANTHER:PTN000035411),KIAA2022,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061104,adrenal chromaffin cell differentiation,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0),INSM1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070877,microprocessor complex,A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens),DGCR8,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090235,regulation of metaphase plate congression,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1900106,positive regulation of hyaluranon cable assembly,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0038163,thrombopoietin-mediated signaling pathway,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4),CIB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0098536,deuterosome,A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702),PLK4,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003419,growth plate cartilage chondrocyte proliferation,F1MP76(Evidence code:IDA/Database source:),SDC3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035272,exocrine system development,Q29RR0(Evidence code:ISS/Database source:UniProtKB:P51156),RAB26,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051499,D-aminoacyl-tRNA deacylase activity,E1B937(Evidence code:IEA/Database source:InterPro:IPR003732),DTD2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043314,negative regulation of neutrophil degranulation,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901674,regulation of histone H3-K27 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046544,development of secondary male sexual characteristics,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232),STAT5B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042613,MHC class II protein complex,F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I),LOC100848815,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090284,positive regulation of protein glycosylation in Golgi,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051787,misfolded protein binding,A5PK75(Evidence code:IEA/Database source:UniProtKB:Q9ER39|ens),TOR1A,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034186,apolipoprotein A-I binding,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048769,sarcomerogenesis,E1BMP3(Evidence code:IBA/Database source:PANTHER:PTN000680821),MYLK3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003939,L-iditol 2-dehydrogenase activity,Q58D31(Evidence code:IEA/Database source:EC:1.1.1.14),SORD,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006361,transcription initiation from RNA polymerase I promoter,P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2),LIPE,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071676,negative regulation of mononuclear cell migration,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034685,integrin alphav-beta6 complex,Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens),ITGB6,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001798,positive regulation of type IIa hypersensitivity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005260,intracellularly ATP-gated chloride channel activity,P35071(Evidence code:IEA/Database source:EC:3.6.3.49),CFTR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034751,aryl hydrocarbon receptor complex,F1ML85(Evidence code:IEA/Database source:InterPro:IPR033348),AHR,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0098560,cytoplasmic side of late endosome membrane,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens),LITAF,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072378,"blood coagulation, fibrin clot formation",Q2TBQ1(Evidence code:IEA/Database source:UniProtKB:Q07968|ens),F13B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070937,CRD-mediated mRNA stability complex,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017168,5-oxoprolinase (ATP-hydrolyzing) activity,Q75WB5(Evidence code:IEA/Database source:EC:3.5.2.9),OPLAH,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903070,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,Q32LM2(Evidence code:ISS/Database source:UniProtKB:O43765),SGTA,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005095,GTPase inhibitor activity,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010484,H3 histone acetyltransferase activity,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0036258,multivesicular body assembly,Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004146,dihydrofolate reductase activity,P00376(Evidence code:IEA/Database source:InterPro:IPR001796|I),DHFR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1905394,retromer complex binding,P11456(Evidence code:IEA/Database source:UniProtKB:P20645|ens),M6PR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045590,negative regulation of regulatory T cell differentiation,Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314),IRF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045650,negative regulation of macrophage differentiation,Q1RMH5(Evidence code:IEA/Database source:UniProtKB:P02747|ens),C1QC,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001739,sex chromatin,E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens),SUZ12,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034464,BBSome,Q0IIM2(Evidence code:IDA/Database source:),ARL6,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004500,dopamine beta-monooxygenase activity,P15101(Evidence code:IEA/Database source:EC:1.14.17.1),DBH,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032057,negative regulation of translational initiation in response to stress,P68102(Evidence code:ISS/Database source:UniProtKB:Q6ZWX6),EIF2S1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1905419,sperm flagellum movement involved in flagellated sperm motility,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051660,establishment of centrosome localization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071492,cellular response to UV-A,P26882(Evidence code:ISS/Database source:UniProtKB:Q08752),PPID,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045765,regulation of angiogenesis,F1MN36(Evidence code:IEA/Database source:UniProtKB:Q14A28|ens),PROK1,BP,1,1 of 62,0.04,1.61,0.1287,0.2165
GO:0099641,anterograde axonal protein transport,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens),MAPK8IP3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009048,dosage compensation by inactivation of X chromosome,Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349142),BRCA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050104,L-gulonate 3-dehydrogenase activity,Q8SPX7(Evidence code:IEA/Database source:EC:1.1.1.45),CRYL1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016206,catechol O-methyltransferase activity,A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128),COMT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070095,fructose-6-phosphate binding,A1A4J1(Evidence code:IEA/Database source:UniProtKB:P17858|ens),PFKL,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004689,phosphorylase kinase activity,F1MJ90(Evidence code:IBA/Database source:PANTHER:PTN000844181),PHKB,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005337,nucleoside transmembrane transporter activity,Q3ZC83(Evidence code:IEA/Database source:InterPro:IPR002259|I),SLC29A1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042806,fucose binding,Q0P563(Evidence code:ISS/Database source:UniProtKB:Q8R2K1),FUOM,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051932,"synaptic transmission, GABAergic",Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens),DNM1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035005,1-phosphatidylinositol-4-phosphate 3-kinase activity,E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005674),PIK3CD,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035811,negative regulation of urine volume,F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens),MLLT6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031871,proteinase activated receptor binding,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens),PDCD6IP,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004463,leukotriene-A4 hydrolase activity,Q3SZH7(Evidence code:IEA/Database source:EC:3.3.2.6),LTA4H,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032998,Fc-epsilon receptor I complex,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004489,methylenetetrahydrofolate reductase (NAD(P)H) activity,Q5I598(Evidence code:IEA/Database source:InterPro:IPR003171|I),MTHFR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071672,negative regulation of smooth muscle cell chemotaxis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019166,trans-2-enoyl-CoA reductase (NADPH) activity,Q3ZBW6(Evidence code:IEA/Database source:UniProtKB:Q9NUI1|ens),DECR2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003334,keratinocyte development,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060903,positive regulation of meiosis I,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034970,histone H3-R2 methylation,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090285,negative regulation of protein glycosylation in Golgi,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002643,regulation of tolerance induction,A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens),MARCH7,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097326,melanocyte adhesion,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043914,NADPH:sulfur oxidoreductase activity,F1MF74(Evidence code:IEA/Database source:InterPro:IPR029939),MICAL2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045862,positive regulation of proteolysis,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens),CYFIP2,BP,1,1 of 63,0.04,1.59,0.1299,0.2165
GO:1905065,positive regulation of vascular smooth muscle cell differentiation,P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens),KIT,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0038036,sphingosine-1-phosphate receptor activity,E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9NRA0|ens),SPHK2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031937,positive regulation of chromatin silencing,Q08DY2(Evidence code:IEA/Database source:UniProtKB:Q8N108|ens),MIER1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033857,diphosphoinositol-pentakisphosphate kinase activity,F1MNG6(Evidence code:IEA/Database source:UniProtKB:Q6ZQB6|ens),PPIP5K2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043754,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,P11181(Evidence code:IEA/Database source:EC:2.3.1.168),DBT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031493,nucleosomal histone binding,A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens),UHRF1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046512,sphingosine biosynthetic process,E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9NRA0|ens),SPHK2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003974,UDP-N-acetylglucosamine 4-epimerase activity,Q3T105(Evidence code:IEA/Database source:EC:5.1.3.7),GALE,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042500,"aspartic endopeptidase activity, intramembrane cleaving",Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031),PSEN1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0052853,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015186,L-glutamine transmembrane transporter activity,Q95JC7(Evidence code:ISS/Database source:UniProtKB:Q15758),SLC1A5,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035408,histone H3-T6 phosphorylation,P05126(Evidence code:ISS/Database source:UniProtKB:P05771),PRKCB,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035359,negative regulation of peroxisome proliferator activated receptor signaling pathway,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033829,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR017374),LFNG,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042158,lipoprotein biosynthetic process,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990423,RZZ complex,E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens),KNTC1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0099639,"neurotransmitter receptor transport, endosome to plasma membrane",Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030644,cellular chloride ion homeostasis,Q5EA61(Evidence code:ISS/Database source:UniProtKB:P07335),CKB,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051228,mitotic spindle disassembly,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9UBP0),SPAST,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031547,brain-derived neurotrophic factor receptor signaling pathway,F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386),RAPGEF2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031268,pseudopodium organization,Q58DW6(Evidence code:ISS/Database source:UniProtKB:P57735),RAB25,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001967,suckling behavior,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens),PEX13,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071008,U2-type post-mRNA release spliceosomal complex,E1BDX0(Evidence code:IEA/Database source:UniProtKB:P16383|ens),GCFC2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004588,orotate phosphoribosyltransferase activity,P31754(Evidence code:IEA/Database source:InterPro:IPR004467|I),UMPS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035912,dorsal aorta morphogenesis,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004155,"6,7-dihydropteridine reductase activity",Q3T0Z7(Evidence code:IEA/Database source:EC:1.5.1.34),QDPR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019441,tryptophan catabolic process to kynurenine,A7MBF5(Evidence code:IEA/Database source:InterPro:IPR037217),IDO1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003338,metanephros morphogenesis,F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens),FRAS1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0007113,endomitotic cell cycle,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828),CIB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0086012,membrane depolarization during cardiac muscle cell action potential,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens),SCN2B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061474,phagolysosome membrane,Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens),LAMP1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043323,positive regulation of natural killer cell degranulation,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032264,IMP salvage,E1BA23(Evidence code:IEA/Database source:InterPro:IPR006329|I),AMPD3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070612,histone methyltransferase activity (H2A-R3 specific),Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0055073,cadmium ion homeostasis,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902255,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,Q3T087(Evidence code:IEA/Database source:UniProtKB:Q9CXW4|ens),RPL11,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990239,steroid hormone binding,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033197,response to vitamin E,P68107(Evidence code:ISA/Database source:UniProtKB:P97534),FKBP1B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046168,glycerol-3-phosphate catabolic process,A6QQR7(Evidence code:IEA/Database source:InterPro:IPR011128),GPD1L,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004363,glutathione synthase activity,Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR004887|I),GSS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060313,negative regulation of blood vessel remodeling,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019408,dolichol biosynthetic process,Q5EA65(Evidence code:ISS/Database source:UniProtKB:P24140),DPAGT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048539,bone marrow development,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901143,insulin catabolic process,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032483,regulation of Rab protein signal transduction,F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8TEH3|ens),DENND1A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046098,guanine metabolic process,F1MLX9(Evidence code:IBA/Database source:PANTHER:PTN000138455),GDA,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035020,regulation of Rac protein signal transduction,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62330|ens),ARF6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003157,endocardium development,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019145,aminobutyraldehyde dehydrogenase activity,Q2KJH9(Evidence code:ISS/Database source:UniProtKB:P49189),ALDH9A1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902513,regulation of organelle transport along microtubule,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050975,sensory perception of touch,P11023(Evidence code:ISS/Database source:UniProtKB:P63011),RAB3A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033690,positive regulation of osteoblast proliferation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003956,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens),SIRT6,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004098,cerebroside-sulfatase activity,Q08DD1(Evidence code:IEA/Database source:EC:3.1.6.8),ARSA,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015174,basic amino acid transmembrane transporter activity,Q08DK7(Evidence code:ISS/Database source:UniProtKB:Q8N8R3),SLC25A29,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904454,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043194,axon initial segment,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001780,neutrophil homeostasis,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902992,negative regulation of amyloid precursor protein catabolic process,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097214,positive regulation of lysosomal membrane permeability,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034477,U6 snRNA 3-end processing,Q0II50(Evidence code:IEA/Database source:InterPro:IPR027521),USB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046709,IDP catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006203,dGTP catabolic process,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003197,endocardial cushion development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903351,cellular response to dopamine,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060800,regulation of cell differentiation involved in embryonic placenta development,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060535,trachea cartilage morphogenesis,F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284),LRP6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0047131,"saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity",A8E657(Evidence code:IEA/Database source:EC:1.5.1.9),AASS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,E1BML0(Evidence code:IEA/Database source:InterPro:IPR030843),PAN2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003231,cardiac ventricle development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens),GREB1L,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021702,cerebellar Purkinje cell differentiation,F1MKS6(Evidence code:IEA/Database source:InterPro:IPR033852),AGTPBP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060072,large conductance calcium-activated potassium channel activity,Q28204(Evidence code:IEA/Database source:InterPro:IPR024939),KCNMA1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000615,regulation of histone H3-K9 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002431,Fc receptor mediated stimulatory signaling pathway,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901641,ITP binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051563,smooth endoplasmic reticulum calcium ion homeostasis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2001303,lipoxin A4 biosynthetic process,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0099590,neurotransmitter receptor internalization,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090068,positive regulation of cell cycle process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 62,0.04,1.61,0.1287,0.2165
GO:0032274,gonadotropin secretion,F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens),FAM129B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0022027,interkinetic nuclear migration,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens),PCM1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016428,tRNA (cytosine-5-)-methyltransferase activity,A1A4K2(Evidence code:IEA/Database source:InterPro:IPR023270),NSUN2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004367,glycerol-3-phosphate dehydrogenase [NAD+] activity,A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006109|I),GPD1L,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006478,peptidyl-tyrosine sulfation,Q3SYY2(Evidence code:IEA/Database source:InterPro:IPR026634),TPST2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060155,platelet dense granule organization,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033624,negative regulation of integrin activation,G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens),KIF14,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000630,positive regulation of miRNA metabolic process,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens),NFKB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048632,negative regulation of skeletal muscle tissue growth,F1MF35(Evidence code:IEA/Database source:UniProtKB:Q9WVM6|ens),TLL2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070671,response to interleukin-12,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034271,"phosphatidylinositol 3-kinase complex, class III, type I",A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048757,pigment granule maturation,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035280,miRNA loading onto RISC involved in gene silencing by miRNA,F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens),AGO4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000125,PCAF complex,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens),TAF10,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061589,calcium activated phosphatidylserine scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060044,negative regulation of cardiac muscle cell proliferation,G3X793(Evidence code:IEA/Database source:UniProtKB:Q9WUI1|ens),MAPK11,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003937,IMP cyclohydrolase activity,Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR002695),ATIC,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903894,regulation of IRE1-mediated unfolded protein response,F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens),COPS5,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016322,neuron remodeling,A7MB18(Evidence code:IEA/Database source:UniProtKB:Q9JI33|ens),NTN4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033677,DNA/RNA helicase activity,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499),DDX1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002467,germinal center formation,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090498,extrinsic component of Golgi membrane,E1B970(Evidence code:IEA/Database source:InterPro:IPR033288),GOLGA3,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006670,sphingosine metabolic process,E1BJM1(Evidence code:IEA/Database source:UniProtKB:Q9JIA7|ens),SPHK2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004809,tRNA (guanine-N2-)-methyltransferase activity,A5D7S3(Evidence code:IEA/Database source:InterPro:IPR002905),TRMT1L,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902560,GMP reductase complex,Q32L93(Evidence code:IEA/Database source:InterPro:IPR005993),GMPR2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042840,D-glucuronate catabolic process,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990450,linear polyubiquitin binding,Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens),IKBKG,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030502,negative regulation of bone mineralization,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0103053,1-ethyladenine demethylase activity,Q58DM4(Evidence code:IEA/Database source:EC:1.14.11.33),ALKBH2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005879,axonemal microtubule,Q0IIM2(Evidence code:IDA/Database source:),ARL6,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:2001137,positive regulation of endocytic recycling,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071316,cellular response to nicotine,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens),NFKB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090482,vitamin transmembrane transporter activity,E1BLU2(Evidence code:IEA/Database source:InterPro:IPR002666),SLC19A2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000155,phosphorelay sensor kinase activity,F1MP51(Evidence code:IEA/Database source:InterPro:IPR000700),KCNH5,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008392,arachidonic acid epoxygenase activity,F1MEU8(Evidence code:IBA/Database source:PANTHER:PTN000670523),LOC540627,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903553,positive regulation of extracellular exosome assembly,E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q8WUM4|ens),PDCD6IP,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060770,negative regulation of epithelial cell proliferation involved in prostate gland development,Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q91ZD6|ens),EAF2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009000,selenocysteine lyase activity,A2VDS1(Evidence code:IEA/Database source:EC:4.4.1.16),SCLY,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019076,viral release from host cell,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004617,phosphoglycerate dehydrogenase activity,Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006236),PHGDH,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006069,ethanol oxidation,Q3ZC42(Evidence code:IEA/Database source:InterPro:IPR014183),ADH5,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019075,virus maturation,Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens),MVB12A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050882,voluntary musculoskeletal movement,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032173,septin collar,Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens),SEPT6,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004644,phosphoribosylglycinamide formyltransferase activity,Q59A32(Evidence code:IEA/Database source:InterPro:IPR004607),GART,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097109,neuroligin family protein binding,Q28146(Evidence code:IPI/Database source:UniProtKB:Q62765),NRXN1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031475,myosin V complex,Q3MHR3(Evidence code:IEA/Database source:UniProtKB:Q9D0M5|ens),DYNLL2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048763,calcium-induced calcium release activity,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:P21817|ens),RYR1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902958,"positive regulation of mitochondrial electron transport, NADH to ubiquinone",A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006426,glycyl-tRNA aminoacylation,A5D7A2(Evidence code:IEA/Database source:InterPro:IPR002315),GARS,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045446,endothelial cell differentiation,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens),KDM6B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010996,response to auditory stimulus,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens),ABHD12,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000564,"regulation of CD8-positive, alpha-beta T cell proliferation",Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314),IRF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071797,LUBAC complex,A6QNU0(Evidence code:IEA/Database source:InterPro:IPR026254),RNF31,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032765,positive regulation of mast cell cytokine production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051500,D-tyrosyl-tRNA(Tyr) deacylase activity,E1B937(Evidence code:IBA/Database source:PANTHER:PTN000049487),DTD2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015578,mannose transmembrane transporter activity,P11456(Evidence code:IEA/Database source:InterPro:IPR000296),M6PR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003358,noradrenergic neuron development,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0),INSM1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015670,carbon dioxide transport,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens),AQP5,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051661,maintenance of centrosome location,E1BIX7(Evidence code:IEA/Database source:UniProtKB:P81274|ens),GPSM2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006704,glucocorticoid biosynthetic process,Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens),CRH,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004726,non-membrane spanning protein tyrosine phosphatase activity,P11064(Evidence code:IEA/Database source:InterPro:IPR002115),ACP1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050115,myosin-light-chain-phosphatase activity,Q3SWW9(Evidence code:IEA/Database source:EC:3.1.3.53),PPP1CB,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033189,response to vitamin A,P02694(Evidence code:IEA/Database source:UniProtKB:Q00915|ens),RBP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035403,histone kinase activity (H3-T6 specific),P05126(Evidence code:ISS/Database source:UniProtKB:P05771),PRKCB,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050917,sensory perception of umami taste,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens),GNAT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001957,intramembranous ossification,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042275,error-free postreplication DNA repair,Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q9D2M8|ens),UBE2V2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090083,regulation of inclusion body assembly,Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens),BAG5,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006685,sphingomyelin catabolic process,A6QQN6(Evidence code:IEA/Database source:InterPro:IPR017064),SMPDL3B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005534,galactose binding,A6H768(Evidence code:IEA/Database source:InterPro:IPR019539),GALK1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000311,regulation of AMPA receptor activity,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061588,calcium activated phospholipid scrambling,F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295),ANO6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061031,endodermal digestive tract morphogenesis,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046523,S-methyl-5-thioribose-1-phosphate isomerase activity,Q2NL31(Evidence code:IEA/Database source:EC:5.3.1.23),MRI1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004052,arachidonate 12-lipoxygenase activity,P27479(Evidence code:IEA/Database source:EC:1.13.11.31),ALOX15,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004590,orotidine-5-phosphate decarboxylase activity,P31754(Evidence code:IEA/Database source:InterPro:IPR001754|I),UMPS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005309,creatine:sodium symporter activity,O18875(Evidence code:IEA/Database source:InterPro:IPR002984),SLC6A8,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004991,parathyroid hormone receptor activity,Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR002170),PTH1R,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015014,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process",A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens),EXT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005041,low-density lipoprotein particle receptor activity,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens),LRP6,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006740,NADPH regeneration,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003896,DNA primase activity,G8JKZ3(Evidence code:IEA/Database source:InterPro:IPR002755|I),PRIM1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033981,D-dopachrome decarboxylase activity,A5PK65(Evidence code:IEA/Database source:EC:4.1.1.84),DDT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016793,triphosphoric monoester hydrolase activity,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q60710),SAMHD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903632,positive regulation of aminoacyl-tRNA ligase activity,Q0II26(Evidence code:IEA/Database source:UniProtKB:Q8R010|ens),AIMP2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000766,negative regulation of cytoplasmic translation,F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q9C0B0|ens),UNK,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031260,pseudopodium membrane,Q58DW6(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),RAB25,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030157,pancreatic juice secretion,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens),AQP5,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990459,transferrin receptor binding,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021797,forebrain anterior/posterior pattern specification,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599),AXIN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009346,citrate lyase complex,Q32PF2(Evidence code:IBA/Database source:PANTHER:PTN000563493),ACLY,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0052338,disruption by host of symbiont cell wall,P05059(Evidence code:IDA/Database source:),CHGA,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006272,leading strand elongation,E1BJF4(Evidence code:IBA/Database source:PANTHER:PTN000035348),POLA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019767,IgE receptor activity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046831,regulation of RNA export from nucleus,Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q60749|ens),KHDRBS1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010038,response to metal ion,F1MQ57(Evidence code:IEA/Database source:UniProtKB:Q9NQX3|ens),GPHN,BP,1,1 of 62,0.04,1.61,0.1287,0.2165
GO:0039536,negative regulation of RIG-I signaling pathway,Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens),UFD1L,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070032,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000455,enzyme-directed rRNA pseudouridine synthesis,F1N088(Evidence code:IBA/Database source:PANTHER:PTN001311753),RPUSD2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017018,myosin phosphatase activity,Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62143),PPP1CB,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903384,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008206,bile acid metabolic process,E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens),ATP8B1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1905166,negative regulation of lysosomal protein catabolic process,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072177,mesonephric duct development,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens),GREB1L,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061590,calcium activated phosphatidylcholine scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0007386,compartment pattern specification,Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens),LFNG,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens),ABL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035407,histone H3-T11 phosphorylation,A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512),PKN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006370,7-methylguanosine mRNA capping,G3MZP6(Evidence code:IEA/Database source:UniProtKB:Q8IYT2|ens),CMTR2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004013,adenosylhomocysteinase activity,A6QLP2(Evidence code:IBA/Database source:PANTHER:PTN001158976),AHCYL2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051891,positive regulation of cardioblast differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019373,epoxygenase P450 pathway,F1MEU8(Evidence code:IBA/Database source:PANTHER:PTN000670523),LOC540627,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050897,cobalt ion binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1900748,positive regulation of vascular endothelial growth factor signaling pathway,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens),MYO1C,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015805,S-adenosyl-L-methionine transport,A6QR09(Evidence code:ISS/Database source:UniProtKB:Q70HW3),SLC25A26,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035722,interleukin-12-mediated signaling pathway,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902685,positive regulation of receptor localization to synapse,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032782,bile acid secretion,F1MXU5(Evidence code:IEA/Database source:UniProtKB:Q9JMD3|ens),STARD10,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032344,regulation of aldosterone metabolic process,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004301,epoxide hydrolase activity,Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960),LTA4H,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035402,histone kinase activity (H3-T11 specific),A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512),PKN1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006264,mitochondrial DNA replication,E1BDI3(Evidence code:IBA/Database source:PANTHER:PTN000030201),POLG,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021870,Cajal-Retzius cell differentiation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0052854,medium-chain-(S)-2-hydroxy-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003909,DNA ligase activity,A4IFC8(Evidence code:IEA/Database source:InterPro:IPR016059),LIG1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003976,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,Q5EA65(Evidence code:IEA/Database source:UniProtKB:Q9H3H5|ens),DPAGT1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021691,cerebellar Purkinje cell layer maturation,P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens),ARCN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061621,canonical glycolysis,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070171,negative regulation of tooth mineralization,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021960,anterior commissure morphogenesis,G5E639(Evidence code:IEA/Database source:UniProtKB:Q8K3B1|ens),FBXO45,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0093001,glycolysis from storage polysaccharide through glucose-1-phosphate,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010310,regulation of hydrogen peroxide metabolic process,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008832,dGTPase activity,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q60710),SAMHD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0086098,angiotensin-activated signaling pathway involved in heart process,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019878,lysine biosynthetic process via aminoadipic acid,A8E657(Evidence code:IBA/Database source:PANTHER:PTN000875283),AASS,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097475,motor neuron migration,E1BFP0(Evidence code:IBA/Database source:PANTHER:PTN000548303),NHSL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008190,eukaryotic initiation factor 4E binding,F1MX04(Evidence code:ISS/Database source:UniProtKB:B2RU06),EIF4G1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003878,ATP citrate synthase activity,Q32PF2(Evidence code:IEA/Database source:InterPro:IPR014608),ACLY,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032623,interleukin-2 production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004421,hydroxymethylglutaryl-CoA synthase activity,Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR013746),HMGCS1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990926,short-term synaptic potentiation,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945),SOX4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004335,galactokinase activity,A6H768(Evidence code:IEA/Database source:InterPro:IPR000705),GALK1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034466,chromaffin granule lumen,P15101(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),DBH,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035878,nail development,Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9R078|ens),PRKAB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0098535,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,A2VDZ4(Evidence code:ISS/Database source:UniProtKB:Q64702),PLK4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071045,nuclear histone mRNA catabolic process,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003975,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,Q5EA65(Evidence code:IEA/Database source:InterPro:IPR033895),DPAGT1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004614,phosphoglucomutase activity,F1MS56(Evidence code:IEA/Database source:UniProtKB:Q9CYR6|ens),PGM3,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035863,dITP catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0),NUDT16,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060268,negative regulation of respiratory burst,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097091,synaptic vesicle clustering,F1N159(Evidence code:IEA/Database source:UniProtKB:Q64332|ens),SYN2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0086016,AV node cell action potential,G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens),SCN10A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0018479,benzaldehyde dehydrogenase (NAD+) activity,P48644(Evidence code:IBA/Database source:PANTHER:PTN000192776),ALDH1A1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0007614,short-term memory,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298),CUX2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002322,B cell proliferation involved in immune response,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2001286,regulation of caveolin-mediated endocytosis,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens),CTNND1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048698,negative regulation of collateral sprouting in absence of injury,A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens),SPG20,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034993,meiotic nuclear membrane microtubule tethering complex,E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q4FZC9|ens),SYNE3,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000628,regulation of miRNA metabolic process,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004641,phosphoribosylformylglycinamidine cyclo-ligase activity,Q59A32(Evidence code:IEA/Database source:InterPro:IPR004733),GART,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006062,sorbitol catabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0036117,hyaluranon cable,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060266,negative regulation of respiratory burst involved in inflammatory response,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens),RPS19,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0044313,protein K6-linked deubiquitination,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072307,regulation of metanephric nephron tubule epithelial cell differentiation,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035610,protein side chain deglutamylation,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens),AGTPBP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030586,[methionine synthase] reductase activity,Q4JIJ2(Evidence code:IEA/Database source:EC:1.16.1.8),MTRR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901223,negative regulation of NIK/NF-kappaB signaling,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens),LITAF,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004559,alpha-mannosidase activity,F1MWT0(Evidence code:IEA/Database source:InterPro:IPR000602|I),MAN2C1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046370,fructose biosynthetic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021798,forebrain dorsal/ventral pattern formation,F6PR93(Evidence code:IEA/Database source:UniProtKB:Q0HA38|ens),TTC21B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0018401,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070449,elongin complex,Q3SZ32(Evidence code:IEA/Database source:InterPro:IPR039049),TCEB2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045903,positive regulation of translational fidelity,A6QLG5(Evidence code:IBA/Database source:PANTHER:PTN000216478),RPS9,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032811,negative regulation of epinephrine secretion,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN001030516),CRH,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015866,ADP transport,P02722(Evidence code:ISS/Database source:UniProtKB:P12235),SLC25A4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990426,mitotic recombination-dependent replication fork processing,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070626,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,A3KN12(Evidence code:IEA/Database source:EC:4.3.2.2),ADSL,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070200,establishment of protein localization to telomere,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902037,negative regulation of hematopoietic stem cell differentiation,Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38647),HSPA9,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001094,TFIID-class transcription factor binding,A7MBG8(Evidence code:IEA/Database source:UniProtKB:P60122|ens),RUVBL1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004359,glutaminase activity,Q3ZBF0(Evidence code:IBA/Database source:PANTHER:PTN000557972),NADSYN1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000584,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens),PHF14,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004591,oxoglutarate dehydrogenase (succinyl-transferring) activity,E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603),DHTKD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045861,negative regulation of proteolysis,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens),CLN3,BP,1,1 of 62,0.04,1.61,0.1287,0.2165
GO:0038094,Fc-gamma receptor signaling pathway,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008274,gamma-tubulin ring complex,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens),CDK5RAP2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903542,negative regulation of exosomal secretion,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0036500,ATF6-mediated unfolded protein response,Q0III2(Evidence code:IBA/Database source:PANTHER:PTN000330398),MBTPS2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030432,peristalsis,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032567,dGTP binding,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060073,micturition,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens),KCNMA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017061,S-methyl-5-thioadenosine phosphorylase activity,Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR010044),MTAP,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048550,negative regulation of pinocytosis,E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens),PROM2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902775,mitochondrial large ribosomal subunit assembly,F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens),FASTKD2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043538,regulation of actin phosphorylation,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q12792|ens),TWF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030215,semaphorin receptor binding,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens),SEMA3E,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051902,negative regulation of mitochondrial depolarization,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000299,negative regulation of Rho-dependent protein serine/threonine kinase activity,Q29RL2(Evidence code:IEA/Database source:UniProtKB:Q9D1P4|ens),CHORDC1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050480,imidazolonepropionase activity,A5PJV3(Evidence code:IEA/Database source:EC:3.5.2.7),AMDHD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003978,UDP-glucose 4-epimerase activity,Q3T105(Evidence code:IEA/Database source:InterPro:IPR005886),GALE,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070676,intralumenal vesicle formation,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens),SNX3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072498,embryonic skeletal joint development,A5D7I4(Evidence code:IEA/Database source:UniProtKB:P97464|ens),EXT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004475,mannose-1-phosphate guanylyltransferase activity,Q2YDJ9(Evidence code:IEA/Database source:EC:2.7.7.13),GMPPB,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070180,large ribosomal subunit rRNA binding,Q3T057(Evidence code:IBA/Database source:PANTHER:PTN000205184),RPL23,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070602,regulation of centromeric sister chromatid cohesion,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000172,ribonuclease MRP complex,E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens),RPP25,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043203,axon hillock,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070262,peptidyl-serine dephosphorylation,F1MG56(Evidence code:IBA/Database source:PANTHER:PTN000221745),PPP2R2A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005743),PIK3CD,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0047006,"17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity",P16116(Evidence code:IEA/Database source:EC:1.1.1.149),AKR1B1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004820,glycine-tRNA ligase activity,A5D7A2(Evidence code:IEA/Database source:InterPro:IPR002315),GARS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006214,thymidine catabolic process,Q28007(Evidence code:ISS/Database source:UniProtKB:Q12882),DPYD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034465,response to carbon monoxide,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens),KCNMA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903298,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090188,negative regulation of pancreatic juice secretion,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens),WNK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003987,acetate-CoA ligase activity,A7YWF1(Evidence code:IEA/Database source:InterPro:IPR011904),ACSS2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043614,multi-eIF complex,P68102(Evidence code:IBA/Database source:PANTHER:PTN000063908),EIF2S1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903416,response to glycoside,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021554,optic nerve development,F1MHF3(Evidence code:IEA/Database source:UniProtKB:V9GX91|ens),NAV2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032361,pyridoxal phosphate catabolic process,Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:P60487),PDXP,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010940,positive regulation of necrotic cell death,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050910,detection of mechanical stimulus involved in sensory perception of sound,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002945,cyclin K-CDK13 complex,E1BB52(Evidence code:IEA/Database source:UniProtKB:Q14004|ens),CDK13,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030889,negative regulation of B cell proliferation,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005639,integral component of nuclear inner membrane,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR018996),LEMD3,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031314,extrinsic component of mitochondrial inner membrane,Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q8NC60),NOA1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003323,type B pancreatic cell development,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens),CDK6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071896,protein localization to adherens junction,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens),SCRIB,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001887,selenium compound metabolic process,E1BHE5(Evidence code:IEA/Database source:UniProtKB:P97364|ens),SEPHS2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990404,protein ADP-ribosylase activity,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004643,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,Q0VCK0(Evidence code:IEA/Database source:InterPro:IPR002695),ATIC,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034418,urate biosynthetic process,Q2HJ58(Evidence code:IEA/Database source:UniProtKB:P60891|ens),PRPS1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071879,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000386,second spliceosomal transesterification activity,A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558),PRPF8,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015867,ATP transport,P02722(Evidence code:IEA/Database source:GO:0005471),SLC25A4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010992,ubiquitin recycling,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016309,1-phosphatidylinositol-5-phosphate 4-kinase activity,Q0P5F7(Evidence code:IEA/Database source:EC:2.7.1.149),PIP4K2C,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035795,negative regulation of mitochondrial membrane permeability,E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens),HK2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903244,positive regulation of cardiac muscle hypertrophy in response to stress,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000156,"regulation of retrograde vesicle-mediated transport, Golgi to ER",A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens),RAB33B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004487,methylenetetrahydrofolate dehydrogenase (NAD+) activity,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019358,nicotinate nucleotide salvage,A5PK51(Evidence code:IEA/Database source:InterPro:IPR006405),NAPRT,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090326,positive regulation of locomotion involved in locomotory behavior,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071866,negative regulation of apoptotic process in bone marrow,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071688,striated muscle myosin thick filament assembly,Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569),MYBPC3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902953,positive regulation of ER to Golgi vesicle-mediated transport,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0047130,"saccharopine dehydrogenase (NADP+, L-lysine-forming) activity",A8E657(Evidence code:IEA/Database source:EC:1.5.1.8),AASS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004476,mannose-6-phosphate isomerase activity,Q3SZI0(Evidence code:IEA/Database source:InterPro:IPR001250|I),MPI,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005854,nascent polypeptide-associated complex,F1MGI0(Evidence code:IEA/Database source:InterPro:IPR016641),NACAD,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000984,negative regulation of ATP citrate synthase activity,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens),PHPT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens),PRKDC,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000293,ferric-chelate reductase activity,P10897(Evidence code:IEA/Database source:InterPro:IPR028837),CYB561,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003105,negative regulation of glomerular filtration,A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824),F2R,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005940,septin ring,Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q9R1T4|ens),SEPT6,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004483,mRNA (nucleoside-2-O-)-methyltransferase activity,G3MZP6(Evidence code:IEA/Database source:UniProtKB:Q8IYT2|ens),CMTR2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904378,maintenance of unfolded protein involved in ERAD pathway,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003205,cardiac chamber development,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030050,vesicle transport along actin filament,Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens),MYO1C,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051586,positive regulation of dopamine uptake involved in synaptic transmission,P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens),RAB3B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000964,mitochondrial RNA 5-end processing,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032000,positive regulation of fatty acid beta-oxidation,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens),IRS1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000798,nuclear cohesin complex,E1B9J3(Evidence code:IBA/Database source:PANTHER:PTN000286904),RAD21L1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019002,GMP binding,Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens),RAB26,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033878,hormone-sensitive lipase activity,P16386(Evidence code:IEA/Database source:EC:3.1.1.79),LIPE,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens),SRI,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043366,beta selection,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904247,positive regulation of polynucleotide adenylyltransferase activity,Q28165(Evidence code:IEA/Database source:InterPro:IPR034911),PABPN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008269,JAK pathway signal transduction adaptor activity,F1MRH8(Evidence code:IEA/Database source:UniProtKB:O14492|ens),SH2B2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050211,procollagen galactosyltransferase activity,A5PK45(Evidence code:IEA/Database source:EC:2.4.1.50),COLGALT1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034687,integrin alphaL-beta2 complex,P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens),ITGB2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000672,negative regulation of motor neuron apoptotic process,A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens),MAP2K4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003920,GMP reductase activity,Q32L93(Evidence code:IEA/Database source:InterPro:IPR005993),GMPR2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071787,endoplasmic reticulum tubular network formation,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q5T4F4),ZFYVE27,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004081,bis(5-nucleosyl)-tetraphosphatase (asymmetrical) activity,A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens),GARS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060698,endoribonuclease inhibitor activity,A4IFE6(Evidence code:IEA/Database source:UniProtKB:P61221|ens),ABCE1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902036,regulation of hematopoietic stem cell differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens),CDK6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005459,UDP-galactose transmembrane transporter activity,Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081293),SLC35B1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000256,positive regulation of male germ cell proliferation,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4),CIB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034353,RNA pyrophosphohydrolase activity,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348),DXO,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0036122,BMP binding,E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606),HFE2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010385,double-stranded methylated DNA binding,G3MYE7(Evidence code:IEA/Database source:InterPro:IPR017353),MECP2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004756,"selenide, water dikinase activity",E1BHE5(Evidence code:IEA/Database source:InterPro:IPR023061),SEPHS2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017057,6-phosphogluconolactonase activity,Q2TBQ8(Evidence code:IEA/Database source:InterPro:IPR005900),PGLS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048169,regulation of long-term neuronal synaptic plasticity,F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens),SYNGAP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097494,regulation of vesicle size,P10948(Evidence code:IEA/Database source:UniProtKB:P20337|ens),RAB3B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061591,calcium activated galactosylceramide scrambling,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033194,response to hydroperoxide,Q08DF2(Evidence code:ISS/Database source:UniProtKB:Q96DY5),RNF112,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004838,L-tyrosine:2-oxoglutarate aminotransferase activity,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005957|I),TAT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004767,sphingomyelin phosphodiesterase activity,A6QQN6(Evidence code:IEA/Database source:InterPro:IPR017064),SMPDL3B,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016476,regulation of embryonic cell shape,Q6Q137(Evidence code:ISS/Database source:UniProtKB:Q6GLZ5),SEPT7,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008432,JUN kinase binding,E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens),MAPK8IP3,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019483,beta-alanine biosynthetic process,Q28007(Evidence code:IEA/Database source:UniPathway:UPA00131),DPYD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0052852,very-long-chain-(S)-2-hydroxy-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003985,acetyl-CoA C-acetyltransferase activity,Q17QI3(Evidence code:IEA/Database source:UniProtKB:Q9BWD1|ens),ACAT2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042582,azurophil granule,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010265,SCF complex assembly,A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6),CAND1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000376,positive regulation of oxygen metabolic process,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005585,collagen type II trimer,P02459(Evidence code:IEA/Database source:UniProtKB:P02458|ens),COL2A1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000828,inositol hexakisphosphate kinase activity,F1MNG6(Evidence code:IEA/Database source:UniProtKB:Q6ZQB6|ens),PPIP5K2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060082,eye blink reflex,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071947,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,E1B9S7(Evidence code:IBA/Database source:PANTHER:PTN001001090),OTUD7B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034124,regulation of MyD88-dependent toll-like receptor signaling pathway,Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314),IRF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000049,positive regulation of cell-cell adhesion mediated by cadherin,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060463,lung lobe morphogenesis,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004618,phosphoglycerate kinase activity,Q32KN6(Evidence code:IEA/Database source:InterPro:IPR001576|I),PGK2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008559,xenobiotic transmembrane transporting ATPase activity,F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334),ABCC3,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071598,neuronal ribonucleoprotein granule,E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens),UHMK1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0018243,protein O-linked glycosylation via threonine,E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens),GALNT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0098967,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens),SNAP25,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019863,IgE binding,Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0389),FCER1G,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001771,immunological synapse formation,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0017151,DEAD/H-box RNA helicase binding,A7MB06(Evidence code:IEA/Database source:UniProtKB:Q8VI67|ens),SP7,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071466,cellular response to xenobiotic stimulus,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens),E2F1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000056,ribosomal small subunit export from nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens),XPO1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002554,serotonin secretion by platelet,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1905183,negative regulation of protein serine/threonine phosphatase activity,P05059(Evidence code:IDA/Database source:),CHGA,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2001287,negative regulation of caveolin-mediated endocytosis,E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens),PROM2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042043,neurexin family protein binding,A8KC68(Evidence code:IEA/Database source:InterPro:IPR000460|I),NLGN2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000627,positive regulation of miRNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor,P03968(Evidence code:IEA/Database source:UniProtKB:P05230|ens),FGF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004816,asparagine-tRNA ligase activity,Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR004522),NARS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003960,NADPH:quinone reductase activity,O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens),CRYZ,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030369,ICAM-3 receptor activity,P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens),ITGB2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048022,negative regulation of melanin biosynthetic process,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072144,glomerular mesangial cell development,Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens),GPR4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048485,sympathetic nervous system development,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831),SOX4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015879,carnitine transport,Q08DK7(Evidence code:ISS/Database source:UniProtKB:Q8N8R3),SLC25A29,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042491,inner ear auditory receptor cell differentiation,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901640,XTP binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032480,negative regulation of type I interferon production,Q0P568(Evidence code:IEA/Database source:UniProtKB:Q92890|ens),UFD1L,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004113,"2,3-cyclic-nucleotide 3-phosphodiesterase activity",P06623(Evidence code:IEA/Database source:InterPro:IPR008431),CNP,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061180,mammary gland epithelium development,F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens),ATP2C2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006589,octopamine biosynthetic process,P15101(Evidence code:IBA/Database source:PANTHER:PTN000806665),DBH,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0007084,mitotic nuclear envelope reassembly,E1BFD1(Evidence code:IEA/Database source:InterPro:IPR035007),ANKLE2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0038044,transforming growth factor-beta secretion,Q8SQB8(Evidence code:IEA/Database source:UniProtKB:Q9Z0T9|ens),ITGB6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031802,type 5 metabotropic glutamate receptor binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046884,follicle-stimulating hormone secretion,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens),TBX3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0097726,LEM domain binding,P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens),BANF1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0018125,peptidyl-cysteine methylation,P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens),RAB3B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000617,positive regulation of histone H3-K9 acetylation,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000320,negative regulation of T-helper 17 cell differentiation,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090191,negative regulation of branching involved in ureteric bud morphogenesis,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens),TACSTD2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990791,dorsal root ganglion development,E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens),POU4F2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1990051,activation of protein kinase C activity,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens),ABL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005161,platelet-derived growth factor receptor binding,E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817),PDGFC,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061179,negative regulation of insulin secretion involved in cellular response to glucose stimulus,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0052651,monoacylglycerol catabolic process,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q8N2K0|ens),ABHD12,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000331,regulation of terminal button organization,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901874,negative regulation of post-translational protein modification,E1BJ75(Evidence code:IEA/Database source:UniProtKB:O75718|ens),CRTAP,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072757,cellular response to camptothecin,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0044194,cytolytic granule,Q05204(Evidence code:IEA/Database source:UniProtKB:P11438|ens),LAMP1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015227,acyl carnitine transmembrane transporter activity,Q08DK7(Evidence code:IBA/Database source:PANTHER:PTN002377726),SLC25A29,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000983,"transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding",E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046061,dATP catabolic process,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0044609,DBIRD complex,E1B9H3(Evidence code:IEA/Database source:InterPro:IPR028811),CCAR2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031931,TORC1 complex,F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens),TTI1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004143,diacylglycerol kinase activity,E1BGA9(Evidence code:IEA/Database source:InterPro:IPR000756|I),DGKQ,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008476,protein-tyrosine sulfotransferase activity,Q3SYY2(Evidence code:IEA/Database source:InterPro:IPR026634),TPST2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061501,cyclic-GMP-AMP synthase activity,E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8C6L5),MB21D1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902544,regulation of DNA N-glycosylase activity,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070187,shelterin complex,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003708,retinoic acid receptor activity,E1BC39(Evidence code:IEA/Database source:InterPro:IPR003078),ESRRG,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:2001045,negative regulation of integrin-mediated signaling pathway,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7),PHACTR4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003149,membranous septum morphogenesis,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens),FZD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006660,phosphatidylserine catabolic process,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q99LR1|ens),ABHD12,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071955,recycling endosome to Golgi transport,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens),GCC2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004016,adenylate cyclase activity,Q29450(Evidence code:ISS/Database source:UniProtKB:P51828),ADCY7,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006404,RNA import into nucleus,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens),TPR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000829,inositol heptakisphosphate kinase activity,F1MNG6(Evidence code:IEA/Database source:InterPro:IPR037446),PPIP5K2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000670,positive regulation of dendritic cell apoptotic process,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051684,maintenance of Golgi location,F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens),ARHGAP21,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904027,negative regulation of collagen fibril organization,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042536,negative regulation of tumor necrosis factor biosynthetic process,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048703,embryonic viscerocranium morphogenesis,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens),NIPBL,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006930,"substrate-dependent cell migration, cell extension",Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens),CTTN,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071987,WD40-repeat domain binding,Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q99459),CDC5L,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090383,phagosome acidification,G3X7D3(Evidence code:IEA/Database source:UniProtKB:Q14964|ens),RAB39A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060083,smooth muscle contraction involved in micturition,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens),KCNMA1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902367,negative regulation of Notch signaling pathway involved in somitogenesis,Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010),LFNG,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048638,regulation of developmental growth,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens),NIPBL,BP,1,1 of 61,0.04,1.64,0.128,0.2165
GO:0048729,tissue morphogenesis,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 61,0.04,1.64,0.128,0.2165
GO:0047757,chondroitin-glucuronate 5-epimerase activity,F1ME12(Evidence code:IEA/Database source:UniProtKB:Q0VBN2|ens),DSEL,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060033,anatomical structure regression,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001805,positive regulation of type III hypersensitivity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045226,extracellular polysaccharide biosynthetic process,O97711(Evidence code:ISS/Database source:UniProtKB:P70312),HAS2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031531,thyrotropin-releasing hormone receptor binding,P62194(Evidence code:ISS/Database source:UniProtKB:P62195),PSMC5,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042796,snRNA transcription by RNA polymerase III,E1BCK9(Evidence code:IEA/Database source:UniProtKB:Q5SXM2|ens),SNAPC4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042309,homoiothermy,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043622,cortical microtubule organization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0038109,Kit signaling pathway,P43481(Evidence code:IEA/Database source:InterPro:IPR027263),KIT,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043570,maintenance of DNA repeat elements,G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens),AXIN2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021903,rostrocaudal neural tube patterning,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060352,cell adhesion molecule production,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens),GOLPH3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033634,positive regulation of cell-cell adhesion mediated by integrin,F1MD64(Evidence code:IEA/Database source:UniProtKB:Q92508|ens),PIEZO1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033596,TSC1-TSC2 complex,E1BNT2(Evidence code:IEA/Database source:InterPro:IPR003913),TSC2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060681,branch elongation involved in ureteric bud branching,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0014807,regulation of somitogenesis,Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens),LFNG,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032835,glomerulus development,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0018467,formaldehyde dehydrogenase activity,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P11766|ens),ADH5,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071397,cellular response to cholesterol,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens),LRP6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050265,RNA uridylyltransferase activity,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens),ZCCHC6,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004018,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity",A3KN12(Evidence code:IEA/Database source:InterPro:IPR004769),ADSL,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1900134,negative regulation of renin secretion into blood stream,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558),F2R,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071504,cellular response to heparin,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051344,negative regulation of cyclic-nucleotide phosphodiesterase activity,P04695(Evidence code:IDA/Database source:),GNAT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034272,"phosphatidylinositol 3-kinase complex, class III, type II",A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043296,apical junction complex,G3N2N2(Evidence code:IEA/Database source:UniProtKB:Q86UD0|ens),SAPCD2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008124,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,Q3ZBD3(Evidence code:IEA/Database source:InterPro:IPR001533|I),PCBD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051160,L-xylitol catabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q00796|ens),SORD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004753,saccharopine dehydrogenase activity,A8E657(Evidence code:IBA/Database source:PANTHER:PTN000875283),AASS,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034750,Scrib-APC-beta-catenin complex,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens),SCRIB,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004594,pantothenate kinase activity,A4FV09(Evidence code:IEA/Database source:InterPro:IPR004567|I),PANK4,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006060,sorbitol metabolic process,Q58D31(Evidence code:IEA/Database source:UniProtKB:Q64442|ens),SORD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004637,phosphoribosylamine-glycine ligase activity,Q59A32(Evidence code:IEA/Database source:InterPro:IPR000115|I),GART,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061670,evoked neurotransmitter secretion,P11023(Evidence code:IEA/Database source:UniProtKB:P63011|ens),RAB3A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035971,peptidyl-histidine dephosphorylation,Q32PA4(Evidence code:IEA/Database source:InterPro:IPR028441),PHPT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046655,folic acid metabolic process,Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q8C1A3),MTRR,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1900112,regulation of histone H3-K9 trimethylation,F1MQ85(Evidence code:IEA/Database source:UniProtKB:P46100|ens),ATRX,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904970,brush border assembly,F1MLR9(Evidence code:IEA/Database source:UniProtKB:Q6PIF6|ens),MYO7B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0001812,positive regulation of type I hypersensitivity,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006212,uracil catabolic process,Q28007(Evidence code:ISS/Database source:UniProtKB:Q12882),DPYD,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042780,tRNA 3-end processing,P10881(Evidence code:IEA/Database source:UniProtKB:P05455|ens),SSB,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032809,neuronal cell body membrane,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:1905168,positive regulation of double-strand break repair via homologous recombination,E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76),MMS19,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002237,response to molecule of bacterial origin,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens),MALT1,BP,1,1 of 62,0.04,1.61,0.1287,0.2165
GO:0035517,PR-DUB complex,F1N4U8(Evidence code:IEA/Database source:UniProtKB:Q8IXJ9|ens),ASXL1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005169,neurotrophin TRKB receptor binding,Q95106(Evidence code:IBA/Database source:PANTHER:PTN000173552),BDNF,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006452,translational frameshifting,F1MN49(Evidence code:IEA/Database source:InterPro:IPR019769|I),EIF5A2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003952,NAD+ synthase (glutamine-hydrolyzing) activity,Q3ZBF0(Evidence code:IEA/Database source:InterPro:IPR003694|I),NADSYN1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071440,regulation of histone H3-K14 acetylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002674,negative regulation of acute inflammatory response,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030870,Mre11 complex,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008963,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,Q5EA65(Evidence code:IEA/Database source:InterPro:IPR000715),DPAGT1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0098623,selenite reductase activity,O62768(Evidence code:TAS/Database source:),TXNRD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072584,caveolin-mediated endocytosis,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9UNF0|ens),PACSIN2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021521,ventral spinal cord interneuron specification,F1MIK5(Evidence code:IEA/Database source:UniProtKB:P53783|ens),SOX1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0038089,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens),MYO1C,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009404,toxin metabolic process,Q2YDM1(Evidence code:ISS/Database source:UniProtKB:P40616),ARL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002371,dendritic cell cytokine production,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0035021,negative regulation of Rac protein signal transduction,E1BBA0(Evidence code:IEA/Database source:UniProtKB:Q8R5G7|ens),ARAP3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004332,fructose-bisphosphate aldolase activity,Q3T0S5(Evidence code:IEA/Database source:InterPro:IPR000741),ALDOB,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0052565,response to defense-related host nitric oxide production,A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q9ERL9|ens),GUCY1A3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004844,uracil DNA N-glycosylase activity,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009008,DNA-methyltransferase activity,Q7YRV8(Evidence code:IEA/Database source:InterPro:IPR030487),DNMT3A,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1900426,positive regulation of defense response to bacterium,F1MP30(Evidence code:IEA/Database source:UniProtKB:Q9Z1N9|ens),UNC13B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061053,somite development,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1905907,negative regulation of amyloid fibril formation,P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens),CRYAB,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070728,leucine binding,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q8IWV8|ens),UBR2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070093,negative regulation of glucagon secretion,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN001030516),CRH,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0016077,snoRNA catabolic process,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903764,regulation of potassium ion export across plasma membrane,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004109,coproporphyrinogen oxidase activity,E1BKY9(Evidence code:IEA/Database source:InterPro:IPR001260|I),CPOX,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042633,hair cycle,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304),SNRPE,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000465,regulation of glycogen (starch) synthase activity,E1BHP3(Evidence code:IEA/Database source:UniProtKB:Q6ZSY5|ens),PPP1R3F,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042178,xenobiotic catabolic process,O97764(Evidence code:IEA/Database source:UniProtKB:Q08257|ens),CRYZ,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045905,positive regulation of translational termination,F1MN49(Evidence code:IEA/Database source:InterPro:IPR019769|I),EIF5A2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004329,formate-tetrahydrofolate ligase activity,A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000559),MTHFD1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903644,regulation of chaperone-mediated protein folding,Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens),DNAJB2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061744,motor behavior,F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens),ADARB1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0102084,L-dopa O-methyltransferase activity,A7MBI7(Evidence code:IEA/Database source:EC:2.1.1.6),COMT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0007529,establishment of synaptic specificity at neuromuscular junction,A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824),F2R,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903147,negative regulation of autophagy of mitochondrion,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072334,UDP-galactose transmembrane transport,Q8MII5(Evidence code:IBA/Database source:PANTHER:PTN000081293),SLC35B1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0047939,L-glucuronate reductase activity,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010256,endomembrane system organization,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060080,inhibitory postsynaptic potential,E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens),ADORA2A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904706,negative regulation of vascular smooth muscle cell proliferation,A4IFD1(Evidence code:IEA/Database source:UniProtKB:Q53EL6|ens),PDCD4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004031,aldehyde oxidase activity,P48034(Evidence code:IEA/Database source:EC:1.2.3.1),AOX1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904692,positive regulation of type B pancreatic cell proliferation,P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens),PTPRN,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0047105,4-trimethylammoniobutyraldehyde dehydrogenase activity,Q2KJH9(Evidence code:IEA/Database source:EC:1.2.1.47),ALDH9A1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903724,positive regulation of centriole elongation,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070695,FHF complex,A7YY62(Evidence code:ISS/Database source:UniProtKB:Q8N612),FAM160A2,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904628,cellular response to phorbol 13-acetate 12-myristate,E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens),ADAM15,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901187,regulation of ephrin receptor signaling pathway,F1MHL2(Evidence code:IEA/Database source:InterPro:IPR033637),ANKS1A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0032767,copper-dependent protein binding,Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O00244|ens),ATOX1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004046,aminoacylase activity,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070981,L-asparagine biosynthetic process,Q1LZA3(Evidence code:IEA/Database source:UniPathway:UPA00134),ASNS,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006776,vitamin A metabolic process,P02694(Evidence code:IEA/Database source:InterPro:IPR031264),RBP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000215,tRNA 2-phosphotransferase activity,Q3ZBM7(Evidence code:IEA/Database source:EC:2.7.1.160),TRPT1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:1901074,regulation of engulfment of apoptotic cell,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002455,humoral immune response mediated by circulating immunoglobulin,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046870,cadmium ion binding,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",E1BML0(Evidence code:IEA/Database source:UniRule:UR000166126),PAN2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070820,tertiary granule,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0045295,gamma-catenin binding,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006285,"base-excision repair, AP site formation",A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006968,cellular defense response,E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens),RAB23,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005955,calcineurin complex,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010593,negative regulation of lamellipodium assembly,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019346,transsulfuration,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071630,nuclear protein quality control by the ubiquitin-proteasome system,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0007158,neuron cell-cell adhesion,F1MLR3(Evidence code:IEA/Database source:UniProtKB:Q61137|ens),ASTN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0010666,positive regulation of cardiac muscle cell apoptotic process,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens),CAMK2A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0047127,thiomorpholine-carboxylate dehydrogenase activity,Q2KHX6(Evidence code:IEA/Database source:EC:1.5.1.25),CRYM,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009386,translational attenuation,Q2TBI4(Evidence code:IEA/Database source:UniProtKB:Q12931|ens),TRAP1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050798,activated T cell proliferation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1902262,apoptotic process involved in blood vessel morphogenesis,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005638,lamin filament,Q9TU47(Evidence code:IEA/Database source:UniProtKB:O55135|ens),EIF6,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:2000791,negative regulation of mesenchymal cell proliferation involved in lung development,F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens),PHF14,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0042769,"DNA damage response, detection of DNA damage",Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945),SOX4,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034983,peptidyl-lysine deacetylation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070973,protein localization to endoplasmic reticulum exit site,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens),BCAP31,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0090658,cone matrix sheath,P12661(Evidence code:IBA/Database source:PANTHER:PTN000137261),RBP3,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0031630,regulation of synaptic vesicle fusion to presynaptic active zone membrane,P11023(Evidence code:ISS/Database source:UniProtKB:P63011),RAB3A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0072393,microtubule anchoring at microtubule organizing center,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q921C5|ens),BICD2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060711,labyrinthine layer development,E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens),BIRC6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033235,positive regulation of protein sumoylation,Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens),PIAS1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0030853,negative regulation of granulocyte differentiation,Q1RMH5(Evidence code:IEA/Database source:UniProtKB:P02747|ens),C1QC,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0008043,intracellular ferritin complex,O46415(Evidence code:ISS/Database source:UniProtKB:P02792),FTL,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:0015234,thiamine transmembrane transporter activity,E1BLU2(Evidence code:IEA/Database source:UniProtKB:O60779|ens),SLC19A2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004615,phosphomannomutase activity,Q3SZJ9(Evidence code:IEA/Database source:InterPro:IPR005002),PMM2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060290,transdifferentiation,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101),INSM1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021517,ventral spinal cord development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002924,negative regulation of humoral immune response mediated by circulating immunoglobulin,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0038095,Fc-epsilon receptor signaling pathway,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P30273|ens),FCER1G,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0009257,10-formyltetrahydrofolate biosynthetic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens),MTHFD1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903286,regulation of potassium ion import,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003973,(S)-2-hydroxy-acid oxidase activity,Q3ZBW2(Evidence code:IEA/Database source:EC:1.1.3.15),HAO2,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0034595,phosphatidylinositol phosphate 5-phosphatase activity,O18964(Evidence code:IEA/Database source:InterPro:IPR034972),SYNJ1,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0060478,acrosomal vesicle exocytosis,E1BGL9(Evidence code:IEA/Database source:UniProtKB:Q5T7P8|ens),SYT6,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006489,dolichyl diphosphate biosynthetic process,Q5EA65(Evidence code:IBA/Database source:PANTHER:PTN000060284),DPAGT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903358,regulation of Golgi organization,A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens),RAB33B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0048935,peripheral nervous system neuron development,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens),ONECUT2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070611,histone methyltransferase activity (H3-R2 specific),Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0033227,dsRNA transport,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0043651,linoleic acid metabolic process,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O35936|ens),ALOX15B,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070776,MOZ/MORF histone acetyltransferase complex,G3N0D9(Evidence code:IEA/Database source:UniProtKB:O95696|ens),BRD1,CC,1,1 of 1,0.04,100,0.1313,0.2165
GO:1903818,positive regulation of voltage-gated potassium channel activity,G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens),LRRC26,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0050861,positive regulation of B cell receptor signaling pathway,P05126(Evidence code:ISS/Database source:UniProtKB:P68404),PRKCB,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1904797,negative regulation of core promoter binding,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071361,cellular response to ethanol,Q29450(Evidence code:ISS/Database source:UniProtKB:P51828),ADCY7,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0019511,peptidyl-proline hydroxylation,Q3SYY3(Evidence code:IEA/Database source:GO:0004656),P4HA2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0021513,spinal cord dorsal/ventral patterning,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0046959,habituation,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0051968,"positive regulation of synaptic transmission, glutamatergic",E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens),SHANK2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0006344,maintenance of chromatin silencing,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0061015,snRNA import into nucleus,Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826),RAN,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:1905205,positive regulation of connective tissue replacement,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0002528,regulation of vascular permeability involved in acute inflammatory response,E1BMP3(Evidence code:IEA/Database source:UniProtKB:Q32MK0|ens),MYLK3,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070150,mitochondrial glycyl-tRNA aminoacylation,A5D7A2(Evidence code:IBA/Database source:PANTHER:PTN000078675),GARS,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0004757,sepiapterin reductase activity,Q17QK8(Evidence code:IEA/Database source:InterPro:IPR006393),SPR,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005247,voltage-gated chloride channel activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens),ANO6,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071442,positive regulation of histone H3-K14 acetylation,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0070092,regulation of glucagon secretion,E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q8CEE6|ens),PASK,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0003886,DNA (cytosine-5-)-methyltransferase activity,Q7YRV8(Evidence code:ISS/Database source:UniProtKB:Q9Y6K1),DNMT3A,MF,1,1 of 1,0.04,100,0.1313,0.2165
GO:0071500,cellular response to nitrosative stress,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 1,0.04,100,0.1313,0.2165
GO:0005261,cation channel activity,F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131),PIEZO1,MF,1,1 of 64,0.04,1.56,0.1314,0.2166
GO:0043086,negative regulation of catalytic activity,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)F1MYQ7(Evidence code:IEA/Database source:GO:0004857)Q2KJ77(Evidence code:IEA/Database source:GO:0004857)A7MBJ5(Evidence code:IEA/Database source:UniProtKB:Q86VP6|ens), CLN3 CCAR2 FRY HSPBP1 CAND1,BP,5,5 of 137,0.21,3.65,0.1333,0.2197
GO:0004518,nuclease activity,E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q0II50(Evidence code:IEA/Database source:InterPro:IPR027521)Q08DM8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q6TUI4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)F1MGC2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)Q2QDE9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540)A5PJT8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0540), PAN2 USB1 TSN DICER1 DXO DDX1 RNASE2 AGO3 DNASE1L1 DNASE1L2,MF,10,10 of 79,0.42,12.66,0.1336,0.22
GO:0030295,protein kinase activator activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q1JPD9(Evidence code:IEA/Database source:UniProtKB:Q9NZH0|ens)E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens), MT3 GPRC5B WNK1,MF,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:0033141,positive regulation of peptidyl-serine phosphorylation of STAT protein,P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053)G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053), IFNT2 LOC104968438 IFNT3,BP,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:0006289,nucleotide-excision repair,A6QLJ0(Evidence code:IEA/Database source:InterPro:IPR001945)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR004806|I), ERCC2 BRCA2 RAD23B,BP,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:1901216,positive regulation of neuron death,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)P68102(Evidence code:IEA/Database source:UniProtKB:P05198|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), ABL1 EIF2S1 PRNP,BP,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:0007041,lysosomal transport,E1BDC9(Evidence code:IEA/Database source:UniProtKB:Q8N1B4|ens)Q3ZC25(Evidence code:IEA/Database source:UniProtKB:Q80X71|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens), VPS52 TMEM106B NEDD4,BP,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:0017022,myosin binding,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q923J1|ens), GIPC1 MYBPC3 TRPM7,MF,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:0010508,positive regulation of autophagy,Q3T0Q2(Evidence code:ISS/Database source:UniProtKB:Q9BXS4)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens), TMEM59 LRRK2 SH3BP4,BP,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:0007612,learning,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BA03(Evidence code:IEA/Database source:UniProtKB:Q3ULB5|ens), RGS14 SHANK2 PAK6,BP,3,3 of 16,0.13,18.75,0.1349,0.2217
GO:0071902,positive regulation of protein serine/threonine kinase activity,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)P67774(Evidence code:IEA/Database source:UniProtKB:P67775|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MJW4(Evidence code:IEA/Database source:GO:0043539)Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74)E1BB92(Evidence code:IEA/Database source:UniProtKB:P56279|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), CIB1 DAB2IP PPP2CA PDCD10 FAM20A ETAA1 TCL1A SRC,BP,8,8 of 59,0.34,13.56,0.1362,0.2237
GO:0030100,regulation of endocytosis,E1BK71(Evidence code:IBA/Database source:PANTHER:PTN000860688)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)Q2TBH7(Evidence code:IEA/Database source:UniProtKB:P56371|ens)F1N7V2(Evidence code:IBA/Database source:PANTHER:PTN001179601)A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens)Q1RMR9(Evidence code:IBA/Database source:PANTHER:PTN000860688), PACSIN3 SNX12 RAB4A RAB17 SYT4 PACSIN2,BP,6,6 of 42,0.25,14.29,0.1393,0.2288
GO:0043235,receptor complex,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)E1BLE8(Evidence code:IEA/Database source:UniProtKB:Q14831|ens)E1BPA0(Evidence code:IEA/Database source:UniProtKB:P18433|ens)F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056261)Q8SQB8(Evidence code:IEA/Database source:UniProtKB:P18564|ens), ITGB7 KCTD16 TAOK2 ITGB2 GRM7 PTPRA LRP6 ITGB6,CC,8,8 of 61,0.34,13.11,0.1422,0.2336
GO:0004527,exonuclease activity,Q5E9Y5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0269)Q0IIK5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0269)E1BML0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0269)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens), DXO DDX1 PAN2 WRN,MF,4,4 of 26,0.17,15.38,0.1435,0.2343
GO:0004869,cysteine-type endopeptidase inhibitor activity,Q9BGU1(Evidence code:IEA/Database source:InterPro:IPR000010)Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q08629)P20811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0789)E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens), BTHRG SPOCK1 CAST BIRC6,MF,4,4 of 26,0.17,15.38,0.1435,0.2343
GO:0048026,"positive regulation of mRNA splicing, via spliceosome",Q08E07(Evidence code:ISS/Database source:UniProtKB:Q5SZQ8)Q1RMR2(Evidence code:IEA/Database source:UniProtKB:Q62376|ens), CELF3 SNRNP70,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0005687,U4 snRNP,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304)Q17QN3(Evidence code:IBA/Database source:PANTHER:PTN000075760), SNRPE SNRPN,CC,2,2 of 8,0.08,25,0.1445,0.2343
GO:0060612,adipose tissue development,A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens), SPG20 ZNF516,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0061337,cardiac conduction,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens), TRPM4 SPTBN4,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0033179,"proton-transporting V-type ATPase, V0 domain",P61420(Evidence code:IEA/Database source:InterPro:IPR016727)P23956(Evidence code:IEA/Database source:InterPro:IPR000245|I), ATP6V0D1 ATP6V0C,CC,2,2 of 8,0.08,25,0.1445,0.2343
GO:0055010,ventricular cardiac muscle tissue morphogenesis,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens), MYBPC3 MYL3,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0051894,positive regulation of focal adhesion assembly,P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), S100A10 ABL1,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0019239,deaminase activity,E1BA23(Evidence code:IEA/Database source:InterPro:IPR001365)F1N088(Evidence code:IBA/Database source:PANTHER:PTN000118214), AMPD3 RPUSD2,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:0006826,iron ion transport,O46414(Evidence code:IEA/Database source:InterPro:IPR001519)O46415(Evidence code:IEA/Database source:InterPro:IPR001519), FTH1 FTL,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0030488,tRNA methylation,A5D7S3(Evidence code:IEA/Database source:GO:0004809)A1A4K2(Evidence code:IEA/Database source:GO:0016428), TRMT1L NSUN2,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0001974,blood vessel remodeling,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), DBH CHD7,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0009072,aromatic amino acid family metabolic process,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005957)Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR001273|I), TAT PAH,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0000993,RNA polymerase II complex binding,E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens), IKBKAP CCAR2,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:0006739,NADP metabolic process,A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens), GCK G6PD,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0001891,phagocytic cup,A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)A6QLJ4(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), DNM2 CDC42SE2,CC,2,2 of 8,0.08,25,0.1445,0.2343
GO:0071985,multivesicular body sorting pathway,Q08DR7(Evidence code:IEA/Database source:InterPro:IPR016689)Q5E9A6(Evidence code:IEA/Database source:InterPro:IPR008570), SNF8 VPS25,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0046626,regulation of insulin receptor signaling pathway,F1MXR0(Evidence code:IEA/Database source:InterPro:IPR030060)E1BH09(Evidence code:IEA/Database source:UniProtKB:Q5GFL6|ens), BAIAP2L1 VWA2,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0004402,histone acetyltransferase activity,F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens), NCOA3 TAF10,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:0045776,negative regulation of blood pressure,G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164305)Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453988), RNPEP NOS2,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0004550,nucleoside diphosphate kinase activity,A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), NME3 NME1,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:0019825,oxygen binding,F1MP20(Evidence code:IEA/Database source:InterPro:IPR012292)E1BEL8(Evidence code:IEA/Database source:InterPro:IPR012292), ADGB HBE1,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:2000114,regulation of establishment of cell polarity,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6), RICTOR ARFGEF1,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0003756,protein disulfide isomerase activity,E1BBS6(Evidence code:IBA/Database source:PANTHER:PTN000528008)A4FUW8(Evidence code:IBA/Database source:PANTHER:PTN000432607), QSOX2 TXNDC11,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:0002726,positive regulation of T cell cytokine production,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens), TRAF6 MALT1,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0030687,"preribosome, large subunit precursor",Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061)E1BC24(Evidence code:IBA/Database source:PANTHER:PTN000529705), EIF6 MDN1,CC,2,2 of 8,0.08,25,0.1445,0.2343
GO:0030017,sarcomere,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens)P68138(Evidence code:IEA/Database source:UniProtKB:P68133|ens), MYBPC3 ACTA1,CC,2,2 of 8,0.08,25,0.1445,0.2343
GO:0000400,four-way junction DNA binding,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens), WRN BLM,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:0017156,calcium ion regulated exocytosis,E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)Q28046(Evidence code:IDA/Database source:), RAPGEF4 SCIN,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0010543,regulation of platelet activation,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens)F1MSH3(Evidence code:IEA/Database source:UniProtKB:P42680|ens), FCER1G TEC,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0097110,scaffold protein binding,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), PDE4D SRC,MF,2,2 of 8,0.08,25,0.1445,0.2343
GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)P04896(Evidence code:ISS/Database source:UniProtKB:P63092), RAPGEF2 GNAS,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0046686,response to cadmium ion,A7YY70(Evidence code:IEA/Database source:UniProtKB:Q06495|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens), SLC34A1 MAPK9,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0070849,response to epidermal growth factor,P46196(Evidence code:ISS/Database source:UniProtKB:P28482)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), MAPK1 TPR,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0001658,branching involved in ureteric bud morphogenesis,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), GREB1L DLG1,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0072546,ER membrane protein complex,A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4)Q3ZCB8(Evidence code:ISS/Database source:UniProtKB:Q9P0I2), EMC10 EMC3,CC,2,2 of 8,0.08,25,0.1445,0.2343
GO:0045668,negative regulation of osteoblast differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens), CDK6 AXIN2,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:1903393,positive regulation of adherens junction organization,E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens), PTPN23 ARF6,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0045672,positive regulation of osteoclast differentiation,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens), TRAF6 POU4F2,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0060998,regulation of dendritic spine development,F1MFI5(Evidence code:IEA/Database source:UniProtKB:Q3UH53|ens)G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens), SDK1 ARF6,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0046326,positive regulation of glucose import,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens), IRS1 PRKCI,BP,2,2 of 8,0.08,25,0.1445,0.2343
GO:0017157,regulation of exocytosis,P10948(Evidence code:IEA/Database source:UniProtKB:Q9CZT8|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens)Q29RR0(Evidence code:ISS/Database source:UniProtKB:P51156)P10949(Evidence code:IEA/Database source:UniProtKB:P62823|ens)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635132), RAB3B RAB3A RAPGEF4 RAB26 RAB3C RAB37,BP,6,6 of 43,0.25,13.95,0.1451,0.2351
GO:0004867,serine-type endopeptidase inhibitor activity,E1BCA5(Evidence code:IEA/Database source:UniProtKB:Q99574|ens)A6QPK7(Evidence code:IEA/Database source:InterPro:IPR002223|I)G3X894(Evidence code:IBA/Database source:PANTHER:PTN000156122)F1N226(Evidence code:IEA/Database source:InterPro:IPR002223|I)G8JKW7(Evidence code:IBA/Database source:PANTHER:PTN000156122)E1B7H2(Evidence code:IEA/Database source:InterPro:IPR002223|I), SERPINI1 PTI LOC786263 APLP2 SERPINA3 COL7A1,MF,6,6 of 43,0.25,13.95,0.1451,0.2351
GO:0030001,metal ion transport,Q3T0E0(Evidence code:IEA/Database source:InterPro:IPR006121|I)F1MKI1(Evidence code:IEA/Database source:InterPro:IPR006121|I)G3MYG6(Evidence code:IEA/Database source:InterPro:IPR003689)A7MBI9(Evidence code:IEA/Database source:InterPro:IPR001046), ATOX1 ATP7B SLC39A6 SLC11A2,BP,4,4 of 117,0.17,3.42,0.1475,0.2389
GO:0007602,phototransduction,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)P04696(Evidence code:IEA/Database source:UniProtKB:P50149|ens)P47803(Evidence code:IEA/Database source:InterPro:IPR001793), GNAT1 GNAT2 RGR,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0030522,intracellular receptor signaling pathway,F1MVD0(Evidence code:IBA/Database source:PANTHER:PTN000074430)A2VDU4(Evidence code:IEA/Database source:GO:0004879)F1N3S3(Evidence code:IEA/Database source:GO:0004879), NCOA3 NR1I2 NR2F6,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0050905,neuromuscular process,F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8R1X6|ens)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens), AGTPBP1 SPG20 AARS,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0001938,positive regulation of endothelial cell proliferation,A1A4M2(Evidence code:ISS/Database source:UniProtKB:Q5UCC4)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q969H8), EMC10 PDCD6 MYDGF,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0046427,positive regulation of JAK-STAT cascade,E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116), AGAP2 KIT F2R,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0030837,negative regulation of actin filament polymerization,Q56JV6(Evidence code:IEA/Database source:InterPro:IPR028458)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens)O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6), TWF1 SLIT2 ARFGEF1,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0009100,glycoprotein metabolic process,E1BI49(Evidence code:IEA/Database source:UniProtKB:P39098|ens)F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens)F1MCT1(Evidence code:IEA/Database source:UniProtKB:P29122|ens), MAN1A2 ST8SIA3 PCSK6,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0006406,mRNA export from nucleus,F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens)E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280)Q0II93(Evidence code:IEA/Database source:InterPro:IPR015245|I), NUP214 SMG6 NXF3,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0048705,skeletal system morphogenesis,A4FUD7(Evidence code:IEA/Database source:UniProtKB:Q9H082|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), RAB33B COL2A1 PSEN1,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0006693,prostaglandin metabolic process,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0644)Q32L99(Evidence code:IEA/Database source:InterPro:IPR037399)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0644), PTGES3 PTGR2 FAM213B,BP,3,3 of 17,0.13,17.65,0.1511,0.244
GO:0007204,positive regulation of cytosolic calcium ion concentration,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752)P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens), F2R C5AR1 FKBP1B BCAP31 ABL1 FIS1,BP,6,6 of 44,0.25,13.64,0.1515,0.2444
GO:0008277,regulation of G-protein coupled receptor protein signaling pathway,A7Z056(Evidence code:ISS/Database source:UniProtKB:Q9Y2K6)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR037881)P63171(Evidence code:ISS/Database source:UniProtKB:P51807)E1B905(Evidence code:IEA/Database source:UniProtKB:Q5DTY9|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)A6QNV8(Evidence code:IEA/Database source:InterPro:IPR030409), USP20 RGS14 DYNLT1 KCTD16 DGKQ RGS1,BP,6,6 of 44,0.25,13.64,0.1515,0.2444
GO:0006633,fatty acid biosynthetic process,Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)Q5BIS9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)Q32PF2(Evidence code:IBA/Database source:PANTHER:PTN000563493)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0275), FAM213B PRKAB1 PTGES3 ACLY BRCA1 PRKAG1,BP,6,6 of 44,0.25,13.64,0.1515,0.2444
GO:0006631,fatty acid metabolic process,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q5BIS9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)P48818(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q3MHR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0276)Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I), PTGES3 PRKAG1 BRCA1 CPT1B PRKAB1 FAM213B ACADVL ALOX15 LYPLA1 CRYL1,BP,10,10 of 86,0.42,11.63,0.1544,0.249
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)P23709(Evidence code:ISS/Database source:UniProtKB:O75489), PINK1 FIGNL1 SRC NDUFS3,BP,4,4 of 27,0.17,14.81,0.1564,0.2522
GO:0016197,endosomal transport,A4IFN6(Evidence code:IEA/Database source:UniProtKB:Q96RF0|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)A5PKA5(Evidence code:IEA/Database source:InterPro:IPR028667)E1B958(Evidence code:IEA/Database source:InterPro:IPR028781)F1MZR9(Evidence code:IEA/Database source:UniProtKB:O43299|ens)Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens), SNX18 ABCA1 SNX27 ALMS1 AP5Z1 VPS4B SNX33 ANKFY1,BP,8,8 of 66,0.34,12.12,0.1638,0.264
GO:0010608,posttranscriptional regulation of gene expression,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8NHU6)E1BP22(Evidence code:IEA/Database source:InterPro:IPR032670), PUM1 TDRD7 RC3H2,BP,3,3 of 100,0.13,3,0.1647,0.2654
GO:0010628,positive regulation of gene expression,Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713)F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O54915|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens)E1BAW2(Evidence code:IEA/Database source:UniProtKB:G3XA59|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens)P68138(Evidence code:ISS/Database source:UniProtKB:P08023)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q64261|ens)F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)G3MYR6(Evidence code:IEA/Database source:UniProtKB:P21952|ens)E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)E1BE66(Evidence code:IEA/Database source:UniProtKB:O00329|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens)Q5BIS9(Evidence code:IEA/Database source:UniProtKB:Q9Y478|ens)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), SNF8 MT3 RPS6KA2 VPS35 NR1I2 SP1 LEF1 PDCD10 TERF2 NCOA3 LRRC32 E2F1 MYLK2 ACTA1 DDX58 CDK6 CUX2 EMILIN1 PPP3CA MAPK9 POU3F1 ETV2 BRAF SOX17 PIK3CD KIT GSK3A MAPK11 PRKAB1 HCFC1 DGKQ,BP,31,31 of 331,1.32,9.37,0.1735,0.2671
GO:0044877,protein-containing complex binding,A5D7H2(Evidence code:IEA/Database source:UniProtKB:Q13033|ens)E1BPU3(Evidence code:IEA/Database source:UniProtKB:O43933|ens)F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q148L0(Evidence code:IEA/Database source:UniProtKB:Q96FZ7|ens)F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens)Q0VCW2(Evidence code:IEA/Database source:UniProtKB:Q8IZP0|ens)A5PKD6(Evidence code:IEA/Database source:UniProtKB:Q9HAV0|ens)E1BJ75(Evidence code:ISS/Database source:UniProtKB:Q90830)E1BP72(Evidence code:IEA/Database source:UniProtKB:Q9Y5S2|ens)A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q9Y6W5|ens)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens)E1BCW3(Evidence code:IEA/Database source:UniProtKB:Q01813|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P02511|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)Q32LH8(Evidence code:IEA/Database source:UniProtKB:Q9NS91|ens)E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens)E1BNN0(Evidence code:IEA/Database source:UniProtKB:Q9NRL3|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), STRN3 PEX1 NCKAP1 TSG101 CHMP6 NUMA1 ABI1 GNB4 CRTAP CDC42BPB WASF2 BCAP31 PFKP PRNP TERF2 CRYAB RRAS RAD18 WRN ATM TNKS1BP1 TWF1 STRN4 DAB2IP,MF,24,24 of 243,1.02,9.88,0.1776,0.2671
GO:0045597,positive regulation of cell differentiation,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens)E1BLU8(Evidence code:ISS/Database source:UniProtKB:Q63934), SOX17 fgfr3 DLX2 NF2 INSM1 SRF POU4F2,BP,7,7 of 167,0.3,4.19,0.173,0.2671
GO:0030534,adult behavior,E1BKK6(Evidence code:IEA/Database source:UniProtKB:Q80Z38|ens)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)G5E618(Evidence code:IEA/Database source:UniProtKB:Q9Y566|ens)E1BFN9(Evidence code:IEA/Database source:UniProtKB:Q9P2S2|ens)E1BD77(Evidence code:IEA/Database source:UniProtKB:Q2MHN3|ens), SHANK2 SPTBN4 SHANK1 NRXN2 ZFHX2,BP,5,5 of 34,0.21,14.71,0.1869,0.2671
GO:0006479,protein methylation,A6QL80(Evidence code:IEA/Database source:InterPro:IPR025799)P15246(Evidence code:IEA/Database source:GO:0004719)Q0VCX5(Evidence code:IEA/Database source:UniProtKB:P62495|ens)Q5E9L5(Evidence code:IEA/Database source:InterPro:IPR025799)A7YW45(Evidence code:IEA/Database source:InterPro:IPR007857|I), PRMT3 PCMT1 ETF1 PRMT6 PRMT5,BP,5,5 of 33,0.21,15.15,0.1818,0.2671
GO:0000422,autophagy of mitochondrion,E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), ATG2B FIS1 PINK1,BP,3,3 of 19,0.13,15.79,0.1852,0.2671
GO:0007517,muscle organ development,Q2KHY2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0517)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)P17667(Evidence code:IEA/Database source:InterPro:IPR002546), VAMP5 CRYAB MYF5,BP,3,3 of 18,0.13,16.67,0.1679,0.2671
GO:0004896,cytokine receptor activity,E1B7G0(Evidence code:IBA/Database source:PANTHER:PTN000466212)G3X7E9(Evidence code:IEA/Database source:InterPro:IPR003532)F1MTF9(Evidence code:IEA/Database source:InterPro:IPR003531), IFNLR1 IL13RA1 IL9R,MF,3,3 of 18,0.13,16.67,0.1679,0.2671
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)Q5E9F1(Evidence code:IEA/Database source:UniProtKB:P51572|ens), LCK FIS1 BCAP31,BP,3,3 of 19,0.13,15.79,0.1852,0.2671
GO:0006635,fatty acid beta-oxidation,F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens)Q17QI3(Evidence code:IBA/Database source:PANTHER:PTN000432120)Q58DK1(Evidence code:IEA/Database source:UniPathway:UPA00659), PEX2 ACAT2 CPT1B,BP,3,3 of 18,0.13,16.67,0.1679,0.2671
GO:0016573,histone acetylation,F1MVD0(Evidence code:IEA/Database source:GO:0004402)A7MBG8(Evidence code:IBA/Database source:PANTHER:PTN000120244)Q2TBU9(Evidence code:IBA/Database source:PANTHER:PTN000120244), NCOA3 RUVBL1 RUVBL2,BP,3,3 of 19,0.13,15.79,0.1852,0.2671
GO:0000123,histone acetyltransferase complex,F1MAT9(Evidence code:IEA/Database source:UniProtKB:Q9P2N6|ens)G3MY36(Evidence code:IEA/Database source:InterPro:IPR026180)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens), KANSL3 KANSL1L HCFC1,CC,3,3 of 19,0.13,15.79,0.1852,0.2671
GO:0016831,carboxy-lyase activity,E1BP41(Evidence code:IEA/Database source:InterPro:IPR002129|I)P31754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0210)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR002129), CSAD UMPS PDXDC1,MF,3,3 of 19,0.13,15.79,0.1852,0.2671
GO:0006308,DNA catabolic process,A5PJT8(Evidence code:IEA/Database source:InterPro:IPR016202)Q2QDE9(Evidence code:IEA/Database source:InterPro:IPR016202), DNASE1L2 DNASE1L1,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0016239,positive regulation of macroautophagy,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens), PINK1 TSC2,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0033700,phospholipid efflux,E1BCG1(Evidence code:IEA/Database source:UniProtKB:Q8IZY2|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), ABCA7 ABCA1,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0046716,muscle cell cellular homeostasis,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), PFKM SRF,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0001708,cell fate specification,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), CDON PSEN1,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0050699,WW domain binding,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8)Q2KHV3(Evidence code:ISS/Database source:UniProtKB:Q99732), RAPGEF2 LITAF,MF,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0043457,regulation of cellular respiration,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens)Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q8NC60), PNPT1 NOA1,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,Q3SZD5(Evidence code:IEA/Database source:UniProtKB:Q66K64|ens)E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129806), DCAF15 LOC780968,CC,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0006900,vesicle budding from membrane,A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens), CHMP4A S100A10,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0032570,response to progesterone,Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)P02668(Evidence code:IDA/Database source:), ABHD2 CSN3,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0002082,regulation of oxidative phosphorylation,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), SHMT2 PINK1,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0007193,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens)G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens), PALM AKAP12,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0030414,peptidase inhibitor activity,P20811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646)P98167(Evidence code:IEA/Database source:InterPro:IPR036201), CAST SSPO,MF,2,2 of 80,0.08,2.5,0.1803,0.2671
GO:0016849,phosphorus-oxygen lyase activity,A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR001054|I)Q29450(Evidence code:IEA/Database source:InterPro:IPR001054|I), GUCY1A3 ADCY7,MF,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0042026,protein refolding,Q2HJ94(Evidence code:IEA/Database source:UniProtKB:O60884|ens)Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens), DNAJA2 DNAJB2,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0004190,aspartic-type endopeptidase activity,Q9XT97(Evidence code:IEA/Database source:InterPro:IPR001108|I)Q2HJ40(Evidence code:IEA/Database source:InterPro:IPR001461|I), PSEN1 BACE1,MF,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0050710,negative regulation of cytokine secretion,F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)E1BAW2(Evidence code:IEA/Database source:UniProtKB:G3XA59|ens), LGR4 LRRC32,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0034709,methylosome,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744)A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304), PRMT5 SNRPE,CC,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0004181,metallocarboxypeptidase activity,F1MKS6(Evidence code:IEA/Database source:InterPro:IPR000834|I)E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084), AGTPBP1 CPXM2,MF,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0042462,eye photoreceptor cell development,P04695(Evidence code:IEA/Database source:UniProtKB:P20612|ens)F1MQ96(Evidence code:IEA/Database source:UniProtKB:Q62074|ens), GNAT1 PRKCI,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0006970,response to osmotic stress,Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens), KCNMA1 PLK3,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0016226,iron-sulfur cluster assembly,E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646), MMS19 HSPA9,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0022407,regulation of cell-cell adhesion,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), LEF1 SRC,BP,2,2 of 76,0.08,2.63,0.1752,0.2671
GO:0021953,central nervous system neuron differentiation,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q62288), BCL11B SPOCK1,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0005978,glycogen biosynthetic process,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR037439), PTGES3 GBE1,BP,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",F1MF74(Evidence code:ISS/Database source:UniProtKB:Q8BML1)G3MWR8(Evidence code:ISS/Database source:UniProtKB:Q8TDZ2), MICAL2 MICAL3,MF,2,2 of 9,0.08,22.22,0.169,0.2671
GO:0050667,homocysteine metabolic process,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens),CPS1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042105,alpha-beta T cell receptor complex,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000310,regulation of NMDA receptor activity,Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens),CRH,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004062,aryl sulfotransferase activity,P50227(Evidence code:IEA/Database source:EC:2.8.2.1),SULT1A1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051974,negative regulation of telomerase activity,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000601,positive regulation of Arp2/3 complex-mediated actin nucleation,F1MPZ9(Evidence code:IEA/Database source:UniProtKB:Q9Y2A7|ens),NCKAP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035662,Toll-like receptor 4 binding,P58754(Evidence code:IEA/Database source:InterPro:IPR039217),LY96,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071321,cellular response to cGMP,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060287,epithelial cilium movement involved in determination of left/right asymmetry,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035928,rRNA import into mitochondrion,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005797,Golgi medial cisterna,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0052833,inositol monophosphate 4-phosphatase activity,P20456(Evidence code:IEA/Database source:EC:3.1.3.25),IMPA1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016480,negative regulation of transcription by RNA polymerase III,Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q15742|ens),NAB2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004477,methenyltetrahydrofolate cyclohydrolase activity,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens),MTHFD1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004365,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,Q2KJE5(Evidence code:IEA/Database source:EC:1.2.1.12),GAPDHS,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051430,corticotropin-releasing hormone receptor 1 binding,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793),GNAS,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:1905820,positive regulation of chromosome separation,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019887,protein kinase regulator activity,Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173),GCN1L1,MF,1,1 of 58,0.04,1.72,0.187,0.2671
GO:0004865,protein serine/threonine phosphatase inhibitor activity,E1BPZ4(Evidence code:IBA/Database source:PANTHER:PTN000395915),PPP1R1C,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004095,carnitine O-palmitoyltransferase activity,Q58DK1(Evidence code:IEA/Database source:EC:2.3.1.21),CPT1B,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000182,regulation of progesterone biosynthetic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071942,XPC complex,Q29RK4(Evidence code:ISS/Database source:UniProtKB:P54727),RAD23B,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048739,cardiac muscle fiber development,E1BA80(Evidence code:IEA/Database source:UniProtKB:E9PV66|ens),MYO18B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0009313,oligosaccharide catabolic process,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004530,deoxyribonuclease I activity,Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN001029377),DICER1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051645,Golgi localization,F1MHG5(Evidence code:IBA/Database source:PANTHER:PTN001141618),ARHGAP21,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000767,positive regulation of cytoplasmic translation,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0050916,sensory perception of sweet taste,P0C7Q4(Evidence code:IBA/Database source:PANTHER:PTN000026546),GNAT3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902732,positive regulation of chondrocyte proliferation,A5D7K6(Evidence code:IEA/Database source:UniProtKB:Q8N6T7|ens),SIRT6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0072162,metanephric mesenchymal cell differentiation,B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0),STAT1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004174,electron-transferring-flavoprotein dehydrogenase activity,A5PJM4(Evidence code:IEA/Database source:UniProtKB:Q9BRQ8|ens),AIFM2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071014,post-mRNA release spliceosomal complex,F1N607(Evidence code:IBA/Database source:PANTHER:PTN000327519),SYF2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061333,renal tubule morphogenesis,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens),COL4A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0009838,abscission,A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens),SPG20,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090331,negative regulation of platelet aggregation,E1B8S3(Evidence code:IEA/Database source:UniProtKB:Q4VC17|ens),ADAMTS18,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006363,termination of RNA polymerase I transcription,P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2),LIPE,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060215,primitive hemopoiesis,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030187,melatonin biosynthetic process,P10950(Evidence code:ISS/Database source:UniProtKB:P46597),ASMT,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097524,sperm plasma membrane,Q5EA42(Evidence code:IEA/Database source:UniProtKB:P08910|ens),ABHD2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060077,inhibitory synapse,A8KC68(Evidence code:IEA/Database source:InterPro:IPR030023),NLGN2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:1905664,regulation of calcium ion import across plasma membrane,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0015095,magnesium ion transmembrane transporter activity,E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens),CNNM2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0002283,neutrophil activation involved in immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0055091,phospholipid homeostasis,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016639,"oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor",Q2KHX6(Evidence code:IBA/Database source:PANTHER:PTN000352164),CRYM,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035631,CD40 receptor complex,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:1990454,L-type voltage-gated calcium channel complex,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens),CACNA1D,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0044729,hemi-methylated DNA-binding,A7E320(Evidence code:ISS/Database source:UniProtKB:Q8VDF2),UHRF1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000233,negative regulation of rRNA processing,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens),PTTG1IP,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035507,regulation of myosin-light-chain-phosphatase activity,E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens),NUAK1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006287,"base-excision repair, gap-filling",E1BDI3(Evidence code:IEA/Database source:UniProtKB:P54098|ens),POLG,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0001778,plasma membrane repair,F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens),MYOF,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035522,monoubiquitinated histone H2A deubiquitination,F1N4U8(Evidence code:IEA/Database source:UniProtKB:Q8IXJ9|ens),ASXL1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033185,dolichol-phosphate-mannose synthase complex,Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens),DPM3,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004517,nitric-oxide synthase activity,Q27995(Evidence code:IEA/Database source:InterPro:IPR004030|I),NOS2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046975,histone methyltransferase activity (H3-K36 specific),E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q9NR48|ens),ASH1L,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005968,Rab-protein geranylgeranyltransferase complex,F1N2I0(Evidence code:IEA/Database source:InterPro:IPR001738),CHML,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061502,early endosome to recycling endosome transport,Q17R14(Evidence code:ISS/Database source:UniProtKB:F1PRN2),MYO1D,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070294,renal sodium ion absorption,Q17QL4(Evidence code:IEA/Database source:UniProtKB:Q9UNF1|ens),MAGED2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1900195,positive regulation of oocyte maturation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045542,positive regulation of cholesterol biosynthetic process,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032717,negative regulation of interleukin-8 production,E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens),OTUD7B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0015824,proline transport,A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens),SLC6A20,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0007341,penetration of zona pellucida,G5E5C6(Evidence code:IEA/Database source:UniProtKB:P23578|ens),ACR,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0034653,retinoic acid catabolic process,P62964(Evidence code:IEA/Database source:InterPro:IPR031279),CRABP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060373,regulation of ventricular cardiac muscle cell membrane depolarization,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens),GPD1L,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046390,ribose phosphate biosynthetic process,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 59,0.04,1.69,0.1896,0.2671
GO:0038162,erythropoietin-mediated signaling pathway,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0044205,de novo UMP biosynthetic process,P31754(Evidence code:IEA/Database source:InterPro:IPR014732),UMPS,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097648,G-protein coupled receptor complex,P04695(Evidence code:IDA/Database source:),GNAT1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042406,extrinsic component of endoplasmic reticulum membrane,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens),TOR1A,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048854,brain morphogenesis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0072006,nephron development,F1MQP6(Evidence code:IEA/Database source:UniProtKB:A0A0A6YW72),DCHS2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045347,negative regulation of MHC class II biosynthetic process,Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens),MARCH8,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032635,interleukin-6 production,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003828,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity",F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens),ST8SIA3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003211,cardiac ventricle formation,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831),SOX4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0000035,acyl binding,P04695(Evidence code:IDA/Database source:),GNAT1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0001825,blastocyst formation,F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens),TJP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0043129,surfactant homeostasis,P35246(Evidence code:ISS/Database source:UniProtKB:P35247),SFTPD,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032324,molybdopterin cofactor biosynthetic process,F1MQ57(Evidence code:IEA/Database source:InterPro:IPR005110|I),GPHN,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1904293,negative regulation of ERAD pathway,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens),UBXN1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004966,galanin receptor activity,F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN001954983),RXFP3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004634,phosphopyruvate hydratase activity,F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941),ENO4,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061299,retina vasculature morphogenesis in camera-type eye,Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens),CLIC4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004066,asparagine synthase (glutamine-hydrolyzing) activity,Q1LZA3(Evidence code:IEA/Database source:InterPro:IPR001962|I),ASNS,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097452,GAIT complex,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens),EPRS,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004342,glucosamine-6-phosphate deaminase activity,Q17QL1(Evidence code:IEA/Database source:InterPro:IPR004547|I),GNPDA2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070345,negative regulation of fat cell proliferation,E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens),E2F1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0021861,forebrain radial glial cell differentiation,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0031372,UBC13-MMS2 complex,Q3SZ43(Evidence code:IEA/Database source:UniProtKB:Q15819|ens),UBE2V2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035871,protein K11-linked deubiquitination,E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens),OTUD7B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035542,regulation of SNARE complex assembly,A3KN15(Evidence code:IEA/Database source:UniRule:UR000570763),VPS41,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033026,negative regulation of mast cell apoptotic process,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0036376,sodium ion export across plasma membrane,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016600,flotillin complex,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042574,retinal metabolic process,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens),ALDH1A3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004366,glycerol-3-phosphate O-acyltransferase activity,F1MLW9(Evidence code:IEA/Database source:UniProtKB:Q14DK4|ens),GPAT2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008187,poly-pyrimidine tract binding,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979),UHMK1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0000712,resolution of meiotic recombination intermediates,F1MU48(Evidence code:IBA/Database source:PANTHER:PTN000018888),TOP2B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus,F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens),ADAMTS12,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010716,negative regulation of extracellular matrix disassembly,P81425(Evidence code:ISS/Database source:UniProtKB:P27487),DPP4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003831,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity",E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q6VNB8|ens),WDFY3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070682,proteasome regulatory particle assembly,Q0P5A6(Evidence code:IBA/Database source:PANTHER:PTN000339132),PSMD5,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1905668,positive regulation of protein localization to endosome,A5PKD9(Evidence code:IEA/Database source:UniProtKB:Q8VCV1|ens),ABHD17C,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004576,oligosaccharyl transferase activity,Q5E9C2(Evidence code:ISS/Database source:UniProtKB:E2R4X3),DAD1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046790,virion binding,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens),TSG101,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051584,regulation of dopamine uptake involved in synaptic transmission,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens),TOR1A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0050811,GABA receptor binding,P67774(Evidence code:IEA/Database source:UniProtKB:P63330|ens),PPP2CA,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0021955,central nervous system neuron axonogenesis,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0031852,mu-type opioid receptor binding,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026793),GNAS,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0002369,T cell cytokine production,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0055131,C3HC4-type RING finger domain binding,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006883,cellular sodium ion homeostasis,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008607,phosphorylase kinase regulator activity,E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens),IKBKAP,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030284,estrogen receptor activity,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008272,sulfate transport,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens),RACGAP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070857,regulation of bile acid biosynthetic process,E1BM29(Evidence code:IEA/Database source:UniProtKB:P22680|ens),CYP7A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035377,transepithelial water transport,P35071(Evidence code:ISS/Database source:UniProtKB:P13569),CFTR,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019556,histidine catabolic process to glutamate and formamide,A5PJV3(Evidence code:IEA/Database source:InterPro:IPR005920),AMDHD1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046689,response to mercury ion,A7YY70(Evidence code:IEA/Database source:UniProtKB:Q06495|ens),SLC34A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030893,meiotic cohesin complex,E1B9J3(Evidence code:IEA/Database source:UniProtKB:A2AU37|ens),RAD21L1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0014041,regulation of neuron maturation,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008585,female gonad development,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048549,positive regulation of pinocytosis,F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens),ANKFY1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046294,formaldehyde catabolic process,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens),ADH5,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003148,outflow tract septum morphogenesis,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens),GATA6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004030,aldehyde dehydrogenase [NAD(P)+] activity,F1MHR3(Evidence code:IEA/Database source:UniProtKB:P47895|ens),ALDH1A3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003938,IMP dehydrogenase activity,Q3SWY3(Evidence code:IEA/Database source:InterPro:IPR005990),IMPDH2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0031957,very long-chain fatty acid-CoA ligase activity,F1MIU7(Evidence code:IEA/Database source:InterPro:IPR030307),SLC27A3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042420,dopamine catabolic process,P15101(Evidence code:IEA/Database source:UniProtKB:P09172|ens),DBH,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0055118,negative regulation of cardiac muscle contraction,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens),SRI,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061574,ASAP complex,Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422),SAP18,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0017128,phospholipid scramblase activity,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q6P9J9|ens),ANO6,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035729,cellular response to hepatocyte growth factor stimulus,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0002248,connective tissue replacement involved in inflammatory response wound healing,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046601,positive regulation of centriole replication,A2VDZ4(Evidence code:ISS/Database source:UniProtKB:O00444),PLK4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033605,positive regulation of catecholamine secretion,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens),PINK1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0015816,glycine transport,A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens),SLC6A20,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004854,xanthine dehydrogenase activity,P48034(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045617,negative regulation of keratinocyte differentiation,E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens),HOXA7,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010216,maintenance of DNA methylation,A7E320(Evidence code:ISS/Database source:UniProtKB:Q8VDF2),UHRF1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0044320,cellular response to leptin stimulus,P61635(Evidence code:ISS/Database source:UniProtKB:P40763),STAT3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004488,methylenetetrahydrofolate dehydrogenase (NADP+) activity,A4FUD0(Evidence code:IEA/Database source:InterPro:IPR000672|I),MTHFD1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:1903093,regulation of protein K48-linked deubiquitination,E1BN58(Evidence code:IEA/Database source:UniProtKB:Q01804|ens),OTUD4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070922,small RNA loading onto RISC,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0043951,negative regulation of cAMP-mediated signaling,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens),PDE4D,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042567,insulin-like growth factor ternary complex,P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens),IGFBP3,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0050733,RS domain binding,Q0VCY7(Evidence code:IEA/Database source:UniProtKB:Q6PDM2|ens),SRSF1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070537,histone H2A K63-linked deubiquitination,A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736),BRCC3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902237,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,A4FUZ5(Evidence code:IEA/Database source:UniProtKB:Q9QZI9|ens),SERINC3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006529,asparagine biosynthetic process,Q1LZA3(Evidence code:IEA/Database source:InterPro:IPR001962|I),ASNS,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033687,osteoblast proliferation,F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens),FIGNL1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005251,delayed rectifier potassium channel activity,F1ML52(Evidence code:IEA/Database source:UniProtKB:Q8TDN1|ens),KCNG4,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0098574,cytoplasmic side of lysosomal membrane,Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q99732|ens),LITAF,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0050509,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,A5D7I4(Evidence code:IEA/Database source:EC:2.4.1.225),EXT1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:1900126,negative regulation of hyaluronan biosynthetic process,E1BMW2(Evidence code:IEA/Database source:UniProtKB:O95782|ens),AP2A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060993,kidney morphogenesis,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097227,sperm annulus,Q3SZN0(Evidence code:IEA/Database source:UniProtKB:Q14141|ens),SEPT6,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0072604,interleukin-6 secretion,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060252,positive regulation of glial cell proliferation,F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens),PRKCI,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0038166,angiotensin-activated signaling pathway,Q08E45(Evidence code:IEA/Database source:UniProtKB:Q9UQM7|ens),CAMK2A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030983,mismatched DNA binding,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0031045,dense core granule,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens),SYT4,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000301,negative regulation of synaptic vesicle exocytosis,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0089701,U2AF,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979),UHMK1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035870,dITP diphosphatase activity,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0),NUDT16,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071800,podosome assembly,F1MF26(Evidence code:IBA/Database source:PANTHER:PTN001038814),SH3PXD2A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006349,regulation of gene expression by genetic imprinting,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045724,positive regulation of cilium assembly,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060113,inner ear receptor cell differentiation,Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851),fgfr3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070034,telomerase RNA binding,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens),SMG6,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035457,cellular response to interferon-alpha,E1BF47(Evidence code:IEA/Database source:UniProtKB:F6ZDS4|ens),TPR,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071864,positive regulation of cell proliferation in bone marrow,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003413,chondrocyte differentiation involved in endochondral bone morphogenesis,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019227,neuronal action potential propagation,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens),FKBP1B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902966,positive regulation of protein localization to early endosome,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045088,regulation of innate immune response,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 56,0.04,1.79,0.1835,0.2671
GO:0051464,positive regulation of cortisol secretion,Q95MI6(Evidence code:IEA/Database source:UniProtKB:P06850|ens),CRH,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens),NF2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071318,cellular response to ATP,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q7TN37|ens),TRPM4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004308,exo-alpha-sialidase activity,E1BMN0(Evidence code:IEA/Database source:InterPro:IPR026856|I),NEU4,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060374,mast cell differentiation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032725,positive regulation of granulocyte macrophage colony-stimulating factor production,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens),DDX58,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006106,fumarate metabolic process,Q148D3(Evidence code:IEA/Database source:InterPro:IPR005677),FH,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0052834,inositol monophosphate phosphatase activity,P20456(Evidence code:IEA/Database source:EC:3.1.3.25),IMPA1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016560,"protein import into peroxisome matrix, docking",Q0P5B1(Evidence code:IEA/Database source:InterPro:IPR007223|I),PEX13,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051694,pointed-end actin filament capping,Q2KJH0(Evidence code:IEA/Database source:InterPro:IPR004934|I),TMOD3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0031094,platelet dense tubular network,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042382,paraspeckles,E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens),SFPQ,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010891,negative regulation of sequestering of triglyceride,Q2KI18(Evidence code:ISS/Database source:UniProtKB:Q8BJ56),PNPLA2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005953,CAAX-protein geranylgeranyltransferase complex,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1901856,negative regulation of cellular respiration,Q2TBI4(Evidence code:ISS/Database source:UniProtKB:Q12931),TRAP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0043553,negative regulation of phosphatidylinositol 3-kinase activity,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030852,regulation of granulocyte differentiation,P02694(Evidence code:IEA/Database source:UniProtKB:Q00915|ens),RBP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032930,positive regulation of superoxide anion generation,P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens),ITGB2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035370,UBC13-UEV1A complex,Q3SZ52(Evidence code:ISS/Database source:UniProtKB:Q13404),UBE2V1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030576,Cajal body organization,E1BB54(Evidence code:IEA/Database source:InterPro:IPR033505),USPL1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902916,positive regulation of protein polyubiquitination,A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens),MARCH7,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060712,spongiotrophoblast layer development,E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens),BIRC6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090219,negative regulation of lipid kinase activity,A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens),PPP2R5A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030167,proteoglycan catabolic process,F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens),ADAMTS12,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0014731,spectrin-associated cytoskeleton,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens),SPTA1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0072321,chaperone-mediated protein transport,A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549),TOR1A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0047179,platelet-activating factor acetyltransferase activity,Q29460(Evidence code:IBA/Database source:PANTHER:PTN000220758),PAFAH1B3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0018343,protein farnesylation,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048156,tau protein binding,P02638(Evidence code:IPI/Database source:UniProtKB:P29172),S100B,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071371,cellular response to gonadotropin stimulus,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005850,eukaryotic translation initiation factor 2 complex,P68102(Evidence code:IEA/Database source:UniProtKB:P05198|ens),EIF2S1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004662,CAAX-protein geranylgeranyltransferase activity,P29702(Evidence code:IBA/Database source:PANTHER:PTN000122903),FNTA,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:1990253,cellular response to leucine starvation,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens),LARS,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030643,cellular phosphate ion homeostasis,A7YY70(Evidence code:IBA/Database source:PANTHER:PTN000000493),SLC34A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004096,catalase activity,P00432(Evidence code:IEA/Database source:InterPro:IPR011614|I),CAT,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032310,prostaglandin secretion,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070933,histone H4 deacetylation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090500,endocardial cushion to mesenchymal transition,O97711(Evidence code:ISS/Database source:UniProtKB:P70312),HAS2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042288,MHC class I protein binding,Q5E9F1(Evidence code:IEA/Database source:UniProtKB:Q61335|ens),BCAP31,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042754,negative regulation of circadian rhythm,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens),SFPQ,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097125,cyclin B1-CDK1 complex,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033600,negative regulation of mammary gland epithelial cell proliferation,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019557,histidine catabolic process to glutamate and formate,A5PJV3(Evidence code:IEA/Database source:UniPathway:UPA00379),AMDHD1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042134,rRNA primary transcript binding,P16386(Evidence code:ISS/Database source:UniProtKB:Q6NZI2),LIPE,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0018312,peptidyl-serine ADP-ribosylation,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071920,cleavage body,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499),DDX1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:1900044,regulation of protein K63-linked ubiquitination,F1N4B0(Evidence code:IEA/Database source:UniProtKB:O94885|ens),SASH1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0007413,axonal fasciculation,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035497,cAMP response element binding,A4FUY2(Evidence code:IEA/Database source:InterPro:IPR029809),ATF6B,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046785,microtubule polymerization,E1B7K5(Evidence code:IBA/Database source:PANTHER:PTN000288762),CKAP5,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000001,regulation of DNA damage checkpoint,Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74),ETAA1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004563,beta-N-acetylhexosaminidase activity,H7BWW2(Evidence code:IEA/Database source:InterPro:IPR025705),HEXB,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042985,negative regulation of amyloid precursor protein biosynthetic process,Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287),ITM2B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0001302,replicative cell aging,E1BEE6(Evidence code:IEA/Database source:UniProtKB:O09053|ens),WRN,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071042,nuclear polyadenylation-dependent mRNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0007412,axon target recognition,P61763(Evidence code:ISS/Database source:UniProtKB:O08599),STXBP1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035749,myelin sheath adaxonal region,E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens),MPP5,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016010,dystrophin-associated glycoprotein complex,F1MRT9(Evidence code:IEA/Database source:UniProtKB:E9Q6R7|ens),UTRN,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0043278,response to morphine,F1MG56(Evidence code:IEA/Database source:UniProtKB:Q6P1F6|ens),PPP2R2A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006369,termination of RNA polymerase II transcription,E1BAS6(Evidence code:IEA/Database source:UniProtKB:A2AKX3|ens),SETX,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060396,growth hormone receptor signaling pathway,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045060,negative thymic T cell selection,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016531,copper chaperone activity,Q3T0E0(Evidence code:IEA/Database source:UniProtKB:O00244|ens),ATOX1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000660,negative regulation of interleukin-1-mediated signaling pathway,E1BN58(Evidence code:IEA/Database source:UniProtKB:B2RRE7|ens),OTUD4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0099073,mitochondrion-derived vesicle,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006817,phosphate ion transport,A7YY70(Evidence code:ISS/Database source:UniProtKB:Q06495),SLC34A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019417,sulfur oxidation,F1MF74(Evidence code:ISS/Database source:UniProtKB:Q8BML1),MICAL2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051567,histone H3-K9 methylation,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071796,K6-linked polyubiquitin modification-dependent protein binding,Q32KW2(Evidence code:ISS/Database source:UniProtKB:Q04323),UBXN1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003084,positive regulation of systemic arterial blood pressure,E1BN63(Evidence code:IEA/Database source:UniProtKB:P83741|ens),WNK1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1903094,negative regulation of protein K48-linked deubiquitination,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens),UBXN1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0000275,"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)",P05630(Evidence code:IBA/Database source:PANTHER:PTN000352457),ATP5D,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0047710,bis(5-adenosyl)-triphosphatase activity,Q1KZG4(Evidence code:IEA/Database source:EC:3.6.1.29),FHIT,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0017034,Rap guanyl-nucleotide exchange factor activity,F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739),RAPGEF2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:1905323,telomerase holoenzyme complex assembly,Q3ZBF7(Evidence code:IEA/Database source:UniProtKB:Q9R0Q7|ens),PTGES3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033300,dehydroascorbic acid transmembrane transporter activity,E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7),SLC23A1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090399,replicative senescence,E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519),ATM,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000116,regulation of cysteine-type endopeptidase activity,Q3SZC2(Evidence code:IEA/Database source:UniProtKB:P28065|ens),PSMB9,BP,1,1 of 56,0.04,1.79,0.1835,0.2671
GO:0048733,sebaceous gland development,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0001886,endothelial cell morphogenesis,Q9XSA7(Evidence code:IEA/Database source:UniProtKB:Q9QYB1|ens),CLIC4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004830,tryptophan-tRNA ligase activity,Q3T099(Evidence code:IEA/Database source:InterPro:IPR002306|I),WARS2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048715,negative regulation of oligodendrocyte differentiation,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens),DLX2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060693,regulation of branching involved in salivary gland morphogenesis,G3X8E7(Evidence code:IEA/Database source:UniProtKB:Q8CFE5|ens),BTBD7,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0015321,sodium-dependent phosphate transmembrane transporter activity,A7YY70(Evidence code:IEA/Database source:InterPro:IPR003841|I),SLC34A1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006436,tryptophanyl-tRNA aminoacylation,Q3T099(Evidence code:IEA/Database source:InterPro:IPR002306),WARS2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004430,1-phosphatidylinositol 4-kinase activity,O02811(Evidence code:IEA/Database source:EC:2.7.1.67),PI4KA,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019046,release from viral latency,E1BGF3(Evidence code:IEA/Database source:UniProtKB:Q61191|ens),HCFC1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006896,Golgi to vacuole transport,E1BDC9(Evidence code:IBA/Database source:PANTHER:PTN000367098),VPS52,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1903044,protein localization to membrane raft,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030285,integral component of synaptic vesicle membrane,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens),SLC17A8,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000481,positive regulation of cAMP-dependent protein kinase activity,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060484,lung-associated mesenchyme development,F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens),PTK7,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010968,regulation of microtubule nucleation,E1BB08(Evidence code:IEA/Database source:UniProtKB:O95834|ens),EML2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030719,P granule organization,E1BPH3(Evidence code:ISS/Database source:UniProtKB:Q5VCS6),TDRD5,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0086005,ventricular cardiac muscle cell action potential,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens),GPD1L,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032494,response to peptidoglycan,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0007221,positive regulation of transcription of Notch receptor target,A5D7F6(Evidence code:IBA/Database source:PANTHER:PTN001437735),MAML2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032754,positive regulation of interleukin-5 production,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens),PDE4D,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004825,methionine-tRNA ligase activity,Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR014758|I),MARS,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046469,platelet activating factor metabolic process,P43033(Evidence code:IDA/Database source:),PAFAH1B1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0001561,fatty acid alpha-oxidation,Q0P5B1(Evidence code:IEA/Database source:UniProtKB:Q9D0K1|ens),PEX13,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000643,positive regulation of early endosome to late endosome transport,E1BIU7(Evidence code:IEA/Database source:UniProtKB:Q9H3S7|ens),PTPN23,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0050816,phosphothreonine residue binding,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens),PIN1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005996,monosaccharide metabolic process,Q0P563(Evidence code:IEA/Database source:InterPro:IPR007721|I),FUOM,BP,1,1 of 56,0.04,1.79,0.1835,0.2671
GO:0005827,polar microtubule,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061458,reproductive system development,F1MYN1(Evidence code:IEA/Database source:UniProtKB:E9Q6H8|ens),PLEKHA5,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003858,3-hydroxybutyrate dehydrogenase activity,Q3T046(Evidence code:IEA/Database source:EC:1.1.1.30),BDH2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005663,DNA replication factor C complex,Q05B83(Evidence code:IEA/Database source:UniProtKB:P35250|ens),RFC2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006177,GMP biosynthetic process,Q3SWY3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0332),IMPDH2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005185,neurohypophyseal hormone activity,P01175(Evidence code:IEA/Database source:InterPro:IPR000981|I),OXT,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:1990001,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,A6QPJ9(Evidence code:IEA/Database source:UniProtKB:Q9HB09|ens),BCL2L12,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0098700,neurotransmitter loading into synaptic vesicle,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8NDX2|ens),SLC17A8,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033028,myeloid cell apoptotic process,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens),ARF6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045329,carnitine biosynthetic process,Q2KJH9(Evidence code:IEA/Database source:UniPathway:UPA00118),ALDH9A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016715,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen",P15101(Evidence code:IEA/Database source:InterPro:IPR000323|I),DBH,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000270,negative regulation of fibroblast apoptotic process,F1MLB2(Evidence code:IEA/Database source:UniProtKB:Q09XV5|ens),CHD8,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048149,behavioral response to ethanol,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016493,C-C chemokine receptor activity,F1MG76(Evidence code:IEA/Database source:UniProtKB:Q6X632|ens),GPR75,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0002377,immunoglobulin production,F1N160(Evidence code:IBA/Database source:PANTHER:PTN000587099),VPREB1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006268,DNA unwinding involved in DNA replication,E1BMW9(Evidence code:IEA/Database source:UniProtKB:Q00577|ens),PURA,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048478,replication fork protection,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004019,adenylosuccinate synthase activity,A7MBG0(Evidence code:IEA/Database source:InterPro:IPR001114|I),ADSS,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033883,pyridoxal phosphatase activity,Q3ZBF9(Evidence code:IEA/Database source:EC:3.1.3.74),PDXP,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060670,branching involved in labyrinthine layer morphogenesis,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens),GRB2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0021902,commitment of neuronal cell to specific neuron type in forebrain,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060171,stereocilium membrane,Q27966(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),MYO1C,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061549,sympathetic ganglion development,A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q63ZV0),INSM1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032926,negative regulation of activin receptor signaling pathway,E1BIJ4(Evidence code:IEA/Database source:UniProtKB:Q9Y2U8|ens),LEMD3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004467,long-chain fatty acid-CoA ligase activity,F1MIU7(Evidence code:IEA/Database source:InterPro:IPR030307),SLC27A3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0009115,xanthine catabolic process,P48034(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046654,tetrahydrofolate biosynthetic process,P00376(Evidence code:IEA/Database source:InterPro:IPR001796),DHFR,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051454,intracellular pH elevation,P35071(Evidence code:ISS/Database source:UniProtKB:P26361),CFTR,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006564,L-serine biosynthetic process,Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006236),PHGDH,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0007603,"phototransduction, visible light",P04695(Evidence code:IEA/Database source:UniProtKB:P11488|ens),GNAT1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048066,developmental pigmentation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003841,1-acylglycerol-3-phosphate O-acyltransferase activity,Q95JH2(Evidence code:IEA/Database source:InterPro:IPR004552),AGPAT1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045917,positive regulation of complement activation,P02638(Evidence code:NAS/Database source:),S100B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010159,specification of animal organ position,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens),TBX3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033152,immunoglobulin V(D)J recombination,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003356,regulation of cilium beat frequency,F1N724(Evidence code:IEA/Database source:UniProtKB:Q96DT5|ens),DNAH11,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0043734,DNA-N1-methyladenine dioxygenase activity,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046548,retinal rod cell development,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens),ALMS1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0043184,vascular endothelial growth factor receptor 2 binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033148,positive regulation of intracellular estrogen receptor signaling pathway,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153),PAK1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060486,Clara cell differentiation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035241,protein-arginine omega-N monomethyltransferase activity,Q5E9L5(Evidence code:ISS/Database source:UniProtKB:Q96LA8),PRMT6,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071374,cellular response to parathyroid hormone stimulus,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens),PRKACA,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0034351,negative regulation of glial cell apoptotic process,F1MQ96(Evidence code:IEA/Database source:UniProtKB:P41743|ens),PRKCI,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006517,protein deglycosylation,F1MWT0(Evidence code:IBA/Database source:PANTHER:PTN000176395),MAN2C1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000345,regulation of hepatocyte proliferation,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens),GLI1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0046974,histone methyltransferase activity (H3-K9 specific),F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0001223,transcription coactivator binding,E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens),ZBTB17,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0052832,inositol monophosphate 3-phosphatase activity,P20456(Evidence code:IEA/Database source:EC:3.1.3.25),IMPA1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0018242,protein O-linked glycosylation via serine,E1BB48(Evidence code:IEA/Database source:UniProtKB:Q10471|ens),GALNT2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035612,AP-2 adaptor complex binding,F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8),AAK1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:1990752,microtubule end,E1BP55(Evidence code:IEA/Database source:UniProtKB:Q8IVL0|ens),NAV3,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004582,dolichyl-phosphate beta-D-mannosyltransferase activity,Q3ZC71(Evidence code:IBA/Database source:PANTHER:PTN000419487),DPM3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006431,methionyl-tRNA aminoacylation,Q2T9L8(Evidence code:IEA/Database source:InterPro:IPR014758|I),MARS,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070327,thyroid hormone transport,Q2KHX6(Evidence code:IEA/Database source:UniProtKB:Q14894|ens),CRYM,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097499,protein localization to non-motile cilium,Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens),ARL6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045842,positive regulation of mitotic metaphase/anaphase transition,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902951,negative regulation of dendritic spine maintenance,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032036,myosin heavy chain binding,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens),MYBPC3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048096,chromatin-mediated maintenance of transcription,E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens),PABPC1L,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005549,odorant binding,G3X8A9(Evidence code:IBA/Database source:PANTHER:PTN001241937),OR5M11,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0003418,growth plate cartilage chondrocyte differentiation,F1MP76(Evidence code:IDA/Database source:),SDC3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0002087,regulation of respiratory gaseous exchange by neurological system process,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0009152,purine ribonucleotide biosynthetic process,A3KN12(Evidence code:IEA/Database source:InterPro:IPR004769),ADSL,BP,1,1 of 54,0.04,1.85,0.182,0.2671
GO:2000157,negative regulation of ubiquitin-specific protease activity,Q32KW2(Evidence code:IEA/Database source:UniProtKB:Q04323|ens),UBXN1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0009331,glycerol-3-phosphate dehydrogenase complex,A6QQR7(Evidence code:IEA/Database source:InterPro:IPR006168),GPD1L,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0050508,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,A5D7I4(Evidence code:IEA/Database source:EC:2.4.1.224),EXT1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048665,neuron fate specification,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004660,protein farnesyltransferase activity,P29702(Evidence code:IBA/Database source:PANTHER:PTN000122903),FNTA,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048251,elastic fiber assembly,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061647,histone H3-K9 modification,A5D7K6(Evidence code:IEA/Database source:GO:0046969),SIRT6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090197,positive regulation of chemokine secretion,F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens),ALOX15B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004514,nicotinate-nucleotide diphosphorylase (carboxylating) activity,A5PK51(Evidence code:IEA/Database source:InterPro:IPR036068),NAPRT,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051747,cytosine C-5 DNA demethylase activity,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0055062,phosphate ion homeostasis,A7YY70(Evidence code:ISS/Database source:UniProtKB:Q06495),SLC34A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008934,inositol monophosphate 1-phosphatase activity,P20456(Evidence code:IEA/Database source:InterPro:IPR033942),IMPA1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019226,transmission of nerve impulse,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens),SPTBN4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0034274,Atg12-Atg5-Atg16 complex,E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens),WDFY3,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008510,sodium:bicarbonate symporter activity,F1N4L1(Evidence code:IBA/Database source:PANTHER:PTN000155503),SLC4A2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005979,regulation of glycogen biosynthetic process,E1BHP3(Evidence code:IEA/Database source:UniProtKB:Q6ZSY5|ens),PPP1R3F,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005545,1-phosphatidylinositol binding,E1BPS3(Evidence code:IEA/Database source:UniProtKB:Q8IZQ1|ens),WDFY3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016593,Cdc73/Paf1 complex,F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens),PEX2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060244,negative regulation of cell proliferation involved in contact inhibition,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153),PAK1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0009410,response to xenobiotic stimulus,F1ML85(Evidence code:IEA/Database source:InterPro:IPR033348|I),AHR,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0000389,mRNA 3-splice site recognition,A2VDN6(Evidence code:IBA/Database source:PANTHER:PTN000393333),SF3A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060012,"synaptic transmission, glycinergic",F1N5R0(Evidence code:IEA/Database source:UniProtKB:Q9Y345|ens),SLC6A5,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0050815,phosphoserine residue binding,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens),PIN1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0042795,snRNA transcription by RNA polymerase II,E1BCK9(Evidence code:IEA/Database source:UniProtKB:Q5SXM2|ens),SNAPC4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019065,receptor-mediated endocytosis of virus by host cell,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42566|ens),EPS15,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045901,positive regulation of translational elongation,F1MN49(Evidence code:IEA/Database source:InterPro:IPR001884|I),EIF5A2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033588,Elongator holoenzyme complex,E1BBQ3(Evidence code:IEA/Database source:InterPro:IPR006849),IKBKAP,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006266,DNA ligation,A4IFC8(Evidence code:IEA/Database source:GO:0003910),LIG1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032041,NAD-dependent histone deacetylase activity (H3-K14 specific),Q2T9N9(Evidence code:IEA/Database source:EC:3.5.1.98),HDAC5,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070634,transepithelial ammonium transport,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004372,glycine hydroxymethyltransferase activity,Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR001085),SHMT2,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0034063,stress granule assembly,P68102(Evidence code:IEA/Database source:UniProtKB:Q6ZWX6|ens),EIF2S1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0000966,RNA 5-end processing,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1902177,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens),SFPQ,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090385,phagosome-lysosome fusion,G3X7D3(Evidence code:IEA/Database source:UniProtKB:Q14964|ens),RAB39A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006903,vesicle targeting,A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473),EXOC4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005584,collagen type I trimer,P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens),COL1A2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0031403,lithium ion binding,P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens),IMPA1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0044300,cerebellar mossy fiber,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0034144,negative regulation of toll-like receptor 4 signaling pathway,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097049,motor neuron apoptotic process,F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens),ADARB1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000369,regulation of clathrin-dependent endocytosis,F1MH24(Evidence code:ISS/Database source:UniProtKB:P0C1X8),AAK1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0021794,thalamus development,F1MDE1(Evidence code:IBA/Database source:PANTHER:PTN000056284),LRP6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0021695,cerebellar cortex development,G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens),KIF14,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0034197,triglyceride transport,P55156(Evidence code:ISS/Database source:UniProtKB:P55157),MTTP,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0043559,insulin binding,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0002327,immature B cell differentiation,P43481(Evidence code:ISS/Database source:UniProtKB:P05532),KIT,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1903181,positive regulation of dopamine biosynthetic process,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071711,basement membrane organization,Q7SIB2(Evidence code:IEA/Database source:UniProtKB:P02462|ens),COL4A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010467,gene expression,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens),GOLPH3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2001032,regulation of double-strand break repair via nonhomologous end joining,A5PJQ1(Evidence code:IEA/Database source:UniProtKB:Q7TNV0|ens),DEK,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0051388,positive regulation of neurotrophin TRK receptor signaling pathway,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens),CYFIP2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008525,phosphatidylcholine transporter activity,Q2HJ54(Evidence code:IEA/Database source:UniProtKB:Q00169|ens),PITPNA,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035511,oxidative DNA demethylation,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033269,internode region of axon,Q3ZBU7(Evidence code:IEA/Database source:UniProtKB:Q9D6F9|ens),TUBB4A,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0052629,"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity",E1BFE6(Evidence code:IEA/Database source:InterPro:IPR030587),MTMR1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097165,nuclear stress granule,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0014033,neural crest cell differentiation,F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens),LRP6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060426,lung vasculature development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005915,zonula adherens,E1BFA7(Evidence code:IEA/Database source:UniProtKB:Q9BVG8|ens),KIFC3,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0097062,dendritic spine maintenance,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens),CTTN,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032971,regulation of muscle filament sliding,A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens),MYLK2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0044292,dendrite terminus,E1B9D3(Evidence code:IEA/Database source:UniProtKB:E9PY61|ens),GPR179,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048679,regulation of axon regeneration,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0098532,histone H3-K27 trimethylation,A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens),HIST1H1D,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0000783,nuclear telomere cap complex,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005965,protein farnesyltransferase complex,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0048011,neurotrophin TRK receptor signaling pathway,Q5BIM5(Evidence code:ISS/Database source:UniProtKB:Q6P7B7),ZFYVE27,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000650,negative regulation of sodium ion transmembrane transporter activity,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004579,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,Q5E9C2(Evidence code:IEA/Database source:InterPro:IPR003038),DAD1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0052405,negative regulation by host of symbiont molecular function,Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens),RAB9A,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0034205,amyloid-beta formation,Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768),PSEN1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0072492,host cell mitochondrial intermembrane space,A1A4J8(Evidence code:IEA/Database source:UniProtKB:O75880|ens),SCO1,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0017144,drug metabolic process,P48034(Evidence code:ISS/Database source:UniProtKB:Q06278),AOX1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010710,regulation of collagen catabolic process,P53712(Evidence code:ISS/Database source:UniProtKB:P05556),ITGB1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0032877,positive regulation of DNA endoreduplication,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2),E2F7,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061470,T follicular helper cell differentiation,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008427,calcium-dependent protein kinase inhibitor activity,Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens),CIB1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0030903,notochord development,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens),COL2A1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0008430,selenium binding,P37141(Evidence code:ISS/Database source:UniProtKB:P22352),GPX3,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0006421,asparaginyl-tRNA aminoacylation,Q2KJG3(Evidence code:IEA/Database source:InterPro:IPR004522),NARS,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1903135,cupric ion binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0031293,membrane protein intracellular domain proteolysis,Q0III2(Evidence code:IEA/Database source:UniProtKB:O43462|ens),MBTPS2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033198,response to ATP,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0061738,late endosomal microautophagy,Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens),VPS4B,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:1903748,negative regulation of establishment of protein localization to mitochondrion,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens),HSPH1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:2000707,positive regulation of dense core granule biogenesis,P05059(Evidence code:ISS/Database source:UniProtKB:P26339),CHGA,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0060075,regulation of resting membrane potential,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0071568,UFM1 transferase activity,Q5E953(Evidence code:ISS/Database source:UniProtKB:Q9Y3C8),UFC1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0021860,pyramidal neuron development,E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens),DCLK2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090043,regulation of tubulin deacetylation,A4IFF6(Evidence code:IEA/Database source:UniProtKB:Q9R0A5|ens),NEK3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0035279,mRNA cleavage involved in gene silencing by miRNA,Q6T5B7(Evidence code:IEA/Database source:GO:0090624),AGO3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0090344,negative regulation of cell aging,Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47),MARCH5,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0070102,interleukin-6-mediated signaling pathway,P61635(Evidence code:ISS/Database source:UniProtKB:P40763),STAT3,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0010875,positive regulation of cholesterol efflux,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0045084,positive regulation of interleukin-12 biosynthetic process,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0004438,phosphatidylinositol-3-phosphatase activity,E1BFE6(Evidence code:IEA/Database source:InterPro:IPR030587),MTMR1,MF,1,1 of 2,0.04,50,0.1903,0.2671
GO:0019800,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens),NDNF,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0033353,S-adenosylmethionine cycle,A6QLP2(Evidence code:IBA/Database source:PANTHER:PTN000602759),AHCYL2,BP,1,1 of 2,0.04,50,0.1903,0.2671
GO:0000138,Golgi trans cisterna,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0016342,catenin complex,E1BI79(Evidence code:IEA/Database source:UniProtKB:O95996|ens),APC2,CC,1,1 of 2,0.04,50,0.1903,0.2671
GO:0005758,mitochondrial intermembrane space,Q2TA37(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8K1R3|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)P62894(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), ARL2 AIFM1 PNPT1 PINK1 CYCS,CC,5,5 of 35,0.21,14.29,0.1926,0.2704
GO:0032496,response to lipopolysaccharide,Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558)F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q3UMW7)Q2KHV3(Evidence code:IEA/Database source:UniProtKB:Q9JLJ0|ens), S100A14 BCR F2R CPS1 ADH5 MAPKAPK3 LITAF,BP,7,7 of 54,0.3,12.96,0.1932,0.2707
GO:0070469,respiratory chain,P23709(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679)P62894(Evidence code:IEA/Database source:UniProtKB-KW:KW-0679), NDUFS3 CYCS,CC,2,2 of 10,0.08,20,0.1941,0.2707
GO:1901741,positive regulation of myoblast fusion,P17667(Evidence code:IBA/Database source:PANTHER:PTN000164853)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens), MYF5 FLOT1,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0006893,Golgi to plasma membrane transport,A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473)E1BDW9(Evidence code:IEA/Database source:InterPro:IPR029175), EXOC4 EXOC2,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0001937,negative regulation of endothelial cell proliferation,E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224), PTPRM STAT1,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0001678,cellular glucose homeostasis,A6QR34(Evidence code:IEA/Database source:InterPro:IPR001312)E1BME6(Evidence code:IEA/Database source:InterPro:IPR001312), GCK HK2,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0008361,regulation of cell size,A6QLR2(Evidence code:IEA/Database source:UniProtKB:Q9P2J5|ens)F1N6T8(Evidence code:IEA/Database source:UniProtKB:P52735|ens), LARS VAV2,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0004602,glutathione peroxidase activity,P37141(Evidence code:IEA/Database source:InterPro:IPR000889)P00435(Evidence code:IEA/Database source:InterPro:IPR000889), GPX3 GPX1,MF,2,2 of 10,0.08,20,0.1941,0.2707
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens)E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458), CCNY CCNL1,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0017080,sodium channel regulator activity,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)E1B757(Evidence code:IEA/Database source:InterPro:IPR029873), GPD1L SCN2B,MF,2,2 of 10,0.08,20,0.1941,0.2707
GO:0030057,desmosome,Q01107(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q99569), DSC1 PKP4,CC,2,2 of 10,0.08,20,0.1941,0.2707
GO:0042056,chemoattractant activity,F1N0Y5(Evidence code:IEA/Database source:UniProtKB:Q9Y6Z7|ens)Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506), COLEC10 CXCL12,MF,2,2 of 10,0.08,20,0.1941,0.2707
GO:1901016,regulation of potassium ion transmembrane transporter activity,F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens), CACNA1D NEDD4,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0010332,response to gamma radiation,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), PRKDC BRCA2,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0042562,hormone binding,Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910)Q2KHX6(Evidence code:IEA/Database source:UniProtKB:O54983|ens), ABHD2 CRYM,MF,2,2 of 10,0.08,20,0.1941,0.2707
GO:0005680,anaphase-promoting complex,E1BAB6(Evidence code:IEA/Database source:InterPro:IPR024990)A7Z061(Evidence code:ISS/Database source:UniProtKB:P30260), ANAPC1 CDC27,CC,2,2 of 10,0.08,20,0.1941,0.2707
GO:0045047,protein targeting to ER,Q3SZU5(Evidence code:IBA/Database source:PANTHER:PTN000301433)Q3SZJ9(Evidence code:IBA/Database source:PANTHER:PTN000049281), SPCS3 PMM2,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0033146,regulation of intracellular estrogen receptor signaling pathway,Q2KJG2(Evidence code:ISS/Database source:UniProtKB:P61960)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), UFM1 SRC,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0004114,"3,5-cyclic-nucleotide phosphodiesterase activity",F1MS27(Evidence code:IEA/Database source:InterPro:IPR002073|I)P22571(Evidence code:IEA/Database source:InterPro:IPR006952|I), PDE4D PDE6H,MF,2,2 of 10,0.08,20,0.1941,0.2707
GO:0042133,neurotransmitter metabolic process,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens), CLN3 AGTPBP1,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0030291,protein serine/threonine kinase inhibitor activity,Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens)A6QP24(Evidence code:IEA/Database source:InterPro:IPR039201), CIB1 FAM212B,MF,2,2 of 10,0.08,20,0.1941,0.2707
GO:0032330,regulation of chondrocyte differentiation,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)Q28046(Evidence code:ISS/Database source:UniProtKB:Q5ZIV9), SHOX2 SCIN,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0008053,mitochondrial fusion,D7GLD1(Evidence code:IEA/Database source:InterPro:IPR006884|I)Q3T0I5(Evidence code:ISS/Database source:UniProtKB:Q9Y3D6), MFN2 FIS1,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0045745,positive regulation of G-protein coupled receptor protein signaling pathway,P22571(Evidence code:IEA/Database source:UniProtKB:P61249|ens)A6QQ95(Evidence code:IEA/Database source:UniProtKB:Q92876|ens), PDE6H KLK6,BP,2,2 of 10,0.08,20,0.1941,0.2707
GO:0008171,O-methyltransferase activity,A7MBI7(Evidence code:IEA/Database source:InterPro:IPR002935)P10950(Evidence code:IEA/Database source:InterPro:IPR001077), COMT ASMT,MF,2,2 of 10,0.08,20,0.1941,0.2707
GO:0043254,regulation of protein complex assembly,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)A6H7J1(Evidence code:ISS/Database source:UniProtKB:Q01101)E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), DAB2IP INSM1 HCFC1 PINK1,BP,4,4 of 113,0.17,3.54,0.1943,0.2709
GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",E1BHD5(Evidence code:IEA/Database source:InterPro:IPR001128|I)A7MBA0(Evidence code:IEA/Database source:InterPro:IPR006620)Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR006620)Q0P5I1(Evidence code:IEA/Database source:InterPro:IPR001128|I)E1BM29(Evidence code:IEA/Database source:InterPro:IPR001128|I)Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR001128|I)F1MEU8(Evidence code:IEA/Database source:InterPro:IPR001128|I), LOC100295883 EGLN3 P4HA2 CYP2R1 CYP7A1 CYP2J2 LOC540627,MF,7,7 of 55,0.3,12.73,0.1968,0.2742
GO:0010629,negative regulation of gene expression,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)P02510(Evidence code:IEA/Database source:UniProtKB:P23927|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens)F1MPW1(Evidence code:IEA/Database source:UniProtKB:Q14689|ens)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens)G3X749(Evidence code:IEA/Database source:UniProtKB:Q96F45|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), PDCD10 CRYAB DGKQ EMILIN1 DIP2A NFKB1 CRKL TERF2 PPP3CA SNX12 TCF7L2 VPS35 ZNF503 PINK1,BP,14,14 of 281,0.59,4.98,0.1992,0.2775
GO:0007338,single fertilization,G5E5C6(Evidence code:IEA/Database source:UniProtKB:P23578|ens)E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)O62826(Evidence code:IBA/Database source:PANTHER:PTN001298123), ACR ASH1L TRPC2,BP,3,3 of 20,0.13,15,0.2029,0.2823
GO:0048167,regulation of synaptic plasticity,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)A4FV33(Evidence code:IEA/Database source:UniProtKB:Q8R071|ens), GIPC1 PSEN1 ITPKA,BP,3,3 of 20,0.13,15,0.2029,0.2823
GO:0000910,cytokinesis,A5D7N6(Evidence code:IEA/Database source:InterPro:IPR032924)A5D793(Evidence code:IEA/Database source:InterPro:IPR026817)E1BLZ4(Evidence code:IEA/Database source:InterPro:IPR028730), KIF23 ECT2 ZFYVE26,BP,3,3 of 20,0.13,15,0.2029,0.2823
GO:0006612,protein targeting to membrane,A6QLD1(Evidence code:IBA/Database source:PANTHER:PTN000365473)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)Q0IIM2(Evidence code:IDA/Database source:), EXOC4 MYO1C ARL6,BP,3,3 of 20,0.13,15,0.2029,0.2823
GO:0005212,structural constituent of eye lens,P02510(Evidence code:IEA/Database source:InterPro:IPR003090)E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36552|ens)Q06002(Evidence code:IEA/Database source:UniProtKB-KW:KW-0273), CRYAB CPOX BFSP1,MF,3,3 of 20,0.13,15,0.2029,0.2823
GO:0005759,mitochondrial matrix,Q3SZK4(Evidence code:ISS/Database source:UniProtKB:Q969Z0)Q3T099(Evidence code:ISS/Database source:UniProtKB:Q9UGM6)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17)Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897)P11181(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0P5H7(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q32KZ1(Evidence code:TAS/Database source:)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)Q2TBI4(Evidence code:ISS/Database source:UniProtKB:Q12931)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens)Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens), TBRG4 WARS2 CCAR2 MTG1 SHMT2 DBT RARS2 MTIF3 CDK1 TRAP1 LRRK2 HSPA9,CC,12,12 of 111,0.51,10.81,0.2051,0.2853
GO:0005102,signaling receptor binding,A7MB15(Evidence code:IEA/Database source:UniProtKB:Q9UP38|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens)F1MXG8(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BQ11(Evidence code:IEA/Database source:UniProtKB:O60716|ens)Q95106(Evidence code:IEA/Database source:InterPro:IPR002072)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)F1N3I2(Evidence code:IBA/Database source:PANTHER:PTN000422452)P81425(Evidence code:ISS/Database source:UniProtKB:P27487)G3MYK9(Evidence code:IEA/Database source:UniProtKB:Q4LFA9|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:O14908|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens)Q3ZBW2(Evidence code:IEA/Database source:UniProtKB:Q9NYQ3|ens)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254)A7YWH4(Evidence code:IBA/Database source:PANTHER:PTN000422452)Q3ZBW6(Evidence code:IEA/Database source:UniProtKB:Q9NUI1|ens)Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Z1Z2|ens)Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BET5(Evidence code:IEA/Database source:InterPro:IPR029325)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens)F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN001231474)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)P62194(Evidence code:IEA/Database source:UniProtKB:P62196|ens)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357), FZD1 ABCA1 FKBP1B ABL1 JAK2 TYK2 LRP6 YES1 CTNND1 BDNF CAT LOC788634 DPP4 SEMA3G GIPC1 SRC HFE2 HAO2 GRB2 PTPA ZAP70 LAMA3 BoLA DECR2 STRAP DNAJB11 FRK SSFA2 FIS1 TEC GSK3A PSMC5 IDE MYO1C LCK,MF,35,35 of 385,1.49,9.09,0.2053,0.2855
GO:0032956,regulation of actin cytoskeleton organization,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens)G3MXG3(Evidence code:IEA/Database source:InterPro:IPR027717)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6R327|ens)Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I)Q5EAD0(Evidence code:IEA/Database source:InterPro:IPR030128)A8E4P5(Evidence code:IEA/Database source:UniProtKB:Q13491|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q6ZQ29|ens), ARHGAP35 CCDC88A ABL1 RICTOR ROCK2 BAIAP2 GPM6B CRK TAOK2,BP,9,9 of 82,0.38,10.98,0.2136,0.297
GO:0006402,mRNA catabolic process,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q9HCK5|ens)Q6T5B7(Evidence code:ISS/Database source:UniProtKB:Q9H9G7)E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR012162)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6P3D0), DXO AGO4 AGO3 PNPT1 NUDT16,BP,5,5 of 38,0.21,13.16,0.2138,0.2972
GO:0050767,regulation of neurogenesis,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q5E9Y6(Evidence code:IEA/Database source:UniProtKB:Q86TP1|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens), NF2 PRUNE1 CHD7,BP,3,3 of 91,0.13,3.3,0.2161,0.3003
GO:0019915,lipid storage,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B STAT5A,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0031663,lipopolysaccharide-mediated signaling pathway,P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168), LY96 TLR4,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0048814,regulation of dendrite morphogenesis,E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR030770), RAP2A SIPA1L1,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0045071,negative regulation of viral genome replication,E1BCF8(Evidence code:IEA/Database source:UniProtKB:Q7Z2W4|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens), ZC3HAV1 BANF1,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0042104,positive regulation of activated T cell proliferation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0006378,mRNA polyadenylation,O19137(Evidence code:IBA/Database source:PANTHER:PTN000559726)E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens), CPSF4 PABPC1L,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0006123,"mitochondrial electron transport, cytochrome c to oxygen",P62894(Evidence code:IBA/Database source:PANTHER:PTN000238899)P00423(Evidence code:IBA/Database source:PANTHER:PTN000076140), CYCS COX4I1,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,F1N6C1(Evidence code:IEA/Database source:UniProtKB:Q3UHC2|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens), LRRK1 PTPN6,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0051443,positive regulation of ubiquitin-protein transferase activity,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens), PIN1 AXIN1,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:2000649,regulation of sodium ion transmembrane transporter activity,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens)E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens), GPD1L SCN2B,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0046928,regulation of neurotransmitter secretion,E1B7T7(Evidence code:IEA/Database source:UniProtKB:Q8R1C0|ens)Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens), KCNC4 CAMK2A,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0071346,cellular response to interferon-gamma,Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens), MYO1C EPRS,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0042149,cellular response to glucose starvation,A6QLW1(Evidence code:IEA/Database source:UniProtKB:Q8VD65|ens)Q1LZA3(Evidence code:IEA/Database source:UniProtKB:P08243|ens), PIK3R4 ASNS,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P25713), LEF1 MT3,MF,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458)A6QQM1(Evidence code:IEA/Database source:UniProtKB:Q8ND76|ens), CCNL1 CCNY,MF,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0046464,acylglycerol catabolic process,Q08DW9(Evidence code:ISS/Database source:UniProtKB:Q99LR1)Q5EA42(Evidence code:ISS/Database source:UniProtKB:P08910), ABHD12 ABHD2,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)G3N127(Evidence code:IEA/Database source:UniProtKB:P27469|ens), PAK2 G0S2,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0043248,proteasome assembly,Q0P5A6(Evidence code:IEA/Database source:InterPro:IPR019538)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911), PSMD5 PSMD13,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0042273,ribosomal large subunit biogenesis,Q56JY1(Evidence code:IBA/Database source:PANTHER:PTN000096770)Q9TU47(Evidence code:IEA/Database source:UniRule:UR000107015), RPL35A EIF6,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0006182,cGMP biosynthetic process,A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR011645)Q29450(Evidence code:IBA/Database source:PANTHER:PTN000229249), GUCY1A3 ADCY7,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0046324,regulation of glucose import,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens), APPL1 HK2,BP,2,2 of 11,0.08,18.18,0.2197,0.3036
GO:0051881,regulation of mitochondrial membrane potential,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)A0JNJ3(Evidence code:IEA/Database source:UniProtKB:Q8N0X7|ens)Q5E9B7(Evidence code:IEA/Database source:UniProtKB:Q9Z1Q5|ens), PINK1 SPG20 CLIC1,BP,3,3 of 21,0.13,14.29,0.221,0.305
GO:0034614,cellular response to reactive oxygen species,Q2KI72(Evidence code:IEA/Database source:UniProtKB:P45984|ens)Q2KIN6(Evidence code:IBA/Database source:PANTHER:PTN002259008)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), MAPK9 MPV17 SRC,BP,3,3 of 21,0.13,14.29,0.221,0.305
GO:0008235,metalloexopeptidase activity,Q3ZC89(Evidence code:IEA/Database source:InterPro:IPR002468)E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180)A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0), METAP2 DPEP3 NUDT16,MF,3,3 of 21,0.13,14.29,0.221,0.305
GO:0055072,iron ion homeostasis,Q3T046(Evidence code:ISS/Database source:UniProtKB:Q8JZV9)F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens)E1BI30(Evidence code:IEA/Database source:InterPro:IPR033606), BDH2 TMPRSS6 HFE2,BP,3,3 of 21,0.13,14.29,0.221,0.305
GO:0032874,positive regulation of stress-activated MAPK cascade,Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)E1BKM6(Evidence code:IEA/Database source:UniProtKB:Q9UL54|ens)E1BHE1(Evidence code:IEA/Database source:UniProtKB:Q9H2K8|ens), PDCD10 TAOK2 TAOK3,BP,3,3 of 21,0.13,14.29,0.221,0.305
GO:0009887,animal organ morphogenesis,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens)E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens)F1MYD0(Evidence code:IEA/Database source:UniProtKB:Q9WTX6|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens), TRAF6 FOXF1 PDGFC TBX3 ASXL1 CUL1 CRKL,BP,7,7 of 60,0.3,11.67,0.2215,0.3057
GO:0043406,positive regulation of MAP kinase activity,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens)E1BJY4(Evidence code:IBA/Database source:PANTHER:PTN000180420)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)P03968(Evidence code:IEA/Database source:UniProtKB:P05230|ens), PSEN1 KIT PDGFC PDCD10 FGF1,BP,5,5 of 39,0.21,12.82,0.222,0.3063
GO:0010942,positive regulation of cell death,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)E1BJA2(Evidence code:IEA/Database source:UniProtKB:Q9Z0X1|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), MT3 AIFM1 EIF4G1 AXIN2 PRNP,BP,5,5 of 128,0.21,3.91,0.2232,0.3077
GO:0012506,vesicle membrane,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1B8X1(Evidence code:IEA/Database source:UniProtKB:Q8BX90|ens), APPL1 GRB2 GIPC1 DGKQ FNDC3A,CC,5,5 of 128,0.21,3.91,0.2232,0.3077
GO:0001934,positive regulation of protein phosphorylation,P37359(Evidence code:ISS/Database source:UniProtKB:P25713)Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens)E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens)Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)G3N016(Evidence code:IEA/Database source:UniProtKB:P46109|ens)Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), MT3 FLOT1 RAP2A FGF1 PIN1 PSEN1 MYDGF CRKL PAK1 CDON FZD1 PINK1 CIB1 ABL1 CLN3 FAM20A PROM2 AXIN2 AXIN1 LRRK2,BP,20,20 of 205,0.85,9.76,0.2295,0.3141
GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",F1MB84(Evidence code:IEA/Database source:InterPro:IPR006139)F1MYP4(Evidence code:IEA/Database source:InterPro:IPR006139)A5PJF9(Evidence code:IEA/Database source:InterPro:IPR001557|I)Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60)Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225)Q5EAD2(Evidence code:IEA/Database source:InterPro:IPR006139)A6QQR7(Evidence code:IEA/Database source:InterPro:IPR011128), GRHPR CTBP1 UEVLD FAM213B HSD3B7 PHGDH GPD1L,MF,7,7 of 62,0.3,11.29,0.2342,0.3141
GO:0009451,RNA modification,F1MRD5(Evidence code:IEA/Database source:InterPro:IPR020103)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR014780|I)F1N088(Evidence code:IEA/Database source:InterPro:IPR006145|I)Q3SX07(Evidence code:IEA/Database source:InterPro:IPR001406|I)E1BPX9(Evidence code:IBA/Database source:PANTHER:PTN000755749), PUS10 TRUB1 RPUSD2 PUS3 LRPPRC,BP,5,5 of 40,0.21,12.5,0.2307,0.3141
GO:0048589,developmental growth,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens)E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)A7MBG9(Evidence code:IEA/Database source:UniProtKB:Q9WUK2|ens), SRF PYGO2 NIPBL GLI2 WBSCR1,BP,5,5 of 41,0.21,12.2,0.2399,0.3141
GO:0032993,protein-DNA complex,A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)E1B9T7(Evidence code:IEA/Database source:UniProtKB:Q80U70|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), ATF6B ZBTB17 SUZ12 PRKDC LEF1,CC,5,5 of 41,0.21,12.2,0.2399,0.3141
GO:0031491,nucleosome binding,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:P55198|ens)Q2TA40(Evidence code:ISS/Database source:UniProtKB:Q99733), ARID1A MLLT6 NAP1L4,MF,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0003899,DNA-directed 5-3 RNA polymerase activity,Q32PE0(Evidence code:IEA/Database source:InterPro:IPR006110|I)G8JKZ3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0240)G3MZY8(Evidence code:IEA/Database source:InterPro:IPR000722|I), POLR2F PRIM1 POLR2A,MF,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0048568,embryonic organ development,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens)D2DVW5(Evidence code:IEA/Database source:InterPro:IPR032851)F1N607(Evidence code:IEA/Database source:UniProtKB:Q9D198|ens), SOX17 Gli3 SYF2,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0002064,epithelial cell development,F1N643(Evidence code:IEA/Database source:InterPro:IPR030494)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)E1BED7(Evidence code:IEA/Database source:UniProtKB:Q80W93|ens), SHROOM3 ONECUT2 HYDIN,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0034644,cellular response to UV,E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens)P68102(Evidence code:ISS/Database source:UniProtKB:Q6ZWX6)F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens), INO80 EIF2S1 NEDD4,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0002218,activation of innate immune response,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:P23246|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884), PRKDC SFPQ MB21D1,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0046328,regulation of JNK cascade,E1BNQ3(Evidence code:IEA/Database source:UniProtKB:P10114|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:Q92905|ens)E1BN82(Evidence code:IEA/Database source:UniProtKB:Q9ESN9|ens), RAP2A COPS5 MAPK8IP3,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,E1BE13(Evidence code:IEA/Database source:UniProtKB:Q9NR09|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), BIRC6 CTTN SRC,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0005977,glycogen metabolic process,P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0321)F1MJ90(Evidence code:IEA/Database source:InterPro:IPR008734)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0321), PPP1CC PHKB PPP1CB,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0032006,regulation of TOR signaling,E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens)F6Q3H3(Evidence code:IEA/Database source:UniProtKB:O43156|ens), GNA12 PKHD1 TTI1,BP,3,3 of 22,0.13,13.64,0.2394,0.3141
GO:0005751,mitochondrial respiratory chain complex IV,A5PK67(Evidence code:IBA/Database source:PANTHER:PTN001023184)P00423(Evidence code:IEA/Database source:UniProtKB:P13073|ens), MGC165862 COX4I1,CC,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0006779,porphyrin-containing compound biosynthetic process,E1BKY9(Evidence code:IEA/Database source:InterPro:IPR001260|I)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens), CPOX SPTA1,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0019674,NAD metabolic process,Q3SZD3(Evidence code:IEA/Database source:InterPro:IPR017437)A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q8N335|ens), NADK GPD1L,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0045646,regulation of erythrocyte differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38646), CDK6 HSPA9,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0050832,defense response to fungus,E1BEQ4(Evidence code:IBA/Database source:PANTHER:PTN000668306)P05059(Evidence code:IEA/Database source:UniProtKB-KW:KW-0295), LOC505658 CHGA,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0097381,photoreceptor disc membrane,P04695(Evidence code:TAS/Database source:)G3N152(Evidence code:IEA/Database source:UniProtKB:Q91Y03|ens), GNAT1 PCDHB8,CC,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0035326,enhancer binding,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens)E1B9X1(Evidence code:IEA/Database source:UniProtKB:Q7Z5J4|ens), LEF1 RAI1,MF,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0006555,methionine metabolic process,Q5I598(Evidence code:IEA/Database source:InterPro:IPR003171|I)A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens), MTHFR MTHFD1,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0032040,small-subunit processome,E1BGE2(Evidence code:IBA/Database source:PANTHER:PTN000427367)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848), UTP20 RPS7,CC,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0043488,regulation of mRNA stability,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q6PHQ9|ens), PUM1 PABPC4,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0006584,catecholamine metabolic process,P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0128)A7MBI7(Evidence code:IEA/Database source:InterPro:IPR017128), SULT1A1 COMT,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0015459,potassium channel regulator activity,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)G3N2S4(Evidence code:IEA/Database source:UniProtKB:Q2I0M4|ens), DLG1 LRRC26,MF,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0008299,isoprenoid biosynthetic process,E1BCH6(Evidence code:IEA/Database source:InterPro:IPR018294)Q6PTA0(Evidence code:IEA/Database source:InterPro:IPR013746), ISPD HMGCS1,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0004879,nuclear receptor activity,F1N3S3(Evidence code:IEA/Database source:InterPro:IPR003068)A2VDU4(Evidence code:IEA/Database source:UniProtKB:O75469|ens), NR2F6 NR1I2,MF,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0005520,insulin-like growth factor binding,F1N152(Evidence code:IEA/Database source:InterPro:IPR000867)P20959(Evidence code:IEA/Database source:InterPro:IPR000867|I), HTRA1 IGFBP3,MF,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0042770,signal transduction in response to DNA damage,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens), ABL1 GRB2,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0043525,positive regulation of neuron apoptotic process,Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens), BACE1 PRNP,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0006144,purine nucleobase metabolic process,Q2HJ58(Evidence code:IEA/Database source:UniProtKB:P60891|ens)Q32L93(Evidence code:IEA/Database source:UniProtKB-KW:KW-0659), PRPS1 GMPR2,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0032757,positive regulation of interleukin-8 production,Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens), AFAP1L2 DDX58,BP,2,2 of 12,0.08,16.67,0.2455,0.3141
GO:0006278,RNA-dependent DNA biosynthetic process,F1MMS4(Evidence code:IEA/Database source:GO:0003720),TERF2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035845,photoreceptor cell outer segment organization,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5),AHI1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0032516,positive regulation of phosphoprotein phosphatase activity,Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens),PTPA,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030681,multimeric ribonuclease P complex,E1BK83(Evidence code:IEA/Database source:UniProtKB:Q9BUL9|ens),RPP25,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004322,ferroxidase activity,O46414(Evidence code:IEA/Database source:EC:1.16.3.1),FTH1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0010614,negative regulation of cardiac muscle hypertrophy,Q58DA7(Evidence code:ISS/Database source:UniProtKB:Q9CQM9),GLRX3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0015937,coenzyme A biosynthetic process,A4FV09(Evidence code:IEA/Database source:InterPro:IPR004567|I),PANK4,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0044387,negative regulation of protein kinase activity by regulation of protein phosphorylation,F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens),ADARB1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0002281,macrophage activation involved in immune response,A0JND4(Evidence code:IEA/Database source:UniProtKB:Q7TNB8|ens),SBNO2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000035,regulation of stem cell division,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046101,hypoxanthine biosynthetic process,Q2HJ58(Evidence code:IEA/Database source:UniProtKB:P60891|ens),PRPS1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045252,oxoglutarate dehydrogenase complex,E1BFI2(Evidence code:IBA/Database source:PANTHER:PTN000568211),DHTKD1,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1901142,insulin metabolic process,Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens),IDE,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043558,regulation of translational initiation in response to stress,P68102(Evidence code:ISS/Database source:UniProtKB:Q6ZWX6),EIF2S1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006021,inositol biosynthetic process,P20456(Evidence code:IEA/Database source:UniPathway:UPA00823),IMPA1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006108,malate metabolic process,Q148D3(Evidence code:IBA/Database source:PANTHER:PTN000154499),FH,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060340,positive regulation of type I interferon-mediated signaling pathway,P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens),UBE2K,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0042711,maternal behavior,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035374,chondroitin sulfate binding,G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q99PI8|ens),RTN4R,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0052650,NADP-retinol dehydrogenase activity,O77769(Evidence code:IEA/Database source:EC:1.1.1.300),DHRS3,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004000,adenosine deaminase activity,F1N0T4(Evidence code:IEA/Database source:InterPro:IPR002466),ADARB1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046325,negative regulation of glucose import,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens),SIRT6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0036132,13-prostaglandin reductase activity,Q32L99(Evidence code:IEA/Database source:EC:1.3.1.48),PTGR2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045322,unmethylated CpG binding,F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens),KMT2A,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004719,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,P15246(Evidence code:IEA/Database source:InterPro:IPR000682),PCMT1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0008179,adenylate cyclase binding,G3MWT9(Evidence code:IEA/Database source:UniProtKB:Q02952|ens),AKAP12,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1990966,ATP generation from poly-ADP-D-ribose,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1904262,negative regulation of TORC1 signaling,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0001733,galactosylceramide sulfotransferase activity,F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729),GAL3ST2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004647,phosphoserine phosphatase activity,Q3ZBF9(Evidence code:IEA/Database source:EC:3.1.3.3),PDXP,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0018026,peptidyl-lysine monomethylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0090308,regulation of methylation-dependent chromatin silencing,A7E320(Evidence code:IBA/Database source:PANTHER:PTN000365142),UHRF1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0002820,negative regulation of adaptive immune response,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046527,glucosyltransferase activity,Q0VD36(Evidence code:IBA/Database source:PANTHER:PTN000258330),KDELC1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030038,contractile actin filament bundle assembly,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0036312,phosphatidylinositol 3-kinase regulatory subunit binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046912,"transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer",Q32PF2(Evidence code:IEA/Database source:InterPro:IPR002020|I),ACLY,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0005471,ATP:ADP antiporter activity,P02722(Evidence code:IBA/Database source:PANTHER:PTN000640049),SLC25A4,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030043,actin filament fragmentation,Q5E9D5(Evidence code:IEA/Database source:UniProtKB:Q9R0P5|ens),DSTN,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045064,T-helper 2 cell differentiation,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0070410,co-SMAD binding,G5E630(Evidence code:IEA/Database source:UniProtKB:Q93008|ens),USP9X,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0070861,regulation of protein exit from endoplasmic reticulum,E1BB16(Evidence code:IEA/Database source:UniProtKB:Q8IWJ2|ens),GCC2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0000930,gamma-tubulin complex,E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens),CKAP5,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0072606,interleukin-8 secretion,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0042989,sequestering of actin monomers,Q56JV6(Evidence code:IEA/Database source:UniProtKB:Q91YR1|ens),TWF1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0010994,free ubiquitin chain polymerization,P61085(Evidence code:IEA/Database source:UniProtKB:P61086|ens),UBE2K,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000232,regulation of rRNA processing,E1BGW4(Evidence code:IEA/Database source:UniProtKB:B1AQJ2|ens),USP36,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051150,regulation of smooth muscle cell differentiation,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0007289,spermatid nucleus differentiation,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens),PYGO2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0047134,protein-disulfide reductase activity,F1MHF7(Evidence code:IEA/Database source:UniProtKB:Q9BRA2|ens),TXNDC17,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0048027,mRNA 5-UTR binding,F1MWD3(Evidence code:IEA/Database source:UniProtKB:P48643|ens),CCT5,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0034141,positive regulation of toll-like receptor 3 signaling pathway,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0019732,antifungal humoral response,P05059(Evidence code:IMP/Database source:),CHGA,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060088,auditory receptor cell stereocilium organization,F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q80U72|ens),SCRIB,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1902626,assembly of large subunit precursor of preribosome,Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061),EIF6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0001931,uropod,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0097150,neuronal stem cell population maintenance,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q9R0L6|ens),PCM1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045654,positive regulation of megakaryocyte differentiation,Q28046(Evidence code:ISS/Database source:UniProtKB:Q9Y6U3),SCIN,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0070836,caveola assembly,Q1RMR9(Evidence code:IEA/Database source:InterPro:IPR028521|I),PACSIN2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,Q0VD59(Evidence code:IEA/Database source:UniProtKB:Q9DBD2|ens),MARCH8,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043560,insulin receptor substrate binding,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens),GRB2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060972,left/right pattern formation,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens),MEGF8,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046209,nitric oxide metabolic process,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens),CPS1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0047017,prostaglandin-F synthase activity,Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60),FAM213B,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0001609,G-protein coupled adenosine receptor activity,E1BKU0(Evidence code:IEA/Database source:InterPro:IPR001634),ADORA2A,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0008603,cAMP-dependent protein kinase regulator activity,P00515(Evidence code:IEA/Database source:InterPro:IPR012198),PRKAR2A,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0002692,negative regulation of cellular extravasation,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1900121,negative regulation of receptor binding,E1BBU4(Evidence code:IEA/Database source:UniProtKB:Q13444|ens),ADAM15,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060017,parathyroid gland development,G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens),CRKL,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0070940,dephosphorylation of RNA polymerase II C-terminal domain,F6RRD7(Evidence code:ISS/Database source:UniProtKB:Q8IXW5),RPAP2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006884,cell volume homeostasis,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0031545,peptidyl-proline 4-dioxygenase activity,A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0071526,semaphorin-plexin signaling pathway,F1MYW3(Evidence code:IEA/Database source:UniProtKB:P70275|ens),SEMA3E,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0016461,unconventional myosin complex,E1BA80(Evidence code:IEA/Database source:UniProtKB:Q8IUG5|ens),MYO18B,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006646,phosphatidylethanolamine biosynthetic process,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0016064,immunoglobulin mediated immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0015693,magnesium ion transport,E1BIL3(Evidence code:IEA/Database source:UniProtKB:Q3TWN3|ens),CNNM2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1902692,regulation of neuroblast proliferation,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1900122,positive regulation of receptor binding,Q95106(Evidence code:IEA/Database source:UniProtKB:P23560|ens),BDNF,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0000055,ribosomal large subunit export from nucleus,E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens),XPO1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0070765,gamma-secretase complex,Q9XT97(Evidence code:ISS/Database source:UniProtKB:P49768),PSEN1,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051580,regulation of neurotransmitter uptake,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0021545,cranial nerve development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0003180,aortic valve morphogenesis,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051988,regulation of attachment of spindle microtubules to kinetochore,E1BJP2(Evidence code:IEA/Database source:UniProtKB:Q9H0H5|ens),RACGAP1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000484,positive regulation of interleukin-8 secretion,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0003857,3-hydroxyacyl-CoA dehydrogenase activity,Q8SPX7(Evidence code:IEA/Database source:InterPro:IPR006108|I),CRYL1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0050775,positive regulation of dendrite morphogenesis,F1MT17(Evidence code:ISS/Database source:UniProtKB:P70298),CUX2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1900449,regulation of glutamate receptor signaling pathway,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045730,respiratory burst,O77775(Evidence code:IEA/Database source:InterPro:IPR034889),NCF2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051481,negative regulation of cytosolic calcium ion concentration,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0001881,receptor recycling,F1MRI6(Evidence code:IEA/Database source:UniProtKB:Q8IWU2|ens),LMTK2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0014883,transition between fast and slow fiber,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0032060,bleb assembly,F1MFY7(Evidence code:IEA/Database source:UniProtKB:Q4KMQ2|ens),ANO6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0044539,long-chain fatty acid import,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens),EPRS,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0048385,regulation of retinoic acid receptor signaling pathway,Q5PXY7(Evidence code:IEA/Database source:InterPro:IPR031281),CRABP2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000811,negative regulation of anoikis,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004622,lysophospholipase activity,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q8N2K0|ens),ABHD12,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060441,epithelial tube branching involved in lung morphogenesis,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens),FOXF1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0086006,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,E1B757(Evidence code:IEA/Database source:UniProtKB:O60939|ens),SCN2B,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030223,neutrophil differentiation,E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens),LEF1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043138,3-5 DNA helicase activity,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens),WRN,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030914,STAGA complex,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens),TAF10,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1900264,positive regulation of DNA-directed DNA polymerase activity,Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250),RFC2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060052,neurofilament cytoskeleton organization,Q08DH7(Evidence code:IEA/Database source:UniProtKB:P46660|ens),INA,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0003854,3-beta-hydroxy-delta5-steroid dehydrogenase activity,Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225),HSD3B7,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0007097,nuclear migration,P43033(Evidence code:IBA/Database source:PANTHER:PTN000752736),PAFAH1B1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1990763,arrestin family protein binding,Q0P5B0(Evidence code:IEA/Database source:UniProtKB:Q8N5I2|ens),ARRDC1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0016307,phosphatidylinositol phosphate kinase activity,Q0P5F7(Evidence code:IEA/Database source:InterPro:IPR002498),PIP4K2C,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045410,positive regulation of interleukin-6 biosynthetic process,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006572,tyrosine catabolic process,Q58CZ9(Evidence code:ISS/Database source:UniProtKB:P17735),TAT,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060159,regulation of dopamine receptor signaling pathway,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens),LRRK2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030628,pre-mRNA 3-splice site binding,E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566979),UHMK1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1905448,positive regulation of mitochondrial ATP synthesis coupled electron transport,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0019388,galactose catabolic process,Q3T105(Evidence code:IEA/Database source:UniProtKB:Q14376|ens),GALE,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0033512,L-lysine catabolic process to acetyl-CoA via saccharopine,A8E657(Evidence code:IEA/Database source:UniPathway:UPA00868),AASS,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030206,chondroitin sulfate biosynthetic process,E1BMM8(Evidence code:IEA/Database source:UniProtKB:Q6IQX7|ens),CHPF,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046827,positive regulation of protein export from nucleus,P00517(Evidence code:IEA/Database source:UniProtKB:P05132|ens),PRKACA,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0031821,G-protein coupled serotonin receptor binding,P63097(Evidence code:IBA/Database source:PANTHER:PTN000026625),GNAI1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0097361,CIA complex,E1BP36(Evidence code:ISS/Database source:UniProtKB:Q96T76),MMS19,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000765,regulation of cytoplasmic translation,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004427,inorganic diphosphatase activity,Q5E9Y6(Evidence code:IEA/Database source:EC:3.6.1.1),PRUNE1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000781,positive regulation of double-strand break repair,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q96DE0),NUDT16,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0005123,death receptor binding,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060628,regulation of ER to Golgi vesicle-mediated transport,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens),RNF139,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035927,RNA import into mitochondrion,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0048806,genitalia development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens),RFFL,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0010766,negative regulation of sodium ion transport,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1900227,positive regulation of NLRP3 inflammasome complex assembly,Q9GL65(Evidence code:ISS/Database source:UniProtKB:Q9QUK6),TLR4,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043139,5-3 DNA helicase activity,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens),IGFBP3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0008195,phosphatidate phosphatase activity,E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256564),LPIN2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0016584,nucleosome positioning,A7MAZ5(Evidence code:IEA/Database source:UniProtKB:P43277|ens),HIST1H1D,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0000305,response to oxygen radical,O62768(Evidence code:IBA/Database source:PANTHER:PTN000530450),TXNRD1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004185,serine-type carboxypeptidase activity,E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084),CPXM2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0015057,thrombin-activated receptor activity,A7YY44(Evidence code:IEA/Database source:InterPro:IPR003912),F2R,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045714,regulation of low-density lipoprotein particle receptor biosynthetic process,A6QNT8(Evidence code:IEA/Database source:UniProtKB:Q3U2P1|ens),SEC24A,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030169,low-density lipoprotein particle binding,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0005483,soluble NSF attachment protein activity,P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241),NAPG,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1900034,regulation of cellular response to heat,Q29RL2(Evidence code:ISS/Database source:UniProtKB:Q9D1P4),CHORDC1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0097421,liver regeneration,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens),GLI1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035904,aorta development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000392,regulation of lamellipodium morphogenesis,Q29423(Evidence code:ISS/Database source:UniProtKB:P16070),CD44,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,Q4TVR5(Evidence code:ISS/Database source:UniProtKB:Q6XUX3),DSTYK,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0017136,NAD-dependent histone deacetylase activity,F6QK60(Evidence code:IEA/Database source:InterPro:IPR017328),SIRT2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2001046,positive regulation of integrin-mediated signaling pathway,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0097157,pre-mRNA intronic binding,A7Z025(Evidence code:IBA/Database source:PANTHER:PTN000124558),PRPF8,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0016577,histone demethylation,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens),KDM6B,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006307,DNA dealkylation involved in DNA repair,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004128,"cytochrome-b5 reductase activity, acting on NAD(P)H",Q32LH7(Evidence code:IEA/Database source:EC:1.6.2.2),CYB5R4,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0047522,15-oxoprostaglandin 13-oxidase activity,Q32L99(Evidence code:IEA/Database source:InterPro:IPR037399),PTGR2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0032933,SREBP signaling pathway,A6QM06(Evidence code:IEA/Database source:InterPro:IPR030225),SCAP,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0071638,negative regulation of monocyte chemotactic protein-1 production,P02638(Evidence code:IGI/Database source:UniProtKB:Q62151),S100B,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0010820,positive regulation of T cell chemotaxis,E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens),WNK1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0044065,regulation of respiratory system process,Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17),MTG1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens),TACSTD2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0071850,mitotic cell cycle arrest,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004022,alcohol dehydrogenase (NAD) activity,Q3ZC42(Evidence code:IEA/Database source:EC:1.1.1.1),ADH5,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046322,negative regulation of fatty acid oxidation,P48818(Evidence code:IEA/Database source:UniProtKB:P50544|ens),ACADVL,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030323,respiratory tube development,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens),FOXF1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0044342,type B pancreatic cell proliferation,P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens),IGFBP3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060546,negative regulation of necroptotic process,P02722(Evidence code:IEA/Database source:UniProtKB:P12235|ens),SLC25A4,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035518,histone H2A monoubiquitination,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046597,negative regulation of viral entry into host cell,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens),SNX3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0007194,negative regulation of adenylate cyclase activity,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:O75781|ens),PALM,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0007548,sex differentiation,Q32LE6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0726),DMRTC2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0050220,prostaglandin-E synthase activity,Q3ZBF7(Evidence code:IEA/Database source:EC:5.3.99.3),PTGES3,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0008241,peptidyl-dipeptidase activity,P12820(Evidence code:IEA/Database source:InterPro:IPR001548),ACE,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046636,negative regulation of alpha-beta T cell activation,E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens),ADORA2A,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0016714,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen",Q2KIH7(Evidence code:IEA/Database source:InterPro:IPR019773|I),PAH,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0038180,nerve growth factor signaling pathway,F1MSG6(Evidence code:ISS/Database source:UniProtKB:F1M386),RAPGEF2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045653,negative regulation of megakaryocyte differentiation,Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4),CIB1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0072201,negative regulation of mesenchymal cell proliferation,F1MHX5(Evidence code:IEA/Database source:UniProtKB:Q9D4H9|ens),PHF14,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035315,hair cell differentiation,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0075525,viral translational termination-reinitiation,A7MB16(Evidence code:IEA/Database source:UniProtKB:P55884|ens),EIF3B,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0019918,"peptidyl-arginine methylation, to symmetrical-dimethyl arginine",A7YW45(Evidence code:IBA/Database source:PANTHER:PTN000077429),PRMT5,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006171,cAMP biosynthetic process,Q29450(Evidence code:IEA/Database source:InterPro:IPR009398|I),ADCY7,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0052745,inositol phosphate phosphatase activity,E1BB73(Evidence code:IEA/Database source:InterPro:IPR037793),INPP5B,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004656,procollagen-proline 4-dioxygenase activity,Q3SYY3(Evidence code:IEA/Database source:InterPro:IPR013547),P4HA2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0071837,HMG box domain binding,A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens),SP1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043023,ribosomal large subunit binding,Q9TU47(Evidence code:IEA/Database source:UniRule:UR000107015),EIF6,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0008622,epsilon DNA polymerase complex,A6QQ14(Evidence code:ISS/Database source:UniProtKB:Q9NR33),POLE4,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0033299,secretion of lysosomal enzymes,P11456(Evidence code:IEA/Database source:UniProtKB:P24668|ens),M6PR,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030325,adrenal gland development,Q95MI6(Evidence code:IEA/Database source:UniProtKB:Q8CIT0|ens),CRH,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0072540,T-helper 17 cell lineage commitment,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens),RNF139,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0097484,dendrite extension,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q5SQX6|ens),CYFIP2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035253,ciliary rootlet,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1903445,protein transport from ciliary membrane to plasma membrane,Q0IIM2(Evidence code:IEA/Database source:UniProtKB:O88848|ens),ARL6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0008347,glial cell migration,F1MY84(Evidence code:IEA/Database source:UniProtKB:Q8VHY0|ens),CSPG4,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0072422,signal transduction involved in DNA damage checkpoint,Q2KJC1(Evidence code:ISS/Database source:UniProtKB:Q99459),CDC5L,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0001955,blood vessel maturation,F1MI56(Evidence code:IEA/Database source:UniProtKB:Q99NH0|ens),ANKRD17,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051571,positive regulation of histone H3-K4 methylation,F1MHA1(Evidence code:IEA/Database source:UniProtKB:P55200|ens),KMT2A,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0071817,MMXD complex,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051000,positive regulation of nitric-oxide synthase activity,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0032593,insulin-responsive compartment,Q2TBH7(Evidence code:IBA/Database source:PANTHER:PTN001179259),RAB4A,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035523,protein K29-linked deubiquitination,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens),USP13,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030422,production of siRNA involved in RNA interference,Q6TUI4(Evidence code:ISS/Database source:UniProtKB:Q9UPY3),DICER1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046966,thyroid hormone receptor binding,E1B7Q7(Evidence code:IEA/Database source:UniProtKB:Q14669|ens),TRIP12,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0010857,calcium-dependent protein kinase activity,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060205,cytoplasmic vesicle lumen,E1BCA5(Evidence code:IEA/Database source:UniProtKB:Q99574|ens),SERPINI1,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0019853,L-ascorbic acid biosynthetic process,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0016723,"oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor",Q4JIJ2(Evidence code:ISS/Database source:UniProtKB:Q9UBK8),MTRR,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030877,beta-catenin destruction complex,E1B714(Evidence code:IEA/Database source:InterPro:IPR029797),AXIN1,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0003139,secondary heart field specification,G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens),AXIN2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0085020,protein K6-linked ubiquitination,Q864U1(Evidence code:ISS/Database source:UniProtKB:P38398),BRCA1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0098505,G-rich strand telomeric DNA binding,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,F1N3I4(Evidence code:IEA/Database source:UniProtKB:Q69ZN7|ens),MYOF,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043034,costamere,E1BIS6(Evidence code:IEA/Database source:UniProtKB:O15061|ens),SYNM,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens),NPAT,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0048266,behavioral response to pain,A6QLN9(Evidence code:IEA/Database source:UniProtKB:Q8R2Z5|ens),VWA1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0019864,IgG binding,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0072358,cardiovascular system development,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0003376,sphingosine-1-phosphate receptor signaling pathway,E1BJM1(Evidence code:IEA/Database source:GO:0038036),SPHK2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0000395,mRNA 5-splice site recognition,Q0VCY7(Evidence code:ISS/Database source:UniProtKB:Q07955),SRSF1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045445,myoblast differentiation,A5PJL3(Evidence code:IEA/Database source:UniProtKB:P53778|ens),MAPK12,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0070371,ERK1 and ERK2 cascade,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0034101,erythrocyte homeostasis,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0000780,"condensed nuclear chromosome, centromeric region",F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens),ATRX,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0097202,activation of cysteine-type endopeptidase activity,F1MX60(Evidence code:IEA/Database source:UniProtKB:Q96F07|ens),CYFIP2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0007512,adult heart development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0046598,positive regulation of viral entry into host cell,A2VDV7(Evidence code:IEA/Database source:UniProtKB:O15393|ens),TMPRSS2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0047429,nucleoside-triphosphate diphosphatase activity,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0019215,intermediate filament binding,E1BIS6(Evidence code:IEA/Database source:UniProtKB:Q70IV5|ens),SYNM,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0038093,Fc receptor signaling pathway,P43481(Evidence code:IEA/Database source:InterPro:IPR027263),KIT,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0070876,SOSS complex,E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens),INTS3,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0048384,retinoic acid receptor signaling pathway,E1BC39(Evidence code:IEA/Database source:InterPro:IPR003078),ESRRG,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035773,insulin secretion involved in cellular response to glucose stimulus,P56722(Evidence code:ISS/Database source:UniProtKB:Q60673),PTPRN,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1902991,regulation of amyloid precursor protein catabolic process,F1MK99(Evidence code:IEA/Database source:UniProtKB:Q4KUS2|ens),UNC13A,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1903136,cuprous ion binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060019,radial glial cell differentiation,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0009214,cyclic nucleotide catabolic process,P06623(Evidence code:IEA/Database source:InterPro:IPR008431),CNP,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045820,negative regulation of glycolytic process,A5D7K6(Evidence code:IEA/Database source:UniProtKB:P59941|ens),SIRT6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0031053,primary miRNA processing,A6QR44(Evidence code:IEA/Database source:UniProtKB:Q8WYQ5|ens),DGCR8,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035243,protein-arginine omega-N symmetric methyltransferase activity,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744),PRMT5,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1903053,regulation of extracellular matrix organization,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006547,histidine metabolic process,A5PJV3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0369),AMDHD1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0043249,erythrocyte maturation,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051895,negative regulation of focal adhesion assembly,F1N6V1(Evidence code:IEA/Database source:UniProtKB:O43182|ens),ARHGAP6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1901409,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,E1BJ67(Evidence code:IBA/Database source:PANTHER:PTN000002458),CCNL1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035970,peptidyl-threonine dephosphorylation,E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens),PPM1D,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0048738,cardiac muscle tissue development,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:1902950,regulation of dendritic spine maintenance,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens),VPS35,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0061133,endopeptidase activator activity,Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens),PSMD14,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035357,peroxisome proliferator activated receptor signaling pathway,A6QNT4(Evidence code:IBA/Database source:PANTHER:PTN000410115),FAM120B,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0042987,amyloid precursor protein catabolic process,Q9XT97(Evidence code:IEA/Database source:InterPro:IPR002031),PSEN1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0005921,gap junction,E1BF03(Evidence code:IEA/Database source:UniProtKB-KW:KW-0303),PANX3,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0002689,negative regulation of leukocyte chemotaxis,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0030130,clathrin coat of trans-Golgi network vesicle,P04973(Evidence code:IEA/Database source:InterPro:IPR000996),CLTA,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060355,positive regulation of cell adhesion molecule production,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060020,Bergmann glial cell differentiation,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens),ABL1,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0051409,response to nitrosative stress,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens),ADH5,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0010764,negative regulation of fibroblast migration,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0001782,B cell homeostasis,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0005697,telomerase holoenzyme complex,E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280),SMG6,CC,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0004045,aminoacyl-tRNA hydrolase activity,E1BK88(Evidence code:IEA/Database source:InterPro:IPR001328|I),PTRH1,MF,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0035093,"spermatogenesis, exchange of chromosomal proteins",G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens),HIST1H2BA,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0048333,mesodermal cell differentiation,G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens),KDM6B,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0060081,membrane hyperpolarization,P35071(Evidence code:ISS/Database source:UniProtKB:P26361),CFTR,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006265,DNA topological change,F1MU48(Evidence code:IEA/Database source:InterPro:IPR001154|I),TOP2B,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0061029,eyelid development in camera-type eye,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0045836,positive regulation of meiotic nuclear division,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0006689,ganglioside catabolic process,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,BP,1,1 of 3,0.04,33.33,0.2453,0.3141
GO:0031647,regulation of protein stability,Q3ZC71(Evidence code:IEA/Database source:UniProtKB:Q9P2X0|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)P46196(Evidence code:ISS/Database source:UniProtKB:P26696)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06945)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)E1BGW4(Evidence code:IEA/Database source:UniProtKB:Q9P275|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens), DPM3 GIPC1 CCAR2 MAPK1 SOX4 NF2 USP36 VPS35,BP,8,8 of 71,0.34,11.27,0.2564,0.3279
GO:0051726,regulation of cell cycle,F1MH31(Evidence code:IEA/Database source:UniProtKB:Q80U93|ens)E1BNT2(Evidence code:IBA/Database source:PANTHER:PTN000006943)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141)E1BB50(Evidence code:IEA/Database source:GO:0004693)P61635(Evidence code:ISS/Database source:UniProtKB:P40763)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:O35864|ens)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)F1MYP4(Evidence code:IEA/Database source:UniProtKB:Q13363|ens)F1MN42(Evidence code:IEA/Database source:GO:0004693)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BGK8(Evidence code:IEA/Database source:InterPro:IPR030445)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q61501|ens)F1MNE5(Evidence code:IEA/Database source:UniProtKB:Q8BPY9|ens)F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens)E1BB52(Evidence code:IEA/Database source:GO:0004693)E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens)F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7)Q5E9B7(Evidence code:IEA/Database source:InterPro:IPR030259), NUP214 TSC2 SRC CDK12 STAT3 NF2 ADARB1 TXLNG COPS5 SFPQ CTBP1 CDK17 ABL1 DOT1L E2F1 FIGNL1 BCR SIRT2 CDK13 PUM1 PHACTR4 CLIC1,BP,22,22 of 232,0.93,9.48,0.2582,0.3302
GO:0070848,response to growth factor,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q92908|ens),GATA6,BP,1,1 of 47,0.04,2.13,0.2585,0.3304
GO:0008654,phospholipid biosynthetic process,Q95JH2(Evidence code:IEA/Database source:InterPro:IPR004552),AGPAT1,BP,1,1 of 48,0.04,2.08,0.2585,0.3304
GO:0065004,protein-DNA complex assembly,A6QPK5(Evidence code:IEA/Database source:UniProtKB:Q60722|ens),TCF7L2,BP,1,1 of 47,0.04,2.13,0.2585,0.3304
GO:1901657,glycosyl compound metabolic process,E1BAI2(Evidence code:IBA/Database source:PANTHER:PTN000039458),KL,BP,1,1 of 49,0.04,2.04,0.2592,0.3311
GO:0017038,protein import,E1BHK6(Evidence code:IEA/Database source:UniProtKB:Q8WV41|ens),SNX33,BP,1,1 of 49,0.04,2.04,0.2592,0.3311
GO:0042110,T cell activation,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 51,0.04,1.96,0.2626,0.3353
GO:1902905,positive regulation of supramolecular fiber organization,P00435(Evidence code:IDA/Database source:),GPX1,BP,1,1 of 51,0.04,1.96,0.2626,0.3353
GO:0030246,carbohydrate binding,F1MWT0(Evidence code:IEA/Database source:InterPro:IPR011013)P81282(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)E1BB48(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)F1N4Q3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)F1MF76(Evidence code:IEA/Database source:InterPro:IPR013784)P13608(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430)G3N2I5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0430), MAN2C1 VCAN GALNT2 SFTPD GALNT7 LOC515570 ACAN KLRF2,MF,8,8 of 73,0.34,10.96,0.2648,0.3379
GO:0006364,rRNA processing,Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0698)E1BC24(Evidence code:IBA/Database source:PANTHER:PTN000529705)Q56JX6(Evidence code:IEA/Database source:UniProtKB:P62857|ens)Q2KHT7(Evidence code:ISS/Database source:UniProtKB:P42677)A6H769(Evidence code:IBA/Database source:PANTHER:PTN000138848)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)E1BGE2(Evidence code:IEA/Database source:UniProtKB:O75691|ens)P61356(Evidence code:ISS/Database source:UniProtKB:P61353), EIF4A3 MDN1 RPS28 RPS27 RPS7 RPS19 UTP20 RPL27,BP,8,8 of 73,0.34,10.96,0.2648,0.3379
GO:0099568,cytoplasmic region,P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens),ITGB2,CC,1,1 of 52,0.04,1.92,0.2653,0.3384
GO:0045927,positive regulation of growth,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 52,0.04,1.92,0.2653,0.3384
GO:0002790,peptide secretion,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 53,0.04,1.89,0.2686,0.3425
GO:0043408,regulation of MAPK cascade,E1BA03(Evidence code:IBA/Database source:PANTHER:PTN000686326)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)E1B7J7(Evidence code:IBA/Database source:PANTHER:PTN000686326)G3MZE2(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q3T0F9(Evidence code:IEA/Database source:UniProtKB:Q60631|ens)G5E5G9(Evidence code:IBA/Database source:PANTHER:PTN000686326)Q08E52(Evidence code:IBA/Database source:PANTHER:PTN000686326), PAK6 SYNGAP1 PAK3 PAK2 GRB2 PAK4 PAK1,BP,7,7 of 152,0.3,4.61,0.2704,0.3447
GO:0009190,cyclic nucleotide biosynthetic process,A0A1P8NW44(Evidence code:IEA/Database source:InterPro:IPR001054|I)Q29450(Evidence code:IEA/Database source:InterPro:IPR001054|I), GUCY1A3 ADCY7,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:1990782,protein tyrosine kinase binding,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), DUSP3 CRK,MF,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0003073,regulation of systemic arterial blood pressure,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)E1BHX7(Evidence code:IEA/Database source:UniProtKB:Q01970|ens), GSK3A PLCB3,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",E1BGE2(Evidence code:IBA/Database source:PANTHER:PTN000427367)Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens), UTP20 RPS19,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:1901799,negative regulation of proteasomal protein catabolic process,A1A4J8(Evidence code:IEA/Database source:UniProtKB:Q5SUC9|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9H992|ens), SCO1 MARCH7,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0008089,anterograde axonal transport,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9QYY8)E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens), SPAST KIF1B,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0055008,cardiac muscle tissue morphogenesis,E1BL04(Evidence code:IEA/Database source:UniProtKB:Q4U4S6|ens)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens), XIRP2 MYLK2,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0031579,membrane raft organization,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens), NPC1 DLG1,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0001516,prostaglandin biosynthetic process,Q58CY6(Evidence code:ISS/Database source:UniProtKB:Q9DB60)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0643), FAM213B PTGES3,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0005501,retinoid binding,P12661(Evidence code:IEA/Database source:InterPro:IPR032956)F1MIF5(Evidence code:IEA/Database source:UniProtKB:Q9EPC5|ens), RBP3 RBP7,MF,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0048662,negative regulation of smooth muscle cell proliferation,P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens)D7GLD1(Evidence code:IEA/Database source:InterPro:IPR027089), IGFBP3 MFN2,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:1901796,regulation of signal transduction by p53 class mediator,E1BB49(Evidence code:IEA/Database source:UniProtKB:Q3V016|ens)Q5E9L5(Evidence code:IEA/Database source:UniProtKB:Q6NZB1|ens), HIPK4 PRMT6,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0045010,actin nucleation,Q28046(Evidence code:IDA/Database source:)E1BGT8(Evidence code:IEA/Database source:InterPro:IPR029901|I), SCIN SPIRE1,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0097755,positive regulation of blood vessel diameter,Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453988)E1BPU9(Evidence code:IEA/Database source:UniProtKB:P28828|ens), NOS2 PTPRM,BP,2,2 of 13,0.08,15.38,0.2714,0.3448
GO:0007281,germ cell development,E1BPH3(Evidence code:IEA/Database source:InterPro:IPR037982)P43033(Evidence code:IBA/Database source:PANTHER:PTN000522053)F1MZE7(Evidence code:IEA/Database source:UniProtKB:Q99MV1|ens)F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens), TDRD5 PAFAH1B1 TDRD1 EHMT2,BP,4,4 of 28,0.17,14.29,0.2748,0.3491
GO:0051592,response to calcium ion,P48452(Evidence code:ISS/Database source:UniProtKB:Q08209)Q28204(Evidence code:IEA/Database source:UniProtKB:Q12791|ens)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:P12815|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens), PPP3CA KCNMA1 PDCD6 PEF1,BP,4,4 of 28,0.17,14.29,0.2748,0.3491
GO:0072593,reactive oxygen species metabolic process,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)P23709(Evidence code:ISS/Database source:UniProtKB:O75489)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)F1MF26(Evidence code:IEA/Database source:UniProtKB:O89032|ens), LRRK2 NDUFS3 PREX1 SH3PXD2A,BP,4,4 of 29,0.17,13.79,0.2814,0.3574
GO:0006520,cellular amino acid metabolic process,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005958)F1MVC0(Evidence code:IEA/Database source:InterPro:IPR006130|I)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A5D7H9(Evidence code:IBA/Database source:PANTHER:PTN000907055)Q5EAC2(Evidence code:IBA/Database source:PANTHER:PTN000122964), TAT CAD CLN3 SLC6A14 GSS,BP,5,5 of 118,0.21,4.24,0.2822,0.3583
GO:0016042,lipid catabolic process,Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)Q5EA59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR014815)P16386(Evidence code:IEA/Database source:InterPro:IPR010468)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033562)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)Q29460(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442)P08487(Evidence code:IEA/Database source:UniProtKB-KW:KW-0442), ABHD2 ABHD4 LIPF PLCB3 LIPE PNPLA2 PAFAH1B1 PAFAH1B3 PLCG1,BP,9,9 of 84,0.38,10.71,0.2963,0.3608
GO:0051213,dioxygenase activity,F1MXW0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223)A5D9D7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223)Q58DM4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0223), ALOX15B ALOX15 PLOD3 ALKBH2,MF,4,4 of 30,0.17,13.33,0.2889,0.3608
GO:0042177,negative regulation of protein catabolic process,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens), PIN1 SNX3 SNX12 SIRT2,BP,4,4 of 31,0.17,12.9,0.297,0.3608
GO:0007623,circadian rhythm,E1BAS6(Evidence code:IEA/Database source:UniProtKB:A2AKX3|ens)Q3SWY3(Evidence code:ISS/Database source:UniProtKB:P12268)Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460)F1MN36(Evidence code:IBA/Database source:PANTHER:PTN001050425), SETX IMPDH2 KCNMA1 PROK1,BP,4,4 of 31,0.17,12.9,0.297,0.3608
GO:0006405,RNA export from nucleus,F1MH31(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1BD05(Evidence code:IBA/Database source:PANTHER:PTN000573960)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604), NUP214 POM121L2 TPR RANBP2,BP,4,4 of 30,0.17,13.33,0.2889,0.3608
GO:0016032,viral process,Q8SQB8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945)P61285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945)P53712(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945)P80746(Evidence code:IEA/Database source:UniProtKB-KW:KW-0945), ITGB6 DYNLL1 ITGB1 ITGAV,BP,4,4 of 30,0.17,13.33,0.2889,0.3608
GO:0044389,ubiquitin-like protein ligase binding,E1BMF7(Evidence code:IEA/Database source:UniProtKB:Q92995|ens)P56722(Evidence code:IEA/Database source:UniProtKB:Q16849|ens)Q08DL9(Evidence code:IEA/Database source:UniProtKB:Q92783|ens), USP13 PTPRN STAM,MF,3,3 of 85,0.13,3.53,0.2862,0.3608
GO:0072657,protein localization to membrane,A7MB21(Evidence code:IEA/Database source:UniProtKB:Q8CIB5|ens)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)A2VDT8(Evidence code:IEA/Database source:UniRule:UR000169773), FERMT2 CLN3 HPS6,BP,3,3 of 85,0.13,3.53,0.2862,0.3608
GO:0055074,calcium ion homeostasis,E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens)P31407(Evidence code:ISS/Database source:UniProtKB:P15313), KL FAM20A ATP6V1B1,BP,3,3 of 88,0.13,3.41,0.2908,0.3608
GO:0008509,anion transmembrane transporter activity,F1MCB5(Evidence code:IEA/Database source:InterPro:IPR013769)F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens)F1N4L1(Evidence code:IEA/Database source:InterPro:IPR013769), SLC4A7 ABCA1 SLC4A2,MF,3,3 of 87,0.13,3.45,0.2889,0.3608
GO:0051058,negative regulation of small GTPase mediated signal transduction,G5E5V6(Evidence code:IEA/Database source:UniProtKB:Q0VF96|ens)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), CGNL1 SLIT2,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0031305,integral component of mitochondrial inner membrane,A1A4J8(Evidence code:ISS/Database source:UniProtKB:O75880)Q2HJE9(Evidence code:IBA/Database source:PANTHER:PTN000050380), SCO1 TIMM17B,CC,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0001659,temperature homeostasis,P48818(Evidence code:IEA/Database source:UniProtKB:P50544|ens)P61635(Evidence code:ISS/Database source:UniProtKB:P42227), ACADVL STAT3,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0009749,response to glucose,P68107(Evidence code:IEA/Database source:UniProtKB:Q9Z2I2|ens)A1A4J1(Evidence code:ISS/Database source:UniProtKB:P17858), FKBP1B PFKL,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0051057,positive regulation of small GTPase mediated signal transduction,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), CDON SRC,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0048015,phosphatidylinositol-mediated signaling,E1BE66(Evidence code:IEA/Database source:InterPro:IPR008290|I)O02811(Evidence code:IEA/Database source:InterPro:IPR015433), PIK3CD PI4KA,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0008483,transaminase activity,Q08DQ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0032)Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR005958), GFPT2 TAT,MF,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0006383,transcription by RNA polymerase III,Q32PE0(Evidence code:IEA/Database source:GO:0001056)F1MMD0(Evidence code:IEA/Database source:UniProtKB:Q969F1|ens), POLR2F GTF3C6,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0071011,precatalytic spliceosome,A4FUI2(Evidence code:IBA/Database source:PANTHER:PTN000127555)Q1RMR2(Evidence code:IBA/Database source:PANTHER:PTN000359236), SNRPE SNRNP70,CC,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0070979,protein K11-linked ubiquitination,Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036)A7Z061(Evidence code:ISS/Database source:UniProtKB:P30260), UBE2L3 CDC27,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0001523,retinoid metabolic process,P48644(Evidence code:IDA/Database source:)Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens), ALDH1A1 ADH5,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0005246,calcium channel regulator activity,P05126(Evidence code:IEA/Database source:UniProtKB:P68404|ens)E1BLE8(Evidence code:IBA/Database source:PANTHER:PTN001173589), PRKCB GRM7,MF,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0030301,cholesterol transport,Q0VD48(Evidence code:IEA/Database source:UniProtKB:P46467|ens)B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens), VPS4B NPC1,BP,2,2 of 14,0.08,14.29,0.2972,0.3608
GO:0060122,inner ear receptor cell stereocilium organization,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens),ALMS1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0007020,microtubule nucleation,A5D7P5(Evidence code:IEA/Database source:InterPro:IPR007259),TUBGCP2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0033549,MAP kinase phosphatase activity,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens),DUSP3,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0060347,heart trabecula formation,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031284,positive regulation of guanylate cyclase activity,Q27995(Evidence code:IBA/Database source:PANTHER:PTN001066032),NOS2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0004661,protein geranylgeranyltransferase activity,P29702(Evidence code:ISS/Database source:UniProtKB:P49354),FNTA,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0035810,positive regulation of urine volume,O97711(Evidence code:ISS/Database source:UniProtKB:O35776),HAS2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0000220,"vacuolar proton-transporting V-type ATPase, V0 domain",P23956(Evidence code:IBA/Database source:PANTHER:PTN000029540),ATP6V0C,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0001103,RNA polymerase II repressing transcription factor binding,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030277,maintenance of gastrointestinal epithelium,Q5E959(Evidence code:IEA/Database source:UniProtKB:Q9Y3F4|ens),STRAP,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0010759,positive regulation of macrophage chemotaxis,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0046641,positive regulation of alpha-beta T cell proliferation,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0048667,cell morphogenesis involved in neuron differentiation,F6QHJ6(Evidence code:IEA/Database source:UniProtKB:Q8BL48|ens),UNK,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0005890,sodium:potassium-exchanging ATPase complex,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0005641,nuclear envelope lumen,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:O88307|ens),SORL1,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030851,granulocyte differentiation,O02754(Evidence code:ISS/Database source:UniProtKB:P53566),CEBPA,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0044321,response to leptin,P61635(Evidence code:ISS/Database source:UniProtKB:P40763),STAT3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0097433,dense body,E1B7E6(Evidence code:IEA/Database source:UniProtKB:Q8CDG1|ens),PIWIL2,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0001504,neurotransmitter uptake,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034244,negative regulation of transcription elongation from RNA polymerase II promoter,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599),AXIN1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0070266,necroptotic process,F1MPF0(Evidence code:IEA/Database source:UniProtKB:Q96QT4|ens),TRPM7,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0001221,transcription cofactor binding,F1N734(Evidence code:IEA/Database source:UniProtKB:Q8TD26|ens),CHD6,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0006298,mismatch repair,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens),TDG,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0048706,embryonic skeletal system development,E1BCF7(Evidence code:IEA/Database source:UniProtKB:P40764|ens),DLX2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0017017,MAP kinase tyrosine/serine/threonine phosphatase activity,A6QLS1(Evidence code:IEA/Database source:InterPro:IPR008343),DUSP7,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0070822,Sin3-type complex,F1MZQ1(Evidence code:IBA/Database source:PANTHER:PTN001004204),SAP130,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034979,NAD-dependent protein deacetylase activity,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045239,tricarboxylic acid cycle enzyme complex,Q148D3(Evidence code:IEA/Database source:InterPro:IPR005677),FH,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0033151,V(D)J recombination,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0060999,positive regulation of dendritic spine development,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,F6Q9J4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0491),LOC100848815,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030060,L-malate dehydrogenase activity,Q5EAD2(Evidence code:IEA/Database source:EC:1.1.1.37),PHGDH,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032466,negative regulation of cytokinesis,E1BE02(Evidence code:ISS/Database source:UniProtKB:Q6S7F2),E2F7,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0051642,centrosome localization,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens),BICD2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0005221,intracellular cyclic nucleotide activated cation channel activity,G3MXA9(Evidence code:IEA/Database source:InterPro:IPR032943),CNGB3,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0007260,tyrosine phosphorylation of STAT protein,E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700624),JAK2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0005865,striated muscle thin filament,P68138(Evidence code:ISS/Database source:UniProtKB:P68133),ACTA1,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030575,nuclear body organization,Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens),CELF3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031639,plasminogen activation,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens),HIST1H2BA,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031362,anchored component of external side of plasma membrane,G3MXX5(Evidence code:IEA/Database source:UniProtKB:Q9BZR6|ens),RTN4R,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0006777,Mo-molybdopterin cofactor biosynthetic process,F1MQ57(Evidence code:IEA/Database source:InterPro:IPR008284),GPHN,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034715,pICln-Sm protein complex,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304),SNRPE,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0060055,angiogenesis involved in wound healing,Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens),GPR4,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0060076,excitatory synapse,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0002063,chondrocyte development,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens),SHOX2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0008090,retrograde axonal transport,P43033(Evidence code:IBA/Database source:PANTHER:PTN000522053),PAFAH1B1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0009264,deoxyribonucleotide catabolic process,Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3),SAMHD1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032050,clathrin heavy chain binding,P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens),CLTA,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0015250,water channel activity,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:P55064|ens),AQP5,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0097512,cardiac myofibril,Q0VD56(Evidence code:IEA/Database source:UniProtKB:Q14896|ens),MYBPC3,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034969,histone arginine methylation,A6QL80(Evidence code:IEA/Database source:GO:0008469),PRMT3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032924,activin receptor signaling pathway,E1BI30(Evidence code:IEA/Database source:UniProtKB:Q6ZVN8|ens),HFE2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030521,androgen receptor signaling pathway,E1B925(Evidence code:IEA/Database source:UniProtKB:O14497|ens),ARID1A,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0042448,progesterone metabolic process,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232),STAT5B,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0010575,positive regulation of vascular endothelial growth factor production,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0001968,fibronectin binding,P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens),IGFBP3,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0019321,pentose metabolic process,E1BNF8(Evidence code:IEA/Database source:UniProtKB:Q96C11|ens),FGGY,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0004535,poly(A)-specific ribonuclease activity,E1BML0(Evidence code:IBA/Database source:PANTHER:PTN000404664),PAN2,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032350,regulation of hormone metabolic process,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:1901612,cardiolipin binding,E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens),ATP8B1,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034227,tRNA thio-modification,Q0VC66(Evidence code:IEA/Database source:InterPro:IPR000541),CTU1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0000137,Golgi cis cisterna,Q3T0Q2(Evidence code:IEA/Database source:UniProtKB:Q9BXS4|ens),TMEM59,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,Q2TA08(Evidence code:IEA/Database source:UniProtKB:Q9UL15|ens),BAG5,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0000774,adenyl-nucleotide exchange factor activity,Q0IIM3(Evidence code:ISS/Database source:UniProtKB:Q92598),HSPH1,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:2000737,negative regulation of stem cell differentiation,E1BB52(Evidence code:IEA/Database source:UniProtKB:Q69ZA1|ens),CDK13,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0015450,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,Q2HJE9(Evidence code:IEA/Database source:InterPro:IPR005678),TIMM17B,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0019430,removal of superoxide radicals,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031145,anaphase-promoting complex-dependent catabolic process,E1BIN5(Evidence code:IEA/Database source:UniProtKB:Q13618|ens),CUL3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0071933,Arp2/3 complex binding,F1MTR1(Evidence code:IEA/Database source:UniProtKB:Q13576|ens),IQGAP2,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0003958,NADPH-hemoprotein reductase activity,Q27995(Evidence code:IBA/Database source:PANTHER:PTN000453822),NOS2,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0072163,mesonephric epithelium development,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0019211,phosphatase activator activity,Q2KJ44(Evidence code:IEA/Database source:InterPro:IPR004327|I),PTPA,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0002320,lymphoid progenitor cell differentiation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0001741,XY body,A2VDZ4(Evidence code:IEA/Database source:UniProtKB:Q64702|ens),PLK4,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0042585,germinal vesicle,Q647I9(Evidence code:IDA/Database source:),NLRP5,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0051350,negative regulation of lyase activity,Q32PA4(Evidence code:IEA/Database source:UniProtKB:Q9NRX4|ens),PHPT1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031390,Ctf18 RFC-like complex,Q05B83(Evidence code:ISS/Database source:UniProtKB:P35250),RFC2,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031424,keratinization,A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0417),TGM3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0042166,acetylcholine binding,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0007131,reciprocal meiotic recombination,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens),UBR2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0090085,regulation of protein deubiquitination,A2VE03(Evidence code:ISS/Database source:UniProtKB:Q8C863),ITCH,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0046475,glycerophospholipid catabolic process,Q08DW9(Evidence code:IEA/Database source:UniProtKB:Q8N2K0|ens),ABHD12,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0060547,negative regulation of necrotic cell death,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0050072,m7G(5)pppN diphosphatase activity,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0048265,response to pain,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0097228,sperm principal piece,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031432,titin binding,E1B8E3(Evidence code:IEA/Database source:InterPro:IPR028780),ANKRD23,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0042474,middle ear morphogenesis,G3MY13(Evidence code:IEA/Database source:UniProtKB:Q5DTH5|ens),TSHZ1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031529,ruffle organization,P85091(Evidence code:IDA/Database source:),CYFIP1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0042256,mature ribosome assembly,Q9TU47(Evidence code:IEA/Database source:InterPro:IPR002769),EIF6,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045721,negative regulation of gluconeogenesis,A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens),GCK,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens),LAMP1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0051280,negative regulation of release of sequestered calcium ion into cytosol,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045494,photoreceptor cell maintenance,F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens),PROM1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0000722,telomere maintenance via recombination,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens),BRCA2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0003847,1-alkyl-2-acetylglycerophosphocholine esterase activity,Q29460(Evidence code:IEA/Database source:EC:3.1.1.47),PAFAH1B3,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0031616,spindle pole centrosome,F1N7I5(Evidence code:IEA/Database source:UniProtKB:Q14980|ens),NUMA1,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0001829,trophectodermal cell differentiation,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0071028,nuclear mRNA surveillance,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348),DXO,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0006596,polyamine biosynthetic process,E1BM12(Evidence code:IEA/Database source:UniProtKB-KW:KW-0620),SRM,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032700,negative regulation of interleukin-17 production,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032528,microvillus organization,E1BN05(Evidence code:IEA/Database source:UniProtKB:Q8BMF8|ens),GLDN,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034115,negative regulation of heterotypic cell-cell adhesion,E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens),WNK1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0048745,smooth muscle tissue development,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0072542,protein phosphatase activator activity,F1MCY2(Evidence code:ISS/Database source:UniProtKB:Q501J7),PHACTR4,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030240,skeletal muscle thin filament assembly,P68138(Evidence code:ISS/Database source:UniProtKB:P68133),ACTA1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0035265,organ growth,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens),EHMT2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032727,positive regulation of interferon-alpha production,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens),DDX58,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0043295,glutathione binding,Q5EAC2(Evidence code:ISS/Database source:UniProtKB:P48637),GSS,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0033683,"nucleotide-excision repair, DNA incision",A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0043268,positive regulation of potassium ion transport,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0005436,sodium:phosphate symporter activity,A7YY70(Evidence code:IBA/Database source:PANTHER:PTN000000493),SLC34A1,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0005683,U7 snRNP,A4FUI2(Evidence code:ISS/Database source:UniProtKB:P62304),SNRPE,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0010829,negative regulation of glucose transmembrane transport,P05126(Evidence code:ISS/Database source:UniProtKB:P68404),PRKCB,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034501,protein localization to kinetochore,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0033147,negative regulation of intracellular estrogen receptor signaling pathway,E1BCS0(Evidence code:IEA/Database source:UniProtKB:Q8N895|ens),ZNF366,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0002076,osteoblast development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0019563,glycerol catabolic process,Q0IID9(Evidence code:IEA/Database source:UniPathway:UPA00618),GK,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034393,positive regulation of smooth muscle cell apoptotic process,A5PJP8(Evidence code:IEA/Database source:UniProtKB:P47809|ens),MAP2K4,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0071564,npBAF complex,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0003401,axis elongation,F1MWK8(Evidence code:IEA/Database source:UniProtKB:Q8BKG3|ens),PTK7,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045988,negative regulation of striated muscle contraction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0018126,protein hydroxylation,A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034616,response to laminar fluid shear stress,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0050765,negative regulation of phagocytosis,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493),SNX3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0051284,positive regulation of sequestering of calcium ion,P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens),FKBP1B,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0046487,glyoxylate metabolic process,F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens),GRHPR,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0022615,protein to membrane docking,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493),SNX3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0072488,ammonium transmembrane transport,F1MS08(Evidence code:IEA/Database source:GO:0008519),SLC12A2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0009650,UV protection,P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens),CAT,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0035567,non-canonical Wnt signaling pathway,A7MB15(Evidence code:IBA/Database source:PANTHER:PTN000139394),FZD1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0008641,ubiquitin-like modifier activating enzyme activity,E1B8X4(Evidence code:IEA/Database source:InterPro:IPR000594|I),NAE1,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0021819,layer formation in cerebral cortex,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045910,negative regulation of DNA recombination,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045061,thymic T cell selection,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045835,negative regulation of meiotic nuclear division,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens),RPS6KA2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0044854,plasma membrane raft assembly,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O75955|ens),FLOT1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:2001214,positive regulation of vasculogenesis,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7),RAPGEF2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0070008,serine-type exopeptidase activity,Q9XTA2(Evidence code:IEA/Database source:InterPro:IPR023302),PREP,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032232,negative regulation of actin filament bundle assembly,G5E618(Evidence code:IEA/Database source:UniProtKB:D3YZU1|ens),SHANK1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0010739,positive regulation of protein kinase A signaling,G3MWT9(Evidence code:IEA/Database source:InterPro:IPR028540),AKAP12,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0042974,retinoic acid receptor binding,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0000095,S-adenosyl-L-methionine transmembrane transporter activity,A6QR09(Evidence code:ISS/Database source:UniProtKB:Q70HW3),SLC25A26,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0071044,histone mRNA catabolic process,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0071493,cellular response to UV-B,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0048645,animal organ formation,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0043020,NADPH oxidase complex,O77775(Evidence code:IEA/Database source:InterPro:IPR034889),NCF2,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0032585,multivesicular body membrane,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030897,HOPS complex,A3KN15(Evidence code:IEA/Database source:UniRule:UR000570763),VPS41,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0000819,sister chromatid segregation,F1MU48(Evidence code:IBA/Database source:PANTHER:PTN000018888),TOP2B,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0016441,posttranscriptional gene silencing,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens),PUM1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0042953,lipoprotein transport,F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens),CUBN,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0072669,tRNA-splicing ligase complex,Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499),DDX1,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0004111,creatine kinase activity,Q5EA61(Evidence code:IEA/Database source:EC:2.7.3.2),CKB,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0019370,leukotriene biosynthetic process,Q3SZH7(Evidence code:ISS/Database source:UniProtKB:P09960),LTA4H,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0035751,regulation of lysosomal lumen pH,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0070295,renal water absorption,O97711(Evidence code:ISS/Database source:UniProtKB:O35776),HAS2,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045876,positive regulation of sister chromatid cohesion,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens),SFPQ,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0043576,regulation of respiratory gaseous exchange,E1BJM5(Evidence code:IEA/Database source:UniProtKB:Q8CEE6|ens),PASK,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0003747,translation release factor activity,Q0VCX5(Evidence code:IEA/Database source:InterPro:IPR004403),ETF1,MF,1,1 of 4,0.04,25,0.2965,0.3608
GO:0030388,"fructose 1,6-bisphosphate metabolic process",A1A4J1(Evidence code:ISS/Database source:UniProtKB:P17858),PFKL,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:1901797,negative regulation of signal transduction by p53 class mediator,F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens),RFFL,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,Q3MI00(Evidence code:ISS/Database source:UniProtKB:P25685),DNAJB1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0051602,response to electrical stimulus,P11023(Evidence code:ISS/Database source:UniProtKB:P63011),RAB3A,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0003279,cardiac septum development,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0006188,IMP biosynthetic process,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0045475,locomotor rhythm,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0034498,early endosome to Golgi transport,Q2KHV6(Evidence code:ISS/Database source:UniProtKB:Q9Y5X2),SNX8,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0050884,neuromuscular process controlling posture,F1N0T4(Evidence code:IEA/Database source:UniProtKB:Q91ZS8|ens),ADARB1,BP,1,1 of 4,0.04,25,0.2965,0.3608
GO:0005744,mitochondrial inner membrane presequence translocase complex,Q2HJE9(Evidence code:IEA/Database source:InterPro:IPR005678),TIMM17B,CC,1,1 of 4,0.04,25,0.2965,0.3608
GO:0008081,phosphoric diester hydrolase activity,A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens)P08487(Evidence code:IEA/Database source:InterPro:IPR017946)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR017946)F1MS27(Evidence code:IEA/Database source:InterPro:IPR023088|I), SMPDL3B PLCG1 PLCB3 PDE4D,MF,4,4 of 32,0.17,12.5,0.3059,0.3712
GO:0017148,negative regulation of translation,Q2NL22(Evidence code:IEA/Database source:UniProtKB:P38919|ens)E1BMW9(Evidence code:IEA/Database source:GO:0000900)G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens), EIF4A3 PURA EPRS RNF139,BP,4,4 of 32,0.17,12.5,0.3059,0.3712
GO:0045598,regulation of fat cell differentiation,E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens)A7MAZ4(Evidence code:IEA/Database source:UniProtKB:Q7Z7C8|ens)F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens), ALMS1 GNB3 TAF8 SIRT2,BP,4,4 of 33,0.17,12.12,0.3155,0.3827
GO:0051480,regulation of cytosolic calcium ion concentration,O18784(Evidence code:IBA/Database source:PANTHER:PTN000012230)F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens)O62826(Evidence code:IBA/Database source:PANTHER:PTN000012230)F1MN60(Evidence code:IEA/Database source:UniProtKB:Q01814|ens)P68107(Evidence code:IEA/Database source:UniProtKB:P68106|ens), TRPC1 CLN3 ATP2B3 TRPC2 ATP2B2 FKBP1B,BP,6,6 of 57,0.25,10.53,0.322,0.3905
GO:1903076,regulation of protein localization to plasma membrane,A5PKI0(Evidence code:IEA/Database source:UniProtKB:Q9UKG1|ens)Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens), APPL1 STX7,BP,2,2 of 15,0.08,13.33,0.3229,0.391
GO:0032760,positive regulation of tumor necrosis factor production,P58754(Evidence code:ISS/Database source:UniProtKB:Q9JHF9)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens), LY96 FCER1G,BP,2,2 of 15,0.08,13.33,0.3229,0.391
GO:0006892,post-Golgi vesicle-mediated transport,Q32P83(Evidence code:IBA/Database source:PANTHER:PTN000328285)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens), RABIF SORL1,BP,2,2 of 15,0.08,13.33,0.3229,0.391
GO:0010631,epithelial cell migration,F1MPF3(Evidence code:IEA/Database source:UniProtKB:Q9NYQ8|ens)A1A4I4(Evidence code:ISS/Database source:UniProtKB:Q16512), FAT2 PKN1,BP,2,2 of 15,0.08,13.33,0.3229,0.391
GO:0032481,positive regulation of type I interferon production,E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8C6L5)Q3SZP0(Evidence code:ISS/Database source:UniProtKB:P15314), MB21D1 IRF1,BP,2,2 of 15,0.08,13.33,0.3229,0.391
GO:0043044,ATP-dependent chromatin remodeling,F1MLB2(Evidence code:IEA/Database source:InterPro:IPR034724)E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens), CHD8 ARID1A,BP,2,2 of 15,0.08,13.33,0.3229,0.391
GO:1901379,regulation of potassium ion transmembrane transport,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q99246|ens), PRNP CACNA1D,BP,2,2 of 15,0.08,13.33,0.3229,0.391
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)Q3ZCC3(Evidence code:IEA/Database source:InterPro:IPR037309), DAB2IP TRAF6,BP,2,2 of 62,0.08,3.23,0.3238,0.392
GO:0005126,cytokine receptor binding,P56831(Evidence code:IEA/Database source:InterPro:IPR000471)Q8MJ29(Evidence code:IEA/Database source:InterPro:IPR000471)G3N183(Evidence code:IEA/Database source:InterPro:IPR000471)P56830(Evidence code:IEA/Database source:InterPro:IPR000471), IFNT3 IFNT LOC104968438 IFNT2,MF,4,4 of 97,0.17,4.12,0.324,0.3921
GO:0050678,regulation of epithelial cell proliferation,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens), FRS2 TACSTD2,BP,2,2 of 64,0.08,3.12,0.325,0.3931
GO:0051276,chromosome organization,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), SFPQ BRCA2,BP,2,2 of 64,0.08,3.12,0.325,0.3931
GO:0005539,glycosaminoglycan binding,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)F6QPI1(Evidence code:IEA/Database source:UniProtKB:Q8C119|ens), PRNP NDNF,MF,2,2 of 64,0.08,3.12,0.325,0.3931
GO:0008652,cellular amino acid biosynthetic process,Q1LZA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028)Q5EAD2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028)Q4JIJ2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028)Q2NL31(Evidence code:IEA/Database source:UniProtKB-KW:KW-0028), ASNS PHGDH MTRR MRI1,BP,4,4 of 34,0.17,11.76,0.3256,0.3937
GO:0052548,regulation of endopeptidase activity,Q3T112(Evidence code:IEA/Database source:UniProtKB:P28062|ens)Q58DU5(Evidence code:IEA/Database source:UniProtKB:P25788|ens), PSMB8 PSMA3,BP,2,2 of 66,0.08,3.03,0.3283,0.3969
GO:0030855,epithelial cell differentiation,A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)P48818(Evidence code:IEA/Database source:UniProtKB:P49748|ens)Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens)F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens)E1BM28(Evidence code:IEA/Database source:UniProtKB:O43598|ens)P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)F1MJ18(Evidence code:IEA/Database source:UniProtKB:O70374|ens), FZD1 ACADVL F11R GATA6 DNPH1 CDK1 CBFA2T2,BP,7,7 of 63,0.3,11.11,0.334,0.4037
GO:0030163,protein catabolic process,Q08DE9(Evidence code:IEA/Database source:UniProtKB:Q9D4H8|ens)Q2HJI9(Evidence code:IEA/Database source:UniProtKB:P62878|ens)F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens)Q2KIW6(Evidence code:IEA/Database source:InterPro:IPR005937)Q2HJ40(Evidence code:IBA/Database source:PANTHER:PTN000342793)Q1JP95(Evidence code:IEA/Database source:InterPro:IPR005937)P62194(Evidence code:IEA/Database source:InterPro:IPR005937)A4FUZ3(Evidence code:IEA/Database source:InterPro:IPR005937)E1BCW1(Evidence code:IEA/Database source:InterPro:IPR003769)Q5E9F9(Evidence code:IEA/Database source:InterPro:IPR005937), CUL2 RBX1 RNF165 PSMC6 BACE1 PSMC3 PSMC5 PSMC1 UBR2 PSMC2,BP,10,10 of 100,0.42,10,0.3389,0.4046
GO:0045296,cadherin binding,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)A6QP29(Evidence code:IEA/Database source:UniProtKB:Q9BYX2|ens)F1MK52(Evidence code:IEA/Database source:UniProtKB:O43490|ens)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR001033)E1BPU9(Evidence code:ISS/Database source:UniProtKB:P28827)E1BQ11(Evidence code:IEA/Database source:InterPro:IPR028439)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR001033|I), PSEN1 TBC1D2 PROM1 CTNNA2 PTPRM CTNND1 CTNNA1,MF,7,7 of 64,0.3,10.94,0.3374,0.4046
GO:0043409,negative regulation of MAPK cascade,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens), ASH1L PTPN6 NF2 DUSP3,BP,4,4 of 35,0.17,11.43,0.3362,0.4046
GO:0030170,pyridoxal phosphate binding,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR004838|I)A7MBC2(Evidence code:IEA/Database source:InterPro:IPR002129)E1BP41(Evidence code:IEA/Database source:InterPro:IPR002129)Q3SZ20(Evidence code:IEA/Database source:InterPro:IPR001085|I), TAT PDXDC1 CSAD SHMT2,MF,4,4 of 35,0.17,11.43,0.3362,0.4046
GO:0010212,response to ionizing radiation,A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)E1BEI6(Evidence code:IEA/Database source:InterPro:IPR015519), BRCC3 PRKDC INTS3 ATM,BP,4,4 of 35,0.17,11.43,0.3362,0.4046
GO:0030125,clathrin vesicle coat,P04973(Evidence code:IBA/Database source:PANTHER:PTN000067451),CLTA,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0000244,spliceosomal tri-snRNP complex assembly,A7Z025(Evidence code:IEA/Database source:UniProtKB:Q6P2Q9|ens),PRPF8,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0030008,TRAPP complex,Q2TBL9(Evidence code:IEA/Database source:InterPro:IPR007233),TRAPPC4,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0033558,protein deacetylase activity,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:1903494,response to dehydroepiandrosterone,P02668(Evidence code:IDA/Database source:),CSN3,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0097602,cullin family protein binding,E1BL52(Evidence code:IBA/Database source:PANTHER:PTN000129805),LOC780968,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0071801,regulation of podosome assembly,E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141),SRC,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010898,positive regulation of triglyceride catabolic process,Q2KI18(Evidence code:IEA/Database source:InterPro:IPR033903),PNPLA2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0000407,phagophore assembly site,E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023),ATG2B,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0070567,cytidylyltransferase activity,E1BCH6(Evidence code:IEA/Database source:InterPro:IPR034683),ISPD,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0048535,lymph node development,E1BP22(Evidence code:IEA/Database source:UniProtKB:P0C090|ens),RC3H2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0017046,peptide hormone binding,Q1LZF7(Evidence code:ISS/Database source:UniProtKB:Q03431),PTH1R,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0003015,heart process,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010669,epithelial structure maintenance,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0032733,positive regulation of interleukin-10 production,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0098586,cellular response to virus,G3X793(Evidence code:IEA/Database source:UniProtKB:Q15759|ens),MAPK11,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0043236,laminin binding,E1B9H1(Evidence code:IEA/Database source:UniProtKB:Q99JR5|ens),TINAGL1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0070527,platelet aggregation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0021542,dentate gyrus development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0046697,decidualization,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0097322,7SK snRNA binding,Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens),CELF3,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0055069,zinc ion homeostasis,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0043691,reverse cholesterol transport,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0009074,aromatic amino acid family catabolic process,Q58CZ9(Evidence code:IEA/Database source:InterPro:IPR011715),TAT,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0005313,L-glutamate transmembrane transporter activity,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens),SLC17A8,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0060047,heart contraction,F1MNR5(Evidence code:IEA/Database source:UniProtKB:Q9WUT3|ens),RPS6KA2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0005688,U6 snRNP,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817),LSM4,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0042403,thyroid hormone metabolic process,Q2KHX6(Evidence code:IEA/Database source:UniProtKB:O54983|ens),CRYM,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0016805,dipeptidase activity,E1BDI1(Evidence code:IEA/Database source:InterPro:IPR000180|I),DPEP3,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010907,positive regulation of glucose metabolic process,F1MYE0(Evidence code:IEA/Database source:UniProtKB:P35568|ens),IRS1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0071392,cellular response to estradiol stimulus,F1MVD0(Evidence code:IEA/Database source:UniProtKB:Q9Y6Q9|ens),NCOA3,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0001942,hair follicle development,A5PJT8(Evidence code:IEA/Database source:UniProtKB:Q9D1G0|ens),DNASE1L2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0097153,cysteine-type endopeptidase activity involved in apoptotic process,Q3T0P5(Evidence code:IBA/Database source:PANTHER:PTN000047947),CASP6,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0042136,neurotransmitter biosynthetic process,Q2KJH9(Evidence code:ISS/Database source:UniProtKB:P49189),ALDH9A1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0006851,mitochondrial calcium ion transmembrane transport,Q0VCA3(Evidence code:ISS/Database source:UniProtKB:O95202),LETM1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0031580,membrane raft distribution,P63026(Evidence code:IMP/Database source:),VAMP2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:1903432,regulation of TORC1 signaling,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0005664,nuclear origin of replication recognition complex,F1N397(Evidence code:IEA/Database source:UniProtKB:Q9UFC0|ens),LRWD1,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010825,positive regulation of centrosome duplication,Q28021(Evidence code:IEA/Database source:InterPro:IPR029878|I),ROCK2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway,P27479(Evidence code:ISS/Database source:UniProtKB:P39654),ALOX15,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0016556,mRNA modification,Q3ZBA6(Evidence code:IEA/Database source:UniProtKB:Q99KV1|ens),DNAJB11,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0045309,protein phosphorylated amino acid binding,E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens),CRK,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0045603,positive regulation of endothelial cell differentiation,E1B7I2(Evidence code:IEA/Database source:UniProtKB:P41163|ens),ETV2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0023019,signal transduction involved in regulation of gene expression,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0000212,meiotic spindle organization,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens),ATRX,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0061351,neural precursor cell proliferation,G3X749(Evidence code:IEA/Database source:UniProtKB:Q7TMA2|ens),ZNF503,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0035375,zymogen binding,P02668(Evidence code:IPI/Database source:UniProtKB:P00750),CSN3,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0060749,mammary gland alveolus development,E1BIQ2(Evidence code:IEA/Database source:UniProtKB:Q3UHD9|ens),AGAP2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0032205,negative regulation of telomere maintenance,F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens),TERF2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0019104,DNA N-glycosylase activity,A4IF83(Evidence code:IEA/Database source:InterPro:IPR003310|I),TDG,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010390,histone monoubiquitination,A7E320(Evidence code:IEA/Database source:UniProtKB:Q8VDF2|ens),UHRF1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q96SN8|ens),CDK5RAP2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0016868,"intramolecular transferase activity, phosphotransferases",F1MS56(Evidence code:IEA/Database source:InterPro:IPR005843|I),PGM3,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0006734,NADH metabolic process,A6QQR7(Evidence code:IEA/Database source:UniProtKB:Q3ULJ0|ens),GPD1L,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0033522,histone H2A ubiquitination,E1BCW1(Evidence code:IEA/Database source:UniProtKB:Q6WKZ8|ens),UBR2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0097225,sperm midpiece,E1BM47(Evidence code:IEA/Database source:UniProtKB:Q7M6Y6|ens),MROH2B,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0052866,phosphatidylinositol phosphate phosphatase activity,E1BFE6(Evidence code:IEA/Database source:InterPro:IPR037857),MTMR1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0033962,cytoplasmic mRNA processing body assembly,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817),LSM4,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0006107,oxaloacetate metabolic process,Q32PF2(Evidence code:IEA/Database source:UniProtKB:P53396|ens),ACLY,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0035994,response to muscle stretch,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens),NFKB1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0016411,acylglycerol O-acyltransferase activity,Q95JH2(Evidence code:IBA/Database source:PANTHER:PTN000046632),AGPAT1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0001704,formation of primary germ layer,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0035646,endosome to melanosome transport,Q9XSK2(Evidence code:ISS/Database source:UniProtKB:P08962),CD63,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0007584,response to nutrient,B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0),STAT1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0097504,Gemini of coiled bodies,F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens),NPAT,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0071732,cellular response to nitric oxide,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:1904358,positive regulation of telomere maintenance via telomere lengthening,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0043394,proteoglycan binding,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010837,regulation of keratinocyte proliferation,E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens),BCL11B,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0004791,thioredoxin-disulfide reductase activity,O62768(Evidence code:IEA/Database source:InterPro:IPR006338),TXNRD1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0048844,artery morphogenesis,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:1903496,response to 11-deoxycorticosterone,P02668(Evidence code:IDA/Database source:),CSN3,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0005845,mRNA cap binding complex,P85091(Evidence code:ISS/Database source:UniProtKB:Q7TMB8),CYFIP1,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0016624,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor",E1BFI2(Evidence code:IEA/Database source:InterPro:IPR001017),DHTKD1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0034975,protein folding in endoplasmic reticulum,Q3ZCB8(Evidence code:IBA/Database source:PANTHER:PTN000319097),EMC3,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0051205,protein insertion into membrane,F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens),GRIN3B,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0034236,protein kinase A catalytic subunit binding,P00515(Evidence code:IEA/Database source:UniProtKB:P13861|ens),PRKAR2A,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0045879,negative regulation of smoothened signaling pathway,E1BPS6(Evidence code:IEA/Database source:UniProtKB:P60882|ens),MEGF8,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0008301,"DNA binding, bending",E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0071280,cellular response to copper ion,P10279(Evidence code:IEA/Database source:UniProtKB:P04156|ens),PRNP,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0006516,glycoprotein catabolic process,E1BMN0(Evidence code:IEA/Database source:UniProtKB:Q8WWR8|ens),NEU4,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0051290,protein heterotetramerization,P60902(Evidence code:IEA/Database source:UniProtKB:P60903|ens),S100A10,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0015813,L-glutamate transmembrane transport,E1BA07(Evidence code:IEA/Database source:UniProtKB:Q8BFU8|ens),SLC17A8,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:1902259,regulation of delayed rectifier potassium channel activity,P63026(Evidence code:ISS/Database source:UniProtKB:P63045),VAMP2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0008443,phosphofructokinase activity,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:1903672,positive regulation of sprouting angiogenesis,P03968(Evidence code:ISS/Database source:UniProtKB:P05230),FGF1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:1990391,DNA repair complex,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens),ATM,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0003993,acid phosphatase activity,P11064(Evidence code:IEA/Database source:InterPro:IPR002115),ACP1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0050872,white fat cell differentiation,F1MYP4(Evidence code:IEA/Database source:UniProtKB:O88712|ens),CTBP1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0014059,regulation of dopamine secretion,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens),SYT4,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0035254,glutamate receptor binding,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens),CAMK2A,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0018342,protein prenylation,P29702(Evidence code:IEA/Database source:InterPro:IPR002088),FNTA,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0045261,"proton-transporting ATP synthase complex, catalytic core F(1)",P05630(Evidence code:IEA/Database source:InterPro:IPR001469),ATP5D,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0006750,glutathione biosynthetic process,Q5EAC2(Evidence code:IEA/Database source:InterPro:IPR004887|I),GSS,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0045120,pronucleus,E1BIB4(Evidence code:IEA/Database source:UniProtKB:Q8R081|ens),HNRNPL,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:2000678,negative regulation of transcription regulatory region DNA binding,Q0IIA3(Evidence code:IEA/Database source:UniProtKB:Q6P069|ens),SRI,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0008318,protein prenyltransferase activity,P29702(Evidence code:IEA/Database source:InterPro:IPR002088),FNTA,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0008106,alcohol dehydrogenase (NADP+) activity,Q3ZCJ2(Evidence code:IEA/Database source:EC:1.1.1.2),AKR1A1,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0034340,response to type I interferon,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897),SHMT2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0060261,positive regulation of transcription initiation from RNA polymerase II promoter,E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens),SRF,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0048070,regulation of developmental pigmentation,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:1904645,response to amyloid-beta,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0046339,diacylglycerol metabolic process,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010485,H4 histone acetyltransferase activity,E1B8X8(Evidence code:IEA/Database source:UniProtKB:P51587|ens),BRCA2,MF,1,1 of 5,0.04,20,0.3443,0.4046
GO:0017119,Golgi transport complex,E1B970(Evidence code:IEA/Database source:UniProtKB:Q08378|ens),GOLGA3,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0060390,regulation of SMAD protein signal transduction,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9GZV5|ens),WWTR1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0060123,regulation of growth hormone secretion,E1BPM4(Evidence code:IEA/Database source:UniProtKB:Q9P2D1|ens),CHD7,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0032460,negative regulation of protein oligomerization,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0006044,N-acetylglucosamine metabolic process,Q17QL1(Evidence code:IEA/Database source:InterPro:IPR004547|I),GNPDA2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0061157,mRNA destabilization,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q80U78|ens),PUM1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0018216,peptidyl-arginine methylation,A7YW45(Evidence code:ISS/Database source:UniProtKB:O14744),PRMT5,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0060765,regulation of androgen receptor signaling pathway,E1BQ22(Evidence code:IEA/Database source:UniProtKB:Q6AZZ1|ens),TRIM68,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0016559,peroxisome fission,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0097730,non-motile cilium,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5),AHI1,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0005675,holo TFIIH complex,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,CC,1,1 of 5,0.04,20,0.3443,0.4046
GO:0036158,outer dynein arm assembly,E1BMG2(Evidence code:IBA/Database source:PANTHER:PTN000840538),DNAH5,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0006625,protein targeting to peroxisome,E1BPU3(Evidence code:IEA/Database source:InterPro:IPR025653),PEX1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0009226,nucleotide-sugar biosynthetic process,Q2KIT8(Evidence code:IEA/Database source:InterPro:IPR028614),TSTA3,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0015012,heparan sulfate proteoglycan biosynthetic process,A5D7I4(Evidence code:IEA/Database source:InterPro:IPR027670),EXT1,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0010591,regulation of lamellipodium assembly,E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922),SSH2,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0019896,axonal transport of mitochondrion,A2VDN5(Evidence code:ISS/Database source:UniProtKB:Q9QYY8),SPAST,BP,1,1 of 5,0.04,20,0.3443,0.4046
GO:0000302,response to reactive oxygen species,Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)P56722(Evidence code:ISS/Database source:UniProtKB:Q16849)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), PLK3 CAT PTPRN HYAL1,BP,4,4 of 36,0.17,11.11,0.3473,0.408
GO:0000070,mitotic sister chromatid segregation,Q3T054(Evidence code:ISS/Database source:UniProtKB:P62826)E1BAN8(Evidence code:IEA/Database source:UniProtKB:Q9ULG1|ens), RAN INO80,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0004180,carboxypeptidase activity,F1MGS8(Evidence code:IEA/Database source:UniProtKB:Q9CZR2|ens)P12820(Evidence code:IEA/Database source:UniProtKB-KW:KW-0121), NAALAD2 ACE,MF,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0008023,transcription elongation factor complex,E1BBQ3(Evidence code:IEA/Database source:UniProtKB:O95163|ens)Q2KIM2(Evidence code:IEA/Database source:UniProtKB:Q96CJ1|ens), IKBKAP EAF2,CC,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0051591,response to cAMP,B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0)E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens), STAT1 DGKQ,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0048747,muscle fiber development,E1BE25(Evidence code:IEA/Database source:UniProtKB:Q8VHX6|ens)E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971), FLNC LEF1,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0035869,ciliary transition zone,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens), PCM1 RPGRIP1L,CC,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0051537,"2 iron, 2 sulfur cluster binding",P48034(Evidence code:IEA/Database source:InterPro:IPR006058)E1BL62(Evidence code:IEA/Database source:InterPro:IPR006058), AOX1 AOX4,MF,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0032729,positive regulation of interferon-gamma production,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q08499|ens)E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens), PDE4D BCL3,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0003796,lysozyme activity,F2X047(Evidence code:IEA/Database source:InterPro:IPR000974|I)Q06285(Evidence code:IEA/Database source:InterPro:IPR000974|I), LYZ LYZ1,MF,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0007568,aging,F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)E1BAI2(Evidence code:IEA/Database source:InterPro:IPR028546), PDE4D KL,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0045070,positive regulation of viral genome replication,F1N0T4(Evidence code:IEA/Database source:UniProtKB:P78563|ens)P26882(Evidence code:IEA/Database source:UniProtKB:Q08752|ens), ADARB1 PPID,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0030500,regulation of bone mineralization,G3X6A9(Evidence code:IEA/Database source:UniProtKB:Q8BHN1|ens)P07507(Evidence code:IEA/Database source:InterPro:IPR002384), TXLNG MGP,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0015030,Cajal body,F1MHZ3(Evidence code:IEA/Database source:UniProtKB:Q14207|ens)E1BB54(Evidence code:IEA/Database source:UniProtKB:Q5W0Q7|ens), NPAT USPL1,CC,2,2 of 16,0.08,12.5,0.3483,0.408
GO:0007163,establishment or maintenance of cell polarity,E1BJB4(Evidence code:IEA/Database source:UniProtKB:Q8CG73|ens)E1BKL9(Evidence code:IEA/Database source:UniProtKB:F2Z4A3|ens), RPGRIP1L FAT1,BP,2,2 of 16,0.08,12.5,0.3483,0.408
GO:2001235,positive regulation of apoptotic signaling pathway,Q2KI72(Evidence code:IEA/Database source:UniProtKB:Q9WTU6|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:Q60613|ens)Q3SZ15(Evidence code:IEA/Database source:UniProtKB:Q9D1M4|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), MAPK9 ADORA2A EEF1E1 DAB2IP,BP,4,4 of 37,0.17,10.81,0.3588,0.4201
GO:0044798,nuclear transcription factor complex,F1N1F9(Evidence code:IEA/Database source:UniProtKB:Q61473|ens),SOX17,CC,1,1 of 41,0.04,2.44,0.3654,0.4277
GO:0050684,regulation of mRNA processing,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,BP,1,1 of 42,0.04,2.38,0.3657,0.4279
GO:0048858,cell projection morphogenesis,Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens),PACSIN2,BP,1,1 of 42,0.04,2.38,0.3657,0.4279
GO:0031668,cellular response to extracellular stimulus,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 43,0.04,2.33,0.3668,0.4289
GO:0016247,channel regulator activity,Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens),SNF8,MF,1,1 of 43,0.04,2.33,0.3668,0.4289
GO:0061136,regulation of proteasomal protein catabolic process,Q17QP9(Evidence code:IEA/Database source:UniProtKB:O00487|ens),PSMD14,BP,1,1 of 43,0.04,2.33,0.3668,0.4289
GO:0009790,embryo development,E1BJY4(Evidence code:IEA/Database source:InterPro:IPR029817),PDGFC,BP,1,1 of 44,0.04,2.27,0.3687,0.4309
GO:1901990,regulation of mitotic cell cycle phase transition,A6QLJ0(Evidence code:ISS/Database source:UniProtKB:P18074),ERCC2,BP,1,1 of 44,0.04,2.27,0.3687,0.4309
GO:0070507,regulation of microtubule cytoskeleton organization,G3N3P0(Evidence code:IEA/Database source:UniProtKB:Q8TD16|ens),BICD2,BP,1,1 of 45,0.04,2.22,0.3713,0.4337
GO:0030098,lymphocyte differentiation,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 45,0.04,2.22,0.3713,0.4337
GO:0010632,regulation of epithelial cell migration,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,BP,1,1 of 45,0.04,2.22,0.3713,0.4337
GO:0006941,striated muscle contraction,Q0VD56(Evidence code:IBA/Database source:PANTHER:PTN001790569)A4IFM7(Evidence code:IEA/Database source:UniProtKB:Q9H1R3|ens), MYBPC3 MYLK2,BP,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0030863,cortical cytoskeleton,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q14247|ens), SPTA1 CTTN,CC,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0045739,positive regulation of DNA repair,A5PJP6(Evidence code:ISS/Database source:UniProtKB:P46736)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211), BRCC3 DHX9,BP,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0002224,toll-like receptor signaling pathway,Q9GL65(Evidence code:IBA/Database source:PANTHER:PTN000687652)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q3UMW7), TLR4 MAPKAPK3,BP,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0045095,keratin filament,G3MXL3(Evidence code:IEA/Database source:InterPro:IPR003054)P67827(Evidence code:ISS/Database source:UniProtKB:P48729), KRT3 CSNK1A1,CC,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0019835,cytolysis,F2X047(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081)Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0081), LYZ LYZ1,BP,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0048278,vesicle docking,Q3ZBT5(Evidence code:IBA/Database source:PANTHER:PTN000461349)Q2KIT7(Evidence code:IEA/Database source:InterPro:IPR009976), STX7 EXOC5,BP,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0019209,kinase activator activity,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens), MALT1 MOB1B,MF,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0003684,damaged DNA binding,Q4VE16(Evidence code:IEA/Database source:InterPro:IPR017961|I)Q29RK4(Evidence code:IEA/Database source:InterPro:IPR015360|I), POLI RAD23B,MF,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:0001952,regulation of cell-matrix adhesion,P17667(Evidence code:IEA/Database source:UniProtKB:P24699|ens)F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens), MYF5 ONECUT2,BP,2,2 of 17,0.08,11.76,0.3735,0.4353
GO:1903039,positive regulation of leukocyte cell-cell adhesion,Q3ZCM0(Evidence code:IEA/Database source:UniProtKB:P06239|ens),LCK,BP,1,1 of 46,0.04,2.17,0.3746,0.4361
GO:0048608,reproductive structure development,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens),DLG1,BP,1,1 of 46,0.04,2.17,0.3746,0.4361
GO:0005747,mitochondrial respiratory chain complex I,P23709(Evidence code:ISS/Database source:UniProtKB:O75489),NDUFS3,CC,1,1 of 46,0.04,2.17,0.3746,0.4361
GO:0090287,regulation of cellular response to growth factor stimulus,F1MZD0(Evidence code:IBA/Database source:PANTHER:PTN001170450),FBN3,BP,1,1 of 46,0.04,2.17,0.3746,0.4361
GO:0006401,RNA catabolic process,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 46,0.04,2.17,0.3746,0.4361
GO:0019001,guanyl nucleotide binding,P38408(Evidence code:IEA/Database source:InterPro:IPR001019)P04695(Evidence code:IEA/Database source:InterPro:IPR001019)G5E6P3(Evidence code:IEA/Database source:InterPro:IPR001019)P04696(Evidence code:IEA/Database source:InterPro:IPR001019)E1BIL1(Evidence code:IEA/Database source:InterPro:IPR001019)P0C7Q4(Evidence code:IEA/Database source:InterPro:IPR001019)A6QPN4(Evidence code:IEA/Database source:InterPro:IPR001019)P63097(Evidence code:IEA/Database source:InterPro:IPR001019)P04896(Evidence code:IEA/Database source:InterPro:IPR001019), GNA14 GNAT1 GNA13 GNAT2 GNA12 GNAT3 GNAL GNAI1 GNAS,MF,9,9 of 175,0.38,5.14,0.3774,0.4393
GO:0004888,transmembrane signaling receptor activity,A7MB15(Evidence code:IEA/Database source:InterPro:IPR017981)Q8SQA4(Evidence code:IEA/Database source:InterPro:IPR017981)E1B7Q8(Evidence code:IEA/Database source:InterPro:IPR017981)P02715(Evidence code:IEA/Database source:InterPro:IPR006201)Q9BDR7(Evidence code:IEA/Database source:InterPro:IPR003110)Q1LZF7(Evidence code:IEA/Database source:InterPro:IPR017981)F1MLX5(Evidence code:ISS/Database source:UniProtKB:A2ARI4)Q08E50(Evidence code:IEA/Database source:InterPro:IPR006028|I)Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168), FZD1 CD97 PTH2R CHRNE FCER1G PTH1R LGR4 GABRA5 TLR4,MF,9,9 of 178,0.38,5.06,0.3793,0.4414
GO:0016485,protein processing,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens)Q9XT97(Evidence code:IEA/Database source:InterPro:IPR001108)P42891(Evidence code:ISS/Database source:UniProtKB:P42893)F1MCT1(Evidence code:IEA/Database source:UniProtKB:F6XJP7|ens)E1BER3(Evidence code:IBA/Database source:PANTHER:PTN000164084), CLN3 PSEN1 ECE1 PCSK6 CPXM2,BP,5,5 of 44,0.21,11.36,0.3835,0.4441
GO:0051056,regulation of small GTPase mediated signal transduction,E1BP38(Evidence code:IEA/Database source:InterPro:IPR000331|I)A0JN64(Evidence code:IEA/Database source:InterPro:IPR000331|I)E1BNT2(Evidence code:IEA/Database source:InterPro:IPR000331|I)E1BNB7(Evidence code:IEA/Database source:InterPro:IPR030061)F1MXV4(Evidence code:IEA/Database source:InterPro:IPR000331|I), RALGAPA1 GARNL3 TSC2 ARHGAP26 SIPA1L1,BP,5,5 of 44,0.21,11.36,0.3835,0.4441
GO:0051647,nucleus localization,E1BNB4(Evidence code:IEA/Database source:UniProtKB:A2A5N3|ens),PABPC1L,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0045324,late endosome to vacuole transport,A6QLW1(Evidence code:IBA/Database source:PANTHER:PTN000426471),PIK3R4,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0019377,glycolipid catabolic process,Q2KIM0(Evidence code:IDA/Database source:),FUCA1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0014823,response to activity,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens),SMTNL1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0005942,phosphatidylinositol 3-kinase complex,E1BE66(Evidence code:IBA/Database source:PANTHER:PTN000005674),PIK3CD,CC,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0016712,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",Q2TBK1(Evidence code:IEA/Database source:InterPro:IPR008071),CYP2J2,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:1902803,regulation of synaptic vesicle transport,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens),LRRK2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0090311,regulation of protein deacetylation,E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens),CCAR2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0017183,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,Q08DM2(Evidence code:IEA/Database source:InterPro:IPR010014),DPH2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0032967,positive regulation of collagen biosynthetic process,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:1903206,negative regulation of hydrogen peroxide-induced cell death,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0031083,BLOC-1 complex,Q17QQ3(Evidence code:IDA/Database source:),SNAP25,CC,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0030118,clathrin coat,P04973(Evidence code:IEA/Database source:UniProtKB:P09496|ens),CLTA,CC,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0045947,negative regulation of translational initiation,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens),TPR,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:2000810,regulation of bicellular tight junction assembly,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens),MYO1C,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0032689,negative regulation of interferon-gamma production,P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens),PRNP,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0017127,cholesterol transporter activity,F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens),ABCA1,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0001916,positive regulation of T cell mediated cytotoxicity,Q3ZBT5(Evidence code:IEA/Database source:UniProtKB:O15400|ens),STX7,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:2000574,regulation of microtubule motor activity,P43033(Evidence code:IBA/Database source:PANTHER:PTN000752736),PAFAH1B1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0050716,positive regulation of interleukin-1 secretion,E1BF03(Evidence code:IEA/Database source:InterPro:IPR039099),PANX3,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0016668,"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",O62768(Evidence code:IEA/Database source:InterPro:IPR012999),TXNRD1,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0008242,omega peptidase activity,P80227(Evidence code:IEA/Database source:UniProtKB:P13798|ens),APEH,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0016024,CDP-diacylglycerol biosynthetic process,Q95JH2(Evidence code:IEA/Database source:UniPathway:UPA00557),AGPAT1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0007064,mitotic sister chromatid cohesion,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens),NIPBL,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0005833,hemoglobin complex,E1BEL8(Evidence code:IEA/Database source:InterPro:IPR002337),HBE1,CC,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0040001,establishment of mitotic spindle localization,E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens),KPNB1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0031995,insulin-like growth factor II binding,P20959(Evidence code:IBA/Database source:PANTHER:PTN000167605),IGFBP3,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:1903205,regulation of hydrogen peroxide-induced cell death,F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens),STK26,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0010447,response to acidic pH,Q1JQB3(Evidence code:IEA/Database source:UniProtKB:Q8BUD0|ens),GPR4,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0042832,defense response to protozoan,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0015106,bicarbonate transmembrane transporter activity,P35071(Evidence code:ISS/Database source:UniProtKB:P13569),CFTR,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,P20959(Evidence code:IBA/Database source:PANTHER:PTN000167605),IGFBP3,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0034706,sodium channel complex,E1BNX9(Evidence code:IEA/Database source:UniProtKB:Q8TD43|ens),TRPM4,CC,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0034333,adherens junction assembly,Q2TA37(Evidence code:IDA/Database source:),ARL2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0031929,TOR signaling,F1MHN4(Evidence code:IEA/Database source:InterPro:IPR028268),RICTOR,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0007176,regulation of epidermal growth factor-activated receptor activity,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0061462,protein localization to lysosome,E1BB46(Evidence code:IEA/Database source:UniProtKB:Q9P0V3|ens),SH3BP4,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:1901798,positive regulation of signal transduction by p53 class mediator,Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4),RPL11,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0008373,sialyltransferase activity,F1MX31(Evidence code:IEA/Database source:InterPro:IPR001675|I),ST8SIA3,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0070131,positive regulation of mitochondrial translation,F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens),FASTKD2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0006360,transcription by RNA polymerase I,Q32PE0(Evidence code:IEA/Database source:GO:0001054),POLR2F,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0031994,insulin-like growth factor I binding,P20959(Evidence code:IEA/Database source:UniProtKB:P17936|ens),IGFBP3,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0006309,apoptotic DNA fragmentation,Q6TUI4(Evidence code:IBA/Database source:PANTHER:PTN001029377),DICER1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens),UBQLN1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0003333,amino acid transmembrane transport,A1A4L2(Evidence code:IEA/Database source:GO:0015171),SLC6A20,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:1900119,positive regulation of execution phase of apoptosis,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0006563,L-serine metabolic process,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897),SHMT2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0010954,positive regulation of protein processing,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0010107,potassium ion import,A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens),ATP1A2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0051798,positive regulation of hair follicle development,F1N7I5(Evidence code:IEA/Database source:UniProtKB:E9Q7G0|ens),NUMA1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0010818,T cell chemotaxis,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0042596,fear response,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0051354,negative regulation of oxidoreductase activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0000030,mannosyltransferase activity,G3MY32(Evidence code:IEA/Database source:InterPro:IPR003342),TMTC2,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0030261,chromosome condensation,Q3MHQ9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0226),NCAPH,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026754),GNAS,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens),GIPC1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0046033,AMP metabolic process,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0016973,poly(A)+ mRNA export from nucleus,Q28165(Evidence code:IEA/Database source:UniProtKB:Q86U42|ens),PABPN1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0019363,pyridine nucleotide biosynthetic process,A5PK51(Evidence code:IEA/Database source:UniProtKB-KW:KW-0662),NAPRT,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:1900078,positive regulation of cellular response to insulin stimulus,Q27966(Evidence code:IEA/Database source:UniProtKB:Q9WTI7|ens),MYO1C,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0043596,nuclear replication fork,Q08DI1(Evidence code:ISS/Database source:UniProtKB:Q9NY74),ETAA1,CC,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0050922,negative regulation of chemotaxis,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens),DUSP3,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0071359,cellular response to dsRNA,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens),NFKB1,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0033561,regulation of water loss via skin,E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0060158,phospholipase C-activating dopamine receptor signaling pathway,P38408(Evidence code:IBA/Database source:PANTHER:PTN000026396),GNA14,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0003688,DNA replication origin binding,Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211),DHX9,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0010762,regulation of fibroblast migration,E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens),GNA12,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0034377,plasma lipoprotein particle assembly,P55156(Evidence code:ISS/Database source:UniProtKB:P55157),MTTP,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0050779,RNA destabilization,Q5E9Y5(Evidence code:ISS/Database source:UniProtKB:O70348),DXO,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0020027,hemoglobin metabolic process,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0030204,chondroitin sulfate metabolic process,F1ME12(Evidence code:IEA/Database source:UniProtKB:Q0VBN2|ens),DSEL,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0031952,regulation of protein autophosphorylation,E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens),MOB1B,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0017049,GTP-Rho binding,A1A4I4(Evidence code:IEA/Database source:InterPro:IPR037313|I),PKN1,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0061436,establishment of skin barrier,Q6BBL6(Evidence code:IEA/Database source:UniProtKB:O14493|ens),CLDN4,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0051446,positive regulation of meiotic cell cycle,Q2KJ92(Evidence code:IEA/Database source:UniProtKB:O09010|ens),LFNG,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0097502,mannosylation,G3MY32(Evidence code:IEA/Database source:GO:0000030),TMTC2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0043306,positive regulation of mast cell degranulation,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0060078,regulation of postsynaptic membrane potential,P02715(Evidence code:IEA/Database source:GO:0022848),CHRNE,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0015295,solute:proton symporter activity,Q0VCP0(Evidence code:IBA/Database source:PANTHER:PTN000299690),SLC33A1,MF,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:2000144,"positive regulation of DNA-templated transcription, initiation",E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens),SETX,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0005980,glycogen catabolic process,Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P47857|ens),PFKM,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0061001,regulation of dendritic spine morphogenesis,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S006|ens),LRRK2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0060259,regulation of feeding behavior,P61635(Evidence code:ISS/Database source:UniProtKB:P42227),STAT3,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0009312,oligosaccharide biosynthetic process,E1BB36(Evidence code:IEA/Database source:InterPro:IPR007754),MGAT2,BP,1,1 of 6,0.04,16.67,0.3889,0.4441
GO:0050714,positive regulation of protein secretion,E1BKQ6(Evidence code:IEA/Database source:UniProtKB:Q92614|ens)F1MP30(Evidence code:IEA/Database source:UniProtKB:O14795|ens)P26882(Evidence code:IEA/Database source:UniProtKB:Q08752|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)A6QNT8(Evidence code:IEA/Database source:UniProtKB:Q3U2P1|ens), MYO18A UNC13B PPID GOLPH3 SEC24A,BP,5,5 of 46,0.21,10.87,0.3945,0.4504
GO:0009055,electron transfer activity,E1BL62(Evidence code:IEA/Database source:InterPro:IPR001041|I)Q58DA7(Evidence code:IEA/Database source:InterPro:IPR002109)O62768(Evidence code:IEA/Database source:InterPro:IPR001100)P48034(Evidence code:IEA/Database source:InterPro:IPR001041|I)P62894(Evidence code:IEA/Database source:InterPro:IPR002327|I), AOX4 GLRX3 TXNRD1 AOX1 CYCS,MF,5,5 of 46,0.21,10.87,0.3945,0.4504
GO:0007267,cell-cell signaling,F1MJ94(Evidence code:IBA/Database source:PANTHER:PTN001932250)A5D7F4(Evidence code:IBA/Database source:PANTHER:PTN001932250)P26917(Evidence code:IBA/Database source:PANTHER:PTN000059370)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q9JHX9)A7MB15(Evidence code:IEA/Database source:UniProtKB:O70421|ens)F1MEC8(Evidence code:IBA/Database source:PANTHER:PTN001932250)E1BF03(Evidence code:IBA/Database source:PANTHER:PTN001039730)Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283), PCDHA13 PCDHGC3 SST fgfr3 FZD1 PCDH8 PANX3 BDNF,BP,8,8 of 83,0.34,9.64,0.4036,0.4607
GO:0007389,pattern specification process,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)G3N016(Evidence code:IEA/Database source:UniProtKB:P47941|ens)Q2KJ92(Evidence code:IEA/Database source:InterPro:IPR017374)F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)E1BHB8(Evidence code:IEA/Database source:UniProtKB:O35602|ens), GLI2 CRKL LFNG SYNGAP1 RAX,BP,5,5 of 48,0.21,10.42,0.4075,0.465
GO:0016746,"transferase activity, transferring acyl groups",F1MLW9(Evidence code:IEA/Database source:InterPro:IPR002123)A6QP57(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012)P51176(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012)Q17QI3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0012)P11181(Evidence code:IEA/Database source:InterPro:IPR001078|I)Q95JH2(Evidence code:IEA/Database source:InterPro:IPR002123)Q58DK1(Evidence code:IEA/Database source:InterPro:IPR000542)Q0VCR6(Evidence code:IEA/Database source:InterPro:IPR002123), GPAT2 TGM3 TGM2 ACAT2 DBT AGPAT1 CPT1B TMEM68,MF,8,8 of 85,0.34,9.41,0.4133,0.4715
GO:0030674,"protein binding, bridging",E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens)F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens), HCFC1 DDX20 COL1A2,MF,3,3 of 23,0.13,13.04,0.4184,0.4772
GO:0051928,positive regulation of calcium ion transport,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P26824)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens), CAMK2A F2R CACNA1D,BP,3,3 of 23,0.13,13.04,0.4184,0.4772
GO:0030833,regulation of actin filament polymerization,Q5E963(Evidence code:IEA/Database source:InterPro:IPR006789|I)F1MXR0(Evidence code:IEA/Database source:InterPro:IPR030060)Q1JP79(Evidence code:IEA/Database source:InterPro:IPR017383)E1B7J7(Evidence code:IEA/Database source:UniProtKB:O75914|ens)F1MSU8(Evidence code:IEA/Database source:UniProtKB:Q9H7P9|ens), ARPC5L BAIAP2L1 ARPC1A PAK3 PLEKHG2,BP,5,5 of 50,0.21,10,0.4223,0.4815
GO:0009617,response to bacterium,E1BE11(Evidence code:IEA/Database source:UniProtKB:D3YXG0|ens)F1N5H2(Evidence code:IEA/Database source:UniProtKB:Q9BTY2|ens)F1MXR0(Evidence code:IEA/Database source:UniProtKB:Q9UHR4|ens)E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens)F1MKV7(Evidence code:IEA/Database source:UniProtKB:Q9JLB4|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q8CID3|ens)Q5EAD0(Evidence code:ISS/Database source:UniProtKB:Q9UQB8)E1BD03(Evidence code:IEA/Database source:UniProtKB:Q9QZ67|ens)Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens), HMCN1 FUCA2 BAIAP2L1 CHD7 CUBN FAM20A BAIAP2 PPM1D SNX3,BP,9,9 of 92,0.38,9.78,0.4236,0.4829
GO:0098656,anion transmembrane transport,F1MG24(Evidence code:IEA/Database source:GO:0008509)F1N4L1(Evidence code:IEA/Database source:GO:0008509)F1MCB5(Evidence code:IEA/Database source:GO:0008509), ABCA1 SLC4A2 SLC4A7,BP,3,3 of 24,0.13,12.5,0.4264,0.4852
GO:0050673,epithelial cell proliferation,F1MJR6(Evidence code:IEA/Database source:UniProtKB:P25318|ens)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), COL8A2 ALMS1 PSEN1,BP,3,3 of 24,0.13,12.5,0.4264,0.4852
GO:0051258,protein polymerization,Q0IIM2(Evidence code:IDA/Database source:)A2VDY3(Evidence code:IEA/Database source:UniProtKB:Q9BY43|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens), ARL6 CHMP4A CHMP2A,BP,3,3 of 24,0.13,12.5,0.4264,0.4852
GO:0051539,"4 iron, 4 sulfur cluster binding",Q28007(Evidence code:IEA/Database source:UniProtKB-KW:KW-0004)E1BJF4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0004)A6QLJ0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0004), DPYD POLA1 ERCC2,MF,3,3 of 24,0.13,12.5,0.4264,0.4852
GO:0044774,mitotic DNA integrity checkpoint,F1MU48(Evidence code:IBA/Database source:PANTHER:PTN000018888),TOP2B,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0006376,mRNA splice site selection,E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens),SETX,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0046466,membrane lipid catabolic process,A6QQN6(Evidence code:IEA/Database source:UniProtKB:P58242|ens),SMPDL3B,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0009101,glycoprotein biosynthetic process,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens),GOLPH3,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0050750,low-density lipoprotein particle receptor binding,E1BMW2(Evidence code:IEA/Database source:UniProtKB:O95782|ens),AP2A1,MF,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0046040,IMP metabolic process,A7MBG0(Evidence code:IBA/Database source:PANTHER:PTN000217844),ADSS,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0006110,regulation of glycolytic process,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135),EIF6,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0030194,positive regulation of blood coagulation,A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116),F2R,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0042157,lipoprotein metabolic process,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0046688,response to copper ion,F1MKI1(Evidence code:IEA/Database source:UniProtKB:P35670|ens),ATP7B,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0034472,snRNA 3-end processing,A5PJS8(Evidence code:IEA/Database source:InterPro:IPR038751),INTS8,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0000793,condensed chromosome,E1BCK1(Evidence code:IEA/Database source:UniProtKB:Q5UIP0|ens),RIF1,CC,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,Q17QQ3(Evidence code:IBA/Database source:PANTHER:PTN000447754),SNAP25,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0006335,DNA replication-dependent nucleosome assembly,A4IFB8(Evidence code:IEA/Database source:UniProtKB:Q8TEX9|ens),IPO4,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0033539,fatty acid beta-oxidation using acyl-CoA dehydrogenase,P48818(Evidence code:IEA/Database source:UniProtKB:P49748|ens),ACADVL,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0060294,cilium movement involved in cell motility,Q2TA38(Evidence code:IBA/Database source:PANTHER:PTN000462267),TEKT4,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0090140,regulation of mitochondrial fission,Q3ZC24(Evidence code:ISS/Database source:UniProtKB:Q9NX47),MARCH5,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0050892,intestinal absorption,Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens),F11R,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,F1MII9(Evidence code:IEA/Database source:UniProtKB:Q8WZ73|ens),RFFL,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0051180,vitamin transport,E1BLU2(Evidence code:IEA/Database source:InterPro:IPR002666),SLC19A2,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0070461,SAGA-type complex,E1BGF3(Evidence code:IEA/Database source:UniProtKB:P51610|ens),HCFC1,CC,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0009070,serine family amino acid biosynthetic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:P11586|ens),MTHFD1,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0002755,MyD88-dependent toll-like receptor signaling pathway,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168),TLR4,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0060043,regulation of cardiac muscle cell proliferation,G3X793(Evidence code:IEA/Database source:UniProtKB:Q9WUI1|ens),MAPK11,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0033599,regulation of mammary gland epithelial cell proliferation,A7E348(Evidence code:IEA/Database source:UniProtKB:Q80V76|ens),PYGO2,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0005742,mitochondrial outer membrane translocase complex,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,CC,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0050982,detection of mechanical stimulus,F1MD64(Evidence code:IBA/Database source:PANTHER:PTN000323131),PIEZO1,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0043114,regulation of vascular permeability,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0061515,myeloid cell development,A4IFC3(Evidence code:IEA/Database source:UniProtKB:Q6PHQ9|ens),PABPC4,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0044804,autophagy of nucleus,E1BH30(Evidence code:IBA/Database source:PANTHER:PTN000324023),ATG2B,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0051900,regulation of mitochondrial depolarization,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0050930,induction of positive chemotaxis,Q0P5I9(Evidence code:IBA/Database source:PANTHER:PTN000428506),CXCL12,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0045604,regulation of epidermal cell differentiation,A7MBG4(Evidence code:IEA/Database source:UniProtKB:Q9Z2X8|ens),KEAP1,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0007566,embryo implantation,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0051560,mitochondrial calcium ion homeostasis,Q0VCA3(Evidence code:ISS/Database source:UniProtKB:O95202),LETM1,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0042107,cytokine metabolic process,E1BF06(Evidence code:IEA/Database source:UniProtKB:O95150|ens),TNFSF15,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0070293,renal absorption,Q6BBL6(Evidence code:ISS/Database source:UniProtKB:O35054),CLDN4,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0008395,steroid hydroxylase activity,F1MEU8(Evidence code:IBA/Database source:PANTHER:PTN000670521),LOC540627,MF,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0050687,negative regulation of defense response to virus,Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens),PCBP2,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0000177,cytoplasmic exosome (RNase complex),Q58DC5(Evidence code:ISS/Database source:UniProtKB:D2XV59),GTPBP1,CC,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0045577,regulation of B cell differentiation,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0051023,regulation of immunoglobulin secretion,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens),TRAF6,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0007190,activation of adenylate cyclase activity,G5E5C6(Evidence code:IEA/Database source:UniProtKB:P10323|ens),ACR,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0032469,endoplasmic reticulum calcium ion homeostasis,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49768|ens),PSEN1,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0005736,RNA polymerase I complex,Q32PE0(Evidence code:IBA/Database source:PANTHER:PTN000080812),POLR2F,CC,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0051782,negative regulation of cell division,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0002360,T cell lineage commitment,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens),PRKDC,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0007214,gamma-aminobutyric acid signaling pathway,Q08E50(Evidence code:IEA/Database source:InterPro:IPR005435),GABRA5,BP,1,1 of 7,0.04,14.29,0.4304,0.4852
GO:0005198,structural molecule activity,Q765N9(Evidence code:IEA/Database source:InterPro:IPR003549|I)A2VE21(Evidence code:IEA/Database source:InterPro:IPR013040|I)F1MFW9(Evidence code:IEA/Database source:InterPro:IPR001664|I)A6QLJ4(Evidence code:IBA/Database source:PANTHER:PTN001004344)F1MUC5(Evidence code:IEA/Database source:InterPro:IPR039070)Q27954(Evidence code:IEA/Database source:InterPro:IPR006692|I)Q3ZCC9(Evidence code:IEA/Database source:InterPro:IPR037363|I)P35605(Evidence code:IEA/Database source:InterPro:IPR006692)G3MXL3(Evidence code:IEA/Database source:InterPro:IPR001664)A6QPC5(Evidence code:IEA/Database source:InterPro:IPR000633)F1MJY9(Evidence code:IEA/Database source:UniProtKB:B1AVK5|ens)A4IFM4(Evidence code:IEA/Database source:InterPro:IPR003926|I)F1N611(Evidence code:IEA/Database source:InterPro:IPR008379)F1MDV3(Evidence code:IEA/Database source:InterPro:IPR015482)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR000633)Q08DH7(Evidence code:IEA/Database source:InterPro:IPR001664)Q6BBL6(Evidence code:IEA/Database source:InterPro:IPR003550|I)Q3B7N4(Evidence code:IEA/Database source:InterPro:IPR003552|I)A0JN39(Evidence code:IEA/Database source:InterPro:IPR011710)Q5E9A6(Evidence code:IBA/Database source:PANTHER:PTN000322234)P04973(Evidence code:IEA/Database source:InterPro:IPR000996)Q28104(Evidence code:IEA/Database source:InterPro:IPR006822)E1BIS6(Evidence code:IEA/Database source:InterPro:IPR001664)Q5E964(Evidence code:IBA/Database source:PANTHER:PTN000056911)Q0P5J7(Evidence code:IEA/Database source:InterPro:IPR001664|I), CLDN3 COPG2 KRT24 CDC42SE2 COL15A1 COPA SEC13 COPB2 KRT3 CTNNA2 COL4A6 CLDN8 EPB41L1 SNTB1 CTNNA1 INA CLDN4 CLDN7 COPB1 VPS25 CLTA COPE SYNM PSMD13 KRT35,MF,25,25 of 294,1.06,8.5,0.4342,0.4895
GO:0048524,positive regulation of viral process,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens), VPS4B TSG101 MVB12A,BP,3,3 of 25,0.13,12,0.4352,0.4902
GO:0006400,tRNA modification,F1MKA6(Evidence code:IBA/Database source:PANTHER:PTN000206950)E1BEB7(Evidence code:IBA/Database source:PANTHER:PTN000349172)A6QLT9(Evidence code:IEA/Database source:UniProtKB:Q8BGQ7|ens), AARS2 TRUB1 AARS,BP,3,3 of 25,0.13,12,0.4352,0.4902
GO:0045807,positive regulation of endocytosis,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens)P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens)Q9XSK2(Evidence code:IBA/Database source:PANTHER:PTN000445299), FLOT1 PPP3CA CD63,BP,3,3 of 25,0.13,12,0.4352,0.4902
GO:0008064,regulation of actin polymerization or depolymerization,E1BPN5(Evidence code:IBA/Database source:PANTHER:PTN000016922)E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens), SSH2 ARHGAP35,BP,2,2 of 55,0.08,3.64,0.4359,0.4908
GO:1901214,regulation of neuron death,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MG76(Evidence code:IEA/Database source:UniProtKB:Q6X632|ens), LRRK2 GPR75,BP,2,2 of 55,0.08,3.64,0.4359,0.4908
GO:0048598,embryonic morphogenesis,E1BLB9(Evidence code:IEA/Database source:UniProtKB:P70390|ens)E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983), SHOX2 CDON,BP,2,2 of 55,0.08,3.64,0.4359,0.4908
GO:0022904,respiratory electron transport chain,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens)A5PJM4(Evidence code:IEA/Database source:GO:0004174), PINK1 AIFM2,BP,2,2 of 56,0.08,3.57,0.436,0.4908
GO:0030695,GTPase regulator activity,E1BIV2(Evidence code:IEA/Database source:InterPro:IPR003109)E1BIX7(Evidence code:IEA/Database source:InterPro:IPR003109), RGS14 GPSM2,MF,2,2 of 57,0.08,3.51,0.4367,0.4915
GO:0090150,establishment of protein localization to membrane,B0JYK2(Evidence code:IEA/Database source:UniProtKB:O15118|ens)E1BJU6(Evidence code:IEA/Database source:UniProtKB:Q6ZMZ3|ens), NPC1 SYNE3,BP,2,2 of 58,0.08,3.45,0.438,0.4928
GO:0032870,cellular response to hormone stimulus,F1MVD0(Evidence code:IBA/Database source:PANTHER:PTN000074430)F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens), NCOA3 SLIT2,BP,2,2 of 59,0.08,3.39,0.4398,0.4945
GO:0002521,leukocyte differentiation,Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens), RRAS SRF,BP,2,2 of 59,0.08,3.39,0.4398,0.4945
GO:0043405,regulation of MAP kinase activity,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q99816|ens)E1BB50(Evidence code:ISS/Database source:UniProtKB:Q9NYV4), TSG101 CDK12,BP,2,2 of 59,0.08,3.39,0.4398,0.4945
GO:0015935,small ribosomal subunit,A6QLG5(Evidence code:IEA/Database source:InterPro:IPR005710)Q3T0R1(Evidence code:ISS/Database source:UniProtKB:P62269), RPS9 RPS18,CC,2,2 of 60,0.08,3.33,0.4421,0.497
GO:0042127,regulation of cell proliferation,F1MSH3(Evidence code:IBA/Database source:PANTHER:PTN000700357)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)E1BC36(Evidence code:IEA/Database source:InterPro:IPR028788)Q3ZCM0(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O88907|ens)E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BMW9(Evidence code:IEA/Database source:InterPro:IPR030500)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828)E1BPI3(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BMP9(Evidence code:IBA/Database source:PANTHER:PTN000700357)F1MSG6(Evidence code:IEA/Database source:InterPro:IPR030739)E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN000700357)E1BE13(Evidence code:IEA/Database source:UniProtKB:O88738|ens)F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)Q3T0F9(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MB57(Evidence code:IBA/Database source:PANTHER:PTN000700357)Q5BIN5(Evidence code:ISS/Database source:UniProtKB:Q9QUR7)F1MCX4(Evidence code:IBA/Database source:PANTHER:PTN000700357)A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens)E1B8X8(Evidence code:IBA/Database source:PANTHER:PTN000139037)Q3SYX0(Evidence code:IEA/Database source:InterPro:IPR030693)F1MJL4(Evidence code:IEA/Database source:UniProtKB:Q5VY09|ens)Q2YDE9(Evidence code:IEA/Database source:InterPro:IPR027683), TEC DBH CDK6 LCK PIAS1 SRC PURA NF2 CIB1 FRK ZAP70 RAPGEF2 TBX3 ABL1 JAK2 BIRC6 BRAF GRB2 YES1 PIN1 TYK2 EGLN3 BRCA2 NDRG1 IER5 TES,BP,26,26 of 309,1.1,8.41,0.446,0.5013
GO:0022900,electron transport chain,A5PK67(Evidence code:IEA/Database source:GO:0004129)E1BL62(Evidence code:IEA/Database source:GO:0009055)O62768(Evidence code:IEA/Database source:GO:0009055)Q58DA7(Evidence code:IEA/Database source:GO:0009055)P10897(Evidence code:IEA/Database source:InterPro:IPR028837)P48034(Evidence code:IEA/Database source:GO:0009055), MGC165862 AOX4 TXNRD1 GLRX3 CYB561 AOX1,BP,6,6 of 59,0.25,10.17,0.4522,0.5082
GO:0005319,lipid transporter activity,P55156(Evidence code:IEA/Database source:InterPro:IPR001747|I)B0JYK2(Evidence code:IEA/Database source:InterPro:IPR004765)E1BPC3(Evidence code:IEA/Database source:UniProtKB:Q148W0|ens), MTTP NPC1 ATP8B1,MF,3,3 of 27,0.13,11.11,0.4549,0.511
GO:0051781,positive regulation of cell division,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)P00432(Evidence code:IEA/Database source:UniProtKB-KW:KW-0497)P03968(Evidence code:ISS/Database source:UniProtKB:P05230), SIRT2 CAT FGF1,BP,3,3 of 27,0.13,11.11,0.4549,0.511
GO:0006396,RNA processing,F1MNA1(Evidence code:IBA/Database source:PANTHER:PTN000433338)F1N543(Evidence code:IEA/Database source:InterPro:IPR003107)P10881(Evidence code:IEA/Database source:InterPro:IPR002344)F1MHP1(Evidence code:IEA/Database source:InterPro:IPR000061|I)E1BNQ2(Evidence code:IBA/Database source:PANTHER:PTN000433338)E1BIQ0(Evidence code:IEA/Database source:InterPro:IPR015848|I)F1N0T4(Evidence code:IEA/Database source:InterPro:IPR002466)E1BJ90(Evidence code:IBA/Database source:PANTHER:PTN000433338)Q28141(Evidence code:IBA/Database source:PANTHER:PTN000433338)A2VDN6(Evidence code:IEA/Database source:InterPro:IPR000061|I)Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR000999|I)E1BEB7(Evidence code:IEA/Database source:InterPro:IPR002501)Q3ZBK6(Evidence code:IEA/Database source:InterPro:IPR027141)E1BJ67(Evidence code:IEA/Database source:InterPro:IPR015431), TDRD9 NRDE2 SSB U2SURP DHX37 PNPT1 ADARB1 DHX34 DHX9 SF3A1 DICER1 TRUB1 LSM4 CCNL1,BP,14,14 of 246,0.59,5.69,0.4565,0.5127
GO:0022829,wide pore channel activity,E1BF03(Evidence code:IBA/Database source:PANTHER:PTN001039730),PANX3,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0050820,positive regulation of coagulation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0006595,polyamine metabolic process,E1BM12(Evidence code:IEA/Database source:InterPro:IPR030668),SRM,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",E1BM28(Evidence code:IEA/Database source:UniRule:UR000107503),DNPH1,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0002724,regulation of T cell cytokine production,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581),TRPM4,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0001935,endothelial cell proliferation,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0006544,glycine metabolic process,Q3SZ20(Evidence code:ISS/Database source:UniProtKB:P34897),SHMT2,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0008378,galactosyltransferase activity,Q2HJA3(Evidence code:IEA/Database source:InterPro:IPR002659),B3GALT4,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0035173,histone kinase activity,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0001836,release of cytochrome c from mitochondria,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0045662,negative regulation of myoblast differentiation,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens),TBX3,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0045777,positive regulation of blood pressure,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P28474|ens),ADH5,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0006029,proteoglycan metabolic process,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens),COL2A1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0097472,cyclin-dependent protein kinase activity,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens),CDK1,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0042634,regulation of hair cycle,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KC79|ens),NIPBL,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0006833,water transport,F1N5Z0(Evidence code:IEA/Database source:UniProtKB:Q9WTY4|ens),AQP5,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0008191,metalloendopeptidase inhibitor activity,Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q08629),SPOCK1,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0018345,protein palmitoylation,A5PKD9(Evidence code:IEA/Database source:UniProtKB:Q6PCB6|ens),ABHD17C,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:1900015,regulation of cytokine production involved in inflammatory response,Q27995(Evidence code:ISS/Database source:UniProtKB:P35228),NOS2,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0001676,long-chain fatty acid metabolic process,F1MIU7(Evidence code:IEA/Database source:GO:0004467),SLC27A3,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0098781,ncRNA transcription,Q08E07(Evidence code:IEA/Database source:UniProtKB:Q8CIN6|ens),CELF3,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0032897,negative regulation of viral transcription,F1MMN0(Evidence code:IEA/Database source:UniProtKB:Q14142|ens),TRIM14,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0050909,sensory perception of taste,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0005344,oxygen carrier activity,E1BEL8(Evidence code:IEA/Database source:UniProtKB-KW:KW-0561),HBE1,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0030553,cGMP binding,P22571(Evidence code:IEA/Database source:InterPro:IPR006952|I),PDE6H,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0001944,vasculature development,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0047555,"3,5-cyclic-GMP phosphodiesterase activity",P22571(Evidence code:IEA/Database source:EC:3.1.4.35),PDE6H,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0051146,striated muscle cell differentiation,E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens),CDON,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0060674,placenta blood vessel development,E1B925(Evidence code:IEA/Database source:UniProtKB:A2BH40|ens),ARID1A,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0008250,oligosaccharyltransferase complex,Q5E9C2(Evidence code:IEA/Database source:InterPro:IPR003038),DAD1,CC,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0045652,regulation of megakaryocyte differentiation,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135),EIF6,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0016504,peptidase activator activity,Q29RY7(Evidence code:ISS/Database source:UniProtKB:Q8MIP7),FGL2,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0033619,membrane protein proteolysis,F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens),TMPRSS6,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0015248,sterol transporter activity,E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens),OSBP,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0070192,chromosome organization involved in meiotic cell cycle,F1MQ85(Evidence code:IEA/Database source:UniProtKB:Q61687|ens),ATRX,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0071467,cellular response to pH,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0006783,heme biosynthetic process,E1BKY9(Evidence code:IEA/Database source:UniProtKB:P36552|ens),CPOX,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q5MJS3|ens),FAM20C,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0006626,protein targeting to mitochondrion,Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens),FIS1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:1902808,positive regulation of cell cycle G1/S phase transition,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens),GLI1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0000118,histone deacetylase complex,Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR017320),HDAC5,CC,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0045823,positive regulation of heart contraction,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:2000279,negative regulation of DNA biosynthetic process,F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens),FAM129B,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens),BRAF,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0030857,negative regulation of epithelial cell differentiation,E1BK57(Evidence code:IEA/Database source:UniProtKB:P70324|ens),TBX3,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0003995,acyl-CoA dehydrogenase activity,P48818(Evidence code:IEA/Database source:InterPro:IPR006089),ACADVL,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0032753,positive regulation of interleukin-4 production,Q9BDR7(Evidence code:ISS/Database source:UniProtKB:P20491),FCER1G,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0014910,regulation of smooth muscle cell migration,E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens),SORL1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0030515,snoRNA binding,A1A4Q9(Evidence code:ISS/Database source:UniProtKB:Q6TEC1),NUDT16,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0033617,mitochondrial respiratory chain complex IV assembly,A1A4J8(Evidence code:ISS/Database source:UniProtKB:O75880),SCO1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0098636,protein complex involved in cell adhesion,O46405(Evidence code:IEA/Database source:UniProtKB:P33681|ens),CD80,CC,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0030212,hyaluronan metabolic process,Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794),HYAL1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0050850,positive regulation of calcium-mediated signaling,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0045920,negative regulation of exocytosis,Q08DF4(Evidence code:IDA/Database source:),DNM1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0019956,chemokine binding,Q6Y1E2(Evidence code:IEA/Database source:UniProtKB:Q04941|ens),PLP2,MF,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,Q08E45(Evidence code:IEA/Database source:UniProtKB:P11798|ens),CAMK2A,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0002260,lymphocyte homeostasis,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens),SPTA1,BP,1,1 of 8,0.04,12.5,0.4691,0.5205
GO:0042102,positive regulation of T cell proliferation,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens)F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens), TFRC SPTA1 TRAF6,BP,3,3 of 29,0.13,10.34,0.477,0.5291
GO:0045665,negative regulation of neuron differentiation,E1BDE3(Evidence code:IEA/Database source:UniProtKB:P58466|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens)F1MGF7(Evidence code:IEA/Database source:UniProtKB:Q8K389|ens), CTDSP1 MEIS1 CDK5RAP2,BP,3,3 of 29,0.13,10.34,0.477,0.5291
GO:0019900,kinase binding,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens)E1BMG1(Evidence code:IEA/Database source:UniProtKB:Q7L9L4|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q811D0|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)F1MF87(Evidence code:IEA/Database source:UniProtKB:Q96AY4|ens)F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)A2VDZ0(Evidence code:IEA/Database source:UniProtKB:Q15172|ens)A1A4J1(Evidence code:IEA/Database source:UniProtKB:P17858|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), DGKQ MOB1B DLG1 PFKM TTC28 WWC1 DAB2IP PPP2R5A PFKL UBQLN1 SRC,MF,11,11 of 120,0.47,9.17,0.4834,0.5361
GO:0048193,Golgi vesicle transport,F1MT17(Evidence code:IBA/Database source:PANTHER:PTN000361901)P53619(Evidence code:IEA/Database source:UniProtKB:Q5XJY5|ens)A6QQ47(Evidence code:IBA/Database source:PANTHER:PTN000409559), CUX2 ARCN1 VPS51,BP,3,3 of 69,0.13,4.35,0.4868,0.5398
GO:0015711,organic anion transport,Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)Q1JQC7(Evidence code:IEA/Database source:GO:0008514)F1N3Y6(Evidence code:IEA/Database source:GO:0008514), ABCC5 SLC22A23 ABCC3,BP,3,3 of 74,0.13,4.05,0.4915,0.5449
GO:0000027,ribosomal large subunit assembly,Q3T087(Evidence code:IBA/Database source:PANTHER:PTN000242048)Q24JY1(Evidence code:IBA/Database source:PANTHER:PTN000178698)E1BC24(Evidence code:IEA/Database source:InterPro:IPR012099), RPL11 RPL23A MDN1,BP,3,3 of 31,0.13,9.68,0.5007,0.5546
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,E1BIL1(Evidence code:IEA/Database source:UniProtKB:P27600|ens)Q29RK4(Evidence code:IEA/Database source:UniProtKB:P54727|ens)P61085(Evidence code:IEA/Database source:UniProtKB:P61087|ens), GNA12 RAD23B UBE2K,BP,3,3 of 31,0.13,9.68,0.5007,0.5546
GO:0050830,defense response to Gram-positive bacterium,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens)Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685984)P05059(Evidence code:IDA/Database source:), C5AR1 LYZ1 CHGA,BP,3,3 of 31,0.13,9.68,0.5007,0.5546
GO:0060170,ciliary membrane,A5D7I1(Evidence code:IEA/Database source:UniProtKB:P42567|ens)Q2NKY7(Evidence code:ISS/Database source:UniProtKB:P42208)Q0IIM2(Evidence code:IEA/Database source:UniProtKB-SubCell:SL), EPS15 SEPT2 ARL6,CC,3,3 of 31,0.13,9.68,0.5007,0.5546
GO:0014013,regulation of gliogenesis,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens),NF2,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0004659,prenyltransferase activity,P29702(Evidence code:IEA/Database source:UniProtKB-KW:KW-0637),FNTA,MF,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0006829,zinc ion transport,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0015035,protein disulfide oxidoreductase activity,Q58DA7(Evidence code:IEA/Database source:InterPro:IPR002109),GLRX3,MF,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:1903202,negative regulation of oxidative stress-induced cell death,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0000460,maturation of 5.8S rRNA,Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061),EIF6,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0046185,aldehyde catabolic process,Q3ZCJ2(Evidence code:IEA/Database source:UniProtKB:Q9JII6|ens),AKR1A1,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0042423,catecholamine biosynthetic process,P15101(Evidence code:IEA/Database source:UniProtKB-KW:KW-0127),DBH,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:1903146,regulation of autophagy of mitochondrion,Q1RMR3(Evidence code:IEA/Database source:UniProtKB:Q60598|ens),CTTN,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens),DAB2IP,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0072678,T cell migration,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26011|ens),ITGB7,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0005892,acetylcholine-gated channel complex,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,CC,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0006687,glycosphingolipid metabolic process,P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens),KIT,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:2000406,positive regulation of T cell migration,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens),CXCL12,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0042555,MCM complex,Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR008047),MCM4,CC,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0030890,positive regulation of B cell proliferation,E1BIG6(Evidence code:IEA/Database source:UniProtKB:P02786|ens),TFRC,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0003009,skeletal muscle contraction,Q2YDF7(Evidence code:ISS/Database source:UniProtKB:Q96MG2),JSRP1,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0002548,monocyte chemotaxis,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens),RPS19,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0035282,segmentation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens),PSEN1,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0051963,regulation of synapse assembly,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens),RAB17,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0071674,mononuclear cell migration,G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens),HIST1H2BA,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0000038,very long-chain fatty acid metabolic process,F6R7C3(Evidence code:IEA/Database source:UniProtKB:P28328|ens),PEX2,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens),COL2A1,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0050691,regulation of defense response to virus by host,E1B7G0(Evidence code:IEA/Database source:UniProtKB:Q8IU57|ens),IFNLR1,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0045236,CXCR chemokine receptor binding,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens),CXCL12,MF,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0035065,regulation of histone acetylation,A7E348(Evidence code:IEA/Database source:GO:0035034),PYGO2,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0002292,T cell differentiation involved in immune response,Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens),FCER1G,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0022848,acetylcholine-gated cation-selective channel activity,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,MF,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0004745,retinol dehydrogenase activity,O77769(Evidence code:IEA/Database source:InterPro:IPR032969),DHRS3,MF,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:1990138,neuron projection extension,Q9BH13(Evidence code:ISS/Database source:UniProtKB:P42292),ALCAM,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0002090,regulation of receptor internalization,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0042438,melanin biosynthetic process,A5PK65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0470),DDT,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0060049,regulation of protein glycosylation,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 9,0.04,11.11,0.5051,0.5557
GO:0031346,positive regulation of cell projection organization,E1BM92(Evidence code:IEA/Database source:UniProtKB:Q8N271|ens),PROM2,BP,1,1 of 35,0.04,2.86,0.5143,0.5654
GO:0032387,negative regulation of intracellular transport,P02510(Evidence code:ISS/Database source:UniProtKB:P02511),CRYAB,BP,1,1 of 35,0.04,2.86,0.5143,0.5654
GO:2001236,regulation of extrinsic apoptotic signaling pathway,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 35,0.04,2.86,0.5143,0.5654
GO:1903828,negative regulation of cellular protein localization,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 36,0.04,2.78,0.515,0.5657
GO:0016298,lipase activity,P16386(Evidence code:IEA/Database source:InterPro:IPR010468),LIPE,MF,1,1 of 36,0.04,2.78,0.515,0.5657
GO:0044770,cell cycle phase transition,Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036),UBE2L3,BP,1,1 of 36,0.04,2.78,0.515,0.5657
GO:0006694,steroid biosynthetic process,Q3MHF2(Evidence code:IEA/Database source:InterPro:IPR002225),HSD3B7,BP,1,1 of 36,0.04,2.78,0.515,0.5657
GO:0043434,response to peptide hormone,B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0),STAT1,BP,1,1 of 37,0.04,2.7,0.5165,0.5673
GO:0007088,regulation of mitotic nuclear division,Q3ZBF9(Evidence code:ISS/Database source:UniProtKB:Q96GD0),PDXP,BP,1,1 of 38,0.04,2.63,0.5188,0.5694
GO:0031669,cellular response to nutrient levels,F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens),EIF4G1,BP,1,1 of 38,0.04,2.63,0.5188,0.5694
GO:0009792,embryo development ending in birth or egg hatching,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens),RICTOR,BP,1,1 of 38,0.04,2.63,0.5188,0.5694
GO:0006937,regulation of muscle contraction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 38,0.04,2.63,0.5188,0.5694
GO:0016773,"phosphotransferase activity, alcohol group as acceptor",A6H768(Evidence code:IEA/Database source:InterPro:IPR006206)A6QR34(Evidence code:IEA/Database source:InterPro:IPR022672|I)E1BNF8(Evidence code:IEA/Database source:InterPro:IPR000577|I)F1MSV5(Evidence code:IEA/Database source:InterPro:IPR000577|I)Q17R18(Evidence code:IEA/Database source:InterPro:IPR002173)Q0IID9(Evidence code:IEA/Database source:InterPro:IPR000577|I)Q2NKZ8(Evidence code:IEA/Database source:InterPro:IPR000577|I)E1BME6(Evidence code:IEA/Database source:InterPro:IPR022672|I), GALK1 GCK FGGY GK2 ADK GK LOC538702 HK2,MF,8,8 of 146,0.34,5.48,0.5219,0.5723
GO:0001076,"transcription factor activity, RNA polymerase II transcription factor binding",E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens),SRF,MF,1,1 of 39,0.04,2.56,0.5218,0.5723
GO:0051168,nuclear export,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens),MALT1,BP,1,1 of 39,0.04,2.56,0.5218,0.5723
GO:0001818,negative regulation of cytokine production,F1MKW9(Evidence code:IEA/Database source:UniProtKB:P25799|ens),NFKB1,BP,1,1 of 39,0.04,2.56,0.5218,0.5723
GO:0034097,response to cytokine,F1MKW9(Evidence code:IBA/Database source:PANTHER:PTN001193216)Q3SYZ2(Evidence code:ISS/Database source:UniProtKB:Q16644)B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0)E1BJP4(Evidence code:IEA/Database source:UniProtKB:P11831|ens), NFKB1 MAPKAPK3 STAT1 SRF,BP,4,4 of 85,0.17,4.71,0.5265,0.5772
GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",E1BAI2(Evidence code:IEA/Database source:InterPro:IPR001360)H7BWW2(Evidence code:IEA/Database source:InterPro:IPR015883)F1MZP0(Evidence code:IEA/Database source:InterPro:IPR004193)F1MIL9(Evidence code:IEA/Database source:InterPro:IPR020004), KL HEXB GBE1 GNE,MF,4,4 of 38,0.17,10.53,0.53,0.5806
GO:0004540,ribonuclease activity,A7YWM6(Evidence code:IBA/Database source:PANTHER:PTN000153528)E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280)Q0VCA5(Evidence code:ISS/Database source:UniProtKB:Q9Y3Z3)F1MGC2(Evidence code:IBA/Database source:PANTHER:PTN001350296), RNASE13 SMG6 SAMHD1 RNASE2,MF,4,4 of 38,0.17,10.53,0.53,0.5806
GO:0006006,glucose metabolic process,A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)E1BME6(Evidence code:IEA/Database source:UniProtKB:O08528|ens)F1MMK2(Evidence code:IEA/Database source:InterPro:IPR001282|I)Q2KJE5(Evidence code:IEA/Database source:InterPro:IPR006424), GCK HK2 G6PD GAPDHS,BP,4,4 of 38,0.17,10.53,0.53,0.5806
GO:0045930,negative regulation of mitotic cell cycle,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens)F1N0Y1(Evidence code:IEA/Database source:UniProtKB:Q14160|ens)F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens)Q5E9L2(Evidence code:IEA/Database source:InterPro:IPR033237), ABL1 SCRIB DLG1 BRINP1,BP,4,4 of 38,0.17,10.53,0.53,0.5806
GO:0045787,positive regulation of cell cycle,E1BK57(Evidence code:IEA/Database source:UniProtKB:O15119|ens)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens)Q76I82(Evidence code:IEA/Database source:UniProtKB:P62244|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens), TBX3 LRP6 RPS15A ANKRD17,BP,4,4 of 89,0.17,4.49,0.5315,0.5821
GO:0090575,RNA polymerase II transcription factor complex,E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)A4FUY2(Evidence code:IEA/Database source:UniProtKB:Q99941|ens)G3MY92(Evidence code:IBA/Database source:PANTHER:PTN000358347)Q32KX6(Evidence code:IEA/Database source:UniProtKB:Q14188|ens), SFPQ ATF6B ASCL4 TFDP2,CC,4,4 of 39,0.17,10.26,0.5349,0.585
GO:2000008,regulation of protein localization to cell surface,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens),TOR1A,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0046834,lipid phosphorylation,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0035094,response to nicotine,P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0043949,regulation of cAMP-mediated signaling,P63097(Evidence code:ISS/Database source:UniProtKB:P10824),GNAI1,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0042730,fibrinolysis,F1MWW8(Evidence code:IEA/Database source:UniProtKB:Q8IU80|ens),TMPRSS6,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0060317,cardiac epithelial to mesenchymal transition,E1BBU4(Evidence code:IEA/Database source:UniProtKB:O88839|ens),ADAM15,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0070206,protein trimerization,A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens),C1QTNF5,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens),GSK3A,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0019233,sensory perception of pain,G3MYM1(Evidence code:IEA/Database source:InterPro:IPR028809),SCN10A,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0007159,leukocyte cell-cell adhesion,P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens),ITGB2,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0097729,9+2 motile cilium,F1N724(Evidence code:IEA/Database source:UniProtKB:E9Q7N9|ens),DNAH11,CC,1,1 of 10,0.04,10,0.5387,0.585
GO:0046638,positive regulation of alpha-beta T cell differentiation,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43404|ens),ZAP70,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0006024,glycosaminoglycan biosynthetic process,A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens),EXT1,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0042310,vasoconstriction,E1BNX9(Evidence code:IEA/Database source:InterPro:IPR029581),TRPM4,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0060706,cell differentiation involved in embryonic placenta development,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0007270,neuron-neuron synaptic transmission,E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens),KIF1B,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0002686,negative regulation of leukocyte migration,E1B8D8(Evidence code:IEA/Database source:UniProtKB:P31268|ens),HOXA7,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0048025,"negative regulation of mRNA splicing, via spliceosome",Q3T022(Evidence code:ISS/Database source:UniProtKB:O00422),SAP18,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0007271,"synaptic transmission, cholinergic",P02715(Evidence code:IBA/Database source:PANTHER:PTN001450363),CHRNE,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0006270,DNA replication initiation,Q0P5I4(Evidence code:IEA/Database source:InterPro:IPR001208|I),MCM4,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0000731,DNA synthesis involved in DNA repair,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens),WRN,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0097581,lamellipodium organization,F1MGT3(Evidence code:IEA/Database source:UniProtKB:Q6P9S0|ens),MTSS1L,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:1902711,GABA-A receptor complex,Q08E50(Evidence code:IBA/Database source:PANTHER:PTN001055383),GABRA5,CC,1,1 of 10,0.04,10,0.5387,0.585
GO:0043550,regulation of lipid kinase activity,Q08DG0(Evidence code:IEA/Database source:UniProtKB:Q8VCQ3|ens),NRBF2,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0006801,superoxide metabolic process,F1MF26(Evidence code:IEA/Database source:UniProtKB:Q5TCZ1|ens),SH3PXD2A,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0008519,ammonium transmembrane transporter activity,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,MF,1,1 of 10,0.04,10,0.5387,0.585
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,F1MVZ2(Evidence code:IEA/Database source:UniProtKB:Q8IWQ3|ens),BRSK2,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0006744,ubiquinone biosynthetic process,Q2NL34(Evidence code:IEA/Database source:InterPro:IPR012762),COQ9,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0031111,negative regulation of microtubule polymerization or depolymerization,Q9TRY0(Evidence code:ISS/Database source:UniProtKB:P27124),FKBP4,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0032095,regulation of response to food,P37359(Evidence code:ISS/Database source:UniProtKB:P28184),MT3,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0061028,establishment of endothelial barrier,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0006476,protein deacetylation,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0090734,site of DNA damage,P18493(Evidence code:ISS/Database source:UniProtKB:P09874),PARP1,CC,1,1 of 10,0.04,10,0.5387,0.585
GO:0048661,positive regulation of smooth muscle cell proliferation,B0JYL6(Evidence code:ISS/Database source:UniProtKB:Q9QXK0),STAT1,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:1900744,regulation of p38MAPK cascade,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens),DAB2IP,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0005761,mitochondrial ribosome,Q4PS77(Evidence code:ISS/Database source:UniProtKB:Q9BT17),MTG1,CC,1,1 of 10,0.04,10,0.5387,0.585
GO:0046933,"proton-transporting ATP synthase activity, rotational mechanism",P05630(Evidence code:IBA/Database source:PANTHER:PTN000352454),ATP5D,MF,1,1 of 10,0.04,10,0.5387,0.585
GO:0090023,positive regulation of neutrophil chemotaxis,Q673L2(Evidence code:IEA/Database source:UniProtKB:P30993|ens),C5AR1,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0004890,GABA-A receptor activity,Q08E50(Evidence code:IBA/Database source:PANTHER:PTN001055383),GABRA5,MF,1,1 of 10,0.04,10,0.5387,0.585
GO:0090200,positive regulation of release of cytochrome c from mitochondria,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0051353,positive regulation of oxidoreductase activity,F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens),ABL1,BP,1,1 of 10,0.04,10,0.5387,0.585
GO:0030334,regulation of cell migration,E1BIU7(Evidence code:IEA/Database source:InterPro:IPR028770)E1B7C4(Evidence code:IEA/Database source:UniProtKB:Q96BY6|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)G3X696(Evidence code:IEA/Database source:UniProtKB:O54988|ens)G5E6P3(Evidence code:IEA/Database source:UniProtKB:P27601|ens)P26917(Evidence code:ISS/Database source:UniProtKB:P60041)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254), PTPN23 DOCK10 FRMD5 DDX58 SLK GNA13 SST KIF14 LAMA3,BP,9,9 of 160,0.38,5.62,0.5406,0.5869
GO:0006417,regulation of translation,Q2NL22(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)P02638(Evidence code:NAS/Database source:)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)Q4PS77(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)Q0P5L1(Evidence code:IEA/Database source:InterPro:IPR033173)Q6T5B7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)F1MXK6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810)P68102(Evidence code:IEA/Database source:UniProtKB-KW:KW-0810), EIF4A3 S100B DHX9 MTG1 GCN1L1 AGO3 AGO4 EIF2S1,BP,8,8 of 89,0.34,8.99,0.5418,0.588
GO:0000976,transcription regulatory region sequence-specific DNA binding,F1MM81(Evidence code:IBA/Database source:PANTHER:PTN000968522)F1MKW9(Evidence code:IEA/Database source:UniProtKB:P19838|ens)E1BLK1(Evidence code:IBA/Database source:PANTHER:PTN000968522)E1BQ37(Evidence code:IEA/Database source:UniProtKB:Q8VIJ6|ens)E1BE97(Evidence code:IBA/Database source:PANTHER:PTN000284569)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831)Q5NUA6(Evidence code:IBA/Database source:PANTHER:PTN000696756), BAHCC1 NFKB1 TNRC18 SFPQ KDM3B MKL1 SOX4 NFE2L2,MF,8,8 of 93,0.34,8.6,0.5558,0.6031
GO:0050900,leukocyte migration,A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26011|ens)P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens)F1MS27(Evidence code:IEA/Database source:UniProtKB:Q01063|ens)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN000658787), ITGB7 DBH PDE4D C5AR1,BP,4,4 of 44,0.17,9.09,0.5664,0.6144
GO:0043523,regulation of neuron apoptotic process,Q08E50(Evidence code:IEA/Database source:UniProtKB:Q8BHJ7|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens)E1B8X4(Evidence code:IEA/Database source:UniProtKB:Q13564|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q99MQ3|ens), GABRA5 KIF14 NAE1 PINK1,BP,4,4 of 44,0.17,9.09,0.5664,0.6144
GO:2000177,regulation of neural precursor cell proliferation,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens),NF2,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0061640,cytoskeleton-dependent cytokinesis,Q0P5A1(Evidence code:IEA/Database source:UniProtKB:O75935|ens),DCTN3,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0071624,positive regulation of granulocyte chemotaxis,Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens),S100A14,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:2000779,regulation of double-strand break repair,A5PJQ1(Evidence code:IEA/Database source:UniProtKB:P35659|ens),DEK,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0030150,protein import into mitochondrial matrix,Q2HJE9(Evidence code:IBA/Database source:PANTHER:PTN000050380),TIMM17B,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0034629,cellular protein-containing complex localization,F1MNQ3(Evidence code:IEA/Database source:UniProtKB:Q12959|ens),DLG1,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0090329,regulation of DNA-dependent DNA replication,E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens),BLM,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:1901890,positive regulation of cell junction assembly,Q08DN8(Evidence code:IEA/Database source:UniProtKB:O08917|ens),FLOT1,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0047496,vesicle transport along microtubule,P43033(Evidence code:IBA/Database source:PANTHER:PTN000752736),PAFAH1B1,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0031519,PcG protein complex,G3X8E4(Evidence code:IEA/Database source:UniProtKB:Q6W2J9|ens),BCOR,CC,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0045814,"negative regulation of gene expression, epigenetic",E1BD03(Evidence code:IEA/Database source:UniProtKB:O15297|ens),PPM1D,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0051926,negative regulation of calcium ion transport,E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens),PACSIN3,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0009395,phospholipid catabolic process,P08487(Evidence code:IEA/Database source:InterPro:IPR016279),PLCG1,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0033692,cellular polysaccharide biosynthetic process,A5D7I4(Evidence code:IEA/Database source:UniProtKB:Q16394|ens),EXT1,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0006111,regulation of gluconeogenesis,E1BGA9(Evidence code:IEA/Database source:UniProtKB:P52824|ens),DGKQ,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0051219,phosphoprotein binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,MF,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0006122,"mitochondrial electron transport, ubiquinol to cytochrome c",P62894(Evidence code:IBA/Database source:PANTHER:PTN000238899),CYCS,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0097756,negative regulation of blood vessel diameter,E1BPV6(Evidence code:IEA/Database source:UniProtKB:Q99LM3|ens),SMTNL1,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0008198,ferrous iron binding,Q58DM4(Evidence code:ISS/Database source:UniProtKB:Q6NS38),ALKBH2,MF,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0032094,response to food,P01175(Evidence code:IDA/Database source:),OXT,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0033555,multicellular organismal response to stress,P48452(Evidence code:IEA/Database source:UniProtKB:P63328|ens),PPP3CA,BP,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0042583,chromaffin granule,P05059(Evidence code:IDA/Database source:),CHGA,CC,1,1 of 11,0.04,9.09,0.5701,0.6156
GO:0008217,regulation of blood pressure,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens)P02465(Evidence code:IEA/Database source:UniProtKB:P08123|ens)Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)A0A1P8NW44(Evidence code:IEA/Database source:UniProtKB:Q9ERL9|ens), ATP1A2 COL1A2 CACNA1B GUCY1A3,BP,4,4 of 45,0.17,8.89,0.5739,0.6193
GO:0002009,morphogenesis of an epithelium,F1N740(Evidence code:IEA/Database source:UniProtKB:Q80T14|ens)Q95M13(Evidence code:ISS/Database source:UniProtKB:Q61851)F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MFH3(Evidence code:IEA/Database source:UniProtKB:Q6NVD0|ens), FRAS1 fgfr3 GLI2 FREM2,BP,4,4 of 45,0.17,8.89,0.5739,0.6193
GO:0052689,carboxylic ester hydrolase activity,Q3MHR0(Evidence code:IBA/Database source:PANTHER:PTN001639375)E1BN79(Evidence code:IBA/Database source:PANTHER:PTN000168392)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0719)P0C6R3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0719), LYPLA1 CES5A ABHD2 CES4A,MF,4,4 of 45,0.17,8.89,0.5739,0.6193
GO:0044242,cellular lipid catabolic process,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens)P37359(Evidence code:ISS/Database source:UniProtKB:P28184), SIRT2 MT3,BP,2,2 of 49,0.08,4.08,0.5817,0.6274
GO:0016758,"transferase activity, transferring hexosyl groups",F1MFF6(Evidence code:IEA/Database source:InterPro:IPR002213)Q17QE7(Evidence code:IEA/Database source:InterPro:IPR005076), UGT2B10 GBGT1,MF,2,2 of 49,0.08,4.08,0.5817,0.6274
GO:0051302,regulation of cell division,Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q99828), PLK3 CIB1,BP,2,2 of 49,0.08,4.08,0.5817,0.6274
GO:0046822,regulation of nucleocytoplasmic transport,P61287(Evidence code:IEA/Database source:UniProtKB:P63087|ens)F1MH31(Evidence code:IEA/Database source:UniProtKB:P35658|ens), PPP1CC NUP214,BP,2,2 of 50,0.08,4,0.5822,0.6278
GO:0016651,"oxidoreductase activity, acting on NAD(P)H",E1BJA2(Evidence code:IEA/Database source:UniProtKB:O95831|ens)P23709(Evidence code:IEA/Database source:InterPro:IPR010218|I), AIFM1 NDUFS3,MF,2,2 of 51,0.08,3.92,0.5832,0.6287
GO:0051224,negative regulation of protein transport,Q1RMH8(Evidence code:IEA/Database source:UniProtKB:O60493|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens), SNX3 SNX12,BP,2,2 of 51,0.08,3.92,0.5832,0.6287
GO:1900180,regulation of protein localization to nucleus,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), PIN1 NF2,BP,2,2 of 52,0.08,3.85,0.5847,0.63
GO:0031301,integral component of organelle membrane,Q3T0P7(Evidence code:ISS/Database source:UniProtKB:Q9Y287)Q2KHY2(Evidence code:IEA/Database source:UniProtKB:Q9Z2P8|ens), ITM2B VAMP5,CC,2,2 of 52,0.08,3.85,0.5847,0.63
GO:0045926,negative regulation of growth,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens), PNPT1 ALOX15B,BP,2,2 of 54,0.08,3.7,0.5891,0.6347
GO:0050795,regulation of behavior,E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8K3E5),AHI1,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0010812,negative regulation of cell-substrate adhesion,Q17QR9(Evidence code:ISS/Database source:UniProtKB:Q08629),SPOCK1,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0001190,"transcriptional activator activity, RNA polymerase II transcription factor binding",Q1LZ94(Evidence code:IEA/Database source:UniProtKB:P25791|ens),LMO2,MF,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0071559,response to transforming growth factor beta,E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens),ZFHX3,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0050810,regulation of steroid biosynthetic process,F1MRW7(Evidence code:IEA/Database source:UniProtKB:Q9JJY4|ens),DDX20,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0045744,negative regulation of G-protein coupled receptor protein signaling pathway,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens),RGS14,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0031124,mRNA 3-end processing,G3MZ78(Evidence code:IEA/Database source:InterPro:IPR026896),CSTF2T,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0006536,glutamate metabolic process,Q58CZ9(Evidence code:ISS/Database source:UniProtKB:P17735),TAT,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0006221,pyrimidine nucleotide biosynthetic process,P31754(Evidence code:IEA/Database source:InterPro:IPR023031),UMPS,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0032411,positive regulation of transporter activity,F1MHA1(Evidence code:IEA/Database source:UniProtKB:Q03164|ens),KMT2A,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:1900407,regulation of cellular response to oxidative stress,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0042168,heme metabolic process,Q3T046(Evidence code:ISS/Database source:UniProtKB:Q561X9),BDH2,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0009913,epidermal cell differentiation,A6H727(Evidence code:IEA/Database source:UniProtKB:P08151|ens),GLI1,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0050840,extracellular matrix binding,E1B818(Evidence code:IEA/Database source:UniProtKB:Q8BHP7|ens),OLFML2A,MF,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0009311,oligosaccharide metabolic process,F1MX31(Evidence code:IEA/Database source:UniProtKB:O43173|ens),ST8SIA3,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",Q2NL34(Evidence code:IEA/Database source:UniProtKB:Q8K1Z0|ens),COQ9,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0033120,positive regulation of RNA splicing,E1BAS6(Evidence code:IEA/Database source:UniProtKB:Q7Z333|ens),SETX,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0043631,RNA polyadenylation,E1BIQ0(Evidence code:IEA/Database source:UniProtKB:Q8TCS8|ens),PNPT1,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:2000677,regulation of transcription regulatory region DNA binding,E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens),DOT1L,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0001508,action potential,F1MX24(Evidence code:IEA/Database source:UniProtKB:Q61124|ens),CLN3,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0071385,cellular response to glucocorticoid stimulus,Q3MHP1(Evidence code:ISS/Database source:UniProtKB:P68036),UBE2L3,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0009620,response to fungus,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens),MALT1,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0032651,regulation of interleukin-1 beta production,A7YY44(Evidence code:ISS/Database source:UniProtKB:P30558),F2R,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0046888,negative regulation of hormone secretion,P05059(Evidence code:IDA/Database source:),CHGA,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0043388,positive regulation of DNA binding,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8VDQ8|ens),SIRT2,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0016628,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",Q3T046(Evidence code:ISS/Database source:UniProtKB:Q8JZV9),BDH2,MF,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0007029,endoplasmic reticulum organization,F1MBM5(Evidence code:IEA/Database source:InterPro:IPR030550),TOR1B,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0008535,respiratory chain complex IV assembly,A1A4J8(Evidence code:IEA/Database source:InterPro:IPR017276),SCO1,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0050891,multicellular organismal water homeostasis,P35071(Evidence code:ISS/Database source:UniProtKB:P13569),CFTR,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:1903429,regulation of cell maturation,G5E5S3(Evidence code:IEA/Database source:UniProtKB:L0N7N1|ens),KIF14,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:1901222,regulation of NIK/NF-kappaB signaling,E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749),BCL3,BP,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0030670,phagocytic vesicle membrane,A6H7I5(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),DNM2,CC,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0016763,"transferase activity, transferring pentosyl groups",Q3MHF7(Evidence code:IEA/Database source:InterPro:IPR018099),MTAP,MF,1,1 of 12,0.04,8.33,0.5993,0.6413
GO:0007009,plasma membrane organization,F1MMQ8(Evidence code:IEA/Database source:UniProtKB:P08032|ens)F1MXR0(Evidence code:IEA/Database source:InterPro:IPR013606)Q5EAD0(Evidence code:IEA/Database source:InterPro:IPR013606)E1BIQ8(Evidence code:IEA/Database source:UniProtKB:Q9JLB2|ens)F1MGT3(Evidence code:IEA/Database source:InterPro:IPR013606), SPTA1 BAIAP2L1 BAIAP2 MPP5 MTSS1L,BP,5,5 of 55,0.21,9.09,0.6032,0.6454
GO:0051020,GTPase binding,G3X6L9(Evidence code:IEA/Database source:UniProtKB:P07814|ens)E1B7E3(Evidence code:IEA/Database source:UniProtKB:Q13439|ens)A7MBC5(Evidence code:IEA/Database source:UniProtKB:P41252|ens)E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens)A3KN15(Evidence code:IBA/Database source:PANTHER:PTN000289375), EPRS GOLGA4 IARS GNB3 VPS41,MF,5,5 of 57,0.21,8.77,0.6122,0.6549
GO:0061025,membrane fusion,Q9BDI7(Evidence code:IBA/Database source:PANTHER:PTN000170085)Q08DF4(Evidence code:IBA/Database source:PANTHER:PTN000170085)A6H7I5(Evidence code:IBA/Database source:PANTHER:PTN000170085)P81127(Evidence code:IBA/Database source:PANTHER:PTN000349241)Q3SZC4(Evidence code:IBA/Database source:PANTHER:PTN000596257), MX2 DNM1 DNM2 NAPG NSFL1C,BP,5,5 of 59,0.21,8.47,0.6223,0.6656
GO:0030133,transport vesicle,P05059(Evidence code:IEA/Database source:UniProtKB-SubCell:SL)Q0VC12(Evidence code:IEA/Database source:UniProtKB:Q9GZM5|ens)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens), CHGA YIPF3 C1QTNF5,CC,3,3 of 63,0.13,4.76,0.6269,0.6704
GO:0006935,chemotaxis,A6YT15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0145)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR033899)Q673L2(Evidence code:IEA/Database source:InterPro:IPR002234), CCL28 CXCL12 C5AR1,BP,3,3 of 66,0.13,4.55,0.6292,0.6727
GO:0019899,enzyme binding,Q3ZCH0(Evidence code:IEA/Database source:UniProtKB:P38647|ens)Q05204(Evidence code:IEA/Database source:UniProtKB:P11279|ens)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P97313|ens)Q05B83(Evidence code:IEA/Database source:UniProtKB:Q9WUK4|ens)F1MU48(Evidence code:IEA/Database source:UniProtKB:Q02880|ens)F1MMS4(Evidence code:IEA/Database source:UniProtKB:Q15554|ens)A6QR61(Evidence code:IEA/Database source:UniProtKB:Q9UMY4|ens)A7MB57(Evidence code:IEA/Database source:UniProtKB:P07947|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:Q9Y2T1|ens)E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)P61283(Evidence code:IEA/Database source:UniProtKB:O75531|ens)E1BFV0(Evidence code:IEA/Database source:UniProtKB:Q14974|ens)A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q12962|ens)E1BKU0(Evidence code:IEA/Database source:UniProtKB:P29274|ens)E1B714(Evidence code:IEA/Database source:UniProtKB:O15169|ens)F1MBP8(Evidence code:IEA/Database source:UniProtKB:O35864|ens)P81948(Evidence code:IEA/Database source:UniProtKB:P68368|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens)E1BPV9(Evidence code:IEA/Database source:UniProtKB:Q15911|ens)Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens)A6QR47(Evidence code:IEA/Database source:UniProtKB:Q9WV66|ens)F1MVC0(Evidence code:IEA/Database source:UniProtKB:P27708|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q24JZ9(Evidence code:IEA/Database source:UniProtKB:O75925|ens)A6QLP0(Evidence code:IEA/Database source:UniProtKB:P98177|ens)E1BP50(Evidence code:IEA/Database source:UniProtKB:Q9C0C2|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens)Q3SYT9(Evidence code:IEA/Database source:UniProtKB:Q15366|ens)A6QNS2(Evidence code:IEA/Database source:UniProtKB:Q9ES00|ens)Q2HJ40(Evidence code:IEA/Database source:UniProtKB:P56817|ens), HSPA9 LAMP1 PPP3CA PRKDC RFC2 TOP2B TERF2 SNX12 YES1 AXIN2 RYR1 BANF1 KPNB1 TAF10 ADORA2A AXIN1 COPS5 TUBA4A TSPAN14 ZFHX3 GOLPH3 CAT MARCH7 CAD CCAR2 PIAS1 FOXO4 TNKS1BP1 SRC PCBP2 UBE4B BACE1,MF,32,32 of 405,1.36,7.9,0.6325,0.6761
GO:0048511,rhythmic process,F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)A7YW45(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)Q28021(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)P61287(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090)Q3SWW9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0090), LGR4 PRMT5 ROCK2 DHX9 PPP1CC PPP1CB,BP,6,6 of 67,0.25,8.96,0.6372,0.681
GO:0071407,cellular response to organic cyclic compound,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)G5E5G9(Evidence code:IEA/Database source:UniProtKB:Q8BTW9|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens)E1B7J7(Evidence code:IEA/Database source:UniProtKB:Q61036|ens)G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q8CIN4|ens), GLI2 FOXF1 PAK4 GSK3A PAK3 PAK2,BP,6,6 of 68,0.25,8.82,0.64,0.6838
GO:0045055,regulated exocytosis,E1BKQ2(Evidence code:IBA/Database source:PANTHER:PTN000405433)Q29RR0(Evidence code:IEA/Database source:UniProtKB:Q9ULW5|ens), RAB11FIP1 RAB26,BP,2,2 of 18,0.08,11.11,0.643,0.6865
GO:0090559,regulation of membrane permeability,Q9XT56(Evidence code:IEA/Database source:UniProtKB:O88792|ens)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens), F11R PDCD6IP,BP,2,2 of 18,0.08,11.11,0.643,0.6865
GO:0070603,SWI/SNF superfamily-type complex,E1BKQ8(Evidence code:IEA/Database source:InterPro:IPR021906)E1B925(Evidence code:IEA/Database source:InterPro:IPR021906|I), ARID1B ARID1A,CC,2,2 of 18,0.08,11.11,0.643,0.6865
GO:0048489,synaptic vesicle transport,Q32LM6(Evidence code:IEA/Database source:UniProtKB:Q8JZS0|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549), LIN7A TOR1A,BP,2,2 of 18,0.08,11.11,0.643,0.6865
GO:1903363,negative regulation of cellular protein catabolic process,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens)Q2TBQ1(Evidence code:IEA/Database source:UniProtKB:Q07968|ens), DAB2IP F13B,BP,2,2 of 19,0.08,10.53,0.6506,0.6939
GO:0008009,chemokine activity,A6YT15(Evidence code:IEA/Database source:InterPro:IPR000827|I)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR001811|I), CCL28 CXCL12,MF,2,2 of 19,0.08,10.53,0.6506,0.6939
GO:0006942,regulation of striated muscle contraction,P85100(Evidence code:IEA/Database source:UniProtKB:P08590|ens)A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens), MYL3 ATP1A2,BP,2,2 of 19,0.08,10.53,0.6506,0.6939
GO:0070098,chemokine-mediated signaling pathway,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)F1MG76(Evidence code:IEA/Database source:UniProtKB:Q6X632|ens), CXCL12 GPR75,BP,2,2 of 19,0.08,10.53,0.6506,0.6939
GO:0002028,regulation of sodium ion transport,Q08DA1(Evidence code:ISS/Database source:UniProtKB:P06685)E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens), ATP1A1 SPTBN4,BP,2,2 of 19,0.08,10.53,0.6506,0.6939
GO:0007093,mitotic cell cycle checkpoint,E1BN70(Evidence code:IEA/Database source:UniProtKB:Q68E01|ens)E1BBQ0(Evidence code:IEA/Database source:UniProtKB:P50748|ens), INTS3 KNTC1,BP,2,2 of 20,0.08,10,0.6588,0.7017
GO:0032755,positive regulation of interleukin-6 production,F1MKU1(Evidence code:IEA/Database source:UniProtKB:O95786|ens)Q9BDR7(Evidence code:IEA/Database source:UniProtKB:P20491|ens), DDX58 FCER1G,BP,2,2 of 20,0.08,10,0.6588,0.7017
GO:0030177,positive regulation of Wnt signaling pathway,G3X6G8(Evidence code:IEA/Database source:UniProtKB:Q9HBX8|ens)P23956(Evidence code:IEA/Database source:UniProtKB:P27449|ens), LGR6 ATP6V0C,BP,2,2 of 20,0.08,10,0.6588,0.7017
GO:0002573,myeloid leukocyte differentiation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P05532|ens), PSEN1 KIT,BP,2,2 of 20,0.08,10,0.6588,0.7017
GO:0030490,maturation of SSU-rRNA,Q32PD5(Evidence code:IEA/Database source:UniProtKB:P39019|ens)Q56JX6(Evidence code:IBA/Database source:PANTHER:PTN000080571), RPS19 RPS28,BP,2,2 of 20,0.08,10,0.6588,0.7017
GO:0070509,calcium ion import,A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens)F1MTK5(Evidence code:IEA/Database source:UniProtKB:Q01668|ens), GCK CACNA1D,BP,2,2 of 20,0.08,10,0.6588,0.7017
GO:0010906,regulation of glucose metabolic process,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens)P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens), GNB3 IGFBP3,BP,2,2 of 20,0.08,10,0.6588,0.7017
GO:0019216,regulation of lipid metabolic process,F1MGG8(Evidence code:IBA/Database source:PANTHER:PTN000064809)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens)F1MYE0(Evidence code:IBA/Database source:PANTHER:PTN000064809)F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens), IRS4 BCL11B IRS1 TNFAIP8L3,BP,4,4 of 80,0.17,5,0.6619,0.7048
GO:0042176,regulation of protein catabolic process,A7MBA2(Evidence code:IEA/Database source:InterPro:IPR016642)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens)P56701(Evidence code:IEA/Database source:InterPro:IPR016643)Q08DR7(Evidence code:IEA/Database source:UniProtKB:Q96H20|ens), PSMD1 XPO1 PSMD2 SNF8,BP,4,4 of 81,0.17,4.94,0.6631,0.7059
GO:0040029,"regulation of gene expression, epigenetic",A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)Q2T9N9(Evidence code:IEA/Database source:InterPro:IPR030703), TDG HDAC5,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0006165,nucleoside diphosphate phosphorylation,A5PK70(Evidence code:IEA/Database source:InterPro:IPR001564)A1A4N9(Evidence code:IEA/Database source:InterPro:IPR001564), NME3 NME1,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0015171,amino acid transmembrane transporter activity,Q08DK7(Evidence code:IBA/Database source:PANTHER:PTN001942979)A1A4L2(Evidence code:IEA/Database source:UniProtKB:Q9NP91|ens), SLC25A29 SLC6A20,MF,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0004129,cytochrome-c oxidase activity,A5PK67(Evidence code:IBA/Database source:PANTHER:PTN001023184)P00423(Evidence code:IEA/Database source:InterPro:IPR004203|I), MGC165862 COX4I1,MF,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:1900181,negative regulation of protein localization to nucleus,E1B9S7(Evidence code:IEA/Database source:UniProtKB:Q6GQQ9|ens)E1BLC5(Evidence code:IEA/Database source:UniProtKB:Q6PGN3|ens), OTUD7B DCLK2,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0009062,fatty acid catabolic process,P48818(Evidence code:IEA/Database source:UniProtKB:P50544|ens)E1BCN1(Evidence code:IBA/Database source:PANTHER:PTN000256565), ACADVL LPIN2,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0048872,homeostasis of number of cells,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens), BCR ASXL1,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0000904,cell morphogenesis involved in differentiation,E1BDK6(Evidence code:IEA/Database source:UniProtKB:Q61292|ens)F1N0T1(Evidence code:IEA/Database source:UniProtKB:Q9R0B6|ens), LAMB2 LAMC3,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0035148,tube formation,E1BB77(Evidence code:IEA/Database source:UniProtKB:Q3UHC7|ens)E1BKZ3(Evidence code:IEA/Database source:UniProtKB:Q80UF4|ens), DAB2IP SDCCAG8,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0003014,renal system process,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens)F1MLY5(Evidence code:IEA/Database source:UniProtKB:B1AR09|ens), BCR MLLT6,BP,2,2 of 21,0.08,9.52,0.6675,0.7093
GO:0005179,hormone activity,P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372)Q2WGK0(Evidence code:IEA/Database source:InterPro:IPR001400|I)Q95MI6(Evidence code:IEA/Database source:InterPro:IPR000187|I)P01175(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372)P26917(Evidence code:IEA/Database source:InterPro:IPR004250|I)Q27954(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0372), IFNT3 PRP8 CRH OXT SST COPA IFNT2,MF,7,7 of 82,0.3,8.54,0.6704,0.7122
GO:0007200,phospholipase C-activating G-protein coupled receptor signaling pathway,F1MSU3(Evidence code:IBA/Database source:PANTHER:PTN000660491)Q673L2(Evidence code:IBA/Database source:PANTHER:PTN001200752), RXFP3 C5AR1,BP,2,2 of 22,0.08,9.09,0.6766,0.7181
GO:0022408,negative regulation of cell-cell adhesion,E1BIG2(Evidence code:IEA/Database source:UniProtKB:P35240|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens), NF2 ABL1,BP,2,2 of 22,0.08,9.09,0.6766,0.7181
GO:0042307,positive regulation of protein import into nucleus,F1MPE5(Evidence code:IEA/Database source:UniProtKB:Q8BKC5|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens), IPO5 TPR,BP,2,2 of 22,0.08,9.09,0.6766,0.7181
GO:0030427,site of polarized growth,E1BKE1(Evidence code:IBA/Database source:PANTHER:PTN000265604)F1MYQ7(Evidence code:IBA/Database source:PANTHER:PTN000265604), FRYL FRY,CC,2,2 of 22,0.08,9.09,0.6766,0.7181
GO:0006275,regulation of DNA replication,F1N413(Evidence code:IEA/Database source:UniProtKB:Q9Z148|ens)F1MI56(Evidence code:IEA/Database source:UniProtKB:O75179|ens), EHMT2 ANKRD17,BP,2,2 of 22,0.08,9.09,0.6766,0.7181
GO:0022604,regulation of cell morphogenesis,F1MHR5(Evidence code:IEA/Database source:UniProtKB:Q5VZL5|ens)G3N135(Evidence code:IEA/Database source:InterPro:IPR027656)F1MXK6(Evidence code:IEA/Database source:UniProtKB:Q8CJF8|ens)E1B8K0(Evidence code:IEA/Database source:UniProtKB:Q86UU0|ens)A6QPH9(Evidence code:IBA/Database source:PANTHER:PTN001364370), ZMYM4 FMNL2 AGO4 BCL9L ZMYM5,BP,5,5 of 90,0.21,5.56,0.6854,0.7266
GO:0045786,negative regulation of cell cycle,Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens)F1MXW0(Evidence code:IEA/Database source:UniProtKB:O15296|ens)Q5E9L2(Evidence code:ISS/Database source:UniProtKB:O60477)E1BHY2(Evidence code:IEA/Database source:InterPro:IPR028319)E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens), CHMP1A ALOX15B BRINP1 PPP1R13B CDK6,BP,5,5 of 90,0.21,5.56,0.6854,0.7266
GO:0045580,regulation of T cell differentiation,F1MDL4(Evidence code:IEA/Database source:UniProtKB:P28028|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00520|ens), BRAF ABL1,BP,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0019218,regulation of steroid metabolic process,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0008643,carbohydrate transport,Q8MII5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0762)Q3ZC26(Evidence code:IEA/Database source:UniProtKB-KW:KW-0762), SLC35B1 SLC5A11,BP,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0051101,regulation of DNA binding,A5PJW1(Evidence code:IEA/Database source:UniProtKB:Q8K0H5|ens)E1BCE6(Evidence code:ISS/Database source:UniProtKB:P20749), TAF10 BCL3,BP,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0045638,negative regulation of myeloid cell differentiation,E1BC36(Evidence code:IEA/Database source:UniProtKB:Q00534|ens)A4FUE0(Evidence code:IEA/Database source:UniProtKB:Q60954|ens), CDK6 MEIS1,BP,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0009612,response to mechanical stimulus,Q2KI72(Evidence code:IBA/Database source:PANTHER:PTN000622311)P01175(Evidence code:IDA/Database source:), MAPK9 OXT,BP,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0042379,chemokine receptor binding,Q3MHP3(Evidence code:IEA/Database source:UniProtKB:Q9HCY8|ens)Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens), S100A14 CXCL12,MF,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0005230,extracellular ligand-gated ion channel activity,Q08E50(Evidence code:IEA/Database source:InterPro:IPR006202|I)P02715(Evidence code:IEA/Database source:InterPro:IPR006202|I), GABRA5 CHRNE,MF,2,2 of 23,0.08,8.7,0.686,0.7266
GO:0016458,gene silencing,E1BKN0(Evidence code:IEA/Database source:UniProtKB:O08550|ens)Q32KR9(Evidence code:IEA/Database source:UniProtKB:Q9HD42|ens), KMT2B CHMP1A,BP,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0070555,response to interleukin-1,Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:Q9Y4K3|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens), TRAF6 SRC,BP,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0097191,extrinsic apoptotic signaling pathway,G3N127(Evidence code:IEA/Database source:UniProtKB:P27469|ens)A6QLB8(Evidence code:IEA/Database source:UniProtKB:Q2NL51|ens), G0S2 GSK3A,BP,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0045165,cell fate commitment,F1MXR2(Evidence code:IEA/Database source:UniProtKB:Q6XBJ3|ens)G3N346(Evidence code:IEA/Database source:UniProtKB:Q5NCY0|ens), ONECUT2 KDM6B,BP,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0006112,energy reserve metabolic process,P37359(Evidence code:ISS/Database source:UniProtKB:P28184)E1BAI2(Evidence code:IEA/Database source:UniProtKB:O35082|ens), MT3 KL,BP,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0030856,regulation of epithelial cell differentiation,Q95115(Evidence code:ISS/Database source:UniProtKB:P42230)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232), STAT5A STAT5B,BP,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0004536,deoxyribonuclease activity,Q2QDE9(Evidence code:IEA/Database source:InterPro:IPR016202)A5PJT8(Evidence code:IEA/Database source:InterPro:IPR016202), DNASE1L1 DNASE1L2,MF,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0006099,tricarboxylic acid cycle,Q148D3(Evidence code:IEA/Database source:InterPro:IPR018951)E1BFI2(Evidence code:IEA/Database source:InterPro:IPR011603), FH DHTKD1,BP,2,2 of 24,0.08,8.33,0.6957,0.7357
GO:0031214,biomineral tissue development,F1MXQ3(Evidence code:IEA/Database source:UniProtKB:Q8IXL6|ens)F1MJW4(Evidence code:IEA/Database source:UniProtKB:Q96MK3|ens), FAM20C FAM20A,BP,2,2 of 25,0.08,8,0.7054,0.7457
GO:0001763,morphogenesis of a branching structure,A7YY40(Evidence code:IEA/Database source:UniProtKB:Q9R1N9|ens)F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q12946|ens), COL13A1 FOXF1,BP,2,2 of 25,0.08,8,0.7054,0.7457
GO:1903364,positive regulation of cellular protein catabolic process,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)Q2KI48(Evidence code:IEA/Database source:UniProtKB:P53801|ens), VPS35 PTTG1IP,BP,2,2 of 26,0.08,7.69,0.7153,0.7558
GO:0009408,response to heat,Q2HJ94(Evidence code:IEA/Database source:InterPro:IPR012724)E1BPB3(Evidence code:IEA/Database source:UniProtKB:Q13144|ens), DNAJA2 EIF2B5,BP,2,2 of 26,0.08,7.69,0.7153,0.7558
GO:0046488,phosphatidylinositol metabolic process,Q0P5F7(Evidence code:IEA/Database source:InterPro:IPR002498),PIP4K2C,BP,1,1 of 29,0.04,3.45,0.7199,0.7593
GO:0003954,NADH dehydrogenase activity,P23709(Evidence code:IEA/Database source:EC:1.6.99.3),NDUFS3,MF,1,1 of 29,0.04,3.45,0.7199,0.7593
GO:0006497,protein lipidation,F1MG24(Evidence code:IEA/Database source:UniProtKB:P41233|ens),ABCA1,BP,1,1 of 29,0.04,3.45,0.7199,0.7593
GO:0015108,chloride transmembrane transporter activity,P35071(Evidence code:ISS/Database source:UniProtKB:P26361),CFTR,MF,1,1 of 28,0.04,3.57,0.7195,0.7593
GO:0046651,lymphocyte proliferation,Q3SWY3(Evidence code:IEA/Database source:UniProtKB:P24547|ens),IMPDH2,BP,1,1 of 28,0.04,3.57,0.7195,0.7593
GO:0099572,postsynaptic specialization,E1BBJ2(Evidence code:IEA/Database source:UniProtKB:Q6PFD5|ens),DLGAP3,CC,1,1 of 28,0.04,3.57,0.7195,0.7593
GO:0030532,small nuclear ribonucleoprotein complex,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,CC,1,1 of 29,0.04,3.45,0.7199,0.7593
GO:0032592,integral component of mitochondrial membrane,P02722(Evidence code:IDA/Database source:),SLC25A4,CC,1,1 of 28,0.04,3.57,0.7195,0.7593
GO:0071219,cellular response to molecule of bacterial origin,F6QK60(Evidence code:IEA/Database source:UniProtKB:Q8IXJ6|ens),SIRT2,BP,1,1 of 29,0.04,3.45,0.7199,0.7593
GO:0046474,glycerophospholipid biosynthetic process,Q95JH2(Evidence code:IBA/Database source:PANTHER:PTN000046638),AGPAT1,BP,1,1 of 30,0.04,3.33,0.7209,0.7599
GO:0002819,regulation of adaptive immune response,Q29450(Evidence code:ISS/Database source:UniProtKB:P51829),ADCY7,BP,1,1 of 30,0.04,3.33,0.7209,0.7599
GO:0070160,occluding junction,F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens),TJP1,CC,1,1 of 30,0.04,3.33,0.7209,0.7599
GO:0051427,hormone receptor binding,E1BIM8(Evidence code:IBA/Database source:PANTHER:PTN000701141),SRC,MF,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0019829,cation-transporting ATPase activity,F1MKI1(Evidence code:IEA/Database source:InterPro:IPR027256),ATP7B,MF,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0010950,positive regulation of endopeptidase activity,Q17QP9(Evidence code:IEA/Database source:GO:0061133),PSMD14,BP,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0006885,regulation of pH,P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6),ATP6V1B1,BP,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0051648,vesicle localization,P10568(Evidence code:ISS/Database source:UniProtKB:Q9UBC5),MYO1A,BP,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0060491,regulation of cell projection assembly,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0006664,glycolipid metabolic process,Q0VD36(Evidence code:IBA/Database source:PANTHER:PTN000258330),KDELC1,BP,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0048024,"regulation of mRNA splicing, via spliceosome",Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q60749|ens),KHDRBS1,BP,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:1903707,negative regulation of hemopoiesis,Q3ZCH0(Evidence code:ISS/Database source:UniProtKB:P38647),HSPA9,BP,1,1 of 31,0.04,3.23,0.7225,0.7603
GO:0007599,hemostasis,A7YY44(Evidence code:IEA/Database source:UniProtKB-KW:KW-0356),F2R,BP,1,1 of 32,0.04,3.12,0.7246,0.7619
GO:0010952,positive regulation of peptidase activity,Q29RY7(Evidence code:IEA/Database source:GO:0016504),FGL2,BP,1,1 of 32,0.04,3.12,0.7246,0.7619
GO:0070851,growth factor receptor binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P12931|ens),SRC,MF,1,1 of 32,0.04,3.12,0.7246,0.7619
GO:0050707,regulation of cytokine secretion,Q9GL65(Evidence code:IEA/Database source:InterPro:IPR027168),TLR4,BP,1,1 of 32,0.04,3.12,0.7246,0.7619
GO:0035239,tube morphogenesis,F1N1M2(Evidence code:IEA/Database source:UniProtKB:Q61169|ens),GATA6,BP,1,1 of 34,0.04,2.94,0.7304,0.7675
GO:0015081,sodium ion transmembrane transporter activity,E1BI45(Evidence code:ISS/Database source:UniProtKB:Q9UHI7),SLC23A1,MF,1,1 of 34,0.04,2.94,0.7304,0.7675
GO:0044772,mitotic cell cycle phase transition,P48734(Evidence code:IEA/Database source:UniProtKB:P11440|ens),CDK1,BP,1,1 of 34,0.04,2.94,0.7304,0.7675
GO:0050679,positive regulation of epithelial cell proliferation,Q673L2(Evidence code:IEA/Database source:UniProtKB:P21730|ens)P03968(Evidence code:IEA/Database source:UniProtKB:P61148|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794), C5AR1 FGF1 HYAL1,BP,3,3 of 33,0.13,9.09,0.734,0.771
GO:0055088,lipid homeostasis,O02754(Evidence code:ISS/Database source:UniProtKB:P53566)Q2KI18(Evidence code:IBA/Database source:PANTHER:PTN000274414)P02694(Evidence code:ISS/Database source:UniProtKB:P09455), CEBPA PNPLA2 RBP1,BP,3,3 of 33,0.13,9.09,0.734,0.771
GO:0031225,anchored component of membrane,E1BDI1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336)A0JNB3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336)P10279(Evidence code:IEA/Database source:UniProtKB-KW:KW-0336), DPEP3 LY6H PRNP,CC,3,3 of 34,0.13,8.82,0.7379,0.7747
GO:0043433,negative regulation of DNA-binding transcription factor activity,E1B7H4(Evidence code:IEA/Database source:UniProtKB:Q02779|ens)A7MBG4(Evidence code:IBA/Database source:PANTHER:PTN000697161)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), MAP3K10 KEAP1 PRNP,BP,3,3 of 34,0.13,8.82,0.7379,0.7747
GO:0032543,mitochondrial translation,Q32LB9(Evidence code:ISS/Database source:UniProtKB:Q9JJG9)Q0P5H7(Evidence code:IBA/Database source:PANTHER:PTN000238101)P0C2B7(Evidence code:IEA/Database source:InterPro:IPR034596), NOA1 RARS2 MRPL52,BP,3,3 of 34,0.13,8.82,0.7379,0.7747
GO:0009267,cellular response to starvation,E1BEE6(Evidence code:IEA/Database source:UniProtKB:Q14191|ens)F1N5W5(Evidence code:IEA/Database source:UniProtKB:Q9P289|ens)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens), WRN STK26 LRRK2,BP,3,3 of 35,0.13,8.57,0.7421,0.7788
GO:0007051,spindle organization,E1B7K5(Evidence code:IEA/Database source:UniProtKB:Q14008|ens)P48820(Evidence code:IBA/Database source:PANTHER:PTN000566604)E1BIV2(Evidence code:IEA/Database source:InterPro:IPR030776), CKAP5 RANBP2 RGS14,BP,3,3 of 35,0.13,8.57,0.7421,0.7788
GO:0046983,protein dimerization activity,E1BEI6(Evidence code:IEA/Database source:UniProtKB:Q13315|ens)A4FV19(Evidence code:IEA/Database source:InterPro:IPR021977)P17667(Evidence code:IEA/Database source:InterPro:IPR011598|I)Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)F1MFY7(Evidence code:IEA/Database source:InterPro:IPR032394)Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)E5CY52(Evidence code:IEA/Database source:InterPro:IPR011598|I)Q08DF4(Evidence code:IEA/Database source:UniProtKB:P39053|ens)E1BJA2(Evidence code:IEA/Database source:InterPro:IPR029324)E1BG94(Evidence code:IEA/Database source:InterPro:IPR032198)F1ML85(Evidence code:IEA/Database source:InterPro:IPR011598|I)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)G3MY92(Evidence code:IEA/Database source:InterPro:IPR011598|I)P61635(Evidence code:ISS/Database source:UniProtKB:P42227)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR002100|I)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens)A5D7A2(Evidence code:IEA/Database source:UniProtKB:P41250|ens)E1BKB7(Evidence code:IEA/Database source:InterPro:IPR011598|I)F1MXB9(Evidence code:IEA/Database source:InterPro:IPR011598|I)Q2NL18(Evidence code:IEA/Database source:InterPro:IPR011598|I)A6QPK5(Evidence code:IEA/Database source:InterPro:IPR011598|I)F1MVD0(Evidence code:IEA/Database source:InterPro:IPR011598|I)A6QPY5(Evidence code:IEA/Database source:InterPro:IPR011598|I)E1BKM4(Evidence code:IEA/Database source:UniProtKB:Q9WU78|ens), ATM BTRC MYF5 PDCD6 ANO6 STAT5B SREBF1 DNM1 AIFM1 E2F1 AHR PPP3CA ASCL4 STAT3 SRF PEF1 GARS MGA TCF4 HEYL TCF7L2 NCOA3 USF2 PDCD6IP,MF,24,24 of 310,1.02,7.74,0.7429,0.7795
GO:0006665,sphingolipid metabolic process,Q58CW5(Evidence code:IEA/Database source:InterPro:IPR029554)A4FUZ5(Evidence code:IEA/Database source:InterPro:IPR029557)F1N5T9(Evidence code:IEA/Database source:InterPro:IPR029555), SERINC2 SERINC3 SERINC5,BP,3,3 of 36,0.13,8.33,0.7466,0.7832
GO:0006629,lipid metabolic process,Q29460(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q5BIS9(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q2KI18(Evidence code:IEA/Database source:InterPro:IPR002641)P48818(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P27479(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q5EA59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P58108(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q95JH2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)E1B958(Evidence code:IEA/Database source:UniProtKB:Q8K4E0|ens)A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q3MHR0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q32PF2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P08487(Evidence code:IEA/Database source:InterPro:IPR001711|I)Q08E55(Evidence code:IEA/Database source:UniProtKB:Q9WTZ2|ens)Q58CY6(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q5EA42(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)E1BHX7(Evidence code:IEA/Database source:InterPro:IPR001711|I)Q3ZBF7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q29458(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)P43033(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q864U1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443)Q58DK1(Evidence code:IEA/Database source:UniProtKB-KW:KW-0443), PAFAH1B3 PRKAB1 PNPLA2 ACADVL ALOX15 ABHD4 PRKAG1 AGPAT1 ALMS1 SCAP SULT1A1 LYPLA1 ACLY PLCG1 MBTPS1 FAM213B ABHD2 LIPE MBTPS2 PLCB3 PTGES3 LIPF PAFAH1B1 BRCA1 CPT1B,BP,25,25 of 325,1.06,7.69,0.7489,0.7855
GO:0034504,protein localization to nucleus,A5PK75(Evidence code:IEA/Database source:UniProtKB:O14656|ens)Q3T087(Evidence code:ISS/Database source:UniProtKB:Q9CXW4)E1BE98(Evidence code:IEA/Database source:UniProtKB:Q6P5F9|ens), TOR1A RPL11 XPO1,BP,3,3 of 37,0.13,8.11,0.7514,0.7879
GO:0043393,regulation of protein binding,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), SRC PSEN1 CRK,BP,3,3 of 38,0.13,7.89,0.7564,0.793
GO:0009156,ribonucleoside monophosphate biosynthetic process,Q2HJ58(Evidence code:IEA/Database source:InterPro:IPR000842)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR000842)G3MY14(Evidence code:IEA/Database source:InterPro:IPR000842), PRPS1 PRPS1L1 PRPS2,BP,3,3 of 40,0.13,7.5,0.767,0.8039
GO:0050769,positive regulation of neurogenesis,F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens)A6H767(Evidence code:ISS/Database source:UniProtKB:P28656), SPEN NAP1L1,BP,2,2 of 42,0.08,4.76,0.7678,0.8045
GO:0016051,carbohydrate biosynthetic process,Q1RMX7(Evidence code:IEA/Database source:InterPro:IPR013132)A3KMX1(Evidence code:IEA/Database source:InterPro:IPR018011), NANS CHST14,BP,2,2 of 42,0.08,4.76,0.7678,0.8045
GO:0007218,neuropeptide signaling pathway,F1MSU3(Evidence code:IEA/Database source:GO:0004966)F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q8CHG7), RXFP3 RAPGEF2,BP,2,2 of 43,0.08,4.65,0.7681,0.8046
GO:0051924,regulation of calcium ion transport,F1MWI8(Evidence code:IEA/Database source:UniProtKB:Q91ZU9|ens)Q0IIA3(Evidence code:IEA/Database source:UniProtKB:P30626|ens), GRIN3B SRI,BP,2,2 of 44,0.08,4.55,0.7688,0.8052
GO:0050870,positive regulation of T cell activation,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)Q3ZCM0(Evidence code:ISS/Database source:UniProtKB:P06239), MALT1 LCK,BP,2,2 of 45,0.08,4.44,0.7698,0.8057
GO:0005762,mitochondrial large ribosomal subunit,Q3ZBX6(Evidence code:ISS/Database source:UniProtKB:P09001)P0C2B7(Evidence code:IEA/Database source:InterPro:IPR034596), MRPL3 MRPL52,CC,2,2 of 45,0.08,4.44,0.7698,0.8057
GO:0008528,G-protein coupled peptide receptor activity,E1BMN4(Evidence code:IEA/Database source:InterPro:IPR001556)F1MSU3(Evidence code:IEA/Database source:UniProtKB:Q8BGE9|ens), NMBR RXFP3,MF,2,2 of 45,0.08,4.44,0.7698,0.8057
GO:2001020,regulation of response to DNA damage stimulus,F1MBL6(Evidence code:IEA/Database source:UniProtKB:Q96Q15|ens)F1MXG8(Evidence code:IEA/Database source:UniProtKB:P00519|ens), SMG1 ABL1,BP,2,2 of 46,0.08,4.35,0.7711,0.8068
GO:0008135,"translation factor activity, RNA binding",F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)Q32KZ1(Evidence code:ISS/Database source:UniProtKB:Q9H2K0), EIF4G1 MTIF3,MF,2,2 of 46,0.08,4.35,0.7711,0.8068
GO:0046425,regulation of JAK-STAT cascade,F1MRH8(Evidence code:IEA/Database source:GO:0008269)E1BGK8(Evidence code:IEA/Database source:UniProtKB:Q8TEK3|ens), SH2B2 DOT1L,BP,2,2 of 47,0.08,4.26,0.7727,0.8083
GO:0009306,protein secretion,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)E1BLD5(Evidence code:IBA/Database source:PANTHER:PTN000635132)A5PJL8(Evidence code:IEA/Database source:UniProtKB:Q8K479|ens)Q29RR0(Evidence code:IBA/Database source:PANTHER:PTN000635132), GOLPH3 RAB37 C1QTNF5 RAB26,BP,4,4 of 47,0.17,8.51,0.7769,0.8125
GO:0006605,protein targeting,Q27966(Evidence code:IEA/Database source:UniProtKB:O00159|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)E1BJQ7(Evidence code:IEA/Database source:UniProtKB:Q9Z0G0|ens)G3MWT9(Evidence code:IEA/Database source:InterPro:IPR001573), MYO1C SORL1 GIPC1 AKAP12,BP,4,4 of 48,0.17,8.33,0.7793,0.8149
GO:2000146,negative regulation of cell motility,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)F1MSN2(Evidence code:IEA/Database source:UniProtKB:Q8BGV3|ens)E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens), PIN1 FRMD5 TACSTD2 CRK,BP,4,4 of 50,0.17,8,0.7848,0.8205
GO:0038023,signaling receptor activity,A7YWN9(Evidence code:IEA/Database source:InterPro:IPR015437)Q8SQB8(Evidence code:IEA/Database source:InterPro:IPR015436)F1MWI8(Evidence code:IEA/Database source:InterPro:IPR001508)F1MBY1(Evidence code:IEA/Database source:InterPro:IPR001508)E1BMA1(Evidence code:IEA/Database source:UniProtKB:Q2EY15|ens)F1MCW8(Evidence code:IEA/Database source:InterPro:IPR001508)P81134(Evidence code:IEA/Database source:InterPro:IPR012493)P32592(Evidence code:IEA/Database source:InterPro:IPR015439)E1BGZ0(Evidence code:IEA/Database source:InterPro:IPR001508)G3X812(Evidence code:IEA/Database source:InterPro:IPR022355)P53712(Evidence code:IEA/Database source:InterPro:IPR027071)G0T3G6(Evidence code:IEA/Database source:InterPro:IPR001508)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens), ITGB7 ITGB6 GRIN3B GRIA2 PRTG GRIK4 ATP6AP2 ITGB2 GRIA3 NOTCH4 ITGB1 GRIA1 PRNP,MF,13,13 of 204,0.55,6.37,0.786,0.8216
GO:0010821,regulation of mitochondrion organization,Q1RMW9(Evidence code:IEA/Database source:UniProtKB:Q9H4A6|ens)Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q96QK1|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)Q3T0I5(Evidence code:IEA/Database source:UniProtKB:Q9Y3D6|ens), GOLPH3 VPS35 PINK1 FIS1,BP,4,4 of 51,0.17,7.84,0.7878,0.8232
GO:0031461,cullin-RING ubiquitin ligase complex,Q08DE9(Evidence code:IEA/Database source:InterPro:IPR016157)A7MBJ5(Evidence code:ISS/Database source:UniProtKB:Q86VP6)F1MYD0(Evidence code:IEA/Database source:InterPro:IPR016157)E1BIN5(Evidence code:IEA/Database source:InterPro:IPR016157), CUL2 CAND1 CUL1 CUL3,CC,4,4 of 51,0.17,7.84,0.7878,0.8232
GO:0000987,proximal promoter sequence-specific DNA binding,E1BE02(Evidence code:IEA/Database source:UniProtKB:Q96AV8|ens)E1BG94(Evidence code:IEA/Database source:UniProtKB:Q01094|ens)E1BCA0(Evidence code:IEA/Database source:UniProtKB:Q7TSH3|ens)E1BJP4(Evidence code:IEA/Database source:InterPro:IPR033897), E2F7 E2F1 ZNF516 SRF,MF,4,4 of 53,0.17,7.55,0.7944,0.8299
GO:0071345,cellular response to cytokine stimulus,F1MBH4(Evidence code:IEA/Database source:UniProtKB:Q61080|ens)E1BLU8(Evidence code:IEA/Database source:UniProtKB:Q63934|ens)E1BJ93(Evidence code:IEA/Database source:UniProtKB:Q9UJU2|ens), FOXF1 POU4F2 LEF1,BP,3,3 of 57,0.13,5.26,0.7978,0.8328
GO:0006959,humoral immune response,G3N183(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56831(Evidence code:IBA/Database source:PANTHER:PTN000190053)P56830(Evidence code:IBA/Database source:PANTHER:PTN000190053), LOC104968438 IFNT3 IFNT2,BP,3,3 of 57,0.13,5.26,0.7978,0.8328
GO:0010975,regulation of neuron projection development,G3N3N1(Evidence code:IEA/Database source:UniProtKB:P62331|ens)O02675(Evidence code:IEA/Database source:UniProtKB:O08553|ens)Q17QQ3(Evidence code:IEA/Database source:UniProtKB:P60879|ens), ARF6 DPYSL2 SNAP25,BP,3,3 of 57,0.13,5.26,0.7978,0.8328
GO:0051604,protein maturation,Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)E1BPZ1(Evidence code:IEA/Database source:UniProtKB:Q92673|ens)Q2KJ41(Evidence code:IEA/Database source:UniProtKB:Q8NG11|ens), PSEN1 SORL1 TSPAN14,BP,3,3 of 55,0.13,5.45,0.7975,0.8328
GO:0035770,ribonucleoprotein granule,F1N1T6(Evidence code:IEA/Database source:UniProtKB:Q9NYY8|ens)A6QLE1(Evidence code:ISS/Database source:UniProtKB:Q8NHU6)E1BCC3(Evidence code:IBA/Database source:PANTHER:PTN000566987), FASTKD2 TDRD7 UHMK1,CC,3,3 of 58,0.13,5.17,0.7983,0.8331
GO:2001234,negative regulation of apoptotic signaling pathway,Q0IIM3(Evidence code:IEA/Database source:UniProtKB:Q61699|ens)E1BDD9(Evidence code:IEA/Database source:UniProtKB:Q8K4J6|ens)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens), HSPH1 MKL1 PSEN1,BP,3,3 of 59,0.13,5.08,0.799,0.8337
GO:0006839,mitochondrial transport,A6QR09(Evidence code:IBA/Database source:PANTHER:PTN000211803)Q9XT97(Evidence code:IEA/Database source:UniProtKB:P49769|ens)Q08DK7(Evidence code:IBA/Database source:PANTHER:PTN000211803), SLC25A26 PSEN1 SLC25A29,BP,3,3 of 60,0.13,5,0.7999,0.8346
GO:0008083,growth factor activity,P03968(Evidence code:IEA/Database source:InterPro:IPR002209)Q95106(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339)E1BJY4(Evidence code:IEA/Database source:InterPro:IPR000072)A4FV80(Evidence code:IEA/Database source:UniProtKB:Q8R089|ens)Q28038(Evidence code:IEA/Database source:UniProtKB-KW:KW-0339), FGF1 BDNF PDGFC FBRS MIA,MF,5,5 of 60,0.21,8.33,0.8025,0.8371
GO:0015078,proton transmembrane transporter activity,P61420(Evidence code:IEA/Database source:InterPro:IPR016727)P21282(Evidence code:IEA/Database source:InterPro:IPR004907|I)P23956(Evidence code:IEA/Database source:InterPro:IPR000245|I)P05630(Evidence code:IDA/Database source:)P31407(Evidence code:ISS/Database source:UniProtKB:Q91YH6), ATP6V0D1 ATP6V1C1 ATP6V0C ATP5D ATP6V1B1,MF,5,5 of 61,0.21,8.2,0.804,0.8385
GO:0090316,positive regulation of intracellular protein transport,E1BC93(Evidence code:IEA/Database source:UniProtKB:Q15154|ens)E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens)Q0VCQ6(Evidence code:IEA/Database source:UniProtKB:Q9BUL8|ens)Q0VCE7(Evidence code:IEA/Database source:UniProtKB:Q9H4B4|ens)E1BKZ0(Evidence code:IEA/Database source:UniProtKB:O95613|ens), PCM1 TPR PDCD10 PLK3 PCNT,BP,5,5 of 62,0.21,8.06,0.8057,0.84
GO:0046034,ATP metabolic process,P31408(Evidence code:IEA/Database source:InterPro:IPR004100)P31404(Evidence code:IEA/Database source:InterPro:IPR004100|I)E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens)P31407(Evidence code:IEA/Database source:InterPro:IPR004100)A2VDL6(Evidence code:IEA/Database source:UniProtKB:P50993|ens), ATP6V1B2 ATP6V1A AMPD3 ATP6V1B1 ATP1A2,BP,5,5 of 62,0.21,8.06,0.8057,0.84
GO:0006913,nucleocytoplasmic transport,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens)E1BM06(Evidence code:IEA/Database source:GO:0017056)E1BE98(Evidence code:IEA/Database source:UniProtKB:O14980|ens)Q3T054(Evidence code:IEA/Database source:InterPro:IPR002041)E1BF47(Evidence code:IBA/Database source:PANTHER:PTN001052033), RGS14 NDC1 XPO1 RAN TPR,BP,5,5 of 65,0.21,7.69,0.8118,0.8461
GO:0050727,regulation of inflammatory response,E1B968(Evidence code:IEA/Database source:UniProtKB:P18581|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens)F1MXQ0(Evidence code:IEA/Database source:UniProtKB:P58397|ens)A0JND4(Evidence code:IEA/Database source:InterPro:IPR030410), SLC7A2 RICTOR JAK2 ADAMTS12 SBNO2,BP,5,5 of 66,0.21,7.58,0.8141,0.8484
GO:0045664,regulation of neuron differentiation,Q95106(Evidence code:IBA/Database source:PANTHER:PTN000904283)E1BHG3(Evidence code:IEA/Database source:InterPro:IPR032983)O02675(Evidence code:IEA/Database source:InterPro:IPR030615)E1BD25(Evidence code:IEA/Database source:UniProtKB:Q99PV8|ens), BDNF CDON DPYSL2 BCL11B,BP,4,4 of 74,0.17,5.41,0.8201,0.8542
GO:0001558,regulation of cell growth,A3KN51(Evidence code:IEA/Database source:UniProtKB:Q61187|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)F1N152(Evidence code:IEA/Database source:InterPro:IPR000867)P20959(Evidence code:IEA/Database source:InterPro:IPR000867), TSG101 KIF14 HTRA1 IGFBP3,BP,4,4 of 74,0.17,5.41,0.8201,0.8542
GO:0016050,vesicle organization,A6QR61(Evidence code:IBA/Database source:PANTHER:PTN000058569)Q1RMH8(Evidence code:IBA/Database source:PANTHER:PTN000058569)F1MKZ3(Evidence code:IEA/Database source:UniProtKB:Q80TJ1|ens)Q2KHV6(Evidence code:IBA/Database source:PANTHER:PTN000058569), SNX12 SNX3 CADPS SNX8,BP,4,4 of 75,0.17,5.33,0.8209,0.855
GO:0050839,cell adhesion molecule binding,F1MEX4(Evidence code:IBA/Database source:PANTHER:PTN000131466)A7YWN9(Evidence code:IEA/Database source:UniProtKB:P26010|ens)P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)E1BMG7(Evidence code:IBA/Database source:PANTHER:PTN000131466)A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens), TENM2 ITGB7 ITGB2 TENM3 PTPN6,MF,5,5 of 89,0.21,5.62,0.8358,0.8703
GO:0007005,mitochondrion organization,Q5E9M9(Evidence code:IEA/Database source:InterPro:IPR021181)Q2HJF8(Evidence code:IEA/Database source:InterPro:IPR021181)E1BIA7(Evidence code:IEA/Database source:UniRule:UR000107144)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)P11023(Evidence code:ISS/Database source:UniProtKB:P63011)E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens)F1MX04(Evidence code:IEA/Database source:UniProtKB:Q04637|ens)F1MKS6(Evidence code:IEA/Database source:UniProtKB:Q641K1|ens), RHOT2 RHOT1 CLUH PINK1 RAB3A LRRK2 EIF4G1 AGTPBP1,BP,8,8 of 104,0.34,7.69,0.85,0.8848
GO:0003712,transcription coregulator activity,Q9BE45(Evidence code:IBA/Database source:PANTHER:PTN001538048)F1MY77(Evidence code:IBA/Database source:PANTHER:PTN000371549)Q0IIK5(Evidence code:ISS/Database source:UniProtKB:Q92499)Q32KX6(Evidence code:IEA/Database source:InterPro:IPR028314)A4IF83(Evidence code:IEA/Database source:UniProtKB:P56581|ens)F1MPU1(Evidence code:IEA/Database source:InterPro:IPR019035)E1BEZ8(Evidence code:IEA/Database source:UniProtKB:Q15678|ens), NFKBIZ ZMYND8 DDX1 TFDP2 TDG MED12L PTPN14,MF,7,7 of 112,0.3,6.25,0.8553,0.8902
GO:0030155,regulation of cell adhesion,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)F1MDD5(Evidence code:IEA/Database source:InterPro:IPR009254)Q3SWW9(Evidence code:ISS/Database source:UniProtKB:P62140)E1B9B6(Evidence code:IEA/Database source:UniProtKB:O60285|ens)G5E5S3(Evidence code:IEA/Database source:UniProtKB:Q15058|ens)P05059(Evidence code:TAS/Database source:)E1BCP6(Evidence code:IBA/Database source:PANTHER:PTN001231348)E1BJP4(Evidence code:IEA/Database source:UniProtKB:Q9JM73|ens)Q95115(Evidence code:ISS/Database source:UniProtKB:P42230), STAT5B LAMA3 PPP1CB NUAK1 KIF14 CHGA JAK2 SRF STAT5A,BP,9,9 of 121,0.38,7.44,0.8618,0.8968
GO:0008092,cytoskeletal protein binding,Q32LP2(Evidence code:IEA/Database source:InterPro:IPR000798)E1BJU6(Evidence code:IEA/Database source:InterPro:IPR030267)Q3MHR3(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BK71(Evidence code:IEA/Database source:UniProtKB:Q99JB8|ens)E1BIG2(Evidence code:IEA/Database source:InterPro:IPR000798)F1MF57(Evidence code:ISS/Database source:UniProtKB:O76041)F1ME41(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1BE25(Evidence code:IEA/Database source:UniProtKB:Q14315|ens)A7YY37(Evidence code:IEA/Database source:InterPro:IPR000798)Q1RMR9(Evidence code:IEA/Database source:UniProtKB:Q9WVE8|ens)A5PK75(Evidence code:IEA/Database source:InterPro:IPR030549)Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens)F1N611(Evidence code:IEA/Database source:InterPro:IPR000798|I)P61285(Evidence code:IBA/Database source:PANTHER:PTN000223361)E1B7A3(Evidence code:IBA/Database source:PANTHER:PTN000223361)Q0P5F3(Evidence code:IEA/Database source:UniProtKB:Q9NUP9|ens), RDX SYNE3 DYNLL2 PACSIN3 NF2 NEBL LOC101902172 FLNC EPB41L4A PACSIN2 TOR1A DUSP3 EPB41L1 DYNLL1 LOC101905447 LIN7C,MF,16,16 of 238,0.68,6.72,0.9001,0.9366
GO:0002376,immune system process,Q3SZC2(Evidence code:IEA/Database source:InterPro:IPR034383)A8E4P0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)P35246(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q28141(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3T0X5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)F6Q9J4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)F1N3I2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A4FUZ5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)P05126(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q0VCA5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)P58754(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)F1MLX5(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q9BDI7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3T0T1(Evidence code:IEA/Database source:InterPro:IPR034384)Q3T112(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q9BH13(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q0VD59(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q9GL65(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)A7YWH4(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)E1BGN7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q9BDR7(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391)Q3SZP0(Evidence code:IEA/Database source:UniProtKB-KW:KW-0391), PSMB9 LOC100125916 SFTPD DHX9 PSMA1 LOC100848815 LOC788634 SERINC3 PRKCB SAMHD1 TRAF6 LY96 LGR4 MX2 PSMB10 PSMB8 ALCAM MARCH8 TLR4 BoLA MB21D1 FCER1G IRF1,BP,23,23 of 334,0.98,6.89,0.9156,0.9525
GO:0006955,immune response,E1B9S7(Evidence code:IBA/Database source:PANTHER:PTN000332227)Q0P5I9(Evidence code:IEA/Database source:InterPro:IPR001811|I)F6Q9J4(Evidence code:IEA/Database source:InterPro:IPR001003|I)E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens)O46414(Evidence code:ISS/Database source:UniProtKB:Q8TD27)A7YWH4(Evidence code:IEA/Database source:InterPro:IPR010579)E1B9H1(Evidence code:IEA/Database source:InterPro:IPR001212)F1N160(Evidence code:IBA/Database source:PANTHER:PTN000587099)E1BL08(Evidence code:IEA/Database source:UniProtKB:Q9WUL6|ens)F1N3I2(Evidence code:IEA/Database source:InterPro:IPR010579)E1BF06(Evidence code:IEA/Database source:InterPro:IPR006052|I)Q0V7N1(Evidence code:IEA/Database source:InterPro:IPR001212|I)A6YT15(Evidence code:IEA/Database source:InterPro:IPR000827|I)Q3ZCC3(Evidence code:IEA/Database source:UniProtKB:P70196|ens)A8E4P0(Evidence code:IEA/Database source:InterPro:IPR010579), OTUD7B CXCL12 LOC100848815 ZAP70 FTH1 BoLA TINAGL1 VPREB1 MAP3K14 LOC788634 TNFSF15 SUSD2 CCL28 TRAF6 LOC100125916,BP,15,15 of 214,0.64,7.01,1,1
GO:0003690,double-stranded DNA binding,A4IF83(Evidence code:IEA/Database source:UniProtKB:Q13569|ens)Q28141(Evidence code:ISS/Database source:UniProtKB:Q08211)Q17QV0(Evidence code:IEA/Database source:UniProtKB:P57722|ens)G3N0W8(Evidence code:IEA/Database source:UniProtKB:O35295|ens)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens)E1BGN7(Evidence code:ISS/Database source:UniProtKB:Q8N884)E1BMW9(Evidence code:IEA/Database source:UniProtKB:P42669|ens)F1MKU1(Evidence code:IEA/Database source:UniProtKB:Q6Q899|ens), TDG DHX9 PCBP3 PURB SP1 PRKDC MB21D1 PURA DDX58,MF,9,9 of 123,0.38,7.32,1,1
GO:0005912,adherens junction,F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens)F1N2D3(Evidence code:IEA/Database source:UniProtKB:P39447|ens)E1B7V9(Evidence code:IEA/Database source:UniProtKB:Q6RHR9|ens)E1BIS6(Evidence code:IEA/Database source:UniProtKB:O15061|ens)Q3MHM6(Evidence code:IEA/Database source:InterPro:IPR030047)F1MD34(Evidence code:IEA/Database source:UniProtKB:Q96TA1|ens)E1BFN3(Evidence code:ISS/Database source:UniProtKB:Q8N157)E1BIG2(Evidence code:IEA/Database source:UniProtKB:P46662|ens), FRMD5 TJP1 MAGI1 SYNM CTNNA1 FAM129B AHI1 NF2,CC,8,8 of 120,0.34,6.67,1,1
GO:0051259,protein complex oligomerization,Q29RQ2(Evidence code:IEA/Database source:UniProtKB:Q07666|ens)E1BQ04(Evidence code:IEA/Database source:UniProtKB:P54132|ens)A6QLM8(Evidence code:IEA/Database source:InterPro:IPR009073|I)A1A4J1(Evidence code:IEA/Database source:UniProtKB:P17858|ens)Q0IIG5(Evidence code:IEA/Database source:UniProtKB:P08237|ens)Q5EA65(Evidence code:ISS/Database source:UniProtKB:P24140)F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q9UDY8|ens)F1MB84(Evidence code:IEA/Database source:UniProtKB:Q9UBQ7|ens), KHDRBS1 BLM HSCB PFKL PFKM DPAGT1 MALT1 GRHPR,BP,8,8 of 120,0.34,6.67,1,1
GO:0043410,positive regulation of MAPK cascade,F1N3I6(Evidence code:IEA/Database source:UniProtKB:Q8IX03|ens)P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens)A7YY44(Evidence code:ISS/Database source:UniProtKB:P25116)P20959(Evidence code:IEA/Database source:UniProtKB:P47878|ens)P62248(Evidence code:ISS/Database source:UniProtKB:Q9CPT4)E1BHG3(Evidence code:IEA/Database source:UniProtKB:Q32MD9|ens)E1BB77(Evidence code:IEA/Database source:UniProtKB:Q5VWQ8|ens), WWC1 KIT F2R IGFBP3 MYDGF CDON DAB2IP,BP,7,7 of 102,0.3,6.86,1,1
GO:0005125,cytokine activity,G3N183(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P56831(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)E1BF06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)P56830(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)A6YT15(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202)Q8MJ29(Evidence code:IEA/Database source:UniProtKB-KW:KW-0202), LOC104968438 IFNT3 TNFSF15 IFNT2 CCL28 IFNT,MF,6,6 of 84,0.25,7.14,1,1
GO:0045785,positive regulation of cell adhesion,Q0P5I9(Evidence code:IEA/Database source:UniProtKB:P48061|ens)Q5E985(Evidence code:ISS/Database source:UniProtKB:Q12794)P48452(Evidence code:IEA/Database source:UniProtKB:Q08209|ens)F1N1Q7(Evidence code:IEA/Database source:UniProtKB:Q69ZK0|ens)F1MGE1(Evidence code:IEA/Database source:UniProtKB:Q7Z6J6|ens), CXCL12 HYAL1 PPP3CA PREX1 FRMD5,BP,5,5 of 77,0.21,6.49,1,1
GO:0009165,nucleotide biosynthetic process,G3MY14(Evidence code:IEA/Database source:InterPro:IPR005946)A2VDS0(Evidence code:IEA/Database source:InterPro:IPR005946)F1MBV2(Evidence code:IEA/Database source:InterPro:IPR005946)Q08DW2(Evidence code:IEA/Database source:InterPro:IPR005946)Q2HJ58(Evidence code:IEA/Database source:InterPro:IPR005946), PRPS2 PRPSAP2 PRPS1L1 PRPSAP1 PRPS1,BP,5,5 of 73,0.21,6.85,1,1
GO:0031396,regulation of protein ubiquitination,Q58DD3(Evidence code:IEA/Database source:UniProtKB:P25686|ens)E1BP63(Evidence code:IEA/Database source:UniProtKB:Q8WU17|ens)Q95M59(Evidence code:IEA/Database source:UniProtKB:Q9UMX0|ens)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), DNAJB2 RNF139 UBQLN1 PINK1,BP,4,4 of 54,0.17,7.41,1,1
GO:0042277,peptide binding,E1BP91(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q24K02(Evidence code:IEA/Database source:UniProtKB:P14735|ens)G3X743(Evidence code:IBA/Database source:PANTHER:PTN000164249)Q3SZH7(Evidence code:IBA/Database source:PANTHER:PTN000164249), NPEPPS IDE RNPEP LTA4H,MF,4,4 of 56,0.17,7.14,1,1
GO:0070372,regulation of ERK1 and ERK2 cascade,E1B7I9(Evidence code:IEA/Database source:UniProtKB:Q8C180|ens)A5D980(Evidence code:IEA/Database source:UniProtKB:P29350|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens)E1BK86(Evidence code:IEA/Database source:UniProtKB:P08F94|ens), FRS2 PTPN6 RRAS PKHD1,BP,4,4 of 60,0.17,6.67,1,1
GO:0008202,steroid metabolic process,A6QM06(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753)Q0III2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753)P16386(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753)P50227(Evidence code:IEA/Database source:UniProtKB-KW:KW-0753), SCAP MBTPS2 LIPE SULT1A1,BP,4,4 of 59,0.17,6.78,1,1
GO:0008514,organic anion transmembrane transporter activity,Q1JQC7(Evidence code:IBA/Database source:PANTHER:PTN001936837)Q1LZD6(Evidence code:IEA/Database source:InterPro:IPR030238)F1N3Y6(Evidence code:IBA/Database source:PANTHER:PTN000658334), SLC22A23 ABCC5 ABCC3,MF,3,3 of 53,0.13,5.66,1,1
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens)P10279(Evidence code:IEA/Database source:UniProtKB:P04925|ens)E1BJY4(Evidence code:IEA/Database source:UniProtKB:Q8CI19|ens), ITGB2 PRNP PDGFC,BP,3,3 of 52,0.13,5.77,1,1
GO:0000982,"transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",E1BJP4(Evidence code:IEA/Database source:InterPro:IPR033897)A0JNC9(Evidence code:IEA/Database source:UniProtKB:P08047|ens)B0JYL6(Evidence code:ISS/Database source:UniProtKB:P42224), SRF SP1 STAT1,MF,3,3 of 50,0.13,6,1,1
GO:0071363,cellular response to growth factor stimulus,Q9TUM3(Evidence code:ISS/Database source:UniProtKB:P42232)Q17QE5(Evidence code:ISS/Database source:UniProtKB:Q9Z0F4)Q0IIE2(Evidence code:ISS/Database source:UniProtKB:P29353), STAT5B CIB1 SHC1,BP,3,3 of 44,0.13,6.82,1,1
GO:0017016,Ras GTPase binding,Q17QE5(Evidence code:IEA/Database source:UniProtKB:Q99828|ens)E1BB46(Evidence code:IEA/Database source:InterPro:IPR035455)E1BPX7(Evidence code:IEA/Database source:UniProtKB:Q9EQZ6|ens), CIB1 SH3BP4 RAPGEF4,MF,3,3 of 48,0.13,6.25,1,1
GO:0031267,small GTPase binding,G3MZE2(Evidence code:IEA/Database source:UniProtKB:Q13177|ens)E1BNT2(Evidence code:IEA/Database source:UniProtKB:P49815|ens)F1MG24(Evidence code:IEA/Database source:UniProtKB:O95477|ens), PAK2 TSC2 ABCA1,MF,3,3 of 50,0.13,6,1,1
GO:0050792,regulation of viral process,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens)Q3T0U5(Evidence code:IEA/Database source:UniProtKB:O43633|ens)Q08E32(Evidence code:IEA/Database source:UniProtKB:Q9H444|ens), VPS4B CHMP2A CHMP4B,BP,3,3 of 46,0.13,6.52,1,1
GO:0030111,regulation of Wnt signaling pathway,Q1RMH8(Evidence code:ISS/Database source:UniProtKB:O60493)E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens)G3X7P3(Evidence code:IEA/Database source:UniProtKB:O88566|ens), SNX3 LEF1 AXIN2,BP,3,3 of 47,0.13,6.38,1,1
GO:0009411,response to UV,A6QNS2(Evidence code:IEA/Database source:UniProtKB:O95155|ens)E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens)Q32LH8(Evidence code:IBA/Database source:PANTHER:PTN001020335), UBE4B CCAR2 RAD18,BP,3,3 of 42,0.13,7.14,1,1
GO:0000956,nuclear-transcribed mRNA catabolic process,E1BJ90(Evidence code:IEA/Database source:UniProtKB:Q14147|ens)Q3ZBK6(Evidence code:IEA/Database source:InterPro:IPR034101), DHX34 LSM4,BP,2,2 of 36,0.08,5.56,1,1
GO:0019838,growth factor binding,P20959(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340)F1N152(Evidence code:IEA/Database source:UniProtKB-KW:KW-0340), IGFBP3 HTRA1,MF,2,2 of 29,0.08,6.9,1,1
GO:0043484,regulation of RNA splicing,Q1RMR2(Evidence code:ISS/Database source:UniProtKB:P08621)F1MVN3(Evidence code:IEA/Database source:UniProtKB:Q6NXG1|ens), SNRNP70 ESRP1,BP,2,2 of 40,0.08,5,1,1
GO:1900182,positive regulation of protein localization to nucleus,P48734(Evidence code:IEA/Database source:UniProtKB:P06493|ens)E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens), CDK1 SRC,BP,2,2 of 30,0.08,6.67,1,1
GO:0007265,Ras protein signal transduction,F1MBI8(Evidence code:IEA/Database source:UniProtKB:F6SEU4|ens)Q3T0F9(Evidence code:IEA/Database source:InterPro:IPR030219), SYNGAP1 GRB2,BP,2,2 of 27,0.08,7.41,1,1
GO:0043021,ribonucleoprotein complex binding,E1BFK4(Evidence code:IEA/Database source:UniProtKB:Q86US8|ens)E1BCC3(Evidence code:IEA/Database source:UniProtKB:P97343|ens), SMG6 UHMK1,MF,2,2 of 31,0.08,6.45,1,1
GO:1901981,phosphatidylinositol phosphate binding,F1MME2(Evidence code:IEA/Database source:UniProtKB:Q8K382|ens)F1MD79(Evidence code:IEA/Database source:UniProtKB:Q9P2R3|ens), DENND1A ANKFY1,MF,2,2 of 29,0.08,6.9,1,1
GO:0004860,protein kinase inhibitor activity,G3MXX5(Evidence code:IBA/Database source:PANTHER:PTN000043893)Q0VCK2(Evidence code:IEA/Database source:UniProtKB-KW:KW-0649), RTN4R PKIB,MF,2,2 of 32,0.08,6.25,1,1
GO:2000377,regulation of reactive oxygen species metabolic process,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135)A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens), EIF6 PINK1,BP,2,2 of 36,0.08,5.56,1,1
GO:0030705,cytoskeleton-dependent intracellular transport,E1BBN7(Evidence code:IEA/Database source:UniProtKB:Q60575|ens)E1BGB0(Evidence code:IBA/Database source:PANTHER:PTN000648522), KIF1B KIF13B,BP,2,2 of 36,0.08,5.56,1,1
GO:0051099,positive regulation of binding,P60902(Evidence code:IEA/Database source:UniProtKB:P08207|ens)G3N053(Evidence code:IEA/Database source:UniProtKB:P70696|ens), S100A10 HIST1H2BA,BP,2,2 of 40,0.08,5,1,1
GO:0070382,exocytic vesicle,E1BBK9(Evidence code:IBA/Database source:PANTHER:PTN000797746)A6QP06(Evidence code:IBA/Database source:PANTHER:PTN000797746), SYTL1 SYTL2,CC,2,2 of 34,0.08,5.88,1,1
GO:0016209,antioxidant activity,Q58CY6(Evidence code:IBA/Database source:PANTHER:PTN002008122)P00432(Evidence code:IEA/Database source:UniProtKB:P04040|ens), FAM213B CAT,MF,2,2 of 37,0.08,5.41,1,1
GO:0042113,B cell activation,F1MBS7(Evidence code:IEA/Database source:UniProtKB:Q2TBA3|ens)P05126(Evidence code:ISS/Database source:UniProtKB:P68404), MALT1 PRKCB,BP,2,2 of 39,0.08,5.13,1,1
GO:0043009,chordate embryonic development,Q864U1(Evidence code:IBA/Database source:PANTHER:PTN000349142)E1B8X8(Evidence code:IEA/Database source:UniProtKB:P97929|ens), BRCA1 BRCA2,BP,2,2 of 37,0.08,5.41,1,1
GO:0001894,tissue homeostasis,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens)P02459(Evidence code:IEA/Database source:UniProtKB:P28481|ens), WWTR1 COL2A1,BP,2,2 of 27,0.08,7.41,1,1
GO:0016627,"oxidoreductase activity, acting on the CH-CH group of donors",Q28007(Evidence code:IEA/Database source:InterPro:IPR005720)P48818(Evidence code:IEA/Database source:InterPro:IPR006091|I), DPYD ACADVL,MF,2,2 of 29,0.08,6.9,1,1
GO:0045333,cellular respiration,Q3SZK4(Evidence code:ISS/Database source:UniProtKB:Q14CZ7)P23709(Evidence code:IBA/Database source:PANTHER:PTN000094347), TBRG4 NDUFS3,BP,2,2 of 27,0.08,7.41,1,1
GO:0010466,negative regulation of peptidase activity,P98167(Evidence code:IEA/Database source:GO:0030414)P20811(Evidence code:IEA/Database source:UniProtKB-KW:KW-0646), SSPO CAST,BP,2,2 of 32,0.08,6.25,1,1
GO:0001047,core promoter binding,E1BDX4(Evidence code:IEA/Database source:UniProtKB:Q13105|ens)G3MZY8(Evidence code:IEA/Database source:UniProtKB:P08775|ens), ZBTB17 POLR2A,MF,2,2 of 33,0.08,6.06,1,1
GO:0051896,regulation of protein kinase B signaling,F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens)Q2TBH2(Evidence code:IEA/Database source:UniProtKB:P10301|ens), RICTOR RRAS,BP,2,2 of 32,0.08,6.25,1,1
GO:0006936,muscle contraction,E1BDQ4(Evidence code:IEA/Database source:UniProtKB:E9PZQ0|ens)A0JNJ5(Evidence code:IEA/Database source:UniProtKB:P05976|ens), RYR1 MYL1,BP,2,2 of 39,0.08,5.13,1,1
GO:0033135,regulation of peptidyl-serine phosphorylation,E1BLT3(Evidence code:IEA/Database source:UniProtKB:E9PX29|ens)F1MHN4(Evidence code:IEA/Database source:UniProtKB:Q6QI06|ens), SPTBN4 RICTOR,BP,2,2 of 41,0.08,4.88,1,1
GO:0072655,establishment of protein localization to mitochondrion,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens)E1BME6(Evidence code:IEA/Database source:UniProtKB:P52789|ens), PINK1 HK2,BP,2,2 of 28,0.08,7.14,1,1
GO:0019210,kinase inhibitor activity,P02638(Evidence code:NAS/Database source:)F1MDE1(Evidence code:IEA/Database source:UniProtKB:O75581|ens), S100B LRP6,MF,2,2 of 34,0.08,5.88,1,1
GO:0008016,regulation of heart contraction,Q9TTA4(Evidence code:ISS/Database source:UniProtKB:O55017)P02639(Evidence code:IEA/Database source:InterPro:IPR028486), CACNA1B S100A1,BP,2,2 of 41,0.08,4.88,1,1
GO:0060090,molecular adaptor activity,Q1LZ81(Evidence code:IEA/Database source:UniProtKB:O75340|ens)A5D7S6(Evidence code:IEA/Database source:UniProtKB:Q9UBV8|ens), PDCD6 PEF1,MF,2,2 of 27,0.08,7.41,1,1
GO:0007606,sensory perception of chemical stimulus,P04896(Evidence code:IBA/Database source:PANTHER:PTN000026754),GNAS,BP,1,1 of 14,0.04,7.14,1,1
GO:0000015,phosphopyruvate hydratase complex,F6RG16(Evidence code:IEA/Database source:InterPro:IPR000941),ENO4,CC,1,1 of 13,0.04,7.69,1,1
GO:0042308,negative regulation of protein import into nucleus,E1BAI0(Evidence code:IEA/Database source:UniProtKB:Q9ULC3|ens),RAB23,BP,1,1 of 19,0.04,5.26,1,1
GO:0006661,phosphatidylinositol biosynthetic process,P20456(Evidence code:IEA/Database source:UniProtKB:P29218|ens),IMPA1,BP,1,1 of 13,0.04,7.69,1,1
GO:0048660,regulation of smooth muscle cell proliferation,E1BLB6(Evidence code:IEA/Database source:UniProtKB:P78527|ens),PRKDC,BP,1,1 of 22,0.04,4.55,1,1
GO:0044306,neuron projection terminus,E1BMN9(Evidence code:IEA/Database source:UniProtKB:O88737|ens),BSN,CC,1,1 of 13,0.04,7.69,1,1
GO:0006754,ATP biosynthetic process,P05630(Evidence code:IEA/Database source:UniProtKB-KW:KW-0066),ATP5D,BP,1,1 of 25,0.04,4,1,1
GO:0005184,neuropeptide hormone activity,Q95MI6(Evidence code:IBA/Database source:PANTHER:PTN000385798),CRH,MF,1,1 of 23,0.04,4.35,1,1
GO:1903725,regulation of phospholipid metabolic process,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 15,0.04,6.67,1,1
GO:0002443,leukocyte mediated immunity,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 18,0.04,5.56,1,1
GO:0042692,muscle cell differentiation,F1N1C5(Evidence code:IEA/Database source:UniProtKB:P62932|ens),FBXO40,BP,1,1 of 14,0.04,7.14,1,1
GO:0048771,tissue remodeling,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 19,0.04,5.26,1,1
GO:0009060,aerobic respiration,P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,BP,1,1 of 17,0.04,5.88,1,1
GO:2000117,negative regulation of cysteine-type endopeptidase activity,P37359(Evidence code:ISS/Database source:UniProtKB:P25713),MT3,BP,1,1 of 26,0.04,3.85,1,1
GO:1903214,regulation of protein targeting to mitochondrion,A5PJP5(Evidence code:IEA/Database source:UniProtKB:Q9BXM7|ens),PINK1,BP,1,1 of 20,0.04,5,1,1
GO:0060395,SMAD protein signal transduction,E1BJI4(Evidence code:IEA/Database source:UniProtKB:Q6GQW0|ens),BTBD11,BP,1,1 of 20,0.04,5,1,1
GO:0090280,positive regulation of calcium ion import,F1MMF3(Evidence code:IEA/Database source:UniProtKB:A7L9Z8|ens),ATP2C2,BP,1,1 of 15,0.04,6.67,1,1
GO:0005753,mitochondrial proton-transporting ATP synthase complex,P05630(Evidence code:IEA/Database source:UniProtKB:P30049|ens),ATP5D,CC,1,1 of 20,0.04,5,1,1
GO:0022843,voltage-gated cation channel activity,E1BM97(Evidence code:IEA/Database source:UniProtKB:O60741|ens),HCN1,MF,1,1 of 26,0.04,3.85,1,1
GO:0010001,glial cell differentiation,F1N5P0(Evidence code:IEA/Database source:UniProtKB:Q8JZM4|ens),DNER,BP,1,1 of 14,0.04,7.14,1,1
GO:0046902,regulation of mitochondrial membrane permeability,P02722(Evidence code:IBA/Database source:PANTHER:PTN000640049),SLC25A4,BP,1,1 of 16,0.04,6.25,1,1
GO:0008154,actin polymerization or depolymerization,Q0VCW2(Evidence code:IEA/Database source:InterPro:IPR028456),ABI1,BP,1,1 of 17,0.04,5.88,1,1
GO:0021782,glial cell development,Q0VCF8(Evidence code:ISS/Database source:UniProtKB:Q06831),SOX4,BP,1,1 of 13,0.04,7.69,1,1
GO:0015696,ammonium transport,F1MS08(Evidence code:IEA/Database source:UniProtKB:P55011|ens),SLC12A2,BP,1,1 of 13,0.04,7.69,1,1
GO:1901888,regulation of cell junction assembly,F1MSG6(Evidence code:ISS/Database source:UniProtKB:Q9Y4G8),RAPGEF2,BP,1,1 of 22,0.04,4.55,1,1
GO:0006940,regulation of smooth muscle contraction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 17,0.04,5.88,1,1
GO:0045682,regulation of epidermis development,Q1RMU0(Evidence code:IEA/Database source:UniProtKB:Q61127|ens),NAB2,BP,1,1 of 15,0.04,6.67,1,1
GO:0019730,antimicrobial humoral response,E1BCE6(Evidence code:IEA/Database source:UniProtKB:Q9Z2F6|ens),BCL3,BP,1,1 of 13,0.04,7.69,1,1
GO:0090288,negative regulation of cellular response to growth factor stimulus,F1MLJ7(Evidence code:IEA/Database source:UniProtKB:O94813|ens),SLIT2,BP,1,1 of 19,0.04,5.26,1,1
GO:0035295,tube development,F1MCY1(Evidence code:IEA/Database source:UniProtKB:Q0VGT2|ens),GLI2,BP,1,1 of 25,0.04,4,1,1
GO:0017004,cytochrome complex assembly,P63026(Evidence code:IMP/Database source:),VAMP2,BP,1,1 of 20,0.04,5,1,1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,Q3T0N1(Evidence code:IEA/Database source:UniProtKB:Q96EY5|ens),MVB12A,BP,1,1 of 14,0.04,7.14,1,1
GO:0006636,unsaturated fatty acid biosynthetic process,Q3ZBW6(Evidence code:IEA/Database source:UniProtKB:Q9NUI1|ens),DECR2,BP,1,1 of 18,0.04,5.56,1,1
GO:0006304,DNA modification,P06526(Evidence code:IEA/Database source:UniProtKB-KW:KW-0780),DNTT,BP,1,1 of 19,0.04,5.26,1,1
GO:0006986,response to unfolded protein,E1BPS0(Evidence code:IEA/Database source:InterPro:IPR039165),CREBRF,BP,1,1 of 17,0.04,5.88,1,1
GO:0016592,mediator complex,F1MPU1(Evidence code:IEA/Database source:InterPro:IPR019035|I),MED12L,CC,1,1 of 18,0.04,5.56,1,1
GO:0045277,respiratory chain complex IV,P00423(Evidence code:IDA/Database source:),COX4I1,CC,1,1 of 17,0.04,5.88,1,1
GO:0045582,positive regulation of T cell differentiation,E1BMP9(Evidence code:IEA/Database source:UniProtKB:P43403|ens),ZAP70,BP,1,1 of 18,0.04,5.56,1,1
GO:0072384,organelle transport along microtubule,F1MHG5(Evidence code:IEA/Database source:UniProtKB:Q5T5U3|ens),ARHGAP21,BP,1,1 of 21,0.04,4.76,1,1
GO:0007062,sister chromatid cohesion,E1B9J3(Evidence code:IBA/Database source:PANTHER:PTN000286904),RAD21L1,BP,1,1 of 14,0.04,7.14,1,1
GO:0005504,fatty acid binding,Q3ZC42(Evidence code:IEA/Database source:UniProtKB:P11766|ens),ADH5,MF,1,1 of 16,0.04,6.25,1,1
GO:0045259,proton-transporting ATP synthase complex,P05630(Evidence code:IDA/Database source:),ATP5D,CC,1,1 of 20,0.04,5,1,1
GO:0048029,monosaccharide binding,Q0P563(Evidence code:IEA/Database source:InterPro:IPR007721|I),FUOM,MF,1,1 of 24,0.04,4.17,1,1
GO:0038024,cargo receptor activity,Q3ZC13(Evidence code:IEA/Database source:UniProtKB:P84091|ens),AP2M1,MF,1,1 of 17,0.04,5.88,1,1
GO:0001191,"transcriptional repressor activity, RNA polymerase II transcription factor binding",F1MRK2(Evidence code:IEA/Database source:UniProtKB:Q96T58|ens),SPEN,MF,1,1 of 22,0.04,4.55,1,1
GO:0033178,"proton-transporting two-sector ATPase complex, catalytic domain",P11019(Evidence code:IEA/Database source:InterPro:IPR002842),ATP6V1E1,CC,1,1 of 14,0.04,7.14,1,1
GO:0060562,epithelial tube morphogenesis,E1BHK3(Evidence code:IEA/Database source:UniProtKB:B9EJV3|ens),GREB1L,BP,1,1 of 15,0.04,6.67,1,1
GO:0005496,steroid binding,E1BC39(Evidence code:IEA/Database source:InterPro:IPR024178|I),ESRRG,MF,1,1 of 27,0.04,3.7,1,1
GO:0016998,cell wall macromolecule catabolic process,Q06285(Evidence code:IBA/Database source:PANTHER:PTN001685978),LYZ1,BP,1,1 of 16,0.04,6.25,1,1
GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",P00432(Evidence code:IEA/Database source:UniProtKB:P24270|ens),CAT,MF,1,1 of 21,0.04,4.76,1,1
GO:0072341,modified amino acid binding,F1ML89(Evidence code:IEA/Database source:UniProtKB:P31327|ens),CPS1,MF,1,1 of 16,0.04,6.25,1,1
GO:0051084,de novo posttranslational protein folding,F1MSL9(Evidence code:IBA/Database source:PANTHER:PTN000132051),UGGT2,BP,1,1 of 17,0.04,5.88,1,1
GO:0001837,epithelial to mesenchymal transition,E1BJ93(Evidence code:IEA/Database source:UniProtKB:P27782|ens),LEF1,BP,1,1 of 16,0.04,6.25,1,1
GO:0061097,regulation of protein tyrosine kinase activity,Q08DI5(Evidence code:ISS/Database source:UniProtKB:Q8BU31),RAP2C,BP,1,1 of 14,0.04,7.14,1,1
GO:0045921,positive regulation of exocytosis,Q08DW1(Evidence code:IEA/Database source:UniProtKB:P51151|ens),RAB9A,BP,1,1 of 21,0.04,4.76,1,1
GO:0048534,hematopoietic or lymphoid organ development,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 26,0.04,3.85,1,1
GO:0050709,negative regulation of protein secretion,A5D7F2(Evidence code:IEA/Database source:UniProtKB:P40749|ens),SYT4,BP,1,1 of 26,0.04,3.85,1,1
GO:0005684,U2-type spliceosomal complex,A2VDN6(Evidence code:ISS/Database source:UniProtKB:Q15459),SF3A1,CC,1,1 of 15,0.04,6.67,1,1
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,Q5E9F8(Evidence code:IEA/Database source:UniProtKB:P84243|ens),H3F3B,MF,1,1 of 13,0.04,7.69,1,1
GO:0032432,actin filament bundle,F6REL8(Evidence code:IEA/Database source:UniProtKB:Q3TN34|ens),MICALL2,CC,1,1 of 17,0.04,5.88,1,1
GO:0051261,protein depolymerization,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 16,0.04,6.25,1,1
GO:0050796,regulation of insulin secretion,A6QR34(Evidence code:IEA/Database source:UniProtKB:P35557|ens),GCK,BP,1,1 of 26,0.04,3.85,1,1
GO:0048260,positive regulation of receptor-mediated endocytosis,G3N131(Evidence code:IEA/Database source:UniProtKB:P43275|ens),HIST1H1A,BP,1,1 of 13,0.04,7.69,1,1
GO:0016706,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors",A7MBA0(Evidence code:IEA/Database source:UniProtKB:Q9H6Z9|ens),EGLN3,MF,1,1 of 17,0.04,5.88,1,1
GO:0019395,fatty acid oxidation,Q3ZBW2(Evidence code:IEA/Database source:UniProtKB:Q9NYQ3|ens),HAO2,BP,1,1 of 21,0.04,4.76,1,1
GO:0019208,phosphatase regulator activity,G5E5Q8(Evidence code:IEA/Database source:InterPro:IPR030574),SBF1,MF,1,1 of 24,0.04,4.17,1,1
GO:0035257,nuclear hormone receptor binding,F1MVD0(Evidence code:IEA/Database source:InterPro:IPR014920|I),NCOA3,MF,1,1 of 21,0.04,4.76,1,1
GO:0050868,negative regulation of T cell activation,Q2T9T7(Evidence code:IEA/Database source:UniProtKB:P51452|ens),DUSP3,BP,1,1 of 13,0.04,7.69,1,1
GO:0045600,positive regulation of fat cell differentiation,A0JN96(Evidence code:IEA/Database source:UniProtKB:Q9JI10|ens),STK3,BP,1,1 of 17,0.04,5.88,1,1
GO:0016891,"endoribonuclease activity, producing 5-phosphomonoesters",Q6TUI4(Evidence code:IEA/Database source:InterPro:IPR005034),DICER1,MF,1,1 of 13,0.04,7.69,1,1
GO:0051650,establishment of vesicle localization,Q95KU9(Evidence code:IEA/Database source:UniProtKB:Q9Y6K9|ens),IKBKG,BP,1,1 of 27,0.04,3.7,1,1
GO:0019229,regulation of vasoconstriction,A2VDL6(Evidence code:IEA/Database source:UniProtKB:Q6PIE5|ens),ATP1A2,BP,1,1 of 17,0.04,5.88,1,1
GO:0060429,epithelium development,E1BPM4(Evidence code:IEA/Database source:UniProtKB:A2AJK6|ens),CHD7,BP,1,1 of 18,0.04,5.56,1,1
GO:0001667,ameboidal-type cell migration,A2VDK6(Evidence code:IEA/Database source:UniProtKB:Q8BH43|ens),WASF2,BP,1,1 of 23,0.04,4.35,1,1
GO:0043487,regulation of RNA stability,E1BFK4(Evidence code:IBA/Database source:PANTHER:PTN000403280),SMG6,BP,1,1 of 14,0.04,7.14,1,1
GO:0048762,mesenchymal cell differentiation,E1BPN1(Evidence code:IEA/Database source:UniProtKB:Q9EPK5|ens),WWTR1,BP,1,1 of 21,0.04,4.76,1,1
GO:0046579,positive regulation of Ras protein signal transduction,Q5E9S7(Evidence code:IEA/Database source:UniProtKB:Q8N9B8|ens),RASGEF1A,BP,1,1 of 14,0.04,7.14,1,1
GO:0009069,serine family amino acid metabolic process,A4FUD0(Evidence code:IEA/Database source:UniProtKB:Q922D8|ens),MTHFD1,BP,1,1 of 16,0.04,6.25,1,1
GO:0032526,response to retinoic acid,F1N4U8(Evidence code:IEA/Database source:UniProtKB:P59598|ens),ASXL1,BP,1,1 of 14,0.04,7.14,1,1
GO:0005666,RNA polymerase III complex,Q32PE0(Evidence code:IBA/Database source:PANTHER:PTN000080812),POLR2F,CC,1,1 of 14,0.04,7.14,1,1
GO:0031279,regulation of cyclase activity,E1BLE8(Evidence code:IEA/Database source:GO:0010855),GRM7,BP,1,1 of 17,0.04,5.88,1,1
GO:0065002,intracellular protein transmembrane transport,F1MBT5(Evidence code:IEA/Database source:UniProtKB:Q6PAJ1|ens),BCR,BP,1,1 of 23,0.04,4.35,1,1
GO:0051646,mitochondrion localization,E1BPU0(Evidence code:IEA/Database source:UniProtKB:Q5S007|ens),LRRK2,BP,1,1 of 14,0.04,7.14,1,1
GO:1903307,positive regulation of regulated secretory pathway,P11023(Evidence code:IEA/Database source:UniProtKB:P20336|ens),RAB3A,BP,1,1 of 14,0.04,7.14,1,1
GO:0033108,mitochondrial respiratory chain complex assembly,F1MKA6(Evidence code:IEA/Database source:UniProtKB:Q5JTZ9|ens),AARS2,BP,1,1 of 27,0.04,3.7,1,1
GO:0043271,negative regulation of ion transport,E1BF90(Evidence code:IEA/Database source:UniProtKB:Q6H1V1|ens),BEST3,BP,1,1 of 20,0.04,5,1,1
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,Q5BIN5(Evidence code:IEA/Database source:UniProtKB:Q13526|ens),PIN1,BP,1,1 of 18,0.04,5.56,1,1
GO:0055117,regulation of cardiac muscle contraction,G3MYM1(Evidence code:IEA/Database source:UniProtKB:Q9Y5Y9|ens),SCN10A,BP,1,1 of 13,0.04,7.69,1,1
GO:0051492,regulation of stress fiber assembly,E1B958(Evidence code:IEA/Database source:InterPro:IPR028781),ALMS1,BP,1,1 of 19,0.04,5.26,1,1
GO:0008593,regulation of Notch signaling pathway,Q2KJ92(Evidence code:ISS/Database source:UniProtKB:O09010),LFNG,BP,1,1 of 15,0.04,6.67,1,1
GO:0030551,cyclic nucleotide binding,P68107(Evidence code:ISA/Database source:UniProtKB:P97534),FKBP1B,MF,1,1 of 16,0.04,6.25,1,1
GO:0048469,cell maturation,Q28204(Evidence code:ISA/Database source:UniProtKB:Q08460),KCNMA1,BP,1,1 of 24,0.04,4.17,1,1
GO:0061045,negative regulation of wound healing,E1BQ32(Evidence code:IEA/Database source:UniProtKB:P46108|ens),CRK,BP,1,1 of 20,0.04,5,1,1
GO:0043620,regulation of DNA-templated transcription in response to stress,E1BIV2(Evidence code:IEA/Database source:UniProtKB:P97492|ens),RGS14,BP,1,1 of 16,0.04,6.25,1,1
GO:0061061,muscle structure development,F1MJP2(Evidence code:IEA/Database source:UniProtKB:E9QAU8|ens),RNF165,BP,1,1 of 19,0.04,5.26,1,1
GO:0055001,muscle cell development,E1B714(Evidence code:IBA/Database source:PANTHER:PTN000090599),AXIN1,BP,1,1 of 24,0.04,4.17,1,1
GO:0051983,regulation of chromosome segregation,E1BE82(Evidence code:IEA/Database source:UniProtKB:Q14671|ens),PUM1,BP,1,1 of 27,0.04,3.7,1,1
GO:0010965,regulation of mitotic sister chromatid separation,E1BF47(Evidence code:IEA/Database source:UniProtKB:P12270|ens),TPR,BP,1,1 of 19,0.04,5.26,1,1
GO:0032355,response to estradiol,P02668(Evidence code:IDA/Database source:),CSN3,BP,1,1 of 13,0.04,7.69,1,1
GO:0090207,regulation of triglyceride metabolic process,E1BB14(Evidence code:IEA/Database source:UniProtKB:P16520|ens),GNB3,BP,1,1 of 16,0.04,6.25,1,1
GO:0006081,cellular aldehyde metabolic process,Q2KJH9(Evidence code:ISS/Database source:UniProtKB:P49189),ALDH9A1,BP,1,1 of 21,0.04,4.76,1,1
GO:0019955,cytokine binding,P43481(Evidence code:IEA/Database source:InterPro:IPR027263),KIT,MF,1,1 of 23,0.04,4.35,1,1
GO:0001816,cytokine production,P15101(Evidence code:IEA/Database source:UniProtKB:Q64237|ens),DBH,BP,1,1 of 21,0.04,4.76,1,1
GO:0031123,RNA 3-end processing,E1BAR2(Evidence code:IEA/Database source:UniProtKB:Q5VYS8|ens),ZCCHC6,BP,1,1 of 22,0.04,4.55,1,1
GO:0034061,DNA polymerase activity,P06526(Evidence code:IEA/Database source:InterPro:IPR001726|I),DNTT,MF,1,1 of 13,0.04,7.69,1,1
GO:0050773,regulation of dendrite development,F1N7V2(Evidence code:IEA/Database source:UniProtKB:P35292|ens),RAB17,BP,1,1 of 15,0.04,6.67,1,1
GO:0050807,regulation of synapse organization,F2Z4C1(Evidence code:IEA/Database source:UniProtKB:P68369|ens),TUBA1A,BP,1,1 of 13,0.04,7.69,1,1
GO:0010827,regulation of glucose transmembrane transport,A7MB57(Evidence code:IEA/Database source:UniProtKB:Q04736|ens),YES1,BP,1,1 of 14,0.04,7.14,1,1
GO:0019205,nucleobase-containing compound kinase activity,F1MUF5(Evidence code:IEA/Database source:InterPro:IPR000850),AK9,MF,1,1 of 18,0.04,5.56,1,1
GO:0043266,regulation of potassium ion transport,A6QR34(Evidence code:IEA/Database source:UniProtKB:P52792|ens),GCK,BP,1,1 of 16,0.04,6.25,1,1
GO:0007043,cell-cell junction assembly,F1MJ11(Evidence code:ISS/Database source:UniProtKB:Q68FH0),PKP4,BP,1,1 of 15,0.04,6.67,1,1
GO:0042304,regulation of fatty acid biosynthetic process,Q9TU47(Evidence code:ISS/Database source:UniProtKB:O55135),EIF6,BP,1,1 of 14,0.04,7.14,1,1
GO:0071375,cellular response to peptide hormone stimulus,E1BIM8(Evidence code:IEA/Database source:UniProtKB:P05480|ens),SRC,BP,1,1 of 22,0.04,4.55,1,1
GO:0015297,antiporter activity,Q0VCA3(Evidence code:IEA/Database source:UniProtKB-KW:KW-0050),LETM1,MF,1,1 of 14,0.04,7.14,1,1
GO:0051453,regulation of intracellular pH,F1N4L1(Evidence code:IBA/Database source:PANTHER:PTN000894242),SLC4A2,BP,1,1 of 26,0.04,3.85,1,1
GO:0099003,vesicle-mediated transport in synapse,Q2HJG5(Evidence code:IEA/Database source:UniProtKB:Q9EQH3|ens),VPS35,BP,1,1 of 21,0.04,4.76,1,1
GO:0000271,polysaccharide biosynthetic process,Q5E9E7(Evidence code:IBA/Database source:PANTHER:PTN000349745),GLT8D1,BP,1,1 of 13,0.04,7.69,1,1
GO:0045778,positive regulation of ossification,E1BKC4(Evidence code:IEA/Database source:UniProtKB:Q6KCD5|ens),NIPBL,BP,1,1 of 17,0.04,5.88,1,1
GO:0044309,neuron spine,F1N3Q4(Evidence code:IEA/Database source:UniProtKB:Q9Z0P4|ens),PALM,CC,1,1 of 14,0.04,7.14,1,1
GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",P48034(Evidence code:IBA/Database source:PANTHER:PTN000225632),AOX1,MF,1,1 of 23,0.04,4.35,1,1
GO:0097526,spliceosomal tri-snRNP complex,Q3ZBK6(Evidence code:IBA/Database source:PANTHER:PTN000596817),LSM4,CC,1,1 of 16,0.04,6.25,1,1
GO:0008137,NADH dehydrogenase (ubiquinone) activity,P23709(Evidence code:IEA/Database source:InterPro:IPR001268),NDUFS3,MF,1,1 of 26,0.04,3.85,1,1
GO:0006695,cholesterol biosynthetic process,F1MMK2(Evidence code:IEA/Database source:UniProtKB:P11413|ens),G6PD,BP,1,1 of 17,0.04,5.88,1,1
GO:0050866,negative regulation of cell activation,E1BLS8(Evidence code:IEA/Database source:UniProtKB:Q99K41|ens),EMILIN1,BP,1,1 of 21,0.04,4.76,1,1
GO:0046824,positive regulation of nucleocytoplasmic transport,F1MJ10(Evidence code:IEA/Database source:UniProtKB:P46934|ens),NEDD4,BP,1,1 of 26,0.04,3.85,1,1
GO:0005518,collagen binding,Q08E52(Evidence code:ISS/Database source:UniProtKB:Q13153),PAK1,MF,1,1 of 15,0.04,6.67,1,1
GO:0051445,regulation of meiotic cell cycle,P48734(Evidence code:IBA/Database source:PANTHER:PTN000756019),CDK1,BP,1,1 of 13,0.04,7.69,1,1
GO:0035308,negative regulation of protein dephosphorylation,Q2KJ44(Evidence code:IEA/Database source:UniProtKB:Q15257|ens),PTPA,BP,1,1 of 13,0.04,7.69,1,1
GO:0090303,positive regulation of wound healing,O46382(Evidence code:ISS/Database source:UniProtKB:Q9Y6D6),ARFGEF1,BP,1,1 of 15,0.04,6.67,1,1
GO:0009247,glycolipid biosynthetic process,F1MX20(Evidence code:IEA/Database source:InterPro:IPR009729),GAL3ST2,BP,1,1 of 19,0.04,5.26,1,1
GO:0015085,calcium ion transmembrane transporter activity,F1MS16(Evidence code:IEA/Database source:UniProtKB:Q16720|ens),ATP2B3,MF,1,1 of 26,0.04,3.85,1,1
GO:0008374,O-acyltransferase activity,F1MLW9(Evidence code:IEA/Database source:InterPro:IPR022284),GPAT2,MF,1,1 of 14,0.04,7.14,1,1
GO:0046031,ADP metabolic process,E1BA23(Evidence code:IEA/Database source:UniProtKB:O08739|ens),AMPD3,BP,1,1 of 18,0.04,5.56,1,1
GO:1990266,neutrophil migration,P32592(Evidence code:IEA/Database source:UniProtKB:P05107|ens),ITGB2,BP,1,1 of 19,0.04,5.26,1,1
GO:0097722,sperm motility,E1BGA4(Evidence code:IEA/Database source:UniProtKB:Q99MY8|ens),ASH1L,BP,1,1 of 18,0.04,5.56,1,1
GO:0005637,nuclear inner membrane,E1BIJ4(Evidence code:IEA/Database source:InterPro:IPR034997),LEMD3,CC,1,1 of 17,0.04,5.88,1,1
GO:0097485,neuron projection guidance,E1B801(Evidence code:IEA/Database source:UniProtKB:Q91YM2|ens),ARHGAP35,BP,1,1 of 24,0.04,4.17,1,1
GO:0032675,regulation of interleukin-6 production,Q17R10(Evidence code:IEA/Database source:UniProtKB:Q8N4X5|ens),AFAP1L2,BP,1,1 of 25,0.04,4,1,1
GO:0015918,sterol transport,E1BPW1(Evidence code:IEA/Database source:UniProtKB:P22059|ens),OSBP,BP,1,1 of 15,0.04,6.67,1,1
GO:2000379,positive regulation of reactive oxygen species metabolic process,Q3T0F9(Evidence code:IEA/Database source:UniProtKB:P62993|ens),GRB2,BP,1,1 of 20,0.04,5,1,1
GO:0000470,maturation of LSU-rRNA,Q9TU47(Evidence code:IBA/Database source:PANTHER:PTN000082061),EIF6,BP,1,1 of 14,0.04,7.14,1,1
GO:0034612,response to tumor necrosis factor,E1BCP6(Evidence code:IEA/Database source:UniProtKB:O60674|ens),JAK2,BP,1,1 of 26,0.04,3.85,1,1
GO:0033177,"proton-transporting two-sector ATPase complex, proton-transporting domain",P23956(Evidence code:IEA/Database source:InterPro:IPR002379),ATP6V0C,CC,1,1 of 19,0.04,5.26,1,1
GO:0045851,pH reduction,P31407(Evidence code:ISS/Database source:UniProtKB:P15313),ATP6V1B1,BP,1,1 of 16,0.04,6.25,1,1
GO:0016202,regulation of striated muscle tissue development,E1BJ93(Evidence code:IBA/Database source:PANTHER:PTN000042971),LEF1,BP,1,1 of 22,0.04,4.55,1,1
GO:0031589,cell-substrate adhesion,F1MPF3(Evidence code:IEA/Database source:UniProtKB:Q9NYQ8|ens),FAT2,BP,1,1 of 21,0.04,4.76,1,1
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,P43481(Evidence code:IEA/Database source:UniProtKB:P10721|ens),KIT,BP,1,1 of 15,0.04,6.67,1,1
GO:1903902,positive regulation of viral life cycle,Q0VD48(Evidence code:IEA/Database source:UniProtKB:O75351|ens),VPS4B,BP,1,1 of 22,0.04,4.55,1,1
GO:0000421,autophagosome membrane,Q32LM0(Evidence code:IEA/Database source:UniProtKB-SubCell:SL),SH3GLB1,CC,1,1 of 13,0.04,7.69,1,1
GO:0015986,ATP synthesis coupled proton transport,P05630(Evidence code:IEA/Database source:InterPro:IPR001469|I),ATP5D,BP,1,1 of 21,0.04,4.76,1,1
GO:0007586,digestion,Q06285(Evidence code:IEA/Database source:UniProtKB-KW:KW-0222),LYZ1,BP,1,1 of 19,0.04,5.26,1,1
GO:0032784,"regulation of DNA-templated transcription, elongation",E1B9H3(Evidence code:IEA/Database source:UniProtKB:Q8N163|ens),CCAR2,BP,1,1 of 13,0.04,7.69,1,1
GO:0034767,positive regulation of ion transmembrane transport,F1MFY7(Evidence code:IEA/Database source:InterPro:IPR031295),ANO6,BP,1,1 of 23,0.04,4.35,1,1
GO:0006101,citrate metabolic process,Q32PF2(Evidence code:IEA/Database source:InterPro:IPR014608),ACLY,BP,1,1 of 25,0.04,4,1,1
GO:0048017,inositol lipid-mediated signaling,F1N6N6(Evidence code:IEA/Database source:UniProtKB:Q3TBL6|ens),TNFAIP8L3,BP,1,1 of 14,0.04,7.14,1,1
GO:0045667,regulation of osteoblast differentiation,A6H727(Evidence code:IEA/Database source:UniProtKB:P47806|ens),GLI1,BP,1,1 of 21,0.04,4.76,1,1
GO:1903038,negative regulation of leukocyte cell-cell adhesion,E1BN63(Evidence code:IEA/Database source:UniProtKB:Q9H4A3|ens),WNK1,BP,1,1 of 15,0.04,6.67,1,1
GO:0051279,regulation of release of sequestered calcium ion into cytosol,A5D980(Evidence code:IEA/Database source:UniProtKB:P29351|ens),PTPN6,BP,1,1 of 18,0.04,5.56,1,1
GO:0050851,antigen receptor-mediated signaling pathway,F1MRH8(Evidence code:IEA/Database source:UniProtKB:Q9JID9|ens),SH2B2,BP,1,1 of 16,0.04,6.25,1,1
